1	Generation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CD1+RelB+	_	JJ	JJ	_	5	amod	_	_
4	dendritic	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	tartrate-resistant	_	JJ	JJ	_	9	amod	_	_
8	acid	_	NN	NN	_	9	npadvmod	_	_
9	phosphatase-positive	_	JJ	JJ	_	13	amod	_	_
10	osteoclast-like	_	JJ	JJ	_	13	amod	_	_
11	multinucleated	_	JJ	JJ	_	13	amod	_	_
12	giant	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	5	conj	_	_
14	from	_	IN	IN	_	1	prep	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	monocytes	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	granulocyte-macrophage	_	JJ	JJ	_	7	amod	_	_
6	colony-stimulating	_	JJ	JJ	_	7	amod	_	_
7	factor	_	NN	NN	_	18	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	GM-CSF	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	macrophage	_	NN	NN	_	14	nn	_	_
13	colony-stimulating	_	JJ	JJ	_	14	amod	_	_
14	factor	_	NN	NN	_	7	conj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	M-CSF	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	stimulate	_	VBP	VBP	_	3	ccomp	_	_
19	the	_	DT	DT	_	20	det	_	_
20	differentiation	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	human	_	JJ	JJ	_	23	amod	_	_
23	monocytes	_	NNS	NNS	_	21	pobj	_	_
24	into	_	IN	IN	_	20	prep	_	_
25	two	_	CD	CD	_	28	num	_	_
26	phenotypically	_	RB	RB	_	27	advmod	_	_
27	distinct	_	JJ	JJ	_	28	amod	_	_
28	types	_	NNS	NNS	_	24	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	macrophages	_	NNS	NNS	_	29	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	in	_	FW	FW	_	4	nn	_	_
4	vivo	_	FW	FW	_	15	advmod	_	_
5	,	_	,	,	_	15	punct	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	only	_	RB	RB	_	8	preconj	_	_
8	CSF	_	NN	NN	_	15	nsubjpass	_	_
9	but	_	CC	CC	_	10	cc	_	_
10	also	_	RB	RB	_	8	cc	_	_
11	many	_	JJ	JJ	_	13	amod	_	_
12	other	_	JJ	JJ	_	13	amod	_	_
13	cytokines	_	NNS	NNS	_	8	conj	_	_
14	are	_	VBP	VBP	_	15	auxpass	_	_
15	produced	_	VBN	VBN	_	0	root	_	_
16	under	_	IN	IN	_	15	prep	_	_
17	various	_	JJ	JJ	_	18	amod	_	_
18	conditions	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	15	punct	_	_

1	Those	_	DT	DT	_	2	det	_	_
2	cytokines	_	NNS	NNS	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	modulate	_	VB	VB	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	differentiation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	monocytes	_	NNS	NNS	_	7	pobj	_	_
9	by	_	IN	IN	_	6	prep	_	_
10	CSFs	_	NNS	NNS	_	9	pobj	_	_
11	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	showed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	14	mark	_	_
9	CD14+	_	JJ	JJ	_	12	amod	_	_
10	adherent	_	JJ	JJ	_	12	amod	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	monocytes	_	NNS	NNS	_	14	nsubj	_	_
13	can	_	MD	MD	_	14	aux	_	_
14	differentiate	_	VB	VB	_	7	ccomp	_	_
15	into	_	IN	IN	_	14	prep	_	_
16	CD1+relB+	_	JJ	JJ	_	18	amod	_	_
17	dendritic	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	DC	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	by	_	IN	IN	_	14	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	combination	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	GM-CSF	_	NN	NN	_	25	pobj	_	_
27	plus	_	CC	CC	_	26	cc	_	_
28	interleukin-4	_	NN	NN	_	26	conj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	IL-4	_	NN	NN	_	28	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	and	_	CC	CC	_	14	cc	_	_
33	that	_	IN	IN	_	35	mark	_	_
34	they	_	PRP	PRP	_	35	nsubj	_	_
35	differentiate	_	VBP	VBP	_	14	conj	_	_
36	into	_	IN	IN	_	35	prep	_	_
37	tartrate-resistant	_	JJ	JJ	_	43	amod	_	_
38	acid	_	NN	NN	_	43	npadvmod	_	_
39	phosphatase	_	NN	NN	_	43	npadvmod	_	_
40	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
41	TRAP	_	NN	NN	_	43	npadvmod	_	_
42	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
43	-positive	_	JJ	JJ	_	47	amod	_	_
44	osteoclast-like	_	JJ	JJ	_	47	amod	_	_
45	multinucleated	_	JJ	JJ	_	47	amod	_	_
46	giant	_	JJ	JJ	_	47	amod	_	_
47	cells	_	NNS	NNS	_	36	pobj	_	_
48	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
49	MGC	_	NN	NN	_	47	appos	_	_
50	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
51	by	_	IN	IN	_	35	prep	_	_
52	the	_	DT	DT	_	53	det	_	_
53	combination	_	NN	NN	_	51	pobj	_	_
54	of	_	IN	IN	_	53	prep	_	_
55	M-CSF	_	NN	NN	_	54	pobj	_	_
56	plus	_	CC	CC	_	55	cc	_	_
57	IL-4	_	NN	NN	_	55	conj	_	_
58	.	_	.	.	_	7	punct	_	_

1	However	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	monocyte-derived	_	JJ	JJ	_	5	amod	_	_
5	DC	_	NN	NN	_	10	nsubj	_	_
6	were	_	VBD	VBD	_	10	cop	_	_
7	not	_	RB	RB	_	10	neg	_	_
8	terminally	_	RB	RB	_	9	advmod	_	_
9	differentiated	_	VBN	VBN	_	10	amod	_	_
10	cells	_	NNS	NNS	_	0	root	_	_
11	;	_	:	:	_	10	punct	_	_
12	they	_	PRP	PRP	_	15	nsubj	_	_
13	could	_	MD	MD	_	15	aux	_	_
14	still	_	RB	RB	_	15	advmod	_	_
15	convert	_	VB	VB	_	10	parataxis	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	macrophages	_	NNS	NNS	_	16	pobj	_	_
18	in	_	IN	IN	_	15	prep	_	_
19	response	_	NN	NN	_	18	dep	_	_
20	to	_	TO	TO	_	18	dep	_	_
21	M-CSF	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	15	punct	_	_

1	Tumor	_	NN	NN	_	3	nn	_	_
2	necrosis	_	NN	NN	_	3	nn	_	_
3	factor-alpha	_	NN	NN	_	7	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	TNF-alpha	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	stimulated	_	VBD	VBD	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	terminal	_	JJ	JJ	_	10	amod	_	_
10	differentiation	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	DC	_	NN	NN	_	11	pobj	_	_
14	by	_	IN	IN	_	7	prep	_	_
15	downregulating	_	VBG	VBG	_	14	pcomp	_	_
16	the	_	DT	DT	_	17	det	_	_
17	expression	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	M-CSF	_	NN	NN	_	21	nn	_	_
21	receptor	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	cfms	_	NN	NN	_	24	nn	_	_
24	mRNA	_	NN	NN	_	21	appos	_	_
25	,	_	,	,	_	15	punct	_	_
26	and	_	CC	CC	_	15	cc	_	_
27	aborting	_	VBG	VBG	_	15	conj	_	_
28	the	_	DT	DT	_	29	det	_	_
29	potential	_	NN	NN	_	27	dobj	_	_
30	to	_	TO	TO	_	31	aux	_	_
31	convert	_	VB	VB	_	29	vmod	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	macrophages	_	NNS	NNS	_	32	pobj	_	_
34	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	contrast	_	NN	NN	_	1	dep	_	_
3	to	_	TO	TO	_	1	dep	_	_
4	IL-4	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	10	punct	_	_
6	interferon-gamma	_	NN	NN	_	10	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	IFN-gamma	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	had	_	VBD	VBD	_	0	root	_	_
11	no	_	DT	DT	_	13	neg	_	_
12	demonstrable	_	JJ	JJ	_	13	amod	_	_
13	effect	_	NN	NN	_	10	dobj	_	_
14	on	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	differentiation	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	monocytes	_	NNS	NNS	_	17	pobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	Rather	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	IFN-gamma	_	NN	NN	_	4	nsubj	_	_
4	antagonized	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	effect	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	IL-4	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	suppressed	_	VBD	VBD	_	4	conj	_	_
11	the	_	DT	DT	_	15	det	_	_
12	DC	_	NN	NN	_	15	nn	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	MGC	_	NN	NN	_	12	conj	_	_
15	formation	_	NN	NN	_	10	dobj	_	_
16	induced	_	VBN	VBN	_	15	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	GM-CSF	_	NN	NN	_	17	pobj	_	_
19	+	_	CC	CC	_	18	cc	_	_
20	IL-4	_	NN	NN	_	18	conj	_	_
21	and	_	CC	CC	_	18	cc	_	_
22	M-CSF	_	NN	NN	_	18	conj	_	_
23	+	_	CC	CC	_	22	cc	_	_
24	IL-4	_	NN	NN	_	22	conj	_	_
25	,	_	,	,	_	18	punct	_	_
26	respectively	_	RB	RB	_	18	advmod	_	_
27	.	_	.	.	_	4	punct	_	_

1	Taken	_	VBN	VBN	_	6	vmod	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	6	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	results	_	NNS	NNS	_	6	nsubj	_	_
6	provide	_	VBP	VBP	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	new	_	JJ	JJ	_	9	amod	_	_
9	aspect	_	NN	NN	_	6	dobj	_	_
10	to	_	TO	TO	_	6	prep	_	_
11	our	_	PRP$	PRP$	_	12	poss	_	_
12	knowledge	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	monocyte	_	NN	NN	_	15	nn	_	_
15	differentiation	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	provide	_	VBP	VBP	_	6	conj	_	_
18	evidence	_	NN	NN	_	17	dobj	_	_
19	that	_	IN	IN	_	23	mark	_	_
20	human	_	JJ	JJ	_	21	amod	_	_
21	monocytes	_	NNS	NNS	_	23	nsubj	_	_
22	are	_	VBP	VBP	_	23	cop	_	_
23	flexible	_	JJ	JJ	_	18	ccomp	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	their	_	PRP$	PRP$	_	27	poss	_	_
26	differentiation	_	NN	NN	_	27	nn	_	_
27	potential	_	NN	NN	_	24	pobj	_	_
28	and	_	CC	CC	_	23	cc	_	_
29	are	_	VBP	VBP	_	30	cop	_	_
30	precursors	_	NNS	NNS	_	23	conj	_	_
31	not	_	RB	RB	_	32	neg	_	_
32	only	_	RB	RB	_	33	preconj	_	_
33	of	_	IN	IN	_	30	prep	_	_
34	macrophages	_	NNS	NNS	_	33	pobj	_	_
35	but	_	CC	CC	_	36	cc	_	_
36	also	_	RB	RB	_	33	cc	_	_
37	of	_	IN	IN	_	33	conj	_	_
38	CD1+relB+DC	_	NN	NN	_	37	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	TRAP-positive	_	JJ	JJ	_	41	amod	_	_
41	MGC	_	NN	NN	_	38	conj	_	_
42	.	_	.	.	_	6	punct	_	_

1	Such	_	PDT	PDT	_	4	predet	_	_
2	a	_	DT	DT	_	4	det	_	_
3	diverse	_	JJ	JJ	_	4	amod	_	_
4	pathway	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	monocyte	_	NN	NN	_	7	nn	_	_
7	differentiation	_	NN	NN	_	5	pobj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	constitute	_	VB	VB	_	0	root	_	_
10	one	_	CD	CD	_	9	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	basic	_	JJ	JJ	_	14	amod	_	_
14	mechanisms	_	NNS	NNS	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	immune	_	JJ	JJ	_	17	amod	_	_
17	regulation	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	9	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	-LSB-Ca2+-RSB-i	_	NN	NN	_	4	nn	_	_
4	rise	_	NN	NN	_	2	pobj	_	_
5	activated	_	VBN	VBN	_	4	vmod	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	doxepin-sensitive	_	JJ	JJ	_	9	amod	_	_
8	H1-histamine	_	JJ	JJ	_	9	amod	_	_
9	receptors	_	NNS	NNS	_	6	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	Jurkat	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	cloned	_	VBN	VBN	_	17	amod	_	_
15	human	_	JJ	JJ	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	lymphocytes	_	NNS	NNS	_	12	appos	_	_
18	.	_	.	.	_	1	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	clarify	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	presence	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	histamine	_	NN	NN	_	7	nn	_	_
7	receptor	_	NN	NN	_	5	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	its	_	PRP$	PRP$	_	11	poss	_	_
10	transmembrane	_	JJ	JJ	_	11	amod	_	_
11	mechanism	_	NN	NN	_	7	conj	_	_
12	in	_	IN	IN	_	4	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
16	,	_	,	,	_	2	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	investigated	_	VBD	VBD	_	2	parataxis	_	_
19	the	_	DT	DT	_	20	det	_	_
20	effects	_	NNS	NNS	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	agonists	_	NNS	NNS	_	21	pobj	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	antagonists	_	NNS	NNS	_	22	conj	_	_
25	of	_	IN	IN	_	22	prep	_	_
26	histamine	_	NN	NN	_	27	nn	_	_
27	receptor	_	NN	NN	_	28	nn	_	_
28	subtypes	_	NNS	NNS	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	bacterial	_	JJ	JJ	_	31	amod	_	_
31	toxins	_	NNS	NNS	_	28	conj	_	_
32	on	_	IN	IN	_	20	prep	_	_
33	intracellular	_	JJ	JJ	_	34	amod	_	_
34	concentration	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	Ca2+	_	NN	NN	_	35	pobj	_	_
37	-LSB-Ca2+-RSB-i	_	NN	NN	_	34	dep	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	,	_	,	,	_	34	punct	_	_
40	-LSB-3H-RSB-pyrilamine	_	NN	NN	_	41	nn	_	_
41	binding	_	NN	NN	_	34	conj	_	_
42	and	_	CC	CC	_	34	cc	_	_
43	c-fos	_	NN	NN	_	44	nn	_	_
44	mRNA	_	NN	NN	_	45	nn	_	_
45	expression	_	NN	NN	_	34	conj	_	_
46	in	_	IN	IN	_	34	prep	_	_
47	Jurkat	_	NN	NN	_	48	nn	_	_
48	cells	_	NNS	NNS	_	46	pobj	_	_
49	,	_	,	,	_	48	punct	_	_
50	cloned	_	VBN	VBN	_	53	amod	_	_
51	human	_	JJ	JJ	_	53	amod	_	_
52	T	_	NN	NN	_	53	nn	_	_
53	lymphocytes	_	NNS	NNS	_	48	appos	_	_
54	.	_	.	.	_	2	punct	_	_

1	H1-agonists	_	NNS	NNS	_	7	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	histamine	_	NN	NN	_	1	dep	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	2-methylhistamine	_	NN	NN	_	3	conj	_	_
6	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
7	caused	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	transient	_	JJ	JJ	_	10	amod	_	_
10	rise	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	-LSB-Ca2+-RSB-	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	7	punct	_	_
14	and	_	CC	CC	_	7	cc	_	_
15	H1-antagonists	_	NNS	NNS	_	21	nsubj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	pyrilamine	_	NN	NN	_	15	dep	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	doxepin	_	NN	NN	_	17	conj	_	_
20	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
21	inhibited	_	VBD	VBD	_	7	conj	_	_
22	the	_	DT	DT	_	25	det	_	_
23	histamine-induced	_	JJ	JJ	_	25	amod	_	_
24	-LSB-Ca2+-RSB-i	_	NN	NN	_	25	nn	_	_
25	rise	_	NN	NN	_	21	dobj	_	_
26	more	_	RBR	RBR	_	27	advmod	_	_
27	potently	_	RB	RB	_	21	advmod	_	_
28	than	_	IN	IN	_	30	mark	_	_
29	the	_	DT	DT	_	30	det	_	_
30	H2-antagonist	_	NN	NN	_	27	advcl	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	cimetidine	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	on	_	IN	IN	_	30	dep	_	_
35	the	_	DT	DT	_	36	det	_	_
36	H3-antagonist	_	NN	NN	_	34	pobj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	impromidine	_	NN	NN	_	36	appos	_	_
39	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
40	.	_	.	.	_	7	punct	_	_

1	Binding	_	NN	NN	_	2	nn	_	_
2	parameters	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	-LSB-3H-RSB-pyrilamine	_	NN	NN	_	5	nn	_	_
5	binding	_	NN	NN	_	3	pobj	_	_
6	were	_	VBD	VBD	_	7	cop	_	_
7	Kd	_	NN	NN	_	0	root	_	_
8	=	_	JJ	JJ	_	7	amod	_	_
9	5.53	_	CD	CD	_	10	num	_	_
10	nM	_	NN	NN	_	8	dep	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	Bmax	_	NN	NN	_	7	conj	_	_
13	=	_	JJ	JJ	_	12	amod	_	_
14	2	_	CD	CD	_	13	dep	_	_
15	,	_	,	,	_	7	punct	_	_
16	647	_	CD	CD	_	17	num	_	_
17	sites/cell	_	NNS	NNS	_	7	appos	_	_
18	.	_	.	.	_	7	punct	_	_

1	Pretreatment	_	NN	NN	_	11	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	B.pertussis	_	FW	FW	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	V.cholera.	_	FW	FW	_	3	conj	_	_
6	or	_	CC	CC	_	3	cc	_	_
7	C.botulinum	_	FW	FW	_	3	conj	_	_
8	toxin	_	NN	NN	_	3	dep	_	_
9	did	_	VBD	VBD	_	11	aux	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	influence	_	VB	VB	_	0	root	_	_
12	histamine-induced	_	JJ	JJ	_	14	amod	_	_
13	-LSB-Ca2+-RSB-i	_	NN	NN	_	14	nn	_	_
14	rise	_	NN	NN	_	11	dobj	_	_
15	.	_	.	.	_	11	punct	_	_

1	Western	_	NN	NN	_	3	nn	_	_
2	Blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	11	nsubj	_	_
4	using	_	VBG	VBG	_	3	vmod	_	_
5	antibodies	_	NNS	NNS	_	4	dobj	_	_
6	against	_	IN	IN	_	5	prep	_	_
7	subunits	_	NNS	NNS	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	GTP-binding	_	JJ	JJ	_	10	amod	_	_
10	proteins	_	NNS	NNS	_	8	pobj	_	_
11	indicated	_	VBD	VBD	_	0	root	_	_
12	that	_	IN	IN	_	15	mark	_	_
13	Gq/G11	_	NN	NN	_	15	nsubj	_	_
14	richly	_	RB	RB	_	15	advmod	_	_
15	existed	_	VBD	VBD	_	11	ccomp	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	Jurkat	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	11	punct	_	_

1	Histamine	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	mRNA	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	an	_	DT	DT	_	9	det	_	_
7	immediate	_	JJ	JJ	_	9	amod	_	_
8	early	_	JJ	JJ	_	9	amod	_	_
9	gene	_	NN	NN	_	5	pobj	_	_
10	c-fos	_	NN	NN	_	9	dep	_	_
11	.	_	.	.	_	2	punct	_	_

1	Pretreatment	_	NN	NN	_	13	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	7	det	_	_
4	protein	_	NN	NN	_	6	nn	_	_
5	kinase	_	NN	NN	_	6	nn	_	_
6	C	_	NN	NN	_	7	nn	_	_
7	activator	_	NN	NN	_	2	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	phorbol	_	NN	NN	_	11	nn	_	_
10	12-myristate	_	NN	NN	_	11	nn	_	_
11	13-acetate	_	NN	NN	_	7	appos	_	_
12	,	_	,	,	_	1	punct	_	_
13	caused	_	VBD	VBD	_	0	root	_	_
14	almost	_	RB	RB	_	15	advmod	_	_
15	complete	_	JJ	JJ	_	16	amod	_	_
16	inhibition	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	histamine-induced	_	JJ	JJ	_	20	amod	_	_
19	-LSB-Ca2+-RSB-i	_	NN	NN	_	20	nn	_	_
20	rise	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	13	punct	_	_
22	but	_	CC	CC	_	13	cc	_	_
23	did	_	VBD	VBD	_	25	aux	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	do	_	VB	VB	_	13	conj	_	_
26	so	_	RB	RB	_	25	advmod	_	_
27	by	_	IN	IN	_	25	prep	_	_
28	activators	_	NNS	NNS	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	cAMP-	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	cGMP-dependent	_	JJ	JJ	_	30	conj	_	_
33	protein	_	NN	NN	_	34	nn	_	_
34	kinases	_	NNS	NNS	_	30	dep	_	_
35	.	_	.	.	_	13	punct	_	_

1	T	_	NN	NN	_	3	nn	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	response	_	NN	NN	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
6	virus	_	NN	NN	_	7	nn	_	_
7	transactivators	_	NNS	NNS	_	4	pobj	_	_
8	in	_	IN	IN	_	3	prep	_	_
9	chronic	_	JJ	JJ	_	11	amod	_	_
10	rheumatoid	_	JJ	JJ	_	11	amod	_	_
11	arthritis	_	NN	NN	_	8	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	Rheumatoid	_	JJ	JJ	_	2	amod	_	_
2	arthritis	_	NN	NN	_	6	nsubj	_	_
3	is	_	VBZ	VBZ	_	6	cop	_	_
4	a	_	DT	DT	_	6	det	_	_
5	multistep	_	JJ	JJ	_	6	amod	_	_
6	disorder	_	NN	NN	_	0	root	_	_
7	associated	_	VBN	VBN	_	6	vmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	autoimmune	_	JJ	JJ	_	10	amod	_	_
10	features	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	yet	_	RB	RB	_	13	advmod	_	_
13	unknown	_	JJ	JJ	_	14	amod	_	_
14	etiology	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Implication	_	NN	NN	_	17	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	viruses	_	NNS	NNS	_	2	pobj	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
7	virus	_	NN	NN	_	5	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	EBV	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	in	_	IN	IN	_	1	prep	_	_
12	rheumatoid	_	JJ	JJ	_	14	amod	_	_
13	arthritis	_	NN	NN	_	14	nn	_	_
14	pathogenesis	_	NN	NN	_	11	pobj	_	_
15	has	_	VBZ	VBZ	_	17	aux	_	_
16	been	_	VBN	VBN	_	17	auxpass	_	_
17	suspected	_	VBN	VBN	_	0	root	_	_
18	on	_	IN	IN	_	21	dep	_	_
19	the	_	DT	DT	_	21	dep	_	_
20	basis	_	NN	NN	_	21	dep	_	_
21	of	_	IN	IN	_	17	prep	_	_
22	several	_	JJ	JJ	_	24	amod	_	_
23	indirect	_	JJ	JJ	_	24	amod	_	_
24	observations	_	NNS	NNS	_	21	pobj	_	_
25	,	_	,	,	_	17	punct	_	_
26	but	_	CC	CC	_	17	cc	_	_
27	thus	_	RB	RB	_	28	advmod	_	_
28	far	_	RB	RB	_	41	advmod	_	_
29	,	_	,	,	_	41	punct	_	_
30	a	_	DT	DT	_	32	det	_	_
31	direct	_	JJ	JJ	_	32	amod	_	_
32	link	_	NN	NN	_	41	nsubjpass	_	_
33	between	_	IN	IN	_	32	prep	_	_
34	EBV	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	rheumatoid	_	JJ	JJ	_	37	amod	_	_
37	arthritis	_	NN	NN	_	34	conj	_	_
38	has	_	VBZ	VBZ	_	41	aux	_	_
39	not	_	RB	RB	_	41	neg	_	_
40	been	_	VBN	VBN	_	41	auxpass	_	_
41	provided	_	VBN	VBN	_	17	conj	_	_
42	.	_	.	.	_	17	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	21	mark	_	_
5	a	_	DT	DT	_	7	det	_	_
6	large	_	JJ	JJ	_	7	amod	_	_
7	fraction	_	NN	NN	_	21	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	infiltrating	_	VBG	VBG	_	7	vmod	_	_
12	affected	_	VBN	VBN	_	13	amod	_	_
13	joints	_	NNS	NNS	_	11	dobj	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	patient	_	NN	NN	_	14	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	chronic	_	JJ	JJ	_	20	amod	_	_
19	rheumatoid	_	JJ	JJ	_	20	amod	_	_
20	arthritis	_	NN	NN	_	17	pobj	_	_
21	recognizes	_	VBZ	VBZ	_	3	ccomp	_	_
22	two	_	CD	CD	_	24	num	_	_
23	EBV	_	NN	NN	_	24	nn	_	_
24	transactivators	_	NNS	NNS	_	21	dobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	BZLF1	_	NN	NN	_	24	dep	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	BMLF1	_	NN	NN	_	26	conj	_	_
29	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
30	in	_	IN	IN	_	21	prep	_	_
31	a	_	DT	DT	_	35	det	_	_
32	major	_	JJ	JJ	_	34	amod	_	_
33	histocompatibility	_	NN	NN	_	34	npadvmod	_	_
34	complex-restricted	_	JJ	JJ	_	35	amod	_	_
35	fashion	_	NN	NN	_	30	pobj	_	_
36	.	_	.	.	_	3	punct	_	_

1	Responses	_	NNS	NNS	_	18	nsubj	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	these	_	DT	DT	_	5	det	_	_
4	EBV	_	NN	NN	_	5	nn	_	_
5	antigens	_	NNS	NNS	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	synovial	_	JJ	JJ	_	8	amod	_	_
8	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	several	_	JJ	JJ	_	15	amod	_	_
11	other	_	JJ	JJ	_	15	amod	_	_
12	chronic	_	JJ	JJ	_	15	amod	_	_
13	rheumatoid	_	JJ	JJ	_	15	amod	_	_
14	arthritis	_	NN	NN	_	15	nn	_	_
15	patients	_	NNS	NNS	_	9	pobj	_	_
16	were	_	VBD	VBD	_	18	cop	_	_
17	readily	_	RB	RB	_	18	advmod	_	_
18	detectable	_	JJ	JJ	_	0	root	_	_
19	.	_	.	.	_	18	punct	_	_

1	Thus	_	RB	RB	_	4	advmod	_	_
2	these	_	DT	DT	_	3	det	_	_
3	results	_	NNS	NNS	_	4	nsubj	_	_
4	suggest	_	VBP	VBP	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	direct	_	JJ	JJ	_	7	amod	_	_
7	contribution	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	EBV	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	7	prep	_	_
11	chronic	_	JJ	JJ	_	14	amod	_	_
12	rheumatoid	_	JJ	JJ	_	14	amod	_	_
13	arthritis	_	NN	NN	_	14	nn	_	_
14	pathogenesis	_	NN	NN	_	10	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	They	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	first	_	JJ	JJ	_	7	amod	_	_
7	time	_	NN	NN	_	4	pobj	_	_
8	the	_	DT	DT	_	9	det	_	_
9	occurrence	_	NN	NN	_	3	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	T	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	responses	_	NNS	NNS	_	10	pobj	_	_
14	against	_	IN	IN	_	13	prep	_	_
15	EBV	_	NN	NN	_	17	nn	_	_
16	transactivating	_	VBG	VBG	_	17	amod	_	_
17	factors	_	NNS	NNS	_	14	pobj	_	_
18	,	_	,	,	_	9	punct	_	_
19	which	_	WDT	WDT	_	22	nsubj	_	_
20	might	_	MD	MD	_	22	aux	_	_
21	be	_	VB	VB	_	22	cop	_	_
22	central	_	JJ	JJ	_	9	rcmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	control	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	virus	_	NN	NN	_	28	nn	_	_
28	reactivation	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Differential	_	JJ	JJ	_	3	amod	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	localization	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	p50	_	NN	NN	_	11	nn	_	_
6	,	_	,	,	_	5	punct	_	_
7	p52	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	RelB	_	NN	NN	_	5	conj	_	_
11	proteins	_	NNS	NNS	_	4	pobj	_	_
12	in	_	IN	IN	_	3	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	accessory	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	immune	_	JJ	JJ	_	19	amod	_	_
19	response	_	NN	NN	_	16	pobj	_	_
20	in	_	FW	FW	_	21	nn	_	_
21	situ	_	FW	FW	_	19	advmod	_	_
22	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	Rel/NF-kappa	_	NN	NN	_	4	nn	_	_
3	B	_	NN	NN	_	4	nn	_	_
4	proteins	_	NNS	NNS	_	17	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	p50	_	NN	NN	_	4	appos	_	_
7	,	_	,	,	_	6	punct	_	_
8	p52	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	p65	_	NN	NN	_	6	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	c-Rel	_	NN	NN	_	6	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	and	_	CC	CC	_	6	cc	_	_
15	RelB	_	NN	NN	_	6	conj	_	_
16	,	_	,	,	_	4	punct	_	_
17	constitute	_	VBP	VBP	_	0	root	_	_
18	a	_	DT	DT	_	19	det	_	_
19	family	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factors	_	NNS	NNS	_	20	pobj	_	_
23	involved	_	VBN	VBN	_	19	vmod	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	positive	_	JJ	JJ	_	27	amod	_	_
27	regulation	_	NN	NN	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	a	_	DT	DT	_	30	det	_	_
30	variety	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	genes	_	NNS	NNS	_	31	pobj	_	_
33	during	_	IN	IN	_	27	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	immune	_	JJ	JJ	_	36	amod	_	_
36	response	_	NN	NN	_	33	pobj	_	_
37	.	_	.	.	_	17	punct	_	_

1	Recently	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	it	_	PRP	PRP	_	6	nsubjpass	_	_
4	has	_	VBZ	VBZ	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	shown	_	VBN	VBN	_	0	root	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	RelB	_	NN	NN	_	10	nn	_	_
9	knockout	_	JJ	JJ	_	10	amod	_	_
10	mice	_	NNS	NNS	_	11	nsubj	_	_
11	have	_	VBP	VBP	_	6	ccomp	_	_
12	no	_	DT	DT	_	14	neg	_	_
13	dendritic	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	11	dobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	DC	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	.	_	.	.	_	6	punct	_	_

1	An	_	DT	DT	_	2	det	_	_
2	overexpression	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p50	_	NN	NN	_	3	pobj	_	_
5	has	_	VBZ	VBZ	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	described	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	follicular	_	JJ	JJ	_	11	amod	_	_
10	dendritic	_	JJ	JJ	_	11	amod	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	FDC	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	.	_	.	.	_	7	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	constitutive	_	JJ	JJ	_	5	amod	_	_
3	NF-kappa	_	NN	NN	_	5	nn	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	8	nsubjpass	_	_
6	has	_	VBZ	VBZ	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	reported	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	mature	_	JJ	JJ	_	11	amod	_	_
11	macrophages	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	8	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	led	_	VBD	VBD	_	0	root	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	hypothesis	_	NN	NN	_	3	pobj	_	_
6	that	_	IN	IN	_	16	mark	_	_
7	some	_	DT	DT	_	16	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	Rel/NF-kappa	_	NN	NN	_	12	nn	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	8	pobj	_	_
13	were	_	VBD	VBD	_	16	cop	_	_
14	key	_	JJ	JJ	_	16	amod	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	factors	_	NNS	NNS	_	5	ccomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	functions	_	NNS	NNS	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	accessory	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	immune	_	JJ	JJ	_	25	amod	_	_
25	response	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	investigated	_	VBD	VBD	_	0	root	_	_
5	in	_	FW	FW	_	6	nn	_	_
6	situ	_	FW	FW	_	4	advmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	localization	_	NN	NN	_	4	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	Rel/NF-kappa	_	NN	NN	_	13	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	proteins	_	NNS	NNS	_	10	pobj	_	_
14	in	_	IN	IN	_	9	prep	_	_
15	accessory	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	immune	_	JJ	JJ	_	20	amod	_	_
20	system	_	NN	NN	_	17	pobj	_	_
21	by	_	IN	IN	_	4	prep	_	_
22	immunohistochemistry	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	double	_	JJ	JJ	_	25	amod	_	_
25	labeling	_	NN	NN	_	22	conj	_	_
26	by	_	IN	IN	_	25	prep	_	_
27	immunofluorescence	_	NN	NN	_	26	pobj	_	_
28	from	_	IN	IN	_	4	prep	_	_
29	five	_	CD	CD	_	32	num	_	_
30	normal	_	JJ	JJ	_	32	amod	_	_
31	human	_	JJ	JJ	_	32	amod	_	_
32	tonsils	_	NNS	NNS	_	28	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	five	_	CD	CD	_	36	num	_	_
35	lymph	_	NN	NN	_	36	nn	_	_
36	nodes	_	NNS	NNS	_	32	conj	_	_
37	with	_	IN	IN	_	36	prep	_	_
38	follicular	_	JJ	JJ	_	39	amod	_	_
39	hyperplasia	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	4	punct	_	_

1	Nuclear	_	JJ	JJ	_	5	amod	_	_
2	p65	_	NN	NN	_	5	nn	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	c-Rel	_	NN	NN	_	2	conj	_	_
5	proteins	_	NNS	NNS	_	7	nsubjpass	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	all	_	DT	DT	_	11	det	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	types	_	NNS	NNS	_	8	pobj	_	_
12	including	_	VBG	VBG	_	11	prep	_	_
13	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	germinal	_	JJ	JJ	_	4	amod	_	_
3	centers	_	NNS	NNS	_	4	nn	_	_
4	GC	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	13	punct	_	_
6	p50	_	NN	NN	_	13	nsubjpass	_	_
7	,	_	,	,	_	6	punct	_	_
8	p52	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	RelB	_	NN	NN	_	6	conj	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	found	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	nuclei	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	FDC	_	NN	NN	_	17	pobj	_	_
19	only	_	RB	RB	_	16	advmod	_	_
20	and	_	CC	CC	_	13	cc	_	_
21	were	_	VBD	VBD	_	23	auxpass	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	detected	_	VBN	VBN	_	13	conj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	nuclei	_	NNS	NNS	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	CD68+	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	T	_	NN	NN	_	4	nn	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	areas	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	13	punct	_	_
6	p50	_	NN	NN	_	13	nsubjpass	_	_
7	,	_	,	,	_	6	punct	_	_
8	p52	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	RelB	_	NN	NN	_	6	conj	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	found	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	nuclei	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	HLA-DR+	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	an	_	DT	DT	_	27	det	_	_
22	antigen-presenting	_	JJ	JJ	_	23	amod	_	_
23	cell	_	NN	NN	_	27	nn	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	APC	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	morphology	_	NN	NN	_	20	pobj	_	_
28	.	_	.	.	_	13	punct	_	_

1	p52	_	NN	NN	_	5	nsubjpass	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	RelB	_	NN	NN	_	1	conj	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	detected	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	nuclei	_	NNS	NNS	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	both	_	CC	CC	_	11	preconj	_	_
11	CD1a+	_	JJ	JJ	_	14	amod	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	CD68+	_	JJ	JJ	_	11	conj	_	_
14	cells	_	NNS	NNS	_	9	pobj	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	T	_	NN	NN	_	19	nn	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	area	_	NN	NN	_	15	pobj	_	_
20	,	_	,	,	_	5	punct	_	_
21	whereas	_	IN	IN	_	5	dep	_	_
22	p50	_	NN	NN	_	24	nsubjpass	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	found	_	VBN	VBN	_	5	parataxis	_	_
25	only	_	RB	RB	_	26	advmod	_	_
26	in	_	IN	IN	_	24	prep	_	_
27	CD68-	_	JJ	JJ	_	30	amod	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	CD1a-	_	JJ	JJ	_	27	conj	_	_
30	cells	_	NNS	NNS	_	26	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	Cells	_	NNS	NNS	_	6	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	p50	_	NN	NN	_	2	pobj	_	_
5	were	_	VBD	VBD	_	6	cop	_	_
6	negative	_	JJ	JJ	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	14	det	_	_
9	CD38	_	NN	NN	_	14	nn	_	_
10	,	_	,	,	_	9	punct	_	_
11	CD20	_	NN	NN	_	9	conj	_	_
12	and	_	CC	CC	_	9	cc	_	_
13	CD2	_	NN	NN	_	9	conj	_	_
14	markers	_	NNS	NNS	_	7	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	,	_	,	,	_	19	punct	_	_
6	physiologically	_	RB	RB	_	19	advmod	_	_
7	,	_	,	,	_	19	punct	_	_
8	high	_	JJ	JJ	_	9	amod	_	_
9	levels	_	NNS	NNS	_	19	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	nuclear	_	JJ	JJ	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	p50	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	p52	_	NN	NN	_	13	conj	_	_
16	and	_	CC	CC	_	13	cc	_	_
17	RelB	_	NN	NN	_	13	conj	_	_
18	are	_	VBP	VBP	_	19	aux	_	_
19	restricted	_	JJ	JJ	_	3	ccomp	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	accessory	_	JJ	JJ	_	22	amod	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	immune	_	JJ	JJ	_	26	amod	_	_
26	system	_	NN	NN	_	23	pobj	_	_
27	,	_	,	,	_	22	punct	_	_
28	which	_	WDT	WDT	_	29	nsubj	_	_
29	include	_	VBP	VBP	_	22	rcmod	_	_
30	FDC	_	NN	NN	_	29	dobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	GC	_	NN	NN	_	31	pobj	_	_
33	,	_	,	,	_	22	punct	_	_
34	and	_	CC	CC	_	22	cc	_	_
35	DC	_	NN	NN	_	22	conj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	macrophages	_	NNS	NNS	_	35	conj	_	_
38	in	_	IN	IN	_	35	prep	_	_
39	the	_	DT	DT	_	42	det	_	_
40	T	_	NN	NN	_	42	nn	_	_
41	cell	_	NN	NN	_	42	nn	_	_
42	zone	_	NN	NN	_	38	pobj	_	_
43	,	_	,	,	_	19	punct	_	_
44	that	_	IN	IN	_	52	mark	_	_
45	specialized	_	VBN	VBN	_	47	amod	_	_
46	scavenger	_	NN	NN	_	47	nn	_	_
47	macrophages	_	NNS	NNS	_	52	nsubj	_	_
48	from	_	IN	IN	_	47	prep	_	_
49	GC	_	NN	NN	_	48	pobj	_	_
50	do	_	VBP	VBP	_	52	aux	_	_
51	not	_	RB	RB	_	52	neg	_	_
52	have	_	VB	VB	_	19	conj	_	_
53	detectable	_	JJ	JJ	_	54	amod	_	_
54	levels	_	NNS	NNS	_	52	dobj	_	_
55	of	_	IN	IN	_	54	prep	_	_
56	p52	_	NN	NN	_	55	pobj	_	_
57	and	_	CC	CC	_	56	cc	_	_
58	RelB	_	NN	NN	_	56	conj	_	_
59	,	_	,	,	_	52	punct	_	_
60	whereas	_	IN	IN	_	52	dep	_	_
61	macrophages	_	NNS	NNS	_	78	nsubj	_	_
62	from	_	IN	IN	_	61	prep	_	_
63	the	_	DT	DT	_	66	det	_	_
64	T	_	NN	NN	_	66	nn	_	_
65	cell	_	NN	NN	_	66	nn	_	_
66	area	_	NN	NN	_	62	pobj	_	_
67	,	_	,	,	_	61	punct	_	_
68	known	_	VBN	VBN	_	61	vmod	_	_
69	to	_	TO	TO	_	70	aux	_	_
70	present	_	VB	VB	_	68	xcomp	_	_
71	the	_	DT	DT	_	72	det	_	_
72	antigen	_	NN	NN	_	70	dobj	_	_
73	to	_	TO	TO	_	70	prep	_	_
74	T	_	NN	NN	_	75	nn	_	_
75	cells	_	NNS	NNS	_	73	pobj	_	_
76	,	_	,	,	_	61	punct	_	_
77	do	_	VBP	VBP	_	78	aux	_	_
78	have	_	VB	VB	_	52	parataxis	_	_
79	both	_	CC	CC	_	81	preconj	_	_
80	nuclear	_	JJ	JJ	_	81	dep	_	_
81	p52	_	NN	NN	_	78	dobj	_	_
82	and	_	CC	CC	_	81	cc	_	_
83	RelB	_	NN	NN	_	81	conj	_	_
84	,	_	,	,	_	19	punct	_	_
85	and	_	CC	CC	_	19	cc	_	_
86	that	_	IN	IN	_	97	mark	_	_
87	in	_	IN	IN	_	97	prep	_	_
88	the	_	DT	DT	_	91	det	_	_
89	T	_	NN	NN	_	91	nn	_	_
90	cell	_	NN	NN	_	91	nn	_	_
91	zone	_	NN	NN	_	87	pobj	_	_
92	,	_	,	,	_	97	punct	_	_
93	p52	_	NN	NN	_	97	nsubj	_	_
94	and	_	CC	CC	_	93	cc	_	_
95	RelB	_	NN	NN	_	93	conj	_	_
96	are	_	VBP	VBP	_	97	cop	_	_
97	located	_	JJ	JJ	_	19	conj	_	_
98	in	_	IN	IN	_	97	prep	_	_
99	nuclei	_	NNS	NNS	_	98	pobj	_	_
100	of	_	IN	IN	_	99	prep	_	_
101	both	_	DT	DT	_	102	preconj	_	_
102	CD1a+	_	JJ	JJ	_	109	amod	_	_
103	,	_	,	,	_	102	punct	_	_
104	CD68+	_	JJ	JJ	_	102	conj	_	_
105	or	_	CC	CC	_	102	cc	_	_
106	both	_	DT	DT	_	102	conj	_	_
107	,	_	,	,	_	102	punct	_	_
108	cells	_	NNS	NNS	_	109	nn	_	_
109	APC	_	NN	NN	_	100	pobj	_	_
110	,	_	,	,	_	97	punct	_	_
111	whereas	_	IN	IN	_	97	dep	_	_
112	p50	_	NN	NN	_	114	nsubj	_	_
113	is	_	VBZ	VBZ	_	114	aux	_	_
114	restricted	_	JJ	JJ	_	97	parataxis	_	_
115	to	_	TO	TO	_	114	prep	_	_
116	CD1a-	_	NN	NN	_	119	amod	_	_
117	and	_	CC	CC	_	116	cc	_	_
118	CD68-	_	JJ	JJ	_	116	conj	_	_
119	APC	_	NN	NN	_	115	pobj	_	_
120	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	different	_	JJ	JJ	_	3	amod	_	_
3	patterns	_	NNS	NNS	_	14	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	p50	_	NN	NN	_	12	nn	_	_
6	,	_	,	,	_	5	punct	_	_
7	p52	_	NN	NN	_	5	conj	_	_
8	and	_	CC	CC	_	5	cc	_	_
9	RelB	_	NN	NN	_	5	conj	_	_
10	protein	_	NN	NN	_	12	nn	_	_
11	nuclear	_	JJ	JJ	_	12	amod	_	_
12	localization	_	NN	NN	_	4	pobj	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	provide	_	VB	VB	_	0	root	_	_
15	insight	_	NN	NN	_	14	dobj	_	_
16	into	_	IN	IN	_	15	prep	_	_
17	their	_	PRP$	PRP$	_	19	poss	_	_
18	different	_	JJ	JJ	_	19	amod	_	_
19	roles	_	NNS	NNS	_	16	pobj	_	_
20	during	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	immune	_	JJ	JJ	_	23	amod	_	_
23	response	_	NN	NN	_	20	pobj	_	_
24	in	_	FW	FW	_	25	nn	_	_
25	vivo	_	FW	FW	_	23	advmod	_	_
26	.	_	.	.	_	14	punct	_	_

1	Signal	_	NN	NN	_	2	nn	_	_
2	transduction	_	NN	NN	_	0	root	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	DR3	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	a	_	DT	DT	_	9	det	_	_
7	death	_	NN	NN	_	8	npadvmod	_	_
8	domain-containing	_	JJ	JJ	_	9	amod	_	_
9	receptor	_	NN	NN	_	4	appos	_	_
10	related	_	JJ	JJ	_	9	amod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	TNFR-1	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	CD95	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Tumor	_	NN	NN	_	4	nn	_	_
2	necrosis	_	NN	NN	_	4	nn	_	_
3	factor	_	NN	NN	_	4	nn	_	_
4	receptor-1	_	NN	NN	_	19	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	TNFR-1	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	CD95	_	NN	NN	_	4	conj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
11	also	_	RB	RB	_	12	advmod	_	_
12	called	_	VBN	VBN	_	9	vmod	_	_
13	Fas	_	NN	NN	_	12	dep	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	APO-1	_	NN	NN	_	13	conj	_	_
16	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
17	are	_	VBP	VBP	_	19	cop	_	_
18	cytokine	_	NN	NN	_	19	nn	_	_
19	receptors	_	NNS	NNS	_	0	root	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	engage	_	VBP	VBP	_	19	rcmod	_	_
22	the	_	DT	DT	_	24	det	_	_
23	apoptosis	_	NN	NN	_	24	nn	_	_
24	pathway	_	NN	NN	_	21	dobj	_	_
25	through	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	27	det	_	_
27	region	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	intracellular	_	JJ	JJ	_	30	amod	_	_
30	homology	_	NN	NN	_	28	pobj	_	_
31	,	_	,	,	_	24	punct	_	_
32	designated	_	VBD	VBD	_	24	vmod	_	_
33	the	_	DT	DT	_	36	det	_	_
34	``	_	``	``	_	36	punct	_	_
35	death	_	NN	NN	_	36	nn	_	_
36	domain	_	NN	NN	_	32	dep	_	_
37	.	_	.	.	_	19	punct	_	_

1	Another	_	DT	DT	_	4	det	_	_
2	death	_	NN	NN	_	3	dep	_	_
3	domain-containing	_	NN	NN	_	4	amod	_	_
4	member	_	NN	NN	_	18	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	TNFR	_	NN	NN	_	8	nn	_	_
8	family	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	death	_	NN	NN	_	11	nn	_	_
11	receptor	_	NN	NN	_	4	appos	_	_
12	3	_	CD	CD	_	11	num	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	DR3	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	4	punct	_	_
17	was	_	VBD	VBD	_	18	auxpass	_	_
18	identified	_	VBN	VBN	_	0	root	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	was	_	VBD	VBD	_	21	auxpass	_	_
21	shown	_	VBN	VBN	_	18	conj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	induce	_	VB	VB	_	21	xcomp	_	_
24	both	_	CC	CC	_	25	preconj	_	_
25	apoptosis	_	NNS	NNS	_	23	dobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	activation	_	NN	NN	_	25	conj	_	_
28	of	_	IN	IN	_	25	prep	_	_
29	nuclear	_	JJ	JJ	_	31	amod	_	_
30	factor	_	NN	NN	_	31	nn	_	_
31	kappaB	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	18	punct	_	_

1	Expression	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	DR3	_	NN	NN	_	2	pobj	_	_
4	appears	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	7	aux	_	_
6	be	_	VB	VB	_	7	aux	_	_
7	restricted	_	JJ	JJ	_	4	xcomp	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	tissues	_	NNS	NNS	_	8	pobj	_	_
10	enriched	_	VBN	VBN	_	9	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	DR3	_	NN	NN	_	3	nn	_	_
2	signal	_	NN	NN	_	3	nn	_	_
3	transduction	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	mediated	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	complex	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	intracellular	_	JJ	JJ	_	12	amod	_	_
11	signaling	_	VBG	VBG	_	12	amod	_	_
12	molecules	_	NNS	NNS	_	9	pobj	_	_
13	including	_	VBG	VBG	_	12	prep	_	_
14	TRADD	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	TRAF2	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	14	punct	_	_
18	FADD	_	NN	NN	_	14	conj	_	_
19	,	_	,	,	_	14	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	FLICE	_	NN	NN	_	14	conj	_	_
22	.	_	.	.	_	5	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	DR3	_	NN	NN	_	5	nsubj	_	_
4	likely	_	RB	RB	_	5	advmod	_	_
5	plays	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	role	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	regulating	_	VBG	VBG	_	8	pcomp	_	_
10	lymphocyte	_	NN	NN	_	11	nn	_	_
11	homeostasis	_	NN	NN	_	9	dobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	Cloning	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	expression	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	Epstein-Barr	_	JJ	JJ	_	7	amod	_	_
7	virus-encoded	_	JJ	JJ	_	8	amod	_	_
8	dUTPase	_	NN	NN	_	4	pobj	_	_
9	:	_	:	:	_	1	punct	_	_
10	patients	_	NNS	NNS	_	19	nsubj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	acute	_	JJ	JJ	_	18	amod	_	_
13	,	_	,	,	_	12	punct	_	_
14	reactivated	_	VBN	VBN	_	12	conj	_	_
15	or	_	CC	CC	_	12	cc	_	_
16	chronic	_	JJ	JJ	_	12	conj	_	_
17	virus	_	NN	NN	_	18	nn	_	_
18	infection	_	NN	NN	_	11	pobj	_	_
19	develop	_	VBP	VBP	_	1	dep	_	_
20	antibodies	_	NNS	NNS	_	19	dobj	_	_
21	against	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	enzyme	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	19	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	gene	_	NN	NN	_	13	nsubjpass	_	_
3	encoding	_	VBG	VBG	_	2	vmod	_	_
4	the	_	DT	DT	_	11	det	_	_
5	Epstein-Barr	_	JJ	JJ	_	6	amod	_	_
6	virus	_	NN	NN	_	10	dep	_	_
7	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
8	EBV	_	NN	NN	_	10	npadvmod	_	_
9	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
10	-specific	_	JJ	JJ	_	11	amod	_	_
11	dUTPase	_	NN	NN	_	3	dobj	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	amplified	_	VBN	VBN	_	0	root	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	virus	_	NN	NN	_	16	nn	_	_
16	DNA	_	NN	NN	_	14	pobj	_	_
17	by	_	IN	IN	_	13	prep	_	_
18	PCR	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	active	_	JJ	JJ	_	3	amod	_	_
3	enzyme	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	expressed	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	Escherichia	_	FW	FW	_	8	nn	_	_
8	coli	_	FW	FW	_	6	pobj	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	in	_	IN	IN	_	6	conj	_	_
11	insect	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	as	_	IN	IN	_	5	prep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	non-fusion	_	JJ	JJ	_	16	amod	_	_
16	protein	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	protein	_	NN	NN	_	7	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	E.	_	FW	FW	_	5	nn	_	_
5	coli	_	FW	FW	_	3	pobj	_	_
6	specifically	_	RB	RB	_	7	advmod	_	_
7	converted	_	VBD	VBD	_	0	root	_	_
8	dUTP	_	NN	NN	_	7	dobj	_	_
9	to	_	TO	TO	_	7	prep	_	_
10	dUMP	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	did	_	VBD	VBD	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	react	_	VB	VB	_	7	conj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	other	_	JJ	JJ	_	17	amod	_	_
17	dNTPs	_	NNS	NNS	_	15	pobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	NTPs	_	NNS	NNS	_	17	conj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Preliminary	_	JJ	JJ	_	2	amod	_	_
2	experiments	_	NNS	NNS	_	3	nsubj	_	_
3	yielded	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	Km	_	NN	NN	_	6	nn	_	_
6	value	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	about	_	RB	RB	_	9	quantmod	_	_
9	0.8	_	CD	CD	_	10	num	_	_
10	microM	_	NN	NN	_	7	pobj	_	_
11	for	_	IN	IN	_	3	prep	_	_
12	dUTP	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	MAbs	_	NNS	NNS	_	5	nsubj	_	_
2	against	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	dUTPase	_	NN	NN	_	2	pobj	_	_
5	reacted	_	VBD	VBD	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	protein	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	approximately	_	RB	RB	_	11	quantmod	_	_
11	31	_	CD	CD	_	12	num	_	_
12	kDa	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	12-O-tetradecanoyl-phorbol-13-acetate	_	NN	NN	_	18	dep	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	TPA	_	NN	NN	_	18	npadvmod	_	_
17	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
18	-stimulated	_	JJ	JJ	_	20	amod	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	13	pobj	_	_
21	harbouring	_	VBG	VBG	_	20	vmod	_	_
22	either	_	CC	CC	_	23	preconj	_	_
23	type	_	NN	NN	_	28	nn	_	_
24	1	_	CD	CD	_	23	num	_	_
25	or	_	CC	CC	_	23	cc	_	_
26	type	_	NN	NN	_	23	conj	_	_
27	2	_	CD	CD	_	26	num	_	_
28	EBV	_	NN	NN	_	21	dobj	_	_
29	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	protein	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	found	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	untreated	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	at	_	IN	IN	_	4	prep	_	_
9	low	_	JJ	JJ	_	10	amod	_	_
10	levels	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	whereas	_	IN	IN	_	4	dep	_	_
13	induction	_	NN	NN	_	32	nsubj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	lytic	_	JJ	JJ	_	18	amod	_	_
17	replication	_	NN	NN	_	18	nn	_	_
18	cycle	_	NN	NN	_	14	pobj	_	_
19	by	_	IN	IN	_	13	prep	_	_
20	TPA	_	NN	NN	_	21	nn	_	_
21	treatment	_	NN	NN	_	19	pobj	_	_
22	or	_	CC	CC	_	19	cc	_	_
23	by	_	IN	IN	_	19	conj	_	_
24	providing	_	VBG	VBG	_	23	pcomp	_	_
25	the	_	DT	DT	_	29	det	_	_
26	immediate	_	JJ	JJ	_	29	amod	_	_
27	early	_	JJ	JJ	_	29	amod	_	_
28	transactivator	_	NN	NN	_	29	nn	_	_
29	BZLF1	_	NN	NN	_	24	dobj	_	_
30	in	_	IN	IN	_	13	prep	_	_
31	trans	_	NN	NN	_	30	pobj	_	_
32	resulted	_	VBD	VBD	_	4	parataxis	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	increased	_	VBN	VBN	_	35	amod	_	_
35	expression	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrated	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	13	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	virus	_	NN	NN	_	6	nn	_	_
6	dUTPase	_	NN	NN	_	13	nsubj	_	_
7	isolated	_	VBN	VBN	_	6	vmod	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	EBV-infected	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	13	cop	_	_
12	a	_	DT	DT	_	13	det	_	_
13	phosphoprotein	_	NN	NN	_	2	ccomp	_	_
14	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	protein	_	NN	NN	_	8	nsubjpass	_	_
3	expressed	_	VBN	VBN	_	2	vmod	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	insect	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	used	_	VBN	VBN	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	test	_	VB	VB	_	8	xcomp	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	presence	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	specific	_	JJ	JJ	_	16	amod	_	_
16	antibodies	_	NNS	NNS	_	14	pobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	sera	_	NN	NN	_	17	pobj	_	_
19	from	_	IN	IN	_	18	prep	_	_
20	normal	_	JJ	JJ	_	23	amod	_	_
21	,	_	,	,	_	20	punct	_	_
22	healthy	_	JJ	JJ	_	20	dep	_	_
23	carriers	_	NNS	NNS	_	19	pobj	_	_
24	and	_	CC	CC	_	19	cc	_	_
25	from	_	IN	IN	_	19	conj	_	_
26	patients	_	NNS	NNS	_	25	pobj	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	various	_	JJ	JJ	_	29	amod	_	_
29	diseases	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	8	punct	_	_

1	While	_	IN	IN	_	18	mark	_	_
2	the	_	DT	DT	_	3	det	_	_
3	sera	_	NN	NN	_	18	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	EBV-negative	_	JJ	JJ	_	6	amod	_	_
6	individuals	_	NNS	NNS	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	0/3	_	CD	CD	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	or	_	CC	CC	_	6	cc	_	_
11	healthy	_	JJ	JJ	_	12	amod	_	_
12	carriers	_	NNS	NNS	_	6	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	0/33	_	CD	CD	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	did	_	VBD	VBD	_	18	aux	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	contain	_	VB	VB	_	51	advcl	_	_
19	detectable	_	JJ	JJ	_	20	amod	_	_
20	levels	_	NNS	NNS	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	antibodies	_	NNS	NNS	_	21	pobj	_	_
23	,	_	,	,	_	51	punct	_	_
24	patients	_	NNS	NNS	_	51	nsubj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	mononucleosis	_	NN	NN	_	25	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	5/18	_	CD	CD	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	,	_	,	,	_	26	punct	_	_
31	chronic	_	JJ	JJ	_	33	amod	_	_
32	EBV	_	NN	NN	_	33	nn	_	_
33	infection	_	NN	NN	_	26	conj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	2/7	_	CD	CD	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	,	_	,	,	_	26	punct	_	_
38	EBV	_	NN	NN	_	39	nn	_	_
39	reactivation	_	NN	NN	_	26	conj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	7/20	_	CD	CD	_	39	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	and	_	CC	CC	_	26	cc	_	_
44	human	_	JJ	JJ	_	47	amod	_	_
45	immunodeficiency	_	NN	NN	_	47	nn	_	_
46	virus	_	NN	NN	_	47	nn	_	_
47	infection	_	NN	NN	_	26	conj	_	_
48	-LRB-	_	-LRB-	-LRB-	_	49	punct	_	_
49	5/24	_	CD	CD	_	47	appos	_	_
50	-RRB-	_	-RRB-	-RRB-	_	49	punct	_	_
51	showed	_	VBD	VBD	_	0	root	_	_
52	elevated	_	JJ	JJ	_	54	amod	_	_
53	antibody	_	NN	NN	_	54	nn	_	_
54	titres	_	NNS	NNS	_	51	dobj	_	_
55	against	_	IN	IN	_	54	prep	_	_
56	the	_	DT	DT	_	57	det	_	_
57	enzyme	_	NN	NN	_	55	pobj	_	_
58	.	_	.	.	_	51	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	indicated	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	the	_	DT	DT	_	5	det	_	_
5	dUTPase	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	expressed	_	VBN	VBN	_	2	ccomp	_	_
8	during	_	IN	IN	_	7	prep	_	_
9	EBV	_	NN	NN	_	8	pobj	_	_
10	replication	_	NN	NN	_	9	dep	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	reactivation	_	NN	NN	_	10	conj	_	_
13	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	enzyme	_	NN	NN	_	8	nsubj	_	_
3	might	_	MD	MD	_	8	aux	_	_
4	therefore	_	RB	RB	_	8	advmod	_	_
5	be	_	VB	VB	_	8	cop	_	_
6	a	_	DT	DT	_	8	det	_	_
7	potential	_	JJ	JJ	_	8	amod	_	_
8	target	_	NN	NN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	drug	_	NN	NN	_	11	nn	_	_
11	therapy	_	NN	NN	_	9	pobj	_	_
12	under	_	IN	IN	_	8	prep	_	_
13	conditions	_	NNS	NNS	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	active	_	JJ	JJ	_	17	amod	_	_
16	DNA	_	NN	NN	_	17	nn	_	_
17	replication	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	Prostaglandin	_	NN	NN	_	3	nn	_	_
2	E2	_	NN	NN	_	3	nn	_	_
3	induction	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	activity	_	NN	NN	_	4	pobj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	CRE	_	NN	NN	_	11	nn	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	AP-2	_	NN	NN	_	8	conj	_	_
11	elements	_	NNS	NNS	_	7	pobj	_	_
12	in	_	IN	IN	_	3	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Prostaglandins	_	NNP	NNP	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	E	_	NN	NN	_	5	nn	_	_
5	series	_	NNS	NNS	_	2	pobj	_	_
6	are	_	VBP	VBP	_	8	cop	_	_
7	immunomodulatory	_	JJ	JJ	_	8	amod	_	_
8	agents	_	NNS	NNS	_	0	root	_	_
9	which	_	WDT	WDT	_	10	nsubj	_	_
10	exert	_	VBP	VBP	_	8	rcmod	_	_
11	inhibitory	_	JJ	JJ	_	16	amod	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	11	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	stimulatory	_	JJ	JJ	_	11	conj	_	_
16	effects	_	NNS	NNS	_	10	dobj	_	_
17	on	_	IN	IN	_	10	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	variety	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	immune	_	JJ	JJ	_	22	amod	_	_
22	responses	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	Since	_	IN	IN	_	4	mark	_	_
2	it	_	PRP	PRP	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	known	_	VBN	VBN	_	15	advcl	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	PGE2	_	NN	NN	_	8	nsubj	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	able	_	JJ	JJ	_	4	ccomp	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	increase	_	VB	VB	_	8	xcomp	_	_
11	cAMP	_	NN	NN	_	12	nn	_	_
12	levels	_	NNS	NNS	_	10	dobj	_	_
13	,	_	,	,	_	15	punct	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	investigated	_	VBD	VBD	_	0	root	_	_
16	whether	_	IN	IN	_	19	mark	_	_
17	it	_	PRP	PRP	_	19	nsubj	_	_
18	can	_	MD	MD	_	19	aux	_	_
19	affect	_	VB	VB	_	15	ccomp	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	19	dobj	_	_
22	through	_	IN	IN	_	19	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	activation	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	transcription	_	NN	NN	_	28	nn	_	_
28	factors	_	NNS	NNS	_	25	pobj	_	_
29	which	_	WDT	WDT	_	30	nsubj	_	_
30	bind	_	VBP	VBP	_	28	rcmod	_	_
31	enhancer	_	NN	NN	_	32	nn	_	_
32	elements	_	NNS	NNS	_	30	dobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	promoter	_	NN	NN	_	36	nn	_	_
36	regions	_	NNS	NNS	_	33	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	cAMP-regulated	_	JJ	JJ	_	39	amod	_	_
39	genes	_	NNS	NNS	_	37	pobj	_	_
40	.	_	.	.	_	15	punct	_	_

1	Using	_	VBG	VBG	_	8	vmod	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	assay	_	NN	NN	_	1	dobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	demonstrated	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	19	mark	_	_
10	a	_	DT	DT	_	12	det	_	_
11	short	_	JJ	JJ	_	12	amod	_	_
12	treatment	_	NN	NN	_	19	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	human	_	JJ	JJ	_	16	amod	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
17	with	_	IN	IN	_	12	prep	_	_
18	PGE2	_	NN	NN	_	17	pobj	_	_
19	induces	_	VBZ	VBZ	_	8	ccomp	_	_
20	specific	_	JJ	JJ	_	22	amod	_	_
21	binding	_	NN	NN	_	22	nn	_	_
22	activity	_	NN	NN	_	19	dobj	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	CRE	_	NN	NN	_	33	nn	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	AP-2	_	NN	NN	_	24	conj	_	_
27	,	_	,	,	_	26	punct	_	_
28	but	_	CC	CC	_	29	cc	_	_
29	not	_	RB	RB	_	26	appos	_	_
30	AP-1	_	NN	NN	_	26	dep	_	_
31	,	_	,	,	_	26	punct	_	_
32	DNA	_	NN	NN	_	33	nn	_	_
33	elements	_	NNS	NNS	_	23	pobj	_	_
34	.	_	.	.	_	8	punct	_	_

1	Since	_	IN	IN	_	12	mark	_	_
2	the	_	DT	DT	_	4	det	_	_
3	okadaic	_	JJ	JJ	_	4	amod	_	_
4	acid	_	NN	NN	_	12	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	a	_	DT	DT	_	10	det	_	_
7	potent	_	JJ	JJ	_	10	amod	_	_
8	protein	_	NN	NN	_	10	nn	_	_
9	phosphatase	_	NN	NN	_	10	nn	_	_
10	inhibitor	_	NN	NN	_	4	appos	_	_
11	,	_	,	,	_	4	punct	_	_
12	prolongs	_	VBZ	VBZ	_	23	advcl	_	_
13	the	_	DT	DT	_	14	det	_	_
14	induction	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	binding	_	NN	NN	_	18	nn	_	_
18	activity	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	23	punct	_	_
20	phosphorylation	_	NN	NN	_	21	nn	_	_
21	events	_	NNS	NNS	_	23	nsubj	_	_
22	are	_	VBP	VBP	_	23	cop	_	_
23	likely	_	JJ	JJ	_	0	root	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	occur	_	VB	VB	_	23	xcomp	_	_
26	.	_	.	.	_	23	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	activity	_	NN	NN	_	3	nsubj	_	_
3	seems	_	VBZ	VBZ	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	be	_	VB	VB	_	3	xcomp	_	_
6	due	_	JJ	JJ	_	7	mwe	_	_
7	to	_	TO	TO	_	5	prep	_	_
8	increased	_	VBN	VBN	_	10	amod	_	_
9	cAMP	_	NN	NN	_	10	nn	_	_
10	levels	_	NNS	NNS	_	7	pobj	_	_
11	because	_	IN	IN	_	15	mark	_	_
12	forskolin	_	NN	NN	_	15	nsubj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	IBMX	_	NN	NN	_	12	conj	_	_
15	mimic	_	VBP	VBP	_	5	advcl	_	_
16	the	_	DT	DT	_	17	det	_	_
17	effects	_	NNS	NNS	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	PGE2	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	More	_	RBR	RBR	_	2	advmod	_	_
2	interestingly	_	RB	RB	_	9	advmod	_	_
3	,	_	,	,	_	9	punct	_	_
4	transfection	_	NN	NN	_	5	nn	_	_
5	experiments	_	NNS	NNS	_	9	nsubj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	CRE-CAT	_	NN	NN	_	8	nn	_	_
8	plasmide	_	NN	NN	_	6	pobj	_	_
9	show	_	VBP	VBP	_	0	root	_	_
10	that	_	IN	IN	_	12	mark	_	_
11	PGE2	_	NN	NN	_	12	nsubj	_	_
12	activates	_	VBZ	VBZ	_	9	ccomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	transcription	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	CRE-containing	_	NN	NN	_	18	nn	_	_
18	promoter	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	support	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	positive	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	PGE2	_	NN	NN	_	7	pobj	_	_
9	on	_	IN	IN	_	6	prep	_	_
10	some	_	DT	DT	_	12	det	_	_
11	immune	_	JJ	JJ	_	12	amod	_	_
12	functions	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cytokine	_	NN	NN	_	7	nn	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	cytokine	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	3	conj	_	_
7	expression	_	NN	NN	_	2	pobj	_	_
8	by	_	IN	IN	_	1	prep	_	_
9	glucocorticoids	_	NNS	NNS	_	8	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	6	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	GCS	_	NNS	NNS	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	profoundly	_	RB	RB	_	6	advmod	_	_
6	inhibit	_	VBP	VBP	_	0	root	_	_
7	several	_	JJ	JJ	_	8	amod	_	_
8	aspects	_	NNS	NNS	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	T	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	immunity	_	NN	NN	_	9	pobj	_	_
13	largely	_	RB	RB	_	14	advmod	_	_
14	through	_	IN	IN	_	6	prep	_	_
15	inhibition	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	cytokine	_	NN	NN	_	18	nn	_	_
18	expression	_	NN	NN	_	16	pobj	_	_
19	at	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	24	det	_	_
21	transcriptional	_	JJ	JJ	_	24	amod	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	posttranscriptional	_	JJ	JJ	_	21	conj	_	_
24	levels	_	NNS	NNS	_	19	pobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	GCS	_	NNS	NNS	_	4	nsubjpass	_	_
2	were	_	VBD	VBD	_	4	auxpass	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	reported	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	act	_	VB	VB	_	4	xcomp	_	_
7	indirectly	_	RB	RB	_	6	advmod	_	_
8	by	_	IN	IN	_	6	prep	_	_
9	inducing	_	VBG	VBG	_	8	pcomp	_	_
10	transforming	_	VBG	VBG	_	13	amod	_	_
11	growth	_	NN	NN	_	13	nn	_	_
12	factor-beta	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	9	dobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	which	_	WDT	WDT	_	18	nsubj	_	_
16	in	_	IN	IN	_	18	prep	_	_
17	turn	_	NN	NN	_	16	pobj	_	_
18	blocks	_	VBZ	VBZ	_	13	rcmod	_	_
19	T	_	NN	NN	_	21	nn	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	immunity	_	NN	NN	_	18	dobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	exerting	_	VBG	VBG	_	1	pcomp	_	_
3	their	_	PRP$	PRP$	_	5	poss	_	_
4	antiproliferative	_	JJ	JJ	_	5	amod	_	_
5	effects	_	NNS	NNS	_	2	dobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	GCS	_	NNS	NNS	_	8	nsubj	_	_
8	diffuse	_	VBP	VBP	_	0	root	_	_
9	into	_	IN	IN	_	8	prep	_	_
10	target	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	where	_	WRB	WRB	_	14	advmod	_	_
13	they	_	PRP	PRP	_	14	nsubj	_	_
14	bind	_	VBP	VBP	_	11	rcmod	_	_
15	their	_	PRP$	PRP$	_	17	poss	_	_
16	cytoplasmic	_	JJ	JJ	_	17	amod	_	_
17	receptor	_	NN	NN	_	14	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	which	_	WDT	WDT	_	22	nsubj	_	_
20	in	_	IN	IN	_	22	prep	_	_
21	turn	_	NN	NN	_	20	pobj	_	_
22	translocates	_	VBZ	VBZ	_	17	rcmod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	nucleus	_	NN	NN	_	23	pobj	_	_
26	where	_	WRB	WRB	_	28	advmod	_	_
27	it	_	PRP	PRP	_	28	nsubj	_	_
28	inhibits	_	VBZ	VBZ	_	25	rcmod	_	_
29	transcription	_	NN	NN	_	28	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	cytokine	_	NN	NN	_	32	nn	_	_
32	genes	_	NNS	NNS	_	30	pobj	_	_
33	through	_	IN	IN	_	28	prep	_	_
34	direct	_	JJ	JJ	_	35	amod	_	_
35	binding	_	NN	NN	_	33	pobj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	the	_	DT	DT	_	40	det	_	_
38	glucocorticoid	_	NN	NN	_	40	nn	_	_
39	response	_	NN	NN	_	40	nn	_	_
40	elements	_	NNS	NNS	_	36	pobj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	42	punct	_	_
42	GRE	_	NN	NN	_	40	appos	_	_
43	-RRB-	_	-RRB-	-RRB-	_	42	punct	_	_
44	,	_	,	,	_	40	punct	_	_
45	which	_	WDT	WDT	_	47	nsubj	_	_
46	are	_	VBP	VBP	_	47	cop	_	_
47	located	_	JJ	JJ	_	40	rcmod	_	_
48	in	_	IN	IN	_	47	prep	_	_
49	the	_	DT	DT	_	51	det	_	_
50	promoter	_	NN	NN	_	51	nn	_	_
51	region	_	NN	NN	_	48	pobj	_	_
52	of	_	IN	IN	_	51	prep	_	_
53	cytokine	_	NN	NN	_	54	nn	_	_
54	genes	_	NNS	NNS	_	52	pobj	_	_
55	or	_	CC	CC	_	33	cc	_	_
56	,	_	,	,	_	33	punct	_	_
57	alternatively	_	RB	RB	_	59	advmod	_	_
58	,	_	,	,	_	59	punct	_	_
59	through	_	IN	IN	_	33	conj	_	_
60	antagonism	_	NN	NN	_	59	pobj	_	_
61	of	_	IN	IN	_	60	prep	_	_
62	the	_	DT	DT	_	63	det	_	_
63	action	_	NN	NN	_	61	pobj	_	_
64	of	_	IN	IN	_	63	prep	_	_
65	transcription	_	NN	NN	_	66	nn	_	_
66	factors	_	NNS	NNS	_	64	pobj	_	_
67	required	_	VBN	VBN	_	66	vmod	_	_
68	for	_	IN	IN	_	67	prep	_	_
69	optimal	_	JJ	JJ	_	71	amod	_	_
70	transcriptional	_	JJ	JJ	_	71	amod	_	_
71	activation	_	NN	NN	_	68	pobj	_	_
72	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	dep	_	_
3	to	_	TO	TO	_	1	dep	_	_
4	their	_	PRP$	PRP$	_	6	poss	_	_
5	inhibitory	_	JJ	JJ	_	6	amod	_	_
6	effects	_	NNS	NNS	_	1	pobj	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	cytokine	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	GCS	_	NNS	NNS	_	12	nsubj	_	_
12	up-regulate	_	VBP	VBP	_	0	root	_	_
13	cytokine	_	NN	NN	_	15	nn	_	_
14	receptor	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	12	dobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	correlates	_	VBZ	VBZ	_	15	rcmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	enhanced	_	VBN	VBN	_	21	amod	_	_
20	cytokine	_	NN	NN	_	21	nn	_	_
21	effects	_	NNS	NNS	_	18	pobj	_	_
22	on	_	IN	IN	_	21	prep	_	_
23	target	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	review	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	summarize	_	VBP	VBP	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	current	_	JJ	JJ	_	9	amod	_	_
9	state	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	knowledge	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	mechanism	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	action	_	NN	NN	_	15	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	GCS	_	NNS	NNS	_	17	pobj	_	_
19	,	_	,	,	_	16	punct	_	_
20	including	_	VBG	VBG	_	16	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	phenomenon	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	steroid-induced	_	JJ	JJ	_	25	amod	_	_
25	rebound	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	16	punct	_	_
27	which	_	WDT	WDT	_	28	nsubj	_	_
28	ensues	_	VBZ	VBZ	_	16	rcmod	_	_
29	upon	_	IN	IN	_	28	prep	_	_
30	GCS	_	NNS	NNS	_	31	nn	_	_
31	withdrawal	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	Oct-2	_	NN	NN	_	4	nn	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	0	root	_	_
5	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	Oct-2	_	NN	NN	_	4	nn	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	7	nsubj	_	_
5	is	_	VBZ	VBZ	_	7	cop	_	_
6	a	_	DT	DT	_	7	det	_	_
7	member	_	NN	NN	_	0	root	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	14	det	_	_
10	POU	_	NN	NN	_	14	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	Pit-Oct-Unc	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	family	_	NN	NN	_	8	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	transcription	_	NN	NN	_	17	nn	_	_
17	factors	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	7	cc	_	_
19	is	_	VBZ	VBZ	_	20	auxpass	_	_
20	expressed	_	VBN	VBN	_	7	conj	_	_
21	only	_	RB	RB	_	22	advmod	_	_
22	in	_	IN	IN	_	20	prep	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	lymphocytes	_	NNS	NNS	_	22	pobj	_	_
25	and	_	CC	CC	_	22	cc	_	_
26	in	_	IN	IN	_	22	conj	_	_
27	neuronal	_	JJ	JJ	_	28	amod	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	but	_	CC	CC	_	22	cc	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	in	_	IN	IN	_	22	conj	_	_
32	other	_	JJ	JJ	_	34	amod	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	types	_	NNS	NNS	_	31	pobj	_	_
35	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	primary	_	JJ	JJ	_	4	amod	_	_
3	RNA	_	NN	NN	_	4	nn	_	_
4	transcript	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	gene	_	NN	NN	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	subject	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	alternative	_	JJ	JJ	_	12	amod	_	_
12	splicing	_	NN	NN	_	10	pobj	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	yield	_	VB	VB	_	9	xcomp	_	_
15	different	_	JJ	JJ	_	16	amod	_	_
16	variants	_	NNS	NNS	_	14	dobj	_	_
17	which	_	WDT	WDT	_	20	nsubj	_	_
18	can	_	MD	MD	_	20	aux	_	_
19	either	_	CC	CC	_	20	preconj	_	_
20	activate	_	VBP	VBP	_	16	rcmod	_	_
21	or	_	CC	CC	_	20	cc	_	_
22	repress	_	VBP	VBP	_	20	conj	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	20	dobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	forms	_	NNS	NNS	_	7	nsubj	_	_
3	produced	_	VBN	VBN	_	2	vmod	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	lymphocytes	_	NNS	NNS	_	4	pobj	_	_
7	have	_	VBP	VBP	_	0	root	_	_
8	a	_	DT	DT	_	11	det	_	_
9	predominantly	_	RB	RB	_	10	advmod	_	_
10	activating	_	JJ	JJ	_	11	amod	_	_
11	effect	_	NN	NN	_	7	dobj	_	_
12	on	_	IN	IN	_	7	prep	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	12	pobj	_	_
15	whereas	_	IN	IN	_	7	dep	_	_
16	those	_	DT	DT	_	21	nsubj	_	_
17	produced	_	VBN	VBN	_	16	vmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	neuronal	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	have	_	VBP	VBP	_	7	parataxis	_	_
22	a	_	DT	DT	_	25	det	_	_
23	predominantly	_	RB	RB	_	24	advmod	_	_
24	inhibitory	_	JJ	JJ	_	25	amod	_	_
25	effect	_	NN	NN	_	21	dobj	_	_
26	and	_	CC	CC	_	21	cc	_	_
27	can	_	MD	MD	_	28	aux	_	_
28	repress	_	VB	VB	_	21	conj	_	_
29	the	_	DT	DT	_	30	det	_	_
30	expression	_	NN	NN	_	28	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	both	_	CC	CC	_	38	preconj	_	_
33	the	_	DT	DT	_	38	det	_	_
34	herpes	_	NN	NN	_	38	nn	_	_
35	simplex	_	NN	NN	_	38	nn	_	_
36	virus	_	NN	NN	_	38	nn	_	_
37	immediate-early	_	JJ	JJ	_	38	amod	_	_
38	genes	_	NNS	NNS	_	31	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	the	_	DT	DT	_	44	det	_	_
41	cellular	_	JJ	JJ	_	44	amod	_	_
42	tyrosine	_	NN	NN	_	44	nn	_	_
43	hydroxylase	_	NN	NN	_	44	nn	_	_
44	gene	_	NN	NN	_	38	conj	_	_
45	.	_	.	.	_	7	punct	_	_

1	Thus	_	RB	RB	_	3	advmod	_	_
2	Oct-2	_	NN	NN	_	3	nsubj	_	_
3	plays	_	VBZ	VBZ	_	0	root	_	_
4	an	_	DT	DT	_	6	det	_	_
5	important	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	in	_	IN	IN	_	3	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	regulation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cellular	_	JJ	JJ	_	13	amod	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	both	_	CC	CC	_	17	preconj	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	neuronal	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	17	conj	_	_
21	as	_	RB	RB	_	22	advmod	_	_
22	well	_	RB	RB	_	7	cc	_	_
23	as	_	IN	IN	_	22	mwe	_	_
24	in	_	IN	IN	_	7	conj	_	_
25	the	_	DT	DT	_	26	det	_	_
26	control	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	viral	_	JJ	JJ	_	29	amod	_	_
29	latency	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Tissue	_	NN	NN	_	4	npadvmod	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	cell-type	_	JJ	JJ	_	1	conj	_	_
4	specific	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	tuberous	_	JJ	JJ	_	10	amod	_	_
9	sclerosis	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	TSC2	_	NN	NN	_	10	appos	_	_
13	,	_	,	,	_	10	punct	_	_
14	in	_	IN	IN	_	5	prep	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	tissues	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	TSC2	_	NN	NN	_	4	nsubj	_	_
2	is	_	VBZ	VBZ	_	4	cop	_	_
3	a	_	DT	DT	_	4	det	_	_
4	gene	_	NN	NN	_	0	root	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	chromosome	_	NN	NN	_	7	nn	_	_
7	16p13.3	_	NN	NN	_	5	pobj	_	_
8	associated	_	VBN	VBN	_	4	vmod	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	autosomal	_	JJ	JJ	_	14	amod	_	_
12	dominant	_	JJ	JJ	_	14	amod	_	_
13	neurocutaneous	_	JJ	JJ	_	14	amod	_	_
14	disorder	_	NN	NN	_	9	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	tuberous	_	JJ	JJ	_	18	amod	_	_
17	sclerosis	_	NN	NN	_	18	nn	_	_
18	complex	_	NN	NN	_	14	appos	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	TSC	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	4	punct	_	_

1	By	_	IN	IN	_	18	prep	_	_
2	using	_	VBG	VBG	_	1	pcomp	_	_
3	a	_	DT	DT	_	6	det	_	_
4	partial	_	JJ	JJ	_	6	amod	_	_
5	nucleotide	_	JJ	JJ	_	6	amod	_	_
6	sequence	_	NN	NN	_	2	dobj	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	cloned	_	VBN	VBN	_	10	amod	_	_
10	TSC2	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	polymerase	_	NN	NN	_	15	nn	_	_
13	chain	_	NN	NN	_	15	nn	_	_
14	reaction	_	NN	NN	_	15	nn	_	_
15	methodology	_	NN	NN	_	6	conj	_	_
16	,	_	,	,	_	18	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	constructed	_	VBD	VBD	_	0	root	_	_
19	a	_	DT	DT	_	23	det	_	_
20	digoxigenin-labeled	_	JJ	JJ	_	23	amod	_	_
21	complementary	_	JJ	JJ	_	23	amod	_	_
22	DNA	_	NN	NN	_	23	nn	_	_
23	probe	_	NN	NN	_	18	dobj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	examine	_	VB	VB	_	18	vmod	_	_
26	TSC2	_	NN	NN	_	28	nn	_	_
27	gene	_	NN	NN	_	28	nn	_	_
28	expression	_	NN	NN	_	25	dobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	autopsy-	_	NN	NN	_	34	amod	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	biopsy-derived	_	JJ	JJ	_	30	conj	_	_
33	human	_	JJ	JJ	_	34	amod	_	_
34	tissues	_	NNS	NNS	_	29	pobj	_	_
35	by	_	IN	IN	_	25	prep	_	_
36	in	_	FW	FW	_	38	amod	_	_
37	situ	_	FW	FW	_	36	dep	_	_
38	hybridization	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	18	punct	_	_

1	TSC2	_	NN	NN	_	3	nn	_	_
2	messenger	_	NN	NN	_	3	nn	_	_
3	RNA	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	widely	_	RB	RB	_	6	advmod	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	various	_	JJ	JJ	_	10	amod	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	types	_	NNS	NNS	_	7	pobj	_	_
11	throughout	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	body	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	10	punct	_	_
15	including	_	VBG	VBG	_	10	prep	_	_
16	epithelia	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	lymphocytes	_	NNS	NNS	_	16	conj	_	_
19	,	_	,	,	_	16	punct	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	cells	_	NNS	NNS	_	16	conj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	endocrine	_	JJ	JJ	_	24	amod	_	_
24	functions	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	21	punct	_	_
26	e.g.	_	FW	FW	_	29	advmod	_	_
27	,	_	,	,	_	29	punct	_	_
28	adrenal	_	JJ	JJ	_	29	amod	_	_
29	cortex	_	NN	NN	_	21	appos	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	anterior	_	JJ	JJ	_	32	amod	_	_
32	pituitary	_	NN	NN	_	29	conj	_	_
33	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	13	nsubjpass	_	_
2	was	_	VBD	VBD	_	13	auxpass	_	_
3	prominently	_	RB	RB	_	13	advmod	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	selectively	_	RB	RB	_	3	conj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
7	within	_	IN	IN	_	13	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	central	_	JJ	JJ	_	11	amod	_	_
10	nervous	_	JJ	JJ	_	11	amod	_	_
11	system	_	NN	NN	_	7	pobj	_	_
12	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
13	expressed	_	VBN	VBN	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	pyramidal	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	cerebral	_	JJ	JJ	_	20	amod	_	_
20	cortex	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	other	_	JJ	JJ	_	24	amod	_	_
23	motor	_	NN	NN	_	24	nn	_	_
24	neurons	_	NNS	NNS	_	20	conj	_	_
25	,	_	,	,	_	14	punct	_	_
26	e.g.	_	FW	FW	_	28	advmod	_	_
27	,	_	,	,	_	28	punct	_	_
28	in	_	IN	IN	_	14	prep	_	_
29	spinal	_	JJ	JJ	_	30	amod	_	_
30	cord	_	NN	NN	_	28	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	brainstem	_	NN	NN	_	33	nn	_	_
33	nuclei	_	NNS	NNS	_	30	conj	_	_
34	.	_	.	.	_	13	punct	_	_

1	Visceral	_	JJ	JJ	_	3	amod	_	_
2	TSC2	_	NN	NN	_	3	nn	_	_
3	expression	_	NN	NN	_	5	nsubj	_	_
4	was	_	VBD	VBD	_	5	cop	_	_
5	comparable	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	autopsy	_	NN	NN	_	8	nn	_	_
8	tissues	_	NNS	NNS	_	6	pobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	patients	_	NNS	NNS	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	without	_	IN	IN	_	11	conj	_	_
14	TSC	_	NN	NN	_	11	dep	_	_
15	;	_	:	:	_	5	punct	_	_
16	TSC2	_	NN	NN	_	19	nn	_	_
17	messenger	_	NN	NN	_	19	nn	_	_
18	RNA	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	22	nsubj	_	_
20	was	_	VBD	VBD	_	22	cop	_	_
21	most	_	RBS	RBS	_	22	advmod	_	_
22	prominent	_	JJ	JJ	_	5	parataxis	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	cells	_	NNS	NNS	_	23	pobj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	29	det	_	_
27	rapid	_	JJ	JJ	_	29	amod	_	_
28	mitotic	_	JJ	JJ	_	29	amod	_	_
29	rate	_	NN	NN	_	25	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	turnover	_	NN	NN	_	29	conj	_	_
32	,	_	,	,	_	24	punct	_	_
33	e.g.	_	FW	FW	_	35	advmod	_	_
34	,	_	,	,	_	35	punct	_	_
35	epithelia	_	NN	NN	_	24	appos	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	lymphocytes	_	NNS	NNS	_	35	conj	_	_
38	,	_	,	,	_	24	punct	_	_
39	with	_	IN	IN	_	24	prep	_	_
40	central	_	JJ	JJ	_	42	amod	_	_
41	nervous	_	JJ	JJ	_	42	amod	_	_
42	system	_	NN	NN	_	51	nsubj	_	_
43	pyramidal	_	JJ	JJ	_	44	amod	_	_
44	cells	_	NNS	NNS	_	42	dep	_	_
45	and	_	CC	CC	_	44	cc	_	_
46	other	_	JJ	JJ	_	47	amod	_	_
47	neurons	_	NNS	NNS	_	44	conj	_	_
48	being	_	VBG	VBG	_	51	cop	_	_
49	an	_	DT	DT	_	51	det	_	_
50	obvious	_	JJ	JJ	_	51	amod	_	_
51	exception	_	NN	NN	_	39	pcomp	_	_
52	,	_	,	,	_	23	punct	_	_
53	and/or	_	CC	CC	_	23	cc	_	_
54	in	_	IN	IN	_	23	conj	_	_
55	cells	_	NNS	NNS	_	54	pobj	_	_
56	with	_	IN	IN	_	55	prep	_	_
57	important	_	JJ	JJ	_	59	amod	_	_
58	secretory/transport	_	NN	NN	_	59	nn	_	_
59	functions	_	NNS	NNS	_	56	pobj	_	_
60	.	_	.	.	_	22	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	widespread	_	JJ	JJ	_	3	amod	_	_
3	expression	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	TSC2	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	4	pobj	_	_
8	supports	_	VBZ	VBZ	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	view	_	NN	NN	_	8	dobj	_	_
11	that	_	IN	IN	_	13	mark	_	_
12	it	_	PRP	PRP	_	13	nsubj	_	_
13	encodes	_	VBZ	VBZ	_	10	ccomp	_	_
14	a	_	DT	DT	_	15	det	_	_
15	protein	_	NN	NN	_	13	dobj	_	_
16	vital	_	JJ	JJ	_	15	amod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	cell	_	NN	NN	_	17	pobj	_	_
19	growth	_	NN	NN	_	18	dep	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	metabolism	_	NN	NN	_	19	conj	_	_
22	or	_	CC	CC	_	15	cc	_	_
23	one	_	CD	CD	_	15	conj	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	functions	_	VBZ	VBZ	_	23	rcmod	_	_
26	as	_	IN	IN	_	25	prep	_	_
27	a	_	DT	DT	_	29	det	_	_
28	tumor/growth	_	NN	NN	_	29	nn	_	_
29	suppressor	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	8	punct	_	_

1	Cell	_	NN	NN	_	3	nn	_	_
2	specific	_	JJ	JJ	_	3	amod	_	_
3	expression	_	NN	NN	_	16	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	11	amod	_	_
6	Bruton	_	NN	NN	_	11	poss	_	_
7	's	_	POS	POS	_	6	possessive	_	_
8	agammaglobulinemia	_	NN	NN	_	11	nn	_	_
9	tyrosine	_	NN	NN	_	11	nn	_	_
10	kinase	_	NN	NN	_	11	nn	_	_
11	gene	_	NN	NN	_	4	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	Btk	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	regulated	_	VBN	VBN	_	0	root	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	Sp1-	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	Spi-1/PU.1-family	_	NN	NN	_	21	nn	_	_
21	members	_	NNS	NNS	_	18	conj	_	_
22	.	_	.	.	_	16	punct	_	_

1	Bruton	_	NN	NN	_	5	poss	_	_
2	's	_	POS	POS	_	1	possessive	_	_
3	agammaglobulinemia	_	NN	NN	_	5	nn	_	_
4	tyrosine	_	NN	NN	_	5	nn	_	_
5	kinase	_	NN	NN	_	13	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	Btk	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	is	_	VBZ	VBZ	_	13	cop	_	_
10	a	_	DT	DT	_	13	det	_	_
11	cytoplasmic	_	JJ	JJ	_	13	amod	_	_
12	tyrosine	_	NN	NN	_	13	nn	_	_
13	kinase	_	NN	NN	_	0	root	_	_
14	involved	_	VBN	VBN	_	13	vmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	human	_	JJ	JJ	_	18	amod	_	_
18	disease	_	NN	NN	_	15	pobj	_	_
19	X-linked	_	JJ	JJ	_	20	amod	_	_
20	agammaglobulinemia	_	NN	NN	_	18	dep	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	XLA	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	gene	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	expressed	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	all	_	DT	DT	_	8	det	_	_
7	hematopoietic	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	exception	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	T-cells	_	NNS	NNS	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	plasma	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	conj	_	_
17	.	_	.	.	_	4	punct	_	_

1	For	_	IN	IN	_	16	prep	_	_
2	this	_	DT	DT	_	4	det	_	_
3	expression	_	NN	NN	_	4	nn	_	_
4	pattern	_	NN	NN	_	1	pobj	_	_
5	the	_	DT	DT	_	8	det	_	_
6	first	_	JJ	JJ	_	8	amod	_	_
7	280	_	CD	CD	_	8	num	_	_
8	bp	_	NN	NN	_	16	nsubj	_	_
9	upstream	_	JJ	JJ	_	8	amod	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	major	_	JJ	JJ	_	15	amod	_	_
13	transcriptional	_	JJ	JJ	_	15	amod	_	_
14	start	_	NN	NN	_	15	nn	_	_
15	site	_	NN	NN	_	10	pobj	_	_
16	seems	_	VBZ	VBZ	_	0	root	_	_
17	to	_	TO	TO	_	19	aux	_	_
18	be	_	VB	VB	_	19	cop	_	_
19	sufficient	_	JJ	JJ	_	16	xcomp	_	_
20	.	_	.	.	_	16	punct	_	_

1	In	_	FW	FW	_	4	amod	_	_
2	vitro	_	FW	FW	_	1	dep	_	_
3	footprinting	_	NN	NN	_	4	nn	_	_
4	analysis	_	NN	NN	_	11	nsubj	_	_
5	within	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	7	det	_	_
7	part	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	promoter	_	NN	NN	_	8	pobj	_	_
11	revealed	_	VBD	VBD	_	0	root	_	_
12	two	_	CD	CD	_	15	num	_	_
13	Sp1	_	NN	NN	_	15	nn	_	_
14	binding	_	NN	NN	_	15	nn	_	_
15	sites	_	NNS	NNS	_	11	dobj	_	_
16	as	_	RB	RB	_	17	advmod	_	_
17	well	_	RB	RB	_	15	cc	_	_
18	as	_	IN	IN	_	17	mwe	_	_
19	a	_	DT	DT	_	20	det	_	_
20	PU-box	_	NN	NN	_	15	conj	_	_
21	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	transcription	_	NN	NN	_	4	nn	_	_
3	factor	_	NN	NN	_	4	nn	_	_
4	Spi-1/PU.1	_	NN	NN	_	13	nsubj	_	_
5	as	_	RB	RB	_	6	advmod	_	_
6	well	_	RB	RB	_	4	cc	_	_
7	as	_	IN	IN	_	6	mwe	_	_
8	the	_	DT	DT	_	12	det	_	_
9	closely	_	RB	RB	_	10	advmod	_	_
10	related	_	JJ	JJ	_	12	amod	_	_
11	factor	_	NN	NN	_	12	nn	_	_
12	Spi-B	_	NN	NN	_	4	conj	_	_
13	bound	_	VBD	VBD	_	0	root	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	PU-box	_	NN	NN	_	14	pobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	B-cells	_	NNS	NNS	_	17	pobj	_	_
19	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	the	_	DT	DT	_	6	det	_	_
3	erythroleukemia	_	NN	NN	_	6	nn	_	_
4	cell	_	NN	NN	_	6	nn	_	_
5	line	_	NN	NN	_	6	nn	_	_
6	K562	_	NN	NN	_	1	pobj	_	_
7	,	_	,	,	_	17	punct	_	_
8	due	_	IN	IN	_	17	prep	_	_
9	to	_	TO	TO	_	8	dep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	absence	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Spi-B	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	17	punct	_	_
15	only	_	RB	RB	_	16	advmod	_	_
16	PU.1	_	NN	NN	_	17	nsubj	_	_
17	bound	_	VBD	VBD	_	0	root	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	Btk	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	17	punct	_	_

1	Mutation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	either	_	DT	DT	_	4	det	_	_
4	site	_	NN	NN	_	2	pobj	_	_
5	reduced	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	transient	_	JJ	JJ	_	11	amod	_	_
10	transfection	_	NN	NN	_	11	nn	_	_
11	experiments	_	NNS	NNS	_	8	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	mutation	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	PU	_	NN	NN	_	7	nn	_	_
7	box	_	NN	NN	_	4	pobj	_	_
8	had	_	VBD	VBD	_	0	root	_	_
9	no	_	DT	DT	_	10	neg	_	_
10	effect	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	T-cell	_	NN	NN	_	15	nn	_	_
14	line	_	NN	NN	_	15	nn	_	_
15	Jurkat	_	NN	NN	_	11	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	where	_	WRB	WRB	_	25	advmod	_	_
18	none	_	NN	NN	_	25	nsubjpass	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	Spi-1	_	NN	NN	_	23	nn	_	_
22	family	_	NN	NN	_	23	nn	_	_
23	members	_	NNS	NNS	_	19	pobj	_	_
24	is	_	VBZ	VBZ	_	25	auxpass	_	_
25	expressed	_	VBN	VBN	_	15	rcmod	_	_
26	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	Spi-B	_	NN	NN	_	9	nsubj	_	_
4	as	_	RB	RB	_	5	advmod	_	_
5	well	_	RB	RB	_	3	cc	_	_
6	as	_	IN	IN	_	5	mwe	_	_
7	PU.1	_	NN	NN	_	3	conj	_	_
8	were	_	VBD	VBD	_	9	cop	_	_
9	able	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	transactivate	_	VB	VB	_	9	xcomp	_	_
12	Btk	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	dobj	_	_
14	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	19	prep	_	_
2	fetal	_	JJ	JJ	_	3	amod	_	_
3	liver	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	PU.1-/-	_	JJ	JJ	_	6	amod	_	_
6	mice	_	NNS	NNS	_	4	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	which	_	WDT	WDT	_	9	nsubj	_	_
9	lack	_	VBP	VBP	_	6	rcmod	_	_
10	lymphoid	_	JJ	JJ	_	13	amod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	myeloid	_	JJ	JJ	_	10	conj	_	_
13	cells	_	NNS	NNS	_	9	dobj	_	_
14	,	_	,	,	_	19	punct	_	_
15	expression	_	NN	NN	_	19	nsubjpass	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	Btk	_	NN	NN	_	16	pobj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	reduced	_	VBN	VBN	_	0	root	_	_
20	two-	_	CD	CD	_	19	advmod	_	_
21	to	_	TO	TO	_	20	dep	_	_
22	threefold	_	RB	RB	_	20	advmod	_	_
23	but	_	CC	CC	_	19	cc	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	abolished	_	VBN	VBN	_	19	conj	_	_
26	.	_	.	.	_	19	punct	_	_

1	Collectively	_	RB	RB	_	4	advmod	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	shows	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	expression	_	NN	NN	_	12	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	Btk	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	7	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	regulated	_	VBN	VBN	_	4	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	combined	_	JJ	JJ	_	16	amod	_	_
16	action	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	Sp1-	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	PU.1-family	_	NN	NN	_	21	nn	_	_
21	members	_	NNS	NNS	_	18	conj	_	_
22	.	_	.	.	_	4	punct	_	_

1	Elf-1	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	Stat5	_	NN	NN	_	1	conj	_	_
4	bind	_	VBP	VBP	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	critical	_	JJ	JJ	_	8	amod	_	_
8	element	_	NN	NN	_	5	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	new	_	JJ	JJ	_	12	amod	_	_
12	enhancer	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	19	det	_	_
15	human	_	JJ	JJ	_	19	amod	_	_
16	interleukin-2	_	NN	NN	_	19	nn	_	_
17	receptor	_	NN	NN	_	19	nn	_	_
18	alpha	_	NN	NN	_	19	nn	_	_
19	gene	_	NN	NN	_	13	pobj	_	_
20	-LSB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	published	_	VBN	VBN	_	22	amod	_	_
22	erratum	_	NN	NN	_	23	nsubj	_	_
23	appears	_	VBZ	VBZ	_	4	parataxis	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	Mol	_	NNP	NNP	_	27	nn	_	_
26	Cell	_	NNP	NNP	_	27	nn	_	_
27	Biol	_	NNP	NNP	_	24	pobj	_	_
28	1997	_	CD	CD	_	29	num	_	_
29	Apr	_	NNP	NNP	_	27	dep	_	_
30	;	_	:	:	_	27	punct	_	_
31	17	_	CD	CD	_	33	num	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	4	_	CD	CD	_	27	dep	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	:	_	:	:	_	27	punct	_	_
36	2351	_	CD	CD	_	27	dep	_	_
37	-RSB-	_	-RRB-	-RRB-	_	23	punct	_	_

1	The	_	DT	DT	_	10	det	_	_
2	interleukin	_	NN	NN	_	5	nn	_	_
3	2	_	CD	CD	_	5	num	_	_
4	receptor	_	NN	NN	_	5	nn	_	_
5	alpha-chain	_	NN	NN	_	10	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
7	IL-2R	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	gene	_	NN	NN	_	14	nsubj	_	_
11	is	_	VBZ	VBZ	_	14	cop	_	_
12	a	_	DT	DT	_	14	det	_	_
13	key	_	JJ	JJ	_	14	amod	_	_
14	regulator	_	NN	NN	_	0	root	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	lymphocyte	_	NN	NN	_	17	nn	_	_
17	proliferation	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	IL-2R	_	NN	NN	_	2	nn	_	_
2	alpha	_	NN	NN	_	7	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	7	auxpass	_	_
4	rapidly	_	RB	RB	_	7	advmod	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	potently	_	RB	RB	_	4	conj	_	_
7	induced	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	response	_	NN	NN	_	11	dep	_	_
13	to	_	TO	TO	_	11	dep	_	_
14	mitogenic	_	JJ	JJ	_	15	amod	_	_
15	stimuli	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	Interleukin	_	NN	NN	_	6	nsubj	_	_
2	2	_	CD	CD	_	1	num	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	IL-2	_	NN	NN	_	1	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	stimulates	_	VBZ	VBZ	_	0	root	_	_
7	IL-2R	_	NN	NN	_	9	nn	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	thereby	_	RB	RB	_	12	advmod	_	_
12	amplifying	_	VBG	VBG	_	6	vmod	_	_
13	expression	_	NN	NN	_	12	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	its	_	PRP$	PRP$	_	18	poss	_	_
16	own	_	JJ	JJ	_	18	amod	_	_
17	high-affinity	_	NN	NN	_	18	nn	_	_
18	receptor	_	NN	NN	_	14	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	IL-2R	_	NN	NN	_	3	nn	_	_
2	alpha	_	NN	NN	_	3	nn	_	_
3	transcription	_	NN	NN	_	9	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	9	auxpass	_	_
5	at	_	IN	IN	_	7	advmod	_	_
6	least	_	JJS	JJS	_	5	pobj	_	_
7	in	_	IN	IN	_	9	prep	_	_
8	part	_	NN	NN	_	7	pobj	_	_
9	controlled	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	two	_	CD	CD	_	14	num	_	_
12	positive	_	JJ	JJ	_	14	amod	_	_
13	regulatory	_	JJ	JJ	_	14	amod	_	_
14	regions	_	NNS	NNS	_	10	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	PRRI	_	NN	NN	_	14	appos	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	PRRII	_	NN	NN	_	16	conj	_	_
19	.	_	.	.	_	9	punct	_	_

1	PRRI	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	an	_	DT	DT	_	6	det	_	_
4	inducible	_	JJ	JJ	_	6	amod	_	_
5	proximal	_	JJ	JJ	_	6	amod	_	_
6	enhancer	_	NN	NN	_	0	root	_	_
7	,	_	,	,	_	6	punct	_	_
8	located	_	JJ	JJ	_	6	amod	_	_
9	between	_	IN	IN	_	8	prep	_	_
10	nucleotides	_	NNS	NNS	_	9	pobj	_	_
11	-276	_	CD	CD	_	10	dep	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	-244	_	CD	CD	_	11	conj	_	_
14	,	_	,	,	_	6	punct	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	contains	_	VBZ	VBZ	_	6	rcmod	_	_
17	NF-kappaB	_	NN	NN	_	20	nn	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	SRE/CArG	_	NN	NN	_	17	conj	_	_
20	motifs	_	NNS	NNS	_	16	dobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	PRRII	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	T-cell-specific	_	JJ	JJ	_	5	amod	_	_
5	enhancer	_	NN	NN	_	0	root	_	_
6	,	_	,	,	_	5	punct	_	_
7	located	_	JJ	JJ	_	5	amod	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	nucleotides	_	NNS	NNS	_	8	pobj	_	_
10	-137	_	CD	CD	_	9	dep	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	-64	_	CD	CD	_	10	conj	_	_
13	,	_	,	,	_	5	punct	_	_
14	which	_	WDT	WDT	_	15	nsubj	_	_
15	binds	_	VBZ	VBZ	_	5	rcmod	_	_
16	the	_	DT	DT	_	20	det	_	_
17	T-cell-specific	_	JJ	JJ	_	20	amod	_	_
18	Ets	_	NN	NN	_	20	nn	_	_
19	protein	_	NN	NN	_	20	nn	_	_
20	Elf-1	_	NN	NN	_	15	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	HMG-I-LRB-Y-RRB-	_	NN	NN	_	23	nn	_	_
23	proteins	_	NNS	NNS	_	20	conj	_	_
24	.	_	.	.	_	5	punct	_	_

1	However	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	none	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	these	_	DT	DT	_	7	det	_	_
6	proximal	_	JJ	JJ	_	7	amod	_	_
7	regions	_	NNS	NNS	_	4	pobj	_	_
8	account	_	VBP	VBP	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	induction	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	IL-2R	_	NN	NN	_	15	nn	_	_
14	alpha	_	NN	NN	_	15	nn	_	_
15	transcription	_	NN	NN	_	12	pobj	_	_
16	by	_	IN	IN	_	11	prep	_	_
17	IL-2	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	find	_	VB	VB	_	27	advcl	_	_
3	new	_	JJ	JJ	_	5	amod	_	_
4	regulatory	_	JJ	JJ	_	5	amod	_	_
5	regions	_	NNS	NNS	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	IL-2R	_	NN	NN	_	10	nn	_	_
9	alpha	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	27	punct	_	_
12	8.5	_	CD	CD	_	13	num	_	_
13	kb	_	NN	NN	_	27	nsubjpass	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	19	det	_	_
16	5'	_	JJ	JJ	_	19	amod	_	_
17	end	_	NN	NN	_	19	nn	_	_
18	noncoding	_	JJ	JJ	_	19	amod	_	_
19	sequence	_	NN	NN	_	14	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	IL-2R	_	NN	NN	_	24	nn	_	_
23	alpha	_	NN	NN	_	24	nn	_	_
24	gene	_	NN	NN	_	20	pobj	_	_
25	have	_	VBP	VBP	_	27	aux	_	_
26	been	_	VBN	VBN	_	27	auxpass	_	_
27	sequenced	_	VBN	VBN	_	0	root	_	_
28	.	_	.	.	_	27	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	identified	_	VBD	VBD	_	0	root	_	_
3	an	_	DT	DT	_	5	det	_	_
4	86-nucleotide	_	JJ	JJ	_	5	amod	_	_
5	fragment	_	NN	NN	_	2	dobj	_	_
6	that	_	WDT	WDT	_	10	nsubj	_	_
7	is	_	VBZ	VBZ	_	10	cop	_	_
8	90	_	CD	CD	_	9	num	_	_
9	%	_	NN	NN	_	10	npadvmod	_	_
10	identical	_	JJ	JJ	_	5	rcmod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	17	det	_	_
13	recently	_	RB	RB	_	14	advmod	_	_
14	characterized	_	VBN	VBN	_	17	amod	_	_
15	murine	_	JJ	JJ	_	17	amod	_	_
16	IL-2-responsive	_	JJ	JJ	_	17	amod	_	_
17	element	_	NN	NN	_	11	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	mIL-2rE	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	4	det	_	_
2	putative	_	JJ	JJ	_	4	amod	_	_
3	human	_	JJ	JJ	_	4	amod	_	_
4	IL-2rE	_	NN	NN	_	9	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	designated	_	VBN	VBN	_	4	vmod	_	_
7	PRRIII	_	NN	NN	_	6	dep	_	_
8	,	_	,	,	_	4	punct	_	_
9	confers	_	VBZ	VBZ	_	0	root	_	_
10	IL-2	_	NN	NN	_	11	nn	_	_
11	responsiveness	_	NN	NN	_	9	dobj	_	_
12	on	_	IN	IN	_	9	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	heterologous	_	JJ	JJ	_	15	amod	_	_
15	promoter	_	NN	NN	_	12	pobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	PRRIII	_	NN	NN	_	2	nsubj	_	_
2	contains	_	VBZ	VBZ	_	0	root	_	_
3	a	_	DT	DT	_	7	det	_	_
4	Stat	_	NN	NN	_	7	nn	_	_
5	protein	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	site	_	NN	NN	_	2	dobj	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	overlaps	_	VBZ	VBZ	_	7	rcmod	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	an	_	DT	DT	_	13	det	_	_
12	EBS	_	NN	NN	_	13	nn	_	_
13	motif	_	NN	NN	_	10	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	GASd/EBSd	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	3	nsubj	_	_
2	are	_	VBP	VBP	_	3	cop	_	_
3	essential	_	JJ	JJ	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	IL-2	_	NN	NN	_	6	nn	_	_
6	inducibility	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	PRRIII/CAT	_	NN	NN	_	10	nn	_	_
9	reporter	_	NN	NN	_	10	nn	_	_
10	constructs	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	IL-2	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	binding	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Stat5a	_	NN	NN	_	9	nn	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	b	_	NN	NN	_	6	conj	_	_
9	proteins	_	NNS	NNS	_	5	pobj	_	_
10	to	_	TO	TO	_	4	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	GASd	_	NN	NN	_	14	nn	_	_
14	element	_	NN	NN	_	10	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	confirm	_	VB	VB	_	11	advcl	_	_
3	the	_	DT	DT	_	5	det	_	_
4	physiological	_	JJ	JJ	_	5	amod	_	_
5	relevance	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	these	_	DT	DT	_	8	det	_	_
8	findings	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	11	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	carried	_	VBD	VBD	_	0	root	_	_
12	out	_	RP	RP	_	11	prt	_	_
13	in	_	FW	FW	_	16	amod	_	_
14	vivo	_	FW	FW	_	13	dep	_	_
15	footprinting	_	NN	NN	_	16	nn	_	_
16	experiments	_	NNS	NNS	_	11	dobj	_	_
17	which	_	WDT	WDT	_	18	nsubj	_	_
18	showed	_	VBD	VBD	_	16	rcmod	_	_
19	that	_	IN	IN	_	25	mark	_	_
20	stimulation	_	NN	NN	_	25	nsubj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	IL-2R	_	NN	NN	_	24	nn	_	_
23	alpha	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	21	pobj	_	_
25	correlated	_	VBD	VBD	_	18	ccomp	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	occupancy	_	NN	NN	_	26	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	GASd	_	NN	NN	_	31	nn	_	_
31	element	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	11	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	major	_	JJ	JJ	_	6	amod	_	_
6	role	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	GASd/EBSd	_	NN	NN	_	10	nn	_	_
10	element	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	IL-2R	_	NN	NN	_	14	nn	_	_
13	alpha	_	NN	NN	_	14	nn	_	_
14	regulation	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	3	cc	_	_
16	suggest	_	VBP	VBP	_	3	conj	_	_
17	that	_	IN	IN	_	23	mark	_	_
18	the	_	DT	DT	_	21	det	_	_
19	T-cell-specific	_	JJ	JJ	_	21	amod	_	_
20	Elf-1	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	23	nsubj	_	_
22	can	_	MD	MD	_	23	aux	_	_
23	serve	_	VB	VB	_	16	ccomp	_	_
24	as	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	transcriptional	_	JJ	JJ	_	27	amod	_	_
27	repressor	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Association	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TRAF1	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	TRAF2	_	NN	NN	_	3	conj	_	_
6	,	_	,	,	_	3	punct	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	TRAF3	_	NN	NN	_	3	conj	_	_
9	with	_	IN	IN	_	1	prep	_	_
10	an	_	DT	DT	_	14	det	_	_
11	Epstein-Barr	_	JJ	JJ	_	14	amod	_	_
12	virus	_	NN	NN	_	14	nn	_	_
13	LMP1	_	NN	NN	_	14	nn	_	_
14	domain	_	NN	NN	_	9	pobj	_	_
15	important	_	JJ	JJ	_	14	amod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	B-lymphocyte	_	NN	NN	_	18	nn	_	_
18	transformation	_	NN	NN	_	16	pobj	_	_
19	:	_	:	:	_	1	punct	_	_
20	role	_	NN	NN	_	1	dep	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	NF-kappaB	_	NN	NN	_	23	nn	_	_
23	activation	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Epstein-Barr	_	JJ	JJ	_	3	amod	_	_
3	virus	_	NN	NN	_	9	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	EBV	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	transforming	_	VBG	VBG	_	9	amod	_	_
8	protein	_	NN	NN	_	9	nn	_	_
9	LMP1	_	NN	NN	_	10	nsubj	_	_
10	appears	_	VBZ	VBZ	_	0	root	_	_
11	to	_	TO	TO	_	19	aux	_	_
12	be	_	VB	VB	_	19	cop	_	_
13	a	_	DT	DT	_	19	det	_	_
14	constitutively	_	RB	RB	_	15	advmod	_	_
15	activated	_	VBN	VBN	_	19	amod	_	_
16	tumor	_	NN	NN	_	19	nn	_	_
17	necrosis	_	NN	NN	_	19	nn	_	_
18	factor	_	NN	NN	_	19	nn	_	_
19	receptor	_	NN	NN	_	10	xcomp	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	TNFR	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	on	_	IN	IN	_	26	dep	_	_
24	the	_	DT	DT	_	26	dep	_	_
25	basis	_	NN	NN	_	26	dep	_	_
26	of	_	IN	IN	_	19	prep	_	_
27	an	_	DT	DT	_	29	det	_	_
28	intrinsic	_	JJ	JJ	_	29	amod	_	_
29	ability	_	NN	NN	_	26	pobj	_	_
30	to	_	TO	TO	_	31	aux	_	_
31	aggregate	_	VB	VB	_	29	vmod	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	plasma	_	NN	NN	_	35	nn	_	_
35	membrane	_	NN	NN	_	32	pobj	_	_
36	and	_	CC	CC	_	29	cc	_	_
37	an	_	DT	DT	_	38	det	_	_
38	association	_	NN	NN	_	29	conj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	its	_	PRP$	PRP$	_	43	poss	_	_
41	cytoplasmic	_	JJ	JJ	_	43	amod	_	_
42	carboxyl	_	NN	NN	_	43	nn	_	_
43	terminus	_	NN	NN	_	39	pobj	_	_
44	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
45	CT	_	NN	NN	_	43	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	with	_	IN	IN	_	38	prep	_	_
48	TNFR-associated	_	JJ	JJ	_	49	amod	_	_
49	factors	_	NNS	NNS	_	47	pobj	_	_
50	-LRB-	_	-LRB-	-LRB-	_	51	punct	_	_
51	TRAFs	_	NNS	NNS	_	49	appos	_	_
52	-RRB-	_	-RRB-	-RRB-	_	51	punct	_	_
53	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	in	_	IN	IN	_	20	prep	_	_
6	EBV-transformed	_	JJ	JJ	_	8	amod	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
9	most	_	JJS	JJS	_	20	nsubjpass	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	TRAF1	_	NN	NN	_	10	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	TRAF3	_	NN	NN	_	11	conj	_	_
14	and	_	CC	CC	_	9	cc	_	_
15	5	_	CD	CD	_	16	num	_	_
16	%	_	NN	NN	_	9	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	TRAF2	_	NN	NN	_	17	pobj	_	_
19	are	_	VBP	VBP	_	20	auxpass	_	_
20	associated	_	VBN	VBN	_	3	ccomp	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	LMP1	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	20	cc	_	_
24	that	_	IN	IN	_	29	mark	_	_
25	most	_	JJS	JJS	_	29	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	LMP1	_	NN	NN	_	26	pobj	_	_
28	is	_	VBZ	VBZ	_	29	auxpass	_	_
29	associated	_	VBN	VBN	_	20	conj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	TRAF1	_	NN	NN	_	30	pobj	_	_
32	or	_	CC	CC	_	31	cc	_	_
33	TRAF3	_	NN	NN	_	31	conj	_	_
34	.	_	.	.	_	3	punct	_	_

1	TRAF1	_	NN	NN	_	7	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	TRAF2	_	NN	NN	_	1	conj	_	_
4	,	_	,	,	_	1	punct	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	TRAF3	_	NN	NN	_	1	conj	_	_
7	bind	_	VBP	VBP	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	single	_	JJ	JJ	_	11	amod	_	_
11	site	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	LMP1	_	NN	NN	_	15	nn	_	_
15	CT	_	NN	NN	_	12	pobj	_	_
16	corresponding	_	VBG	VBG	_	15	vmod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	amino	_	NN	NN	_	19	nn	_	_
19	acids	_	NNS	NNS	_	17	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	aa	_	NNS	NNS	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	199	_	CD	CD	_	19	dep	_	_
24	to	_	TO	TO	_	23	dep	_	_
25	214	_	CD	CD	_	23	dep	_	_
26	,	_	,	,	_	11	punct	_	_
27	within	_	IN	IN	_	11	prep	_	_
28	a	_	DT	DT	_	29	det	_	_
29	domain	_	NN	NN	_	27	pobj	_	_
30	which	_	WDT	WDT	_	32	nsubj	_	_
31	is	_	VBZ	VBZ	_	32	cop	_	_
32	important	_	JJ	JJ	_	29	rcmod	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	B-lymphocyte	_	NN	NN	_	36	nn	_	_
35	growth	_	NN	NN	_	36	nn	_	_
36	transformation	_	NN	NN	_	33	pobj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	aa	_	NNS	NNS	_	27	dep	_	_
39	187	_	CD	CD	_	38	dep	_	_
40	to	_	TO	TO	_	39	dep	_	_
41	231	_	CD	CD	_	39	dep	_	_
42	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
43	.	_	.	.	_	7	punct	_	_

1	Further	_	JJ	JJ	_	6	amod	_	_
2	deletional	_	JJ	JJ	_	6	amod	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	alanine	_	NN	NN	_	5	nn	_	_
5	mutagenesis	_	NN	NN	_	2	conj	_	_
6	analyses	_	NNS	NNS	_	26	nsubj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	comparison	_	NN	NN	_	6	conj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	TRAF	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	sequences	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	CD40	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	13	punct	_	_
16	in	_	IN	IN	_	13	conj	_	_
17	CD30	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	in	_	IN	IN	_	13	conj	_	_
21	the	_	DT	DT	_	22	det	_	_
22	LMP1	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	other	_	JJ	JJ	_	25	amod	_	_
25	lymphycryptoviruses	_	NNS	NNS	_	23	pobj	_	_
26	provide	_	VBP	VBP	_	0	root	_	_
27	the	_	DT	DT	_	29	det	_	_
28	first	_	JJ	JJ	_	29	amod	_	_
29	evidence	_	NN	NN	_	26	dobj	_	_
30	that	_	IN	IN	_	37	mark	_	_
31	PXQXT/S	_	NN	NN	_	37	nsubj	_	_
32	is	_	VBZ	VBZ	_	37	cop	_	_
33	a	_	DT	DT	_	37	det	_	_
34	core	_	NN	NN	_	37	nn	_	_
35	TRAF	_	NN	NN	_	37	nn	_	_
36	binding	_	NN	NN	_	37	nn	_	_
37	motif	_	NN	NN	_	29	ccomp	_	_
38	.	_	.	.	_	26	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	negative	_	JJ	JJ	_	3	amod	_	_
3	effects	_	NNS	NNS	_	21	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	point	_	NN	NN	_	6	nn	_	_
6	mutations	_	NNS	NNS	_	4	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	13	det	_	_
9	LMP1-LRB-1-231-RRB-	_	NN	NN	_	13	nn	_	_
10	core	_	NN	NN	_	13	nn	_	_
11	TRAF	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	motif	_	NN	NN	_	7	pobj	_	_
14	on	_	IN	IN	_	3	prep	_	_
15	TRAF	_	NN	NN	_	16	nn	_	_
16	binding	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	NF-kappaB	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	16	conj	_	_
20	genetically	_	RB	RB	_	21	advmod	_	_
21	link	_	VBP	VBP	_	0	root	_	_
22	the	_	DT	DT	_	23	det	_	_
23	TRAFs	_	NNS	NNS	_	21	dobj	_	_
24	to	_	TO	TO	_	21	prep	_	_
25	LMP1-LRB-1-231-RRB--mediated	_	JJ	JJ	_	27	amod	_	_
26	NF-kappaB	_	NN	NN	_	27	nn	_	_
27	activation	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	21	punct	_	_

1	NF-kappaB	_	NN	NN	_	2	nn	_	_
2	activation	_	NN	NN	_	6	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	LMP1-LRB-1-231-RRB-	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	likely	_	JJ	JJ	_	0	root	_	_
7	to	_	TO	TO	_	9	aux	_	_
8	be	_	VB	VB	_	9	auxpass	_	_
9	mediated	_	VBN	VBN	_	6	xcomp	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	TRAF1/TRAF2	_	NN	NN	_	12	nn	_	_
12	heteroaggregates	_	NNS	NNS	_	10	pobj	_	_
13	since	_	IN	IN	_	16	mark	_	_
14	TRAF1	_	NN	NN	_	16	nsubj	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	unique	_	JJ	JJ	_	9	advcl	_	_
17	among	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	TRAFs	_	NNS	NNS	_	17	pobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	coactivating	_	VBG	VBG	_	20	pcomp	_	_
22	NF-kappaB	_	NN	NN	_	21	dobj	_	_
23	with	_	IN	IN	_	21	prep	_	_
24	LMP1-LRB-1-231-RRB-	_	NN	NN	_	23	pobj	_	_
25	,	_	,	,	_	6	punct	_	_
26	a	_	DT	DT	_	29	det	_	_
27	TRAF2	_	NN	NN	_	29	nn	_	_
28	dominant-negative	_	JJ	JJ	_	29	amod	_	_
29	mutant	_	NN	NN	_	31	nsubj	_	_
30	can	_	MD	MD	_	31	aux	_	_
31	block	_	VB	VB	_	6	ccomp	_	_
32	LMP1-LRB-1-231-RRB--mediated	_	JJ	JJ	_	34	amod	_	_
33	NF-kappaB	_	NN	NN	_	34	nn	_	_
34	activation	_	NN	NN	_	31	dobj	_	_
35	as	_	RB	RB	_	36	advmod	_	_
36	well	_	RB	RB	_	34	cc	_	_
37	as	_	IN	IN	_	36	mwe	_	_
38	TRAF1	_	NN	NN	_	39	nn	_	_
39	coactivation	_	NN	NN	_	34	conj	_	_
40	,	_	,	,	_	6	punct	_	_
41	and	_	CC	CC	_	6	cc	_	_
42	30	_	CD	CD	_	43	num	_	_
43	%	_	NN	NN	_	47	nsubjpass	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	TRAF2	_	NN	NN	_	44	pobj	_	_
46	is	_	VBZ	VBZ	_	47	auxpass	_	_
47	associated	_	VBN	VBN	_	6	conj	_	_
48	with	_	IN	IN	_	47	prep	_	_
49	TRAF1	_	NN	NN	_	48	pobj	_	_
50	in	_	IN	IN	_	47	prep	_	_
51	EBV-transformed	_	JJ	JJ	_	53	amod	_	_
52	B	_	NN	NN	_	53	nn	_	_
53	cells	_	NNS	NNS	_	50	pobj	_	_
54	.	_	.	.	_	6	punct	_	_

1	TRAF3	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	negative	_	JJ	JJ	_	5	amod	_	_
5	modulator	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	LMP1-LRB-1-231-RRB--mediated	_	JJ	JJ	_	9	amod	_	_
8	NF-kappaB	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	pobj	_	_
10	.	_	.	.	_	5	punct	_	_

1	Surprisingly	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	TRAF1	_	NN	NN	_	11	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	-2	_	CD	CD	_	3	conj	_	_
6	,	_	,	,	_	3	punct	_	_
7	or	_	CC	CC	_	3	cc	_	_
8	-3	_	CD	CD	_	3	conj	_	_
9	does	_	VBZ	VBZ	_	11	aux	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	interact	_	VB	VB	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	terminal	_	JJ	JJ	_	17	amod	_	_
15	LMP1	_	NN	NN	_	17	nn	_	_
16	CT	_	NN	NN	_	17	nn	_	_
17	aa	_	NNS	NNS	_	12	pobj	_	_
18	333	_	CD	CD	_	17	dep	_	_
19	to	_	TO	TO	_	18	dep	_	_
20	386	_	CD	CD	_	18	dep	_	_
21	which	_	WDT	WDT	_	24	nsubj	_	_
22	can	_	MD	MD	_	24	aux	_	_
23	independently	_	RB	RB	_	24	advmod	_	_
24	mediate	_	VBP	VBP	_	17	rcmod	_	_
25	NF-kappaB	_	NN	NN	_	26	nn	_	_
26	activation	_	NN	NN	_	24	dobj	_	_
27	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	constitutive	_	JJ	JJ	_	3	amod	_	_
3	association	_	NN	NN	_	26	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	TRAFs	_	NNS	NNS	_	4	pobj	_	_
6	with	_	IN	IN	_	3	prep	_	_
7	LMP1	_	NN	NN	_	6	pobj	_	_
8	through	_	IN	IN	_	3	prep	_	_
9	the	_	DT	DT	_	14	det	_	_
10	aa	_	NNS	NNS	_	14	nn	_	_
11	187	_	CD	CD	_	14	nn	_	_
12	to	_	TO	TO	_	11	dep	_	_
13	231	_	CD	CD	_	11	dep	_	_
14	domain	_	NN	NN	_	8	pobj	_	_
15	which	_	WDT	WDT	_	17	nsubj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	important	_	JJ	JJ	_	14	rcmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	NF-kappaB	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	primary	_	JJ	JJ	_	25	amod	_	_
23	B-lymphocyte	_	NN	NN	_	25	nn	_	_
24	growth	_	NN	NN	_	25	nn	_	_
25	transformation	_	NN	NN	_	20	conj	_	_
26	implicates	_	VBZ	VBZ	_	0	root	_	_
27	TRAF	_	NN	NN	_	28	nn	_	_
28	aggregation	_	NN	NN	_	26	dobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	LMP1	_	NN	NN	_	31	nn	_	_
31	signaling	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	26	punct	_	_

1	CD40	_	NN	NN	_	8	nn	_	_
2	,	_	,	,	_	1	punct	_	_
3	but	_	CC	CC	_	4	cc	_	_
4	not	_	RB	RB	_	1	cc	_	_
5	lipopolysaccharide	_	NN	NN	_	1	conj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	anti-IgM	_	JJ	JJ	_	5	conj	_	_
8	stimulation	_	NN	NN	_	14	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	primary	_	JJ	JJ	_	12	amod	_	_
11	B	_	NN	NN	_	12	nn	_	_
12	lymphocytes	_	NNS	NNS	_	9	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	leads	_	VBZ	VBZ	_	0	root	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	persistent	_	JJ	JJ	_	19	amod	_	_
18	nuclear	_	JJ	JJ	_	19	amod	_	_
19	accumulation	_	NN	NN	_	15	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	RelB	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	analyzed	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	effect	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	CD40	_	NN	NN	_	10	nn	_	_
10	stimulation	_	NN	NN	_	8	pobj	_	_
11	on	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activity	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	appearance	_	NN	NN	_	13	conj	_	_
17	of	_	IN	IN	_	13	prep	_	_
18	Rel/nuclear	_	NN	NN	_	20	nn	_	_
19	factor	_	NN	NN	_	20	nn	_	_
20	kappaB	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	NF-kappaB	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	factors	_	NNS	NNS	_	17	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	primary	_	JJ	JJ	_	29	amod	_	_
27	murine	_	JJ	JJ	_	29	amod	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	lymphocytes	_	NNS	NNS	_	25	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	19	mark	_	_
4	triggering	_	NN	NN	_	19	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CD40	_	NN	NN	_	10	nn	_	_
7	signaling	_	NN	NN	_	10	nn	_	_
8	pathway	_	NN	NN	_	10	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	s	_	NNS	NNS	_	5	pobj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	by	_	IN	IN	_	4	prep	_	_
13	CD40	_	NN	NN	_	14	nn	_	_
14	ligands	_	NNS	NNS	_	12	pobj	_	_
15	expressed	_	VBN	VBN	_	14	vmod	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	L	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	led	_	VBD	VBD	_	2	ccomp	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	strong	_	JJ	JJ	_	22	amod	_	_
22	activation	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	an	_	DT	DT	_	28	det	_	_
25	NF-kappaB-controlled	_	JJ	JJ	_	28	amod	_	_
26	beta-globin	_	NN	NN	_	28	nn	_	_
27	reporter	_	NN	NN	_	28	nn	_	_
28	gene	_	NN	NN	_	23	pobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	primary	_	JJ	JJ	_	32	amod	_	_
31	B	_	NN	NN	_	32	nn	_	_
32	lymphocytes	_	NNS	NNS	_	29	pobj	_	_
33	from	_	IN	IN	_	32	prep	_	_
34	transgenic	_	JJ	JJ	_	35	amod	_	_
35	mice	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	Analyses	_	NNS	NNS	_	18	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	translocation	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	individual	_	JJ	JJ	_	7	amod	_	_
7	members	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Rel	_	NN	NN	_	10	nn	_	_
10	proteins	_	NNS	NNS	_	8	pobj	_	_
11	after	_	IN	IN	_	4	prep	_	_
12	CD40	_	NN	NN	_	13	nn	_	_
13	induction	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	primary	_	JJ	JJ	_	17	amod	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	showed	_	VBD	VBD	_	0	root	_	_
19	a	_	DT	DT	_	23	det	_	_
20	strong	_	JJ	JJ	_	23	amod	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	long-lasting	_	JJ	JJ	_	20	conj	_	_
23	accumulation	_	NN	NN	_	18	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	RelB	_	NN	NN	_	24	pobj	_	_
26	and	_	CC	CC	_	23	cc	_	_
27	,	_	,	,	_	29	punct	_	_
28	less	_	RBR	RBR	_	29	advmod	_	_
29	pronounced	_	JJ	JJ	_	23	conj	_	_
30	,	_	,	,	_	29	punct	_	_
31	of	_	IN	IN	_	29	prep	_	_
32	c-Rel	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	18	punct	_	_

1	LPS	_	NN	NN	_	2	nn	_	_
2	stimulation	_	NN	NN	_	5	nsubj	_	_
3	did	_	VBD	VBD	_	5	aux	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	give	_	VB	VB	_	0	root	_	_
6	rise	_	NN	NN	_	5	dobj	_	_
7	to	_	TO	TO	_	5	prep	_	_
8	a	_	DT	DT	_	11	det	_	_
9	persistent	_	JJ	JJ	_	11	amod	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	accumulation	_	NN	NN	_	7	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	RelB	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	c-Rel	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	5	punct	_	_
17	whereas	_	IN	IN	_	5	dep	_	_
18	nuclear	_	JJ	JJ	_	19	amod	_	_
19	c-Rel	_	NN	NN	_	25	nsubj	_	_
20	,	_	,	,	_	19	punct	_	_
21	but	_	CC	CC	_	22	cc	_	_
22	not	_	RB	RB	_	19	cc	_	_
23	RelB	_	NN	NN	_	19	conj	_	_
24	,	_	,	,	_	19	punct	_	_
25	accumulated	_	VBD	VBD	_	5	parataxis	_	_
26	after	_	IN	IN	_	25	prep	_	_
27	B	_	NN	NN	_	30	nn	_	_
28	cell	_	NN	NN	_	30	nn	_	_
29	receptor	_	NN	NN	_	30	nn	_	_
30	stimulation	_	NN	NN	_	26	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	CD40	_	NN	NN	_	2	nsubj	_	_
2	induced	_	VBD	VBD	_	0	root	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	only	_	RB	RB	_	6	preconj	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	translocation	_	NN	NN	_	2	dobj	_	_
7	but	_	CC	CC	_	8	cc	_	_
8	also	_	RB	RB	_	6	cc	_	_
9	de	_	FW	FW	_	11	amod	_	_
10	novo	_	FW	FW	_	9	dep	_	_
11	synthesis	_	NN	NN	_	6	conj	_	_
12	of	_	IN	IN	_	6	prep	_	_
13	RelB	_	NN	NN	_	12	pobj	_	_
14	RNA	_	NN	NN	_	13	dep	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	protein	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	2	punct	_	_

1	S107	_	NN	NN	_	3	nn	_	_
2	plasmacytoma	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	20	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	which	_	WDT	WDT	_	6	nsubj	_	_
6	express	_	VBP	VBP	_	3	rcmod	_	_
7	CD40	_	NN	NN	_	6	dobj	_	_
8	but	_	CC	CC	_	6	cc	_	_
9	are	_	VBP	VBP	_	10	cop	_	_
10	defective	_	JJ	JJ	_	6	conj	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	nuclear	_	JJ	JJ	_	14	amod	_	_
14	appearance	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	p50/p65-NF-kappaB	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	3	punct	_	_
18	do	_	VBP	VBP	_	20	aux	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	express	_	VB	VB	_	0	root	_	_
21	RelB	_	NN	NN	_	20	dobj	_	_
22	after	_	IN	IN	_	20	prep	_	_
23	CD40	_	NN	NN	_	24	nn	_	_
24	stimulation	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	20	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	S107	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	stably	_	RB	RB	_	5	advmod	_	_
5	transfected	_	VBN	VBN	_	3	vmod	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	relB	_	NN	NN	_	8	nn	_	_
8	genes	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	18	punct	_	_
10	stimulation	_	NN	NN	_	18	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	nuclear	_	JJ	JJ	_	14	amod	_	_
13	RelB	_	NN	NN	_	14	nn	_	_
14	translocation	_	NN	NN	_	11	pobj	_	_
15	by	_	IN	IN	_	10	prep	_	_
16	CD40	_	NN	NN	_	15	pobj	_	_
17	was	_	VBD	VBD	_	18	auxpass	_	_
18	observed	_	VBN	VBN	_	0	root	_	_
19	.	_	.	.	_	18	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	stimulation	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	CD40	_	NN	NN	_	9	nn	_	_
8	signaling	_	NN	NN	_	9	nn	_	_
9	pathways	_	NNS	NNS	_	6	pobj	_	_
10	exerts	_	VBZ	VBZ	_	3	ccomp	_	_
11	a	_	DT	DT	_	14	det	_	_
12	long-lasting	_	JJ	JJ	_	14	amod	_	_
13	stimulatory	_	JJ	JJ	_	14	amod	_	_
14	effect	_	NN	NN	_	10	dobj	_	_
15	on	_	IN	IN	_	10	prep	_	_
16	both	_	CC	CC	_	18	preconj	_	_
17	the	_	DT	DT	_	18	det	_	_
18	transcription	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	translocation	_	NN	NN	_	18	conj	_	_
22	of	_	IN	IN	_	18	prep	_	_
23	RelB	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Since	_	IN	IN	_	6	mark	_	_
2	LPS	_	NN	NN	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	anti-IgM	_	NN	NN	_	2	conj	_	_
5	were	_	VBD	VBD	_	6	cop	_	_
6	unable	_	JJ	JJ	_	12	advcl	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	activate	_	VB	VB	_	6	xcomp	_	_
9	RelB	_	NN	NN	_	8	dobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	CD40	_	NN	NN	_	12	nsubj	_	_
12	appears	_	VBZ	VBZ	_	0	root	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	trigger	_	VB	VB	_	12	xcomp	_	_
15	a	_	DT	DT	_	17	det	_	_
16	special	_	JJ	JJ	_	17	amod	_	_
17	program	_	NN	NN	_	14	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	18	pobj	_	_
21	involved	_	VBN	VBN	_	17	vmod	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	proliferation	_	NN	NN	_	22	pobj	_	_
25	and/or	_	CC	CC	_	24	cc	_	_
26	differentiation	_	NN	NN	_	24	conj	_	_
27	of	_	IN	IN	_	24	prep	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	lymphocytes	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	12	punct	_	_

1	Sterol	_	NN	NN	_	2	npadvmod	_	_
2	dependent	_	JJ	JJ	_	5	amod	_	_
3	LDL-receptor	_	NN	NN	_	5	nn	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	transcription	_	NN	NN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	normal	_	JJ	JJ	_	12	amod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	CML	_	NN	NN	_	9	conj	_	_
12	patients	_	NNS	NNS	_	8	pobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	Sterol	_	NN	NN	_	3	nn	_	_
2	regulatory	_	JJ	JJ	_	3	amod	_	_
3	element	_	NN	NN	_	9	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	SRE	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	recognized	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	regulate	_	VB	VB	_	9	xcomp	_	_
12	various	_	JJ	JJ	_	14	amod	_	_
13	key	_	JJ	JJ	_	14	amod	_	_
14	genes	_	NNS	NNS	_	11	dobj	_	_
15	coding	_	VBG	VBG	_	14	vmod	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	especially	_	RB	RB	_	18	advmod	_	_
18	low	_	JJ	JJ	_	24	amod	_	_
19	density	_	NN	NN	_	24	nn	_	_
20	lipoprotein	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	LDL	_	NN	NN	_	24	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
24	-receptor	_	NN	NN	_	16	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	3-hydroxy-3-methylglutaryl	_	NN	NN	_	28	nn	_	_
27	coenzyme	_	NN	NN	_	28	nn	_	_
28	A	_	NN	NN	_	32	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	HMG-CoA	_	NN	NN	_	32	appos	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	reductase	_	NN	NN	_	24	conj	_	_
33	and	_	CC	CC	_	24	cc	_	_
34	HMG-CoA	_	NN	NN	_	35	nn	_	_
35	synthase	_	NN	NN	_	24	conj	_	_
36	known	_	VBN	VBN	_	24	vmod	_	_
37	to	_	TO	TO	_	38	aux	_	_
38	play	_	VB	VB	_	36	xcomp	_	_
39	a	_	DT	DT	_	41	det	_	_
40	crucial	_	JJ	JJ	_	41	amod	_	_
41	role	_	NN	NN	_	38	dobj	_	_
42	in	_	IN	IN	_	38	prep	_	_
43	the	_	DT	DT	_	46	det	_	_
44	cholesterol	_	NN	NN	_	46	nn	_	_
45	feedback	_	NN	NN	_	46	nn	_	_
46	mechanism	_	NN	NN	_	42	pobj	_	_
47	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	deranged	_	JJ	JJ	_	5	amod	_	_
3	cholesterol	_	NN	NN	_	5	nn	_	_
4	feedback	_	NN	NN	_	5	nn	_	_
5	mechanism	_	NN	NN	_	9	nsubjpass	_	_
6	has	_	VBZ	VBZ	_	9	aux	_	_
7	been	_	VBN	VBN	_	9	auxpass	_	_
8	widely	_	RB	RB	_	9	advmod	_	_
9	recognised	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	initiation	_	NN	NN	_	10	pobj	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	11	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	progression	_	NN	NN	_	11	conj	_	_
16	of	_	IN	IN	_	11	prep	_	_
17	various	_	JJ	JJ	_	18	amod	_	_
18	types	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	cancers	_	NNS	NNS	_	19	pobj	_	_
21	including	_	VBG	VBG	_	18	prep	_	_
22	chronic	_	JJ	JJ	_	24	amod	_	_
23	myeloid	_	JJ	JJ	_	24	amod	_	_
24	leukaemia	_	NN	NN	_	21	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	CML	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	.	_	.	.	_	9	punct	_	_

1	Consequently	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	present	_	JJ	JJ	_	5	amod	_	_
5	study	_	NN	NN	_	7	nsubjpass	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	addressed	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	understand	_	VB	VB	_	7	xcomp	_	_
10	this	_	DT	DT	_	11	det	_	_
11	phenomenon	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	7	cc	_	_
13	revealed	_	VBD	VBD	_	7	conj	_	_
14	the	_	DT	DT	_	15	det	_	_
15	existence	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	22	det	_	_
18	unique	_	JJ	JJ	_	22	amod	_	_
19	47	_	CD	CD	_	20	number	_	_
20	kDa	_	NN	NN	_	22	amod	_	_
21	protein	_	NN	NN	_	22	nn	_	_
22	factor	_	NN	NN	_	16	pobj	_	_
23	having	_	VBG	VBG	_	22	vmod	_	_
24	affinity	_	NN	NN	_	23	dobj	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	this	_	DT	DT	_	28	det	_	_
27	SRE	_	NN	NN	_	28	nn	_	_
28	sequence	_	NN	NN	_	25	pobj	_	_
29	in	_	IN	IN	_	15	prep	_	_
30	lymphocytes	_	NNS	NNS	_	29	pobj	_	_
31	from	_	IN	IN	_	30	prep	_	_
32	normal	_	JJ	JJ	_	33	amod	_	_
33	subjects	_	NNS	NNS	_	31	pobj	_	_
34	as	_	RB	RB	_	35	advmod	_	_
35	well	_	RB	RB	_	15	cc	_	_
36	as	_	IN	IN	_	35	mwe	_	_
37	its	_	PRP$	PRP$	_	38	poss	_	_
38	absence	_	NN	NN	_	15	conj	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	lymphocytes	_	NNS	NNS	_	39	pobj	_	_
41	from	_	IN	IN	_	40	prep	_	_
42	untreated	_	JJ	JJ	_	44	amod	_	_
43	CML	_	NN	NN	_	44	nn	_	_
44	patients	_	NNS	NNS	_	41	pobj	_	_
45	.	_	.	.	_	7	punct	_	_

1	However	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	this	_	DT	DT	_	4	det	_	_
4	factor	_	NN	NN	_	5	nsubj	_	_
5	appeared	_	VBD	VBD	_	0	root	_	_
6	when	_	WRB	WRB	_	10	advmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	CML	_	NN	NN	_	9	nn	_	_
9	patients	_	NNS	NNS	_	10	nsubj	_	_
10	achieved	_	VBD	VBD	_	5	advcl	_	_
11	complete	_	JJ	JJ	_	13	amod	_	_
12	haematological	_	JJ	JJ	_	13	amod	_	_
13	remission	_	NN	NN	_	10	dobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	CHR	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	through	_	IN	IN	_	10	prep	_	_
18	alpha-interferon	_	NN	NN	_	19	nn	_	_
19	therapy	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Further	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	an	_	DT	DT	_	5	det	_	_
4	inverse	_	NN	NN	_	5	nn	_	_
5	relationship	_	NN	NN	_	8	nsubjpass	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	between	_	IN	IN	_	8	prep	_	_
10	sterol	_	NN	NN	_	11	npadvmod	_	_
11	modulated	_	JJ	JJ	_	14	amod	_	_
12	LDL-receptor	_	NN	NN	_	14	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	9	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	binding	_	NN	NN	_	18	nn	_	_
18	affinity	_	NN	NN	_	14	conj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	this	_	DT	DT	_	23	det	_	_
21	47	_	CD	CD	_	22	number	_	_
22	kDa	_	NN	NN	_	23	amod	_	_
23	factor	_	NN	NN	_	19	pobj	_	_
24	to	_	TO	TO	_	18	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	SRE	_	NN	NN	_	27	nn	_	_
27	sequence	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	8	punct	_	_

1	Based	_	VBN	VBN	_	6	prep	_	_
2	upon	_	IN	IN	_	1	pcomp	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	2	pobj	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	propose	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	12	mark	_	_
8	alpha-interferon	_	NN	NN	_	12	nsubj	_	_
9	through	_	IN	IN	_	12	prep	_	_
10	its	_	PRP$	PRP$	_	11	poss	_	_
11	receptor	_	NN	NN	_	9	pobj	_	_
12	initiates	_	VBZ	VBZ	_	6	ccomp	_	_
13	phosphatidic	_	JJ	JJ	_	14	amod	_	_
14	acid	_	NN	NN	_	15	npadvmod	_	_
15	dependent	_	JJ	JJ	_	16	amod	_	_
16	signalling	_	NN	NN	_	12	dobj	_	_
17	which	_	WDT	WDT	_	20	nsubj	_	_
18	in	_	IN	IN	_	20	prep	_	_
19	turn	_	NN	NN	_	18	pobj	_	_
20	regulates	_	VBZ	VBZ	_	16	rcmod	_	_
21	the	_	DT	DT	_	22	det	_	_
22	affinity	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	47	_	CD	CD	_	25	number	_	_
25	kDa	_	NN	NN	_	30	amod	_	_
26	sterol	_	NN	NN	_	30	nn	_	_
27	regulatory	_	JJ	JJ	_	30	amod	_	_
28	element	_	NN	NN	_	30	nn	_	_
29	binding	_	NN	NN	_	30	nn	_	_
30	factor	_	NN	NN	_	23	pobj	_	_
31	as	_	RB	RB	_	32	advmod	_	_
32	well	_	RB	RB	_	22	cc	_	_
33	as	_	IN	IN	_	32	mwe	_	_
34	LDL-receptor	_	NN	NN	_	36	nn	_	_
35	gene	_	NN	NN	_	36	nn	_	_
36	transcription	_	NN	NN	_	22	conj	_	_
37	in	_	IN	IN	_	16	prep	_	_
38	lymphocytes	_	NNS	NNS	_	37	pobj	_	_
39	from	_	IN	IN	_	38	prep	_	_
40	CML	_	NN	NN	_	41	nn	_	_
41	patients	_	NNS	NNS	_	39	pobj	_	_
42	.	_	.	.	_	6	punct	_	_

1	Effects	_	NNS	NNS	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Ara-C	_	NN	NN	_	2	pobj	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	neutral	_	JJ	JJ	_	6	amod	_	_
6	sphingomyelinase	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	mitogen-	_	NN	NN	_	12	amod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	stress-activated	_	JJ	JJ	_	8	conj	_	_
11	protein	_	NN	NN	_	12	nn	_	_
12	kinases	_	NNS	NNS	_	6	conj	_	_
13	in	_	IN	IN	_	6	prep	_	_
14	T-lymphocyte	_	NN	NN	_	16	nn	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Neutral	_	JJ	JJ	_	2	amod	_	_
2	sphingomyelinase	_	NN	NN	_	8	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	SMase	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	can	_	MD	MD	_	8	aux	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	activated	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	extracellular	_	JJ	JJ	_	11	amod	_	_
11	signals	_	NNS	NNS	_	9	pobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	produce	_	VB	VB	_	8	xcomp	_	_
14	ceramide	_	NN	NN	_	13	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	which	_	WDT	WDT	_	18	nsubj	_	_
17	may	_	MD	MD	_	18	aux	_	_
18	affect	_	VB	VB	_	14	rcmod	_	_
19	mitogen-activated	_	JJ	JJ	_	21	amod	_	_
20	protein	_	NN	NN	_	21	nn	_	_
21	kinase	_	NN	NN	_	25	nn	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	MAPK	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	activities	_	NNS	NNS	_	18	dobj	_	_
26	.	_	.	.	_	8	punct	_	_

1	Neutral	_	JJ	JJ	_	3	amod	_	_
2	SMase	_	NN	NN	_	3	nn	_	_
3	activity	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	assessed	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	membranes	_	NNS	NNS	_	6	pobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	Jurkat	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	a	_	DT	DT	_	14	det	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	T-cell	_	NN	NN	_	14	nn	_	_
14	line	_	NN	NN	_	9	appos	_	_
15	,	_	,	,	_	9	punct	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	EL4	_	NN	NN	_	9	conj	_	_
18	,	_	,	,	_	17	punct	_	_
19	a	_	DT	DT	_	22	det	_	_
20	murine	_	JJ	JJ	_	22	amod	_	_
21	T-cell	_	NN	NN	_	22	nn	_	_
22	line	_	NN	NN	_	17	appos	_	_
23	.	_	.	.	_	5	punct	_	_

1	Ara-C	_	NN	NN	_	2	nsubj	_	_
2	activated	_	VBD	VBD	_	0	root	_	_
3	SMase	_	NN	NN	_	2	dobj	_	_
4	with	_	IN	IN	_	2	prep	_	_
5	10	_	CD	CD	_	6	num	_	_
6	minutes	_	NNS	NNS	_	4	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	both	_	CC	CC	_	9	preconj	_	_
9	Jurkat	_	NN	NN	_	12	nn	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	EL4	_	NN	NN	_	9	conj	_	_
12	cells	_	NNS	NNS	_	7	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	while	_	IN	IN	_	20	mark	_	_
15	phorbol	_	NN	NN	_	16	nn	_	_
16	ester	_	NN	NN	_	20	nsubj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	PMA	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	had	_	VBD	VBD	_	2	advcl	_	_
21	no	_	DT	DT	_	22	neg	_	_
22	effect	_	NN	NN	_	20	dobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	PMA	_	NN	NN	_	9	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	but	_	CC	CC	_	4	cc	_	_
4	not	_	RB	RB	_	1	cc	_	_
5	Ara-C	_	NN	NN	_	1	conj	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	ceramides	_	NNS	NNS	_	5	conj	_	_
8	,	_	,	,	_	1	punct	_	_
9	activated	_	VBD	VBD	_	0	root	_	_
10	ERK	_	NN	NN	_	11	nn	_	_
11	MAPKS	_	NNS	NNS	_	9	dobj	_	_
12	,	_	,	,	_	9	punct	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	Jurkat	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	EL4	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	9	punct	_	_

1	PMA	_	NN	NN	_	2	nsubj	_	_
2	acted	_	VBD	VBD	_	0	root	_	_
3	synergistically	_	RB	RB	_	2	advmod	_	_
4	with	_	IN	IN	_	2	prep	_	_
5	ionomycin	_	NN	NN	_	4	pobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	activate	_	VB	VB	_	2	xcomp	_	_
8	JNK	_	NN	NN	_	9	nn	_	_
9	MAPKs	_	NNS	NNS	_	7	dobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	Jurkat	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	EL4	_	NN	NN	_	11	conj	_	_
14	within	_	IN	IN	_	7	prep	_	_
15	10	_	CD	CD	_	16	num	_	_
16	minutes	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Ara-C	_	NN	NN	_	2	nsubj	_	_
2	activated	_	VBD	VBD	_	0	root	_	_
3	JNKs	_	NNS	NNS	_	2	dobj	_	_
4	only	_	RB	RB	_	5	advmod	_	_
5	after	_	IN	IN	_	2	prep	_	_
6	prolonged	_	JJ	JJ	_	7	amod	_	_
7	incubation	_	NN	NN	_	5	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
9	90-120	_	CD	CD	_	10	num	_	_
10	minutes	_	NNS	NNS	_	7	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	.	_	.	.	_	2	punct	_	_

1	Thus	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	ceramide	_	NN	NN	_	8	nsubj	_	_
4	is	_	VBZ	VBZ	_	8	cop	_	_
5	not	_	RB	RB	_	8	neg	_	_
6	a	_	DT	DT	_	8	det	_	_
7	positive	_	JJ	JJ	_	8	amod	_	_
8	signal	_	NN	NN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	ERK	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	T-cell	_	NN	NN	_	14	nn	_	_
14	lines	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effects	_	NNS	NNS	_	10	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Ara-C	_	NN	NN	_	3	pobj	_	_
5	on	_	IN	IN	_	2	prep	_	_
6	JNK	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	5	pobj	_	_
8	may	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	mediated	_	VBN	VBN	_	0	root	_	_
11	through	_	IN	IN	_	10	prep	_	_
12	secondary	_	JJ	JJ	_	14	amod	_	_
13	response	_	NN	NN	_	14	nn	_	_
14	pathways	_	NNS	NNS	_	11	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	-LSB-	_	-LRB-	-LRB-	_	4	punct	_	_
2	Cortisone-resistant	_	JJ	JJ	_	4	amod	_	_
3	bronchial	_	JJ	JJ	_	4	amod	_	_
4	asthma	_	NN	NN	_	0	root	_	_
5	-RSB-	_	-RRB-	-RRB-	_	4	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	is	_	VBZ	VBZ	_	0	root	_	_
3	general	_	JJ	JJ	_	4	amod	_	_
4	agreement	_	NN	NN	_	2	nsubj	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	inflammatory	_	JJ	JJ	_	8	amod	_	_
8	pathogenesis	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	bronchial	_	JJ	JJ	_	11	amod	_	_
11	asthma	_	NN	NN	_	9	pobj	_	_
12	:	_	:	:	_	2	punct	_	_
13	an	_	DT	DT	_	14	det	_	_
14	accumulation	_	NN	NN	_	35	nsubjpass	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	activated	_	VBN	VBN	_	17	amod	_	_
17	eosinophils	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	degranulated	_	VBN	VBN	_	21	amod	_	_
20	mast	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	14	conj	_	_
22	,	_	,	,	_	14	punct	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	lymphocytes	_	NNS	NNS	_	14	conj	_	_
25	and	_	CC	CC	_	14	cc	_	_
26	in	_	IN	IN	_	31	prep	_	_
27	very	_	RB	RB	_	28	advmod	_	_
28	severe	_	JJ	JJ	_	29	amod	_	_
29	forms	_	NNS	NNS	_	26	pobj	_	_
30	,	_	,	,	_	31	punct	_	_
31	granulocytes	_	NNS	NNS	_	14	conj	_	_
32	has	_	VBZ	VBZ	_	35	aux	_	_
33	constantly	_	RB	RB	_	35	advmod	_	_
34	been	_	VBN	VBN	_	35	auxpass	_	_
35	found	_	VBN	VBN	_	2	parataxis	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	bronchial	_	JJ	JJ	_	39	amod	_	_
39	mucosa	_	NN	NN	_	36	pobj	_	_
40	.	_	.	.	_	35	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	allergic	_	JJ	JJ	_	4	amod	_	_
3	bronchial	_	JJ	JJ	_	4	amod	_	_
4	asthma	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	inflammation	_	NN	NN	_	7	nsubj	_	_
7	seems	_	VBZ	VBZ	_	0	root	_	_
8	to	_	TO	TO	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	orchestrated	_	VBN	VBN	_	7	xcomp	_	_
11	predominantly	_	RB	RB	_	12	advmod	_	_
12	by	_	IN	IN	_	10	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	subset	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	lymphocytes	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	with	_	IN	IN	_	14	prep	_	_
20	a	_	DT	DT	_	21	det	_	_
21	phenotype	_	NN	NN	_	19	pobj	_	_
22	similar	_	JJ	JJ	_	21	amod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	Th2	_	NN	NN	_	26	nn	_	_
26	subset	_	NN	NN	_	23	pobj	_	_
27	able	_	JJ	JJ	_	26	amod	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	produce	_	VB	VB	_	27	xcomp	_	_
30	IL-4	_	NN	NN	_	29	dobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	IL-5	_	NN	NN	_	30	conj	_	_
33	.	_	.	.	_	7	punct	_	_

1	Although	_	IN	IN	_	8	mark	_	_
2	corticosteroids	_	NNS	NNS	_	8	nsubj	_	_
3	are	_	VBP	VBP	_	8	cop	_	_
4	the	_	DT	DT	_	8	det	_	_
5	most	_	RBS	RBS	_	6	advmod	_	_
6	potent	_	JJ	JJ	_	8	amod	_	_
7	therapeutic	_	JJ	JJ	_	8	amod	_	_
8	agents	_	NNS	NNS	_	17	advcl	_	_
9	used	_	VBN	VBN	_	8	vmod	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	this	_	DT	DT	_	12	det	_	_
12	disease	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	17	punct	_	_
14	their	_	PRP$	PRP$	_	16	poss	_	_
15	anti-inflammatory	_	JJ	JJ	_	16	amod	_	_
16	effect	_	NN	NN	_	17	nsubj	_	_
17	differs	_	VBZ	VBZ	_	0	root	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	patient	_	NN	NN	_	18	pobj	_	_
20	to	_	TO	TO	_	18	prep	_	_
21	patient	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	17	punct	_	_

1	Some	_	DT	DT	_	2	det	_	_
2	criteria	_	NNS	NNS	_	13	nsubjpass	_	_
3	which	_	WDT	WDT	_	6	nsubjpass	_	_
4	can	_	MD	MD	_	6	aux	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	used	_	VBN	VBN	_	2	rcmod	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	define	_	VB	VB	_	6	xcomp	_	_
9	steroid-resistant	_	JJ	JJ	_	11	amod	_	_
10	bronchial	_	JJ	JJ	_	11	amod	_	_
11	asthma	_	NN	NN	_	8	dobj	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	listed	_	VBN	VBN	_	0	root	_	_
14	here	_	RB	RB	_	13	advmod	_	_
15	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	review	_	NN	NN	_	3	nsubj	_	_
3	analyzes	_	VBZ	VBZ	_	0	root	_	_
4	various	_	JJ	JJ	_	6	amod	_	_
5	molecular	_	JJ	JJ	_	6	amod	_	_
6	alterations	_	NNS	NNS	_	3	dobj	_	_
7	responsible	_	JJ	JJ	_	6	amod	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	deficient	_	JJ	JJ	_	11	amod	_	_
11	response	_	NN	NN	_	8	pobj	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	corticosteroid	_	NN	NN	_	14	nn	_	_
14	treatment	_	NN	NN	_	12	pobj	_	_
15	observed	_	VBN	VBN	_	11	vmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	steroid-resistant	_	JJ	JJ	_	19	amod	_	_
18	bronchial	_	JJ	JJ	_	19	amod	_	_
19	asthmatic	_	JJ	JJ	_	20	amod	_	_
20	subjects	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	New	_	JJ	JJ	_	2	amod	_	_
2	knowledge	_	NN	NN	_	10	nsubj	_	_
3	on	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	mechanism	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	steroid	_	NN	NN	_	8	nn	_	_
8	resistance	_	NN	NN	_	6	pobj	_	_
9	may	_	MD	MD	_	10	aux	_	_
10	have	_	VB	VB	_	0	root	_	_
11	important	_	JJ	JJ	_	12	amod	_	_
12	implications	_	NNS	NNS	_	10	dobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	treatment	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	chronic	_	JJ	JJ	_	18	amod	_	_
18	asthma	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	other	_	JJ	JJ	_	21	amod	_	_
21	diseases	_	NNS	NNS	_	18	conj	_	_
22	.	_	.	.	_	10	punct	_	_

1	Expression	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Egr-1	_	NN	NN	_	2	pobj	_	_
4	correlates	_	VBZ	VBZ	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	transformed	_	VBN	VBN	_	8	amod	_	_
8	phenotype	_	NN	NN	_	5	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	the	_	DT	DT	_	11	det	_	_
11	type	_	NN	NN	_	8	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	viral	_	JJ	JJ	_	14	amod	_	_
14	latency	_	NN	NN	_	12	pobj	_	_
15	in	_	IN	IN	_	8	prep	_	_
16	EBV	_	NN	NN	_	17	nn	_	_
17	genome	_	NN	NN	_	18	npadvmod	_	_
18	positive	_	JJ	JJ	_	21	amod	_	_
19	lymphoid	_	JJ	JJ	_	21	amod	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	lines	_	NNS	NNS	_	15	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	paper	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	investigated	_	VBN	VBN	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	role	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	Egr-1	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	8	prep	_	_
12	B	_	NN	NN	_	15	nn	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	growth	_	NN	NN	_	15	nn	_	_
15	regulation	_	NN	NN	_	11	pobj	_	_
16	by	_	IN	IN	_	6	prep	_	_
17	examining	_	VBG	VBG	_	16	pcomp	_	_
18	the	_	DT	DT	_	20	det	_	_
19	gene	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	23	det	_	_
23	panel	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	B	_	NN	NN	_	27	nn	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	lines	_	NNS	NNS	_	24	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	including	_	VBG	VBG	_	27	prep	_	_
30	both	_	CC	CC	_	33	preconj	_	_
31	EBV	_	NN	NN	_	32	nn	_	_
32	genome	_	NN	NN	_	33	npadvmod	_	_
33	negative	_	JJ	JJ	_	38	amod	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	EBV	_	NN	NN	_	36	dep	_	_
36	carrying	_	VBG	VBG	_	33	conj	_	_
37	cell	_	NN	NN	_	38	nn	_	_
38	lines	_	NNS	NNS	_	29	pobj	_	_
39	.	_	.	.	_	6	punct	_	_

1	Egr-1	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	3	nsubj	_	_
3	correlates	_	VBZ	VBZ	_	0	root	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cellular	_	JJ	JJ	_	7	amod	_	_
7	phenotype	_	NN	NN	_	4	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	the	_	DT	DT	_	11	det	_	_
10	specific	_	JJ	JJ	_	11	amod	_	_
11	pattern	_	NN	NN	_	7	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	viral	_	JJ	JJ	_	14	amod	_	_
14	latency	_	NN	NN	_	12	pobj	_	_
15	established	_	VBN	VBN	_	7	vmod	_	_
16	within	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	individual	_	JJ	JJ	_	20	amod	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	constitutive	_	JJ	JJ	_	4	amod	_	_
4	activation	_	NN	NN	_	10	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Egr-1	_	NN	NN	_	7	nn	_	_
7	gene	_	NN	NN	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	10	auxpass	_	_
9	invariably	_	RB	RB	_	10	advmod	_	_
10	associated	_	VBN	VBN	_	0	root	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	unrestricted	_	JJ	JJ	_	13	amod	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	viral	_	JJ	JJ	_	17	amod	_	_
16	latent	_	JJ	JJ	_	17	amod	_	_
17	genes	_	NNS	NNS	_	14	pobj	_	_
18	in	_	IN	IN	_	13	prep	_	_
19	all	_	DT	DT	_	26	det	_	_
20	group	_	NN	NN	_	26	nn	_	_
21	III	_	CD	CD	_	26	num	_	_
22	EBV	_	NN	NN	_	23	nn	_	_
23	genome	_	NN	NN	_	24	dep	_	_
24	carrying	_	VBG	VBG	_	26	amod	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	lines	_	NNS	NNS	_	18	pobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	Egr-1	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	abrogated	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	group	_	NN	NN	_	13	nn	_	_
10	I	_	NN	NN	_	13	nn	_	_
11	Burkitt	_	NN	NN	_	13	nn	_	_
12	tumor	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	8	pobj	_	_
14	,	_	,	,	_	7	punct	_	_
15	irrespective	_	JJ	JJ	_	7	advmod	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	21	det	_	_
18	EBV	_	NN	NN	_	21	nn	_	_
19	genome	_	NN	NN	_	21	nn	_	_
20	carrying	_	NN	NN	_	21	nn	_	_
21	status	_	NN	NN	_	16	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	Activated	_	VBN	VBN	_	4	amod	_	_
2	viral	_	JJ	JJ	_	4	amod	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	20	nsubj	_	_
5	associated	_	VBN	VBN	_	4	vmod	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	phenotypic	_	JJ	JJ	_	8	amod	_	_
8	conversion	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	group	_	NN	NN	_	13	nn	_	_
11	I	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	lines	_	NNS	NNS	_	9	pobj	_	_
14	in	_	IN	IN	_	8	prep	_	_
15	to	_	TO	TO	_	14	dep	_	_
16	group	_	NN	NN	_	14	pobj	_	_
17	II	_	CD	CD	_	16	dep	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	III	_	CD	CD	_	17	conj	_	_
20	restores	_	VBZ	VBZ	_	0	root	_	_
21	the	_	DT	DT	_	24	det	_	_
22	Egr-1	_	NN	NN	_	24	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	20	dobj	_	_
25	.	_	.	.	_	20	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	forms	_	NNS	NNS	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	EGR-1	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	3	pobj	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	within	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	different	_	JJ	JJ	_	11	amod	_	_
11	groups	_	NNS	NNS	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	lines	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	7	punct	_	_
16	and	_	CC	CC	_	7	cc	_	_
17	the	_	DT	DT	_	19	det	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	activity	_	NN	NN	_	25	nsubjpass	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	DNA	_	NN	NN	_	23	nn	_	_
22	consensus	_	NN	NN	_	23	nn	_	_
23	sequences	_	NNS	NNS	_	20	pobj	_	_
24	was	_	VBD	VBD	_	25	auxpass	_	_
25	investigated	_	VBN	VBN	_	7	conj	_	_
26	.	_	.	.	_	7	punct	_	_

1	Finally	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	time	_	NN	NN	_	5	nn	_	_
4	course	_	NN	NN	_	5	nn	_	_
5	analysis	_	NN	NN	_	18	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	Egr-1	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	6	pobj	_	_
9	during	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	early	_	JJ	JJ	_	12	amod	_	_
12	steps	_	NNS	NNS	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	EBV	_	NN	NN	_	15	nn	_	_
15	infection	_	NN	NN	_	13	pobj	_	_
16	in	_	FW	FW	_	17	nn	_	_
17	vitro	_	FW	FW	_	15	advmod	_	_
18	demonstrated	_	VBD	VBD	_	0	root	_	_
19	that	_	IN	IN	_	22	mark	_	_
20	Egr-1	_	NN	NN	_	22	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	upregulated	_	VBN	VBN	_	18	ccomp	_	_
23	within	_	IN	IN	_	22	prep	_	_
24	minutes	_	NNS	NNS	_	23	pobj	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	initial	_	JJ	JJ	_	28	amod	_	_
28	interaction	_	NN	NN	_	25	pobj	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	B	_	NN	NN	_	32	nn	_	_
32	lymphocyte	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	18	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	proximal	_	JJ	JJ	_	4	amod	_	_
3	regulatory	_	JJ	JJ	_	4	amod	_	_
4	element	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	interferon-gamma	_	NN	NN	_	8	nn	_	_
8	promoter	_	NN	NN	_	5	pobj	_	_
9	mediates	_	VBZ	VBZ	_	0	root	_	_
10	selective	_	JJ	JJ	_	11	amod	_	_
11	expression	_	NN	NN	_	9	dobj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	9	punct	_	_

1	Interferon-gamma	_	NN	NN	_	6	nsubjpass	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IFN-gamma	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	produced	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	natural	_	JJ	JJ	_	10	amod	_	_
9	killer	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	certain	_	JJ	JJ	_	13	amod	_	_
13	subsets	_	NNS	NNS	_	10	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	6	punct	_	_
18	but	_	CC	CC	_	6	cc	_	_
19	the	_	DT	DT	_	20	det	_	_
20	basis	_	NN	NN	_	26	nsubj	_	_
21	for	_	IN	IN	_	20	prep	_	_
22	its	_	PRP$	PRP$	_	24	poss	_	_
23	selective	_	JJ	JJ	_	24	amod	_	_
24	expression	_	NN	NN	_	21	pobj	_	_
25	is	_	VBZ	VBZ	_	26	cop	_	_
26	unknown	_	JJ	JJ	_	6	conj	_	_
27	.	_	.	.	_	6	punct	_	_

1	Within	_	IN	IN	_	14	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	region	_	NN	NN	_	1	pobj	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	-108	_	CD	CD	_	9	nn	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	-40	_	CD	CD	_	5	conj	_	_
8	base	_	NN	NN	_	9	nn	_	_
9	pairs	_	NNS	NNS	_	4	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	IFN-gamma	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	10	pobj	_	_
14	are	_	VBP	VBP	_	0	root	_	_
15	two	_	CD	CD	_	20	num	_	_
16	conserved	_	VBN	VBN	_	20	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	essential	_	JJ	JJ	_	16	conj	_	_
19	regulatory	_	JJ	JJ	_	20	amod	_	_
20	elements	_	NNS	NNS	_	14	nsubj	_	_
21	,	_	,	,	_	20	punct	_	_
22	which	_	WDT	WDT	_	23	nsubj	_	_
23	confer	_	VBP	VBP	_	20	rcmod	_	_
24	activation-specific	_	JJ	JJ	_	25	amod	_	_
25	expression	_	NN	NN	_	23	dobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	T	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	14	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	report	_	NN	NN	_	3	nsubj	_	_
3	describes	_	VBZ	VBZ	_	0	root	_	_
4	studies	_	NNS	NNS	_	3	dobj	_	_
5	indicating	_	VBG	VBG	_	4	vmod	_	_
6	that	_	IN	IN	_	18	mark	_	_
7	the	_	DT	DT	_	9	det	_	_
8	most	_	RBS	RBS	_	9	advmod	_	_
9	proximal	_	JJ	JJ	_	18	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	these	_	DT	DT	_	14	det	_	_
12	two	_	CD	CD	_	14	num	_	_
13	regulatory	_	JJ	JJ	_	14	amod	_	_
14	elements	_	NNS	NNS	_	10	pobj	_	_
15	is	_	VBZ	VBZ	_	18	cop	_	_
16	an	_	DT	DT	_	18	det	_	_
17	important	_	JJ	JJ	_	18	amod	_	_
18	determinant	_	NN	NN	_	5	ccomp	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	its	_	PRP$	PRP$	_	22	poss	_	_
21	restricted	_	JJ	JJ	_	22	amod	_	_
22	expression	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	proximal	_	JJ	JJ	_	3	amod	_	_
3	element	_	NN	NN	_	7	nsubj	_	_
4	is	_	VBZ	VBZ	_	7	cop	_	_
5	a	_	DT	DT	_	7	det	_	_
6	composite	_	JJ	JJ	_	7	amod	_	_
7	site	_	NN	NN	_	0	root	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	binds	_	VBZ	VBZ	_	7	rcmod	_	_
10	members	_	NNS	NNS	_	9	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	19	det	_	_
13	CREB/ATF	_	NN	NN	_	19	nn	_	_
14	,	_	,	,	_	13	punct	_	_
15	AP-1	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	octamer	_	NN	NN	_	13	conj	_	_
19	families	_	NNS	NNS	_	11	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	transcription	_	NN	NN	_	22	nn	_	_
22	factors	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	7	punct	_	_

1	Jun	_	NN	NN	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	essential	_	JJ	JJ	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	activation-induced	_	JJ	JJ	_	6	amod	_	_
6	transcription	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	binds	_	VBZ	VBZ	_	3	conj	_	_
9	preferably	_	RB	RB	_	8	advmod	_	_
10	as	_	IN	IN	_	8	prep	_	_
11	a	_	DT	DT	_	12	det	_	_
12	heterodimer	_	NN	NN	_	10	pobj	_	_
13	with	_	IN	IN	_	8	prep	_	_
14	ATF-2	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	CREB	_	NN	NN	_	5	nsubj	_	_
5	appears	_	VBZ	VBZ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	dampen	_	VB	VB	_	5	xcomp	_	_
8	transcription	_	NN	NN	_	7	dobj	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	this	_	DT	DT	_	11	det	_	_
11	element	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	CpG	_	NN	NN	_	3	nn	_	_
3	dinucleotide	_	NN	NN	_	9	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	this	_	DT	DT	_	6	det	_	_
6	element	_	NN	NN	_	4	pobj	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	selectively	_	RB	RB	_	9	advmod	_	_
9	methylated	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	Th2	_	NN	NN	_	13	nn	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	other	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	13	conj	_	_
17	that	_	WDT	WDT	_	20	nsubj	_	_
18	do	_	VBP	VBP	_	20	aux	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	express	_	VB	VB	_	16	rcmod	_	_
21	IFN-gamma	_	NN	NN	_	20	dobj	_	_
22	,	_	,	,	_	9	punct	_	_
23	and	_	CC	CC	_	9	cc	_	_
24	methylation	_	NN	NN	_	26	nsubj	_	_
25	markedly	_	RB	RB	_	26	advmod	_	_
26	reduces	_	VBZ	VBZ	_	9	conj	_	_
27	transcription	_	NN	NN	_	29	nn	_	_
28	factor	_	NN	NN	_	29	nn	_	_
29	binding	_	NN	NN	_	26	dobj	_	_
30	.	_	.	.	_	9	punct	_	_

1	As	_	IN	IN	_	21	prep	_	_
2	a	_	DT	DT	_	3	det	_	_
3	target	_	NN	NN	_	1	pobj	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	DNA	_	NN	NN	_	6	nn	_	_
6	methylation	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	for	_	IN	IN	_	4	conj	_	_
9	binding	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	10	pobj	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	mediate	_	VBP	VBP	_	12	rcmod	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	impede	_	VBP	VBP	_	14	conj	_	_
17	transcription	_	NN	NN	_	14	dobj	_	_
18	,	_	,	,	_	21	punct	_	_
19	this	_	DT	DT	_	20	det	_	_
20	element	_	NN	NN	_	21	nsubj	_	_
21	appears	_	VBZ	VBZ	_	0	root	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	play	_	VB	VB	_	21	xcomp	_	_
24	a	_	DT	DT	_	26	det	_	_
25	central	_	JJ	JJ	_	26	amod	_	_
26	role	_	NN	NN	_	23	dobj	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	controlling	_	VBG	VBG	_	27	pcomp	_	_
29	IFN-gamma	_	NN	NN	_	30	nn	_	_
30	expression	_	NN	NN	_	28	dobj	_	_
31	.	_	.	.	_	21	punct	_	_

1	Activation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	factor-kappaB	_	NN	NN	_	2	pobj	_	_
5	via	_	IN	IN	_	1	prep	_	_
6	T	_	NN	NN	_	8	nn	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	5	pobj	_	_
9	requires	_	VBZ	VBZ	_	0	root	_	_
10	a	_	DT	DT	_	15	det	_	_
11	Raf	_	NN	NN	_	12	nn	_	_
12	kinase	_	NN	NN	_	15	nn	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Ca2+	_	NN	NN	_	12	conj	_	_
15	influx	_	NN	NN	_	9	dobj	_	_
16	.	_	.	.	_	9	punct	_	_

1	Functional	_	JJ	JJ	_	2	amod	_	_
2	synergy	_	NN	NN	_	0	root	_	_
3	between	_	IN	IN	_	2	prep	_	_
4	Raf	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	calcineurin	_	NN	NN	_	4	conj	_	_
7	.	_	.	.	_	2	punct	_	_

1	Signals	_	NNS	NNS	_	6	nsubj	_	_
2	transduced	_	VBN	VBN	_	1	vmod	_	_
3	via	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	TCR	_	NN	NN	_	3	pobj	_	_
6	activate	_	VBP	VBP	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	6	dobj	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	factor-kappaB	_	NN	NN	_	9	dep	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	NF-kappaB	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	9	punct	_	_
16	which	_	WDT	WDT	_	22	nsubj	_	_
17	,	_	,	,	_	22	punct	_	_
18	in	_	IN	IN	_	22	prep	_	_
19	turn	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	22	punct	_	_
21	is	_	VBZ	VBZ	_	22	cop	_	_
22	critical	_	JJ	JJ	_	9	rcmod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	transcriptional	_	JJ	JJ	_	26	amod	_	_
26	induction	_	NN	NN	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	many	_	JJ	JJ	_	29	amod	_	_
29	genes	_	NNS	NNS	_	27	pobj	_	_
30	important	_	JJ	JJ	_	29	amod	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	proliferation	_	NN	NN	_	31	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	expression	_	NN	NN	_	33	conj	_	_
36	of	_	IN	IN	_	33	prep	_	_
37	a	_	DT	DT	_	39	det	_	_
38	differentiated	_	VBN	VBN	_	39	amod	_	_
39	phenotype	_	NN	NN	_	36	pobj	_	_
40	.	_	.	.	_	6	punct	_	_

1	Treatment	_	NN	NN	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	T	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	11	det	_	_
7	protein	_	NN	NN	_	11	nn	_	_
8	kinase	_	NN	NN	_	11	nn	_	_
9	C	_	NN	NN	_	11	nn	_	_
10	activator	_	NN	NN	_	11	nn	_	_
11	PMA	_	NN	NN	_	5	pobj	_	_
12	in	_	IN	IN	_	1	prep	_	_
13	combination	_	NN	NN	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	Ca2+	_	NN	NN	_	16	nn	_	_
16	ionophores	_	NNS	NNS	_	14	pobj	_	_
17	mimics	_	VBZ	VBZ	_	0	root	_	_
18	this	_	DT	DT	_	19	det	_	_
19	process	_	NN	NN	_	17	dobj	_	_
20	,	_	,	,	_	17	punct	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	the	_	DT	DT	_	24	det	_	_
23	two	_	CD	CD	_	24	num	_	_
24	agents	_	NNS	NNS	_	27	nsubjpass	_	_
25	are	_	VBP	VBP	_	27	auxpass	_	_
26	often	_	RB	RB	_	27	advmod	_	_
27	substituted	_	VBN	VBN	_	17	conj	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	TCR	_	NN	NN	_	30	nn	_	_
30	stimulation	_	NN	NN	_	28	pobj	_	_
31	,	_	,	,	_	27	punct	_	_
32	bypassing	_	VBG	VBG	_	27	vmod	_	_
33	the	_	DT	DT	_	34	det	_	_
34	TCR	_	NN	NN	_	32	dobj	_	_
35	.	_	.	.	_	17	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	identify	_	VBP	VBP	_	0	root	_	_
4	intracellular	_	JJ	JJ	_	6	amod	_	_
5	signaling	_	VBG	VBG	_	6	amod	_	_
6	components	_	NNS	NNS	_	3	dobj	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	activation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	NF-kappaB	_	NN	NN	_	10	pobj	_	_
12	following	_	VBG	VBG	_	9	prep	_	_
13	TCR	_	NN	NN	_	14	nn	_	_
14	stimulation	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	TCR	_	NN	NN	_	2	nn	_	_
2	signaling	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	triggered	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	treating	_	VBG	VBG	_	5	pcomp	_	_
7	Jurkat	_	NN	NN	_	9	nn	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	dobj	_	_
10	with	_	IN	IN	_	6	prep	_	_
11	PHA	_	NN	NN	_	14	nn	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	anti-CD3	_	JJ	JJ	_	11	conj	_	_
14	Abs	_	NNS	NNS	_	10	pobj	_	_
15	,	_	,	,	_	4	punct	_	_
16	and	_	CC	CC	_	4	cc	_	_
17	NF-kappaB	_	NN	NN	_	18	nn	_	_
18	activation	_	NN	NN	_	20	nsubjpass	_	_
19	was	_	VBD	VBD	_	20	auxpass	_	_
20	monitored	_	VBN	VBN	_	4	conj	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	electrophoretic	_	JJ	JJ	_	25	amod	_	_
23	mobility	_	NN	NN	_	25	nn	_	_
24	shift	_	NN	NN	_	25	nn	_	_
25	assays	_	NNS	NNS	_	21	pobj	_	_
26	and/or	_	CC	CC	_	21	cc	_	_
27	by	_	IN	IN	_	21	conj	_	_
28	kappaB-dependent	_	JJ	JJ	_	30	amod	_	_
29	reporter	_	NN	NN	_	30	nn	_	_
30	assays	_	NNS	NNS	_	27	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	Contrary	_	JJ	JJ	_	2	dep	_	_
2	to	_	TO	TO	_	23	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	idea	_	NN	NN	_	2	pobj	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	protein	_	NN	NN	_	8	nn	_	_
7	kinase	_	NN	NN	_	8	nn	_	_
8	C	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	involved	_	VBN	VBN	_	4	ccomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	TCR-mediated	_	JJ	JJ	_	13	amod	_	_
13	activation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	NF-kappaB	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	23	punct	_	_
17	high	_	JJ	JJ	_	18	amod	_	_
18	doses	_	NNS	NNS	_	23	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	staurosporine	_	NN	NN	_	19	pobj	_	_
21	did	_	VBD	VBD	_	23	aux	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	interfere	_	VB	VB	_	0	root	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	activation	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	NF-kappaB	_	NN	NN	_	26	pobj	_	_
28	by	_	IN	IN	_	25	prep	_	_
29	PHA	_	NN	NN	_	28	pobj	_	_
30	,	_	,	,	_	23	punct	_	_
31	while	_	IN	IN	_	38	mark	_	_
32	the	_	DT	DT	_	34	det	_	_
33	same	_	JJ	JJ	_	34	amod	_	_
34	dose	_	NN	NN	_	38	nsubj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	staurosporine	_	NN	NN	_	35	pobj	_	_
37	completely	_	RB	RB	_	38	advmod	_	_
38	blocked	_	VBD	VBD	_	23	advcl	_	_
39	activation	_	NN	NN	_	38	dobj	_	_
40	by	_	IN	IN	_	39	prep	_	_
41	PMA	_	NN	NN	_	40	pobj	_	_
42	.	_	.	.	_	23	punct	_	_

1	PHA-induced	_	JJ	JJ	_	4	amod	_	_
2	kappaB-dependent	_	JJ	JJ	_	4	amod	_	_
3	reporter	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	10	nsubjpass	_	_
5	was	_	VBD	VBD	_	10	auxpass	_	_
6	,	_	,	,	_	10	punct	_	_
7	however	_	RB	RB	_	10	advmod	_	_
8	,	_	,	,	_	10	punct	_	_
9	effectively	_	RB	RB	_	10	advmod	_	_
10	blocked	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	15	det	_	_
13	dominant	_	JJ	JJ	_	15	amod	_	_
14	negative	_	JJ	JJ	_	15	amod	_	_
15	form	_	NN	NN	_	11	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	Raf-1	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	10	punct	_	_
19	suggesting	_	VBG	VBG	_	10	xcomp	_	_
20	a	_	DT	DT	_	22	det	_	_
21	critical	_	JJ	JJ	_	22	amod	_	_
22	role	_	NN	NN	_	19	dobj	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	Raf	_	NN	NN	_	26	nn	_	_
26	kinase	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	TCR-mediated	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	NF-kappaB	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	8	cop	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	dependent	_	JJ	JJ	_	0	root	_	_
9	on	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	Ca2+	_	NN	NN	_	12	nn	_	_
12	influx	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	because	_	IN	IN	_	34	mark	_	_
15	the	_	DT	DT	_	18	det	_	_
16	Ca2+	_	NN	NN	_	18	nn	_	_
17	channel	_	NN	NN	_	18	nn	_	_
18	blocker	_	NN	NN	_	34	nsubj	_	_
19	,	_	,	,	_	18	punct	_	_
20	SK&amp;F	_	NN	NN	_	18	appos	_	_
21	96365	_	CD	CD	_	20	num	_	_
22	,	_	,	,	_	18	punct	_	_
23	as	_	RB	RB	_	24	advmod	_	_
24	well	_	RB	RB	_	18	cc	_	_
25	as	_	IN	IN	_	24	mwe	_	_
26	other	_	JJ	JJ	_	27	amod	_	_
27	agents	_	NNS	NNS	_	18	conj	_	_
28	that	_	WDT	WDT	_	29	nsubj	_	_
29	prevented	_	VBD	VBD	_	27	rcmod	_	_
30	the	_	DT	DT	_	32	det	_	_
31	Ca2+	_	NN	NN	_	32	nn	_	_
32	influx	_	NN	NN	_	29	dobj	_	_
33	,	_	,	,	_	18	punct	_	_
34	inhibited	_	VBD	VBD	_	8	advcl	_	_
35	NF-kappaB	_	NN	NN	_	36	nn	_	_
36	activation	_	NN	NN	_	34	dobj	_	_
37	.	_	.	.	_	8	punct	_	_

1	Cotransfection	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	constitutively	_	RB	RB	_	5	advmod	_	_
5	active	_	JJ	JJ	_	6	amod	_	_
6	form	_	NN	NN	_	2	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	calcineurin	_	NN	NN	_	7	pobj	_	_
9	largely	_	RB	RB	_	10	advmod	_	_
10	substituted	_	VBD	VBD	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	Ca2+	_	NN	NN	_	14	nn	_	_
14	requirement	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	reversed	_	VBD	VBD	_	10	conj	_	_
17	the	_	DT	DT	_	18	det	_	_
18	blockade	_	NN	NN	_	16	dobj	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	SK&amp;F	_	NN	NN	_	19	pobj	_	_
21	96365	_	CD	CD	_	20	num	_	_
22	.	_	.	.	_	10	punct	_	_

1	Consistent	_	JJ	JJ	_	16	dep	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	observations	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	16	punct	_	_
6	coexpression	_	NN	NN	_	16	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	constitutively	_	RB	RB	_	9	advmod	_	_
9	active	_	JJ	JJ	_	10	amod	_	_
10	forms	_	NNS	NNS	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Raf-1	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	calcineurin	_	NN	NN	_	12	conj	_	_
15	synergistically	_	RB	RB	_	16	advmod	_	_
16	induced	_	VBD	VBD	_	0	root	_	_
17	kappaB-dependent	_	JJ	JJ	_	19	amod	_	_
18	reporter	_	NN	NN	_	19	nn	_	_
19	activity	_	NN	NN	_	16	dobj	_	_
20	,	_	,	,	_	16	punct	_	_
21	suggesting	_	VBG	VBG	_	16	vmod	_	_
22	a	_	DT	DT	_	26	det	_	_
23	physiologically	_	RB	RB	_	24	advmod	_	_
24	relevant	_	JJ	JJ	_	26	amod	_	_
25	functional	_	JJ	JJ	_	26	amod	_	_
26	interaction	_	NN	NN	_	21	dobj	_	_
27	between	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	kinase	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	the	_	DT	DT	_	32	det	_	_
32	phosphatase	_	NN	NN	_	29	conj	_	_
33	.	_	.	.	_	16	punct	_	_

1	Induction	_	NN	NN	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	CD11b	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	pobj	_	_
6	during	_	IN	IN	_	1	prep	_	_
7	activation	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	monocytic	_	JJ	JJ	_	13	amod	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	line	_	NN	NN	_	13	nn	_	_
13	U937	_	NN	NN	_	8	pobj	_	_
14	requires	_	VBZ	VBZ	_	0	root	_	_
15	a	_	DT	DT	_	19	det	_	_
16	novel	_	JJ	JJ	_	19	amod	_	_
17	nuclear	_	JJ	JJ	_	19	amod	_	_
18	factor	_	NN	NN	_	19	nn	_	_
19	MS-2	_	NN	NN	_	14	dobj	_	_
20	-LSB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	published	_	VBN	VBN	_	22	amod	_	_
22	erratum	_	NN	NN	_	23	nsubj	_	_
23	appears	_	VBZ	VBZ	_	14	parataxis	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	J	_	NNP	NNP	_	26	nn	_	_
26	Immunol	_	NNP	NNP	_	24	pobj	_	_
27	1999	_	CD	CD	_	28	num	_	_
28	Jul	_	NNP	NNP	_	26	dep	_	_
29	15	_	CD	CD	_	28	num	_	_
30	;	_	:	:	_	26	punct	_	_
31	163	_	CD	CD	_	33	num	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	2	_	CD	CD	_	26	dep	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	:	_	:	:	_	26	punct	_	_
36	1091	_	CD	CD	_	26	dep	_	_
37	-RSB-	_	-RRB-	-RRB-	_	23	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	differentiation	_	NN	NN	_	11	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	myeloid	_	JJ	JJ	_	5	amod	_	_
5	precursors	_	NNS	NNS	_	3	pobj	_	_
6	into	_	IN	IN	_	2	prep	_	_
7	mature	_	JJ	JJ	_	9	amod	_	_
8	myelomonocytic	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	characterized	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	induction	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	gene	_	NN	NN	_	15	pobj	_	_
18	encoding	_	VBG	VBG	_	17	vmod	_	_
19	the	_	DT	DT	_	22	det	_	_
20	beta2	_	NN	NN	_	22	nn	_	_
21	integrin	_	NN	NN	_	22	nn	_	_
22	CD11b	_	NN	NN	_	18	dobj	_	_
23	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factors	_	NNS	NNS	_	7	nsubj	_	_
4	Sp1	_	NN	NN	_	3	dep	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	PU.1	_	NN	NN	_	4	conj	_	_
7	prime	_	VBP	VBP	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	CD11b	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	7	dobj	_	_
11	,	_	,	,	_	7	punct	_	_
12	but	_	CC	CC	_	7	cc	_	_
13	the	_	DT	DT	_	14	det	_	_
14	nature	_	NN	NN	_	24	nsubj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	factors	_	NNS	NNS	_	15	pobj	_	_
18	responsible	_	JJ	JJ	_	17	amod	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	its	_	PRP$	PRP$	_	22	poss	_	_
21	inducible	_	JJ	JJ	_	22	amod	_	_
22	expression	_	NN	NN	_	19	pobj	_	_
23	are	_	VBP	VBP	_	24	cop	_	_
24	unknown	_	JJ	JJ	_	7	conj	_	_
25	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	16	prep	_	_
2	addition	_	NN	NN	_	1	mwe	_	_
3	to	_	TO	TO	_	1	dep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	CD11b	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	1	pobj	_	_
7	,	_	,	,	_	16	punct	_	_
8	the	_	DT	DT	_	10	det	_	_
9	homologous	_	JJ	JJ	_	10	amod	_	_
10	genes	_	NNS	NNS	_	16	nsubj	_	_
11	encoding	_	VBG	VBG	_	10	vmod	_	_
12	CD11a	_	NN	NN	_	11	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	CD11c	_	NN	NN	_	12	conj	_	_
15	also	_	RB	RB	_	16	advmod	_	_
16	exhibit	_	VBP	VBP	_	0	root	_	_
17	inducible	_	JJ	JJ	_	18	amod	_	_
18	expression	_	NN	NN	_	16	dobj	_	_
19	during	_	IN	IN	_	16	prep	_	_
20	myeloid	_	JJ	JJ	_	21	amod	_	_
21	differentiation	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	16	punct	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	compared	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	nucleotide	_	JJ	JJ	_	7	amod	_	_
7	sequences	_	NNS	NNS	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	17	det	_	_
10	CD11a	_	NN	NN	_	17	nn	_	_
11	,	_	,	,	_	10	punct	_	_
12	CD11b	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	10	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	CD11c	_	NN	NN	_	10	conj	_	_
16	gene	_	NN	NN	_	17	nn	_	_
17	promoters	_	NNS	NNS	_	8	pobj	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	identify	_	VB	VB	_	4	vmod	_	_
20	common	_	JJ	JJ	_	21	amod	_	_
21	elements	_	NNS	NNS	_	19	dobj	_	_
22	that	_	WDT	WDT	_	24	nsubj	_	_
23	might	_	MD	MD	_	24	aux	_	_
24	contribute	_	VB	VB	_	21	rcmod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	inducible	_	JJ	JJ	_	27	amod	_	_
27	expression	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	identified	_	VBD	VBD	_	0	root	_	_
4	one	_	CD	CD	_	6	num	_	_
5	such	_	JJ	JJ	_	6	amod	_	_
6	element	_	NN	NN	_	3	dobj	_	_
7	repeated	_	VBN	VBN	_	6	vmod	_	_
8	four	_	CD	CD	_	9	num	_	_
9	times	_	NNS	NNS	_	7	dobj	_	_
10	within	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	CD11b	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Mutation	_	NN	NN	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	elements	_	NNS	NNS	_	2	pobj	_	_
5	indicated	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	14	mark	_	_
7	two	_	CD	CD	_	14	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	MS-2beta	_	NN	NN	_	7	appos	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	MS-2gamma	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	7	punct	_	_
13	are	_	VBP	VBP	_	14	cop	_	_
14	critical	_	JJ	JJ	_	5	ccomp	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	induction	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	CD11b	_	NN	NN	_	21	nn	_	_
21	gene	_	NN	NN	_	18	pobj	_	_
22	during	_	IN	IN	_	17	prep	_	_
23	differentiation	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	29	det	_	_
26	pro-monocytic	_	JJ	JJ	_	29	amod	_	_
27	cell	_	NN	NN	_	29	nn	_	_
28	line	_	NN	NN	_	29	nn	_	_
29	U937	_	NN	NN	_	24	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	4	amod	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	5	nsubj	_	_
5	indicate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	MS-2beta	_	NN	NN	_	10	nsubj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	MS-2gamma	_	NN	NN	_	7	conj	_	_
10	interact	_	VBP	VBP	_	5	ccomp	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	factors	_	NNS	NNS	_	11	pobj	_	_
14	that	_	WDT	WDT	_	16	nsubjpass	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	induced	_	VBN	VBN	_	13	rcmod	_	_
17	during	_	IN	IN	_	16	prep	_	_
18	U937	_	NN	NN	_	19	nn	_	_
19	differentiation	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	factors	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	detected	_	VBN	VBN	_	0	root	_	_
5	at	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	time	_	NN	NN	_	5	pobj	_	_
8	the	_	DT	DT	_	10	det	_	_
9	CD11b	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	12	nsubjpass	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	activated	_	VBN	VBN	_	7	rcmod	_	_
13	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	molecular	_	JJ	JJ	_	3	amod	_	_
3	mass	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	these	_	DT	DT	_	6	det	_	_
6	factors	_	NNS	NNS	_	4	pobj	_	_
7	is	_	VBZ	VBZ	_	10	cop	_	_
8	approximately	_	RB	RB	_	9	quantmod	_	_
9	28	_	CD	CD	_	10	num	_	_
10	kDa	_	NN	NN	_	0	root	_	_
11	,	_	,	,	_	10	punct	_	_
12	and	_	CC	CC	_	10	cc	_	_
13	their	_	PRP$	PRP$	_	16	poss	_	_
14	DNA	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	characteristics	_	NNS	NNS	_	18	nsubj	_	_
17	are	_	VBP	VBP	_	18	cop	_	_
18	indistinguishable	_	JJ	JJ	_	10	conj	_	_
19	from	_	IN	IN	_	18	prep	_	_
20	those	_	DT	DT	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	26	det	_	_
23	novel	_	JJ	JJ	_	26	amod	_	_
24	nuclear	_	JJ	JJ	_	26	amod	_	_
25	factor	_	NN	NN	_	26	nn	_	_
26	MS-2	_	NN	NN	_	21	pobj	_	_
27	.	_	.	.	_	10	punct	_	_

1	Taken	_	VBN	VBN	_	6	vmod	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	6	punct	_	_
4	our	_	PRP$	PRP$	_	5	poss	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	indicate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	9	mark	_	_
8	MS-2	_	NN	NN	_	9	nsubj	_	_
9	mediates	_	VBZ	VBZ	_	6	ccomp	_	_
10	induction	_	NN	NN	_	9	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	CD11b	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	11	pobj	_	_
15	as	_	IN	IN	_	21	mark	_	_
16	cells	_	NNS	NNS	_	21	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	monocytic	_	JJ	JJ	_	20	amod	_	_
20	lineage	_	NN	NN	_	17	pobj	_	_
21	mature	_	VBP	VBP	_	9	advcl	_	_
22	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	presence	_	NN	NN	_	25	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	multiple	_	JJ	JJ	_	7	amod	_	_
5	potential	_	JJ	JJ	_	7	amod	_	_
6	binding	_	VBG	VBG	_	7	amod	_	_
7	sites	_	NNS	NNS	_	3	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	MS-2	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	2	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	promoter	_	NN	NN	_	13	nn	_	_
13	regions	_	NNS	NNS	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	wide	_	JJ	JJ	_	17	amod	_	_
17	range	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	genes	_	NNS	NNS	_	18	pobj	_	_
20	expressed	_	VBN	VBN	_	19	vmod	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	mature	_	JJ	JJ	_	24	amod	_	_
23	myeloid	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	suggests	_	VBZ	VBZ	_	0	root	_	_
26	this	_	DT	DT	_	27	det	_	_
27	factor	_	NN	NN	_	28	nsubj	_	_
28	plays	_	VBZ	VBZ	_	25	ccomp	_	_
29	a	_	DT	DT	_	31	det	_	_
30	general	_	JJ	JJ	_	31	amod	_	_
31	role	_	NN	NN	_	28	dobj	_	_
32	in	_	IN	IN	_	28	prep	_	_
33	myeloid	_	JJ	JJ	_	34	amod	_	_
34	differentiation	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	25	punct	_	_

1	HIV-1	_	NN	NN	_	3	nn	_	_
2	LTR	_	NN	NN	_	3	nn	_	_
3	activity	_	NN	NN	_	10	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	8	amod	_	_
6	CD40-activated	_	JJ	JJ	_	8	amod	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	lymphocytes	_	NNS	NNS	_	4	pobj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	dependent	_	JJ	JJ	_	0	root	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	NF-kappaB	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	10	punct	_	_

1	CD40-stimulated	_	JJ	JJ	_	4	amod	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	B	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	7	nsubj	_	_
5	are	_	VBP	VBP	_	7	cop	_	_
6	highly	_	RB	RB	_	7	advmod	_	_
7	permissive	_	JJ	JJ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	productive	_	JJ	JJ	_	11	amod	_	_
11	infection	_	NN	NN	_	8	pobj	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	human	_	JJ	JJ	_	17	amod	_	_
15	immunodeficiency	_	NN	NN	_	17	nn	_	_
16	virus	_	NN	NN	_	17	nn	_	_
17	type	_	NN	NN	_	12	pobj	_	_
18	1	_	CD	CD	_	17	num	_	_
19	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	26	prep	_	_
2	these	_	DT	DT	_	3	det	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	26	punct	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	factors	_	NNS	NNS	_	26	nsubj	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	activation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	HIV-1	_	NN	NN	_	13	nn	_	_
13	LTR	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	contains	_	VBZ	VBZ	_	13	rcmod	_	_
17	the	_	DT	DT	_	20	det	_	_
18	transcriptional	_	JJ	JJ	_	20	amod	_	_
19	control	_	NN	NN	_	20	nn	_	_
20	elements	_	NNS	NNS	_	16	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	virus	_	NN	NN	_	21	pobj	_	_
24	,	_	,	,	_	13	punct	_	_
25	are	_	VBP	VBP	_	26	cop	_	_
26	unknown	_	JJ	JJ	_	0	root	_	_
27	.	_	.	.	_	26	punct	_	_

1	Transient	_	JJ	JJ	_	3	amod	_	_
2	expression	_	NN	NN	_	3	nn	_	_
3	assays	_	NNS	NNS	_	18	nsubj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	plasmids	_	NNS	NNS	_	4	pobj	_	_
6	containing	_	VBG	VBG	_	5	vmod	_	_
7	deleted	_	VBN	VBN	_	8	amod	_	_
8	parts	_	NNS	NNS	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	LTR	_	NN	NN	_	12	nn	_	_
12	region	_	NN	NN	_	9	pobj	_	_
13	linked	_	VBN	VBN	_	12	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	reporter	_	NN	NN	_	17	nn	_	_
17	gene	_	NN	NN	_	14	pobj	_	_
18	showed	_	VBD	VBD	_	0	root	_	_
19	that	_	IN	IN	_	25	mark	_	_
20	the	_	DT	DT	_	23	det	_	_
21	NF-kappaB	_	NN	NN	_	23	nn	_	_
22	binding	_	NN	NN	_	23	nn	_	_
23	site	_	NN	NN	_	25	nsubj	_	_
24	was	_	VBD	VBD	_	25	cop	_	_
25	essential	_	JJ	JJ	_	18	ccomp	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	HIV-1	_	NN	NN	_	29	nn	_	_
28	LTR	_	NN	NN	_	29	nn	_	_
29	activity	_	NN	NN	_	26	pobj	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	CD40-stimulated	_	JJ	JJ	_	33	amod	_	_
32	B	_	NN	NN	_	33	nn	_	_
33	lymphocytes	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	18	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	10	punct	_	_
4	electrophoretic	_	JJ	JJ	_	6	amod	_	_
5	mobility	_	NN	NN	_	6	nn	_	_
6	shift	_	NN	NN	_	9	nn	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	supershift	_	NN	NN	_	6	conj	_	_
9	assays	_	NNS	NNS	_	10	nsubj	_	_
10	revealed	_	VBD	VBD	_	0	root	_	_
11	that	_	IN	IN	_	29	mark	_	_
12	important	_	JJ	JJ	_	15	amod	_	_
13	NF-kappaB	_	NN	NN	_	15	nn	_	_
14	binding	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	29	nsubj	_	_
16	composed	_	VBN	VBN	_	15	vmod	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	at	_	IN	IN	_	27	advmod	_	_
19	least	_	JJS	JJS	_	18	pobj	_	_
20	p50	_	NN	NN	_	27	nn	_	_
21	,	_	,	,	_	20	punct	_	_
22	p65	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	20	punct	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	c-Rel	_	NN	NN	_	26	nn	_	_
26	NF-kappaB	_	NN	NN	_	20	conj	_	_
27	subunits	_	NNS	NNS	_	17	pobj	_	_
28	was	_	VBD	VBD	_	29	cop	_	_
29	present	_	JJ	JJ	_	10	ccomp	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	nuclei	_	NNS	NNS	_	30	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	CD40-stimulated	_	JJ	JJ	_	35	amod	_	_
34	B	_	NN	NN	_	35	nn	_	_
35	cells	_	NNS	NNS	_	32	pobj	_	_
36	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	confirm	_	VBP	VBP	_	0	root	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	level	_	NN	NN	_	4	pobj	_	_
8	the	_	DT	DT	_	9	det	_	_
9	ability	_	NN	NN	_	3	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HIV-1	_	NN	NN	_	10	pobj	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	replicate	_	VB	VB	_	9	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	and	_	CC	CC	_	3	cc	_	_
18	that	_	IN	IN	_	23	mark	_	_
19	this	_	DT	DT	_	20	det	_	_
20	activity	_	NN	NN	_	23	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	23	auxpass	_	_
22	strongly	_	RB	RB	_	23	advmod	_	_
23	associated	_	VBN	VBN	_	3	conj	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	NF-kappaB	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Mutation	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	tyrosines	_	NNS	NNS	_	2	pobj	_	_
4	492/493	_	CD	CD	_	3	num	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	kinase	_	NN	NN	_	8	nn	_	_
8	domain	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	ZAP-70	_	NN	NN	_	9	pobj	_	_
11	affects	_	VBZ	VBZ	_	0	root	_	_
12	multiple	_	JJ	JJ	_	16	amod	_	_
13	T-cell	_	NN	NN	_	16	nn	_	_
14	receptor	_	NN	NN	_	16	nn	_	_
15	signaling	_	NN	NN	_	16	nn	_	_
16	pathways	_	NNS	NNS	_	11	dobj	_	_
17	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	protein-tyrosine	_	JJ	JJ	_	4	amod	_	_
3	kinase	_	NN	NN	_	4	nn	_	_
4	ZAP-70	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	implicated	_	VBN	VBN	_	0	root	_	_
7	,	_	,	,	_	6	punct	_	_
8	together	_	RB	RB	_	9	advmod	_	_
9	with	_	IN	IN	_	6	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	Src	_	NN	NN	_	13	nn	_	_
12	kinase	_	NN	NN	_	13	nn	_	_
13	p56-LRB-lck-RRB-	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	in	_	IN	IN	_	6	prep	_	_
16	controlling	_	VBG	VBG	_	15	pcomp	_	_
17	the	_	DT	DT	_	19	det	_	_
18	early	_	JJ	JJ	_	19	amod	_	_
19	steps	_	NNS	NNS	_	16	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	29	det	_	_
22	T-cell	_	NN	NN	_	24	nn	_	_
23	antigen	_	NN	NN	_	24	nn	_	_
24	receptor	_	NN	NN	_	29	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	TCR	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	signaling	_	NN	NN	_	29	nn	_	_
29	cascade	_	NN	NN	_	20	pobj	_	_
30	.	_	.	.	_	6	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	help	_	VB	VB	_	16	advcl	_	_
3	elucidate	_	VB	VB	_	2	ccomp	_	_
4	further	_	RBR	RBR	_	3	advmod	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mechanism	_	NN	NN	_	3	dobj	_	_
7	by	_	IN	IN	_	10	prep	_	_
8	which	_	WDT	WDT	_	7	pobj	_	_
9	ZAP-70	_	NN	NN	_	10	nsubj	_	_
10	regulates	_	VBZ	VBZ	_	6	rcmod	_	_
11	these	_	DT	DT	_	13	det	_	_
12	initial	_	JJ	JJ	_	13	amod	_	_
13	events	_	NNS	NNS	_	10	dobj	_	_
14	,	_	,	,	_	16	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	used	_	VBD	VBD	_	0	root	_	_
17	a	_	DT	DT	_	20	det	_	_
18	dominant-negative	_	JJ	JJ	_	20	amod	_	_
19	mutant	_	NN	NN	_	20	nn	_	_
20	approach	_	NN	NN	_	16	dobj	_	_
21	.	_	.	.	_	16	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	overexpressed	_	VBD	VBD	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	Jurkat	_	NN	NN	_	7	nn	_	_
6	T-cell	_	NN	NN	_	7	nn	_	_
7	line	_	NN	NN	_	3	pobj	_	_
8	ZAP-70	_	NN	NN	_	2	dobj	_	_
9	mutated	_	VBN	VBN	_	8	vmod	_	_
10	on	_	IN	IN	_	9	prep	_	_
11	Tyr-492	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	Tyr-493	_	NN	NN	_	11	conj	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	putative	_	JJ	JJ	_	18	amod	_	_
17	regulatory	_	JJ	JJ	_	18	amod	_	_
18	loop	_	NN	NN	_	14	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	its	_	PRP$	PRP$	_	22	poss	_	_
21	kinase	_	NN	NN	_	22	nn	_	_
22	domain	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	mutant	_	NN	NN	_	3	nsubj	_	_
3	inhibited	_	VBD	VBD	_	0	root	_	_
4	TCR-induced	_	JJ	JJ	_	5	amod	_	_
5	activation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	factor	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	activated	_	VBN	VBN	_	12	amod	_	_
11	T	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	by	_	IN	IN	_	3	prep	_	_
14	interfering	_	VBG	VBG	_	13	pcomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	both	_	CC	CC	_	19	preconj	_	_
17	intracellular	_	JJ	JJ	_	19	amod	_	_
18	calcium	_	NN	NN	_	19	nn	_	_
19	increase	_	NN	NN	_	15	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	Ras-regulated	_	JJ	JJ	_	22	amod	_	_
22	activation	_	NN	NN	_	19	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	extracellular	_	JJ	JJ	_	26	amod	_	_
25	signal-regulated	_	JJ	JJ	_	26	amod	_	_
26	kinases	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Moreover	_	RB	RB	_	19	advmod	_	_
2	,	_	,	,	_	19	punct	_	_
3	TCR-induced	_	JJ	JJ	_	4	amod	_	_
4	phosphorylation	_	NN	NN	_	19	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	pp36-38	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	4	punct	_	_
8	thought	_	VBN	VBN	_	4	vmod	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	play	_	VB	VB	_	8	xcomp	_	_
11	a	_	DT	DT	_	12	det	_	_
12	role	_	NN	NN	_	10	dobj	_	_
13	upstream	_	RB	RB	_	10	advmod	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	these	_	DT	DT	_	16	det	_	_
16	pathways	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	4	punct	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	found	_	VBN	VBN	_	0	root	_	_
20	to	_	TO	TO	_	22	aux	_	_
21	be	_	VB	VB	_	22	auxpass	_	_
22	reduced	_	VBN	VBN	_	19	xcomp	_	_
23	.	_	.	.	_	19	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	overexpression	_	NN	NN	_	8	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	wild-type	_	JJ	JJ	_	7	amod	_	_
7	ZAP-70	_	NN	NN	_	5	pobj	_	_
8	induced	_	VBD	VBD	_	0	root	_	_
9	constitutive	_	JJ	JJ	_	10	amod	_	_
10	activation	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	factor	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	activated	_	VBN	VBN	_	17	amod	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	ZAP-70	_	NN	NN	_	3	nn	_	_
3	mutant	_	NN	NN	_	8	nsubjpass	_	_
4	studied	_	VBN	VBN	_	3	vmod	_	_
5	here	_	RB	RB	_	4	advmod	_	_
6	could	_	MD	MD	_	8	aux	_	_
7	be	_	VB	VB	_	8	auxpass	_	_
8	phosphorylated	_	VBN	VBN	_	0	root	_	_
9	on	_	IN	IN	_	8	prep	_	_
10	tyrosine	_	NN	NN	_	9	pobj	_	_
11	when	_	WRB	WRB	_	12	advmod	_	_
12	associated	_	VBN	VBN	_	8	advcl	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	TCR	_	NN	NN	_	17	nn	_	_
16	zeta	_	NN	NN	_	17	nn	_	_
17	chain	_	NN	NN	_	13	pobj	_	_
18	and	_	CC	CC	_	8	cc	_	_
19	was	_	VBD	VBD	_	20	cop	_	_
20	able	_	JJ	JJ	_	8	conj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	bind	_	VB	VB	_	20	xcomp	_	_
23	p56-LRB-lck-RRB-	_	NN	NN	_	22	dobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	result	_	NN	NN	_	3	nsubj	_	_
3	demonstrates	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	Tyr-492	_	NN	NN	_	10	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	Tyr-493	_	NN	NN	_	5	conj	_	_
8	are	_	VBP	VBP	_	10	cop	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	responsible	_	JJ	JJ	_	3	ccomp	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	17	det	_	_
13	Src	_	NN	NN	_	16	npadvmod	_	_
14	homology	_	NN	NN	_	16	npadvmod	_	_
15	domain	_	NN	NN	_	16	npadvmod	_	_
16	2-mediated	_	JJ	JJ	_	17	amod	_	_
17	association	_	NN	NN	_	11	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	p56-LRB-lck-RRB-	_	NN	NN	_	18	pobj	_	_
20	with	_	IN	IN	_	17	prep	_	_
21	ZAP-70	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	5	nsubj	_	_
3	are	_	VBP	VBP	_	5	cop	_	_
4	most	_	RBS	RBS	_	5	advmod	_	_
5	consistent	_	JJ	JJ	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	model	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	15	prep	_	_
10	which	_	WDT	WDT	_	9	pobj	_	_
11	recruitment	_	NN	NN	_	15	nsubj	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	TCR	_	NN	NN	_	12	pobj	_	_
15	allows	_	VBZ	VBZ	_	8	rcmod	_	_
16	ZAP-70	_	NN	NN	_	15	dobj	_	_
17	autophosphorylation	_	NN	NN	_	16	dep	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	binding	_	NN	NN	_	17	conj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	p56-LRB-lck-RRB-	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	16	punct	_	_
23	which	_	WDT	WDT	_	26	nsubj	_	_
24	in	_	IN	IN	_	26	prep	_	_
25	turn	_	NN	NN	_	24	pobj	_	_
26	phosphorylates	_	VBZ	VBZ	_	16	rcmod	_	_
27	Tyr-492	_	NN	NN	_	26	dobj	_	_
28	and/or	_	CC	CC	_	27	cc	_	_
29	Tyr-493	_	NN	NN	_	27	conj	_	_
30	with	_	IN	IN	_	26	prep	_	_
31	consequent	_	JJ	JJ	_	32	amod	_	_
32	up-regulation	_	NN	NN	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	37	det	_	_
35	ZAP-70	_	NN	NN	_	37	nn	_	_
36	kinase	_	NN	NN	_	37	nn	_	_
37	activity	_	NN	NN	_	33	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	ZAP-70	_	NN	NN	_	5	nsubj	_	_
2	will	_	MD	MD	_	5	aux	_	_
3	then	_	RB	RB	_	5	advmod	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	8	aux	_	_
7	effectively	_	RB	RB	_	8	advmod	_	_
8	control	_	VB	VB	_	5	xcomp	_	_
9	phosphorylation	_	NN	NN	_	8	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	its	_	PRP$	PRP$	_	12	poss	_	_
12	substrates	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	lead	_	VB	VB	_	8	conj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	gene	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Dexamethasone	_	NN	NN	_	3	nn	_	_
2	suppression	_	NN	NN	_	3	nn	_	_
3	test	_	NN	NN	_	0	root	_	_
4	:	_	:	:	_	3	punct	_	_
5	corticosteroid	_	NN	NN	_	7	nn	_	_
6	receptors	_	NNS	NNS	_	7	nn	_	_
7	regulation	_	NN	NN	_	3	dep	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	mononuclear	_	JJ	JJ	_	10	amod	_	_
10	leukocytes	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	young	_	JJ	JJ	_	15	amod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	aged	_	JJ	JJ	_	12	conj	_	_
15	subjects	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	dexamethasone	_	NN	NN	_	4	nn	_	_
3	suppression	_	NN	NN	_	4	nn	_	_
4	test	_	NN	NN	_	9	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	DST	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	considered	_	VBN	VBN	_	0	root	_	_
10	an	_	DT	DT	_	11	det	_	_
11	indicator	_	NN	NN	_	9	xcomp	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	function	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	adrenal	_	JJ	JJ	_	19	amod	_	_
18	pituitary	_	JJ	JJ	_	19	amod	_	_
19	axis	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	steroid	_	NN	NN	_	3	pobj	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	mediated	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	its	_	PRP$	PRP$	_	10	poss	_	_
10	binding	_	NN	NN	_	8	pobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	corticosteroid	_	NN	NN	_	13	nn	_	_
13	receptors	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	suggested	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	measurement	_	NN	NN	_	14	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	corticosteroid	_	NN	NN	_	9	nn	_	_
9	receptors	_	NNS	NNS	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	lymphocytes	_	NNS	NNS	_	10	pobj	_	_
12	is	_	VBZ	VBZ	_	14	cop	_	_
13	an	_	DT	DT	_	14	det	_	_
14	index	_	NN	NN	_	3	ccomp	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	an	_	DT	DT	_	18	det	_	_
17	analogous	_	JJ	JJ	_	18	amod	_	_
18	pattern	_	NN	NN	_	15	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	brain	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	17	punct	_	_
6	corticosteroid	_	NN	NN	_	12	nn	_	_
7	Type	_	NN	NN	_	12	nn	_	_
8	I	_	CD	CD	_	7	num	_	_
9	and	_	CC	CC	_	7	cc	_	_
10	Type	_	NN	NN	_	7	conj	_	_
11	II	_	CD	CD	_	10	num	_	_
12	receptors	_	NNS	NNS	_	17	nsubjpass	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	mononuclear	_	JJ	JJ	_	15	amod	_	_
15	leukocytes	_	NNS	NNS	_	13	pobj	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	measured	_	VBN	VBN	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	10	_	CD	CD	_	21	num	_	_
20	elderly	_	JJ	JJ	_	21	amod	_	_
21	subjects	_	NNS	NNS	_	18	pobj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	in	_	IN	IN	_	18	conj	_	_
24	9	_	CD	CD	_	26	num	_	_
25	young	_	JJ	JJ	_	26	amod	_	_
26	adults	_	NNS	NNS	_	23	pobj	_	_
27	,	_	,	,	_	17	punct	_	_
28	before	_	IN	IN	_	17	prep	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	after	_	IN	IN	_	28	conj	_	_
31	overnight	_	JJ	JJ	_	32	amod	_	_
32	DST	_	NN	NN	_	28	dep	_	_
33	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
34	1	_	CD	CD	_	35	num	_	_
35	mg	_	NN	NN	_	32	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	17	punct	_	_

1	Receptors	_	NNS	NNS	_	3	nsubjpass	_	_
2	were	_	VBD	VBD	_	3	auxpass	_	_
3	measured	_	VBN	VBN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	radioreceptor	_	NN	NN	_	6	nn	_	_
6	assay	_	NN	NN	_	4	pobj	_	_
7	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	all	_	PDT	PDT	_	4	predet	_	_
3	the	_	DT	DT	_	4	det	_	_
4	subjects	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	dexamethasone	_	NN	NN	_	8	nsubj	_	_
7	was	_	VBD	VBD	_	8	cop	_	_
8	able	_	JJ	JJ	_	0	root	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	suppress	_	VB	VB	_	8	xcomp	_	_
11	plasma	_	NN	NN	_	12	nn	_	_
12	cortisol	_	NN	NN	_	10	dobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	number	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Type	_	NN	NN	_	9	nn	_	_
5	I	_	CD	CD	_	4	num	_	_
6	and	_	CC	CC	_	4	cc	_	_
7	Type	_	NN	NN	_	4	conj	_	_
8	II	_	CD	CD	_	7	num	_	_
9	receptors	_	NNS	NNS	_	3	pobj	_	_
10	before	_	IN	IN	_	2	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	test	_	NN	NN	_	10	pobj	_	_
13	was	_	VBD	VBD	_	14	cop	_	_
14	lower	_	JJR	JJR	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	elderly	_	JJ	JJ	_	17	amod	_	_
17	subjects	_	NNS	NNS	_	15	pobj	_	_
18	than	_	IN	IN	_	14	prep	_	_
19	in	_	IN	IN	_	18	dep	_	_
20	adults	_	NNS	NNS	_	19	pobj	_	_
21	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	control	_	NN	NN	_	4	nn	_	_
4	group	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	dexamethasone	_	NN	NN	_	7	nsubj	_	_
7	produced	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	significant	_	JJ	JJ	_	10	amod	_	_
10	depression	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Type	_	NN	NN	_	14	nn	_	_
13	I	_	CD	CD	_	14	num	_	_
14	receptors	_	NNS	NNS	_	11	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
16	from	_	IN	IN	_	10	prep	_	_
17	267	_	CD	CD	_	16	pobj	_	_
18	+/-	_	CC	CC	_	17	cc	_	_
19	72	_	CD	CD	_	17	conj	_	_
20	to	_	TO	TO	_	10	prep	_	_
21	169	_	CD	CD	_	20	pobj	_	_
22	+/-	_	CC	CC	_	21	cc	_	_
23	71	_	CD	CD	_	21	conj	_	_
24	receptors	_	NNS	NNS	_	10	dep	_	_
25	per	_	IN	IN	_	24	prep	_	_
26	cell	_	NN	NN	_	25	pobj	_	_
27	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
28	,	_	,	,	_	10	punct	_	_
29	which	_	WDT	WDT	_	32	nsubjpass	_	_
30	can	_	MD	MD	_	32	aux	_	_
31	be	_	VB	VB	_	32	auxpass	_	_
32	interpreted	_	VBN	VBN	_	10	rcmod	_	_
33	as	_	IN	IN	_	32	prep	_	_
34	a	_	DT	DT	_	36	det	_	_
35	primary	_	JJ	JJ	_	36	amod	_	_
36	involvement	_	NN	NN	_	33	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	Type	_	NN	NN	_	40	nn	_	_
39	I	_	CD	CD	_	40	num	_	_
40	receptors	_	NNS	NNS	_	37	pobj	_	_
41	in	_	IN	IN	_	36	prep	_	_
42	the	_	DT	DT	_	43	det	_	_
43	response	_	NN	NN	_	41	pobj	_	_
44	to	_	TO	TO	_	43	prep	_	_
45	dexamethasone	_	NN	NN	_	44	pobj	_	_
46	;	_	:	:	_	7	punct	_	_
47	Type	_	NN	NN	_	49	nn	_	_
48	II	_	CD	CD	_	49	num	_	_
49	receptors	_	NNS	NNS	_	50	nsubj	_	_
50	decreased	_	VBD	VBD	_	7	parataxis	_	_
51	in	_	IN	IN	_	50	prep	_	_
52	half	_	PDT	PDT	_	54	predet	_	_
53	the	_	DT	DT	_	54	det	_	_
54	subjects	_	NNS	NNS	_	51	pobj	_	_
55	-LRB-	_	-LRB-	-LRB-	_	50	punct	_	_
56	from	_	IN	IN	_	50	prep	_	_
57	2849	_	CD	CD	_	56	pobj	_	_
58	+/-	_	CC	CC	_	57	cc	_	_
59	703	_	CD	CD	_	57	conj	_	_
60	to	_	TO	TO	_	50	prep	_	_
61	2345	_	CD	CD	_	60	pobj	_	_
62	+/-	_	CC	CC	_	61	cc	_	_
63	569	_	CD	CD	_	61	conj	_	_
64	receptors	_	NNS	NNS	_	50	dobj	_	_
65	per	_	IN	IN	_	64	prep	_	_
66	cell	_	NN	NN	_	65	pobj	_	_
67	-RRB-	_	-RRB-	-RRB-	_	50	punct	_	_
68	.	_	.	.	_	50	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	elderly	_	JJ	JJ	_	4	amod	_	_
3	healthy	_	JJ	JJ	_	4	amod	_	_
4	subjects	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	12	punct	_	_
6	Type	_	NN	NN	_	8	nn	_	_
7	II	_	CD	CD	_	8	num	_	_
8	receptors	_	NNS	NNS	_	12	nsubjpass	_	_
9	were	_	VBD	VBD	_	12	auxpass	_	_
10	also	_	RB	RB	_	12	advmod	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	decreased	_	VBN	VBN	_	0	root	_	_
13	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
14	from	_	IN	IN	_	12	prep	_	_
15	1796	_	CD	CD	_	14	pobj	_	_
16	+/-	_	CC	CC	_	15	cc	_	_
17	671	_	CD	CD	_	15	conj	_	_
18	to	_	TO	TO	_	12	prep	_	_
19	720	_	CD	CD	_	18	pobj	_	_
20	+/-	_	CC	CC	_	19	cc	_	_
21	345	_	CD	CD	_	19	conj	_	_
22	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
23	.	_	.	.	_	12	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	suggest	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	12	mark	_	_
4	in	_	IN	IN	_	12	prep	_	_
5	young	_	JJ	JJ	_	6	amod	_	_
6	subjects	_	NNS	NNS	_	4	pobj	_	_
7	Type	_	NN	NN	_	9	nn	_	_
8	II	_	CD	CD	_	9	num	_	_
9	receptors	_	NNS	NNS	_	12	nsubjpass	_	_
10	are	_	VBP	VBP	_	12	auxpass	_	_
11	initially	_	RB	RB	_	12	advmod	_	_
12	up-regulated	_	VBN	VBN	_	2	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	dexamethasone	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	12	punct	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	then	_	RB	RB	_	18	advmod	_	_
18	down-regulated	_	VBN	VBN	_	12	conj	_	_
19	,	_	,	,	_	12	punct	_	_
20	while	_	IN	IN	_	29	mark	_	_
21	in	_	RB	RB	_	29	prep	_	_
22	aged	_	JJ	JJ	_	23	amod	_	_
23	subjects	_	NNS	NNS	_	21	pobj	_	_
24	an	_	DT	DT	_	25	det	_	_
25	up-regulation	_	NN	NN	_	29	nsubjpass	_	_
26	can	_	MD	MD	_	29	aux	_	_
27	not	_	RB	RB	_	29	neg	_	_
28	be	_	VB	VB	_	29	auxpass	_	_
29	achieved	_	VBN	VBN	_	12	advcl	_	_
30	,	_	,	,	_	29	punct	_	_
31	as	_	IN	IN	_	32	mark	_	_
32	suggested	_	VBN	VBN	_	29	advcl	_	_
33	by	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	higher	_	JJR	JJR	_	36	amod	_	_
36	values	_	NNS	NNS	_	33	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	plasma	_	NN	NN	_	39	nn	_	_
39	cortisol	_	NN	NN	_	37	pobj	_	_
40	usually	_	RB	RB	_	41	advmod	_	_
41	found	_	VBN	VBN	_	36	vmod	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	aging	_	VBG	VBG	_	44	amod	_	_
44	subjects	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	2	punct	_	_

1	Lymphocytes	_	NNS	NNS	_	5	nsubj	_	_
2	from	_	IN	IN	_	1	prep	_	_
3	CML	_	NN	NN	_	4	nn	_	_
4	patients	_	NNS	NNS	_	2	pobj	_	_
5	lack	_	VBP	VBP	_	0	root	_	_
6	a	_	DT	DT	_	9	det	_	_
7	47	_	CD	CD	_	8	number	_	_
8	kDa	_	NN	NN	_	9	amod	_	_
9	factor	_	NN	NN	_	5	dobj	_	_
10	having	_	VBG	VBG	_	9	vmod	_	_
11	affinity	_	NN	NN	_	10	dobj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	17	det	_	_
14	genomic	_	JJ	JJ	_	17	amod	_	_
15	sterol	_	NN	NN	_	17	nn	_	_
16	regulatory	_	JJ	JJ	_	17	amod	_	_
17	sequence	_	NN	NN	_	12	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Deranged	_	VBN	VBN	_	4	amod	_	_
2	cellular	_	JJ	JJ	_	4	amod	_	_
3	cholesterol	_	NN	NN	_	4	nn	_	_
4	homeostasis	_	NN	NN	_	8	nsubjpass	_	_
5	has	_	VBZ	VBZ	_	8	aux	_	_
6	been	_	VBN	VBN	_	8	auxpass	_	_
7	widely	_	RB	RB	_	8	advmod	_	_
8	recognized	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	initiation	_	NN	NN	_	9	pobj	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	11	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	progression	_	NN	NN	_	11	conj	_	_
16	of	_	IN	IN	_	11	prep	_	_
17	various	_	JJ	JJ	_	18	amod	_	_
18	types	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	cancers	_	NNS	NNS	_	19	pobj	_	_
21	including	_	VBG	VBG	_	18	prep	_	_
22	chronic	_	JJ	JJ	_	24	amod	_	_
23	myeloid	_	JJ	JJ	_	24	amod	_	_
24	leukaemia	_	NN	NN	_	21	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	CML	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	.	_	.	.	_	8	punct	_	_

1	Since	_	IN	IN	_	13	mark	_	_
2	the	_	DT	DT	_	7	det	_	_
3	human	_	JJ	JJ	_	7	amod	_	_
4	genomic	_	JJ	JJ	_	7	amod	_	_
5	sterol	_	NN	NN	_	7	nn	_	_
6	regulatory	_	JJ	JJ	_	7	amod	_	_
7	element	_	NN	NN	_	13	nsubjpass	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	SRE	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	has	_	VBZ	VBZ	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	shown	_	VBN	VBN	_	27	advcl	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	regulate	_	VB	VB	_	13	xcomp	_	_
16	various	_	JJ	JJ	_	18	amod	_	_
17	key	_	JJ	JJ	_	18	amod	_	_
18	genes	_	NNS	NNS	_	15	dobj	_	_
19	involved	_	VBN	VBN	_	18	vmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	this	_	DT	DT	_	22	det	_	_
22	phenomenon	_	NN	NN	_	20	pobj	_	_
23	,	_	,	,	_	27	punct	_	_
24	the	_	DT	DT	_	26	det	_	_
25	present	_	JJ	JJ	_	26	amod	_	_
26	study	_	NN	NN	_	27	nsubj	_	_
27	revealed	_	VBD	VBD	_	0	root	_	_
28	the	_	DT	DT	_	29	det	_	_
29	existence	_	NN	NN	_	27	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	a	_	DT	DT	_	36	det	_	_
32	unique	_	JJ	JJ	_	36	amod	_	_
33	47	_	CD	CD	_	34	number	_	_
34	kDa	_	NN	NN	_	36	amod	_	_
35	protein	_	NN	NN	_	36	nn	_	_
36	factor	_	NN	NN	_	30	pobj	_	_
37	having	_	VBG	VBG	_	36	vmod	_	_
38	affinity	_	NN	NN	_	37	dobj	_	_
39	for	_	IN	IN	_	38	prep	_	_
40	this	_	DT	DT	_	42	det	_	_
41	SRE	_	JJ	JJ	_	42	amod	_	_
42	sequence	_	NN	NN	_	39	pobj	_	_
43	in	_	IN	IN	_	29	prep	_	_
44	lymphocytes	_	NNS	NNS	_	43	pobj	_	_
45	from	_	IN	IN	_	44	prep	_	_
46	normal	_	JJ	JJ	_	47	amod	_	_
47	subjects	_	NNS	NNS	_	45	pobj	_	_
48	,	_	,	,	_	29	punct	_	_
49	as	_	RB	RB	_	50	advmod	_	_
50	well	_	RB	RB	_	29	cc	_	_
51	as	_	IN	IN	_	50	mwe	_	_
52	its	_	PRP$	PRP$	_	53	poss	_	_
53	absence	_	NN	NN	_	29	conj	_	_
54	in	_	IN	IN	_	53	prep	_	_
55	lymphocytes	_	NNS	NNS	_	54	pobj	_	_
56	from	_	IN	IN	_	55	prep	_	_
57	untreated	_	JJ	JJ	_	59	amod	_	_
58	CML	_	NN	NN	_	59	nn	_	_
59	patients	_	NNS	NNS	_	56	pobj	_	_
60	.	_	.	.	_	27	punct	_	_

1	However	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	this	_	DT	DT	_	4	det	_	_
4	factor	_	NN	NN	_	5	nsubj	_	_
5	appeared	_	VBD	VBD	_	0	root	_	_
6	when	_	WRB	WRB	_	10	advmod	_	_
7	these	_	DT	DT	_	9	det	_	_
8	CML	_	NN	NN	_	9	nn	_	_
9	patients	_	NNS	NNS	_	10	nsubj	_	_
10	achieved	_	VBD	VBD	_	5	advcl	_	_
11	complete	_	JJ	JJ	_	13	amod	_	_
12	haematological	_	JJ	JJ	_	13	amod	_	_
13	remission	_	NN	NN	_	10	dobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	CHR	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	through	_	IN	IN	_	10	prep	_	_
18	alpha-interferon	_	NN	NN	_	19	nn	_	_
19	therapy	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Furthermore	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	an	_	DT	DT	_	5	det	_	_
4	inverse	_	JJ	JJ	_	5	amod	_	_
5	relationship	_	NN	NN	_	8	nsubjpass	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	between	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	LDL	_	NN	NN	_	14	nn	_	_
12	receptor	_	NN	NN	_	14	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	9	pobj	_	_
15	at	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	level	_	NN	NN	_	15	pobj	_	_
19	and	_	CC	CC	_	14	cc	_	_
20	the	_	DT	DT	_	22	det	_	_
21	binding	_	NN	NN	_	22	nn	_	_
22	affinity	_	NN	NN	_	14	conj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	this	_	DT	DT	_	28	det	_	_
25	47	_	CD	CD	_	26	number	_	_
26	kDa	_	NN	NN	_	28	amod	_	_
27	protein	_	NN	NN	_	28	nn	_	_
28	factor	_	NN	NN	_	23	pobj	_	_
29	to	_	TO	TO	_	22	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	SRE	_	NN	NN	_	32	nn	_	_
32	sequence	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	8	punct	_	_

1	Based	_	VBN	VBN	_	6	prep	_	_
2	upon	_	IN	IN	_	1	pcomp	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	2	pobj	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	propose	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	this	_	DT	DT	_	9	det	_	_
9	factor	_	NN	NN	_	11	nsubj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	have	_	VB	VB	_	6	ccomp	_	_
12	a	_	DT	DT	_	13	det	_	_
13	role	_	NN	NN	_	11	dobj	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	pathophysiology	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	chronic	_	JJ	JJ	_	19	amod	_	_
18	myeloid	_	JJ	JJ	_	19	amod	_	_
19	leukaemia	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	novel	_	JJ	JJ	_	4	amod	_	_
3	immunosuppressive	_	JJ	JJ	_	4	amod	_	_
4	factor	_	NN	NN	_	8	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	bovine	_	JJ	JJ	_	7	amod	_	_
7	colostrum	_	NN	NN	_	5	pobj	_	_
8	blocks	_	VBZ	VBZ	_	0	root	_	_
9	activation	_	NN	NN	_	8	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	interleukin	_	NN	NN	_	15	nn	_	_
13	2	_	CD	CD	_	15	num	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	enhancer	_	NN	NN	_	10	pobj	_	_
16	at	_	IN	IN	_	9	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	NFAT	_	NN	NN	_	19	nn	_	_
19	site	_	NN	NN	_	16	pobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	factor	_	NN	NN	_	13	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	bovine	_	JJ	JJ	_	5	amod	_	_
5	colostrum	_	NN	NN	_	3	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	colostrum	_	NN	NN	_	9	nn	_	_
8	inhibitory	_	JJ	JJ	_	9	amod	_	_
9	factor	_	NN	NN	_	2	dep	_	_
10	,	_	,	,	_	9	punct	_	_
11	CIF	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
13	inhibits	_	VBZ	VBZ	_	0	root	_	_
14	interleukin	_	NN	NN	_	19	nn	_	_
15	2	_	CD	CD	_	14	num	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	IL2	_	NN	NN	_	14	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	production	_	NN	NN	_	13	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	activated	_	JJ	JJ	_	24	amod	_	_
22	T	_	NN	NN	_	24	nn	_	_
23	helper	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	20	pobj	_	_
25	by	_	IN	IN	_	13	prep	_	_
26	blocking	_	VBG	VBG	_	25	pcomp	_	_
27	the	_	DT	DT	_	28	det	_	_
28	accumulation	_	NN	NN	_	26	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	IL2	_	NN	NN	_	31	nn	_	_
31	mRNA	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	13	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	whether	_	IN	IN	_	5	mark	_	_
4	CIF	_	NN	NN	_	5	nsubj	_	_
5	blocks	_	VBZ	VBZ	_	2	ccomp	_	_
6	at	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	level	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	IL2	_	NN	NN	_	11	nn	_	_
11	transcription	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	introduced	_	VBD	VBD	_	2	parataxis	_	_
15	reporter	_	NN	NN	_	16	nn	_	_
16	plasmids	_	NNS	NNS	_	14	dobj	_	_
17	into	_	IN	IN	_	14	prep	_	_
18	the	_	DT	DT	_	24	det	_	_
19	human	_	JJ	JJ	_	24	amod	_	_
20	T	_	NN	NN	_	24	nn	_	_
21	leukemia	_	NN	NN	_	24	nn	_	_
22	cell	_	NN	NN	_	24	nn	_	_
23	line	_	NN	NN	_	24	nn	_	_
24	Jurkat	_	NN	NN	_	17	pobj	_	_
25	by	_	IN	IN	_	14	prep	_	_
26	transient	_	JJ	JJ	_	27	amod	_	_
27	transfection	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	2	nsubj	_	_
2	contained	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	luciferase	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	dobj	_	_
6	under	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	control	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	either	_	CC	CC	_	16	preconj	_	_
11	the	_	DT	DT	_	16	det	_	_
12	human	_	JJ	JJ	_	15	amod	_	_
13	IL2	_	NN	NN	_	15	nn	_	_
14	upstream	_	JJ	JJ	_	15	amod	_	_
15	enhancer	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	9	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	segments	_	NNS	NNS	_	16	appos	_	_
19	-326	_	CD	CD	_	21	number	_	_
20	to	_	TO	TO	_	21	dep	_	_
21	+45	_	CD	CD	_	18	num	_	_
22	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
23	or	_	CC	CC	_	16	cc	_	_
24	three	_	CD	CD	_	25	num	_	_
25	repeats	_	NNS	NNS	_	16	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	NFAT	_	NN	NN	_	29	nn	_	_
29	element	_	NN	NN	_	26	pobj	_	_
30	contained	_	VBN	VBN	_	25	vmod	_	_
31	within	_	IN	IN	_	30	prep	_	_
32	it	_	PRP	PRP	_	31	pobj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	segments	_	NNS	NNS	_	32	appos	_	_
35	-255	_	CD	CD	_	37	number	_	_
36	to	_	TO	TO	_	37	dep	_	_
37	-285	_	CD	CD	_	34	num	_	_
38	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
39	.	_	.	.	_	2	punct	_	_

1	Expression	_	NN	NN	_	8	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	luciferase	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	these	_	DT	DT	_	6	det	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	induced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	phorbol	_	NN	NN	_	12	nn	_	_
11	myristate	_	NN	NN	_	12	nn	_	_
12	acetate	_	NN	NN	_	9	pobj	_	_
13	plus	_	CC	CC	_	12	cc	_	_
14	a	_	DT	DT	_	16	det	_	_
15	calcium	_	NN	NN	_	16	nn	_	_
16	ionophore	_	NN	NN	_	12	conj	_	_
17	.	_	.	.	_	8	punct	_	_

1	CIF	_	NN	NN	_	2	nsubj	_	_
2	inhibited	_	VBD	VBD	_	0	root	_	_
3	induction	_	NN	NN	_	2	dobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	either	_	DT	DT	_	6	det	_	_
6	construct	_	NN	NN	_	4	pobj	_	_
7	as	_	IN	IN	_	8	dep	_	_
8	did	_	VBD	VBD	_	2	advcl	_	_
9	cyclosporine	_	NN	NN	_	8	nsubj	_	_
10	,	_	,	,	_	8	punct	_	_
11	which	_	WDT	WDT	_	13	nsubjpass	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	known	_	VBN	VBN	_	8	dep	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	block	_	VB	VB	_	13	xcomp	_	_
16	activation	_	NN	NN	_	15	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	NFAT	_	NN	NN	_	20	nn	_	_
20	element	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	2	punct	_	_

1	CIF	_	NN	NN	_	2	nsubj	_	_
2	failed	_	VBD	VBD	_	0	root	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	inhibit	_	VB	VB	_	2	xcomp	_	_
5	several	_	JJ	JJ	_	6	amod	_	_
6	other	_	JJ	JJ	_	8	amod	_	_
7	enhancer	_	NN	NN	_	8	nn	_	_
8	elements	_	NNS	NNS	_	4	dobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	NFAT-controlled	_	JJ	JJ	_	5	amod	_	_
3	luciferase	_	NN	NN	_	5	nn	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	system	_	NN	NN	_	6	nsubj	_	_
6	distinguishes	_	VBZ	VBZ	_	0	root	_	_
7	CIF	_	NN	NN	_	6	dobj	_	_
8	from	_	IN	IN	_	6	prep	_	_
9	other	_	JJ	JJ	_	13	amod	_	_
10	T	_	NN	NN	_	13	nn	_	_
11	cell	_	NN	NN	_	13	nn	_	_
12	inhibitory	_	JJ	JJ	_	13	amod	_	_
13	activities	_	NNS	NNS	_	8	pobj	_	_
14	present	_	JJ	JJ	_	13	amod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	colostrum	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	6	punct	_	_
18	in	_	IN	IN	_	6	prep	_	_
19	particular	_	JJ	JJ	_	18	pobj	_	_
20	,	_	,	,	_	6	punct	_	_
21	TGF	_	NN	NN	_	22	nn	_	_
22	beta	_	NN	NN	_	6	dobj	_	_
23	1	_	CD	CD	_	22	num	_	_
24	and	_	CC	CC	_	22	cc	_	_
25	TGF	_	NN	NN	_	26	nn	_	_
26	beta	_	NN	NN	_	22	conj	_	_
27	2	_	CD	CD	_	26	num	_	_
28	and	_	CC	CC	_	22	cc	_	_
29	the	_	DT	DT	_	30	det	_	_
30	glucocorticoids	_	NNS	NNS	_	22	conj	_	_
31	.	_	.	.	_	6	punct	_	_

1	Stably	_	RB	RB	_	2	advmod	_	_
2	transfected	_	VBN	VBN	_	4	amod	_	_
3	Jurkat	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	5	nsubj	_	_
5	behaved	_	VBD	VBD	_	0	root	_	_
6	similarly	_	RB	RB	_	5	advmod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	transiently	_	RB	RB	_	10	advmod	_	_
10	transfected	_	VBN	VBN	_	11	amod	_	_
11	ones	_	NNS	NNS	_	7	pobj	_	_
12	with	_	IN	IN	_	5	prep	_	_
13	respect	_	NN	NN	_	12	pobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	inhibition	_	NN	NN	_	14	pobj	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	CIF	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	cyclosporine	_	NN	NN	_	17	conj	_	_
20	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	NFAT-luc	_	JJ	JJ	_	3	amod	_	_
3	assay	_	NN	NN	_	7	nsubj	_	_
4	is	_	VBZ	VBZ	_	7	cop	_	_
5	a	_	DT	DT	_	7	det	_	_
6	useful	_	JJ	JJ	_	7	amod	_	_
7	technique	_	NN	NN	_	0	root	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	rapid	_	JJ	JJ	_	13	amod	_	_
11	,	_	,	,	_	10	punct	_	_
12	sensitive	_	JJ	JJ	_	10	dep	_	_
13	measurement	_	NN	NN	_	8	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	CIF	_	NN	NN	_	14	pobj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	other	_	JJ	JJ	_	18	amod	_	_
18	immunosuppressants	_	NNS	NNS	_	15	conj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	similar	_	JJ	JJ	_	22	amod	_	_
22	mode	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	action	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	7	punct	_	_

1	Synergistic	_	JJ	JJ	_	2	amod	_	_
2	interactions	_	NNS	NNS	_	15	nsubj	_	_
3	between	_	IN	IN	_	2	prep	_	_
4	overlapping	_	VBG	VBG	_	6	amod	_	_
5	binding	_	VBG	VBG	_	6	amod	_	_
6	sites	_	NNS	NNS	_	3	pobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	serum	_	NN	NN	_	11	nn	_	_
10	response	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	7	pobj	_	_
12	and	_	CC	CC	_	6	cc	_	_
13	ELK-1	_	NN	NN	_	14	nn	_	_
14	proteins	_	NNS	NNS	_	6	conj	_	_
15	mediate	_	VBP	VBP	_	0	root	_	_
16	both	_	CC	CC	_	18	preconj	_	_
17	basal	_	JJ	JJ	_	18	amod	_	_
18	enhancement	_	NN	NN	_	15	dobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	phorbol	_	NN	NN	_	22	nn	_	_
21	ester	_	NN	NN	_	22	nn	_	_
22	responsiveness	_	NN	NN	_	18	conj	_	_
23	of	_	IN	IN	_	18	prep	_	_
24	primate	_	JJ	JJ	_	28	amod	_	_
25	cytomegalovirus	_	NN	NN	_	28	nn	_	_
26	major	_	JJ	JJ	_	28	amod	_	_
27	immediate-early	_	JJ	JJ	_	28	amod	_	_
28	promoters	_	NNS	NNS	_	23	pobj	_	_
29	in	_	IN	IN	_	15	prep	_	_
30	monocyte	_	NN	NN	_	34	nn	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	T-lymphocyte	_	NN	NN	_	30	conj	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	types	_	NNS	NNS	_	29	pobj	_	_
35	.	_	.	.	_	15	punct	_	_

1	Cytomegalovirus	_	NN	NN	_	5	nn	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	CMV	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	infection	_	NN	NN	_	7	nsubj	_	_
6	is	_	VBZ	VBZ	_	7	cop	_	_
7	nonpermissive	_	JJ	JJ	_	0	root	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	persistent	_	JJ	JJ	_	7	conj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	many	_	JJ	JJ	_	16	amod	_	_
12	lymphoid	_	JJ	JJ	_	16	amod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	myeloid	_	JJ	JJ	_	12	conj	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	types	_	NNS	NNS	_	10	pobj	_	_
17	but	_	CC	CC	_	7	cc	_	_
18	can	_	MD	MD	_	20	aux	_	_
19	be	_	VB	VB	_	20	auxpass	_	_
20	activated	_	VBN	VBN	_	7	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	differentiated	_	VBN	VBN	_	23	amod	_	_
23	macrophages	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	elsewhere	_	RB	RB	_	3	advmod	_	_
5	that	_	IN	IN	_	23	mark	_	_
6	both	_	CC	CC	_	20	preconj	_	_
7	the	_	DT	DT	_	20	det	_	_
8	major	_	JJ	JJ	_	10	amod	_	_
9	immediate-early	_	JJ	JJ	_	10	amod	_	_
10	gene	_	NN	NN	_	20	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	MIE	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	lytic	_	JJ	JJ	_	19	amod	_	_
16	cycle	_	NN	NN	_	19	nn	_	_
17	infectious	_	JJ	JJ	_	19	amod	_	_
18	progeny	_	NN	NN	_	19	nn	_	_
19	virus	_	NN	NN	_	10	conj	_	_
20	expression	_	NN	NN	_	23	nsubjpass	_	_
21	can	_	MD	MD	_	23	aux	_	_
22	be	_	VB	VB	_	23	auxpass	_	_
23	induced	_	VBN	VBN	_	3	ccomp	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	otherwise	_	JJ	JJ	_	26	advmod	_	_
26	nonpermissive	_	JJ	JJ	_	30	amod	_	_
27	monocyte-like	_	JJ	JJ	_	30	amod	_	_
28	U-937	_	NN	NN	_	30	nn	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	cultures	_	NNS	NNS	_	24	pobj	_	_
31	infected	_	VBN	VBN	_	30	vmod	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	either	_	CC	CC	_	35	preconj	_	_
34	human	_	JJ	JJ	_	35	amod	_	_
35	CMV	_	NN	NN	_	32	pobj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	HCMV	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	or	_	CC	CC	_	35	cc	_	_
40	simian	_	JJ	JJ	_	41	amod	_	_
41	CMV	_	NN	NN	_	35	conj	_	_
42	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
43	SCMV	_	NN	NN	_	41	appos	_	_
44	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
45	by	_	IN	IN	_	23	prep	_	_
46	treatment	_	NN	NN	_	45	pobj	_	_
47	with	_	IN	IN	_	46	prep	_	_
48	the	_	DT	DT	_	51	det	_	_
49	phorbol	_	NN	NN	_	51	nn	_	_
50	ester	_	NN	NN	_	51	nn	_	_
51	12-O-tetradecanoylphorbol-13-acetate	_	NN	NN	_	47	pobj	_	_
52	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
53	TPA	_	NN	NN	_	51	appos	_	_
54	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
55	.	_	.	.	_	3	punct	_	_

1	Two	_	CD	CD	_	5	num	_	_
2	multicopy	_	JJ	JJ	_	5	amod	_	_
3	basal	_	JJ	JJ	_	5	amod	_	_
4	enhancer	_	NN	NN	_	5	nn	_	_
5	motifs	_	NNS	NNS	_	62	nsubj	_	_
6	within	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	SCMV	_	NN	NN	_	10	nn	_	_
9	MIE	_	NN	NN	_	10	nn	_	_
10	enhancer	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	5	punct	_	_
12	namely	_	RB	RB	_	5	advmod	_	_
13	,	_	,	,	_	5	punct	_	_
14	11	_	CD	CD	_	15	num	_	_
15	copies	_	NNS	NNS	_	5	appos	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	22	det	_	_
18	16-bp	_	JJ	JJ	_	22	amod	_	_
19	cyclic	_	JJ	JJ	_	22	amod	_	_
20	AMP	_	NN	NN	_	22	nn	_	_
21	response	_	NN	NN	_	22	nn	_	_
22	element	_	NN	NN	_	16	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	CRE	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	and	_	CC	CC	_	15	cc	_	_
27	3	_	CD	CD	_	28	num	_	_
28	copies	_	NNS	NNS	_	15	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	novel	_	JJ	JJ	_	39	amod	_	_
31	17-bp	_	JJ	JJ	_	39	amod	_	_
32	serum	_	NN	NN	_	34	nn	_	_
33	response	_	NN	NN	_	34	nn	_	_
34	factor	_	NN	NN	_	39	nn	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	SRF	_	NN	NN	_	34	appos	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	binding	_	NN	NN	_	39	nn	_	_
39	sites	_	NNS	NNS	_	29	pobj	_	_
40	referred	_	VBN	VBN	_	15	vmod	_	_
41	to	_	TO	TO	_	40	prep	_	_
42	as	_	IN	IN	_	40	prep	_	_
43	the	_	DT	DT	_	44	det	_	_
44	SNE	_	NN	NN	_	42	pobj	_	_
45	-LRB-	_	-LRB-	-LRB-	_	47	punct	_	_
46	SRF/NFkappaB-like	_	JJ	JJ	_	47	amod	_	_
47	element	_	NN	NN	_	44	appos	_	_
48	-RRB-	_	-RRB-	-RRB-	_	47	punct	_	_
49	,	_	,	,	_	44	punct	_	_
50	as	_	RB	RB	_	51	advmod	_	_
51	well	_	RB	RB	_	44	cc	_	_
52	as	_	IN	IN	_	51	mwe	_	_
53	four	_	CD	CD	_	56	num	_	_
54	classical	_	JJ	JJ	_	56	amod	_	_
55	NFkappaB	_	NN	NN	_	56	nn	_	_
56	sites	_	NNS	NNS	_	44	conj	_	_
57	within	_	IN	IN	_	56	prep	_	_
58	the	_	DT	DT	_	60	det	_	_
59	HCMV	_	NN	NN	_	60	nn	_	_
60	version	_	NN	NN	_	57	pobj	_	_
61	,	_	,	,	_	44	punct	_	_
62	contribute	_	VBP	VBP	_	0	root	_	_
63	to	_	TO	TO	_	62	prep	_	_
64	TPA	_	NN	NN	_	65	nn	_	_
65	responsiveness	_	NN	NN	_	63	pobj	_	_
66	in	_	IN	IN	_	65	prep	_	_
67	transient	_	JJ	JJ	_	68	amod	_	_
68	assays	_	NNS	NNS	_	66	pobj	_	_
69	in	_	IN	IN	_	65	prep	_	_
70	monocyte	_	NN	NN	_	73	nn	_	_
71	and	_	CC	CC	_	70	cc	_	_
72	T-cell	_	NN	NN	_	70	conj	_	_
73	types	_	NNS	NNS	_	69	pobj	_	_
74	.	_	.	.	_	62	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	SCMV	_	NN	NN	_	4	nn	_	_
3	SNE	_	NN	NN	_	4	nn	_	_
4	sites	_	NNS	NNS	_	5	nsubj	_	_
5	contain	_	VBP	VBP	_	0	root	_	_
6	potential	_	JJ	JJ	_	11	amod	_	_
7	overlapping	_	VBG	VBG	_	11	amod	_	_
8	core	_	NN	NN	_	11	nn	_	_
9	recognition	_	NN	NN	_	11	nn	_	_
10	binding	_	NN	NN	_	11	nn	_	_
11	motifs	_	NNS	NNS	_	5	dobj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	SRF	_	NN	NN	_	23	nn	_	_
14	,	_	,	,	_	13	punct	_	_
15	Rel/NFkappaB	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	ETS	_	NN	NN	_	13	conj	_	_
18	,	_	,	,	_	13	punct	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	YY1	_	NN	NN	_	13	conj	_	_
21	class	_	NN	NN	_	23	nn	_	_
22	transcription	_	NN	NN	_	23	nn	_	_
23	factors	_	NNS	NNS	_	12	pobj	_	_
24	but	_	CC	CC	_	5	cc	_	_
25	fail	_	VBP	VBP	_	5	conj	_	_
26	to	_	TO	TO	_	27	aux	_	_
27	respond	_	VB	VB	_	25	xcomp	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	either	_	CC	CC	_	30	preconj	_	_
30	serum	_	NN	NN	_	28	pobj	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	tumor	_	NN	NN	_	35	nn	_	_
33	necrosis	_	NN	NN	_	35	nn	_	_
34	factor	_	NN	NN	_	35	nn	_	_
35	alpha	_	NN	NN	_	30	conj	_	_
36	.	_	.	.	_	5	punct	_	_

1	Therefore	_	RB	RB	_	37	advmod	_	_
2	,	_	,	,	_	37	punct	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	evaluate	_	VB	VB	_	37	advcl	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mechanism	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	TPA	_	NN	NN	_	9	nn	_	_
9	responsiveness	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	SNE	_	NN	NN	_	13	nn	_	_
13	motifs	_	NNS	NNS	_	10	pobj	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	of	_	IN	IN	_	10	conj	_	_
16	a	_	DT	DT	_	24	det	_	_
17	related	_	JJ	JJ	_	24	amod	_	_
18	16-bp	_	JJ	JJ	_	24	amod	_	_
19	SEE	_	NN	NN	_	24	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
21	SRF/ETS	_	NN	NN	_	22	nn	_	_
22	element	_	NN	NN	_	19	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	motif	_	NN	NN	_	15	pobj	_	_
25	found	_	VBN	VBN	_	24	vmod	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	33	det	_	_
28	HCMV	_	NN	NN	_	33	nn	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	chimpanzee	_	NN	NN	_	31	nn	_	_
31	CMV	_	NN	NN	_	28	conj	_	_
32	MIE	_	NN	NN	_	33	nn	_	_
33	enhancers	_	NNS	NNS	_	26	pobj	_	_
34	,	_	,	,	_	37	punct	_	_
35	we	_	PRP	PRP	_	37	nsubj	_	_
36	have	_	VBP	VBP	_	37	aux	_	_
37	examined	_	VBN	VBN	_	0	root	_	_
38	the	_	DT	DT	_	40	det	_	_
39	functional	_	JJ	JJ	_	40	amod	_	_
40	responses	_	NNS	NNS	_	37	dobj	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	protein	_	NN	NN	_	44	nn	_	_
43	binding	_	NN	NN	_	44	nn	_	_
44	properties	_	NNS	NNS	_	40	conj	_	_
45	of	_	IN	IN	_	40	prep	_	_
46	multimerized	_	JJ	JJ	_	50	amod	_	_
47	wild-type	_	JJ	JJ	_	50	amod	_	_
48	and	_	CC	CC	_	47	cc	_	_
49	mutant	_	JJ	JJ	_	47	conj	_	_
50	elements	_	NNS	NNS	_	45	pobj	_	_
51	added	_	VBN	VBN	_	50	vmod	_	_
52	upstream	_	RB	RB	_	53	advmod	_	_
53	to	_	TO	TO	_	51	prep	_	_
54	the	_	DT	DT	_	63	det	_	_
55	SCMV	_	NN	NN	_	56	nn	_	_
56	MIE	_	NN	NN	_	63	nn	_	_
57	or	_	CC	CC	_	56	cc	_	_
58	simian	_	JJ	JJ	_	59	amod	_	_
59	virus	_	NN	NN	_	56	conj	_	_
60	40	_	CD	CD	_	63	num	_	_
61	minimal	_	JJ	JJ	_	63	amod	_	_
62	promoter	_	NN	NN	_	63	nn	_	_
63	regions	_	NNS	NNS	_	53	pobj	_	_
64	in	_	IN	IN	_	63	prep	_	_
65	the	_	DT	DT	_	77	det	_	_
66	U-937	_	NN	NN	_	77	nn	_	_
67	,	_	,	,	_	66	punct	_	_
68	K-562	_	NN	NN	_	66	conj	_	_
69	,	_	,	,	_	66	punct	_	_
70	HL-60	_	NN	NN	_	66	conj	_	_
71	,	_	,	,	_	66	punct	_	_
72	THP-1	_	NN	NN	_	66	conj	_	_
73	,	_	,	,	_	66	punct	_	_
74	and	_	CC	CC	_	66	cc	_	_
75	Jurkat	_	NN	NN	_	66	conj	_	_
76	cell	_	NN	NN	_	77	nn	_	_
77	lines	_	NNS	NNS	_	64	pobj	_	_
78	.	_	.	.	_	37	punct	_	_

1	Unlike	_	IN	IN	_	13	prep	_	_
2	classical	_	JJ	JJ	_	4	amod	_	_
3	NFkappaB	_	NN	NN	_	4	nn	_	_
4	sites	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	13	punct	_	_
6	neither	_	CC	CC	_	8	preconj	_	_
7	the	_	DT	DT	_	8	det	_	_
8	SNE	_	NN	NN	_	12	nn	_	_
9	nor	_	CC	CC	_	8	cc	_	_
10	the	_	DT	DT	_	11	det	_	_
11	SEE	_	NN	NN	_	8	conj	_	_
12	motif	_	NN	NN	_	13	nsubj	_	_
13	responded	_	VBD	VBD	_	0	root	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	phosphatase	_	NN	NN	_	16	nn	_	_
16	inhibition	_	NN	NN	_	14	pobj	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	okadaic	_	JJ	JJ	_	19	amod	_	_
19	acid	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	13	punct	_	_

1	However	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	TPA	_	NN	NN	_	5	nn	_	_
5	responsiveness	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	both	_	DT	DT	_	9	det	_	_
8	CMV	_	NN	NN	_	9	nn	_	_
9	elements	_	NNS	NNS	_	6	pobj	_	_
10	proved	_	VBD	VBD	_	0	root	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	involve	_	VB	VB	_	10	xcomp	_	_
13	synergistic	_	JJ	JJ	_	14	amod	_	_
14	interactions	_	NNS	NNS	_	12	dobj	_	_
15	between	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	core	_	NN	NN	_	20	nn	_	_
18	SRF	_	NN	NN	_	20	nn	_	_
19	binding	_	NN	NN	_	20	nn	_	_
20	site	_	NN	NN	_	15	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	CCATATATGG	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	the	_	DT	DT	_	30	det	_	_
26	adjacent	_	JJ	JJ	_	30	amod	_	_
27	inverted	_	VBN	VBN	_	30	amod	_	_
28	ETS	_	NN	NN	_	30	nn	_	_
29	binding	_	NN	NN	_	30	nn	_	_
30	motifs	_	NNS	NNS	_	20	conj	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	TTCC	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	,	_	,	,	_	14	punct	_	_
35	which	_	WDT	WDT	_	36	nsubj	_	_
36	correlated	_	VBD	VBD	_	14	rcmod	_	_
37	directly	_	RB	RB	_	36	advmod	_	_
38	with	_	IN	IN	_	36	prep	_	_
39	formation	_	NN	NN	_	38	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	a	_	DT	DT	_	44	det	_	_
42	bound	_	VBN	VBN	_	44	amod	_	_
43	tripartite	_	JJ	JJ	_	44	amod	_	_
44	complex	_	NN	NN	_	40	pobj	_	_
45	containing	_	VBG	VBG	_	44	vmod	_	_
46	both	_	CC	CC	_	49	preconj	_	_
47	the	_	DT	DT	_	49	det	_	_
48	cellular	_	JJ	JJ	_	49	amod	_	_
49	SRF	_	NN	NN	_	45	dobj	_	_
50	and	_	CC	CC	_	49	cc	_	_
51	ELK-1	_	NN	NN	_	52	nn	_	_
52	proteins	_	NNS	NNS	_	49	conj	_	_
53	.	_	.	.	_	10	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	protein	_	NN	NN	_	3	nn	_	_
3	complex	_	NN	NN	_	6	nsubj	_	_
4	was	_	VBD	VBD	_	6	cop	_	_
5	more	_	RBR	RBR	_	6	advmod	_	_
6	abundant	_	JJ	JJ	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	U-937	_	NN	NN	_	15	nn	_	_
9	,	_	,	,	_	8	punct	_	_
10	K-562	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	HeLa	_	NN	NN	_	8	conj	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	extracts	_	NNS	NNS	_	7	pobj	_	_
16	than	_	IN	IN	_	6	prep	_	_
17	in	_	IN	IN	_	16	dep	_	_
18	Raji	_	NN	NN	_	27	nn	_	_
19	,	_	,	,	_	18	punct	_	_
20	HF	_	NN	NN	_	18	conj	_	_
21	,	_	,	,	_	18	punct	_	_
22	BALB/c	_	NN	NN	_	23	nn	_	_
23	3T3	_	NN	NN	_	18	conj	_	_
24	,	_	,	,	_	18	punct	_	_
25	or	_	CC	CC	_	18	cc	_	_
26	HL-60	_	NN	NN	_	18	conj	_	_
27	cells	_	NNS	NNS	_	17	pobj	_	_
28	,	_	,	,	_	6	punct	_	_
29	but	_	CC	CC	_	6	cc	_	_
30	the	_	DT	DT	_	32	det	_	_
31	binding	_	NN	NN	_	32	nn	_	_
32	activity	_	NN	NN	_	34	nsubjpass	_	_
33	was	_	VBD	VBD	_	34	auxpass	_	_
34	altered	_	VBN	VBN	_	6	conj	_	_
35	only	_	RB	RB	_	36	advmod	_	_
36	twofold	_	RB	RB	_	34	advmod	_	_
37	after	_	IN	IN	_	34	prep	_	_
38	TPA	_	NN	NN	_	39	nn	_	_
39	treatment	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	40-fold	_	JJ	JJ	_	3	amod	_	_
3	stimulation	_	NN	NN	_	18	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	chloramphenicol	_	JJ	JJ	_	7	amod	_	_
6	acetyltransferase	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	4	pobj	_	_
8	mediated	_	VBN	VBN	_	3	vmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	four	_	CD	CD	_	12	num	_	_
11	tandem	_	JJ	JJ	_	12	amod	_	_
12	repeats	_	NNS	NNS	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	SNE	_	NN	NN	_	13	pobj	_	_
16	could	_	MD	MD	_	18	aux	_	_
17	be	_	VB	VB	_	18	aux	_	_
18	induced	_	VBN	VBN	_	0	root	_	_
19	within	_	IN	IN	_	18	prep	_	_
20	2	_	CD	CD	_	21	num	_	_
21	h	_	NN	NN	_	19	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	up	_	RB	RB	_	26	advmod	_	_
25	to	_	TO	TO	_	26	dep	_	_
26	250-fold	_	JJ	JJ	_	18	conj	_	_
27	within	_	IN	IN	_	26	prep	_	_
28	6	_	CD	CD	_	29	num	_	_
29	h	_	NN	NN	_	27	pobj	_	_
30	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
31	after	_	IN	IN	_	18	prep	_	_
32	addition	_	NN	NN	_	31	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	TPA	_	NN	NN	_	33	pobj	_	_
35	in	_	IN	IN	_	32	prep	_	_
36	DNA-transfected	_	JJ	JJ	_	38	amod	_	_
37	U-937	_	NN	NN	_	38	nn	_	_
38	cells	_	NNS	NNS	_	35	pobj	_	_
39	,	_	,	,	_	18	punct	_	_
40	indicating	_	VBG	VBG	_	18	xcomp	_	_
41	that	_	IN	IN	_	44	mark	_	_
42	the	_	DT	DT	_	43	det	_	_
43	stimulation	_	NN	NN	_	44	nsubj	_	_
44	appeared	_	VBD	VBD	_	40	ccomp	_	_
45	likely	_	JJ	JJ	_	44	acomp	_	_
46	to	_	TO	TO	_	55	aux	_	_
47	be	_	VB	VB	_	55	cop	_	_
48	a	_	DT	DT	_	55	det	_	_
49	true	_	JJ	JJ	_	55	amod	_	_
50	protein	_	NN	NN	_	52	npadvmod	_	_
51	kinase	_	NN	NN	_	52	npadvmod	_	_
52	C-mediated	_	JJ	JJ	_	55	amod	_	_
53	signal	_	NN	NN	_	55	nn	_	_
54	transduction	_	NN	NN	_	55	nn	_	_
55	event	_	NN	NN	_	45	xcomp	_	_
56	rather	_	RB	RB	_	55	cc	_	_
57	than	_	IN	IN	_	56	mwe	_	_
58	a	_	DT	DT	_	60	det	_	_
59	differentiation	_	NN	NN	_	60	nn	_	_
60	response	_	NN	NN	_	55	conj	_	_
61	.	_	.	.	_	18	punct	_	_

1	Slight	_	JJ	JJ	_	2	amod	_	_
2	differences	_	NNS	NNS	_	37	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	sequence	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	core	_	NN	NN	_	11	nn	_	_
9	SRF	_	NN	NN	_	11	nn	_	_
10	binding	_	NN	NN	_	11	nn	_	_
11	site	_	NN	NN	_	6	pobj	_	_
12	compared	_	VBN	VBN	_	2	prep	_	_
13	with	_	IN	IN	_	12	pcomp	_	_
14	that	_	DT	DT	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	22	det	_	_
17	classical	_	JJ	JJ	_	22	amod	_	_
18	c-Fos	_	NN	NN	_	22	nn	_	_
19	promoter	_	NN	NN	_	22	nn	_	_
20	serum	_	NN	NN	_	22	nn	_	_
21	response	_	NN	NN	_	22	nn	_	_
22	element	_	NN	NN	_	15	pobj	_	_
23	,	_	,	,	_	2	punct	_	_
24	together	_	RB	RB	_	25	advmod	_	_
25	with	_	IN	IN	_	2	prep	_	_
26	differences	_	NNS	NNS	_	25	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	spacing	_	NN	NN	_	27	pobj	_	_
30	between	_	IN	IN	_	26	prep	_	_
31	the	_	DT	DT	_	35	det	_	_
32	SRF	_	NN	NN	_	35	nn	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	ETS	_	NN	NN	_	32	conj	_	_
35	motifs	_	NNS	NNS	_	30	pobj	_	_
36	,	_	,	,	_	2	punct	_	_
37	appear	_	VBP	VBP	_	0	root	_	_
38	to	_	TO	TO	_	39	aux	_	_
39	account	_	VB	VB	_	37	xcomp	_	_
40	for	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	42	det	_	_
42	inability	_	NN	NN	_	40	pobj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	the	_	DT	DT	_	46	det	_	_
45	SCMV	_	NN	NN	_	46	nn	_	_
46	SNEs	_	NNS	NNS	_	43	pobj	_	_
47	to	_	TO	TO	_	48	aux	_	_
48	respond	_	VB	VB	_	42	vmod	_	_
49	to	_	TO	TO	_	48	prep	_	_
50	serum	_	NN	NN	_	51	nn	_	_
51	induction	_	NN	NN	_	49	pobj	_	_
52	.	_	.	.	_	37	punct	_	_

1	Energy	_	NN	NN	_	2	nn	_	_
2	substrates	_	NNS	NNS	_	0	root	_	_
3	,	_	,	,	_	2	punct	_	_
4	hormone	_	NN	NN	_	5	nn	_	_
5	responses	_	NNS	NNS	_	2	conj	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	glucocorticoid	_	NN	NN	_	8	nn	_	_
8	binding	_	NN	NN	_	2	conj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	lymphocytes	_	NNS	NNS	_	9	pobj	_	_
11	during	_	IN	IN	_	2	prep	_	_
12	intense	_	JJ	JJ	_	14	amod	_	_
13	physical	_	JJ	JJ	_	12	dep	_	_
14	exercise	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	2	prep	_	_
16	humans	_	NNS	NNS	_	15	pobj	_	_
17	following	_	VBG	VBG	_	2	prep	_	_
18	phosphocreatine	_	JJ	JJ	_	19	amod	_	_
19	administration	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	Eight	_	CD	CD	_	5	num	_	_
2	healthy	_	JJ	JJ	_	4	amod	_	_
3	untrained	_	JJ	JJ	_	4	amod	_	_
4	male	_	JJ	JJ	_	5	amod	_	_
5	volunteers	_	NNS	NNS	_	6	nsubj	_	_
6	pedalled	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	cycle	_	NN	NN	_	9	nn	_	_
9	ergometer	_	NN	NN	_	6	dobj	_	_
10	according	_	VBG	VBG	_	6	prep	_	_
11	to	_	TO	TO	_	10	pcomp	_	_
12	two	_	CD	CD	_	14	num	_	_
13	exercise	_	NN	NN	_	14	nn	_	_
14	protocols	_	NNS	NNS	_	11	pobj	_	_
15	:	_	:	:	_	6	punct	_	_
16	the	_	DT	DT	_	17	det	_	_
17	first	_	JJ	JJ	_	18	nsubj	_	_
18	involved	_	VBD	VBD	_	6	parataxis	_	_
19	step-wise	_	RB	RB	_	20	advmod	_	_
20	increasing	_	VBG	VBG	_	22	amod	_	_
21	physical	_	JJ	JJ	_	22	amod	_	_
22	exercise	_	NN	NN	_	18	dobj	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	maximal	_	JJ	JJ	_	23	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	MPE	_	NN	NN	_	22	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	;	_	:	:	_	18	punct	_	_
29	the	_	DT	DT	_	30	det	_	_
30	second	_	JJ	JJ	_	31	nsubj	_	_
31	involved	_	VBD	VBD	_	18	parataxis	_	_
32	prolonged	_	JJ	JJ	_	39	amod	_	_
33	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
34	35	_	CD	CD	_	35	num	_	_
35	min	_	NN	NN	_	32	dep	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	submaximal	_	JJ	JJ	_	32	dep	_	_
38	physical	_	JJ	JJ	_	39	amod	_	_
39	exercise	_	NN	NN	_	31	dobj	_	_
40	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
41	PPE	_	NN	NN	_	39	appos	_	_
42	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
43	at	_	IN	IN	_	39	prep	_	_
44	70	_	CD	CD	_	45	num	_	_
45	%	_	NN	NN	_	43	pobj	_	_
46	of	_	IN	IN	_	45	prep	_	_
47	the	_	DT	DT	_	52	det	_	_
48	individual	_	NN	NN	_	52	poss	_	_
49	's	_	POS	POS	_	52	possessive	_	_
50	maximal	_	JJ	JJ	_	52	amod	_	_
51	oxygen	_	NN	NN	_	52	nn	_	_
52	uptake	_	NN	NN	_	46	pobj	_	_
53	.	_	.	.	_	6	punct	_	_

1	Each	_	DT	DT	_	2	det	_	_
2	volunteer	_	NN	NN	_	3	nsubj	_	_
3	performed	_	VBD	VBD	_	0	root	_	_
4	these	_	DT	DT	_	5	det	_	_
5	exercise	_	NN	NN	_	3	dobj	_	_
6	twice	_	RB	RB	_	3	advmod	_	_
7	,	_	,	,	_	3	punct	_	_
8	following	_	VBG	VBG	_	3	vmod	_	_
9	either	_	CC	CC	_	12	dep	_	_
10	an	_	DT	DT	_	12	det	_	_
11	intravenous	_	JJ	JJ	_	12	amod	_	_
12	injection	_	NN	NN	_	8	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	phosphocreatine	_	JJ	JJ	_	13	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	PCr	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	or	_	CC	CC	_	14	cc	_	_
19	a	_	DT	DT	_	20	det	_	_
20	placebo	_	NN	NN	_	14	conj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	an	_	DT	DT	_	25	det	_	_
23	isotonic	_	JJ	JJ	_	25	amod	_	_
24	NaCl	_	NN	NN	_	25	nn	_	_
25	solution	_	NN	NN	_	21	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Anaerobic	_	JJ	JJ	_	2	amod	_	_
2	threshold	_	NN	NN	_	7	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	AT	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	determined	_	VBN	VBN	_	0	root	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	point	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	departure	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	ventilatory	_	JJ	JJ	_	16	amod	_	_
16	response	_	NN	NN	_	13	pobj	_	_
17	from	_	IN	IN	_	12	prep	_	_
18	linearity	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	8	cc	_	_
20	from	_	IN	IN	_	8	conj	_	_
21	the	_	DT	DT	_	23	det	_	_
22	sudden	_	JJ	JJ	_	23	amod	_	_
23	increase	_	NN	NN	_	20	pobj	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	venous	_	JJ	JJ	_	28	amod	_	_
26	blood	_	NN	NN	_	28	nn	_	_
27	lactate	_	NN	NN	_	28	nn	_	_
28	concentrations	_	NNS	NNS	_	24	pobj	_	_
29	during	_	IN	IN	_	23	prep	_	_
30	MPE	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	7	punct	_	_

1	After	_	IN	IN	_	7	prep	_	_
2	exercise	_	NN	NN	_	1	pobj	_	_
3	following	_	VBG	VBG	_	2	prep	_	_
4	placebo	_	NN	NN	_	5	nn	_	_
5	administration	_	NN	NN	_	3	pobj	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	observed	_	VBD	VBD	_	0	root	_	_
8	increases	_	NNS	NNS	_	7	dobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	concentrations	_	NNS	NNS	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	blood	_	NN	NN	_	13	nn	_	_
13	substrates	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	plasma	_	NN	NN	_	16	nn	_	_
16	adrenocorticotropin	_	NN	NN	_	13	conj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	ACTH	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	13	punct	_	_
21	growth	_	NN	NN	_	22	nn	_	_
22	hormone	_	NN	NN	_	13	conj	_	_
23	and	_	CC	CC	_	13	cc	_	_
24	cortisol	_	NN	NN	_	13	conj	_	_
25	and	_	CC	CC	_	9	cc	_	_
26	in	_	IN	IN	_	9	conj	_	_
27	the	_	DT	DT	_	28	det	_	_
28	number	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	glucocorticoid	_	NN	NN	_	31	nn	_	_
31	receptors	_	NNS	NNS	_	29	pobj	_	_
32	in	_	IN	IN	_	28	prep	_	_
33	lymphocytes	_	NNS	NNS	_	32	pobj	_	_
34	without	_	IN	IN	_	7	prep	_	_
35	changes	_	NNS	NNS	_	34	pobj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	dissociation	_	NN	NN	_	39	nn	_	_
39	constant	_	NN	NN	_	36	pobj	_	_
40	.	_	.	.	_	7	punct	_	_

1	Intravenous	_	JJ	JJ	_	2	amod	_	_
2	administration	_	NN	NN	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	PCr	_	NN	NN	_	3	pobj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	starting	_	VBG	VBG	_	2	dep	_	_
7	1	_	CD	CD	_	8	num	_	_
8	day	_	NN	NN	_	9	npadvmod	_	_
9	before	_	IN	IN	_	6	prep	_	_
10	exercise	_	NN	NN	_	9	pobj	_	_
11	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
12	led	_	VBD	VBD	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	an	_	DT	DT	_	15	det	_	_
15	increase	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	total	_	JJ	JJ	_	19	amod	_	_
19	workload	_	NN	NN	_	16	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	on	_	IN	IN	_	19	prep	_	_
22	average	_	NN	NN	_	21	pobj	_	_
23	by	_	IN	IN	_	21	prep	_	_
24	5.8	_	CD	CD	_	25	num	_	_
25	%	_	NN	NN	_	23	pobj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
27	and	_	CC	CC	_	16	cc	_	_
28	in	_	IN	IN	_	16	conj	_	_
29	AT	_	NN	NN	_	28	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	on	_	IN	IN	_	29	prep	_	_
32	average	_	NN	NN	_	31	pobj	_	_
33	by	_	IN	IN	_	31	prep	_	_
34	6.8	_	CD	CD	_	35	num	_	_
35	%	_	NN	NN	_	33	pobj	_	_
36	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
37	during	_	IN	IN	_	15	prep	_	_
38	MPE	_	NN	NN	_	37	pobj	_	_
39	and	_	CC	CC	_	13	cc	_	_
40	to	_	TO	TO	_	13	conj	_	_
41	a	_	DT	DT	_	43	det	_	_
42	better	_	JJR	JJR	_	43	amod	_	_
43	tolerance	_	NN	NN	_	40	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	exercise	_	NN	NN	_	44	pobj	_	_
46	during	_	IN	IN	_	43	prep	_	_
47	PPE	_	NN	NN	_	46	pobj	_	_
48	.	_	.	.	_	12	punct	_	_

1	Following	_	VBG	VBG	_	5	prep	_	_
2	PCr	_	NN	NN	_	3	nn	_	_
3	administration	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	observed	_	VBD	VBD	_	0	root	_	_
6	lower	_	JJR	JJR	_	9	amod	_	_
7	blood	_	NN	NN	_	9	nn	_	_
8	lactate	_	NN	NN	_	9	nn	_	_
9	concentrations	_	NNS	NNS	_	5	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	different	_	JJ	JJ	_	12	amod	_	_
12	patterns	_	NNS	NNS	_	9	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	some	_	DT	DT	_	16	det	_	_
15	enzyme	_	NN	NN	_	16	nn	_	_
16	activities	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	9	punct	_	_
18	less	_	RBR	RBR	_	19	advmod	_	_
19	pronounced	_	JJ	JJ	_	20	amod	_	_
20	changes	_	NNS	NNS	_	9	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	plasma	_	NN	NN	_	23	nn	_	_
23	ACTH	_	NN	NN	_	21	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	cortisol	_	NN	NN	_	23	conj	_	_
26	concentrations	_	NNS	NNS	_	23	dep	_	_
27	and	_	CC	CC	_	21	cc	_	_
28	in	_	IN	IN	_	21	conj	_	_
29	glucocorticoid	_	NN	NN	_	30	nn	_	_
30	binding	_	NN	NN	_	28	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	lymphocytes	_	NNS	NNS	_	31	pobj	_	_
33	,	_	,	,	_	9	punct	_	_
34	but	_	CC	CC	_	9	cc	_	_
35	no	_	DT	DT	_	36	neg	_	_
36	changes	_	NNS	NNS	_	9	conj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	plasma	_	NN	NN	_	41	nn	_	_
39	growth	_	NN	NN	_	41	nn	_	_
40	hormone	_	NN	NN	_	41	nn	_	_
41	concentrations	_	NNS	NNS	_	37	pobj	_	_
42	compared	_	VBN	VBN	_	36	prep	_	_
43	to	_	TO	TO	_	42	pcomp	_	_
44	the	_	DT	DT	_	45	det	_	_
45	placebo	_	NN	NN	_	43	pobj	_	_
46	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	intense	_	JJ	JJ	_	7	amod	_	_
6	physical	_	JJ	JJ	_	5	dep	_	_
7	exercise	_	NN	NN	_	8	nsubj	_	_
8	led	_	VBD	VBD	_	3	ccomp	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	only	_	RB	RB	_	11	preconj	_	_
11	to	_	TO	TO	_	8	prep	_	_
12	increases	_	NNS	NNS	_	11	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	blood	_	NN	NN	_	16	nn	_	_
15	hormone	_	NN	NN	_	16	nn	_	_
16	concentrations	_	NNS	NNS	_	13	pobj	_	_
17	but	_	CC	CC	_	18	cc	_	_
18	also	_	RB	RB	_	11	cc	_	_
19	to	_	TO	TO	_	11	conj	_	_
20	an	_	DT	DT	_	21	det	_	_
21	increase	_	NN	NN	_	19	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	density	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	glucocorticoid	_	NN	NN	_	27	nn	_	_
27	receptors	_	NNS	NNS	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	lymphocytes	_	NNS	NNS	_	28	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Intravenous	_	JJ	JJ	_	3	amod	_	_
2	PCr	_	NN	NN	_	3	nn	_	_
3	injection	_	NN	NN	_	4	nsubj	_	_
4	led	_	VBD	VBD	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	smaller	_	JJR	JJR	_	7	amod	_	_
7	changes	_	NNS	NNS	_	5	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	ACTH	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	cortisol	_	NN	NN	_	9	conj	_	_
12	concentrations	_	NNS	NNS	_	9	dep	_	_
13	as	_	RB	RB	_	14	advmod	_	_
14	well	_	RB	RB	_	5	cc	_	_
15	as	_	IN	IN	_	14	mwe	_	_
16	to	_	TO	TO	_	5	conj	_	_
17	a	_	DT	DT	_	19	det	_	_
18	lower	_	JJR	JJR	_	19	amod	_	_
19	activation	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	glucocorticoid	_	NN	NN	_	22	nn	_	_
22	binding	_	NN	NN	_	20	pobj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	lymphocytes	_	NNS	NNS	_	23	pobj	_	_
25	.	_	.	.	_	4	punct	_	_

1	Acetylsalicylic	_	JJ	JJ	_	2	amod	_	_
2	acid	_	NN	NN	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	sodium	_	NN	NN	_	5	nn	_	_
5	salicylate	_	NN	NN	_	2	conj	_	_
6	inhibit	_	VBP	VBP	_	0	root	_	_
7	LPS-induced	_	JJ	JJ	_	11	amod	_	_
8	NF-kappa	_	NN	NN	_	11	nn	_	_
9	B/c-Rel	_	NN	NN	_	11	nn	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	translocation	_	NN	NN	_	6	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	synthesis	_	NN	NN	_	11	conj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	tissue	_	NN	NN	_	17	nn	_	_
17	factor	_	NN	NN	_	15	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	TF	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	tumor	_	NN	NN	_	25	nn	_	_
23	necrosis	_	NN	NN	_	25	nn	_	_
24	factor	_	NN	NN	_	25	nn	_	_
25	alfa	_	NN	NN	_	17	conj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	TNF-alpha	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	in	_	IN	IN	_	11	prep	_	_
30	human	_	JJ	JJ	_	31	amod	_	_
31	monocytes	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	investigated	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	effects	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	acetylsalicylic	_	JJ	JJ	_	8	amod	_	_
8	acid	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	sodium	_	NN	NN	_	11	nn	_	_
11	salicylate	_	NN	NN	_	8	conj	_	_
12	on	_	IN	IN	_	5	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	LPS-induced	_	JJ	JJ	_	15	amod	_	_
15	synthesis	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	pro-coagulant	_	JJ	JJ	_	19	amod	_	_
19	protein	_	NN	NN	_	16	pobj	_	_
20	tissue	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	19	dep	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	TF	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	the	_	DT	DT	_	28	det	_	_
27	pro-inflammatory	_	JJ	JJ	_	28	amod	_	_
28	protein	_	NN	NN	_	19	conj	_	_
29	tumor	_	NN	NN	_	31	nn	_	_
30	necrosis	_	NN	NN	_	31	nn	_	_
31	factor-alpha	_	NN	NN	_	28	dep	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	TNF-alpha	_	NN	NN	_	31	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	,	_	,	,	_	15	punct	_	_
36	as	_	RB	RB	_	37	advmod	_	_
37	well	_	RB	RB	_	15	cc	_	_
38	as	_	IN	IN	_	37	mwe	_	_
39	the	_	DT	DT	_	41	det	_	_
40	prostaglandin	_	NN	NN	_	41	nn	_	_
41	PGE2	_	NN	NN	_	15	conj	_	_
42	in	_	IN	IN	_	15	prep	_	_
43	human	_	JJ	JJ	_	44	amod	_	_
44	monocytes	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	3	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	drugs	_	NNS	NNS	_	4	nsubj	_	_
3	dose-dependently	_	RB	RB	_	4	advmod	_	_
4	inhibited	_	VBD	VBD	_	0	root	_	_
5	LPS-induced	_	JJ	JJ	_	9	amod	_	_
6	TF	_	NN	NN	_	9	nn	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	TNF-alpha	_	NN	NN	_	6	conj	_	_
9	synthesis	_	NN	NN	_	4	dobj	_	_
10	at	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	mRNA	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	the	_	DT	DT	_	15	det	_	_
15	protein	_	NN	NN	_	12	conj	_	_
16	level	_	NN	NN	_	12	dep	_	_
17	,	_	,	,	_	4	punct	_	_
18	and	_	CC	CC	_	4	cc	_	_
19	reduced	_	VBD	VBD	_	4	conj	_	_
20	PGE2	_	NN	NN	_	21	nn	_	_
21	production	_	NN	NN	_	19	dobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	As	_	IN	IN	_	2	mark	_	_
2	evidenced	_	VBN	VBN	_	24	advcl	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	electro	_	NN	NN	_	7	nn	_	_
5	mobility	_	NN	NN	_	7	nn	_	_
6	shift	_	NN	NN	_	7	nn	_	_
7	assay	_	NN	NN	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	EMSA	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	the	_	DT	DT	_	13	det	_	_
13	use	_	NN	NN	_	7	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	19	det	_	_
16	NF-kappa	_	NN	NN	_	19	nn	_	_
17	B	_	NN	NN	_	19	nn	_	_
18	prototypic	_	JJ	JJ	_	19	amod	_	_
19	probe	_	NN	NN	_	14	pobj	_	_
20	,	_	,	,	_	24	punct	_	_
21	these	_	DT	DT	_	22	det	_	_
22	drugs	_	NNS	NNS	_	24	nsubj	_	_
23	probably	_	RB	RB	_	24	advmod	_	_
24	exert	_	VBP	VBP	_	0	root	_	_
25	their	_	PRP$	PRP$	_	27	poss	_	_
26	inhibitory	_	JJ	JJ	_	27	amod	_	_
27	effects	_	NNS	NNS	_	24	dobj	_	_
28	by	_	IN	IN	_	24	prep	_	_
29	interference	_	NN	NN	_	28	pobj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	nuclear	_	JJ	JJ	_	33	amod	_	_
33	translocation	_	NN	NN	_	30	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	NF-kappa	_	NN	NN	_	37	nn	_	_
36	B/c-Rel	_	NN	NN	_	37	nn	_	_
37	proteins	_	NNS	NNS	_	34	pobj	_	_
38	.	_	.	.	_	24	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	expand	_	VB	VB	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	understanding	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	anti-thrombotic	_	JJ	JJ	_	12	amod	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	anti-inflammatory	_	JJ	JJ	_	9	conj	_	_
12	effects	_	NNS	NNS	_	7	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	these	_	DT	DT	_	15	det	_	_
15	drugs	_	NNS	NNS	_	13	pobj	_	_
16	when	_	WRB	WRB	_	20	advmod	_	_
17	activation	_	NN	NN	_	20	nsubj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	monocytes	_	NNS	NNS	_	18	pobj	_	_
20	occurs	_	VBZ	VBZ	_	12	rcmod	_	_
21	.	_	.	.	_	4	punct	_	_

1	Octamer	_	NN	NN	_	2	npadvmod	_	_
2	independent	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	transcription	_	NN	NN	_	4	pobj	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	kappa	_	NN	NN	_	11	nn	_	_
9	immunoglobulin	_	NN	NN	_	11	nn	_	_
10	germline	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	6	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	Previous	_	JJ	JJ	_	2	amod	_	_
2	analyses	_	NNS	NNS	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	immunoglobulin	_	NN	NN	_	7	nn	_	_
5	V	_	JJ	JJ	_	7	amod	_	_
6	region	_	NN	NN	_	7	nn	_	_
7	promoters	_	NNS	NNS	_	3	pobj	_	_
8	has	_	VBZ	VBZ	_	9	aux	_	_
9	led	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	discovery	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	common	_	JJ	JJ	_	17	amod	_	_
16	octamer	_	NN	NN	_	17	nn	_	_
17	motif	_	NN	NN	_	13	pobj	_	_
18	which	_	WDT	WDT	_	21	nsubj	_	_
19	is	_	VBZ	VBZ	_	21	cop	_	_
20	functionally	_	RB	RB	_	21	advmod	_	_
21	important	_	JJ	JJ	_	17	rcmod	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	29	det	_	_
24	tissue-specific	_	JJ	JJ	_	29	amod	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	developmentally	_	RB	RB	_	27	advmod	_	_
27	regulated	_	VBN	VBN	_	24	conj	_	_
28	transcriptional	_	JJ	JJ	_	29	amod	_	_
29	activation	_	NN	NN	_	22	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	immunoglobulin	_	NN	NN	_	32	nn	_	_
32	genes	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	germline	_	NN	NN	_	3	nn	_	_
3	promoters	_	NNS	NNS	_	20	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	Ko	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	located	_	JJ	JJ	_	3	amod	_	_
8	upstream	_	RB	RB	_	7	advmod	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	J	_	JJ	JJ	_	14	amod	_	_
12	region	_	NN	NN	_	14	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	segments	_	NNS	NNS	_	9	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	kappa	_	NN	NN	_	18	nn	_	_
18	locus	_	NN	NN	_	15	pobj	_	_
19	also	_	RB	RB	_	20	advmod	_	_
20	contain	_	VBP	VBP	_	0	root	_	_
21	an	_	DT	DT	_	23	det	_	_
22	octamer	_	NN	NN	_	23	nn	_	_
23	motif	_	NN	NN	_	20	dobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
25	containing	_	VBG	VBG	_	23	dep	_	_
26	a	_	DT	DT	_	30	det	_	_
27	single	_	JJ	JJ	_	30	amod	_	_
28	base	_	NN	NN	_	30	nn	_	_
29	pair	_	NN	NN	_	30	nn	_	_
30	mutation	_	NN	NN	_	25	dobj	_	_
31	and	_	CC	CC	_	25	cc	_	_
32	referred	_	VBN	VBN	_	25	conj	_	_
33	to	_	TO	TO	_	32	prep	_	_
34	as	_	IN	IN	_	32	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	variant	_	JJ	JJ	_	37	amod	_	_
37	octamer	_	NN	NN	_	34	pobj	_	_
38	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
39	which	_	WDT	WDT	_	42	nsubjpass	_	_
40	has	_	VBZ	VBZ	_	42	aux	_	_
41	been	_	VBN	VBN	_	42	auxpass	_	_
42	shown	_	VBN	VBN	_	23	rcmod	_	_
43	previously	_	RB	RB	_	42	advmod	_	_
44	to	_	TO	TO	_	45	aux	_	_
45	bind	_	VB	VB	_	42	xcomp	_	_
46	Oct-1	_	NN	NN	_	50	nn	_	_
47	and	_	CC	CC	_	46	cc	_	_
48	Oct-2	_	NN	NN	_	46	conj	_	_
49	transcription	_	NN	NN	_	50	nn	_	_
50	factors	_	NNS	NNS	_	45	dobj	_	_
51	in	_	FW	FW	_	52	nn	_	_
52	vitro	_	FW	FW	_	45	advmod	_	_
53	.	_	.	.	_	20	punct	_	_

1	To	_	TO	TO	_	3	aux	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	elucidate	_	VB	VB	_	25	advcl	_	_
4	the	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	this	_	DT	DT	_	10	det	_	_
8	variant	_	JJ	JJ	_	10	amod	_	_
9	octamer	_	NN	NN	_	10	nn	_	_
10	motif	_	NN	NN	_	6	pobj	_	_
11	in	_	IN	IN	_	5	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	regulation	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	germline	_	NN	NN	_	16	nn	_	_
16	transcription	_	NN	NN	_	14	pobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	unrearranged	_	JJ	JJ	_	21	amod	_	_
20	kappa	_	NN	NN	_	21	nn	_	_
21	locus	_	NN	NN	_	17	pobj	_	_
22	,	_	,	,	_	25	punct	_	_
23	we	_	PRP	PRP	_	25	nsubj	_	_
24	have	_	VBP	VBP	_	25	aux	_	_
25	quantitated	_	VBN	VBN	_	0	root	_	_
26	the	_	DT	DT	_	29	det	_	_
27	relative	_	JJ	JJ	_	29	amod	_	_
28	binding	_	NN	NN	_	29	nn	_	_
29	affinity	_	NN	NN	_	25	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	Oct-1	_	NN	NN	_	30	pobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	Oct-2	_	NN	NN	_	31	conj	_	_
34	for	_	IN	IN	_	29	prep	_	_
35	the	_	DT	DT	_	38	det	_	_
36	variant	_	JJ	JJ	_	38	amod	_	_
37	octamer	_	NN	NN	_	38	nn	_	_
38	motif	_	NN	NN	_	34	pobj	_	_
39	and	_	CC	CC	_	25	cc	_	_
40	determined	_	VBD	VBD	_	25	conj	_	_
41	the	_	DT	DT	_	43	det	_	_
42	functional	_	JJ	JJ	_	43	amod	_	_
43	role	_	NN	NN	_	40	dobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	this	_	DT	DT	_	47	det	_	_
46	octamer	_	NN	NN	_	47	nn	_	_
47	motif	_	NN	NN	_	44	pobj	_	_
48	in	_	IN	IN	_	43	prep	_	_
49	transcriptional	_	JJ	JJ	_	50	amod	_	_
50	activation	_	NN	NN	_	48	pobj	_	_
51	.	_	.	.	_	25	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	find	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	40	mark	_	_
4	,	_	,	,	_	40	punct	_	_
5	although	_	IN	IN	_	10	mark	_	_
6	the	_	DT	DT	_	9	det	_	_
7	variant	_	JJ	JJ	_	9	amod	_	_
8	octamer	_	NN	NN	_	9	nn	_	_
9	motif	_	NN	NN	_	10	nsubj	_	_
10	binds	_	VBZ	VBZ	_	40	advcl	_	_
11	Oct-1	_	NN	NN	_	10	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	Oct-2	_	NN	NN	_	11	conj	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vitro	_	FW	FW	_	10	advmod	_	_
16	with	_	IN	IN	_	10	prep	_	_
17	5-fold	_	JJ	JJ	_	19	amod	_	_
18	lower	_	JJR	JJR	_	17	dep	_	_
19	affinity	_	NN	NN	_	16	pobj	_	_
20	than	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	consensus	_	NN	NN	_	24	nn	_	_
23	octamer	_	NN	NN	_	24	nn	_	_
24	motif	_	NN	NN	_	20	pobj	_	_
25	,	_	,	,	_	40	punct	_	_
26	mutation	_	NN	NN	_	40	nsubj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	variant	_	JJ	JJ	_	31	amod	_	_
30	octamer	_	NN	NN	_	31	nn	_	_
31	motif	_	NN	NN	_	27	pobj	_	_
32	to	_	TO	TO	_	26	prep	_	_
33	either	_	CC	CC	_	39	preconj	_	_
34	a	_	DT	DT	_	39	det	_	_
35	consensus	_	NN	NN	_	36	nn	_	_
36	octamer	_	NN	NN	_	39	nn	_	_
37	or	_	CC	CC	_	36	cc	_	_
38	non-octamer	_	JJ	JJ	_	36	conj	_	_
39	motif	_	NN	NN	_	32	pobj	_	_
40	has	_	VBZ	VBZ	_	2	ccomp	_	_
41	no	_	DT	DT	_	42	neg	_	_
42	effect	_	NN	NN	_	40	dobj	_	_
43	on	_	IN	IN	_	40	prep	_	_
44	transcriptional	_	JJ	JJ	_	45	amod	_	_
45	activation	_	NN	NN	_	43	pobj	_	_
46	from	_	IN	IN	_	45	prep	_	_
47	the	_	DT	DT	_	49	det	_	_
48	germline	_	NN	NN	_	49	nn	_	_
49	promoter	_	NN	NN	_	46	pobj	_	_
50	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	find	_	VBP	VBP	_	0	root	_	_
4	significant	_	JJ	JJ	_	5	amod	_	_
5	differences	_	NNS	NNS	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	activation	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	germline	_	NN	NN	_	13	nn	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	V	_	JJ	JJ	_	12	amod	_	_
12	region	_	NN	NN	_	9	conj	_	_
13	promoters	_	NNS	NNS	_	8	pobj	_	_
14	by	_	IN	IN	_	7	prep	_	_
15	kappa	_	NN	NN	_	16	nn	_	_
16	enhancers	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	germline	_	NN	NN	_	7	nn	_	_
7	promoters	_	NNS	NNS	_	12	nsubj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	V	_	JJ	JJ	_	11	amod	_	_
10	region	_	NN	NN	_	11	nn	_	_
11	promoters	_	NNS	NNS	_	7	conj	_	_
12	differ	_	VBP	VBP	_	3	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	their	_	PRP$	PRP$	_	15	poss	_	_
15	dependence	_	NN	NN	_	13	pobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	octamer	_	NN	NN	_	16	pobj	_	_
18	for	_	IN	IN	_	15	prep	_	_
19	activation	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	12	cc	_	_
21	respond	_	VBP	VBP	_	12	conj	_	_
22	differently	_	RB	RB	_	21	advmod	_	_
23	to	_	TO	TO	_	21	prep	_	_
24	enhancer	_	NN	NN	_	25	nn	_	_
25	activation	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	have	_	VBP	VBP	_	0	root	_	_
4	important	_	JJ	JJ	_	5	amod	_	_
5	implications	_	NNS	NNS	_	3	dobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	regulation	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	germline	_	NN	NN	_	10	nn	_	_
10	transcription	_	NN	NN	_	8	pobj	_	_
11	as	_	RB	RB	_	12	advmod	_	_
12	well	_	RB	RB	_	7	cc	_	_
13	as	_	IN	IN	_	12	mwe	_	_
14	concomitant	_	JJ	JJ	_	15	amod	_	_
15	activation	_	NN	NN	_	7	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	V-J	_	JJ	JJ	_	19	amod	_	_
19	recombination	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	25	det	_	_
22	kappa	_	NN	NN	_	25	nn	_	_
23	light	_	JJ	JJ	_	25	amod	_	_
24	chain	_	NN	NN	_	25	nn	_	_
25	locus	_	NN	NN	_	20	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Characterization	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	murine	_	JJ	JJ	_	9	amod	_	_
5	cyclin-dependent	_	JJ	JJ	_	9	amod	_	_
6	kinase	_	NN	NN	_	9	nn	_	_
7	inhibitor	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	p27Kip1	_	NN	NN	_	2	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	cyclin-dependent	_	JJ	JJ	_	5	amod	_	_
3	kinase	_	NN	NN	_	5	nn	_	_
4	inhibitor	_	NN	NN	_	5	nn	_	_
5	p27Kip1	_	NN	NN	_	6	nsubj	_	_
6	plays	_	VBZ	VBZ	_	0	root	_	_
7	an	_	DT	DT	_	9	det	_	_
8	important	_	JJ	JJ	_	9	amod	_	_
9	role	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	regulating	_	VBG	VBG	_	10	pcomp	_	_
12	cell-cycle	_	JJ	JJ	_	13	amod	_	_
13	progression	_	NN	NN	_	11	dobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	p27Kip1	_	NN	NN	_	3	nsubj	_	_
2	directly	_	RB	RB	_	3	advmod	_	_
3	inhibits	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	catalytic	_	JJ	JJ	_	6	amod	_	_
6	activity	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	cyclin/cdks	_	NNS	NNS	_	13	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
10	cyclin-dependent	_	JJ	JJ	_	11	amod	_	_
11	kinase	_	NN	NN	_	13	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	complexes	_	NNS	NNS	_	7	pobj	_	_
14	and/or	_	CC	CC	_	3	cc	_	_
15	interferes	_	VBZ	VBZ	_	3	conj	_	_
16	physically	_	RB	RB	_	15	advmod	_	_
17	with	_	IN	IN	_	15	prep	_	_
18	cyclin/cdks	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	17	pobj	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	CAK	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Interestingly	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	expression	_	NN	NN	_	5	nn	_	_
5	level	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	p27Kip1	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	6	pobj	_	_
9	was	_	VBD	VBD	_	10	cop	_	_
10	maximal	_	JJ	JJ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	resting	_	VBG	VBG	_	14	amod	_	_
13	Go	_	NN	NN	_	14	nn	_	_
14	T-cells	_	NNS	NNS	_	11	pobj	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	rapidly	_	RB	RB	_	17	advmod	_	_
17	declined	_	VBD	VBD	_	10	conj	_	_
18	following	_	VBG	VBG	_	17	prep	_	_
19	anti-CD3	_	JJ	JJ	_	20	amod	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	the	_	DT	DT	_	5	det	_	_
5	cloning	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	p27Kip1	_	NN	NN	_	8	nn	_	_
8	gene	_	NN	NN	_	6	pobj	_	_
9	from	_	IN	IN	_	5	prep	_	_
10	murine	_	JJ	JJ	_	12	amod	_	_
11	genomic	_	JJ	JJ	_	12	amod	_	_
12	DNA	_	NN	NN	_	9	pobj	_	_
13	and	_	CC	CC	_	5	cc	_	_
14	the	_	DT	DT	_	16	det	_	_
15	functional	_	JJ	JJ	_	16	amod	_	_
16	analysis	_	NN	NN	_	5	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	promoter	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	p27Kip1	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	gene	_	NN	NN	_	3	nsubj	_	_
3	consists	_	VBZ	VBZ	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	at	_	IN	IN	_	7	quantmod	_	_
6	least	_	JJS	JJS	_	5	mwe	_	_
7	three	_	CD	CD	_	8	num	_	_
8	exons	_	NNS	NNS	_	4	pobj	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	spans	_	NNS	NNS	_	3	conj	_	_
11	more	_	RBR	RBR	_	12	advmod	_	_
12	than	_	IN	IN	_	13	quantmod	_	_
13	5.6	_	CD	CD	_	14	num	_	_
14	kb	_	NN	NN	_	10	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	DNA	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Primer	_	NN	NN	_	2	nn	_	_
2	extension	_	NN	NN	_	7	nn	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	nuclease	_	NN	NN	_	6	nn	_	_
5	S1	_	NN	NN	_	6	nn	_	_
6	protection	_	NN	NN	_	2	conj	_	_
7	analysis	_	NN	NN	_	8	nsubj	_	_
8	revealed	_	VBD	VBD	_	0	root	_	_
9	two	_	CD	CD	_	13	num	_	_
10	major	_	JJ	JJ	_	13	amod	_	_
11	transcription	_	NN	NN	_	13	nn	_	_
12	initiation	_	NN	NN	_	13	nn	_	_
13	sites	_	NNS	NNS	_	8	dobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	promoter	_	NN	NN	_	3	nn	_	_
3	region	_	NN	NN	_	4	nsubj	_	_
4	lacked	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	TATA	_	NN	NN	_	7	nn	_	_
7	box	_	NN	NN	_	4	dobj	_	_
8	but	_	CC	CC	_	4	cc	_	_
9	contained	_	VBD	VBD	_	4	conj	_	_
10	potential	_	JJ	JJ	_	12	amod	_	_
11	binding	_	VBG	VBG	_	12	amod	_	_
12	sites	_	NNS	NNS	_	9	dobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	transcriptional	_	JJ	JJ	_	16	amod	_	_
16	factors	_	NNS	NNS	_	13	pobj	_	_
17	including	_	VBG	VBG	_	16	prep	_	_
18	two	_	CD	CD	_	19	num	_	_
19	Sp1	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	CRE	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	19	punct	_	_
23	Myb	_	NN	NN	_	19	conj	_	_
24	and	_	CC	CC	_	19	cc	_	_
25	NFkB	_	NN	NN	_	19	conj	_	_
26	located	_	JJ	JJ	_	12	amod	_	_
27	at	_	IN	IN	_	26	prep	_	_
28	positions	_	NNS	NNS	_	27	pobj	_	_
29	-153	_	CD	CD	_	28	dep	_	_
30	,	_	,	,	_	29	punct	_	_
31	-178	_	CD	CD	_	29	conj	_	_
32	,	_	,	,	_	29	punct	_	_
33	-286	_	CD	CD	_	29	conj	_	_
34	,	_	,	,	_	29	punct	_	_
35	-875	_	CD	CD	_	29	conj	_	_
36	,	_	,	,	_	29	punct	_	_
37	and	_	CC	CC	_	29	cc	_	_
38	-1011	_	CD	CD	_	29	conj	_	_
39	,	_	,	,	_	28	punct	_	_
40	respectively	_	RB	RB	_	28	advmod	_	_
41	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	analyze	_	VB	VB	_	12	advcl	_	_
3	the	_	DT	DT	_	5	det	_	_
4	regulatory	_	JJ	JJ	_	5	amod	_	_
5	mechanisms	_	NNS	NNS	_	2	dobj	_	_
6	controlling	_	VBG	VBG	_	5	vmod	_	_
7	p27Kip1	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	12	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	characterized	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	15	det	_	_
14	5'-flanking	_	JJ	JJ	_	15	amod	_	_
15	region	_	NN	NN	_	12	dobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	nt	_	NN	NN	_	16	pobj	_	_
18	-1609	_	CD	CD	_	17	num	_	_
19	to	_	TO	TO	_	16	prep	_	_
20	+178	_	CD	CD	_	19	pobj	_	_
21	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	-326	_	CD	CD	_	4	number	_	_
3	to	_	TO	TO	_	4	dep	_	_
4	-615	_	CD	CD	_	5	num	_	_
5	region	_	NN	NN	_	6	nsubj	_	_
6	contained	_	VBD	VBD	_	0	root	_	_
7	positive	_	JJ	JJ	_	9	amod	_	_
8	regulatory	_	JJ	JJ	_	9	amod	_	_
9	elements	_	NNS	NNS	_	6	dobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	Glucocorticoid-mediated	_	JJ	JJ	_	2	amod	_	_
2	inhibition	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RANTES	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
10	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	chemokine	_	NN	NN	_	3	nn	_	_
3	RANTES	_	NN	NN	_	6	nsubjpass	_	_
4	has	_	VBZ	VBZ	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	implicated	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	pathogenesis	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	allergic	_	JJ	JJ	_	13	amod	_	_
12	inflammatory	_	JJ	JJ	_	13	amod	_	_
13	diseases	_	NNS	NNS	_	10	pobj	_	_
14	including	_	VBG	VBG	_	13	prep	_	_
15	asthma	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	rhinitis	_	NN	NN	_	15	conj	_	_
18	which	_	WDT	WDT	_	21	nsubjpass	_	_
19	are	_	VBP	VBP	_	21	auxpass	_	_
20	frequently	_	RB	RB	_	21	advmod	_	_
21	treated	_	VBN	VBN	_	15	rcmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	glucocorticoids	_	NNS	NNS	_	22	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	observed	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	6	mark	_	_
4	dexamethasone	_	NN	NN	_	6	nsubj	_	_
5	dramatically	_	RB	RB	_	6	advmod	_	_
6	inhibited	_	VBD	VBD	_	2	ccomp	_	_
7	RANTES	_	NN	NN	_	9	nn	_	_
8	mRNA	_	NN	NN	_	9	nn	_	_
9	expression	_	NN	NN	_	6	dobj	_	_
10	dose	_	NN	NN	_	11	dep	_	_
11	dependently	_	RB	RB	_	6	advmod	_	_
12	in	_	IN	IN	_	6	prep	_	_
13	anti-CD3	_	NN	NN	_	14	npadvmod	_	_
14	activated	_	JJ	JJ	_	17	amod	_	_
15	Hut-78	_	NN	NN	_	17	nn	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	12	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	human	_	JJ	JJ	_	20	amod	_	_
20	PBMCs	_	NNS	NNS	_	17	conj	_	_
21	.	_	.	.	_	2	punct	_	_

1	Inhibition	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	RANTES	_	NNS	NNS	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	appear	_	VB	VB	_	0	root	_	_
8	to	_	TO	TO	_	10	aux	_	_
9	be	_	VB	VB	_	10	cop	_	_
10	secondary	_	JJ	JJ	_	7	xcomp	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	IL-2	_	NN	NN	_	13	nn	_	_
13	inhibition	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	7	cc	_	_
15	required	_	VBD	VBD	_	7	conj	_	_
16	binding	_	VBG	VBG	_	15	dobj	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	intracellular	_	JJ	JJ	_	21	amod	_	_
20	glucocorticoid	_	NN	NN	_	21	nn	_	_
21	receptor	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	down-regulation	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RANTES	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	by	_	IN	IN	_	2	prep	_	_
7	glucocorticoids	_	NNS	NNS	_	6	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	may	_	MD	MD	_	13	aux	_	_
12	directly	_	RB	RB	_	13	advmod	_	_
13	contribute	_	VB	VB	_	0	root	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	efficacy	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	these	_	DT	DT	_	19	det	_	_
19	agents	_	NNS	NNS	_	17	pobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	suppressing	_	VBG	VBG	_	20	pcomp	_	_
22	cellular	_	JJ	JJ	_	23	amod	_	_
23	infiltration	_	NN	NN	_	21	dobj	_	_
24	and	_	CC	CC	_	14	cc	_	_
25	to	_	TO	TO	_	14	conj	_	_
26	their	_	PRP$	PRP$	_	28	poss	_	_
27	anti-inflammatory	_	JJ	JJ	_	28	amod	_	_
28	properties	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	state	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	maturation	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	monocytes	_	NNS	NNS	_	5	pobj	_	_
7	into	_	IN	IN	_	4	prep	_	_
8	macrophages	_	NNS	NNS	_	7	pobj	_	_
9	determines	_	VBZ	VBZ	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	effects	_	NNS	NNS	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	IL-4	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	IL-13	_	NN	NN	_	13	conj	_	_
16	on	_	IN	IN	_	11	prep	_	_
17	HIV	_	NN	NN	_	18	nn	_	_
18	replication	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	molecular	_	JJ	JJ	_	3	amod	_	_
3	mechanisms	_	NNS	NNS	_	27	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	effects	_	NNS	NNS	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	IL-4	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	IL-13	_	NN	NN	_	8	conj	_	_
11	on	_	IN	IN	_	6	prep	_	_
12	HIV	_	NN	NN	_	13	nn	_	_
13	infection	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	3	prep	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	monocytes	_	NNS	NNS	_	14	pobj	_	_
17	as	_	IN	IN	_	19	mark	_	_
18	they	_	PRP	PRP	_	19	nsubj	_	_
19	matured	_	VBD	VBD	_	27	dep	_	_
20	into	_	IN	IN	_	19	prep	_	_
21	monocyte-derived	_	JJ	JJ	_	22	amod	_	_
22	macrophages	_	NNS	NNS	_	20	pobj	_	_
23	over	_	IN	IN	_	19	prep	_	_
24	7	_	CD	CD	_	25	num	_	_
25	days	_	NNS	NNS	_	23	pobj	_	_
26	were	_	VBD	VBD	_	27	auxpass	_	_
27	investigated	_	VBN	VBN	_	0	root	_	_
28	using	_	VBG	VBG	_	27	xcomp	_	_
29	HIV-1	_	NN	NN	_	28	dobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	BaL	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	,	_	,	,	_	29	punct	_	_
34	and	_	CC	CC	_	29	cc	_	_
35	low	_	JJ	JJ	_	38	amod	_	_
36	passage	_	NN	NN	_	38	nn	_	_
37	clinical	_	JJ	JJ	_	38	amod	_	_
38	strains	_	NNS	NNS	_	29	conj	_	_
39	.	_	.	.	_	27	punct	_	_

1	IL-4	_	NN	NN	_	4	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	IL-13	_	NN	NN	_	1	conj	_	_
4	up-regulated	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	both	_	CC	CC	_	9	preconj	_	_
9	genomic	_	JJ	JJ	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	spliced	_	VBN	VBN	_	9	conj	_	_
12	HIV	_	NN	NN	_	13	nn	_	_
13	mRNA	_	NN	NN	_	9	dep	_	_
14	in	_	IN	IN	_	6	prep	_	_
15	monocytes	_	NNS	NNS	_	14	pobj	_	_
16	cultured	_	VBN	VBN	_	15	vmod	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	Teflon	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	4	punct	_	_
20	as	_	IN	IN	_	21	mark	_	_
21	determined	_	VBN	VBN	_	4	advcl	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	Northern	_	NN	NN	_	24	nn	_	_
24	analysis	_	NN	NN	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	p24	_	NN	NN	_	27	nn	_	_
27	Ag	_	NN	NN	_	28	nn	_	_
28	assay	_	NN	NN	_	24	conj	_	_
29	.	_	.	.	_	4	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	5	det	_	_
3	nuclear	_	JJ	JJ	_	5	amod	_	_
4	run-on	_	JJ	JJ	_	5	amod	_	_
5	assay	_	NN	NN	_	1	dobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	IL-4	_	NN	NN	_	8	nn	_	_
8	stimulation	_	NN	NN	_	10	nsubjpass	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	shown	_	VBN	VBN	_	1	parataxis	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	enhance	_	VB	VB	_	10	xcomp	_	_
13	transcription	_	NN	NN	_	12	dobj	_	_
14	by	_	IN	IN	_	12	prep	_	_
15	two-	_	CD	CD	_	14	pobj	_	_
16	to	_	TO	TO	_	15	dep	_	_
17	threefold	_	RB	RB	_	15	advmod	_	_
18	.	_	.	.	_	1	punct	_	_

1	IL-4	_	NN	NN	_	2	nsubj	_	_
2	stimulated	_	VBD	VBD	_	0	root	_	_
3	nuclear	_	JJ	JJ	_	4	amod	_	_
4	factor-kappaB	_	NN	NN	_	2	dobj	_	_
5	nuclear	_	JJ	JJ	_	6	amod	_	_
6	translocation	_	NN	NN	_	4	dep	_	_
7	and	_	CC	CC	_	4	cc	_	_
8	binding	_	NN	NN	_	4	conj	_	_
9	before	_	IN	IN	_	2	prep	_	_
10	enhancement	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	HIV	_	NN	NN	_	13	nn	_	_
13	RNA	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Conversely	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	IL-4	_	NN	NN	_	9	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	IL-13	_	NN	NN	_	3	conj	_	_
6	markedly	_	RB	RB	_	9	advmod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	significantly	_	RB	RB	_	6	conj	_	_
9	inhibited	_	VBD	VBD	_	0	root	_	_
10	HIV	_	NN	NN	_	11	nn	_	_
11	replication	_	NN	NN	_	9	dobj	_	_
12	at	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	level	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	11	prep	_	_
17	monocyte-derived	_	JJ	JJ	_	18	amod	_	_
18	macrophages	_	NNS	NNS	_	16	pobj	_	_
19	,	_	,	,	_	9	punct	_	_
20	and	_	CC	CC	_	9	cc	_	_
21	this	_	DT	DT	_	22	nsubj	_	_
22	occurred	_	VBD	VBD	_	9	conj	_	_
23	whether	_	IN	IN	_	27	mark	_	_
24	these	_	DT	DT	_	25	det	_	_
25	cytokines	_	NNS	NNS	_	27	nsubjpass	_	_
26	were	_	VBD	VBD	_	27	auxpass	_	_
27	added	_	VBN	VBN	_	22	ccomp	_	_
28	before	_	IN	IN	_	27	prep	_	_
29	or	_	CC	CC	_	28	cc	_	_
30	after	_	IN	IN	_	28	conj	_	_
31	HIV	_	NN	NN	_	32	nn	_	_
32	infection	_	NN	NN	_	28	pobj	_	_
33	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	reversal	_	NN	NN	_	7	nsubj	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	stimulation	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	2	prep	_	_
6	inhibition	_	NN	NN	_	5	pobj	_	_
7	occurred	_	VBD	VBD	_	0	root	_	_
8	after	_	IN	IN	_	7	prep	_	_
9	3	_	CD	CD	_	11	number	_	_
10	to	_	TO	TO	_	11	dep	_	_
11	5	_	CD	CD	_	12	num	_	_
12	days	_	NNS	NNS	_	8	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	adherence	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	plastic	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	IL-4	_	NN	NN	_	2	nsubj	_	_
2	had	_	VBD	VBD	_	0	root	_	_
3	no	_	DT	DT	_	5	neg	_	_
4	significant	_	JJ	JJ	_	5	amod	_	_
5	effect	_	NN	NN	_	2	dobj	_	_
6	on	_	IN	IN	_	2	prep	_	_
7	HIV	_	NN	NN	_	9	nn	_	_
8	reverse	_	JJ	JJ	_	9	amod	_	_
9	transcription	_	NN	NN	_	6	pobj	_	_
10	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	28	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	both	_	DT	DT	_	5	dep	_	_
5	cytokines	_	NNS	NNS	_	3	pobj	_	_
6	on	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	monocyte	_	NN	NN	_	9	nn	_	_
9	maturation/differentiation	_	NN	NN	_	6	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	CD11b	_	NN	NN	_	9	dep	_	_
12	,	_	,	,	_	11	punct	_	_
13	CD13	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	11	punct	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	CD26	_	NN	NN	_	11	conj	_	_
17	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
18	and	_	CC	CC	_	9	cc	_	_
19	other	_	JJ	JJ	_	21	amod	_	_
20	macrophage	_	NN	NN	_	21	nn	_	_
21	markers	_	NNS	NNS	_	9	conj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	CD14	_	NN	NN	_	21	dep	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	CD68	_	NN	NN	_	23	conj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
27	was	_	VBD	VBD	_	28	auxpass	_	_
28	examined	_	VBN	VBN	_	0	root	_	_
29	.	_	.	.	_	28	punct	_	_

1	IL-4	_	NN	NN	_	2	nsubj	_	_
2	enhanced	_	VBD	VBD	_	0	root	_	_
3	CD11b	_	NN	NN	_	2	dobj	_	_
4	,	_	,	,	_	2	punct	_	_
5	but	_	CC	CC	_	2	cc	_	_
6	inhibited	_	VBD	VBD	_	2	conj	_	_
7	CD26	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	6	dobj	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	delayed	_	VBD	VBD	_	6	conj	_	_
11	CD13	_	NN	NN	_	12	nn	_	_
12	loss	_	NN	NN	_	10	dobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	IL-13	_	NN	NN	_	2	nsubj	_	_
2	had	_	VBD	VBD	_	0	root	_	_
3	similar	_	JJ	JJ	_	4	amod	_	_
4	effects	_	NNS	NNS	_	2	dobj	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	CD11b	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	CD13	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	4	punct	_	_
10	but	_	CC	CC	_	4	cc	_	_
11	no	_	DT	DT	_	12	neg	_	_
12	effect	_	NN	NN	_	4	conj	_	_
13	on	_	IN	IN	_	4	prep	_	_
14	CD26	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Hence	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	cytokines	_	NNS	NNS	_	8	nsubj	_	_
5	do	_	VBP	VBP	_	8	aux	_	_
6	not	_	RB	RB	_	8	neg	_	_
7	simply	_	RB	RB	_	8	advmod	_	_
8	enhance	_	VB	VB	_	0	root	_	_
9	monocyte	_	NN	NN	_	10	nn	_	_
10	differentiation	_	NN	NN	_	8	dobj	_	_
11	,	_	,	,	_	8	punct	_	_
12	but	_	CC	CC	_	8	cc	_	_
13	have	_	VBP	VBP	_	8	conj	_	_
14	complex	_	JJ	JJ	_	18	amod	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	slightly	_	RB	RB	_	17	advmod	_	_
17	divergent	_	JJ	JJ	_	14	conj	_	_
18	effects	_	NNS	NNS	_	13	dobj	_	_
19	that	_	WDT	WDT	_	20	nsubj	_	_
20	impact	_	VBP	VBP	_	18	rcmod	_	_
21	on	_	IN	IN	_	20	prep	_	_
22	HIV	_	NN	NN	_	23	nn	_	_
23	replication	_	NN	NN	_	21	pobj	_	_
24	probably	_	RB	RB	_	25	advmod	_	_
25	through	_	IN	IN	_	20	prep	_	_
26	cell	_	NN	NN	_	28	nn	_	_
27	signaling	_	NN	NN	_	28	nn	_	_
28	pathways	_	NNS	NNS	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	nuclear	_	JJ	JJ	_	31	amod	_	_
31	factor-kappaB	_	NN	NN	_	32	nn	_	_
32	translocation	_	NN	NN	_	28	conj	_	_
33	.	_	.	.	_	8	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	novel	_	JJ	JJ	_	4	amod	_	_
3	SP-1	_	NN	NN	_	4	nn	_	_
4	site	_	NN	NN	_	11	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	human	_	JJ	JJ	_	10	amod	_	_
8	interleukin-1	_	NN	NN	_	10	nn	_	_
9	beta	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	5	pobj	_	_
11	confers	_	VBZ	VBZ	_	0	root	_	_
12	preferential	_	JJ	JJ	_	14	amod	_	_
13	transcriptional	_	JJ	JJ	_	14	amod	_	_
14	activity	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	keratinocytes	_	NNS	NNS	_	15	pobj	_	_
17	.	_	.	.	_	11	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	18	advcl	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	transcriptional	_	JJ	JJ	_	7	amod	_	_
7	activation	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	interleukin-1beta	_	NN	NN	_	8	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	IL-1beta	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	non-monocytic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	,	_	,	,	_	18	punct	_	_
17	we	_	PRP	PRP	_	18	nsubj	_	_
18	constructed	_	VBD	VBD	_	0	root	_	_
19	a	_	DT	DT	_	20	det	_	_
20	series	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	reporter	_	NN	NN	_	23	nn	_	_
23	plasmids	_	NNS	NNS	_	21	pobj	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	29	det	_	_
26	bacterial	_	JJ	JJ	_	29	amod	_	_
27	chloramphenicol	_	NN	NN	_	29	nn	_	_
28	acetyltransferase	_	NN	NN	_	29	nn	_	_
29	gene	_	NN	NN	_	24	pobj	_	_
30	linked	_	VBN	VBN	_	29	vmod	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	various	_	JJ	JJ	_	33	amod	_	_
33	parts	_	NNS	NNS	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	38	det	_	_
36	human	_	JJ	JJ	_	38	amod	_	_
37	IL-1beta	_	NN	NN	_	38	nn	_	_
38	promoter	_	NN	NN	_	34	pobj	_	_
39	and	_	CC	CC	_	18	cc	_	_
40	performed	_	VBD	VBD	_	18	conj	_	_
41	transient	_	JJ	JJ	_	43	amod	_	_
42	transfection	_	NN	NN	_	43	nn	_	_
43	experiments	_	NNS	NNS	_	40	dobj	_	_
44	.	_	.	.	_	18	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	identified	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	promoter	_	NN	NN	_	5	nn	_	_
5	segment	_	NN	NN	_	2	dobj	_	_
6	that	_	WDT	WDT	_	7	nsubj	_	_
7	activates	_	VBZ	VBZ	_	5	rcmod	_	_
8	transcription	_	NN	NN	_	7	dobj	_	_
9	most	_	RBS	RBS	_	10	advmod	_	_
10	efficiently	_	RB	RB	_	7	advmod	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	keratinocytes	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	4	amod	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	19	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	EMSA	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	with	_	IN	IN	_	4	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	43-mer	_	NN	NN	_	11	amod	_	_
11	oligonucleotide	_	NN	NN	_	8	pobj	_	_
12	derived	_	VBN	VBN	_	11	vmod	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	functionally	_	RB	RB	_	16	advmod	_	_
16	identified	_	VBN	VBN	_	18	amod	_	_
17	cis-acting	_	JJ	JJ	_	18	amod	_	_
18	element	_	NN	NN	_	13	pobj	_	_
19	revealed	_	VBD	VBD	_	0	root	_	_
20	specific	_	JJ	JJ	_	21	amod	_	_
21	complexes	_	NNS	NNS	_	19	dobj	_	_
22	.	_	.	.	_	19	punct	_	_

1	By	_	IN	IN	_	23	prep	_	_
2	competition	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	1	pobj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	transcription	_	NN	NN	_	9	nn	_	_
6	factor	_	NN	NN	_	9	nn	_	_
7	consensus	_	NN	NN	_	9	nn	_	_
8	sequence	_	NN	NN	_	9	nn	_	_
9	oligonucleotides	_	NNS	NNS	_	4	pobj	_	_
10	and	_	CC	CC	_	1	cc	_	_
11	by	_	IN	IN	_	1	conj	_	_
12	immunosupershift	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	23	punct	_	_
14	transcription	_	NN	NN	_	16	nn	_	_
15	factor	_	NN	NN	_	16	nn	_	_
16	SP-1	_	NN	NN	_	23	nsubjpass	_	_
17	or	_	CC	CC	_	16	cc	_	_
18	a	_	DT	DT	_	21	det	_	_
19	closely	_	RB	RB	_	20	advmod	_	_
20	related	_	JJ	JJ	_	21	amod	_	_
21	protein	_	NN	NN	_	16	conj	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	shown	_	VBN	VBN	_	0	root	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	bind	_	VBP	VBP	_	23	xcomp	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	this	_	DT	DT	_	29	det	_	_
28	regulatory	_	JJ	JJ	_	29	amod	_	_
29	element	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	23	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	closest	_	JJS	JJS	_	3	amod	_	_
3	match	_	NN	NN	_	17	nsubj	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	known	_	VBN	VBN	_	9	amod	_	_
7	SP-1	_	NN	NN	_	9	nn	_	_
8	consensus	_	NN	NN	_	9	nn	_	_
9	sequence	_	NN	NN	_	4	pobj	_	_
10	within	_	IN	IN	_	3	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	respective	_	JJ	JJ	_	13	amod	_	_
13	region	_	NN	NN	_	10	pobj	_	_
14	is	_	VBZ	VBZ	_	17	cop	_	_
15	a	_	DT	DT	_	17	det	_	_
16	TCCCCTCCCCT	_	NN	NN	_	17	nn	_	_
17	motif	_	NN	NN	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	Mutation	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	this	_	DT	DT	_	4	det	_	_
4	motif	_	NN	NN	_	2	pobj	_	_
5	almost	_	RB	RB	_	6	advmod	_	_
6	completely	_	RB	RB	_	11	advmod	_	_
7	,	_	,	,	_	6	punct	_	_
8	and	_	CC	CC	_	6	cc	_	_
9	specifically	_	RB	RB	_	6	conj	_	_
10	,	_	,	,	_	6	punct	_	_
11	abolished	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	13	det	_	_
13	binding	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	two	_	CD	CD	_	17	num	_	_
16	low-mobility	_	JJ	JJ	_	17	amod	_	_
17	complexes	_	NNS	NNS	_	14	pobj	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	led	_	VBD	VBD	_	11	conj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	a	_	DT	DT	_	24	det	_	_
22	95	_	CD	CD	_	24	num	_	_
23	%	_	NN	NN	_	24	nn	_	_
24	decrease	_	NN	NN	_	20	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	constitutive	_	JJ	JJ	_	28	amod	_	_
27	transcriptional	_	JJ	JJ	_	28	amod	_	_
28	activation	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	a	_	DT	DT	_	33	det	_	_
31	reporter	_	NN	NN	_	33	nn	_	_
32	construct	_	NN	NN	_	33	nn	_	_
33	IL-1beta	_	NN	NN	_	29	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	-170/+108	_	CD	CD	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	11	punct	_	_

1	Likewise	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	activation	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	this	_	DT	DT	_	7	det	_	_
6	reporter	_	NN	NN	_	7	nn	_	_
7	construct	_	NN	NN	_	4	pobj	_	_
8	by	_	IN	IN	_	3	prep	_	_
9	tumor	_	NN	NN	_	11	nn	_	_
10	necrosis	_	NN	NN	_	11	nn	_	_
11	factor-alpha	_	NN	NN	_	8	pobj	_	_
12	depended	_	VBD	VBD	_	0	root	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	SP-1	_	NN	NN	_	16	nn	_	_
16	site	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	a	_	DT	DT	_	8	det	_	_
6	so-far-unrecognized	_	JJ	JJ	_	8	amod	_	_
7	SP-1	_	NN	NN	_	8	nn	_	_
8	site	_	NN	NN	_	15	nsubj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	IL-1beta	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	9	pobj	_	_
14	may	_	MD	MD	_	15	aux	_	_
15	participate	_	VB	VB	_	3	ccomp	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	transcriptional	_	JJ	JJ	_	19	amod	_	_
19	regulation	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	this	_	DT	DT	_	22	det	_	_
22	gene	_	NN	NN	_	20	pobj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	keratinocytes	_	NNS	NNS	_	23	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Effects	_	NNS	NNS	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	glucocorticoids	_	NNS	NNS	_	2	pobj	_	_
4	on	_	IN	IN	_	1	prep	_	_
5	lymphocyte	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	4	pobj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	patients	_	NNS	NNS	_	7	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	steroid-sensitive	_	JJ	JJ	_	13	amod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	steroid-resistant	_	JJ	JJ	_	10	conj	_	_
13	asthma	_	NN	NN	_	9	pobj	_	_
14	.	_	.	.	_	1	punct	_	_

1	BACKGROUND	_	NN	NN	_	6	dep	_	_
2	:	_	:	:	_	1	punct	_	_
3	Glucocorticoids	_	NNS	NNS	_	6	nsubj	_	_
4	are	_	VBP	VBP	_	6	cop	_	_
5	important	_	JJ	JJ	_	6	amod	_	_
6	medications	_	NNS	NNS	_	0	root	_	_
7	used	_	VBN	VBN	_	6	vmod	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	control	_	VB	VB	_	7	xcomp	_	_
10	the	_	DT	DT	_	12	det	_	_
11	airway	_	NN	NN	_	12	nn	_	_
12	inflammation	_	NN	NN	_	9	dobj	_	_
13	associated	_	VBN	VBN	_	12	vmod	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	asthma	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Synthetic	_	JJ	JJ	_	2	amod	_	_
2	glucocorticoids	_	NNS	NNS	_	3	nsubj	_	_
3	vary	_	VBP	VBP	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	their	_	PRP$	PRP$	_	7	poss	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	affinity	_	NN	NN	_	4	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	glucocorticoid	_	NN	NN	_	11	nn	_	_
11	receptor	_	NN	NN	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	GCR	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	.	_	.	.	_	3	punct	_	_

1	METHODS	_	NNS	NNS	_	4	dep	_	_
2	:	_	:	:	_	1	punct	_	_
3	We	_	PRP	PRP	_	4	nsubj	_	_
4	compared	_	VBD	VBD	_	0	root	_	_
5	hydrocortisone	_	NN	NN	_	4	dobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	beclomethasone	_	NN	NN	_	8	nn	_	_
8	dipropionate	_	NN	NN	_	5	conj	_	_
9	,	_	,	,	_	5	punct	_	_
10	triamcinolone	_	NN	NN	_	11	nn	_	_
11	acetonide	_	NN	NN	_	5	conj	_	_
12	,	_	,	,	_	5	punct	_	_
13	flunisolide	_	NN	NN	_	5	conj	_	_
14	,	_	,	,	_	5	punct	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	budesonide	_	NN	NN	_	5	conj	_	_
17	with	_	IN	IN	_	4	prep	_	_
18	regard	_	NN	NN	_	17	pobj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	their	_	PRP$	PRP$	_	21	poss	_	_
21	capacity	_	NN	NN	_	19	pobj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	inhibit	_	VB	VB	_	21	vmod	_	_
24	phytohemagglutinin-induced	_	JJ	JJ	_	29	amod	_	_
25	peripheral	_	JJ	JJ	_	29	amod	_	_
26	blood	_	NN	NN	_	29	nn	_	_
27	mononuclear	_	JJ	JJ	_	29	amod	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	proliferation	_	NN	NN	_	23	dobj	_	_
30	from	_	IN	IN	_	4	prep	_	_
31	six	_	CD	CD	_	32	num	_	_
32	patients	_	NNS	NNS	_	30	pobj	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	steroid-sensitive	_	JJ	JJ	_	35	amod	_	_
35	asthma	_	NN	NN	_	33	pobj	_	_
36	and	_	CC	CC	_	32	cc	_	_
37	seven	_	CD	CD	_	38	num	_	_
38	patients	_	NNS	NNS	_	32	conj	_	_
39	with	_	IN	IN	_	38	prep	_	_
40	steroid-resistant	_	JJ	JJ	_	41	amod	_	_
41	asthma	_	NN	NN	_	39	pobj	_	_
42	.	_	.	.	_	4	punct	_	_

1	Peripheral	_	JJ	JJ	_	7	amod	_	_
2	blood	_	NN	NN	_	7	nn	_	_
3	mononuclear	_	JJ	JJ	_	7	amod	_	_
4	cell	_	NN	NN	_	7	nn	_	_
5	GCR	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	affinities	_	NNS	NNS	_	14	nsubjpass	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	dexamethasone	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	budesonide	_	NN	NN	_	9	conj	_	_
12	were	_	VBD	VBD	_	14	auxpass	_	_
13	also	_	RB	RB	_	14	advmod	_	_
14	determined	_	VBN	VBN	_	0	root	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	both	_	DT	DT	_	18	det	_	_
17	patient	_	NN	NN	_	18	nn	_	_
18	groups	_	NNS	NNS	_	15	pobj	_	_
19	by	_	IN	IN	_	14	prep	_	_
20	using	_	VBG	VBG	_	19	pcomp	_	_
21	a	_	DT	DT	_	24	det	_	_
22	radioligand	_	NN	NN	_	24	nn	_	_
23	binding	_	NN	NN	_	24	nn	_	_
24	assay	_	NN	NN	_	20	dobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	Scatchard	_	NN	NN	_	27	nn	_	_
27	analysis	_	NN	NN	_	24	conj	_	_
28	.	_	.	.	_	14	punct	_	_

1	RESULTS	_	NNS	NNS	_	6	dep	_	_
2	:	_	:	:	_	1	punct	_	_
3	Dose-dependent	_	JJ	JJ	_	4	amod	_	_
4	inhibition	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	demonstrated	_	VBN	VBN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	all	_	DT	DT	_	9	det	_	_
9	glucocorticoids	_	NNS	NNS	_	7	pobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	both	_	DT	DT	_	13	det	_	_
12	patient	_	NN	NN	_	13	nn	_	_
13	groups	_	NNS	NNS	_	10	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	with	_	IN	IN	_	6	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	steroid-resistant	_	JJ	JJ	_	18	amod	_	_
18	group	_	NN	NN	_	19	nsubj	_	_
19	requiring	_	VBG	VBG	_	15	pcomp	_	_
20	approximately	_	RB	RB	_	21	quantmod	_	_
21	2	_	CD	CD	_	24	num	_	_
22	log-fold	_	JJ	JJ	_	21	quantmod	_	_
23	more	_	JJR	JJR	_	21	quantmod	_	_
24	glucocorticoids	_	NNS	NNS	_	19	dobj	_	_
25	for	_	IN	IN	_	19	prep	_	_
26	an	_	DT	DT	_	28	det	_	_
27	equivalent	_	JJ	JJ	_	28	amod	_	_
28	degree	_	NN	NN	_	25	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	inhibition	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	mean	_	NN	NN	_	3	nn	_	_
3	concentrations	_	NNS	NNS	_	20	nsubj	_	_
4	necessary	_	JJ	JJ	_	3	amod	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	cause	_	VB	VB	_	4	xcomp	_	_
7	50	_	CD	CD	_	9	num	_	_
8	%	_	NN	NN	_	9	nn	_	_
9	inhibition	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	lymphocyte	_	NN	NN	_	12	nn	_	_
12	proliferation	_	NN	NN	_	10	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	IC50s	_	NNS	NNS	_	9	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	for	_	IN	IN	_	6	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	steroid-sensitive	_	JJ	JJ	_	19	amod	_	_
19	group	_	NN	NN	_	16	pobj	_	_
20	ranged	_	VBD	VBD	_	0	root	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	2	_	CD	CD	_	25	num	_	_
23	x	_	CC	CC	_	22	cc	_	_
24	10-LRB--10-RRB-	_	CD	CD	_	22	conj	_	_
25	mol/L	_	NN	NN	_	21	pobj	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	budesonide	_	NN	NN	_	26	pobj	_	_
28	to	_	TO	TO	_	21	prep	_	_
29	7	_	CD	CD	_	32	num	_	_
30	x	_	CC	CC	_	29	cc	_	_
31	10-LRB--8-RRB-	_	CD	CD	_	29	conj	_	_
32	mol/L	_	NN	NN	_	28	pobj	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	hydrocortisone	_	NN	NN	_	33	pobj	_	_
35	,	_	,	,	_	20	punct	_	_
36	whereas	_	IN	IN	_	20	dep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	mean	_	NN	NN	_	39	nn	_	_
39	IC50s	_	NNS	NNS	_	44	nsubj	_	_
40	for	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	43	det	_	_
42	steroid-resistant	_	JJ	JJ	_	43	amod	_	_
43	group	_	NN	NN	_	40	pobj	_	_
44	ranged	_	VBD	VBD	_	20	parataxis	_	_
45	from	_	IN	IN	_	44	prep	_	_
46	approximately	_	RB	RB	_	47	advmod	_	_
47	2	_	CD	CD	_	50	num	_	_
48	x	_	CC	CC	_	47	cc	_	_
49	10-LRB--8-RRB-	_	CD	CD	_	47	conj	_	_
50	mol/L	_	NN	NN	_	45	pobj	_	_
51	for	_	IN	IN	_	50	prep	_	_
52	budesonide	_	NN	NN	_	51	pobj	_	_
53	to	_	TO	TO	_	45	prep	_	_
54	greater	_	JJR	JJR	_	55	mwe	_	_
55	than	_	IN	IN	_	56	quantmod	_	_
56	10-LRB--6-RRB-	_	CD	CD	_	57	num	_	_
57	mol/L	_	NN	NN	_	53	pobj	_	_
58	for	_	IN	IN	_	57	prep	_	_
59	hydrocortisone	_	NN	NN	_	58	pobj	_	_
60	.	_	.	.	_	20	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	a	_	DT	DT	_	6	det	_	_
5	significant	_	JJ	JJ	_	6	amod	_	_
6	correlation	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	noted	_	VBN	VBN	_	0	root	_	_
9	between	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	degree	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	inhibition	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	lymphocyte	_	NN	NN	_	16	nn	_	_
16	proliferation	_	NN	NN	_	14	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	IC50	_	NN	NN	_	13	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	and	_	CC	CC	_	11	cc	_	_
21	the	_	DT	DT	_	23	det	_	_
22	binding	_	NN	NN	_	23	nn	_	_
23	affinity	_	NN	NN	_	11	conj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	dexamethasone	_	NN	NN	_	24	pobj	_	_
26	to	_	TO	TO	_	23	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	GCR	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	8	punct	_	_

1	Patients	_	NNS	NNS	_	7	nsubjpass	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	steroid-resistant	_	JJ	JJ	_	4	amod	_	_
4	asthma	_	NN	NN	_	2	pobj	_	_
5	have	_	VBP	VBP	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	shown	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	have	_	VB	VB	_	7	xcomp	_	_
10	a	_	DT	DT	_	14	det	_	_
11	reduced	_	VBN	VBN	_	14	amod	_	_
12	GCR	_	NN	NN	_	14	nn	_	_
13	binding	_	NN	NN	_	14	nn	_	_
14	affinity	_	NN	NN	_	9	dobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	GCR	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	affinity	_	NN	NN	_	9	nsubj	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	budesonide	_	NN	NN	_	5	pobj	_	_
7	was	_	VBD	VBD	_	9	cop	_	_
8	significantly	_	RB	RB	_	9	advmod	_	_
9	higher	_	JJR	JJR	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	both	_	DT	DT	_	12	det	_	_
12	groups	_	NNS	NNS	_	10	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
14	i.e.	_	FW	FW	_	18	advmod	_	_
15	,	_	,	,	_	18	punct	_	_
16	lower	_	JJR	JJR	_	18	amod	_	_
17	dissociation	_	NN	NN	_	18	nn	_	_
18	constant	_	NN	NN	_	9	dobj	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	than	_	IN	IN	_	9	prep	_	_
21	that	_	DT	DT	_	20	pobj	_	_
22	obtained	_	VBN	VBN	_	21	vmod	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	dexamethasone	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	CONCLUSION	_	NN	NN	_	5	dep	_	_
2	:	_	:	:	_	1	punct	_	_
3	These	_	DT	DT	_	4	det	_	_
4	data	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	31	mark	_	_
7	glucocorticoids	_	NNS	NNS	_	31	nsubj	_	_
8	such	_	JJ	JJ	_	9	mwe	_	_
9	as	_	IN	IN	_	7	prep	_	_
10	budesonide	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	31	punct	_	_
12	by	_	IN	IN	_	14	dep	_	_
13	virtue	_	NN	NN	_	14	dep	_	_
14	of	_	IN	IN	_	31	prep	_	_
15	their	_	PRP$	PRP$	_	19	poss	_	_
16	high	_	JJ	JJ	_	19	amod	_	_
17	GCR	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	affinities	_	NNS	NNS	_	14	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	greater	_	JJR	JJR	_	22	amod	_	_
22	ability	_	NN	NN	_	19	conj	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	suppress	_	VB	VB	_	22	vmod	_	_
25	lymphocyte	_	NN	NN	_	26	nn	_	_
26	proliferation	_	NN	NN	_	24	dobj	_	_
27	,	_	,	,	_	31	punct	_	_
28	may	_	MD	MD	_	31	aux	_	_
29	therefore	_	RB	RB	_	31	advmod	_	_
30	be	_	VB	VB	_	31	cop	_	_
31	beneficial	_	JJ	JJ	_	5	ccomp	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	management	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	difficult-to-control	_	JJ	JJ	_	37	amod	_	_
37	asthma	_	NN	NN	_	35	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nuclear	_	JJ	JJ	_	6	amod	_	_
4	factor-kappa	_	NN	NN	_	6	nn	_	_
5	B	_	NN	NN	_	6	nn	_	_
6	activation	_	NN	NN	_	2	pobj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	IgE	_	NN	NN	_	9	nn	_	_
9	synthesis	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	.	_	.	.	_	1	punct	_	_

1	Nuclear	_	JJ	JJ	_	3	amod	_	_
2	factor-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	11	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B	_	NN	NN	_	3	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	a	_	DT	DT	_	11	det	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	0	root	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	binds	_	VBZ	VBZ	_	11	rcmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	consensus	_	NN	NN	_	18	nn	_	_
17	DNA	_	NN	NN	_	18	nn	_	_
18	sequence	_	NN	NN	_	14	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	cis-acting	_	JJ	JJ	_	22	amod	_	_
22	elements	_	NNS	NNS	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	various	_	JJ	JJ	_	25	amod	_	_
25	genes	_	NNS	NNS	_	23	pobj	_	_
26	.	_	.	.	_	11	punct	_	_

1	Although	_	IN	IN	_	4	mark	_	_
2	NF-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	4	nsubj	_	_
4	activates	_	VBZ	VBZ	_	19	advcl	_	_
5	the	_	DT	DT	_	6	det	_	_
6	expression	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	many	_	JJ	JJ	_	9	amod	_	_
9	genes	_	NNS	NNS	_	7	pobj	_	_
10	involved	_	VBN	VBN	_	9	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	immune	_	JJ	JJ	_	15	amod	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	inflammatory	_	JJ	JJ	_	12	conj	_	_
15	responses	_	NNS	NNS	_	11	pobj	_	_
16	,	_	,	,	_	19	punct	_	_
17	little	_	JJ	JJ	_	19	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	known	_	VBN	VBN	_	0	root	_	_
20	about	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	role	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	NF-kappa	_	NN	NN	_	26	nn	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	activation	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	22	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	induction	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	IgE	_	NN	NN	_	32	nn	_	_
32	synthesis	_	NN	NN	_	30	pobj	_	_
33	in	_	IN	IN	_	29	prep	_	_
34	human	_	JJ	JJ	_	36	amod	_	_
35	B	_	NN	NN	_	36	nn	_	_
36	cells	_	NNS	NNS	_	33	pobj	_	_
37	.	_	.	.	_	19	punct	_	_

1	Therefore	_	RB	RB	_	4	advmod	_	_
2	we	_	PRP	PRP	_	4	nsubj	_	_
3	first	_	RB	RB	_	4	advmod	_	_
4	examined	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	participation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	germline	_	NN	NN	_	14	nn	_	_
12	C	_	NN	NN	_	14	nn	_	_
13	epsilon	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	22	det	_	_
17	human	_	JJ	JJ	_	22	amod	_	_
18	Burkitt	_	NN	NN	_	22	nn	_	_
19	lymphoma	_	NN	NN	_	22	nn	_	_
20	B	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	line	_	NN	NN	_	15	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	DND39	_	NN	NN	_	22	appos	_	_
25	.	_	.	.	_	4	punct	_	_

1	Stimulation	_	NN	NN	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	DND39	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	IL-4	_	NN	NN	_	5	pobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	anti-CD40	_	JJ	JJ	_	10	amod	_	_
9	monoclonal	_	JJ	JJ	_	10	amod	_	_
10	antibody	_	NN	NN	_	6	conj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	mAb	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	activated	_	VBD	VBD	_	0	root	_	_
15	phosphatidylinositol	_	NN	NN	_	16	nn	_	_
16	3-kinase	_	NN	NN	_	14	dobj	_	_
17	and	_	CC	CC	_	14	cc	_	_
18	subsequently	_	RB	RB	_	19	advmod	_	_
19	induced	_	VBD	VBD	_	14	conj	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	expression	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	22	pobj	_	_
25	,	_	,	,	_	21	punct	_	_
26	which	_	WDT	WDT	_	28	nsubjpass	_	_
27	was	_	VBD	VBD	_	28	auxpass	_	_
28	identified	_	VBN	VBN	_	21	rcmod	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	electrophoretic	_	JJ	JJ	_	33	amod	_	_
31	mobility	_	NN	NN	_	33	nn	_	_
32	shift	_	NN	NN	_	33	nn	_	_
33	assays	_	NNS	NNS	_	29	pobj	_	_
34	.	_	.	.	_	14	punct	_	_

1	n-Acetyl-L-cysteine	_	NN	NN	_	10	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	NAC	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	,	_	,	,	_	1	punct	_	_
6	a	_	DT	DT	_	8	det	_	_
7	potent	_	JJ	JJ	_	8	amod	_	_
8	antioxidant	_	NN	NN	_	1	appos	_	_
9	,	_	,	,	_	1	punct	_	_
10	blocked	_	VBD	VBD	_	0	root	_	_
11	NF-kappa	_	NN	NN	_	13	nn	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	10	dobj	_	_
14	caused	_	VBN	VBN	_	13	vmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	IL-4	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	15	cc	_	_
18	by	_	IN	IN	_	15	conj	_	_
19	anti-CD40	_	JJ	JJ	_	20	amod	_	_
20	mAb	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	Although	_	IN	IN	_	13	mark	_	_
2	inhibition	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IL-4-driven	_	JJ	JJ	_	8	amod	_	_
5	germline	_	NN	NN	_	8	nn	_	_
6	C	_	NN	NN	_	8	nn	_	_
7	epsilon	_	NN	NN	_	8	nn	_	_
8	transcription	_	NN	NN	_	3	pobj	_	_
9	by	_	IN	IN	_	2	prep	_	_
10	NAC	_	NN	NN	_	9	pobj	_	_
11	was	_	VBD	VBD	_	13	cop	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	sufficient	_	JJ	JJ	_	18	advcl	_	_
14	,	_	,	,	_	18	punct	_	_
15	the	_	DT	DT	_	16	det	_	_
16	agent	_	NN	NN	_	18	nsubj	_	_
17	remarkably	_	RB	RB	_	18	advmod	_	_
18	diminished	_	VBD	VBD	_	0	root	_	_
19	anti-CD40	_	JJ	JJ	_	20	amod	_	_
20	mAb-mediated	_	JJ	JJ	_	21	amod	_	_
21	up-regulation	_	NN	NN	_	18	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	germline	_	NN	NN	_	26	nn	_	_
24	C	_	NN	NN	_	26	nn	_	_
25	epsilon	_	NN	NN	_	26	nn	_	_
26	transcription	_	NN	NN	_	22	pobj	_	_
27	.	_	.	.	_	18	punct	_	_

1	Second	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	studied	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	effect	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NAC	_	NN	NN	_	7	pobj	_	_
9	on	_	IN	IN	_	6	prep	_	_
10	IgE	_	NN	NN	_	11	nn	_	_
11	synthesis	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	16	amod	_	_
14	normal	_	JJ	JJ	_	16	amod	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	costimulated	_	VBN	VBN	_	16	vmod	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	IL-4	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	anti-CD40	_	JJ	JJ	_	22	amod	_	_
22	mAb	_	NN	NN	_	19	conj	_	_
23	.	_	.	.	_	4	punct	_	_

1	NAC	_	NN	NN	_	3	nsubj	_	_
2	was	_	VBD	VBD	_	3	cop	_	_
3	effective	_	JJ	JJ	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	inhibiting	_	VBG	VBG	_	4	pcomp	_	_
6	mature	_	JJ	JJ	_	9	amod	_	_
7	C	_	NN	NN	_	9	nn	_	_
8	epsilon	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	5	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	IgE	_	NN	NN	_	12	nn	_	_
12	synthesis	_	NN	NN	_	9	conj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	T	_	NN	NN	_	16	npadvmod	_	_
16	cell-independent	_	JJ	JJ	_	18	amod	_	_
17	culture	_	NN	NN	_	18	nn	_	_
18	system	_	NN	NN	_	13	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	NAC	_	NN	NN	_	7	nsubj	_	_
4	did	_	VBD	VBD	_	7	aux	_	_
5	not	_	RB	RB	_	7	neg	_	_
6	significantly	_	RB	RB	_	7	advmod	_	_
7	affect	_	VB	VB	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	spontaneous	_	JJ	JJ	_	10	amod	_	_
10	production	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	IgE	_	NN	NN	_	11	pobj	_	_
13	by	_	IN	IN	_	10	prep	_	_
14	atopic	_	JJ	JJ	_	16	amod	_	_
15	B	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	NF-kappa	_	NN	NN	_	7	nn	_	_
6	B	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	10	nsubj	_	_
8	is	_	VBZ	VBZ	_	10	cop	_	_
9	commonly	_	RB	RB	_	10	advmod	_	_
10	inducible	_	JJ	JJ	_	3	ccomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	DND39	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	by	_	IN	IN	_	10	prep	_	_
15	IL-4	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	anti-CD40	_	JJ	JJ	_	18	amod	_	_
18	mAb	_	NN	NN	_	15	conj	_	_
19	and	_	CC	CC	_	3	cc	_	_
20	suggest	_	VBP	VBP	_	3	conj	_	_
21	that	_	IN	IN	_	28	mark	_	_
22	NF-kappa	_	NN	NN	_	23	nn	_	_
23	B	_	NN	NN	_	28	nsubj	_	_
24	sensitive	_	JJ	JJ	_	23	amod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	NAC	_	NN	NN	_	25	pobj	_	_
27	may	_	MD	MD	_	28	aux	_	_
28	play	_	VB	VB	_	20	ccomp	_	_
29	a	_	DT	DT	_	30	det	_	_
30	role	_	NN	NN	_	28	dobj	_	_
31	in	_	IN	IN	_	28	prep	_	_
32	regulating	_	VBG	VBG	_	31	pcomp	_	_
33	IgE	_	NN	NN	_	34	nn	_	_
34	synthesis	_	NN	NN	_	32	dobj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	B	_	NN	NN	_	37	nn	_	_
37	cells	_	NNS	NNS	_	35	pobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	-LSB-	_	-LRB-	-LRB-	_	3	punct	_	_
2	Molecular	_	JJ	JJ	_	3	amod	_	_
3	mechanisms	_	NNS	NNS	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	age-related	_	JJ	JJ	_	7	amod	_	_
6	lymphocyte	_	NN	NN	_	7	nn	_	_
7	dysfunction	_	NN	NN	_	4	pobj	_	_
8	-RSB-	_	-RRB-	-RRB-	_	3	punct	_	_

1	Aging	_	NN	NN	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	classically	_	RB	RB	_	4	advmod	_	_
4	accompanied	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	dysregulation	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	immunologic	_	JJ	JJ	_	11	amod	_	_
11	machinery	_	NN	NN	_	8	pobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	As	_	IN	IN	_	14	prep	_	_
2	a	_	DT	DT	_	3	det	_	_
3	consequence	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	14	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	immune	_	JJ	JJ	_	7	amod	_	_
7	response	_	NN	NN	_	14	nsubj	_	_
8	developed	_	VBN	VBN	_	7	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	senescent	_	JJ	JJ	_	11	amod	_	_
11	organisms	_	NNS	NNS	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	14	cop	_	_
13	usually	_	RB	RB	_	14	advmod	_	_
14	inappropriate	_	JJ	JJ	_	0	root	_	_
15	,	_	,	,	_	14	punct	_	_
16	often	_	RB	RB	_	17	advmod	_	_
17	inefficient	_	JJ	JJ	_	14	conj	_	_
18	,	_	,	,	_	14	punct	_	_
19	sometimes	_	RB	RB	_	20	advmod	_	_
20	aberrant	_	JJ	JJ	_	14	conj	_	_
21	,	_	,	,	_	14	punct	_	_
22	and	_	CC	CC	_	14	cc	_	_
23	potentially	_	RB	RB	_	24	advmod	_	_
24	detrimental	_	JJ	JJ	_	14	conj	_	_
25	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	age-associated	_	JJ	JJ	_	4	amod	_	_
3	immune	_	JJ	JJ	_	4	amod	_	_
4	dysfunction	_	NN	NN	_	7	nsubjpass	_	_
5	may	_	MD	MD	_	7	aux	_	_
6	be	_	VB	VB	_	7	auxpass	_	_
7	implicated	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	some	_	DT	DT	_	10	det	_	_
10	degree	_	NN	NN	_	8	pobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	extreme	_	JJ	JJ	_	14	amod	_	_
14	susceptibility	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	elderly	_	JJ	JJ	_	15	pobj	_	_
18	to	_	TO	TO	_	14	prep	_	_
19	infection	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	neoplasia	_	NN	NN	_	19	conj	_	_
22	and	_	CC	CC	_	7	cc	_	_
23	may	_	MD	MD	_	25	aux	_	_
24	even	_	RB	RB	_	25	advmod	_	_
25	participate	_	VB	VB	_	7	conj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	various	_	JJ	JJ	_	28	amod	_	_
28	aspects	_	NNS	NNS	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	senescence	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	current	_	JJ	JJ	_	3	amod	_	_
3	understanding	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	mechanisms	_	NNS	NNS	_	4	pobj	_	_
8	underlying	_	VBG	VBG	_	7	vmod	_	_
9	immunosenescence	_	NN	NN	_	8	dobj	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	still	_	RB	RB	_	12	advmod	_	_
12	fragmentary	_	JJ	JJ	_	0	root	_	_
13	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	most	_	RBS	RBS	_	3	advmod	_	_
3	extensively	_	RB	RB	_	4	advmod	_	_
4	studied	_	VBN	VBN	_	5	amod	_	_
5	phenomenon	_	NN	NN	_	9	nsubj	_	_
6	is	_	VBZ	VBZ	_	9	cop	_	_
7	the	_	DT	DT	_	9	det	_	_
8	progressive	_	JJ	JJ	_	9	amod	_	_
9	decline	_	NN	NN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	proliferative	_	JJ	JJ	_	13	amod	_	_
13	capacities	_	NNS	NNS	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	lymphocytes	_	NNS	NNS	_	14	pobj	_	_
17	with	_	IN	IN	_	9	prep	_	_
18	aging	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	loss	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	proliferative	_	JJ	JJ	_	5	amod	_	_
5	potential	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	response	_	NN	NN	_	6	dep	_	_
8	to	_	TO	TO	_	6	dep	_	_
9	antigenic	_	JJ	JJ	_	10	amod	_	_
10	challenge	_	NN	NN	_	6	pobj	_	_
11	is	_	VBZ	VBZ	_	14	cop	_	_
12	a	_	DT	DT	_	14	det	_	_
13	characteristic	_	JJ	JJ	_	14	amod	_	_
14	feature	_	NN	NN	_	0	root	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	immune	_	JJ	JJ	_	17	amod	_	_
17	senescence	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	directly	_	RB	RB	_	4	advmod	_	_
4	implicated	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	emergence	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	age-related	_	JJ	JJ	_	12	amod	_	_
11	immune	_	JJ	JJ	_	12	amod	_	_
12	deficiency	_	NN	NN	_	8	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	purpose	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	review	_	NN	NN	_	3	pobj	_	_
6	is	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	show	_	VB	VB	_	6	xcomp	_	_
9	how	_	WRB	WRB	_	19	advmod	_	_
10	the	_	DT	DT	_	11	det	_	_
11	accumulation	_	NN	NN	_	19	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	various	_	JJ	JJ	_	15	amod	_	_
14	biochemical	_	JJ	JJ	_	15	amod	_	_
15	lesions	_	NNS	NNS	_	12	pobj	_	_
16	with	_	IN	IN	_	11	prep	_	_
17	advancing	_	VBG	VBG	_	18	amod	_	_
18	age	_	NN	NN	_	16	pobj	_	_
19	leads	_	VBZ	VBZ	_	8	ccomp	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	failure	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	27	det	_	_
25	critical	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	function	_	NN	NN	_	23	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	namely	_	RB	RB	_	27	advmod	_	_
30	the	_	DT	DT	_	33	det	_	_
31	activation-induced	_	JJ	JJ	_	33	amod	_	_
32	lymphocyte	_	NN	NN	_	33	nn	_	_
33	proliferation	_	NN	NN	_	27	dep	_	_
34	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	biochemical	_	JJ	JJ	_	3	amod	_	_
3	modifications	_	NNS	NNS	_	17	nsubjpass	_	_
4	responsible	_	JJ	JJ	_	3	amod	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	defect	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	transduction	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	execution	_	NN	NN	_	9	conj	_	_
12	of	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	proliferative	_	JJ	JJ	_	15	amod	_	_
15	signal	_	NN	NN	_	12	pobj	_	_
16	are	_	VBP	VBP	_	17	auxpass	_	_
17	analyzed	_	VBN	VBN	_	0	root	_	_
18	as	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	20	det	_	_
20	function	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	age	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	multiple	_	JJ	JJ	_	3	amod	_	_
3	alterations	_	NNS	NNS	_	11	nsubj	_	_
4	observed	_	VBN	VBN	_	3	vmod	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	various	_	JJ	JJ	_	9	amod	_	_
8	biochemical	_	JJ	JJ	_	9	amod	_	_
9	pathways	_	NNS	NNS	_	5	pobj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	appear	_	VB	VB	_	0	root	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	consequence	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	unique	_	JJ	JJ	_	19	amod	_	_
18	deleterious	_	JJ	JJ	_	19	amod	_	_
19	mechanism	_	NN	NN	_	15	pobj	_	_
20	more	_	RBR	RBR	_	21	advmod	_	_
21	fundamentally	_	RB	RB	_	22	advmod	_	_
22	related	_	JJ	JJ	_	19	amod	_	_
23	to	_	TO	TO	_	22	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	process	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	senescence	_	NN	NN	_	26	pobj	_	_
28	such	_	JJ	JJ	_	29	mwe	_	_
29	as	_	IN	IN	_	27	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	inability	_	NN	NN	_	29	pobj	_	_
32	to	_	TO	TO	_	33	aux	_	_
33	cope	_	VB	VB	_	31	vmod	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	oxidative	_	JJ	JJ	_	36	amod	_	_
36	stress	_	NN	NN	_	34	pobj	_	_
37	.	_	.	.	_	11	punct	_	_

1	Engagement	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	Lewis	_	NN	NN	_	6	nn	_	_
5	X	_	NN	NN	_	6	nn	_	_
6	antigen	_	NN	NN	_	2	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	CD15	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	results	_	VBZ	VBZ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	monocyte	_	NN	NN	_	13	nn	_	_
13	activation	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	previously	_	RB	RB	_	3	advmod	_	_
3	reported	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	17	mark	_	_
5	monocyte	_	NN	NN	_	6	nn	_	_
6	adhesion	_	NN	NN	_	17	nsubj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	tumor	_	NN	NN	_	16	nn	_	_
9	necrosis	_	NN	NN	_	16	nn	_	_
10	factor-alpha	_	NN	NN	_	16	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
12	TNF-alpha	_	NN	NN	_	16	nn	_	_
13	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
14	-treated	_	JJ	JJ	_	16	amod	_	_
15	endothelial	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	7	pobj	_	_
17	increased	_	VBD	VBD	_	3	ccomp	_	_
18	expression	_	NN	NN	_	17	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	tissue	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	CD36	_	NN	NN	_	21	conj	_	_
24	on	_	IN	IN	_	18	prep	_	_
25	monocytes	_	NNS	NNS	_	24	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	immunological	_	JJ	JJ	_	3	amod	_	_
3	cross-linking	_	NN	NN	_	1	dobj	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	mimic	_	VB	VB	_	1	vmod	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	engagement	_	NN	NN	_	5	dobj	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	natural	_	JJ	JJ	_	10	amod	_	_
10	ligands	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	1	punct	_	_
12	we	_	PRP	PRP	_	14	nsubj	_	_
13	now	_	RB	RB	_	14	advmod	_	_
14	show	_	VBP	VBP	_	1	parataxis	_	_
15	that	_	IN	IN	_	29	mark	_	_
16	CD15	_	NN	NN	_	29	nsubj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
18	Lewis	_	NN	NN	_	19	nn	_	_
19	X	_	NN	NN	_	16	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	16	punct	_	_
22	a	_	DT	DT	_	24	det	_	_
23	monocyte	_	NN	NN	_	24	nn	_	_
24	counter-receptor	_	NN	NN	_	16	appos	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	endothelial	_	JJ	JJ	_	27	amod	_	_
27	selectins	_	NNS	NNS	_	25	pobj	_	_
28	may	_	MD	MD	_	29	aux	_	_
29	participate	_	VB	VB	_	14	ccomp	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	this	_	DT	DT	_	32	det	_	_
32	response	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	used	_	VBD	VBD	_	0	root	_	_
3	cytokine	_	NN	NN	_	4	nn	_	_
4	production	_	NN	NN	_	2	dobj	_	_
5	as	_	IN	IN	_	2	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	readout	_	NN	NN	_	5	pobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	monocyte	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	2	cc	_	_
12	found	_	VBD	VBD	_	2	conj	_	_
13	that	_	IN	IN	_	16	mark	_	_
14	CD15	_	NN	NN	_	15	nn	_	_
15	cross-linking	_	NN	NN	_	16	nsubj	_	_
16	induced	_	VBD	VBD	_	12	ccomp	_	_
17	TNF-alpha	_	NN	NN	_	18	nn	_	_
18	release	_	NN	NN	_	16	dobj	_	_
19	from	_	IN	IN	_	18	prep	_	_
20	peripheral	_	JJ	JJ	_	22	amod	_	_
21	blood	_	NN	NN	_	22	nn	_	_
22	monocytes	_	NNS	NNS	_	19	pobj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	cells	_	NNS	NNS	_	18	conj	_	_
25	from	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	30	det	_	_
27	monocytic	_	JJ	JJ	_	30	amod	_	_
28	cell	_	NN	NN	_	30	nn	_	_
29	line	_	NN	NN	_	30	nn	_	_
30	MM6	_	NN	NN	_	25	pobj	_	_
31	.	_	.	.	_	2	punct	_	_

1	Quantitative	_	JJ	JJ	_	5	amod	_	_
2	reverse	_	JJ	JJ	_	5	amod	_	_
3	transcriptase-polymerase	_	JJ	JJ	_	5	amod	_	_
4	chain	_	NN	NN	_	5	nn	_	_
5	reaction	_	NN	NN	_	9	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	RT-PCR	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	showed	_	VBD	VBD	_	0	root	_	_
10	an	_	DT	DT	_	11	det	_	_
11	increase	_	NN	NN	_	9	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	steady-state	_	JJ	JJ	_	15	amod	_	_
14	TNF-alpha	_	NN	NN	_	15	nn	_	_
15	mRNA	_	NN	NN	_	12	pobj	_	_
16	after	_	IN	IN	_	9	prep	_	_
17	3	_	CD	CD	_	19	number	_	_
18	to	_	TO	TO	_	19	dep	_	_
19	4	_	CD	CD	_	20	num	_	_
20	hours	_	NNS	NNS	_	16	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	cross-linking	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	CD15	_	NN	NN	_	2	nn	_	_
2	cross-linking	_	NN	NN	_	5	nsubj	_	_
3	also	_	RB	RB	_	5	advmod	_	_
4	concomitantly	_	RB	RB	_	5	advmod	_	_
5	increased	_	VBD	VBD	_	0	root	_	_
6	interleukin-1	_	NN	NN	_	12	nn	_	_
7	beta	_	NN	NN	_	12	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
9	IL-1	_	NN	NN	_	12	nn	_	_
10	beta	_	NN	NN	_	12	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
12	mRNA	_	NN	NN	_	5	dobj	_	_
13	,	_	,	,	_	5	punct	_	_
14	while	_	IN	IN	_	19	mark	_	_
15	no	_	DT	DT	_	17	neg	_	_
16	apparent	_	JJ	JJ	_	17	amod	_	_
17	change	_	NN	NN	_	19	nsubjpass	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	observed	_	VBN	VBN	_	5	advcl	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	levels	_	NNS	NNS	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	beta-actin	_	NN	NN	_	25	nn	_	_
25	mRNA	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	19	punct	_	_
27	indicating	_	VBG	VBG	_	5	xcomp	_	_
28	specificity	_	NN	NN	_	27	dobj	_	_
29	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	examine	_	VB	VB	_	0	root	_	_
3	transcriptional	_	JJ	JJ	_	4	amod	_	_
4	regulation	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	cytokine	_	NN	NN	_	7	nn	_	_
7	genes	_	NNS	NNS	_	5	pobj	_	_
8	by	_	IN	IN	_	4	prep	_	_
9	CD15	_	NN	NN	_	10	nn	_	_
10	engagement	_	NN	NN	_	8	pobj	_	_
11	,	_	,	,	_	2	punct	_	_
12	a	_	DT	DT	_	16	det	_	_
13	CAT	_	NN	NN	_	16	nn	_	_
14	plasmid	_	NN	NN	_	16	nn	_	_
15	reporter	_	NN	NN	_	16	nn	_	_
16	construct	_	NN	NN	_	23	nsubjpass	_	_
17	containing	_	VBG	VBG	_	16	vmod	_	_
18	IL-1	_	NN	NN	_	21	nn	_	_
19	beta	_	NN	NN	_	21	nn	_	_
20	promoter/enhancer	_	NN	NN	_	21	nn	_	_
21	sequences	_	NNS	NNS	_	17	dobj	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	introduced	_	VBN	VBN	_	2	parataxis	_	_
24	into	_	IN	IN	_	23	prep	_	_
25	MM6	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	Subsequent	_	JJ	JJ	_	2	amod	_	_
2	cross-linking	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	CD15	_	NN	NN	_	3	pobj	_	_
5	increased	_	VBD	VBD	_	0	root	_	_
6	CAT	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	5	dobj	_	_
8	.	_	.	.	_	5	punct	_	_

1	CD15	_	NN	NN	_	2	nn	_	_
2	engagement	_	NN	NN	_	7	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	monoclonal	_	JJ	JJ	_	5	amod	_	_
5	antibody	_	NN	NN	_	3	pobj	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	attenuated	_	VBD	VBD	_	0	root	_	_
8	IL-1	_	NN	NN	_	9	nn	_	_
9	beta	_	NN	NN	_	11	nn	_	_
10	transcript	_	NN	NN	_	11	nn	_	_
11	degradation	_	NN	NN	_	7	dobj	_	_
12	,	_	,	,	_	7	punct	_	_
13	demonstrating	_	VBG	VBG	_	7	vmod	_	_
14	that	_	IN	IN	_	19	mark	_	_
15	signaling	_	NN	NN	_	19	nsubj	_	_
16	via	_	IN	IN	_	15	prep	_	_
17	CD15	_	NN	NN	_	16	pobj	_	_
18	also	_	RB	RB	_	19	advmod	_	_
19	had	_	VBD	VBD	_	13	ccomp	_	_
20	posttranscriptional	_	JJ	JJ	_	21	amod	_	_
21	effects	_	NNS	NNS	_	19	dobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	extracts	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	anti-CD15	_	JJ	JJ	_	6	amod	_	_
5	cross-linked	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	demonstrated	_	VBD	VBD	_	0	root	_	_
8	enhanced	_	VBN	VBN	_	9	amod	_	_
9	levels	_	NNS	NNS	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	transcriptional	_	JJ	JJ	_	15	amod	_	_
13	factor	_	NN	NN	_	15	nn	_	_
14	activator	_	NN	NN	_	15	nn	_	_
15	protein-1	_	NN	NN	_	10	pobj	_	_
16	,	_	,	,	_	7	punct	_	_
17	minimally	_	RB	RB	_	18	advmod	_	_
18	changed	_	VBD	VBD	_	7	conj	_	_
19	nuclear	_	JJ	JJ	_	21	amod	_	_
20	factor-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	18	dobj	_	_
22	,	_	,	,	_	7	punct	_	_
23	and	_	CC	CC	_	7	cc	_	_
24	did	_	VBD	VBD	_	26	aux	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	affect	_	VB	VB	_	7	conj	_	_
27	SV40	_	NN	NN	_	30	nn	_	_
28	promoter	_	NN	NN	_	30	nn	_	_
29	specific	_	JJ	JJ	_	30	amod	_	_
30	protein-1	_	NN	NN	_	26	dobj	_	_
31	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	9	mark	_	_
4	engagement	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	CD15	_	NN	NN	_	5	pobj	_	_
7	on	_	IN	IN	_	4	prep	_	_
8	monocytes	_	NNS	NNS	_	7	pobj	_	_
9	results	_	VBZ	VBZ	_	2	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	monocyte	_	NN	NN	_	12	nn	_	_
12	activation	_	NN	NN	_	10	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	its	_	PRP$	PRP$	_	7	poss	_	_
5	well-recognized	_	JJ	JJ	_	7	amod	_	_
6	adhesive	_	JJ	JJ	_	7	amod	_	_
7	role	_	NN	NN	_	3	pobj	_	_
8	,	_	,	,	_	11	punct	_	_
9	CD15	_	NN	NN	_	11	nsubj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	function	_	VB	VB	_	0	root	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	an	_	DT	DT	_	16	det	_	_
14	important	_	JJ	JJ	_	16	amod	_	_
15	signaling	_	VBG	VBG	_	16	amod	_	_
16	molecule	_	NN	NN	_	12	pobj	_	_
17	capable	_	JJ	JJ	_	16	amod	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	initiating	_	VBG	VBG	_	18	pcomp	_	_
20	proinflammatory	_	JJ	JJ	_	21	amod	_	_
21	events	_	NNS	NNS	_	19	dobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	monocytes	_	NNS	NNS	_	22	pobj	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	come	_	VBP	VBP	_	23	rcmod	_	_
26	into	_	IN	IN	_	25	prep	_	_
27	contact	_	NN	NN	_	26	pobj	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	activated	_	VBN	VBN	_	30	amod	_	_
30	endothelium	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	11	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	signaling	_	NN	NN	_	4	nn	_	_
4	pathways	_	NNS	NNS	_	2	pobj	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	prevention	_	NN	NN	_	1	conj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	apoptosis	_	NN	NN	_	7	pobj	_	_
9	by	_	IN	IN	_	1	prep	_	_
10	cytokines	_	NNS	NNS	_	9	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	eosinophils	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	Inhibition	_	NN	NN	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	apoptosis	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	eosinophils	_	NNS	NNS	_	4	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	cytokines	_	NNS	NNS	_	6	pobj	_	_
8	such	_	JJ	JJ	_	9	mwe	_	_
9	as	_	IN	IN	_	7	prep	_	_
10	IL-5	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	GM-CSF	_	NN	NN	_	10	conj	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	play	_	VB	VB	_	0	root	_	_
15	an	_	DT	DT	_	17	det	_	_
16	important	_	JJ	JJ	_	17	amod	_	_
17	role	_	NN	NN	_	14	dobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	pathogenesis	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	allergic	_	JJ	JJ	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	parasitic	_	JJ	JJ	_	22	conj	_	_
25	disorders	_	NNS	NNS	_	22	dep	_	_
26	.	_	.	.	_	14	punct	_	_

1	Recently	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	there	_	EX	EX	_	7	expl	_	_
4	has	_	VBZ	VBZ	_	7	aux	_	_
5	been	_	VBN	VBN	_	7	cop	_	_
6	some	_	DT	DT	_	7	det	_	_
7	progress	_	NN	NN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	understanding	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	signal	_	NN	NN	_	15	nn	_	_
14	transduction	_	NN	NN	_	15	nn	_	_
15	pathways	_	NNS	NNS	_	11	pobj	_	_
16	activated	_	VBN	VBN	_	15	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	these	_	DT	DT	_	19	det	_	_
19	cytokines	_	NNS	NNS	_	17	pobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	eosinophils	_	NNS	NNS	_	20	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	IL-3	_	NN	NN	_	8	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	IL-5	_	NN	NN	_	2	conj	_	_
5	and	_	CC	CC	_	2	cc	_	_
6	GM-CSF	_	NN	NN	_	7	nn	_	_
7	receptors	_	NNS	NNS	_	2	conj	_	_
8	share	_	VBP	VBP	_	0	root	_	_
9	a	_	DT	DT	_	12	det	_	_
10	common	_	JJ	JJ	_	12	amod	_	_
11	signal	_	NN	NN	_	12	nn	_	_
12	transducer	_	NN	NN	_	8	dobj	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	possesses	_	VBZ	VBZ	_	12	rcmod	_	_
15	no	_	DT	DT	_	18	neg	_	_
16	intrinsic	_	JJ	JJ	_	18	amod	_	_
17	kinase	_	NN	NN	_	18	nn	_	_
18	domain	_	NN	NN	_	14	dobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	eosinophil	_	NN	NN	_	7	nn	_	_
7	stimulation	_	NN	NN	_	12	nsubjpass	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	these	_	DT	DT	_	10	det	_	_
10	cytokines	_	NNS	NNS	_	8	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	associated	_	VBN	VBN	_	4	ccomp	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	increases	_	NNS	NNS	_	13	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	tyrosine	_	NN	NN	_	17	nn	_	_
17	phosphorylation	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	several	_	JJ	JJ	_	21	amod	_	_
20	cellular	_	JJ	JJ	_	21	amod	_	_
21	substrates	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	past	_	JJ	JJ	_	5	amod	_	_
4	few	_	JJ	JJ	_	5	amod	_	_
5	years	_	NNS	NNS	_	1	pobj	_	_
6	,	_	,	,	_	11	punct	_	_
7	there	_	EX	EX	_	11	expl	_	_
8	has	_	VBZ	VBZ	_	11	aux	_	_
9	been	_	VBN	VBN	_	11	cop	_	_
10	some	_	DT	DT	_	11	det	_	_
11	progress	_	NN	NN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	defining	_	VBG	VBG	_	12	pcomp	_	_
14	the	_	DT	DT	_	16	det	_	_
15	tyrosine	_	NN	NN	_	16	nn	_	_
16	kinases	_	NNS	NNS	_	13	dobj	_	_
17	that	_	WDT	WDT	_	19	nsubjpass	_	_
18	are	_	VBP	VBP	_	19	auxpass	_	_
19	activated	_	VBN	VBN	_	16	rcmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	IL-3/IL-5/GM-CSF	_	NN	NN	_	24	nn	_	_
23	receptor	_	NN	NN	_	24	nn	_	_
24	beta-subunit	_	NN	NN	_	20	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	eosinophils	_	NNS	NNS	_	25	pobj	_	_
27	.	_	.	.	_	11	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	review	_	NN	NN	_	4	nsubj	_	_
3	will	_	MD	MD	_	4	aux	_	_
4	concentrate	_	VB	VB	_	0	root	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	this	_	DT	DT	_	7	det	_	_
7	topic	_	JJ	JJ	_	5	pobj	_	_
8	and	_	CC	CC	_	5	cc	_	_
9	on	_	IN	IN	_	5	conj	_	_
10	its	_	PRP$	PRP$	_	11	poss	_	_
11	role	_	NN	NN	_	9	pobj	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	regulation	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	eosinophil	_	NN	NN	_	17	nn	_	_
17	apoptosis	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Stimulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	7	amod	_	_
4	peripheral	_	JJ	JJ	_	7	amod	_	_
5	blood	_	NN	NN	_	7	nn	_	_
6	mononuclear	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	2	pobj	_	_
8	by	_	IN	IN	_	1	prep	_	_
9	zinc	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	related	_	JJ	JJ	_	12	amod	_	_
12	cations	_	NNS	NNS	_	9	conj	_	_
13	.	_	.	.	_	1	punct	_	_

1	Zinc	_	NN	NN	_	6	nsubj	_	_
2	is	_	VBZ	VBZ	_	6	cop	_	_
3	an	_	DT	DT	_	6	det	_	_
4	important	_	JJ	JJ	_	6	amod	_	_
5	trace	_	NN	NN	_	6	nn	_	_
6	element	_	NN	NN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	immune	_	JJ	JJ	_	9	amod	_	_
9	function	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	16	mark	_	_
6	zinc	_	NN	NN	_	7	nn	_	_
7	addition	_	NN	NN	_	16	nsubj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	15	det	_	_
10	serum-	_	NN	NN	_	15	amod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	lipopolysaccharide-free	_	JJ	JJ	_	10	conj	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	culture	_	NN	NN	_	15	nn	_	_
15	system	_	NN	NN	_	8	pobj	_	_
16	leads	_	VBZ	VBZ	_	4	ccomp	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	significantly	_	RB	RB	_	19	advmod	_	_
19	enhanced	_	JJ	JJ	_	20	amod	_	_
20	levels	_	NNS	NNS	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	interleukin	_	NN	NN	_	24	nn	_	_
23	1	_	CD	CD	_	24	num	_	_
24	beta	_	NN	NN	_	21	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
26	IL-1	_	NN	NN	_	27	nn	_	_
27	beta	_	NN	NN	_	24	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	and	_	CC	CC	_	24	cc	_	_
30	tumour	_	NN	NN	_	33	nn	_	_
31	necrosis	_	NN	NN	_	33	nn	_	_
32	factor	_	NN	NN	_	33	nn	_	_
33	alpha	_	NN	NN	_	24	conj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	TNF-alpha	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	and	_	CC	CC	_	17	cc	_	_
38	to	_	TO	TO	_	17	conj	_	_
39	expression	_	NN	NN	_	38	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	43	det	_	_
42	corresponding	_	JJ	JJ	_	43	amod	_	_
43	mRNA	_	NN	NN	_	40	pobj	_	_
44	in	_	IN	IN	_	43	prep	_	_
45	human	_	JJ	JJ	_	49	amod	_	_
46	peripheral	_	JJ	JJ	_	49	amod	_	_
47	blood	_	NN	NN	_	49	nn	_	_
48	mononuclear	_	JJ	JJ	_	49	amod	_	_
49	cells	_	NNS	NNS	_	44	pobj	_	_
50	-LRB-	_	-LRB-	-LRB-	_	51	punct	_	_
51	PBMC	_	NN	NN	_	49	appos	_	_
52	-RRB-	_	-RRB-	-RRB-	_	51	punct	_	_
53	.	_	.	.	_	4	punct	_	_

1	Structurally	_	RB	RB	_	2	advmod	_	_
2	related	_	JJ	JJ	_	4	amod	_	_
3	divalent	_	JJ	JJ	_	4	amod	_	_
4	cations	_	NNS	NNS	_	14	nsubj	_	_
5	like	_	IN	IN	_	4	prep	_	_
6	cobalt	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	nickel	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	mercury	_	NN	NN	_	6	conj	_	_
12	also	_	RB	RB	_	14	advmod	_	_
13	partially	_	RB	RB	_	14	advmod	_	_
14	increase	_	VBP	VBP	_	0	root	_	_
15	monokine	_	NN	NN	_	16	nn	_	_
16	secretion	_	NN	NN	_	14	dobj	_	_
17	but	_	CC	CC	_	14	cc	_	_
18	to	_	TO	TO	_	14	conj	_	_
19	a	_	DT	DT	_	25	det	_	_
20	much	_	RB	RB	_	21	advmod	_	_
21	lower	_	JJR	JJR	_	25	amod	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	thus	_	RB	RB	_	21	advmod	_	_
24	insignificant	_	JJ	JJ	_	21	dep	_	_
25	extent	_	NN	NN	_	18	pobj	_	_
26	.	_	.	.	_	14	punct	_	_

1	They	_	PRP	PRP	_	2	nsubj	_	_
2	fail	_	VBP	VBP	_	0	root	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	induce	_	VB	VB	_	2	xcomp	_	_
5	mRNA	_	NN	NN	_	4	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	TNF-alpha	_	NN	NN	_	6	pobj	_	_
8	after	_	IN	IN	_	4	prep	_	_
9	3	_	CD	CD	_	10	num	_	_
10	h	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	culture	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	Therefore	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	monokine	_	NN	NN	_	4	nn	_	_
4	induction	_	NN	NN	_	8	nsubj	_	_
5	is	_	VBZ	VBZ	_	8	cop	_	_
6	a	_	DT	DT	_	8	det	_	_
7	zinc-specific	_	JJ	JJ	_	8	amod	_	_
8	effect	_	NN	NN	_	0	root	_	_
9	influenced	_	VBN	VBN	_	8	vmod	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	physicochemical	_	JJ	JJ	_	13	amod	_	_
13	properties	_	NNS	NNS	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	ion	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Confirmation	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	unique	_	JJ	JJ	_	5	amod	_	_
5	significance	_	NN	NN	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	zinc	_	NN	NN	_	6	pobj	_	_
8	for	_	IN	IN	_	5	prep	_	_
9	immune	_	JJ	JJ	_	10	amod	_	_
10	function	_	NN	NN	_	8	pobj	_	_
11	provides	_	VBZ	VBZ	_	0	root	_	_
12	a	_	DT	DT	_	14	det	_	_
13	better	_	JJR	JJR	_	14	amod	_	_
14	understanding	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	mechanisms	_	NNS	NNS	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	specific	_	JJ	JJ	_	22	amod	_	_
20	zinc-mediated	_	JJ	JJ	_	22	amod	_	_
21	immune	_	JJ	JJ	_	22	amod	_	_
22	modulation	_	NN	NN	_	18	pobj	_	_
23	.	_	.	.	_	11	punct	_	_

1	Sequence	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	expression	_	NN	NN	_	2	conj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	cultured	_	VBN	VBN	_	7	amod	_	_
7	lymphocytes	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	2	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	human	_	JJ	JJ	_	12	amod	_	_
11	FOSB	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	8	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	G0S3	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	.	_	.	.	_	2	punct	_	_

1	G0S3	_	NN	NN	_	4	nsubj	_	_
2	is	_	VBZ	VBZ	_	4	cop	_	_
3	a	_	DT	DT	_	4	det	_	_
4	member	_	NN	NN	_	0	root	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	set	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	putative	_	JJ	JJ	_	13	amod	_	_
10	G0/G1	_	NN	NN	_	13	nn	_	_
11	switch	_	NN	NN	_	13	nn	_	_
12	regulatory	_	JJ	JJ	_	13	amod	_	_
13	genes	_	NNS	NNS	_	8	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
15	G0S	_	NN	NN	_	16	nn	_	_
16	genes	_	NNS	NNS	_	13	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	selected	_	VBN	VBN	_	13	vmod	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	screening	_	VBG	VBG	_	19	pcomp	_	_
21	cDNA	_	NN	NN	_	22	nn	_	_
22	libraries	_	NNS	NNS	_	20	dobj	_	_
23	prepared	_	VBN	VBN	_	22	vmod	_	_
24	from	_	IN	IN	_	23	prep	_	_
25	human	_	JJ	JJ	_	28	amod	_	_
26	blood	_	NN	NN	_	28	nn	_	_
27	mononuclear	_	JJ	JJ	_	28	amod	_	_
28	cells	_	NNS	NNS	_	24	pobj	_	_
29	cultured	_	VBN	VBN	_	28	vmod	_	_
30	for	_	IN	IN	_	29	prep	_	_
31	2	_	CD	CD	_	32	num	_	_
32	hr	_	NN	NN	_	30	pobj	_	_
33	with	_	IN	IN	_	29	prep	_	_
34	lectin	_	NN	NN	_	33	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	cycloheximide	_	NN	NN	_	34	conj	_	_
37	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	sequence	_	NN	NN	_	3	nsubj	_	_
3	shows	_	VBZ	VBZ	_	0	root	_	_
4	high	_	JJ	JJ	_	5	amod	_	_
5	homology	_	NN	NN	_	3	dobj	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	murine	_	JJ	JJ	_	10	amod	_	_
9	FOSB	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	6	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	encodes	_	VBZ	VBZ	_	10	rcmod	_	_
14	a	_	DT	DT	_	15	det	_	_
15	component	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	AP1	_	NN	NN	_	20	nn	_	_
19	transcriptional	_	JJ	JJ	_	20	amod	_	_
20	regulator	_	NN	NN	_	16	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Comparison	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cDNA	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	genomic	_	JJ	JJ	_	6	amod	_	_
6	sequences	_	NNS	NNS	_	3	conj	_	_
7	reveals	_	VBZ	VBZ	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	4-exon	_	JJ	JJ	_	10	amod	_	_
10	structure	_	NN	NN	_	7	dobj	_	_
11	characteristic	_	JJ	JJ	_	10	amod	_	_
12	of	_	IN	IN	_	10	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	FOS	_	NN	NN	_	15	nn	_	_
15	family	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	genes	_	NNS	NNS	_	16	pobj	_	_
18	.	_	.	.	_	7	punct	_	_

1	Freshly	_	RB	RB	_	2	advmod	_	_
2	isolated	_	VBN	VBN	_	3	amod	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	high	_	JJ	JJ	_	6	amod	_	_
6	levels	_	NNS	NNS	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	FOSB/G0S3	_	NN	NN	_	11	nn	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	FOS/G0S7	_	NN	NN	_	8	conj	_	_
11	mRNAs	_	NNS	NNS	_	7	pobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	decline	_	VBP	VBP	_	6	rcmod	_	_
15	rapidly	_	RB	RB	_	14	advmod	_	_
16	during	_	IN	IN	_	14	prep	_	_
17	incubation	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	culture	_	NN	NN	_	20	nn	_	_
20	medium	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	kinetics	_	NNS	NNS	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	expression	_	NN	NN	_	3	pobj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	12	mark	_	_
7	the	_	DT	DT	_	10	det	_	_
8	high	_	JJ	JJ	_	10	amod	_	_
9	initial	_	JJ	JJ	_	10	amod	_	_
10	levels	_	NNS	NNS	_	12	nsubjpass	_	_
11	are	_	VBP	VBP	_	12	auxpass	_	_
12	caused	_	VBN	VBN	_	5	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	isolation	_	NN	NN	_	16	nn	_	_
16	procedure	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	5	punct	_	_
18	and	_	CC	CC	_	5	cc	_	_
19	do	_	VBP	VBP	_	21	aux	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	reflect	_	VB	VB	_	5	conj	_	_
22	constitutive	_	JJ	JJ	_	23	amod	_	_
23	expression	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	cells	_	NNS	NNS	_	1	pobj	_	_
3	preincubated	_	VBN	VBN	_	2	vmod	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	6	det	_	_
6	day	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	12	punct	_	_
8	levels	_	NNS	NNS	_	12	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	FOS	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	9	pobj	_	_
12	reach	_	VBP	VBP	_	0	root	_	_
13	a	_	DT	DT	_	14	det	_	_
14	maximum	_	NN	NN	_	12	dobj	_	_
15	20	_	CD	CD	_	16	num	_	_
16	min	_	NN	NN	_	17	npadvmod	_	_
17	after	_	IN	IN	_	12	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	addition	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	lectin	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	12	cc	_	_
23	decline	_	VBP	VBP	_	12	conj	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	control	_	NN	NN	_	26	nn	_	_
26	levels	_	NNS	NNS	_	24	pobj	_	_
27	over	_	IN	IN	_	23	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	next	_	JJ	JJ	_	31	amod	_	_
30	3	_	CD	CD	_	31	num	_	_
31	hr	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	12	punct	_	_

1	Levels	_	NNS	NNS	_	5	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	FOSB	_	NN	NN	_	4	nn	_	_
4	mRNA	_	NN	NN	_	2	pobj	_	_
5	reach	_	VBP	VBP	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	maximum	_	JJ	JJ	_	5	dobj	_	_
8	40	_	CD	CD	_	9	num	_	_
9	min	_	NN	NN	_	10	npadvmod	_	_
10	after	_	IN	IN	_	5	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	addition	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	lectin	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	decline	_	VBP	VBP	_	5	conj	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	control	_	NN	NN	_	19	nn	_	_
19	levels	_	NNS	NNS	_	17	pobj	_	_
20	over	_	IN	IN	_	16	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	next	_	JJ	JJ	_	24	amod	_	_
23	6	_	CD	CD	_	24	num	_	_
24	hr	_	NN	NN	_	20	pobj	_	_
25	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	11	prep	_	_
2	freshly	_	RB	RB	_	3	advmod	_	_
3	isolated	_	VBN	VBN	_	4	amod	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	both	_	CC	CC	_	7	preconj	_	_
7	FOS	_	NNS	NNS	_	10	nn	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	FOSB	_	NN	NN	_	7	conj	_	_
10	mRNAs	_	NNS	NNS	_	11	nsubj	_	_
11	increase	_	VBP	VBP	_	0	root	_	_
12	dramatically	_	RB	RB	_	11	advmod	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	response	_	NN	NN	_	13	dep	_	_
15	to	_	TO	TO	_	13	dep	_	_
16	the	_	DT	DT	_	20	det	_	_
17	protein	_	NN	NN	_	20	nn	_	_
18	synthesis	_	NN	NN	_	20	nn	_	_
19	inhibitor	_	NN	NN	_	20	nn	_	_
20	cycloheximide	_	NN	NN	_	13	pobj	_	_
21	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	preincubated	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cycloheximide	_	NN	NN	_	7	nn	_	_
7	response	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	decreased	_	VBN	VBN	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	especially	_	RB	RB	_	12	advmod	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	case	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	FOSB	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	differences	_	NNS	NNS	_	9	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	expression	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	FOS	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	FOSB	_	NN	NN	_	6	conj	_	_
9	suggest	_	VBP	VBP	_	0	root	_	_
10	different	_	JJ	JJ	_	11	amod	_	_
11	roles	_	NNS	NNS	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	regulation	_	NN	NN	_	11	conj	_	_
14	.	_	.	.	_	9	punct	_	_

1	Regions	_	NNS	NNS	_	15	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	low	_	JJ	JJ	_	7	amod	_	_
4	base	_	NN	NN	_	5	npadvmod	_	_
5	order-dependent	_	JJ	JJ	_	7	amod	_	_
6	stem-loop	_	JJ	JJ	_	7	amod	_	_
7	potential	_	NN	NN	_	2	pobj	_	_
8	in	_	IN	IN	_	1	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	region	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	gene	_	NN	NN	_	11	pobj	_	_
14	are	_	VBP	VBP	_	15	auxpass	_	_
15	defined	_	VBN	VBN	_	0	root	_	_
16	.	_	.	.	_	15	punct	_	_

1	These	_	DT	DT	_	2	nsubj	_	_
2	indicate	_	VBP	VBP	_	0	root	_	_
3	where	_	WRB	WRB	_	8	advmod	_	_
4	base	_	NN	NN	_	5	nn	_	_
5	order	_	NN	NN	_	8	nsubjpass	_	_
6	has	_	VBZ	VBZ	_	8	aux	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	adapted	_	VBN	VBN	_	2	advcl	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	purposes	_	NNS	NNS	_	9	pobj	_	_
11	other	_	JJ	JJ	_	12	dep	_	_
12	than	_	IN	IN	_	10	prep	_	_
13	stem-loop	_	JJ	JJ	_	14	amod	_	_
14	stability	_	NN	NN	_	12	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	e.g.	_	FW	FW	_	10	dep	_	_
17	,	_	,	,	_	16	punct	_	_
18	encoding	_	VBG	VBG	_	16	dep	_	_
19	proteins	_	NNS	NNS	_	18	dobj	_	_
20	or	_	CC	CC	_	18	cc	_	_
21	gene	_	NN	NN	_	22	nn	_	_
22	regulation	_	NN	NN	_	18	conj	_	_
23	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
24	.	_	.	.	_	2	punct	_	_

1	Regions	_	NNS	NNS	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	low	_	JJ	JJ	_	4	amod	_	_
4	potential	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	68.5-kb	_	JJ	JJ	_	9	amod	_	_
8	genomic	_	JJ	JJ	_	9	amod	_	_
9	segment	_	NN	NN	_	5	pobj	_	_
10	containing	_	VBG	VBG	_	9	vmod	_	_
11	the	_	DT	DT	_	13	det	_	_
12	FOSB	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	10	dobj	_	_
14	suggest	_	VBP	VBP	_	0	root	_	_
15	that	_	IN	IN	_	19	mark	_	_
16	the	_	DT	DT	_	17	det	_	_
17	potential	_	NN	NN	_	19	nsubj	_	_
18	may	_	MD	MD	_	19	aux	_	_
19	help	_	VB	VB	_	14	ccomp	_	_
20	locate	_	VB	VB	_	19	ccomp	_	_
21	genes	_	NNS	NNS	_	20	dobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	uncharted	_	JJ	JJ	_	25	amod	_	_
24	DNA	_	NN	NN	_	25	nn	_	_
25	sequences	_	NNS	NNS	_	22	pobj	_	_
26	.	_	.	.	_	14	punct	_	_

1	STAT1	_	NN	NN	_	2	nn	_	_
2	pathway	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	involved	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	activation	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	caprine	_	JJ	JJ	_	13	amod	_	_
9	arthritis-encephalitis	_	JJ	JJ	_	13	amod	_	_
10	virus	_	NN	NN	_	13	nn	_	_
11	long	_	JJ	JJ	_	13	amod	_	_
12	terminal	_	JJ	JJ	_	13	amod	_	_
13	repeat	_	NN	NN	_	7	pobj	_	_
14	in	_	IN	IN	_	6	prep	_	_
15	monocytes	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	10	det	_	_
2	caprine	_	JJ	JJ	_	10	amod	_	_
3	arthritis-encephalitis	_	JJ	JJ	_	10	amod	_	_
4	virus	_	NN	NN	_	10	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
6	CAEV	_	NN	NN	_	10	nn	_	_
7	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
8	long	_	JJ	JJ	_	10	amod	_	_
9	terminal	_	JJ	JJ	_	10	amod	_	_
10	repeat	_	NN	NN	_	15	nsubjpass	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	LTR	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	activated	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	gamma	_	NN	NN	_	18	nn	_	_
18	interferon	_	NN	NN	_	16	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	IFN-gamma	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	promonocytic	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	15	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	a	_	DT	DT	_	8	det	_	_
7	70-bp	_	JJ	JJ	_	8	amod	_	_
8	element	_	NN	NN	_	10	nsubj	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	necessary	_	JJ	JJ	_	4	ccomp	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	sufficient	_	JJ	JJ	_	10	conj	_	_
13	for	_	IN	IN	_	10	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	response	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	CAEV	_	NN	NN	_	19	nn	_	_
19	LTR	_	NN	NN	_	16	pobj	_	_
20	to	_	TO	TO	_	15	prep	_	_
21	this	_	DT	DT	_	22	det	_	_
22	cytokine	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	At	_	IN	IN	_	11	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	5'	_	JJ	JJ	_	4	amod	_	_
4	end	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	11	punct	_	_
6	this	_	DT	DT	_	10	det	_	_
7	70-bp	_	JJ	JJ	_	10	amod	_	_
8	IFN-gamma	_	NN	NN	_	10	nn	_	_
9	response	_	NN	NN	_	10	nn	_	_
10	element	_	NN	NN	_	11	nsubj	_	_
11	contains	_	VBZ	VBZ	_	0	root	_	_
12	sequence	_	NN	NN	_	13	nn	_	_
13	similarity	_	NN	NN	_	11	dobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	gamma	_	NN	NN	_	18	nn	_	_
17	activated	_	JJ	JJ	_	18	amod	_	_
18	site	_	NN	NN	_	14	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	GAS	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	.	_	.	.	_	11	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	13	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	putative	_	JJ	JJ	_	8	amod	_	_
7	GAS	_	NN	NN	_	8	nn	_	_
8	element	_	NN	NN	_	13	nsubj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	CAEV	_	NN	NN	_	12	nn	_	_
12	LTR	_	NN	NN	_	9	pobj	_	_
13	binds	_	VBZ	VBZ	_	3	ccomp	_	_
14	specifically	_	RB	RB	_	15	advmod	_	_
15	to	_	TO	TO	_	13	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	cellular	_	JJ	JJ	_	18	amod	_	_
18	factor	_	NN	NN	_	15	pobj	_	_
19	induced	_	VBN	VBN	_	18	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	IFN-gamma	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	promonocytic	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Substitution	_	NN	NN	_	2	nn	_	_
2	mutations	_	NNS	NNS	_	7	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	6	det	_	_
5	consensus	_	NN	NN	_	6	nn	_	_
6	sequence	_	NN	NN	_	3	pobj	_	_
7	eliminate	_	VBP	VBP	_	0	root	_	_
8	binding	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	inducible	_	JJ	JJ	_	12	amod	_	_
12	factor	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	GAS	_	NN	NN	_	3	nn	_	_
3	element	_	NN	NN	_	9	nsubj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	70-bp	_	JJ	JJ	_	7	amod	_	_
7	motif	_	NN	NN	_	4	pobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	sufficient	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	confer	_	VB	VB	_	9	xcomp	_	_
12	responsiveness	_	NN	NN	_	11	dobj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	IFN-gamma	_	NN	NN	_	13	pobj	_	_
15	using	_	VBG	VBG	_	11	xcomp	_	_
16	a	_	DT	DT	_	19	det	_	_
17	heterologous	_	JJ	JJ	_	19	amod	_	_
18	minimal	_	JJ	JJ	_	17	dep	_	_
19	promoter	_	NN	NN	_	15	dobj	_	_
20	.	_	.	.	_	9	punct	_	_

1	Consistent	_	JJ	JJ	_	14	advmod	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	binding	_	NN	NN	_	5	nn	_	_
5	data	_	NNS	NNS	_	2	pobj	_	_
6	,	_	,	,	_	14	punct	_	_
7	the	_	DT	DT	_	9	det	_	_
8	same	_	JJ	JJ	_	9	amod	_	_
9	mutations	_	NNS	NNS	_	14	nsubj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	GAS	_	NN	NN	_	13	nn	_	_
13	element	_	NN	NN	_	10	pobj	_	_
14	eliminate	_	VBP	VBP	_	0	root	_	_
15	responsiveness	_	NN	NN	_	14	dobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	IFN-gamma	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	context	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	both	_	CC	CC	_	26	preconj	_	_
23	a	_	DT	DT	_	26	det	_	_
24	functional	_	JJ	JJ	_	26	amod	_	_
25	CAEV	_	NN	NN	_	26	nn	_	_
26	LTR	_	NN	NN	_	21	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	a	_	DT	DT	_	30	det	_	_
29	heterologous	_	JJ	JJ	_	30	amod	_	_
30	promoter	_	NN	NN	_	26	conj	_	_
31	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	cellular	_	JJ	JJ	_	3	amod	_	_
3	factor	_	NN	NN	_	11	nsubj	_	_
4	that	_	WDT	WDT	_	5	nsubj	_	_
5	binds	_	VBZ	VBZ	_	3	rcmod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	GAS	_	NN	NN	_	9	nn	_	_
9	element	_	NN	NN	_	6	pobj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	present	_	JJ	JJ	_	0	root	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	5	_	CD	CD	_	14	num	_	_
14	min	_	NN	NN	_	12	pobj	_	_
15	to	_	TO	TO	_	11	prep	_	_
16	14	_	CD	CD	_	17	num	_	_
17	h	_	NN	NN	_	15	pobj	_	_
18	after	_	IN	IN	_	11	prep	_	_
19	stimulation	_	NN	NN	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	IFN-gamma	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	11	punct	_	_

1	Binding	_	NN	NN	_	15	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	nuclear	_	JJ	JJ	_	5	amod	_	_
5	factor	_	NN	NN	_	2	pobj	_	_
6	to	_	TO	TO	_	1	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	GAS	_	NN	NN	_	9	nn	_	_
9	element	_	NN	NN	_	6	pobj	_	_
10	in	_	IN	IN	_	1	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	CAEV	_	NN	NN	_	13	nn	_	_
13	LTR	_	NN	NN	_	10	pobj	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	inhibited	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	antibody	_	NN	NN	_	16	pobj	_	_
18	directed	_	VBN	VBN	_	17	vmod	_	_
19	against	_	IN	IN	_	18	prep	_	_
20	STAT1	_	NN	NN	_	19	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	p91/84	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	.	_	.	.	_	15	punct	_	_

1	Thus	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	GAS	_	NN	NN	_	5	nn	_	_
5	sequence	_	NN	NN	_	11	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	CAEV	_	NN	NN	_	9	nn	_	_
9	LTR	_	NN	NN	_	6	pobj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	essential	_	JJ	JJ	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	response	_	NN	NN	_	12	pobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	IFN-gamma	_	NN	NN	_	15	pobj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	a	_	DT	DT	_	20	det	_	_
19	STAT1-like	_	JJ	JJ	_	20	amod	_	_
20	factor	_	NN	NN	_	21	nsubj	_	_
21	binds	_	VBZ	VBZ	_	11	conj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	this	_	DT	DT	_	24	det	_	_
24	site	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	STAT-1	_	NN	NN	_	4	nn	_	_
3	signaling	_	NN	NN	_	4	nn	_	_
4	pathway	_	NN	NN	_	5	nsubj	_	_
5	provides	_	VBZ	VBZ	_	0	root	_	_
6	at	_	IN	IN	_	8	quantmod	_	_
7	least	_	JJS	JJS	_	6	mwe	_	_
8	one	_	CD	CD	_	9	num	_	_
9	mechanism	_	NN	NN	_	5	dobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	activation	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	CAEV	_	NN	NN	_	15	nn	_	_
15	LTR	_	NN	NN	_	12	pobj	_	_
16	by	_	IN	IN	_	11	prep	_	_
17	IFN-gamma	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	monocytes	_	NNS	NNS	_	18	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	6	nsubj	_	_
3	are	_	VBP	VBP	_	6	cop	_	_
4	the	_	DT	DT	_	6	det	_	_
5	first	_	JJ	JJ	_	6	amod	_	_
6	demonstration	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	pobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	14	det	_	_
12	STAT	_	NN	NN	_	14	nn	_	_
13	family	_	NN	NN	_	14	nn	_	_
14	member	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	regulation	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	21	det	_	_
20	viral	_	JJ	JJ	_	21	amod	_	_
21	promoter	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	6	punct	_	_

1	Signaling	_	NN	NN	_	0	root	_	_
2	via	_	IN	IN	_	1	prep	_	_
3	IL-2	_	NN	NN	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	IL-4	_	NN	NN	_	3	conj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	JAK3-deficient	_	JJ	JJ	_	11	amod	_	_
8	severe	_	JJ	JJ	_	11	amod	_	_
9	combined	_	JJ	JJ	_	11	amod	_	_
10	immunodeficiency	_	NN	NN	_	11	nn	_	_
11	lymphocytes	_	NNS	NNS	_	6	pobj	_	_
12	:	_	:	:	_	1	punct	_	_
13	JAK3-dependent	_	JJ	JJ	_	16	amod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	independent	_	JJ	JJ	_	13	conj	_	_
16	pathways	_	NNS	NNS	_	1	dep	_	_
17	.	_	.	.	_	1	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	IL-2	_	NN	NN	_	5	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	IL-4	_	NN	NN	_	2	conj	_	_
5	bind	_	VBP	VBP	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	receptors	_	NNS	NNS	_	6	pobj	_	_
8	containing	_	VBG	VBG	_	7	vmod	_	_
9	the	_	DT	DT	_	12	det	_	_
10	common	_	JJ	JJ	_	12	amod	_	_
11	gamma	_	NN	NN	_	12	nn	_	_
12	chain	_	NN	NN	_	8	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	JAK3	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	5	punct	_	_

1	Although	_	IN	IN	_	4	mark	_	_
2	JAK3	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	required	_	VBN	VBN	_	26	advcl	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	proper	_	JJ	JJ	_	8	amod	_	_
7	lymphoid	_	JJ	JJ	_	8	amod	_	_
8	development	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	26	punct	_	_
10	the	_	DT	DT	_	12	det	_	_
11	precise	_	JJ	JJ	_	12	amod	_	_
12	roles	_	NNS	NNS	_	26	nsubjpass	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	this	_	DT	DT	_	15	det	_	_
15	kinase	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	IL-2	_	NN	NN	_	20	nn	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	IL-4	_	NN	NN	_	17	conj	_	_
20	signaling	_	NN	NN	_	16	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	lymphocytes	_	NNS	NNS	_	21	pobj	_	_
23	have	_	VBP	VBP	_	26	aux	_	_
24	not	_	RB	RB	_	26	neg	_	_
25	been	_	VBN	VBN	_	26	auxpass	_	_
26	defined	_	VBN	VBN	_	0	root	_	_
27	.	_	.	.	_	26	punct	_	_

1	Here	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	studied	_	VBN	VBN	_	0	root	_	_
6	IL-2	_	NN	NN	_	9	nn	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	IL-4	_	NN	NN	_	6	conj	_	_
9	signaling	_	NN	NN	_	5	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	B	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	lines	_	NNS	NNS	_	10	pobj	_	_
14	lacking	_	VBG	VBG	_	13	vmod	_	_
15	JAK3	_	NN	NN	_	14	dobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	Although	_	IN	IN	_	13	mark	_	_
2	IL-2-induced	_	JJ	JJ	_	3	amod	_	_
3	phosphorylation	_	NN	NN	_	13	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	IL-2R	_	NN	NN	_	6	nn	_	_
6	beta	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	JAK1	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	and	_	CC	CC	_	6	cc	_	_
11	STAT5	_	NN	NN	_	6	conj	_	_
12	all	_	DT	DT	_	3	advmod	_	_
13	required	_	VBN	VBN	_	33	advcl	_	_
14	the	_	DT	DT	_	15	det	_	_
15	presence	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	JAK3	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	33	punct	_	_
19	IL-4-mediated	_	JJ	JJ	_	20	amod	_	_
20	phosphorylation	_	NN	NN	_	33	nsubj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	JAK1	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	STAT6	_	NN	NN	_	22	conj	_	_
25	,	_	,	,	_	22	punct	_	_
26	and	_	CC	CC	_	22	cc	_	_
27	insulin	_	NN	NN	_	29	nn	_	_
28	receptor	_	NN	NN	_	29	nn	_	_
29	substrates	_	NNS	NNS	_	22	conj	_	_
30	1	_	CD	CD	_	29	dep	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	2	_	CD	CD	_	30	conj	_	_
33	did	_	VBD	VBD	_	0	root	_	_
34	not	_	RB	RB	_	33	neg	_	_
35	.	_	.	.	_	33	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	IL-4-induced	_	JJ	JJ	_	4	amod	_	_
4	effects	_	NNS	NNS	_	7	nsubjpass	_	_
5	were	_	VBD	VBD	_	7	auxpass	_	_
6	clearly	_	RB	RB	_	7	advmod	_	_
7	improved	_	VBN	VBN	_	0	root	_	_
8	following	_	VBG	VBG	_	7	prep	_	_
9	JAK3	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	IL-4	_	NN	NN	_	6	nn	_	_
6	signaling	_	NN	NN	_	7	nsubj	_	_
7	occurs	_	VBZ	VBZ	_	3	ccomp	_	_
8	in	_	IN	IN	_	12	dep	_	_
9	the	_	DT	DT	_	12	dep	_	_
10	absence	_	NN	NN	_	12	dep	_	_
11	of	_	IN	IN	_	12	dep	_	_
12	of	_	IN	IN	_	7	prep	_	_
13	JAK3	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	7	punct	_	_
15	but	_	CC	CC	_	7	cc	_	_
16	is	_	VBZ	VBZ	_	18	cop	_	_
17	comparatively	_	RB	RB	_	18	advmod	_	_
18	inefficient	_	JJ	JJ	_	7	conj	_	_
19	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	help	_	VB	VB	_	0	root	_	_
5	in	_	RP	RP	_	4	prep	_	_
6	understanding	_	VBG	VBG	_	5	dep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	pathogenesis	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	immunodeficiency	_	NN	NN	_	9	pobj	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	occurs	_	VBZ	VBZ	_	11	rcmod	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	mutations	_	NNS	NNS	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	JAK3	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	4	cc	_	_
19	may	_	MD	MD	_	20	aux	_	_
20	suggest	_	VB	VB	_	4	conj	_	_
21	a	_	DT	DT	_	22	det	_	_
22	mechanism	_	NN	NN	_	20	dobj	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	pleiotropic	_	JJ	JJ	_	26	amod	_	_
26	effects	_	NNS	NNS	_	23	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	IL-4	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	4	punct	_	_

1	Differentiation-dependent	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	6	det	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	carboxylesterase	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	monocytic	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factor	_	NN	NN	_	9	conj	_	_
13	binding	_	VBG	VBG	_	12	vmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	promoter	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Carboxylesterases	_	NNS	NNS	_	2	nsubj	_	_
2	play	_	VBP	VBP	_	0	root	_	_
3	an	_	DT	DT	_	5	det	_	_
4	important	_	JJ	JJ	_	5	amod	_	_
5	role	_	NN	NN	_	2	dobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	defense	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	clearance	_	NN	NN	_	7	conj	_	_
10	mechanisms	_	NNS	NNS	_	7	dep	_	_
11	of	_	IN	IN	_	7	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	monocyte/macrophage	_	NN	NN	_	14	nn	_	_
14	system	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	During	_	IN	IN	_	14	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	differentiation	_	NN	NN	_	4	nn	_	_
4	process	_	NN	NN	_	1	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	cells	_	NNS	NNS	_	5	pobj	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	monocytic	_	JJ	JJ	_	12	amod	_	_
10	cell	_	NN	NN	_	12	nn	_	_
11	line	_	NN	NN	_	12	nn	_	_
12	THP-1	_	NN	NN	_	7	pobj	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	observed	_	VBD	VBD	_	0	root	_	_
15	a	_	DT	DT	_	18	det	_	_
16	transient	_	JJ	JJ	_	18	amod	_	_
17	transcriptional	_	JJ	JJ	_	16	dep	_	_
18	upregulation	_	NN	NN	_	14	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	human	_	JJ	JJ	_	22	amod	_	_
22	carboxylesterase	_	NN	NN	_	19	pobj	_	_
23	analyzed	_	VBN	VBN	_	18	vmod	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	means	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	Northern	_	NN	NN	_	28	nn	_	_
28	blots	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	PMA-treated	_	JJ	JJ	_	4	amod	_	_
3	THP-1	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	could	_	MD	MD	_	7	aux	_	_
7	detect	_	VB	VB	_	0	root	_	_
8	three	_	CD	CD	_	12	num	_	_
9	major	_	JJ	JJ	_	12	amod	_	_
10	transcription	_	NN	NN	_	12	nn	_	_
11	initiation	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	7	dobj	_	_
13	as	_	IN	IN	_	14	mark	_	_
14	revealed	_	VBN	VBN	_	7	advcl	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	Nuclease	_	NN	NN	_	18	nn	_	_
17	Protection	_	NN	NN	_	18	nn	_	_
18	Assay	_	NN	NN	_	15	pobj	_	_
19	carried	_	VBN	VBN	_	18	vmod	_	_
20	out	_	IN	IN	_	19	prt	_	_
21	with	_	IN	IN	_	19	prep	_	_
22	two	_	CD	CD	_	26	num	_	_
23	overlapping	_	VBG	VBG	_	26	amod	_	_
24	antisense	_	JJ	JJ	_	26	amod	_	_
25	RNA	_	NN	NN	_	26	nn	_	_
26	probes	_	NNS	NNS	_	21	pobj	_	_
27	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	cloned	_	VBN	VBN	_	0	root	_	_
5	the	_	DT	DT	_	8	det	_	_
6	carboxylesterase	_	NN	NN	_	8	nn	_	_
7	upstream	_	JJ	JJ	_	8	amod	_	_
8	sequence	_	NN	NN	_	4	dobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	showed	_	VBN	VBN	_	4	conj	_	_
11	its	_	PRP$	PRP$	_	14	poss	_	_
12	basal	_	JJ	JJ	_	13	amod	_	_
13	promoter	_	NN	NN	_	14	nn	_	_
14	activity	_	NN	NN	_	10	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	CHO	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	analysis	_	NN	NN	_	1	dobj	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	demonstrated	_	VBD	VBD	_	1	parataxis	_	_
8	that	_	IN	IN	_	30	mark	_	_
9	the	_	DT	DT	_	11	det	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	30	nsubjpass	_	_
12	spanning	_	VBG	VBG	_	11	vmod	_	_
13	base	_	NN	NN	_	14	nn	_	_
14	pairs	_	NNS	NNS	_	12	dobj	_	_
15	-1	_	CD	CD	_	14	num	_	_
16	to	_	TO	TO	_	14	dep	_	_
17	-275	_	CD	CD	_	14	num	_	_
18	,	_	,	,	_	11	punct	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	contains	_	VBZ	VBZ	_	11	rcmod	_	_
21	several	_	JJ	JJ	_	22	amod	_	_
22	putative	_	JJ	JJ	_	24	amod	_	_
23	binding	_	VBG	VBG	_	24	amod	_	_
24	sites	_	NNS	NNS	_	20	dobj	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	transcription	_	NN	NN	_	27	nn	_	_
27	factors	_	NNS	NNS	_	25	pobj	_	_
28	,	_	,	,	_	11	punct	_	_
29	is	_	VBZ	VBZ	_	30	auxpass	_	_
30	bound	_	VBN	VBN	_	7	ccomp	_	_
31	by	_	IN	IN	_	30	prep	_	_
32	nuclear	_	JJ	JJ	_	33	amod	_	_
33	factors	_	NNS	NNS	_	31	pobj	_	_
34	Sp1	_	NN	NN	_	33	dep	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	IRBP	_	NN	NN	_	34	conj	_	_
37	but	_	CC	CC	_	31	cc	_	_
38	not	_	RB	RB	_	39	neg	_	_
39	by	_	IN	IN	_	31	conj	_	_
40	C/EBPs	_	NNS	NNS	_	39	pobj	_	_
41	.	_	.	.	_	1	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	these	_	DT	DT	_	4	det	_	_
4	data	_	NNS	NNS	_	5	nsubj	_	_
5	indicate	_	VBP	VBP	_	1	parataxis	_	_
6	that	_	IN	IN	_	13	mark	_	_
7	carboxylesterase	_	NN	NN	_	9	nn	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	transcription	_	NN	NN	_	13	nsubj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	THP-1	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	starts	_	VBZ	VBZ	_	5	ccomp	_	_
14	at	_	IN	IN	_	13	prep	_	_
15	multiple	_	JJ	JJ	_	17	amod	_	_
16	initiation	_	NN	NN	_	17	nn	_	_
17	sites	_	NNS	NNS	_	14	pobj	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	that	_	IN	IN	_	26	mark	_	_
20	Sp1	_	NN	NN	_	26	nsubj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	IRBP	_	NN	NN	_	20	conj	_	_
23	may	_	MD	MD	_	26	aux	_	_
24	be	_	VB	VB	_	26	cop	_	_
25	critical	_	JJ	JJ	_	26	amod	_	_
26	factors	_	NNS	NNS	_	13	conj	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	modulating	_	VBG	VBG	_	27	pcomp	_	_
29	the	_	DT	DT	_	31	det	_	_
30	differentiation-dependent	_	JJ	JJ	_	31	amod	_	_
31	transcription	_	NN	NN	_	28	dobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	this	_	DT	DT	_	36	det	_	_
34	human	_	JJ	JJ	_	36	amod	_	_
35	carboxylesterase	_	NN	NN	_	36	nn	_	_
36	gene	_	NN	NN	_	32	pobj	_	_
37	.	_	.	.	_	1	punct	_	_

1	Glycation-dependent	_	JJ	JJ	_	6	amod	_	_
2	,	_	,	,	_	1	punct	_	_
3	reactive	_	JJ	JJ	_	5	amod	_	_
4	oxygen	_	NN	NN	_	5	npadvmod	_	_
5	species-mediated	_	JJ	JJ	_	1	dep	_	_
6	suppression	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	insulin	_	NN	NN	_	12	nn	_	_
10	gene	_	NN	NN	_	12	nn	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	7	pobj	_	_
13	in	_	IN	IN	_	6	prep	_	_
14	HIT	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Prolonged	_	JJ	JJ	_	4	amod	_	_
2	poor	_	JJ	JJ	_	1	dep	_	_
3	glycemic	_	JJ	JJ	_	1	dep	_	_
4	control	_	NN	NN	_	11	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	non-insulin-dependent	_	JJ	JJ	_	9	amod	_	_
7	diabetes	_	NN	NN	_	9	nn	_	_
8	mellitus	_	NN	NN	_	9	nn	_	_
9	patients	_	NNS	NNS	_	5	pobj	_	_
10	often	_	RB	RB	_	11	advmod	_	_
11	leads	_	VBZ	VBZ	_	0	root	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	a	_	DT	DT	_	14	det	_	_
14	decline	_	NN	NN	_	12	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	insulin	_	NN	NN	_	17	nn	_	_
17	secretion	_	NN	NN	_	15	pobj	_	_
18	from	_	IN	IN	_	17	prep	_	_
19	pancreatic	_	JJ	JJ	_	21	amod	_	_
20	beta	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	,	_	,	,	_	14	punct	_	_
23	accompanied	_	VBN	VBN	_	14	vmod	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	a	_	DT	DT	_	26	det	_	_
26	decrease	_	NN	NN	_	24	pobj	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	insulin	_	NN	NN	_	30	nn	_	_
30	content	_	NN	NN	_	27	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	cells	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	11	punct	_	_

1	As	_	IN	IN	_	20	prep	_	_
2	a	_	DT	DT	_	3	det	_	_
3	step	_	NN	NN	_	1	pobj	_	_
4	toward	_	IN	IN	_	3	prep	_	_
5	elucidating	_	VBG	VBG	_	4	pcomp	_	_
6	the	_	DT	DT	_	8	det	_	_
7	pathophysiological	_	JJ	JJ	_	8	amod	_	_
8	background	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	so-called	_	JJ	JJ	_	13	amod	_	_
12	glucose	_	NN	NN	_	13	nn	_	_
13	toxicity	_	NN	NN	_	9	pobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	pancreatic	_	JJ	JJ	_	17	amod	_	_
16	beta	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	,	_	,	,	_	20	punct	_	_
19	we	_	PRP	PRP	_	20	nsubj	_	_
20	induced	_	VBD	VBD	_	0	root	_	_
21	glycation	_	NN	NN	_	20	dobj	_	_
22	in	_	IN	IN	_	20	prep	_	_
23	HIT-T15	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	using	_	VBG	VBG	_	20	xcomp	_	_
26	a	_	DT	DT	_	27	det	_	_
27	sugar	_	NN	NN	_	25	dobj	_	_
28	with	_	IN	IN	_	27	prep	_	_
29	strong	_	JJ	JJ	_	31	amod	_	_
30	deoxidizing	_	NN	NN	_	31	nn	_	_
31	activity	_	NN	NN	_	28	pobj	_	_
32	,	_	,	,	_	27	punct	_	_
33	D-ribose	_	NN	NN	_	27	appos	_	_
34	,	_	,	,	_	20	punct	_	_
35	and	_	CC	CC	_	20	cc	_	_
36	examined	_	VBD	VBD	_	20	conj	_	_
37	the	_	DT	DT	_	38	det	_	_
38	effects	_	NNS	NNS	_	36	dobj	_	_
39	on	_	IN	IN	_	38	prep	_	_
40	insulin	_	NN	NN	_	42	nn	_	_
41	gene	_	NN	NN	_	42	nn	_	_
42	transcription	_	NN	NN	_	39	pobj	_	_
43	.	_	.	.	_	20	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	reporter	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	analyses	_	NNS	NNS	_	3	pobj	_	_
7	revealed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	15	mark	_	_
9	the	_	DT	DT	_	12	det	_	_
10	insulin	_	NN	NN	_	12	nn	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	promoter	_	NN	NN	_	15	nsubj	_	_
13	is	_	VBZ	VBZ	_	15	cop	_	_
14	more	_	RBR	RBR	_	15	advmod	_	_
15	sensitive	_	JJ	JJ	_	7	ccomp	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	glycation	_	NN	NN	_	16	pobj	_	_
18	than	_	IN	IN	_	23	mark	_	_
19	the	_	DT	DT	_	23	det	_	_
20	control	_	JJ	JJ	_	23	amod	_	_
21	beta-actin	_	NN	NN	_	23	nn	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	promoter	_	NN	NN	_	15	ccomp	_	_
24	;	_	:	:	_	7	punct	_	_
25	approximately	_	RB	RB	_	26	advmod	_	_
26	50	_	CD	CD	_	29	num	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	80	_	CD	CD	_	26	conj	_	_
29	%	_	NN	NN	_	37	nsubjpass	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	35	det	_	_
32	insulin	_	NN	NN	_	34	nn	_	_
33	gene	_	NN	NN	_	34	nn	_	_
34	promoter	_	NN	NN	_	35	nn	_	_
35	activity	_	NN	NN	_	30	pobj	_	_
36	was	_	VBD	VBD	_	37	auxpass	_	_
37	lost	_	VBN	VBN	_	7	parataxis	_	_
38	when	_	WRB	WRB	_	42	advmod	_	_
39	the	_	DT	DT	_	40	det	_	_
40	cells	_	NNS	NNS	_	42	nsubjpass	_	_
41	were	_	VBD	VBD	_	42	auxpass	_	_
42	kept	_	VBN	VBN	_	37	advcl	_	_
43	for	_	IN	IN	_	42	prep	_	_
44	3	_	CD	CD	_	45	num	_	_
45	d	_	NN	NN	_	43	pobj	_	_
46	in	_	IN	IN	_	42	prep	_	_
47	the	_	DT	DT	_	48	det	_	_
48	presence	_	NN	NN	_	46	pobj	_	_
49	of	_	IN	IN	_	48	prep	_	_
50	40	_	CD	CD	_	53	dep	_	_
51	and	_	CC	CC	_	50	cc	_	_
52	60	_	CD	CD	_	50	conj	_	_
53	mM	_	NN	NN	_	54	dep	_	_
54	D-ribose	_	NN	NN	_	49	pobj	_	_
55	,	_	,	,	_	42	punct	_	_
56	respectively	_	RB	RB	_	42	advmod	_	_
57	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	agreement	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	3	pobj	_	_
5	,	_	,	,	_	15	punct	_	_
6	decrease	_	NN	NN	_	15	nsubjpass	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	dep	_	_
9	insulin	_	NN	NN	_	10	nn	_	_
10	mRNA	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	insulin	_	NN	NN	_	13	nn	_	_
13	content	_	NN	NN	_	10	conj	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	observed	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	glycation-induced	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	15	punct	_	_

1	Also	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	gel	_	NN	NN	_	6	nn	_	_
4	mobility	_	NN	NN	_	6	nn	_	_
5	shift	_	NN	NN	_	6	nn	_	_
6	analyses	_	NNS	NNS	_	10	nsubj	_	_
7	using	_	VBG	VBG	_	6	vmod	_	_
8	specific	_	JJ	JJ	_	9	amod	_	_
9	antiserum	_	NN	NN	_	7	dobj	_	_
10	revealed	_	VBD	VBD	_	0	root	_	_
11	decrease	_	NN	NN	_	10	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	DNA-binding	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	an	_	DT	DT	_	21	det	_	_
18	insulin	_	NN	NN	_	21	nn	_	_
19	gene	_	NN	NN	_	21	nn	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	16	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	PDX-1/IPF1/STF-1	_	NN	NN	_	21	appos	_	_
24	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	effects	_	NNS	NNS	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	D-ribose	_	NN	NN	_	3	pobj	_	_
5	seemed	_	VBD	VBD	_	0	root	_	_
6	almost	_	RB	RB	_	7	advmod	_	_
7	irreversible	_	JJ	JJ	_	5	acomp	_	_
8	but	_	CC	CC	_	5	cc	_	_
9	could	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	auxpass	_	_
11	prevented	_	VBN	VBN	_	5	conj	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	addition	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	1	_	CD	CD	_	16	number	_	_
16	mM	_	NN	NN	_	17	amod	_	_
17	aminoguanidine	_	NN	NN	_	14	pobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	10	_	CD	CD	_	20	number	_	_
20	mM	_	NN	NN	_	21	amod	_	_
21	N-acetylcysteine	_	NN	NN	_	17	conj	_	_
22	,	_	,	,	_	5	punct	_	_
23	thus	_	RB	RB	_	24	advmod	_	_
24	suggesting	_	VBG	VBG	_	5	vmod	_	_
25	that	_	IN	IN	_	38	mark	_	_
26	glycation	_	NN	NN	_	38	nsubj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	reactive	_	JJ	JJ	_	30	amod	_	_
29	oxygen	_	NN	NN	_	30	nn	_	_
30	species	_	NNS	NNS	_	26	conj	_	_
31	,	_	,	,	_	30	punct	_	_
32	generated	_	VBN	VBN	_	30	vmod	_	_
33	through	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	glycation	_	NN	NN	_	36	nn	_	_
36	reaction	_	NN	NN	_	33	pobj	_	_
37	,	_	,	,	_	26	punct	_	_
38	serve	_	VBP	VBP	_	24	ccomp	_	_
39	as	_	IN	IN	_	38	prep	_	_
40	mediators	_	NNS	NNS	_	39	pobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	43	det	_	_
43	phenomena	_	NNS	NNS	_	41	pobj	_	_
44	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	protein	_	NN	NN	_	6	nn	_	_
6	glycation	_	NN	NN	_	20	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	pancreatic	_	JJ	JJ	_	10	amod	_	_
9	beta	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	,	_	,	,	_	6	punct	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	occurs	_	VBZ	VBZ	_	6	rcmod	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vivo	_	FW	FW	_	13	advmod	_	_
16	under	_	IN	IN	_	13	prep	_	_
17	chronic	_	JJ	JJ	_	18	amod	_	_
18	hyperglycemia	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	6	punct	_	_
20	suppresses	_	VBZ	VBZ	_	3	ccomp	_	_
21	insulin	_	NN	NN	_	23	nn	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	transcription	_	NN	NN	_	20	dobj	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	thus	_	RB	RB	_	27	advmod	_	_
26	can	_	MD	MD	_	27	aux	_	_
27	explain	_	VB	VB	_	20	conj	_	_
28	part	_	NN	NN	_	27	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	34	det	_	_
31	beta	_	NN	NN	_	34	nn	_	_
32	cell	_	NN	NN	_	34	nn	_	_
33	glucose	_	NN	NN	_	34	nn	_	_
34	toxicity	_	NN	NN	_	29	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	novel	_	JJ	JJ	_	4	amod	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	5	nsubj	_	_
5	regulates	_	VBZ	VBZ	_	0	root	_	_
6	expression	_	NN	NN	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	vacuolar	_	JJ	JJ	_	12	amod	_	_
10	H+-ATPase	_	NN	NN	_	12	nn	_	_
11	B2	_	NN	NN	_	12	nn	_	_
12	subunit	_	NN	NN	_	7	pobj	_	_
13	through	_	IN	IN	_	5	prep	_	_
14	AP-2	_	NN	NN	_	15	nn	_	_
15	sites	_	NNS	NNS	_	13	pobj	_	_
16	during	_	IN	IN	_	5	prep	_	_
17	monocytic	_	JJ	JJ	_	18	amod	_	_
18	differentiation	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	5	punct	_	_

1	During	_	IN	IN	_	14	prep	_	_
2	monocyte-to-macrophage	_	JJ	JJ	_	3	amod	_	_
3	differentiation	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	14	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	cellular	_	JJ	JJ	_	7	amod	_	_
7	content	_	NN	NN	_	14	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	vacuolar	_	JJ	JJ	_	10	amod	_	_
10	H+-ATPase	_	NN	NN	_	8	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	V-ATPase	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	increases	_	VBZ	VBZ	_	0	root	_	_
15	more	_	RBR	RBR	_	17	advmod	_	_
16	than	_	IN	IN	_	17	amod	_	_
17	4-fold	_	RB	RB	_	14	dobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	previously	_	RB	RB	_	3	advmod	_	_
5	that	_	IN	IN	_	15	mark	_	_
6	amplified	_	VBN	VBN	_	7	amod	_	_
7	expression	_	NN	NN	_	15	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	B2	_	NN	NN	_	11	nn	_	_
11	subunit	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	V-ATPase	_	NN	NN	_	12	pobj	_	_
15	occurs	_	VBZ	VBZ	_	3	ccomp	_	_
16	solely	_	RB	RB	_	17	advmod	_	_
17	by	_	IN	IN	_	15	prep	_	_
18	increased	_	VBN	VBN	_	19	amod	_	_
19	transcription	_	NN	NN	_	17	pobj	_	_
20	,	_	,	,	_	15	punct	_	_
21	and	_	CC	CC	_	15	cc	_	_
22	that	_	IN	IN	_	45	mark	_	_
23	the	_	DT	DT	_	25	det	_	_
24	5'-untranslated	_	JJ	JJ	_	25	amod	_	_
25	region	_	NN	NN	_	45	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	B2	_	NN	NN	_	29	nn	_	_
29	gene	_	NN	NN	_	26	pobj	_	_
30	,	_	,	,	_	25	punct	_	_
31	containing	_	VBG	VBG	_	25	vmod	_	_
32	multiple	_	JJ	JJ	_	35	amod	_	_
33	consensus	_	NN	NN	_	35	nn	_	_
34	binding	_	NN	NN	_	35	nn	_	_
35	sites	_	NNS	NNS	_	31	dobj	_	_
36	for	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	transcription	_	NN	NN	_	39	nn	_	_
39	factors	_	NNS	NNS	_	36	pobj	_	_
40	AP-2	_	NN	NN	_	39	dep	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	Sp1	_	NN	NN	_	40	conj	_	_
43	,	_	,	,	_	25	punct	_	_
44	is	_	VBZ	VBZ	_	45	auxpass	_	_
45	required	_	VBN	VBN	_	15	conj	_	_
46	for	_	IN	IN	_	45	prep	_	_
47	this	_	DT	DT	_	48	det	_	_
48	expression	_	NN	NN	_	46	pobj	_	_
49	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	demonstrates	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	AP-2	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	sequences	_	NNS	NNS	_	10	nsubj	_	_
9	are	_	VBP	VBP	_	10	cop	_	_
10	essential	_	JJ	JJ	_	4	ccomp	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	increased	_	VBN	VBN	_	13	amod	_	_
13	transcription	_	NN	NN	_	11	pobj	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	B2	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	14	pobj	_	_
18	during	_	IN	IN	_	13	prep	_	_
19	monocyte-macrophage	_	JJ	JJ	_	20	amod	_	_
20	differentiation	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	10	cc	_	_
22	that	_	IN	IN	_	33	mark	_	_
23	AP-2	_	NN	NN	_	33	nsubj	_	_
24	,	_	,	,	_	23	punct	_	_
25	expressed	_	VBN	VBN	_	23	vmod	_	_
26	exogenously	_	RB	RB	_	25	advmod	_	_
27	in	_	IN	IN	_	25	prep	_	_
28	THP-1	_	NN	NN	_	27	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	other	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	28	conj	_	_
32	,	_	,	,	_	23	punct	_	_
33	activates	_	VBZ	VBZ	_	10	conj	_	_
34	transcription	_	NN	NN	_	33	dobj	_	_
35	from	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	B2	_	NN	NN	_	38	nn	_	_
38	promoter	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	mobility	_	NN	NN	_	4	nn	_	_
3	shift	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	15	punct	_	_
6	a	_	DT	DT	_	8	det	_	_
7	nuclear	_	JJ	JJ	_	8	amod	_	_
8	factor	_	NN	NN	_	15	nsubjpass	_	_
9	from	_	IN	IN	_	8	prep	_	_
10	THP-1	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	U-937	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	conj	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	identified	_	VBN	VBN	_	0	root	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	binds	_	VBZ	VBZ	_	15	dep	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	several	_	JJ	JJ	_	22	amod	_	_
20	AP-2	_	NN	NN	_	22	nn	_	_
21	response	_	NN	NN	_	22	nn	_	_
22	elements	_	NNS	NNS	_	18	pobj	_	_
23	within	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	B2	_	NN	NN	_	26	nn	_	_
26	promoter	_	NN	NN	_	23	pobj	_	_
27	,	_	,	,	_	17	punct	_	_
28	but	_	CC	CC	_	17	cc	_	_
29	does	_	VBZ	VBZ	_	31	aux	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	react	_	VB	VB	_	17	conj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	AP-2	_	NN	NN	_	34	nn	_	_
34	antibodies	_	NNS	NNS	_	32	pobj	_	_
35	,	_	,	,	_	17	punct	_	_
36	and	_	CC	CC	_	17	cc	_	_
37	has	_	VBZ	VBZ	_	17	conj	_	_
38	a	_	DT	DT	_	43	det	_	_
39	DNA	_	NN	NN	_	40	nn	_	_
40	sequence	_	NN	NN	_	43	nn	_	_
41	binding	_	NN	NN	_	43	nn	_	_
42	affinity	_	NN	NN	_	43	nn	_	_
43	profile	_	NN	NN	_	37	dobj	_	_
44	that	_	WDT	WDT	_	45	nsubj	_	_
45	differs	_	VBZ	VBZ	_	43	rcmod	_	_
46	from	_	IN	IN	_	45	prep	_	_
47	AP-2	_	NN	NN	_	46	pobj	_	_
48	.	_	.	.	_	15	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	a	_	DT	DT	_	9	det	_	_
6	novel	_	JJ	JJ	_	9	amod	_	_
7	AP-2-like	_	JJ	JJ	_	9	amod	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	11	nsubj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	responsible	_	JJ	JJ	_	3	ccomp	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	V-ATPase	_	NN	NN	_	15	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	subunit	_	NN	NN	_	16	nn	_	_
16	amplification	_	NN	NN	_	12	pobj	_	_
17	during	_	IN	IN	_	11	prep	_	_
18	monocyte	_	NN	NN	_	19	nn	_	_
19	differentiation	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	Identification	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Bcd	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	a	_	DT	DT	_	7	det	_	_
6	novel	_	JJ	JJ	_	7	amod	_	_
7	proto-oncogene	_	NN	NN	_	3	appos	_	_
8	expressed	_	VBN	VBN	_	7	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	B-cells	_	NNS	NNS	_	9	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	A	_	DT	DT	_	8	det	_	_
2	novel	_	JJ	JJ	_	8	amod	_	_
3	B-cell	_	NN	NN	_	4	npadvmod	_	_
4	derived	_	JJ	JJ	_	8	amod	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	Bcd	_	NN	NN	_	4	dep	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	oncogene	_	NN	NN	_	11	nsubjpass	_	_
9	has	_	VBZ	VBZ	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	isolated	_	VBN	VBN	_	0	root	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	peripheral	_	JJ	JJ	_	16	amod	_	_
15	blood	_	NN	NN	_	16	nn	_	_
16	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	one	_	CD	CD	_	26	num	_	_
19	B-cell	_	NN	NN	_	22	nn	_	_
20	chronic	_	JJ	JJ	_	22	amod	_	_
21	lymphocytic	_	JJ	JJ	_	22	amod	_	_
22	leukemia	_	NN	NN	_	26	nn	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	B-CLL	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	patient	_	NN	NN	_	17	pobj	_	_
27	using	_	VBG	VBG	_	11	xcomp	_	_
28	DNA	_	NN	NN	_	29	nn	_	_
29	transfer	_	NN	NN	_	27	dobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	a	_	DT	DT	_	34	det	_	_
32	mouse	_	NN	NN	_	34	nn	_	_
33	tumorigenicity	_	NN	NN	_	34	nn	_	_
34	assay	_	NN	NN	_	29	conj	_	_
35	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Bcd	_	NN	NN	_	3	nn	_	_
3	proto-oncogene	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	activated	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	truncation	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	5'	_	JJ	JJ	_	12	amod	_	_
12	UTR	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	predicts	_	VBZ	VBZ	_	0	root	_	_
3	for	_	IN	IN	_	2	prep	_	_
4	two	_	CD	CD	_	7	num	_	_
5	open	_	JJ	JJ	_	7	amod	_	_
6	reading	_	NN	NN	_	7	nn	_	_
7	frames	_	NNS	NNS	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	ORFs	_	NNS	NNS	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	.	_	.	.	_	2	punct	_	_

1	ORF1	_	NN	NN	_	2	nsubj	_	_
2	consists	_	VBZ	VBZ	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	240	_	CD	CD	_	5	num	_	_
5	bp	_	NN	NN	_	3	pobj	_	_
6	that	_	WDT	WDT	_	8	nsubj	_	_
7	would	_	MD	MD	_	8	aux	_	_
8	encode	_	VB	VB	_	5	rcmod	_	_
9	80	_	CD	CD	_	11	num	_	_
10	amino	_	NN	NN	_	11	nn	_	_
11	acids	_	NNS	NNS	_	8	dobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	while	_	IN	IN	_	17	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	major	_	JJ	JJ	_	16	amod	_	_
16	ORF2	_	NN	NN	_	17	nsubj	_	_
17	consists	_	VBZ	VBZ	_	2	advcl	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	648	_	CD	CD	_	20	num	_	_
20	bp	_	NN	NN	_	18	pobj	_	_
21	capable	_	JJ	JJ	_	20	amod	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	coding	_	VBG	VBG	_	22	pcomp	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	216	_	CD	CD	_	27	num	_	_
26	amino	_	NN	NN	_	27	nn	_	_
27	acids	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	2	punct	_	_

1	Predicted	_	VBN	VBN	_	3	amod	_	_
2	peptide	_	NN	NN	_	3	nn	_	_
3	sequence	_	NN	NN	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	ORF2	_	NN	NN	_	4	pobj	_	_
6	contained	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	10	det	_	_
8	zinc	_	NN	NN	_	10	nn	_	_
9	finger	_	NN	NN	_	10	nn	_	_
10	domain	_	NN	NN	_	6	dobj	_	_
11	which	_	WDT	WDT	_	12	nsubj	_	_
12	showed	_	VBD	VBD	_	10	rcmod	_	_
13	significant	_	JJ	JJ	_	14	amod	_	_
14	homology	_	NN	NN	_	12	dobj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	GC	_	NN	NN	_	19	nn	_	_
17	box	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	proteins	_	NNS	NNS	_	15	pobj	_	_
20	BTEB2	_	NN	NN	_	19	dep	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	SP1	_	NN	NN	_	20	conj	_	_
23	.	_	.	.	_	6	punct	_	_

1	Transfection	_	NN	NN	_	14	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	an	_	DT	DT	_	5	det	_	_
4	expression	_	NN	NN	_	5	nn	_	_
5	vector	_	NN	NN	_	2	pobj	_	_
6	containing	_	VBG	VBG	_	5	vmod	_	_
7	ORF2	_	NN	NN	_	6	dobj	_	_
8	but	_	CC	CC	_	9	cc	_	_
9	not	_	RB	RB	_	7	cc	_	_
10	full	_	JJ	JJ	_	12	amod	_	_
11	length	_	NN	NN	_	12	nn	_	_
12	cDNA	_	NN	NN	_	7	conj	_	_
13	was	_	VBD	VBD	_	14	cop	_	_
14	able	_	JJ	JJ	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	transform	_	VB	VB	_	14	xcomp	_	_
17	NIH3T3	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	dobj	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	induce	_	VB	VB	_	16	conj	_	_
21	tumors	_	NNS	NNS	_	20	dobj	_	_
22	in	_	IN	IN	_	20	prep	_	_
23	nude	_	JJ	JJ	_	24	amod	_	_
24	mice	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	14	punct	_	_

1	Bcd	_	NN	NN	_	3	nn	_	_
2	mRNA	_	NN	NN	_	3	nn	_	_
3	transcripts	_	NNS	NNS	_	12	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	&lt;	_	JJR	JJR	_	9	amod	_	_
6	or	_	CC	CC	_	5	cc	_	_
7	=	_	JJ	JJ	_	5	conj	_	_
8	2.6	_	CD	CD	_	9	num	_	_
9	kb	_	NN	NN	_	4	pobj	_	_
10	were	_	VBD	VBD	_	12	auxpass	_	_
11	selectively	_	RB	RB	_	12	advmod	_	_
12	expressed	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	PBL	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	testis	_	NN	NN	_	14	conj	_	_
17	of	_	IN	IN	_	14	prep	_	_
18	healthy	_	JJ	JJ	_	19	amod	_	_
19	individuals	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	12	punct	_	_

1	Within	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	PBL	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	Bcd	_	NN	NN	_	7	nn	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	9	nsubj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	restricted	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	CD19+	_	JJ	JJ	_	12	amod	_	_
12	B-cells	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	absent	_	JJ	JJ	_	9	conj	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	CD14+	_	JJ	JJ	_	17	amod	_	_
17	monocytes	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	T-cells	_	NNS	NNS	_	17	conj	_	_
20	.	_	.	.	_	9	punct	_	_

1	Bcd	_	NN	NN	_	2	nn	_	_
2	transcripts	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	detected	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	all	_	DT	DT	_	9	det	_	_
7	normal	_	JJ	JJ	_	9	amod	_	_
8	PBL	_	NN	NN	_	9	nn	_	_
9	samples	_	NNS	NNS	_	5	pobj	_	_
10	tested	_	VBN	VBN	_	9	vmod	_	_
11	but	_	CC	CC	_	5	cc	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	in	_	IN	IN	_	5	conj	_	_
14	several	_	JJ	JJ	_	18	amod	_	_
15	malignant	_	JJ	JJ	_	18	amod	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	B-cell	_	NN	NN	_	18	nn	_	_
18	lines	_	NNS	NNS	_	13	pobj	_	_
19	and	_	CC	CC	_	5	cc	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	in	_	IN	IN	_	5	conj	_	_
22	50	_	CD	CD	_	23	num	_	_
23	%	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	B-cells	_	NNS	NNS	_	24	pobj	_	_
26	from	_	IN	IN	_	25	prep	_	_
27	B-CLL	_	NN	NN	_	28	nn	_	_
28	patients	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	stimulation	_	NN	NN	_	18	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	B-cells	_	NNS	NNS	_	4	pobj	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	B-CLL	_	NN	NN	_	8	nn	_	_
8	patients	_	NNS	NNS	_	6	pobj	_	_
9	under	_	IN	IN	_	3	prep	_	_
10	conditions	_	NNS	NNS	_	9	pobj	_	_
11	which	_	WDT	WDT	_	12	nsubj	_	_
12	induced	_	VBD	VBD	_	10	rcmod	_	_
13	differentiation	_	NN	NN	_	12	dobj	_	_
14	into	_	IN	IN	_	13	prep	_	_
15	plasma	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	was	_	VBD	VBD	_	18	auxpass	_	_
18	associated	_	VBN	VBN	_	0	root	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	induction	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	Bcd	_	NN	NN	_	24	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	18	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Bcd	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	6	nsubj	_	_
4	may	_	MD	MD	_	6	aux	_	_
5	therefore	_	RB	RB	_	6	advmod	_	_
6	play	_	VB	VB	_	0	root	_	_
7	an	_	DT	DT	_	9	det	_	_
8	important	_	JJ	JJ	_	9	amod	_	_
9	role	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	B-cell	_	NN	NN	_	10	pobj	_	_
12	growth	_	NN	NN	_	11	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	development	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	6	punct	_	_

1	GATA-1	_	NN	NN	_	4	nn	_	_
2	DNA	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	down-regulated	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	late	_	JJ	JJ	_	10	amod	_	_
9	S	_	NN	NN	_	10	nn	_	_
10	phase	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	erythroid	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	set	_	VBN	VBN	_	0	root	_	_
4	out	_	RP	RP	_	3	prt	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	test	_	VB	VB	_	3	xcomp	_	_
7	a	_	DT	DT	_	8	det	_	_
8	model	_	NN	NN	_	6	dobj	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	tissue-specific	_	JJ	JJ	_	12	amod	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	9	pobj	_	_
13	that	_	WDT	WDT	_	14	nsubj	_	_
14	relies	_	VBZ	VBZ	_	8	rcmod	_	_
15	on	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	early	_	JJ	JJ	_	18	amod	_	_
18	replication	_	NN	NN	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	expressed	_	VBN	VBN	_	21	amod	_	_
21	genes	_	NNS	NNS	_	19	pobj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	sequester	_	VB	VB	_	14	xcomp	_	_
24	limiting	_	VBG	VBG	_	27	amod	_	_
25	activating	_	VBG	VBG	_	27	amod	_	_
26	transcription	_	NN	NN	_	27	nn	_	_
27	factors	_	NNS	NNS	_	23	dobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	an	_	DT	DT	_	5	det	_	_
3	erythroid	_	JJ	JJ	_	5	amod	_	_
4	cell	_	NN	NN	_	5	nn	_	_
5	line	_	NN	NN	_	1	dobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	we	_	PRP	PRP	_	9	nsubj	_	_
8	have	_	VBP	VBP	_	9	aux	_	_
9	tested	_	VBN	VBN	_	1	parataxis	_	_
10	the	_	DT	DT	_	11	det	_	_
11	changes	_	NNS	NNS	_	9	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	DNA	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	activity	_	NN	NN	_	12	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	lineage-restricted	_	JJ	JJ	_	21	amod	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	17	pobj	_	_
22	GATA-1	_	NN	NN	_	21	dep	_	_
23	through	_	IN	IN	_	11	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	cycle	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	find	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	GATA-1	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	7	nsubj	_	_
6	is	_	VBZ	VBZ	_	7	cop	_	_
7	low	_	JJ	JJ	_	2	ccomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	G1	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	7	punct	_	_
11	peaks	_	VBZ	VBZ	_	7	conj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	mid-S	_	NN	NN	_	14	nn	_	_
14	phase	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	7	punct	_	_
16	and	_	CC	CC	_	7	cc	_	_
17	then	_	RB	RB	_	18	advmod	_	_
18	decreases	_	VBZ	VBZ	_	7	conj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	G2/M	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	17	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	activities	_	NNS	NNS	_	17	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	two	_	CD	CD	_	11	num	_	_
9	ubiquitous	_	JJ	JJ	_	11	amod	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	7	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	Oct1	_	NN	NN	_	11	appos	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Sp1	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	6	punct	_	_
17	remain	_	VBP	VBP	_	0	root	_	_
18	high	_	JJ	JJ	_	17	acomp	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	G2/M	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	17	punct	_	_

1	GATA-1	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	5	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	mRNA	_	NN	NN	_	2	conj	_	_
5	vary	_	VBP	VBP	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	similar	_	JJ	JJ	_	9	amod	_	_
9	manner	_	NN	NN	_	6	pobj	_	_
10	through	_	IN	IN	_	5	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	cycle	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	suggesting	_	VBG	VBG	_	5	xcomp	_	_
16	that	_	IN	IN	_	29	mark	_	_
17	the	_	DT	DT	_	18	det	_	_
18	expression	_	NN	NN	_	29	nsubjpass	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	gene	_	NN	NN	_	19	pobj	_	_
22	or	_	CC	CC	_	18	cc	_	_
23	the	_	DT	DT	_	24	det	_	_
24	stability	_	NN	NN	_	18	conj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	its	_	PRP$	PRP$	_	27	poss	_	_
27	message	_	NN	NN	_	25	pobj	_	_
28	is	_	VBZ	VBZ	_	29	auxpass	_	_
29	regulated	_	VBN	VBN	_	15	ccomp	_	_
30	.	_	.	.	_	5	punct	_	_

1	Although	_	IN	IN	_	20	mark	_	_
2	a	_	DT	DT	_	3	det	_	_
3	number	_	NN	NN	_	20	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factors	_	NNS	NNS	_	4	pobj	_	_
7	involved	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	control	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	cycle	_	NN	NN	_	11	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	DNA	_	NN	NN	_	17	nn	_	_
17	replication	_	NN	NN	_	14	conj	_	_
18	have	_	VBP	VBP	_	20	aux	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	shown	_	VBN	VBN	_	31	advcl	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	peak	_	VB	VB	_	20	xcomp	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	S	_	NN	NN	_	25	nn	_	_
25	phase	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	31	punct	_	_
27	this	_	DT	DT	_	31	nsubj	_	_
28	is	_	VBZ	VBZ	_	31	cop	_	_
29	the	_	DT	DT	_	31	det	_	_
30	first	_	JJ	JJ	_	31	amod	_	_
31	example	_	NN	NN	_	0	root	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	a	_	DT	DT	_	36	det	_	_
34	lineage-restricted	_	JJ	JJ	_	36	amod	_	_
35	transcription	_	NN	NN	_	36	nn	_	_
36	factor	_	NN	NN	_	32	pobj	_	_
37	displaying	_	VBG	VBG	_	36	vmod	_	_
38	S	_	NN	NN	_	42	nn	_	_
39	phase-specific	_	JJ	JJ	_	42	amod	_	_
40	DNA	_	NN	NN	_	42	nn	_	_
41	binding	_	NN	NN	_	42	nn	_	_
42	activity	_	NN	NN	_	37	dobj	_	_
43	.	_	.	.	_	31	punct	_	_

1	One	_	CD	CD	_	2	num	_	_
2	interpretation	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	3	pobj	_	_
6	leads	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	a	_	DT	DT	_	9	det	_	_
9	model	_	NN	NN	_	7	pobj	_	_
10	in	_	IN	IN	_	18	prep	_	_
11	which	_	WDT	WDT	_	10	pobj	_	_
12	the	_	DT	DT	_	13	det	_	_
13	peak	_	NN	NN	_	18	nsubj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	GATA-1	_	NN	NN	_	17	nn	_	_
16	DNA	_	NN	NN	_	17	nn	_	_
17	binding	_	NN	NN	_	14	pobj	_	_
18	amplifies	_	VBZ	VBZ	_	9	rcmod	_	_
19	the	_	DT	DT	_	20	det	_	_
20	effect	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	early	_	JJ	JJ	_	23	amod	_	_
23	replication	_	NN	NN	_	21	pobj	_	_
24	on	_	IN	IN	_	20	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	activation	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	erythroid-specific	_	JJ	JJ	_	29	amod	_	_
29	genes	_	NNS	NNS	_	27	pobj	_	_
30	at	_	IN	IN	_	20	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	same	_	JJ	JJ	_	33	amod	_	_
33	time	_	NN	NN	_	30	pobj	_	_
34	as	_	IN	IN	_	33	prep	_	_
35	preventing	_	VBG	VBG	_	36	amod	_	_
36	activation	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	non-erythroid	_	JJ	JJ	_	39	amod	_	_
39	genes	_	NNS	NNS	_	37	pobj	_	_
40	containing	_	VBG	VBG	_	39	vmod	_	_
41	GATA-responsive	_	JJ	JJ	_	42	amod	_	_
42	elements	_	NNS	NNS	_	40	dobj	_	_
43	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	5	nsubj	_	_
3	may	_	MD	MD	_	5	aux	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	relate	_	VB	VB	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	recent	_	JJ	JJ	_	8	amod	_	_
8	data	_	NNS	NNS	_	6	pobj	_	_
9	implicating	_	VBG	VBG	_	8	vmod	_	_
10	GATA-1	_	NN	NN	_	11	nn	_	_
11	function	_	NN	NN	_	9	dobj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	apoptosis	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	cell	_	NN	NN	_	17	nn	_	_
16	cycle	_	NN	NN	_	17	nn	_	_
17	progression	_	NN	NN	_	13	conj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Constitutive	_	JJ	JJ	_	2	amod	_	_
2	dephosphorylation	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	activation	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	member	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	15	det	_	_
10	nuclear	_	JJ	JJ	_	15	amod	_	_
11	factor	_	NN	NN	_	15	nn	_	_
12	of	_	IN	IN	_	15	amod	_	_
13	activated	_	VBN	VBN	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	8	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	NF-AT1	_	NN	NN	_	15	appos	_	_
18	,	_	,	,	_	2	punct	_	_
19	in	_	IN	IN	_	2	prep	_	_
20	Tax-expressing	_	JJ	JJ	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	type	_	NN	NN	_	26	nn	_	_
23	I	_	CD	CD	_	26	num	_	_
24	human	_	JJ	JJ	_	26	amod	_	_
25	T-cell	_	NN	NN	_	26	nn	_	_
26	leukemia	_	NN	NN	_	20	conj	_	_
27	virus-infected	_	JJ	JJ	_	26	amod	_	_
28	human	_	JJ	JJ	_	30	amod	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	20	dep	_	_
31	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	tax	_	NN	NN	_	4	nn	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	product	_	NN	NN	_	16	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	12	det	_	_
7	type	_	NN	NN	_	12	nn	_	_
8	I	_	CD	CD	_	12	num	_	_
9	human	_	JJ	JJ	_	12	amod	_	_
10	T-cell	_	NN	NN	_	12	nn	_	_
11	leukemia	_	NN	NN	_	12	nn	_	_
12	virus	_	NN	NN	_	5	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	HTLV-I	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	transactivates	_	VBZ	VBZ	_	0	root	_	_
17	interleukin-2	_	NN	NN	_	21	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	IL-2	_	NN	NN	_	21	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
21	gene	_	NN	NN	_	16	dobj	_	_
22	through	_	IN	IN	_	16	prep	_	_
23	activation	_	NN	NN	_	22	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	an	_	DT	DT	_	26	det	_	_
26	enhancer	_	NN	NN	_	24	pobj	_	_
27	termed	_	VBN	VBN	_	26	vmod	_	_
28	CD28	_	NN	NN	_	30	nn	_	_
29	responsive	_	JJ	JJ	_	30	amod	_	_
30	element	_	NN	NN	_	27	dep	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	CD28RE	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	.	_	.	.	_	16	punct	_	_

1	Tax	_	NN	NN	_	2	nn	_	_
2	activation	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	CD28RE	_	NN	NN	_	3	pobj	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	partially	_	RB	RB	_	8	advmod	_	_
8	mediated	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	11	det	_	_
11	member	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	19	det	_	_
14	nuclear	_	JJ	JJ	_	19	amod	_	_
15	factor	_	NN	NN	_	19	nn	_	_
16	of	_	IN	IN	_	19	amod	_	_
17	activated	_	VBN	VBN	_	19	amod	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	12	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	NF-AT1	_	NN	NN	_	19	appos	_	_
22	.	_	.	.	_	8	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	NF-AT1	_	NN	NN	_	9	nsubj	_	_
7	is	_	VBZ	VBZ	_	9	cop	_	_
8	constitutively	_	RB	RB	_	9	advmod	_	_
9	active	_	JJ	JJ	_	4	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	Jurkat	_	NN	NN	_	13	nn	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	10	pobj	_	_
14	stably	_	RB	RB	_	15	advmod	_	_
15	transfected	_	VBN	VBN	_	13	vmod	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	Tax	_	NN	NN	_	19	nn	_	_
19	cDNA	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	9	punct	_	_
21	although	_	IN	IN	_	32	mark	_	_
22	the	_	DT	DT	_	25	det	_	_
23	underlying	_	VBG	VBG	_	25	amod	_	_
24	molecular	_	JJ	JJ	_	25	amod	_	_
25	mechanism	_	NN	NN	_	32	nsubj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	physiological	_	JJ	JJ	_	28	amod	_	_
28	relevance	_	NN	NN	_	25	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	this	_	DT	DT	_	31	det	_	_
31	finding	_	NN	NN	_	29	pobj	_	_
32	remain	_	VBP	VBP	_	9	advcl	_	_
33	unclear	_	JJ	JJ	_	32	acomp	_	_
34	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	15	mark	_	_
8	the	_	DT	DT	_	10	det	_	_
9	active	_	JJ	JJ	_	10	amod	_	_
10	form	_	NN	NN	_	15	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	NF-AT1	_	NN	NN	_	11	pobj	_	_
13	is	_	VBZ	VBZ	_	15	cop	_	_
14	also	_	RB	RB	_	15	advmod	_	_
15	present	_	JJ	JJ	_	6	ccomp	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	nuclei	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	HTLV-I-transformed	_	JJ	JJ	_	22	amod	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	that	_	WDT	WDT	_	24	nsubj	_	_
24	express	_	VBP	VBP	_	18	rcmod	_	_
25	the	_	DT	DT	_	27	det	_	_
26	Tax	_	NN	NN	_	27	nn	_	_
27	protein	_	NN	NN	_	24	dobj	_	_
28	.	_	.	.	_	6	punct	_	_

1	Interestingly	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	constitutive	_	JJ	JJ	_	5	amod	_	_
5	activation	_	NN	NN	_	13	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF-AT1	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	these	_	DT	DT	_	11	det	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	associated	_	VBN	VBN	_	0	root	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	its	_	PRP$	PRP$	_	16	poss	_	_
16	dephosphorylation	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	13	punct	_	_

1	Furthermore	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	dephosphorylated	_	VBN	VBN	_	5	amod	_	_
5	NF-AT1	_	NN	NN	_	9	nsubjpass	_	_
6	can	_	MD	MD	_	9	aux	_	_
7	be	_	VB	VB	_	9	auxpass	_	_
8	rapidly	_	RB	RB	_	9	advmod	_	_
9	rephosphorylated	_	VBN	VBN	_	0	root	_	_
10	when	_	WRB	WRB	_	14	advmod	_	_
11	the	_	DT	DT	_	12	det	_	_
12	cells	_	NNS	NNS	_	14	nsubjpass	_	_
13	are	_	VBP	VBP	_	14	auxpass	_	_
14	incubated	_	VBN	VBN	_	9	advcl	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	cyclosporin	_	NN	NN	_	17	nn	_	_
17	A	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	an	_	DT	DT	_	20	det	_	_
20	immunosuppressant	_	NN	NN	_	17	appos	_	_
21	inhibiting	_	VBG	VBG	_	20	vmod	_	_
22	the	_	DT	DT	_	24	det	_	_
23	serine/threonine	_	NN	NN	_	24	nn	_	_
24	phosphatase	_	NN	NN	_	21	dobj	_	_
25	calcineurin	_	NN	NN	_	24	dep	_	_
26	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	activation	_	NN	NN	_	14	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF-AT1	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	Tax-expressing	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	HTLV-I-transformed	_	JJ	JJ	_	9	conj	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	9	dep	_	_
14	results	_	VBZ	VBZ	_	3	ccomp	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	its	_	PRP$	PRP$	_	17	poss	_	_
17	dephosphorylation	_	NN	NN	_	15	pobj	_	_
18	,	_	,	,	_	14	punct	_	_
19	which	_	WDT	WDT	_	24	nsubj	_	_
20	in	_	IN	IN	_	24	prep	_	_
21	turn	_	NN	NN	_	20	pobj	_	_
22	may	_	MD	MD	_	24	aux	_	_
23	be	_	VB	VB	_	24	cop	_	_
24	due	_	JJ	JJ	_	14	ccomp	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	deregulation	_	NN	NN	_	25	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	calcineurin	_	NN	NN	_	27	pobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Elf-2	_	NN	NN	_	0	root	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	8	det	_	_
4	rhombotin-2	_	NN	NN	_	8	nn	_	_
5	binding	_	NN	NN	_	8	nn	_	_
6	ets	_	NN	NN	_	8	nn	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factor	_	NN	NN	_	1	appos	_	_
9	:	_	:	:	_	1	punct	_	_
10	discovery	_	NN	NN	_	1	dep	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	potential	_	JJ	JJ	_	13	amod	_	_
13	role	_	NN	NN	_	10	conj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	leukemia	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	1	punct	_	_

1	Rhombotin-2	_	NN	NN	_	7	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	RBTN-2	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	7	cop	_	_
6	a	_	DT	DT	_	7	det	_	_
7	proto-oncogene	_	NN	NN	_	0	root	_	_
8	only	_	RB	RB	_	9	advmod	_	_
9	in	_	IN	IN	_	7	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	context	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	lymphocytes	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	postulated	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	14	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	oncogenic	_	JJ	JJ	_	6	amod	_	_
6	effect	_	NN	NN	_	14	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	RBTN-2	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	14	auxpass	_	_
13	likely	_	RB	RB	_	14	advmod	_	_
14	mediated	_	VBN	VBN	_	2	ccomp	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	binding	_	VBG	VBG	_	17	amod	_	_
17	protein	_	NN	NN	_	19	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	s	_	NNS	NNS	_	15	pobj	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	with	_	IN	IN	_	19	prep	_	_
22	T	_	NN	NN	_	24	nn	_	_
23	cell-specific	_	JJ	JJ	_	24	amod	_	_
24	expression	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	By	_	IN	IN	_	10	prep	_	_
2	screening	_	VBG	VBG	_	1	pcomp	_	_
3	a	_	DT	DT	_	5	det	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cell	_	NN	NN	_	2	dobj	_	_
6	cDNA	_	NN	NN	_	7	nn	_	_
7	library	_	NN	NN	_	5	dep	_	_
8	,	_	,	,	_	10	punct	_	_
9	we	_	PRP	PRP	_	10	nsubj	_	_
10	identified	_	VBD	VBD	_	0	root	_	_
11	a	_	DT	DT	_	15	det	_	_
12	novel	_	JJ	JJ	_	15	amod	_	_
13	ets	_	NN	NN	_	15	nn	_	_
14	transcription	_	NN	NN	_	15	nn	_	_
15	factor	_	NN	NN	_	10	dobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	binds	_	VBZ	VBZ	_	15	rcmod	_	_
18	RBTN-2	_	NN	NN	_	17	dobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	protein	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	named	_	VBN	VBN	_	0	root	_	_
5	elf-2	_	NN	NN	_	4	xcomp	_	_
6	because	_	IN	IN	_	12	mark	_	_
7	its	_	PRP$	PRP$	_	9	poss	_	_
8	DNA-binding	_	JJ	JJ	_	9	amod	_	_
9	domain	_	NN	NN	_	12	nsubj	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	virtually	_	RB	RB	_	12	advmod	_	_
12	identical	_	JJ	JJ	_	4	advcl	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	that	_	DT	DT	_	13	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	ets	_	NN	NN	_	18	nn	_	_
17	family	_	NN	NN	_	18	nn	_	_
18	member	_	NN	NN	_	15	pobj	_	_
19	elf-1	_	NN	NN	_	18	dep	_	_
20	.	_	.	.	_	4	punct	_	_

1	Northern	_	NN	NN	_	2	nn	_	_
2	analyses	_	NNS	NNS	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	similar	_	JJ	JJ	_	5	amod	_	_
5	levels	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	two	_	CD	CD	_	9	num	_	_
8	elf-2	_	NN	NN	_	9	nn	_	_
9	transcripts	_	NNS	NNS	_	6	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	3.5	_	CD	CD	_	12	num	_	_
12	kb	_	NN	NN	_	9	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	3.8	_	CD	CD	_	15	num	_	_
15	kb	_	NN	NN	_	12	conj	_	_
16	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
17	in	_	IN	IN	_	3	prep	_	_
18	all	_	DT	DT	_	19	det	_	_
19	tissues	_	NNS	NNS	_	17	pobj	_	_
20	except	_	IN	IN	_	19	prep	_	_
21	thymus	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Thymocytes	_	NNS	NNS	_	2	nsubj	_	_
2	expressed	_	VBD	VBD	_	0	root	_	_
3	four-	_	CD	CD	_	6	npadvmod	_	_
4	to	_	TO	TO	_	3	dep	_	_
5	10-fold	_	RB	RB	_	3	advmod	_	_
6	greater	_	JJR	JJR	_	7	amod	_	_
7	amounts	_	NNS	NNS	_	2	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	3.5	_	CD	CD	_	12	num	_	_
11	kb	_	NN	NN	_	12	nn	_	_
12	transcript	_	NN	NN	_	8	pobj	_	_
13	than	_	IN	IN	_	15	mark	_	_
14	other	_	JJ	JJ	_	15	amod	_	_
15	tissues	_	NNS	NNS	_	7	dep	_	_
16	.	_	.	.	_	2	punct	_	_

1	Sequence	_	NN	NN	_	2	nn	_	_
2	analyses	_	NNS	NNS	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cDNA	_	NN	NN	_	5	nn	_	_
5	clones	_	NNS	NNS	_	3	pobj	_	_
6	indicated	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	10	mark	_	_
8	these	_	DT	DT	_	9	det	_	_
9	transcripts	_	NNS	NNS	_	10	nsubj	_	_
10	encode	_	VBP	VBP	_	6	ccomp	_	_
11	proteins	_	NNS	NNS	_	10	dobj	_	_
12	differing	_	VBG	VBG	_	11	vmod	_	_
13	only	_	RB	RB	_	14	advmod	_	_
14	at	_	IN	IN	_	12	prep	_	_
15	their	_	PRP$	PRP$	_	17	poss	_	_
16	amino	_	NN	NN	_	17	nn	_	_
17	termini	_	NNS	NNS	_	14	pobj	_	_
18	,	_	,	,	_	10	punct	_	_
19	and	_	CC	CC	_	10	cc	_	_
20	likely	_	RB	RB	_	21	advmod	_	_
21	represent	_	VBP	VBP	_	10	conj	_	_
22	alternatively	_	RB	RB	_	23	advmod	_	_
23	spliced	_	VBN	VBN	_	24	amod	_	_
24	isoforms	_	NNS	NNS	_	21	dobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	isoforms	_	NNS	NNS	_	8	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	elf-2a	_	NN	NN	_	2	dep	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	elf-2b	_	NN	NN	_	4	conj	_	_
7	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
8	contain	_	VBP	VBP	_	0	root	_	_
9	identical	_	JJ	JJ	_	12	amod	_	_
10	RBTN-2	_	NN	NN	_	12	nn	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	regions	_	NNS	NNS	_	8	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	DNA-binding	_	JJ	JJ	_	15	amod	_	_
15	domains	_	NNS	NNS	_	12	conj	_	_
16	.	_	.	.	_	8	punct	_	_

1	Elf-2b	_	NN	NN	_	2	nsubj	_	_
2	lacks	_	VBZ	VBZ	_	0	root	_	_
3	a	_	DT	DT	_	6	det	_	_
4	putative	_	JJ	JJ	_	6	amod	_	_
5	transactivation	_	NN	NN	_	6	nn	_	_
6	domain	_	NN	NN	_	2	dobj	_	_
7	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	expression	_	NN	NN	_	3	nn	_	_
3	patterns	_	NNS	NNS	_	4	nsubj	_	_
4	suggest	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	RBTN-2	_	NN	NN	_	8	nsubj	_	_
7	normally	_	RB	RB	_	8	advmod	_	_
8	interacts	_	VBZ	VBZ	_	4	ccomp	_	_
9	equally	_	RB	RB	_	8	advmod	_	_
10	with	_	IN	IN	_	8	prep	_	_
11	elf-2a	_	NN	NN	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	elf-2b	_	NN	NN	_	11	conj	_	_
14	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	15	punct	_	_
4	when	_	WRB	WRB	_	8	advmod	_	_
5	RBTN-2	_	NN	NN	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	inappropriately	_	RB	RB	_	8	advmod	_	_
8	expressed	_	VBN	VBN	_	15	advcl	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	15	punct	_	_
13	RBTN-2	_	NN	NN	_	15	nsubj	_	_
14	would	_	MD	MD	_	15	aux	_	_
15	interact	_	VB	VB	_	0	root	_	_
16	predominantly	_	RB	RB	_	17	advmod	_	_
17	with	_	IN	IN	_	15	prep	_	_
18	elf-2b	_	NN	NN	_	17	pobj	_	_
19	;	_	:	:	_	15	punct	_	_
20	this	_	DT	DT	_	21	det	_	_
21	interaction	_	NN	NN	_	23	nsubj	_	_
22	may	_	MD	MD	_	23	aux	_	_
23	lead	_	VB	VB	_	15	parataxis	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	T	_	NN	NN	_	27	nn	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	proliferation	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	15	punct	_	_

1	Isolation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	5	det	_	_
4	B-cell-specific	_	JJ	JJ	_	5	amod	_	_
5	promoter	_	NN	NN	_	2	pobj	_	_
6	for	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	human	_	JJ	JJ	_	11	amod	_	_
9	class	_	NN	NN	_	11	nn	_	_
10	II	_	CD	CD	_	11	num	_	_
11	transactivator	_	NN	NN	_	6	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	class	_	NN	NN	_	4	nn	_	_
3	II	_	CD	CD	_	4	num	_	_
4	transactivator	_	NN	NN	_	9	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	CIITA	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	essential	_	JJ	JJ	_	0	root	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	major	_	JJ	JJ	_	22	amod	_	_
15	histocompatibility	_	NN	NN	_	22	nn	_	_
16	complex	_	NN	NN	_	22	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
18	MHC	_	NN	NN	_	22	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
20	class	_	NN	NN	_	22	nn	_	_
21	II	_	CD	CD	_	22	num	_	_
22	antigens	_	NNS	NNS	_	13	pobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	tissular	_	JJ	JJ	_	3	amod	_	_
3	patterns	_	NNS	NNS	_	14	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	CIITA	_	NN	NN	_	4	pobj	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	MHC	_	NN	NN	_	11	nn	_	_
8	class	_	NN	NN	_	11	nn	_	_
9	II	_	CD	CD	_	11	num	_	_
10	gene	_	NN	NN	_	11	nn	_	_
11	expression	_	NN	NN	_	3	conj	_	_
12	are	_	VBP	VBP	_	14	auxpass	_	_
13	tightly	_	RB	RB	_	14	advmod	_	_
14	correlated	_	VBN	VBN	_	0	root	_	_
15	:	_	:	:	_	14	punct	_	_
16	CIITA	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	20	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	20	auxpass	_	_
19	highly	_	RB	RB	_	20	advmod	_	_
20	expressed	_	VBN	VBN	_	14	parataxis	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	B	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	,	_	,	,	_	20	punct	_	_
25	and	_	CC	CC	_	20	cc	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	induced	_	VBN	VBN	_	20	conj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	interferon	_	NN	NN	_	30	nn	_	_
30	gamma	_	NN	NN	_	28	pobj	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	IFN-gamma	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	in	_	IN	IN	_	30	prep	_	_
35	macrophage	_	NN	NN	_	34	pobj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	epithelial	_	JJ	JJ	_	35	conj	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	lines	_	NNS	NNS	_	35	dep	_	_
40	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	first	_	RB	RB	_	3	advmod	_	_
3	isolated	_	VBD	VBD	_	0	root	_	_
4	two	_	CD	CD	_	6	num	_	_
5	overlapping	_	VBG	VBG	_	6	amod	_	_
6	cosmids	_	NNS	NNS	_	3	dobj	_	_
7	encoding	_	VBG	VBG	_	6	vmod	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	CIITA	_	NN	NN	_	7	dobj	_	_
10	which	_	WDT	WDT	_	16	dep	_	_
11	,	_	,	,	_	16	punct	_	_
12	when	_	WRB	WRB	_	13	advmod	_	_
13	co-transfected	_	VBN	VBN	_	16	advcl	_	_
14	,	_	,	,	_	16	punct	_	_
15	are	_	VBP	VBP	_	16	cop	_	_
16	able	_	JJ	JJ	_	6	rcmod	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	restore	_	VB	VB	_	16	xcomp	_	_
19	MHC	_	NN	NN	_	20	nn	_	_
20	class	_	NN	NN	_	22	nn	_	_
21	II	_	CD	CD	_	20	num	_	_
22	expression	_	NN	NN	_	18	dobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	27	det	_	_
25	B-lymphoblastoid	_	JJ	JJ	_	27	amod	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	line	_	NN	NN	_	23	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	B-LCL	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	defective	_	JJ	JJ	_	27	amod	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	CIITA	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	3	punct	_	_

1	Subsequently	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	a	_	DT	DT	_	9	det	_	_
4	1.8	_	CD	CD	_	9	num	_	_
5	kilobase	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	kb	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	fragment	_	NN	NN	_	15	nsubjpass	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	CIITA	_	NN	NN	_	13	nn	_	_
13	promoter	_	NN	NN	_	10	pobj	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	isolated	_	VBN	VBN	_	0	root	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	sequenced	_	VBN	VBN	_	15	conj	_	_
18	.	_	.	.	_	15	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	motif	_	NN	NN	_	11	nsubjpass	_	_
3	presenting	_	VBG	VBG	_	2	vmod	_	_
4	a	_	DT	DT	_	6	det	_	_
5	strong	_	JJ	JJ	_	6	amod	_	_
6	similarity	_	NN	NN	_	3	dobj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	an	_	DT	DT	_	9	det	_	_
9	initiator	_	NN	NN	_	7	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	detected	_	VBN	VBN	_	0	root	_	_
12	,	_	,	,	_	11	punct	_	_
13	as	_	RB	RB	_	14	advmod	_	_
14	well	_	RB	RB	_	11	cc	_	_
15	as	_	IN	IN	_	14	mwe	_	_
16	putative	_	JJ	JJ	_	18	amod	_	_
17	binding	_	VBG	VBG	_	18	amod	_	_
18	sites	_	NNS	NNS	_	11	conj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	Sp1	_	NN	NN	_	19	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	GATA-2	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	20	punct	_	_
24	LyF-1	_	NN	NN	_	20	conj	_	_
25	,	_	,	,	_	20	punct	_	_
26	ets-1	_	NN	NN	_	20	conj	_	_
27	,	_	,	,	_	20	punct	_	_
28	AP1	_	NN	NN	_	20	conj	_	_
29	,	_	,	,	_	20	punct	_	_
30	and	_	CC	CC	_	20	cc	_	_
31	MZF1	_	NN	NN	_	20	conj	_	_
32	transcription	_	NN	NN	_	33	nn	_	_
33	factors	_	NNS	NNS	_	20	dep	_	_
34	,	_	,	,	_	20	punct	_	_
35	and	_	CC	CC	_	20	cc	_	_
36	two	_	CD	CD	_	38	num	_	_
37	GAS	_	NN	NN	_	38	nn	_	_
38	motifs	_	NNS	NNS	_	20	conj	_	_
39	.	_	.	.	_	11	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	introduced	_	VBN	VBN	_	14	advcl	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	front	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	9	det	_	_
7	luciferase	_	NN	NN	_	9	nn	_	_
8	reporter	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	5	pobj	_	_
10	,	_	,	,	_	14	punct	_	_
11	this	_	DT	DT	_	12	det	_	_
12	promoter	_	NN	NN	_	14	nsubj	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	able	_	JJ	JJ	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	direct	_	VB	VB	_	14	xcomp	_	_
17	a	_	DT	DT	_	20	det	_	_
18	high	_	JJ	JJ	_	20	amod	_	_
19	luciferase	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	16	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	24	det	_	_
23	human	_	JJ	JJ	_	24	amod	_	_
24	B-LCL	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	luciferase	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	8	nsubjpass	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	stimulated	_	VBN	VBN	_	0	root	_	_
9	after	_	IN	IN	_	8	prep	_	_
10	IFN-gamma	_	NN	NN	_	11	nn	_	_
11	treatment	_	NN	NN	_	9	pobj	_	_
12	when	_	WRB	WRB	_	16	advmod	_	_
13	the	_	DT	DT	_	14	det	_	_
14	construct	_	NN	NN	_	16	nsubjpass	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	transfected	_	VBN	VBN	_	8	advcl	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	macrophage	_	NN	NN	_	17	pobj	_	_
19	or	_	CC	CC	_	17	cc	_	_
20	in	_	IN	IN	_	17	conj	_	_
21	epithelial	_	JJ	JJ	_	23	amod	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	lines	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	8	punct	_	_

1	However	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	an	_	DT	DT	_	4	det	_	_
4	induction	_	NN	NN	_	11	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	CIITA	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	5	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	observed	_	VBN	VBN	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	mouse	_	NN	NN	_	14	nn	_	_
14	macrophage	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	fibrosarcoma	_	NN	NN	_	14	conj	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	lines	_	NNS	NNS	_	14	dep	_	_
19	,	_	,	,	_	11	punct	_	_
20	when	_	WRB	WRB	_	24	advmod	_	_
21	the	_	DT	DT	_	22	det	_	_
22	cells	_	NNS	NNS	_	24	nsubjpass	_	_
23	were	_	VBD	VBD	_	24	auxpass	_	_
24	transfected	_	VBN	VBN	_	11	advcl	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	27	det	_	_
27	cosmid	_	NN	NN	_	25	pobj	_	_
28	containing	_	VBG	VBG	_	27	dep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	human	_	JJ	JJ	_	32	amod	_	_
31	CIITA	_	NN	NN	_	32	nn	_	_
32	gene	_	NN	NN	_	28	dobj	_	_
33	,	_	,	,	_	28	punct	_	_
34	but	_	CC	CC	_	28	cc	_	_
35	lacking	_	VBG	VBG	_	28	conj	_	_
36	the	_	DT	DT	_	39	det	_	_
37	1.8	_	CD	CD	_	39	num	_	_
38	kb	_	NN	NN	_	39	nn	_	_
39	promoter	_	NN	NN	_	35	dobj	_	_
40	described	_	VBN	VBN	_	39	vmod	_	_
41	above	_	RB	RB	_	40	advmod	_	_
42	.	_	.	.	_	11	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggest	_	VBP	VBP	_	1	parataxis	_	_
7	the	_	DT	DT	_	8	det	_	_
8	existence	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	12	det	_	_
11	intragenic	_	JJ	JJ	_	12	amod	_	_
12	promoter	_	NN	NN	_	9	pobj	_	_
13	driving	_	VBG	VBG	_	12	vmod	_	_
14	an	_	DT	DT	_	16	det	_	_
15	IFN-gamma-inducible	_	JJ	JJ	_	16	amod	_	_
16	expression	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	CIITA	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	1	punct	_	_

1	Shared	_	JJ	JJ	_	3	amod	_	_
2	gamma-LRB-c-RRB-	_	NN	NN	_	3	nn	_	_
3	subunit	_	NN	NN	_	0	root	_	_
4	within	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	human	_	JJ	JJ	_	9	amod	_	_
7	interleukin-7	_	NN	NN	_	9	nn	_	_
8	receptor	_	NN	NN	_	9	nn	_	_
9	complex	_	NN	NN	_	4	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	molecular	_	JJ	JJ	_	3	amod	_	_
3	basis	_	NN	NN	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	pathogenesis	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	X-linked	_	JJ	JJ	_	11	amod	_	_
9	severe	_	JJ	JJ	_	11	amod	_	_
10	combined	_	JJ	JJ	_	11	amod	_	_
11	immunodeficiency	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	Genetic	_	JJ	JJ	_	2	amod	_	_
2	evidence	_	NN	NN	_	3	nsubj	_	_
3	suggests	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	mutations	_	NNS	NNS	_	11	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	gamma-LRB-c-RRB-	_	NN	NN	_	10	nn	_	_
9	receptor	_	NN	NN	_	10	nn	_	_
10	subunit	_	NN	NN	_	6	pobj	_	_
11	cause	_	VBP	VBP	_	3	ccomp	_	_
12	X-linked	_	JJ	JJ	_	15	amod	_	_
13	severe	_	JJ	JJ	_	15	amod	_	_
14	combined	_	JJ	JJ	_	15	amod	_	_
15	immunodeficiency	_	NN	NN	_	11	dobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	X-SCID	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	gamma-LRB-c-RRB-	_	NN	NN	_	3	nn	_	_
3	subunit	_	NN	NN	_	6	nsubjpass	_	_
4	can	_	MD	MD	_	6	aux	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	employed	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	receptor	_	NN	NN	_	9	nn	_	_
9	complexes	_	NNS	NNS	_	7	pobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	IL-2	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	-4	_	CD	CD	_	11	conj	_	_
14	,	_	,	,	_	11	punct	_	_
15	-7	_	CD	CD	_	11	conj	_	_
16	,	_	,	,	_	11	punct	_	_
17	-9	_	CD	CD	_	11	conj	_	_
18	,	_	,	,	_	11	punct	_	_
19	and	_	CC	CC	_	11	cc	_	_
20	-15	_	CD	CD	_	11	conj	_	_
21	,	_	,	,	_	6	punct	_	_
22	and	_	CC	CC	_	6	cc	_	_
23	the	_	DT	DT	_	26	det	_	_
24	multiple	_	JJ	JJ	_	26	amod	_	_
25	signaling	_	NN	NN	_	26	nn	_	_
26	defects	_	NNS	NNS	_	39	nsubjpass	_	_
27	that	_	WDT	WDT	_	29	nsubj	_	_
28	would	_	MD	MD	_	29	aux	_	_
29	result	_	VB	VB	_	26	rcmod	_	_
30	from	_	IN	IN	_	29	prep	_	_
31	a	_	DT	DT	_	34	det	_	_
32	defective	_	JJ	JJ	_	34	amod	_	_
33	gamma-LRB-c-RRB-	_	NN	NN	_	34	nn	_	_
34	chain	_	NN	NN	_	30	pobj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	these	_	DT	DT	_	37	det	_	_
37	receptors	_	NNS	NNS	_	35	pobj	_	_
38	are	_	VBP	VBP	_	39	auxpass	_	_
39	proposed	_	VBN	VBN	_	6	conj	_	_
40	to	_	TO	TO	_	41	aux	_	_
41	cause	_	VB	VB	_	39	xcomp	_	_
42	the	_	DT	DT	_	44	det	_	_
43	severe	_	JJ	JJ	_	44	amod	_	_
44	phenotype	_	NN	NN	_	41	dobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	X-SCID	_	NN	NN	_	47	nn	_	_
47	patients	_	NNS	NNS	_	45	pobj	_	_
48	.	_	.	.	_	6	punct	_	_

1	Interestingly	_	RB	RB	_	19	advmod	_	_
2	,	_	,	,	_	19	punct	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	disruption	_	NN	NN	_	19	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	either	_	CC	CC	_	7	preconj	_	_
7	IL-7	_	NN	NN	_	5	pobj	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	the	_	DT	DT	_	16	det	_	_
10	IL-7	_	NN	NN	_	16	nn	_	_
11	receptor	_	NN	NN	_	16	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
13	IL-7R	_	NN	NN	_	16	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
15	alpha	_	NN	NN	_	16	nn	_	_
16	subunit	_	NN	NN	_	7	conj	_	_
17	in	_	IN	IN	_	4	prep	_	_
18	mice	_	NNS	NNS	_	17	pobj	_	_
19	leads	_	VBZ	VBZ	_	0	root	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	immunological	_	JJ	JJ	_	22	amod	_	_
22	defects	_	NNS	NNS	_	20	pobj	_	_
23	that	_	WDT	WDT	_	25	nsubj	_	_
24	are	_	VBP	VBP	_	25	cop	_	_
25	similar	_	JJ	JJ	_	22	rcmod	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	human	_	JJ	JJ	_	28	amod	_	_
28	X-SCID	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	19	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	functional	_	JJ	JJ	_	6	amod	_	_
6	importance	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	gamma-LRB-c-RRB-	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	IL-7R	_	NN	NN	_	12	nn	_	_
12	complex	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	17	punct	_	_
6	structure/function	_	NN	NN	_	7	nn	_	_
7	analyses	_	NNS	NNS	_	17	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	IL-7R	_	NN	NN	_	11	nn	_	_
11	complex	_	NN	NN	_	8	pobj	_	_
12	using	_	VBG	VBG	_	7	vmod	_	_
13	a	_	DT	DT	_	16	det	_	_
14	chimeric	_	JJ	JJ	_	15	amod	_	_
15	receptor	_	NN	NN	_	16	nn	_	_
16	system	_	NN	NN	_	12	dobj	_	_
17	demonstrated	_	VBD	VBD	_	0	root	_	_
18	that	_	IN	IN	_	22	mark	_	_
19	gamma-LRB-c-RRB-	_	NN	NN	_	22	nsubj	_	_
20	is	_	VBZ	VBZ	_	22	cop	_	_
21	indeed	_	RB	RB	_	22	advmod	_	_
22	critical	_	JJ	JJ	_	17	ccomp	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	IL-7R	_	NN	NN	_	25	nn	_	_
25	function	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	17	punct	_	_

1	Nonetheless	_	RB	RB	_	14	advmod	_	_
2	,	_	,	,	_	14	punct	_	_
3	only	_	RB	RB	_	6	advmod	_	_
4	a	_	DT	DT	_	6	det	_	_
5	limited	_	JJ	JJ	_	6	amod	_	_
6	portion	_	NN	NN	_	14	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	cytoplasmic	_	JJ	JJ	_	10	amod	_	_
10	domain	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	gamma-LRB-c-RRB-	_	NN	NN	_	11	pobj	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	necessary	_	JJ	JJ	_	0	root	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	IL-7R	_	NN	NN	_	18	nn	_	_
17	signal	_	NN	NN	_	18	nn	_	_
18	transduction	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	14	punct	_	_

1	Furthermore	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	replacement	_	NN	NN	_	17	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	gamma-LRB-c-RRB-	_	NN	NN	_	4	pobj	_	_
7	cytoplasmic	_	JJ	JJ	_	8	amod	_	_
8	domain	_	NN	NN	_	6	dep	_	_
9	by	_	IN	IN	_	3	prep	_	_
10	a	_	DT	DT	_	14	det	_	_
11	severely	_	RB	RB	_	14	advmod	_	_
12	truncated	_	VBN	VBN	_	14	amod	_	_
13	erythropoeitin	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	9	pobj	_	_
15	does	_	VBZ	VBZ	_	17	aux	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	affect	_	VB	VB	_	0	root	_	_
18	measured	_	VBN	VBN	_	21	amod	_	_
19	IL-7R	_	NN	NN	_	21	nn	_	_
20	signaling	_	NN	NN	_	21	nn	_	_
21	events	_	NNS	NNS	_	17	dobj	_	_
22	.	_	.	.	_	17	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	support	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	model	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	9	prep	_	_
7	which	_	WDT	WDT	_	6	pobj	_	_
8	gamma-LRB-c-RRB-	_	NN	NN	_	9	nsubj	_	_
9	serves	_	VBZ	VBZ	_	5	rcmod	_	_
10	primarily	_	RB	RB	_	12	advmod	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	activate	_	VB	VB	_	9	xcomp	_	_
13	signal	_	NN	NN	_	14	nn	_	_
14	transduction	_	NN	NN	_	12	dobj	_	_
15	by	_	IN	IN	_	12	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	IL-7R	_	NN	NN	_	18	nn	_	_
18	complex	_	NN	NN	_	15	pobj	_	_
19	,	_	,	,	_	9	punct	_	_
20	while	_	IN	IN	_	23	mark	_	_
21	IL-7R	_	NN	NN	_	22	nn	_	_
22	alpha	_	NN	NN	_	23	nsubj	_	_
23	determines	_	VBZ	VBZ	_	9	advcl	_	_
24	specific	_	JJ	JJ	_	26	amod	_	_
25	signaling	_	NN	NN	_	26	nn	_	_
26	events	_	NNS	NNS	_	23	dobj	_	_
27	through	_	IN	IN	_	23	prep	_	_
28	its	_	PRP$	PRP$	_	29	poss	_	_
29	association	_	NN	NN	_	27	pobj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	cytoplasmic	_	JJ	JJ	_	33	amod	_	_
32	signaling	_	NN	NN	_	33	nn	_	_
33	molecules	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	3	punct	_	_

1	Finally	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	studies	_	NNS	NNS	_	6	nsubj	_	_
5	are	_	VBP	VBP	_	6	cop	_	_
6	consistent	_	JJ	JJ	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	hypothesis	_	NN	NN	_	7	pobj	_	_
10	that	_	IN	IN	_	17	mark	_	_
11	the	_	DT	DT	_	13	det	_	_
12	molecular	_	JJ	JJ	_	13	amod	_	_
13	pathogenesis	_	NN	NN	_	17	nsubj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	X-SCID	_	NN	NN	_	14	pobj	_	_
16	is	_	VBZ	VBZ	_	17	cop	_	_
17	due	_	JJ	JJ	_	9	ccomp	_	_
18	primarily	_	RB	RB	_	19	advmod	_	_
19	to	_	TO	TO	_	17	prep	_	_
20	gamma-LRB-c-RRB--mediated	_	JJ	JJ	_	21	amod	_	_
21	defects	_	NNS	NNS	_	19	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	IL-7/IL-7R	_	NN	NN	_	25	nn	_	_
25	system	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	6	punct	_	_

1	V3	_	NN	NN	_	2	nn	_	_
2	loop	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	human	_	JJ	JJ	_	7	amod	_	_
5	immunodeficiency	_	NN	NN	_	7	nn	_	_
6	virus	_	NN	NN	_	7	nn	_	_
7	type	_	NN	NN	_	3	pobj	_	_
8	1	_	CD	CD	_	7	num	_	_
9	suppresses	_	VBZ	VBZ	_	0	root	_	_
10	interleukin	_	NN	NN	_	14	nn	_	_
11	2-induced	_	JJ	JJ	_	14	amod	_	_
12	T	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	growth	_	NN	NN	_	9	dobj	_	_
15	-LSB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	published	_	VBN	VBN	_	17	amod	_	_
17	erratum	_	NN	NN	_	18	nsubj	_	_
18	appears	_	VBZ	VBZ	_	9	parataxis	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	AIDS	_	NNP	NNP	_	23	nn	_	_
21	Res	_	NNP	NNP	_	23	nn	_	_
22	Hum	_	NNP	NNP	_	23	nn	_	_
23	Retroviruses	_	NNPS	NNPS	_	19	pobj	_	_
24	1997	_	CD	CD	_	25	num	_	_
25	May	_	NN	NN	_	23	dep	_	_
26	1	_	CD	CD	_	25	num	_	_
27	;	_	:	:	_	23	punct	_	_
28	13	_	CD	CD	_	30	num	_	_
29	-LRB-	_	-LRB-	-LRB-	_	30	punct	_	_
30	7	_	CD	CD	_	23	dep	_	_
31	-RRB-	_	-RRB-	-RRB-	_	30	punct	_	_
32	:	_	:	:	_	23	punct	_	_
33	633	_	CD	CD	_	23	dep	_	_
34	-RSB-	_	-RRB-	-RRB-	_	18	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	tested	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	effect	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	three	_	CD	CD	_	5	pobj	_	_
7	linear	_	JJ	JJ	_	6	amod	_	_
8	or	_	CC	CC	_	6	cc	_	_
9	two	_	CD	CD	_	10	num	_	_
10	loop	_	NN	NN	_	6	conj	_	_
11	peptides	_	NNS	NNS	_	6	dep	_	_
12	derived	_	VBN	VBN	_	6	vmod	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	V3	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	HTLV-III	_	NN	NN	_	21	nn	_	_
20	BH10	_	NN	NN	_	21	nn	_	_
21	clone	_	NN	NN	_	17	pobj	_	_
22	or	_	CC	CC	_	16	cc	_	_
23	the	_	DT	DT	_	25	det	_	_
24	SF2	_	NN	NN	_	25	nn	_	_
25	strain	_	NN	NN	_	16	conj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	human	_	JJ	JJ	_	30	amod	_	_
28	immunodeficiency	_	NN	NN	_	30	nn	_	_
29	virus	_	NN	NN	_	30	nn	_	_
30	type	_	NN	NN	_	26	pobj	_	_
31	1	_	CD	CD	_	30	num	_	_
32	on	_	IN	IN	_	4	prep	_	_
33	IL-2-driven	_	JJ	JJ	_	36	amod	_	_
34	T	_	NN	NN	_	36	nn	_	_
35	cell	_	NN	NN	_	36	nn	_	_
36	proliferation	_	NN	NN	_	32	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	V3-BH10	_	NN	NN	_	15	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	which	_	WDT	WDT	_	4	nsubj	_	_
4	consists	_	VBZ	VBZ	_	1	rcmod	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	42	_	CD	CD	_	8	num	_	_
7	amino	_	NN	NN	_	8	nn	_	_
8	acids	_	NNS	NNS	_	5	pobj	_	_
9	and	_	CC	CC	_	4	cc	_	_
10	has	_	VBZ	VBZ	_	4	conj	_	_
11	a	_	DT	DT	_	13	det	_	_
12	loop	_	NN	NN	_	13	nn	_	_
13	structure	_	NN	NN	_	10	dobj	_	_
14	,	_	,	,	_	1	punct	_	_
15	suppressed	_	VBD	VBD	_	0	root	_	_
16	IL-2-driven	_	JJ	JJ	_	17	amod	_	_
17	proliferation	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	all	_	DT	DT	_	21	det	_	_
20	IL-2-dependent	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	-LSB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	Kit225	_	NN	NN	_	21	dep	_	_
24	,	_	,	,	_	23	punct	_	_
25	ED-40515-LRB-+-RRB-	_	NN	NN	_	23	conj	_	_
26	,	_	,	,	_	23	punct	_	_
27	KT-3	_	NN	NN	_	23	conj	_	_
28	,	_	,	,	_	23	punct	_	_
29	7-day	_	JJ	JJ	_	30	amod	_	_
30	PHA-blasts	_	NNS	NNS	_	23	conj	_	_
31	,	_	,	,	_	23	punct	_	_
32	and	_	CC	CC	_	23	cc	_	_
33	fresh	_	JJ	JJ	_	37	amod	_	_
34	peripheral	_	JJ	JJ	_	37	amod	_	_
35	blood	_	NN	NN	_	37	nn	_	_
36	mononuclear	_	JJ	JJ	_	37	amod	_	_
37	cells	_	NNS	NNS	_	23	conj	_	_
38	-RSB-	_	-RRB-	-RRB-	_	23	punct	_	_
39	tested	_	VBN	VBN	_	21	vmod	_	_
40	,	_	,	,	_	15	punct	_	_
41	whereas	_	IN	IN	_	45	mark	_	_
42	it	_	PRP	PRP	_	45	nsubj	_	_
43	did	_	VBD	VBD	_	45	aux	_	_
44	not	_	RB	RB	_	45	neg	_	_
45	suppress	_	VB	VB	_	15	advcl	_	_
46	the	_	DT	DT	_	48	det	_	_
47	cell	_	NN	NN	_	48	nn	_	_
48	growth	_	NN	NN	_	45	dobj	_	_
49	of	_	IN	IN	_	48	prep	_	_
50	IL-2-independent	_	JJ	JJ	_	52	amod	_	_
51	cell	_	NN	NN	_	52	nn	_	_
52	lines	_	NNS	NNS	_	49	pobj	_	_
53	-LRB-	_	-LRB-	-LRB-	_	54	punct	_	_
54	Hut102	_	NN	NN	_	52	dep	_	_
55	,	_	,	,	_	54	punct	_	_
56	Molt-4	_	NN	NN	_	54	conj	_	_
57	,	_	,	,	_	54	punct	_	_
58	and	_	CC	CC	_	54	cc	_	_
59	Jurkat	_	NN	NN	_	54	conj	_	_
60	-RRB-	_	-RRB-	-RRB-	_	54	punct	_	_
61	.	_	.	.	_	15	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	suppressive	_	JJ	JJ	_	3	amod	_	_
3	effect	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	seen	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	IL-2-driven	_	JJ	JJ	_	10	amod	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	growth	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	CD8-positive	_	JJ	JJ	_	13	amod	_	_
13	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
14	purified	_	VBN	VBN	_	13	vmod	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	7-day	_	JJ	JJ	_	17	amod	_	_
17	PHA-blasts	_	NNS	NNS	_	15	pobj	_	_
18	,	_	,	,	_	6	punct	_	_
19	indicating	_	VBG	VBG	_	6	vmod	_	_
20	that	_	IN	IN	_	25	mark	_	_
21	CD4	_	NN	NN	_	22	nn	_	_
22	molecules	_	NNS	NNS	_	25	nsubjpass	_	_
23	were	_	VBD	VBD	_	25	auxpass	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	required	_	VBN	VBN	_	19	ccomp	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	suppression	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	treatment	_	NN	NN	_	13	nsubj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	anti-V3	_	JJ	JJ	_	7	amod	_	_
5	loop	_	NN	NN	_	7	nn	_	_
6	monoclonal	_	JJ	JJ	_	7	amod	_	_
7	antibody	_	NN	NN	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
9	902	_	CD	CD	_	10	num	_	_
10	antibody	_	NN	NN	_	7	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	completely	_	RB	RB	_	13	advmod	_	_
13	abolished	_	VBD	VBD	_	0	root	_	_
14	the	_	DT	DT	_	16	det	_	_
15	suppressive	_	JJ	JJ	_	16	amod	_	_
16	effect	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	V3-BH10	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	V3-BH10	_	NN	NN	_	5	nsubj	_	_
5	generated	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	arrest	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Kit225	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	also	_	RB	RB	_	15	advmod	_	_
13	purified	_	VBD	VBD	_	15	amod	_	_
14	CD8-positive	_	JJ	JJ	_	15	amod	_	_
15	lymphocytes	_	NNS	NNS	_	10	conj	_	_
16	in	_	IN	IN	_	7	prep	_	_
17	G1	_	NN	NN	_	18	nn	_	_
18	phase	_	NN	NN	_	16	pobj	_	_
19	in	_	IN	IN	_	7	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	presence	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	IL-2	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	5	punct	_	_

1	Neither	_	CC	CC	_	3	preconj	_	_
2	chromatin	_	NN	NN	_	3	nn	_	_
3	condensation	_	NN	NN	_	8	nsubjpass	_	_
4	nor	_	CC	CC	_	3	cc	_	_
5	DNA	_	NN	NN	_	6	nn	_	_
6	fragmentation	_	NN	NN	_	3	conj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	detected	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	Kit225	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	cultured	_	VBN	VBN	_	11	vmod	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	V3-BH10	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	IL-2	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	8	punct	_	_

1	V3-BH10	_	NN	NN	_	3	nsubj	_	_
2	neither	_	CC	CC	_	3	preconj	_	_
3	blocked	_	VBD	VBD	_	0	root	_	_
4	radiolabeled	_	VBN	VBN	_	6	amod	_	_
5	IL-2	_	NN	NN	_	6	nn	_	_
6	binding	_	NN	NN	_	3	dobj	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	IL-2	_	NN	NN	_	9	nn	_	_
9	receptors	_	NNS	NNS	_	7	pobj	_	_
10	nor	_	CC	CC	_	3	cc	_	_
11	affected	_	VBD	VBD	_	3	conj	_	_
12	tyrosyl	_	NN	NN	_	13	nn	_	_
13	phosphorylation	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	several	_	JJ	JJ	_	17	amod	_	_
16	cellular	_	JJ	JJ	_	17	amod	_	_
17	proteins	_	NNS	NNS	_	14	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	p120	_	NN	NN	_	17	dep	_	_
20	,	_	,	,	_	19	punct	_	_
21	p98	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	19	punct	_	_
23	p96	_	NN	NN	_	19	conj	_	_
24	,	_	,	,	_	19	punct	_	_
25	p54	_	NN	NN	_	19	conj	_	_
26	,	_	,	,	_	19	punct	_	_
27	and	_	CC	CC	_	19	cc	_	_
28	p38	_	NN	NN	_	19	conj	_	_
29	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
30	,	_	,	,	_	13	punct	_	_
31	which	_	WDT	WDT	_	34	nsubjpass	_	_
32	is	_	VBZ	VBZ	_	34	auxpass	_	_
33	immediately	_	RB	RB	_	34	advmod	_	_
34	induced	_	VBN	VBN	_	13	rcmod	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	IL-2	_	NN	NN	_	37	nn	_	_
37	stimulation	_	NN	NN	_	35	pobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	V3-BH10	_	NN	NN	_	4	nsubj	_	_
4	enhanced	_	VBD	VBD	_	0	root	_	_
5	IL-2-induced	_	JJ	JJ	_	7	amod	_	_
6	mRNA	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	c-fos	_	NN	NN	_	8	pobj	_	_
10	but	_	CC	CC	_	11	cc	_	_
11	not	_	RB	RB	_	9	cc	_	_
12	c-myc	_	NN	NN	_	9	conj	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	junB	_	NN	NN	_	12	conj	_	_
15	.	_	.	.	_	4	punct	_	_

1	Thus	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	binding	_	NN	NN	_	18	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	V3	_	NN	NN	_	7	nn	_	_
7	loop	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	gp120	_	NN	NN	_	8	pobj	_	_
10	to	_	TO	TO	_	4	prep	_	_
11	the	_	DT	DT	_	16	det	_	_
12	cell	_	NN	NN	_	16	nn	_	_
13	surface	_	NN	NN	_	16	nn	_	_
14	molecule	_	NN	NN	_	16	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	s	_	NNS	NNS	_	10	pobj	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	appears	_	VBZ	VBZ	_	0	root	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	affect	_	VB	VB	_	18	xcomp	_	_
21	intracellular	_	JJ	JJ	_	23	amod	_	_
22	IL-2	_	NN	NN	_	23	nn	_	_
23	signaling	_	NN	NN	_	20	dobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	which	_	WDT	WDT	_	26	nsubj	_	_
26	leads	_	VBZ	VBZ	_	23	rcmod	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	suppression	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	IL-2-induced	_	JJ	JJ	_	34	amod	_	_
32	T	_	NN	NN	_	34	nn	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	growth	_	NN	NN	_	30	pobj	_	_
35	.	_	.	.	_	18	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	factor-kappaB	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	11	nsubjpass	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	monocytes	_	NNS	NNS	_	4	pobj	_	_
7	stimulated	_	VBN	VBN	_	6	vmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	lipopolysaccharide	_	NN	NN	_	8	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	inhibited	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	fibroblast	_	NN	NN	_	15	nn	_	_
14	conditioned	_	JJ	JJ	_	15	amod	_	_
15	medium	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	exogenous	_	JJ	JJ	_	18	amod	_	_
18	PGE2	_	NN	NN	_	15	conj	_	_
19	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	nuclear	_	JJ	JJ	_	4	amod	_	_
3	factor	_	NN	NN	_	4	nn	_	_
4	kappaB	_	NN	NN	_	9	nsubjpass	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	NF-kappaB	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	thought	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	13	aux	_	_
11	be	_	VB	VB	_	13	auxpass	_	_
12	crucially	_	RB	RB	_	13	advmod	_	_
13	involved	_	VBN	VBN	_	9	xcomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	gene	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	several	_	JJ	JJ	_	20	amod	_	_
20	cytokines	_	NNS	NNS	_	18	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	including	_	VBG	VBG	_	20	prep	_	_
23	tumor	_	NN	NN	_	26	nn	_	_
24	necrosis	_	NN	NN	_	26	nn	_	_
25	factor	_	NN	NN	_	26	nn	_	_
26	alpha	_	NN	NN	_	22	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	TNF	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	.	_	.	.	_	9	punct	_	_

1	Previously	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	13	mark	_	_
6	fibroblast	_	NN	NN	_	8	nn	_	_
7	conditioned	_	JJ	JJ	_	8	amod	_	_
8	medium	_	NN	NN	_	13	nsubj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	FCM	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	able	_	JJ	JJ	_	4	ccomp	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	inhibit	_	VB	VB	_	13	xcomp	_	_
16	both	_	CC	CC	_	19	preconj	_	_
17	TNF	_	NN	NN	_	18	nn	_	_
18	mRNA	_	NN	NN	_	19	nn	_	_
19	accumulation	_	NN	NN	_	15	dobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	protein	_	NN	NN	_	22	nn	_	_
22	release	_	NN	NN	_	19	conj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	peripheral	_	JJ	JJ	_	27	amod	_	_
25	blood-derived	_	JJ	JJ	_	27	amod	_	_
26	human	_	JJ	JJ	_	27	amod	_	_
27	monocytes	_	NNS	NNS	_	23	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	PBM	_	NNS	NNS	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	stimulated	_	VBN	VBN	_	27	vmod	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	lipopolysaccharide	_	NN	NN	_	32	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	LPS	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	investigated	_	VBN	VBN	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	effect	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	FCM	_	NN	NN	_	9	pobj	_	_
11	on	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	LPS-induced	_	JJ	JJ	_	15	amod	_	_
14	DNA-binding	_	NN	NN	_	15	nn	_	_
15	activity	_	NN	NN	_	11	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	NF-kappaB	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	6	punct	_	_
19	by	_	IN	IN	_	6	prep	_	_
20	means	_	NNS	NNS	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	electrophoretic	_	JJ	JJ	_	24	amod	_	_
23	shift	_	NN	NN	_	24	nn	_	_
24	assay	_	NN	NN	_	21	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	EMSA	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	provide	_	VBP	VBP	_	0	root	_	_
3	evidence	_	NN	NN	_	2	dobj	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	FCM	_	NN	NN	_	7	nsubj	_	_
6	strongly	_	RB	RB	_	7	advmod	_	_
7	inhibits	_	VBZ	VBZ	_	3	ccomp	_	_
8	the	_	DT	DT	_	11	det	_	_
9	LPS-induced	_	JJ	JJ	_	11	amod	_	_
10	NF-kappaB	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	7	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	PBM	_	NNS	NNS	_	12	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Furthermore	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	exogenous	_	JJ	JJ	_	7	amod	_	_
7	PGE2	_	NN	NN	_	8	nsubj	_	_
8	mimics	_	VBZ	VBZ	_	4	ccomp	_	_
9	the	_	DT	DT	_	12	det	_	_
10	NF-kappaB	_	NN	NN	_	12	nn	_	_
11	inhibitory	_	JJ	JJ	_	12	amod	_	_
12	effect	_	NN	NN	_	8	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	FCM	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	On	_	IN	IN	_	15	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	other	_	JJ	JJ	_	4	amod	_	_
4	hand	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	15	punct	_	_
6	FCM	_	NN	NN	_	15	nsubj	_	_
7	produced	_	VBN	VBN	_	6	vmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	presence	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	indomethacin	_	NN	NN	_	11	pobj	_	_
13	does	_	VBZ	VBZ	_	15	aux	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	inhibit	_	VB	VB	_	0	root	_	_
16	NF-kappaB	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	15	dobj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	LPS	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	15	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	lend	_	VBP	VBP	_	0	root	_	_
4	further	_	JJ	JJ	_	5	amod	_	_
5	support	_	NN	NN	_	3	dobj	_	_
6	to	_	TO	TO	_	3	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	hypothesis	_	NN	NN	_	6	pobj	_	_
9	that	_	IN	IN	_	18	mark	_	_
10	inflammatory	_	JJ	JJ	_	18	nsubjpass	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	immune	_	JJ	JJ	_	10	conj	_	_
13	responses	_	NNS	NNS	_	10	dep	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	monocytes/macrophages	_	NNS	NNS	_	14	pobj	_	_
16	may	_	MD	MD	_	18	aux	_	_
17	be	_	VB	VB	_	18	auxpass	_	_
18	modulated	_	VBN	VBN	_	8	ccomp	_	_
19	at	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	molecular	_	JJ	JJ	_	22	amod	_	_
22	level	_	NN	NN	_	19	pobj	_	_
23	by	_	IN	IN	_	18	prep	_	_
24	signals	_	NNS	NNS	_	23	pobj	_	_
25	originating	_	VBG	VBG	_	24	vmod	_	_
26	from	_	IN	IN	_	25	prep	_	_
27	tissue	_	NN	NN	_	29	nn	_	_
28	structural	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	26	pobj	_	_
30	such	_	JJ	JJ	_	31	mwe	_	_
31	as	_	IN	IN	_	29	prep	_	_
32	fibroblasts	_	NNS	NNS	_	31	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Differential	_	JJ	JJ	_	2	amod	_	_
2	interaction	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	nuclear	_	JJ	JJ	_	5	amod	_	_
5	factors	_	NNS	NNS	_	3	pobj	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	PRE-I	_	NN	NN	_	10	nn	_	_
9	enhancer	_	NN	NN	_	10	nn	_	_
10	element	_	NN	NN	_	6	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	IL-4	_	NN	NN	_	15	nn	_	_
15	promoter	_	NN	NN	_	11	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	different	_	JJ	JJ	_	20	amod	_	_
18	T	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	subsets	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	immunomodulatory	_	JJ	JJ	_	3	amod	_	_
3	cytokine	_	NN	NN	_	5	nsubj	_	_
4	IL-4	_	NN	NN	_	3	dep	_	_
5	affects	_	VBZ	VBZ	_	0	root	_	_
6	cells	_	NNS	NNS	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	most	_	JJS	JJS	_	10	amod	_	_
9	hemopoietic	_	JJ	JJ	_	10	amod	_	_
10	lineages	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	5	punct	_	_

1	IL-4	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	secreted	_	VBN	VBN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	activated	_	VBN	VBN	_	6	amod	_	_
6	Th2	_	NN	NN	_	4	pobj	_	_
7	but	_	CC	CC	_	6	cc	_	_
8	not	_	RB	RB	_	10	neg	_	_
9	Th1	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	6	conj	_	_
11	and	_	CC	CC	_	3	cc	_	_
12	plays	_	VBZ	VBZ	_	3	conj	_	_
13	a	_	DT	DT	_	15	det	_	_
14	major	_	JJ	JJ	_	15	amod	_	_
15	role	_	NN	NN	_	12	dobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	immune	_	JJ	JJ	_	19	amod	_	_
19	response	_	NN	NN	_	16	pobj	_	_
20	by	_	IN	IN	_	12	prep	_	_
21	modulating	_	VBG	VBG	_	20	pcomp	_	_
22	the	_	DT	DT	_	23	det	_	_
23	differentiation	_	NN	NN	_	21	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	naive	_	JJ	JJ	_	27	amod	_	_
26	Th	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	24	pobj	_	_
28	toward	_	IN	IN	_	23	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	Th2	_	NN	NN	_	31	nn	_	_
31	phenotype	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	identified	_	VBN	VBN	_	0	root	_	_
5	an	_	DT	DT	_	7	det	_	_
6	enhancer	_	NN	NN	_	7	nn	_	_
7	element	_	NN	NN	_	4	dobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	PRE-I	_	NN	NN	_	7	appos	_	_
10	,	_	,	,	_	7	punct	_	_
11	that	_	WDT	WDT	_	13	nsubj	_	_
12	is	_	VBZ	VBZ	_	13	cop	_	_
13	essential	_	JJ	JJ	_	7	rcmod	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	function	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	human	_	JJ	JJ	_	21	amod	_	_
20	IL-4	_	NN	NN	_	21	nn	_	_
21	promoter	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	mechanisms	_	NNS	NNS	_	2	dobj	_	_
5	responsible	_	JJ	JJ	_	4	amod	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	tissue-specific	_	JJ	JJ	_	8	amod	_	_
8	expression	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	IL-4	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	9	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	we	_	PRP	PRP	_	15	nsubj	_	_
15	analyzed	_	VBD	VBD	_	2	parataxis	_	_
16	nuclear	_	JJ	JJ	_	17	amod	_	_
17	factors	_	NNS	NNS	_	15	dobj	_	_
18	binding	_	VBG	VBG	_	17	vmod	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	PRE-I	_	NN	NN	_	22	nn	_	_
22	site	_	NN	NN	_	19	pobj	_	_
23	and	_	CC	CC	_	15	cc	_	_
24	compared	_	VBD	VBD	_	15	conj	_	_
25	the	_	DT	DT	_	27	det	_	_
26	binding	_	NN	NN	_	27	nn	_	_
27	activities	_	NNS	NNS	_	24	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	these	_	DT	DT	_	30	det	_	_
30	factors	_	NNS	NNS	_	28	pobj	_	_
31	to	_	TO	TO	_	24	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	IL-4	_	NN	NN	_	34	nn	_	_
34	promoter	_	NN	NN	_	31	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	Th1	_	NN	NN	_	35	pobj	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	Th2	_	NN	NN	_	36	conj	_	_
39	cells	_	NNS	NNS	_	36	dep	_	_
40	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	PRE-I	_	NN	NN	_	5	nsubj	_	_
5	interacts	_	VBZ	VBZ	_	2	ccomp	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	PMA-	_	NN	NN	_	14	amod	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	PMA/ionomycin-inducible	_	JJ	JJ	_	7	conj	_	_
10	,	_	,	,	_	7	punct	_	_
11	cyclosporin	_	NN	NN	_	12	npadvmod	_	_
12	A-sensitive	_	JJ	JJ	_	7	dep	_	_
13	nuclear	_	JJ	JJ	_	14	amod	_	_
14	factors	_	NNS	NNS	_	6	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	anti-C/EBPbeta	_	JJ	JJ	_	1	dobj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	NF-IL6	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	,	_	,	,	_	2	punct	_	_
7	anti-C/EBPdelta	_	JJ	JJ	_	2	conj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	NF-IL6beta	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	,	_	,	,	_	2	punct	_	_
12	anti-NF-ATc	_	JJ	JJ	_	2	conj	_	_
13	,	_	,	,	_	2	punct	_	_
14	anti-NF-ATp	_	JJ	JJ	_	2	conj	_	_
15	,	_	,	,	_	2	punct	_	_
16	anti-Fos	_	JJ	JJ	_	2	conj	_	_
17	,	_	,	,	_	2	punct	_	_
18	and	_	CC	CC	_	2	cc	_	_
19	anti-Jun	_	JJ	JJ	_	20	amod	_	_
20	Abs	_	NNS	NNS	_	2	conj	_	_
21	we	_	PRP	PRP	_	22	nsubj	_	_
22	demonstrate	_	VBP	VBP	_	1	parataxis	_	_
23	that	_	IN	IN	_	32	mark	_	_
24	the	_	DT	DT	_	29	det	_	_
25	previously	_	RB	RB	_	26	advmod	_	_
26	identified	_	VBN	VBN	_	29	amod	_	_
27	PRE-I	_	NN	NN	_	29	nn	_	_
28	binding	_	NN	NN	_	29	nn	_	_
29	factor	_	NN	NN	_	32	nsubjpass	_	_
30	POS-1	_	NN	NN	_	29	dep	_	_
31	is	_	VBZ	VBZ	_	32	auxpass	_	_
32	composed	_	VBN	VBN	_	22	ccomp	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	different	_	JJ	JJ	_	36	amod	_	_
35	transcription	_	NN	NN	_	36	nn	_	_
36	factors	_	NNS	NNS	_	33	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	different	_	JJ	JJ	_	41	amod	_	_
39	Th	_	NN	NN	_	41	nn	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	subsets	_	NNS	NNS	_	37	pobj	_	_
42	.	_	.	.	_	1	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	the	_	DT	DT	_	6	dep	_	_
3	IL-4-producing	_	JJ	JJ	_	6	amod	_	_
4	Th0-like	_	JJ	JJ	_	6	amod	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	Jurkat	_	NN	NN	_	1	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	mouse	_	NN	NN	_	10	nn	_	_
9	EL-4	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	6	conj	_	_
11	,	_	,	,	_	17	punct	_	_
12	POS-1	_	NN	NN	_	17	nsubj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	designated	_	VBN	VBN	_	12	dep	_	_
15	POS-1a	_	NN	NN	_	14	dep	_	_
16	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
17	contains	_	VBZ	VBZ	_	0	root	_	_
18	NF-IL6beta	_	NN	NN	_	17	dobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	Jun	_	NN	NN	_	18	conj	_	_
21	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	19	prep	_	_
2	the	_	DT	DT	_	6	det	_	_
3	mouse	_	NN	NN	_	6	nn	_	_
4	Th2	_	NN	NN	_	6	nn	_	_
5	D10	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	1	pobj	_	_
7	and	_	CC	CC	_	1	cc	_	_
8	in	_	IN	IN	_	1	conj	_	_
9	the	_	DT	DT	_	12	det	_	_
10	human	_	JJ	JJ	_	12	amod	_	_
11	Th2	_	NN	NN	_	12	nn	_	_
12	clones	_	NNS	NNS	_	8	pobj	_	_
13	,	_	,	,	_	19	punct	_	_
14	POS-1	_	NN	NN	_	19	nsubj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	designated	_	VBN	VBN	_	14	dep	_	_
17	POS-1b	_	NN	NN	_	16	dep	_	_
18	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
19	contains	_	VBZ	VBZ	_	0	root	_	_
20	NF-IL6beta	_	NN	NN	_	19	dobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	Jun	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	20	punct	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	NF-ATc/p	_	NN	NN	_	20	conj	_	_
26	.	_	.	.	_	19	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	POS-1	_	NN	NN	_	7	nsubjpass	_	_
5	was	_	VBD	VBD	_	7	auxpass	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	extracts	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	14	amod	_	_
13	Th1	_	NN	NN	_	14	nn	_	_
14	clones	_	NNS	NNS	_	11	pobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	PRE-I	_	NN	NN	_	7	nsubj	_	_
6	may	_	MD	MD	_	7	aux	_	_
7	play	_	VB	VB	_	3	ccomp	_	_
8	a	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	differential	_	JJ	JJ	_	13	amod	_	_
13	regulation	_	NN	NN	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	IL-4	_	NN	NN	_	16	nn	_	_
16	gene	_	NN	NN	_	18	nn	_	_
17	expression	_	NN	NN	_	18	nn	_	_
18	levels	_	NNS	NNS	_	14	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Inhibitory	_	JJ	JJ	_	2	amod	_	_
2	effect	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	growth	_	NN	NN	_	5	nn	_	_
5	hormone	_	NN	NN	_	3	pobj	_	_
6	on	_	IN	IN	_	2	prep	_	_
7	TNF-alpha	_	NN	NN	_	8	nn	_	_
8	secretion	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	nuclear	_	JJ	JJ	_	11	amod	_	_
11	factor-kappaB	_	NN	NN	_	12	nn	_	_
12	translocation	_	NN	NN	_	8	conj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	lipopolysaccharide-stimulated	_	JJ	JJ	_	16	amod	_	_
15	human	_	JJ	JJ	_	16	amod	_	_
16	monocytes	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Several	_	JJ	JJ	_	2	amod	_	_
2	studies	_	NNS	NNS	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	pointed	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	link	_	NN	NN	_	5	pobj	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	immune	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	endocrine	_	JJ	JJ	_	9	conj	_	_
12	systems	_	NNS	NNS	_	9	dep	_	_
13	,	_	,	,	_	9	punct	_	_
14	including	_	VBG	VBG	_	9	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	regulatory	_	JJ	JJ	_	17	amod	_	_
17	function	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	GH	_	NN	NN	_	18	pobj	_	_
20	on	_	IN	IN	_	17	prep	_	_
21	monocyte	_	NN	NN	_	22	nn	_	_
22	activation	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	study	_	NN	NN	_	4	nsubj	_	_
4	demonstrates	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	25	mark	_	_
6	human	_	JJ	JJ	_	9	amod	_	_
7	THP-1	_	NN	NN	_	9	nn	_	_
8	promonocytic	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	25	nsubj	_	_
10	,	_	,	,	_	9	punct	_	_
11	engineered	_	VBN	VBN	_	9	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	transfer	_	NN	NN	_	12	pobj	_	_
15	to	_	TO	TO	_	17	aux	_	_
16	constitutively	_	RB	RB	_	17	advmod	_	_
17	produce	_	VB	VB	_	11	xcomp	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	growth	_	NN	NN	_	20	nn	_	_
20	hormone	_	NN	NN	_	17	dobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	hGH	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	,	_	,	,	_	9	punct	_	_
25	secreted	_	VBD	VBD	_	4	ccomp	_	_
26	depressed	_	VBN	VBN	_	27	amod	_	_
27	amounts	_	NNS	NNS	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	TNF-alpha	_	NN	NN	_	28	pobj	_	_
30	in	_	IN	IN	_	25	prep	_	_
31	response	_	NN	NN	_	30	pobj	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	challenge	_	NN	NN	_	32	pobj	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	LPS	_	NN	NN	_	34	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GH	_	NN	NN	_	3	pobj	_	_
5	appears	_	VBZ	VBZ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	occur	_	VB	VB	_	5	xcomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	an	_	DT	DT	_	11	det	_	_
10	autocrine	_	JJ	JJ	_	11	amod	_	_
11	fashion	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	since	_	IN	IN	_	26	mark	_	_
14	the	_	DT	DT	_	16	det	_	_
15	inhibitory	_	JJ	JJ	_	16	amod	_	_
16	effect	_	NN	NN	_	26	nsubjpass	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	TNF-alpha	_	NN	NN	_	19	nn	_	_
19	secretion	_	NN	NN	_	17	pobj	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	constitutive	_	JJ	JJ	_	23	amod	_	_
22	GH	_	NN	NN	_	23	nn	_	_
23	production	_	NN	NN	_	20	pobj	_	_
24	could	_	MD	MD	_	26	aux	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	abolished	_	VBN	VBN	_	5	advcl	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	presence	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	anti-hGH	_	JJ	JJ	_	32	amod	_	_
32	mAb	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	GH-induced	_	JJ	JJ	_	4	amod	_	_
3	inhibitory	_	JJ	JJ	_	2	dep	_	_
4	effect	_	NN	NN	_	7	nsubjpass	_	_
5	was	_	VBD	VBD	_	7	auxpass	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	observed	_	VBN	VBN	_	0	root	_	_
8	using	_	VBG	VBG	_	7	xcomp	_	_
9	normal	_	JJ	JJ	_	11	amod	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	monocytes	_	NNS	NNS	_	8	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	monocyte-derived	_	JJ	JJ	_	14	amod	_	_
14	macrophages	_	NNS	NNS	_	11	conj	_	_
15	.	_	.	.	_	7	punct	_	_

1	Inhibition	_	NN	NN	_	15	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TNF-alpha	_	NN	NN	_	4	nn	_	_
4	production	_	NN	NN	_	2	pobj	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	THP-1-hGH-transfected	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	cultured	_	VBN	VBN	_	7	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	presence	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	LPS	_	NN	NN	_	12	pobj	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	dependent	_	JJ	JJ	_	0	root	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	19	det	_	_
18	selective	_	JJ	JJ	_	19	amod	_	_
19	pathway	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	15	punct	_	_
21	since	_	IN	IN	_	28	mark	_	_
22	no	_	DT	DT	_	23	neg	_	_
23	inhibition	_	NN	NN	_	28	nsubjpass	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	TNF-alpha	_	NN	NN	_	26	nn	_	_
26	production	_	NN	NN	_	24	pobj	_	_
27	was	_	VBD	VBD	_	28	auxpass	_	_
28	observed	_	VBN	VBN	_	15	advcl	_	_
29	when	_	WRB	WRB	_	32	advmod	_	_
30	cells	_	NNS	NNS	_	32	nsubjpass	_	_
31	were	_	VBD	VBD	_	32	auxpass	_	_
32	cultured	_	VBN	VBN	_	28	advcl	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	presence	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	PMA	_	NN	NN	_	36	pobj	_	_
38	.	_	.	.	_	15	punct	_	_

1	Inhibition	_	NN	NN	_	10	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TNF-alpha	_	NN	NN	_	4	nn	_	_
4	secretion	_	NN	NN	_	2	pobj	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	LPS-stimulated	_	JJ	JJ	_	8	amod	_	_
7	THP-1-hGH	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	associated	_	VBN	VBN	_	0	root	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	13	det	_	_
13	decrease	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	translocation	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	nuclear	_	JJ	JJ	_	19	amod	_	_
19	factor-kappaB	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	capacity	_	NN	NN	_	21	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	GH	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	inhibit	_	VB	VB	_	2	vmod	_	_
7	LPS-induced	_	JJ	JJ	_	9	amod	_	_
8	TNF-alpha	_	NN	NN	_	9	nn	_	_
9	production	_	NN	NN	_	6	dobj	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	monocytes	_	NNS	NNS	_	10	pobj	_	_
12	without	_	IN	IN	_	6	prep	_	_
13	altering	_	VBG	VBG	_	12	pcomp	_	_
14	other	_	JJ	JJ	_	15	amod	_	_
15	pathways	_	NNS	NNS	_	13	dobj	_	_
16	leading	_	VBG	VBG	_	15	vmod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	TNF-alpha	_	NN	NN	_	19	nn	_	_
19	production	_	NN	NN	_	17	pobj	_	_
20	may	_	MD	MD	_	21	aux	_	_
21	be	_	VB	VB	_	0	root	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	potential	_	JJ	JJ	_	24	amod	_	_
24	relevance	_	NN	NN	_	22	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	septic	_	JJ	JJ	_	27	amod	_	_
27	shock	_	NN	NN	_	25	pobj	_	_
28	,	_	,	,	_	21	punct	_	_
29	since	_	IN	IN	_	32	mark	_	_
30	GH	_	NN	NN	_	32	nsubj	_	_
31	is	_	VBZ	VBZ	_	32	cop	_	_
32	available	_	JJ	JJ	_	21	advcl	_	_
33	for	_	IN	IN	_	32	prep	_	_
34	clinical	_	JJ	JJ	_	35	amod	_	_
35	use	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	21	punct	_	_

1	Impaired	_	JJ	JJ	_	2	amod	_	_
2	induction	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	c-fos/c-jun	_	NN	NN	_	5	nn	_	_
5	genes	_	NNS	NNS	_	3	pobj	_	_
6	and	_	CC	CC	_	3	cc	_	_
7	of	_	IN	IN	_	3	conj	_	_
8	transcriptional	_	JJ	JJ	_	10	amod	_	_
9	regulatory	_	JJ	JJ	_	10	amod	_	_
10	proteins	_	NNS	NNS	_	7	pobj	_	_
11	binding	_	VBG	VBG	_	10	vmod	_	_
12	distinct	_	JJ	JJ	_	15	amod	_	_
13	c-fos/c-jun	_	NN	NN	_	15	nn	_	_
14	promoter	_	NN	NN	_	15	nn	_	_
15	elements	_	NNS	NNS	_	11	dobj	_	_
16	in	_	IN	IN	_	2	prep	_	_
17	activated	_	VBN	VBN	_	20	amod	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	pobj	_	_
21	during	_	IN	IN	_	2	prep	_	_
22	aging	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	activation	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	transcriptional	_	JJ	JJ	_	5	amod	_	_
5	factor	_	NN	NN	_	3	pobj	_	_
6	c-Fos/c-Jun	_	NN	NN	_	5	dep	_	_
7	AP-1	_	NN	NN	_	6	dep	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	essential	_	JJ	JJ	_	0	root	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	normal	_	JJ	JJ	_	14	amod	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	responsiveness	_	NN	NN	_	10	pobj	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	is	_	VBZ	VBZ	_	18	cop	_	_
17	often	_	RB	RB	_	18	advmod	_	_
18	impaired	_	JJ	JJ	_	9	conj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	T	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	during	_	IN	IN	_	18	prep	_	_
23	aging	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	investigated	_	VBD	VBD	_	0	root	_	_
8	whether	_	IN	IN	_	22	mark	_	_
9	aberrancies	_	NNS	NNS	_	22	nsubj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	regulation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	c-fos/c-jun	_	NN	NN	_	13	pobj	_	_
15	at	_	IN	IN	_	9	prep	_	_
16	the	_	DT	DT	_	17	dep	_	_
17	mRNA	_	NN	NN	_	15	pobj	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	protein	_	NN	NN	_	17	conj	_	_
20	level	_	NN	NN	_	17	dep	_	_
21	might	_	MD	MD	_	22	aux	_	_
22	underlie	_	VB	VB	_	7	ccomp	_	_
23	the	_	DT	DT	_	25	det	_	_
24	age-associated	_	JJ	JJ	_	25	amod	_	_
25	impairments	_	NNS	NNS	_	22	dobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	AP-1	_	NN	NN	_	26	pobj	_	_
28	in	_	IN	IN	_	25	prep	_	_
29	human	_	JJ	JJ	_	31	amod	_	_
30	T	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	7	punct	_	_

1	Whereas	_	IN	IN	_	22	mark	_	_
2	T	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	22	nsubj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	young	_	JJ	JJ	_	6	amod	_	_
6	subjects	_	NNS	NNS	_	4	pobj	_	_
7	stimulated	_	VBN	VBN	_	3	vmod	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	cross-linked	_	JJ	JJ	_	11	amod	_	_
10	anti-CD3epsilon	_	JJ	JJ	_	11	amod	_	_
11	mAb	_	NN	NN	_	8	pobj	_	_
12	OKT3	_	NN	NN	_	11	dep	_	_
13	plus	_	CC	CC	_	11	cc	_	_
14	PMA	_	NN	NN	_	11	conj	_	_
15	or	_	CC	CC	_	8	cc	_	_
16	with	_	IN	IN	_	8	conj	_	_
17	the	_	DT	DT	_	18	det	_	_
18	lectin	_	NN	NN	_	16	pobj	_	_
19	PHA	_	NN	NN	_	18	dep	_	_
20	plus	_	CC	CC	_	18	cc	_	_
21	PMA	_	NN	NN	_	18	conj	_	_
22	demonstrated	_	VBD	VBD	_	39	advcl	_	_
23	considerable	_	JJ	JJ	_	24	amod	_	_
24	increases	_	NNS	NNS	_	22	dobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	c-Fos	_	NN	NN	_	28	nn	_	_
27	protein	_	NN	NN	_	28	nn	_	_
28	expression	_	NN	NN	_	25	pobj	_	_
29	,	_	,	,	_	39	punct	_	_
30	the	_	DT	DT	_	31	det	_	_
31	expression	_	NN	NN	_	39	nsubjpass	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	c-Fos	_	NN	NN	_	32	pobj	_	_
34	but	_	CC	CC	_	35	cc	_	_
35	not	_	RB	RB	_	33	cc	_	_
36	c-Jun	_	NN	NN	_	33	conj	_	_
37	was	_	VBD	VBD	_	39	auxpass	_	_
38	markedly	_	RB	RB	_	39	advmod	_	_
39	reduced	_	VBN	VBN	_	0	root	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	stimulated	_	VBN	VBN	_	43	amod	_	_
42	T	_	NN	NN	_	43	nn	_	_
43	cells	_	NNS	NNS	_	40	pobj	_	_
44	from	_	IN	IN	_	43	prep	_	_
45	certain	_	JJ	JJ	_	47	amod	_	_
46	elderly	_	JJ	JJ	_	47	amod	_	_
47	subjects	_	NNS	NNS	_	44	pobj	_	_
48	.	_	.	.	_	39	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	RNase	_	NN	NN	_	6	nn	_	_
5	protection	_	NN	NN	_	6	nn	_	_
6	assays	_	NNS	NNS	_	7	nsubj	_	_
7	revealed	_	VBD	VBD	_	0	root	_	_
8	that	_	IN	IN	_	19	mark	_	_
9	anti-CD3/PMA-stimulated	_	JJ	JJ	_	11	amod	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	19	nsubj	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	substantial	_	JJ	JJ	_	15	amod	_	_
15	proportion	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	elderly	_	JJ	JJ	_	18	amod	_	_
18	subjects	_	NNS	NNS	_	16	pobj	_	_
19	exhibited	_	VBD	VBD	_	7	ccomp	_	_
20	decreased	_	JJ	JJ	_	21	amod	_	_
21	levels	_	NNS	NNS	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	c-fos	_	NN	NN	_	22	pobj	_	_
24	and/or	_	CC	CC	_	23	cc	_	_
25	c-jun	_	NN	NN	_	23	conj	_	_
26	mRNA	_	NN	NN	_	23	dep	_	_
27	compared	_	VBN	VBN	_	19	prep	_	_
28	to	_	TO	TO	_	27	pcomp	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	from	_	IN	IN	_	30	prep	_	_
32	young	_	JJ	JJ	_	33	amod	_	_
33	subjects	_	NNS	NNS	_	31	pobj	_	_
34	.	_	.	.	_	7	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	assays	_	NNS	NNS	_	1	dobj	_	_
6	,	_	,	,	_	1	punct	_	_
7	the	_	DT	DT	_	8	det	_	_
8	levels	_	NNS	NNS	_	37	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	nuclear	_	JJ	JJ	_	12	amod	_	_
11	regulatory	_	JJ	JJ	_	12	amod	_	_
12	proteins	_	NNS	NNS	_	9	pobj	_	_
13	recognizing	_	VBG	VBG	_	12	vmod	_	_
14	the	_	DT	DT	_	18	det	_	_
15	AP-1	_	NN	NN	_	18	nn	_	_
16	consensus	_	NN	NN	_	18	nn	_	_
17	TRE	_	NN	NN	_	18	nn	_	_
18	motif	_	NN	NN	_	13	dobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	the	_	DT	DT	_	25	det	_	_
21	proximal	_	JJ	JJ	_	25	amod	_	_
22	c-jun	_	NN	NN	_	25	nn	_	_
23	TRE-like	_	JJ	JJ	_	25	amod	_	_
24	promoter	_	NN	NN	_	25	nn	_	_
25	element	_	NN	NN	_	18	conj	_	_
26	,	_	,	,	_	18	punct	_	_
27	and	_	CC	CC	_	18	cc	_	_
28	the	_	DT	DT	_	32	det	_	_
29	c-fos	_	NN	NN	_	32	nn	_	_
30	serum	_	NN	NN	_	32	nn	_	_
31	response	_	NN	NN	_	32	nn	_	_
32	element	_	NN	NN	_	18	conj	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	SRE	_	NN	NN	_	32	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	were	_	VBD	VBD	_	37	auxpass	_	_
37	determined	_	VBN	VBN	_	1	parataxis	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	resting	_	VBG	VBG	_	38	pobj	_	_
40	and	_	CC	CC	_	39	cc	_	_
41	stimulated	_	VBN	VBN	_	39	conj	_	_
42	T	_	NN	NN	_	43	nn	_	_
43	cells	_	NNS	NNS	_	39	dep	_	_
44	.	_	.	.	_	1	punct	_	_

1	Although	_	IN	IN	_	10	dep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	stimulation	_	NN	NN	_	10	dep	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	young	_	JJ	JJ	_	9	amod	_	_
9	subjects	_	NNS	NNS	_	7	pobj	_	_
10	resulted	_	VBD	VBD	_	41	advcl	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	coordinated	_	VBN	VBN	_	13	amod	_	_
13	increases	_	NNS	NNS	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	nuclear	_	JJ	JJ	_	17	amod	_	_
16	protein	_	NN	NN	_	17	nn	_	_
17	complexes	_	NNS	NNS	_	14	pobj	_	_
18	binding	_	VBG	VBG	_	17	vmod	_	_
19	the	_	DT	DT	_	21	dep	_	_
20	AP-1	_	NN	NN	_	21	nn	_	_
21	TRE	_	NN	NN	_	18	dobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	c-jun	_	NN	NN	_	24	nn	_	_
24	TRE	_	NN	NN	_	21	conj	_	_
25	,	_	,	,	_	21	punct	_	_
26	and	_	CC	CC	_	21	cc	_	_
27	c-fos	_	NN	NN	_	31	nn	_	_
28	SRE	_	NN	NN	_	31	nn	_	_
29	DNA	_	NN	NN	_	31	nn	_	_
30	sequence	_	NN	NN	_	31	nn	_	_
31	motifs	_	NNS	NNS	_	21	conj	_	_
32	,	_	,	,	_	41	punct	_	_
33	age-related	_	JJ	JJ	_	34	amod	_	_
34	reductions	_	NNS	NNS	_	41	nsubjpass	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	activation	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	AP-1	_	NN	NN	_	38	pobj	_	_
40	were	_	VBD	VBD	_	41	auxpass	_	_
41	accompanied	_	VBN	VBN	_	0	root	_	_
42	by	_	IN	IN	_	41	prep	_	_
43	decreased	_	VBN	VBN	_	44	amod	_	_
44	levels	_	NNS	NNS	_	42	pobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	c-jun	_	NN	NN	_	47	nn	_	_
47	TRE	_	NN	NN	_	45	pobj	_	_
48	and	_	CC	CC	_	47	cc	_	_
49	c-fos	_	NN	NN	_	50	nn	_	_
50	SRE	_	NN	NN	_	47	conj	_	_
51	binding	_	NN	NN	_	52	nn	_	_
52	complexes	_	NNS	NNS	_	47	dep	_	_
53	.	_	.	.	_	41	punct	_	_

1	Furthermore	_	RB	RB	_	21	advmod	_	_
2	,	_	,	,	_	21	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	nuclear	_	JJ	JJ	_	6	amod	_	_
5	protein	_	NN	NN	_	6	nn	_	_
6	complexes	_	NNS	NNS	_	21	nsubj	_	_
7	binding	_	VBG	VBG	_	6	vmod	_	_
8	the	_	DT	DT	_	10	det	_	_
9	SRE	_	NN	NN	_	10	nn	_	_
10	motif	_	NN	NN	_	7	dobj	_	_
11	induced	_	VBN	VBN	_	10	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	activated	_	VBN	VBN	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	young	_	JJ	JJ	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	elderly	_	JJ	JJ	_	17	conj	_	_
20	subjects	_	NNS	NNS	_	17	dep	_	_
21	contained	_	VBD	VBD	_	0	root	_	_
22	serum	_	NN	NN	_	24	nn	_	_
23	response	_	NN	NN	_	24	nn	_	_
24	factor	_	NN	NN	_	21	dobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	Elk-1	_	NN	NN	_	24	conj	_	_
27	pointing	_	VBG	VBG	_	24	vmod	_	_
28	toward	_	IN	IN	_	27	prep	_	_
29	age-related	_	JJ	JJ	_	30	amod	_	_
30	defects	_	NNS	NNS	_	28	pobj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	activation	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	transcriptional	_	JJ	JJ	_	37	amod	_	_
36	regulatory	_	JJ	JJ	_	37	amod	_	_
37	proteins	_	NNS	NNS	_	34	pobj	_	_
38	distinct	_	JJ	JJ	_	37	amod	_	_
39	from	_	IN	IN	_	38	prep	_	_
40	c-jun/AP-1	_	NN	NN	_	39	pobj	_	_
41	.	_	.	.	_	21	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	underlying	_	VBG	VBG	_	6	amod	_	_
6	aberrancies	_	NNS	NNS	_	20	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	induction	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	c-fos/c-jun	_	NN	NN	_	10	pobj	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	11	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	their	_	PRP$	PRP$	_	18	poss	_	_
16	nuclear	_	JJ	JJ	_	18	amod	_	_
17	regulatory	_	JJ	JJ	_	18	amod	_	_
18	proteins	_	NNS	NNS	_	11	conj	_	_
19	may	_	MD	MD	_	20	aux	_	_
20	contribute	_	VB	VB	_	3	ccomp	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	age-related	_	JJ	JJ	_	24	amod	_	_
24	impairments	_	NNS	NNS	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	AP-1	_	NN	NN	_	27	nn	_	_
27	activation	_	NN	NN	_	25	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	human	_	JJ	JJ	_	31	amod	_	_
30	T	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	Dissociation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	Jak	_	NN	NN	_	5	nn	_	_
5	kinase	_	NN	NN	_	6	nn	_	_
6	pathway	_	NN	NN	_	2	pobj	_	_
7	from	_	IN	IN	_	1	prep	_	_
8	G-CSF	_	NN	NN	_	9	nn	_	_
9	receptor	_	NN	NN	_	10	nn	_	_
10	signaling	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	neutrophils	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	1	punct	_	_

1	Activation	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	7	det	_	_
4	granulocyte	_	NN	NN	_	7	nn	_	_
5	colony-stimulating	_	JJ	JJ	_	7	amod	_	_
6	factor	_	NN	NN	_	7	nn	_	_
7	receptor	_	NN	NN	_	2	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	G-CSFR	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	induces	_	VBZ	VBZ	_	0	root	_	_
12	rapid	_	JJ	JJ	_	14	amod	_	_
13	tyrosine	_	NN	NN	_	14	nn	_	_
14	phosphorylation	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	multiple	_	JJ	JJ	_	18	amod	_	_
17	intracellular	_	JJ	JJ	_	18	amod	_	_
18	substrates	_	NNS	NNS	_	15	pobj	_	_
19	in	_	IN	IN	_	11	prep	_	_
20	proliferating	_	VBG	VBG	_	21	amod	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	nonproliferating	_	JJ	JJ	_	27	amod	_	_
24	,	_	,	,	_	27	punct	_	_
25	terminally	_	RB	RB	_	27	advmod	_	_
26	differentiated	_	VBN	VBN	_	27	amod	_	_
27	neutrophils	_	NNS	NNS	_	21	conj	_	_
28	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	kinases	_	NNS	NNS	_	24	nsubj	_	_
3	that	_	WDT	WDT	_	4	nsubj	_	_
4	couple	_	VBP	VBP	_	2	rcmod	_	_
5	ligand	_	NN	NN	_	4	dobj	_	_
6	binding	_	VBG	VBG	_	5	amod	_	_
7	to	_	TO	TO	_	4	prep	_	_
8	tyrosine	_	NN	NN	_	9	nn	_	_
9	phosphorylation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	cellular	_	JJ	JJ	_	12	amod	_	_
12	substrates	_	NNS	NNS	_	10	pobj	_	_
13	by	_	IN	IN	_	9	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	G-CSFR	_	NN	NN	_	13	pobj	_	_
16	with	_	IN	IN	_	4	prep	_	_
17	activation	_	NN	NN	_	16	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	specific	_	JJ	JJ	_	21	amod	_	_
20	functional	_	JJ	JJ	_	19	dep	_	_
21	programs	_	NNS	NNS	_	18	pobj	_	_
22	are	_	VBP	VBP	_	24	cop	_	_
23	largely	_	RB	RB	_	24	advmod	_	_
24	unknown	_	JJ	JJ	_	0	root	_	_
25	.	_	.	.	_	24	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	examined	_	VBD	VBD	_	0	root	_	_
7	early	_	JJ	JJ	_	9	amod	_	_
8	signaling	_	NN	NN	_	9	nn	_	_
9	events	_	NNS	NNS	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	proliferating	_	VBG	VBG	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	terminally	_	RB	RB	_	15	advmod	_	_
14	differentiated	_	VBN	VBN	_	15	amod	_	_
15	cells	_	NNS	NNS	_	11	conj	_	_
16	following	_	VBG	VBG	_	9	prep	_	_
17	G-CSF	_	NN	NN	_	18	nn	_	_
18	stimulation	_	NN	NN	_	16	pobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	determine	_	VB	VB	_	6	vmod	_	_
21	whether	_	IN	IN	_	26	mark	_	_
22	identical	_	JJ	JJ	_	24	amod	_	_
23	signaling	_	NN	NN	_	24	nn	_	_
24	cascades	_	NNS	NNS	_	26	nsubjpass	_	_
25	are	_	VBP	VBP	_	26	auxpass	_	_
26	activated	_	VBN	VBN	_	20	ccomp	_	_
27	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	20	prep	_	_
2	murine	_	JJ	JJ	_	4	amod	_	_
3	Ba/F3	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	1	pobj	_	_
5	transfected	_	VBN	VBN	_	4	vmod	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	G-CSFR	_	NN	NN	_	6	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	NFS-60	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	conj	_	_
13	constitutively	_	RB	RB	_	14	advmod	_	_
14	expressing	_	VBG	VBG	_	9	vmod	_	_
15	the	_	DT	DT	_	17	det	_	_
16	murine	_	JJ	JJ	_	17	amod	_	_
17	G-CSFR	_	NN	NN	_	14	dobj	_	_
18	,	_	,	,	_	20	punct	_	_
19	G-CSF	_	NN	NN	_	20	nsubj	_	_
20	induced	_	VBD	VBD	_	0	root	_	_
21	tyrosine	_	NN	NN	_	22	nn	_	_
22	phosphorylation	_	NN	NN	_	20	dobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	activation	_	NN	NN	_	22	conj	_	_
25	of	_	IN	IN	_	22	prep	_	_
26	Jak1	_	NN	NN	_	25	pobj	_	_
27	,	_	,	,	_	26	punct	_	_
28	Jak2	_	NN	NN	_	26	conj	_	_
29	,	_	,	,	_	26	punct	_	_
30	and	_	CC	CC	_	26	cc	_	_
31	Tyk2	_	NN	NN	_	26	conj	_	_
32	.	_	.	.	_	20	punct	_	_

1	Tyrosine	_	NN	NN	_	2	nn	_	_
2	phosphorylation	_	NN	NN	_	15	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Stat3	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	,	_	,	,	_	4	punct	_	_
7	to	_	TO	TO	_	4	conj	_	_
8	a	_	DT	DT	_	10	det	_	_
9	lesser	_	JJR	JJR	_	10	amod	_	_
10	extent	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	4	punct	_	_
12	Stat1	_	NN	NN	_	4	conj	_	_
13	was	_	VBD	VBD	_	15	auxpass	_	_
14	also	_	RB	RB	_	15	advmod	_	_
15	detected	_	VBN	VBN	_	0	root	_	_
16	following	_	VBG	VBG	_	15	prep	_	_
17	G-CSF	_	NN	NN	_	18	nn	_	_
18	stimulation	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	15	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	7	det	_	_
3	mitogenically	_	RB	RB	_	7	advmod	_	_
4	incompetent	_	JJ	JJ	_	7	amod	_	_
5	human	_	JJ	JJ	_	7	amod	_	_
6	G-CSFR	_	NN	NN	_	7	nn	_	_
7	mutant	_	NN	NN	_	1	dobj	_	_
8	in	_	IN	IN	_	14	prep	_	_
9	which	_	WDT	WDT	_	8	pobj	_	_
10	Pro639	_	NN	NN	_	14	nsubjpass	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	Pro641	_	NN	NN	_	10	conj	_	_
13	were	_	VBD	VBD	_	14	auxpass	_	_
14	substituted	_	VBN	VBN	_	7	rcmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	alanine	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	1	punct	_	_
18	the	_	DT	DT	_	22	det	_	_
19	box	_	NN	NN	_	22	nn	_	_
20	1	_	CD	CD	_	22	num	_	_
21	PDP	_	NN	NN	_	22	nn	_	_
22	motif	_	NN	NN	_	24	nsubjpass	_	_
23	was	_	VBD	VBD	_	24	auxpass	_	_
24	found	_	VBN	VBN	_	1	parataxis	_	_
25	to	_	TO	TO	_	27	aux	_	_
26	be	_	VB	VB	_	27	auxpass	_	_
27	required	_	VBN	VBN	_	24	xcomp	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	activation	_	NN	NN	_	28	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	Jak	_	NN	NN	_	32	nn	_	_
32	kinases	_	NNS	NNS	_	30	pobj	_	_
33	,	_	,	,	_	29	punct	_	_
34	tyrosine	_	NN	NN	_	35	nn	_	_
35	phosphorylation	_	NN	NN	_	29	conj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	38	det	_	_
38	G-CSFR	_	NN	NN	_	36	pobj	_	_
39	,	_	,	,	_	29	punct	_	_
40	and	_	CC	CC	_	29	cc	_	_
41	recruitment	_	NN	NN	_	29	conj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	Stat	_	NN	NN	_	44	nn	_	_
44	proteins	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	1	punct	_	_

1	Notably	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	no	_	DT	DT	_	4	neg	_	_
4	activation	_	NN	NN	_	17	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Jak1	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	Jak2	_	NN	NN	_	6	conj	_	_
9	,	_	,	,	_	6	punct	_	_
10	Tyk2	_	NN	NN	_	6	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	Stat1	_	NN	NN	_	6	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	or	_	CC	CC	_	6	cc	_	_
15	Stat3	_	NN	NN	_	6	conj	_	_
16	was	_	VBD	VBD	_	17	auxpass	_	_
17	observed	_	VBN	VBN	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	neutrophils	_	NNS	NNS	_	18	pobj	_	_
20	following	_	VBG	VBG	_	17	prep	_	_
21	G-CSF	_	NN	NN	_	22	nn	_	_
22	stimulation	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	there	_	EX	EX	_	5	expl	_	_
5	was	_	VBD	VBD	_	0	root	_	_
6	no	_	DT	DT	_	8	neg	_	_
7	detectable	_	JJ	JJ	_	8	amod	_	_
8	activation	_	NN	NN	_	5	nsubj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	neutrophils	_	NNS	NNS	_	9	pobj	_	_
11	of	_	IN	IN	_	8	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	recently	_	RB	RB	_	14	advmod	_	_
14	cloned	_	VBN	VBN	_	16	amod	_	_
15	Jak3	_	NN	NN	_	16	nn	_	_
16	kinase	_	NN	NN	_	11	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	which	_	WDT	WDT	_	21	nsubjpass	_	_
19	has	_	VBZ	VBZ	_	21	aux	_	_
20	been	_	VBN	VBN	_	21	auxpass	_	_
21	reported	_	VBN	VBN	_	16	rcmod	_	_
22	to	_	TO	TO	_	24	aux	_	_
23	be	_	VB	VB	_	24	auxpass	_	_
24	expressed	_	VBN	VBN	_	21	xcomp	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	high	_	JJ	JJ	_	27	amod	_	_
27	levels	_	NNS	NNS	_	25	pobj	_	_
28	as	_	IN	IN	_	31	mark	_	_
29	myeloid	_	JJ	JJ	_	30	amod	_	_
30	cells	_	NNS	NNS	_	31	nsubj	_	_
31	undergo	_	VBP	VBP	_	21	advcl	_	_
32	terminal	_	JJ	JJ	_	34	amod	_	_
33	neutrophilic	_	JJ	JJ	_	32	dep	_	_
34	maturation	_	NN	NN	_	31	dobj	_	_
35	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	lack	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	involvement	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	Jak	_	NN	NN	_	10	nn	_	_
10	kinases	_	NNS	NNS	_	8	pobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	signaling	_	NN	NN	_	11	pobj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	G-CSFR	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	12	prep	_	_
17	neutrophils	_	NNS	NNS	_	16	pobj	_	_
18	,	_	,	,	_	3	punct	_	_
19	and	_	CC	CC	_	3	cc	_	_
20	suggest	_	VBP	VBP	_	3	conj	_	_
21	utilization	_	NN	NN	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	alternative	_	JJ	JJ	_	26	amod	_	_
24	signal	_	NN	NN	_	26	nn	_	_
25	transduction	_	NN	NN	_	26	nn	_	_
26	pathways	_	NNS	NNS	_	22	pobj	_	_
27	distinct	_	JJ	JJ	_	26	amod	_	_
28	from	_	IN	IN	_	27	prep	_	_
29	those	_	DT	DT	_	28	pobj	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	proliferating	_	VBG	VBG	_	32	amod	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Activation	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	Jak-Stat	_	JJ	JJ	_	5	amod	_	_
5	pathway	_	NN	NN	_	2	pobj	_	_
6	correlates	_	VBZ	VBZ	_	0	root	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	proliferative	_	JJ	JJ	_	9	amod	_	_
9	signaling	_	NN	NN	_	7	pobj	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	G-CSFR	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	requires	_	VBZ	VBZ	_	6	conj	_	_
15	the	_	DT	DT	_	20	det	_	_
16	membrane-proximal	_	JJ	JJ	_	20	amod	_	_
17	box	_	NN	NN	_	20	nn	_	_
18	1	_	CD	CD	_	20	num	_	_
19	PXP	_	NN	NN	_	20	nn	_	_
20	motif	_	NN	NN	_	14	dobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	which	_	WDT	WDT	_	24	nsubjpass	_	_
23	is	_	VBZ	VBZ	_	24	auxpass	_	_
24	conserved	_	VBN	VBN	_	20	rcmod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	members	_	NNS	NNS	_	25	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	cytokine	_	NN	NN	_	31	nn	_	_
30	receptor	_	NN	NN	_	31	nn	_	_
31	superfamily	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	6	punct	_	_

1	Adenovirus	_	NN	NN	_	4	nn	_	_
2	E1B	_	NN	NN	_	4	nn	_	_
3	19K	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	required	_	VBN	VBN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	efficient	_	JJ	JJ	_	10	amod	_	_
9	DNA	_	NN	NN	_	10	nn	_	_
10	replication	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	U937	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	adenovirus	_	NN	NN	_	5	nn	_	_
3	E1B	_	NN	NN	_	5	nn	_	_
4	19K	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	6	nsubj	_	_
6	plays	_	VBZ	VBZ	_	0	root	_	_
7	an	_	DT	DT	_	9	det	_	_
8	essential	_	JJ	JJ	_	9	amod	_	_
9	role	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	6	prep	_	_
11	transformation	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	primary	_	JJ	JJ	_	15	amod	_	_
14	rodent	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	in	_	IN	IN	_	11	prep	_	_
17	cooperation	_	NN	NN	_	16	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	E1A	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	10	cc	_	_
21	in	_	IN	IN	_	10	conj	_	_
22	the	_	DT	DT	_	23	det	_	_
23	inhibition	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	apoptosis	_	NN	NN	_	24	pobj	_	_
26	during	_	IN	IN	_	23	prep	_	_
27	lytic	_	JJ	JJ	_	28	amod	_	_
28	infection	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	6	punct	_	_

1	It	_	PRP	PRP	_	4	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	shown	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	this	_	DT	DT	_	9	det	_	_
7	E1B	_	NN	NN	_	9	nn	_	_
8	19K	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	12	nsubj	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	not	_	RB	RB	_	12	neg	_	_
12	necessary	_	JJ	JJ	_	4	ccomp	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	viral	_	JJ	JJ	_	16	amod	_	_
15	DNA	_	NN	NN	_	16	nn	_	_
16	replication	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	such	_	JJ	JJ	_	23	mwe	_	_
23	as	_	IN	IN	_	20	prep	_	_
24	HeLa	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	KB	_	NN	NN	_	24	conj	_	_
27	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	reported	_	VBD	VBD	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	the	_	DT	DT	_	9	det	_	_
6	E1B	_	NN	NN	_	7	nn	_	_
7	19K	_	NN	NN	_	9	nn	_	_
8	mutant	_	JJ	JJ	_	9	amod	_	_
9	viruses	_	NNS	NNS	_	11	nsubj	_	_
10	were	_	VBD	VBD	_	11	cop	_	_
11	unable	_	JJ	JJ	_	2	ccomp	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	replicate	_	VB	VB	_	11	xcomp	_	_
14	efficiently	_	RB	RB	_	13	advmod	_	_
15	in	_	IN	IN	_	13	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	monocyte	_	NN	NN	_	19	nn	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	line	_	NN	NN	_	15	pobj	_	_
20	,	_	,	,	_	19	punct	_	_
21	U937	_	NN	NN	_	19	appos	_	_
22	.	_	.	.	_	2	punct	_	_

1	Viral	_	JJ	JJ	_	3	amod	_	_
2	DNA	_	NN	NN	_	3	nn	_	_
3	synthesis	_	NN	NN	_	9	nsubjpass	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	late	_	JJ	JJ	_	7	amod	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	3	conj	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	found	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	be	_	VB	VB	_	12	cop	_	_
12	defective	_	JJ	JJ	_	9	xcomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	U937	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	infected	_	VBN	VBN	_	15	vmod	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	E1B	_	NN	NN	_	19	nn	_	_
19	19K	_	NN	NN	_	20	nn	_	_
20	mutants	_	NNS	NNS	_	17	pobj	_	_
21	compared	_	VBN	VBN	_	12	prep	_	_
22	with	_	IN	IN	_	21	pcomp	_	_
23	wild-type	_	JJ	JJ	_	24	amod	_	_
24	virus	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	9	punct	_	_

1	Early	_	RB	RB	_	5	amod	_	_
2	viral	_	JJ	JJ	_	1	dep	_	_
3	RNA	_	NN	NN	_	5	nn	_	_
4	splicing	_	NN	NN	_	5	nn	_	_
5	patterns	_	NNS	NNS	_	7	nsubj	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	differ	_	VBP	VBP	_	0	root	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	wild-type	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	dl337-infected	_	JJ	JJ	_	9	conj	_	_
12	cells	_	NNS	NNS	_	9	dep	_	_
13	.	_	.	.	_	7	punct	_	_

1	Furthermore	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	defect	_	NN	NN	_	10	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	viral	_	JJ	JJ	_	7	amod	_	_
7	replication	_	NN	NN	_	5	pobj	_	_
8	could	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	complemented	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	dl312	_	NN	NN	_	13	nn	_	_
13	virus	_	NN	NN	_	11	pobj	_	_
14	defective	_	JJ	JJ	_	13	amod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	E1A	_	NN	NN	_	17	nn	_	_
17	expression	_	NN	NN	_	15	pobj	_	_
18	4	_	CD	CD	_	19	num	_	_
19	days	_	NNS	NNS	_	20	npadvmod	_	_
20	after	_	IN	IN	_	10	prep	_	_
21	infection	_	NN	NN	_	20	pobj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	E1B	_	NN	NN	_	24	nn	_	_
24	mutants	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	10	punct	_	_
26	suggesting	_	VBG	VBG	_	10	vmod	_	_
27	persistence	_	NN	NN	_	26	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	32	det	_	_
30	E1B	_	NN	NN	_	32	nn	_	_
31	mutant	_	JJ	JJ	_	32	amod	_	_
32	genome	_	NN	NN	_	28	pobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	infected	_	JJ	JJ	_	36	amod	_	_
36	cells	_	NNS	NNS	_	33	pobj	_	_
37	despite	_	IN	IN	_	27	prep	_	_
38	defective	_	JJ	JJ	_	39	amod	_	_
39	onset	_	NN	NN	_	37	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	the	_	DT	DT	_	43	det	_	_
42	late	_	JJ	JJ	_	43	amod	_	_
43	phase	_	NN	NN	_	40	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	replication	_	NN	NN	_	44	pobj	_	_
46	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	imply	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	E1B	_	NN	NN	_	6	nn	_	_
6	19K	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	required	_	VBN	VBN	_	3	ccomp	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	efficient	_	JJ	JJ	_	13	amod	_	_
11	viral	_	JJ	JJ	_	10	dep	_	_
12	DNA	_	NN	NN	_	13	nn	_	_
13	replication	_	NN	NN	_	9	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	U937	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Inefficient	_	JJ	JJ	_	3	amod	_	_
2	DNA	_	NN	NN	_	3	nn	_	_
3	replication	_	NN	NN	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	another	_	DT	DT	_	11	det	_	_
9	monocyte	_	NN	NN	_	11	nn	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	line	_	NN	NN	_	7	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	THP-1	_	NN	NN	_	11	appos	_	_
14	.	_	.	.	_	6	punct	_	_

1	Interaction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	2	pobj	_	_
5	RFX1	_	NN	NN	_	4	dep	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	MIBP1	_	NN	NN	_	5	conj	_	_
8	with	_	IN	IN	_	1	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	gamma	_	NN	NN	_	11	nn	_	_
11	motif	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	negative	_	JJ	JJ	_	16	amod	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	element	_	NN	NN	_	12	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	23	det	_	_
19	hepatitis	_	NN	NN	_	23	nn	_	_
20	B	_	NN	NN	_	23	nn	_	_
21	virus	_	NN	NN	_	23	nn	_	_
22	core	_	NN	NN	_	23	nn	_	_
23	promoter	_	NN	NN	_	17	pobj	_	_
24	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	negative	_	JJ	JJ	_	4	amod	_	_
3	regulatory	_	JJ	JJ	_	4	amod	_	_
4	element	_	NN	NN	_	18	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	NRE	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	of	_	IN	IN	_	4	prep	_	_
9	the	_	DT	DT	_	17	det	_	_
10	hepatitis	_	NN	NN	_	17	nn	_	_
11	B	_	NN	NN	_	17	nn	_	_
12	virus	_	NN	NN	_	17	nn	_	_
13	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
14	HBV	_	NN	NN	_	17	nn	_	_
15	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
16	core	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	8	pobj	_	_
18	contains	_	VBZ	VBZ	_	0	root	_	_
19	three	_	CD	CD	_	20	num	_	_
20	subregions	_	NNS	NNS	_	18	dobj	_	_
21	which	_	WDT	WDT	_	22	nsubj	_	_
22	act	_	VBP	VBP	_	20	rcmod	_	_
23	synergistically	_	RB	RB	_	22	advmod	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	suppress	_	VB	VB	_	22	xcomp	_	_
26	core	_	NN	NN	_	28	nn	_	_
27	promoter	_	NN	NN	_	28	nn	_	_
28	activity	_	NN	NN	_	25	dobj	_	_
29	.	_	.	.	_	18	punct	_	_

1	One	_	CD	CD	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	subregions	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	1	punct	_	_
6	NRE	_	NN	NN	_	7	nn	_	_
7	gamma	_	NN	NN	_	1	appos	_	_
8	,	_	,	,	_	1	punct	_	_
9	is	_	VBZ	VBZ	_	10	cop	_	_
10	active	_	JJ	JJ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	both	_	CC	CC	_	16	preconj	_	_
13	HeLa	_	NN	NN	_	16	nn	_	_
14	cervical	_	JJ	JJ	_	16	amod	_	_
15	carcinoma	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	11	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	Huh7	_	NN	NN	_	20	nn	_	_
19	hepatoma	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	conj	_	_
21	and	_	CC	CC	_	10	cc	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	found	_	VBN	VBN	_	10	conj	_	_
24	to	_	TO	TO	_	26	aux	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	bound	_	VBN	VBN	_	23	xcomp	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	a	_	DT	DT	_	30	det	_	_
29	protein	_	NN	NN	_	30	nn	_	_
30	factor	_	NN	NN	_	27	pobj	_	_
31	present	_	JJ	JJ	_	30	amod	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	both	_	DT	DT	_	35	det	_	_
34	cell	_	NN	NN	_	35	nn	_	_
35	types	_	NNS	NNS	_	32	pobj	_	_
36	.	_	.	.	_	10	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	10	nsubj	_	_
8	RFX1	_	NN	NN	_	7	dep	_	_
9	can	_	MD	MD	_	10	aux	_	_
10	bind	_	VB	VB	_	3	ccomp	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	NRE	_	NN	NN	_	13	nn	_	_
13	gamma	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	transactivate	_	VB	VB	_	10	conj	_	_
16	the	_	DT	DT	_	18	det	_	_
17	core	_	NN	NN	_	18	nn	_	_
18	promoter	_	NN	NN	_	15	dobj	_	_
19	through	_	IN	IN	_	15	prep	_	_
20	this	_	DT	DT	_	21	det	_	_
21	site	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Mutations	_	NNS	NNS	_	10	nsubj	_	_
2	which	_	WDT	WDT	_	3	nsubj	_	_
3	abrogated	_	VBD	VBD	_	1	rcmod	_	_
4	the	_	DT	DT	_	6	det	_	_
5	gene-suppressive	_	JJ	JJ	_	6	amod	_	_
6	activity	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	NRE	_	NN	NN	_	9	nn	_	_
9	gamma	_	NN	NN	_	7	pobj	_	_
10	prevented	_	VBD	VBD	_	0	root	_	_
11	RFX1	_	NN	NN	_	10	dobj	_	_
12	from	_	IN	IN	_	10	prep	_	_
13	binding	_	NN	NN	_	12	pobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	NRE	_	NN	NN	_	16	nn	_	_
16	gamma	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	RFX1	_	NN	NN	_	6	nsubj	_	_
5	can	_	MD	MD	_	6	aux	_	_
6	bind	_	VB	VB	_	0	root	_	_
7	simultaneously	_	RB	RB	_	6	advmod	_	_
8	,	_	,	,	_	6	punct	_	_
9	most	_	RBS	RBS	_	10	advmod	_	_
10	likely	_	JJ	JJ	_	11	advmod	_	_
11	as	_	IN	IN	_	6	prep	_	_
12	a	_	DT	DT	_	13	det	_	_
13	heterodimer	_	NN	NN	_	11	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	with	_	IN	IN	_	6	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	transcription	_	NN	NN	_	18	nn	_	_
18	factor	_	NN	NN	_	15	pobj	_	_
19	MIBP1	_	NN	NN	_	18	dep	_	_
20	to	_	TO	TO	_	18	prep	_	_
21	NRE	_	NN	NN	_	22	nn	_	_
22	gamma	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	absence	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	8	det	_	_
6	cloned	_	VBN	VBN	_	8	amod	_	_
7	MIBP1	_	NN	NN	_	8	nn	_	_
8	gene	_	NN	NN	_	4	pobj	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	further	_	JJ	JJ	_	11	amod	_	_
11	studies	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	14	punct	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	hypothesize	_	VBP	VBP	_	0	root	_	_
15	that	_	IN	IN	_	17	mark	_	_
16	RFX1	_	NN	NN	_	17	nsubj	_	_
17	acts	_	VBZ	VBZ	_	14	ccomp	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	MIBP1	_	NN	NN	_	18	pobj	_	_
20	to	_	TO	TO	_	22	aux	_	_
21	negatively	_	RB	RB	_	22	advmod	_	_
22	regulate	_	VB	VB	_	17	xcomp	_	_
23	the	_	DT	DT	_	26	det	_	_
24	core	_	NN	NN	_	26	nn	_	_
25	promoter	_	NN	NN	_	26	nn	_	_
26	activity	_	NN	NN	_	22	dobj	_	_
27	through	_	IN	IN	_	22	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	NRE	_	NN	NN	_	31	nn	_	_
30	gamma	_	NN	NN	_	31	nn	_	_
31	site	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	10	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	RFX1	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	transactivate	_	VB	VB	_	2	vmod	_	_
7	the	_	DT	DT	_	9	det	_	_
8	core	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	6	dobj	_	_
10	raises	_	VBZ	VBZ	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	possibility	_	NN	NN	_	10	dobj	_	_
13	that	_	IN	IN	_	16	mark	_	_
14	RFX1	_	NN	NN	_	16	nsubj	_	_
15	may	_	MD	MD	_	16	aux	_	_
16	play	_	VB	VB	_	12	ccomp	_	_
17	a	_	DT	DT	_	19	det	_	_
18	dual	_	JJ	JJ	_	19	amod	_	_
19	role	_	NN	NN	_	16	dobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	regulating	_	VBG	VBG	_	20	pcomp	_	_
22	HBV	_	NN	NN	_	24	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	10	punct	_	_

1	Evaluation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	monoclonal	_	JJ	JJ	_	5	amod	_	_
4	anti-D	_	JJ	JJ	_	5	amod	_	_
5	reagents	_	NNS	NNS	_	2	pobj	_	_
6	using	_	VBG	VBG	_	1	vmod	_	_
7	D	_	NN	NN	_	9	nn	_	_
8	variant	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	6	dobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Monoclonal	_	JJ	JJ	_	3	amod	_	_
2	anti-D	_	JJ	JJ	_	3	amod	_	_
3	antibodies	_	NNS	NNS	_	12	nsubjpass	_	_
4	submitted	_	VBN	VBN	_	3	vmod	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	Third	_	NNP	NNP	_	10	nn	_	_
8	Monoclonal	_	NNP	NNP	_	10	nn	_	_
9	International	_	NNP	NNP	_	10	nn	_	_
10	Workshop	_	NNP	NNP	_	5	pobj	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	evaluated	_	VBN	VBN	_	0	root	_	_
13	against	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	15	det	_	_
15	number	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	D	_	NN	NN	_	19	nn	_	_
18	variant	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	using	_	VBG	VBG	_	12	xcomp	_	_
21	standard	_	JJ	JJ	_	23	amod	_	_
22	serological	_	JJ	JJ	_	21	dep	_	_
23	techniques	_	NNS	NNS	_	20	dobj	_	_
24	.	_	.	.	_	12	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	monoclonal	_	JJ	JJ	_	3	amod	_	_
3	antibodies	_	NNS	NNS	_	5	nsubj	_	_
4	were	_	VBD	VBD	_	5	cop	_	_
5	able	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	discriminate	_	VB	VB	_	5	xcomp	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	Categories	_	NNS	NNS	_	11	pobj	_	_
13	Va	_	NN	NN	_	12	dep	_	_
14	,	_	,	,	_	12	punct	_	_
15	VI	_	NN	NN	_	12	conj	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	DFR	_	NN	NN	_	12	conj	_	_
18	but	_	CC	CC	_	19	cc	_	_
19	not	_	RB	RB	_	10	cc	_	_
20	Category	_	NN	NN	_	22	nn	_	_
21	III	_	CD	CD	_	22	num	_	_
22	cells	_	NNS	NNS	_	10	conj	_	_
23	.	_	.	.	_	5	punct	_	_

1	Cells	_	NNS	NNS	_	7	nsubj	_	_
2	within	_	IN	IN	_	1	prep	_	_
3	each	_	DT	DT	_	4	det	_	_
4	category	_	NN	NN	_	2	pobj	_	_
5	did	_	VBD	VBD	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	give	_	VB	VB	_	0	root	_	_
8	any	_	DT	DT	_	10	det	_	_
9	aberrant	_	JJ	JJ	_	10	amod	_	_
10	results	_	NNS	NNS	_	7	dobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	Rh	_	NN	NN	_	5	nn	_	_
3	:	_	:	:	_	5	punct	_	_
4	33	_	CD	CD	_	5	num	_	_
5	cells	_	NNS	NNS	_	6	nsubj	_	_
6	behaved	_	VBD	VBD	_	0	root	_	_
7	as	_	IN	IN	_	6	prep	_	_
8	normal	_	JJ	JJ	_	14	amod	_	_
9	Rh	_	NN	NN	_	14	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
11	D	_	NN	NN	_	14	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
13	positive	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	7	pobj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Pancreatic	_	JJ	JJ	_	2	amod	_	_
2	development	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	maturation	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	islet	_	NN	NN	_	9	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	cell	_	NN	NN	_	5	pobj	_	_
10	.	_	.	.	_	2	punct	_	_

1	Studies	_	NNS	NNS	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	pluripotent	_	JJ	JJ	_	5	amod	_	_
4	islet	_	NN	NN	_	5	nn	_	_
5	cultures	_	NNS	NNS	_	2	pobj	_	_
6	.	_	.	.	_	1	punct	_	_

1	Pancreas	_	NN	NN	_	2	nn	_	_
2	organogenesis	_	NN	NN	_	7	nsubj	_	_
3	is	_	VBZ	VBZ	_	7	cop	_	_
4	a	_	DT	DT	_	7	det	_	_
5	highly	_	RB	RB	_	6	advmod	_	_
6	regulated	_	VBN	VBN	_	7	amod	_	_
7	process	_	NN	NN	_	0	root	_	_
8	,	_	,	,	_	7	punct	_	_
9	in	_	IN	IN	_	13	prep	_	_
10	which	_	WDT	WDT	_	9	pobj	_	_
11	two	_	CD	CD	_	12	num	_	_
12	anlage	_	NNS	NNS	_	13	nsubj	_	_
13	evaginate	_	VBP	VBP	_	7	rcmod	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	primitive	_	JJ	JJ	_	17	amod	_	_
17	gut	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	7	punct	_	_

1	They	_	PRP	PRP	_	3	nsubj	_	_
2	later	_	RB	RB	_	3	advmod	_	_
3	fuse	_	VBP	VBP	_	0	root	_	_
4	,	_	,	,	_	3	punct	_	_
5	and	_	CC	CC	_	3	cc	_	_
6	,	_	,	,	_	3	punct	_	_
7	under	_	IN	IN	_	18	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	influence	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	surrounding	_	VBG	VBG	_	13	amod	_	_
13	mesenchyme	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	18	punct	_	_
15	the	_	DT	DT	_	17	det	_	_
16	mature	_	JJ	JJ	_	17	amod	_	_
17	organ	_	NN	NN	_	18	nsubj	_	_
18	develops	_	VBZ	VBZ	_	3	conj	_	_
19	,	_	,	,	_	18	punct	_	_
20	being	_	VBG	VBG	_	22	auxpass	_	_
21	mainly	_	RB	RB	_	22	advmod	_	_
22	composed	_	VBN	VBN	_	18	xcomp	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	ductal	_	JJ	JJ	_	29	amod	_	_
25	,	_	,	,	_	24	punct	_	_
26	exocrine	_	JJ	JJ	_	24	conj	_	_
27	and	_	CC	CC	_	24	cc	_	_
28	endocrine	_	JJ	JJ	_	24	conj	_	_
29	compartments	_	NNS	NNS	_	23	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Early	_	JJ	JJ	_	2	amod	_	_
2	buds	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	characterized	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	a	_	DT	DT	_	8	det	_	_
7	branching	_	VBG	VBG	_	8	amod	_	_
8	morphogenesis	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	ductal	_	JJ	JJ	_	12	amod	_	_
12	epithelium	_	NN	NN	_	9	pobj	_	_
13	from	_	IN	IN	_	20	prep	_	_
14	which	_	WDT	WDT	_	13	pobj	_	_
15	endocrine	_	JJ	JJ	_	19	amod	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	exocrine	_	JJ	JJ	_	15	conj	_	_
18	precursor	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	20	nsubj	_	_
20	bud	_	VBP	VBP	_	12	rcmod	_	_
21	to	_	TO	TO	_	23	aux	_	_
22	eventually	_	RB	RB	_	23	advmod	_	_
23	form	_	VB	VB	_	20	xcomp	_	_
24	the	_	DT	DT	_	27	det	_	_
25	two	_	CD	CD	_	27	num	_	_
26	other	_	JJ	JJ	_	27	amod	_	_
27	compartments	_	NNS	NNS	_	23	dobj	_	_
28	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	three	_	CD	CD	_	3	num	_	_
3	compartments	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	thought	_	VBN	VBN	_	0	root	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	be	_	VB	VB	_	5	xcomp	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	common	_	JJ	JJ	_	11	amod	_	_
10	endodermal	_	JJ	JJ	_	11	amod	_	_
11	origin	_	NN	NN	_	8	pobj	_	_
12	;	_	:	:	_	7	punct	_	_
13	in	_	IN	IN	_	7	prep	_	_
14	contrast	_	NN	NN	_	13	dep	_	_
15	to	_	TO	TO	_	13	dep	_	_
16	earlier	_	JJR	JJR	_	17	amod	_	_
17	hypotheses	_	NNS	NNS	_	13	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	suggested	_	VBD	VBD	_	17	rcmod	_	_
21	that	_	IN	IN	_	25	mark	_	_
22	the	_	DT	DT	_	24	det	_	_
23	endocrine	_	JJ	JJ	_	24	amod	_	_
24	compartment	_	NN	NN	_	25	nsubj	_	_
25	was	_	VBD	VBD	_	20	ccomp	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	neuroectodermal	_	JJ	JJ	_	28	amod	_	_
28	origin	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	5	punct	_	_

1	It	_	PRP	PRP	_	5	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	5	auxpass	_	_
3	thus	_	RB	RB	_	5	advmod	_	_
4	generally	_	RB	RB	_	5	advmod	_	_
5	believed	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	the	_	DT	DT	_	9	det	_	_
8	pancreatic	_	JJ	JJ	_	9	amod	_	_
9	endocrine-lineage	_	NN	NN	_	10	nsubj	_	_
10	possesses	_	VBZ	VBZ	_	5	ccomp	_	_
11	the	_	DT	DT	_	12	det	_	_
12	ability	_	NN	NN	_	10	dobj	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	mature	_	VB	VB	_	12	vmod	_	_
15	along	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	differentiation	_	NN	NN	_	18	nn	_	_
18	pathway	_	NN	NN	_	15	pobj	_	_
19	that	_	WDT	WDT	_	20	nsubj	_	_
20	shares	_	VBZ	VBZ	_	18	rcmod	_	_
21	many	_	JJ	JJ	_	22	amod	_	_
22	characteristics	_	NNS	NNS	_	20	dobj	_	_
23	with	_	IN	IN	_	20	prep	_	_
24	those	_	DT	DT	_	23	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	neuronal	_	JJ	JJ	_	27	amod	_	_
27	differentiation	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	5	punct	_	_

1	During	_	IN	IN	_	22	prep	_	_
2	recent	_	JJ	JJ	_	3	amod	_	_
3	years	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	22	punct	_	_
5	studies	_	NNS	NNS	_	22	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	insulin-gene	_	JJ	JJ	_	8	amod	_	_
8	regulation	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	,	_	,	,	_	8	punct	_	_
11	in	_	IN	IN	_	17	prep	_	_
12	particular	_	JJ	JJ	_	11	pobj	_	_
13	,	_	,	,	_	17	punct	_	_
14	the	_	DT	DT	_	17	det	_	_
15	tissue-specific	_	JJ	JJ	_	17	amod	_	_
16	transcriptional	_	JJ	JJ	_	17	amod	_	_
17	control	_	NN	NN	_	8	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	insulin-gene	_	JJ	JJ	_	20	amod	_	_
20	activity	_	NN	NN	_	18	pobj	_	_
21	have	_	VBP	VBP	_	22	aux	_	_
22	provided	_	VBN	VBN	_	0	root	_	_
23	information	_	NN	NN	_	22	dobj	_	_
24	on	_	IN	IN	_	23	prep	_	_
25	pancreas	_	NN	NN	_	26	nn	_	_
26	development	_	NN	NN	_	24	pobj	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	general	_	JJ	JJ	_	27	pobj	_	_
29	.	_	.	.	_	22	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	review	_	NN	NN	_	4	nsubj	_	_
4	summarizes	_	VBZ	VBZ	_	0	root	_	_
5	these	_	DT	DT	_	6	det	_	_
6	findings	_	NNS	NNS	_	4	dobj	_	_
7	,	_	,	,	_	4	punct	_	_
8	with	_	IN	IN	_	4	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	special	_	JJ	JJ	_	11	amod	_	_
11	focus	_	NN	NN	_	8	pobj	_	_
12	on	_	IN	IN	_	11	prep	_	_
13	our	_	PRP$	PRP$	_	15	poss	_	_
14	own	_	JJ	JJ	_	15	amod	_	_
15	studies	_	NNS	NNS	_	12	pobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	pluripotent	_	JJ	JJ	_	19	amod	_	_
18	endocrine	_	JJ	JJ	_	19	amod	_	_
19	cultures	_	NNS	NNS	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	rat	_	NN	NN	_	22	nn	_	_
22	pancreas	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	vascular	_	JJ	JJ	_	6	amod	_	_
4	cell	_	NN	NN	_	6	nn	_	_
5	adhesion	_	NN	NN	_	6	nn	_	_
6	molecule-1	_	NN	NN	_	2	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	low-density	_	JJ	JJ	_	9	amod	_	_
9	lipoprotein	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Low-density	_	JJ	JJ	_	2	amod	_	_
2	lipoprotein	_	NN	NN	_	10	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	LDL	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	is	_	VBZ	VBZ	_	10	cop	_	_
7	a	_	DT	DT	_	10	det	_	_
8	well-established	_	JJ	JJ	_	10	amod	_	_
9	risk	_	NN	NN	_	10	nn	_	_
10	factor	_	NN	NN	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	atherosclerosis	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	10	punct	_	_

1	When	_	WRB	WRB	_	5	advmod	_	_
2	endothelial	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	incubated	_	VBN	VBN	_	16	advcl	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	this	_	DT	DT	_	8	det	_	_
8	lipoprotein	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	pathophysiologic	_	JJ	JJ	_	11	amod	_	_
11	amounts	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	16	punct	_	_
13	the	_	DT	DT	_	14	det	_	_
14	cells	_	NNS	NNS	_	16	nsubjpass	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	activated	_	VBN	VBN	_	0	root	_	_
17	.	_	.	.	_	16	punct	_	_

1	Among	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	documented	_	VBN	VBN	_	5	amod	_	_
4	cellular	_	JJ	JJ	_	5	amod	_	_
5	responses	_	NNS	NNS	_	1	pobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	LDL	_	NN	NN	_	6	pobj	_	_
8	is	_	VBZ	VBZ	_	0	root	_	_
9	increased	_	VBN	VBN	_	10	amod	_	_
10	recruitment	_	NN	NN	_	8	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	monocytes	_	NNS	NNS	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	which	_	WDT	WDT	_	16	nsubjpass	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	believed	_	VBN	VBN	_	12	rcmod	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	play	_	VB	VB	_	16	xcomp	_	_
19	a	_	DT	DT	_	21	det	_	_
20	major	_	JJ	JJ	_	21	amod	_	_
21	role	_	NN	NN	_	18	dobj	_	_
22	in	_	IN	IN	_	18	prep	_	_
23	promoting	_	VBG	VBG	_	22	pcomp	_	_
24	intimal	_	JJ	JJ	_	26	amod	_	_
25	plaque	_	NN	NN	_	26	nn	_	_
26	formation	_	NN	NN	_	23	dobj	_	_
27	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	findings	_	NNS	NNS	_	5	nsubj	_	_
3	presented	_	VBN	VBN	_	2	vmod	_	_
4	here	_	RB	RB	_	3	advmod	_	_
5	link	_	VB	VB	_	0	root	_	_
6	an	_	DT	DT	_	8	det	_	_
7	atheogenic	_	JJ	JJ	_	8	amod	_	_
8	lipoprotein	_	NN	NN	_	5	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	LDL	_	NN	NN	_	8	appos	_	_
11	,	_	,	,	_	8	punct	_	_
12	with	_	IN	IN	_	5	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	induction	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	an	_	DT	DT	_	18	det	_	_
17	adhesion	_	NN	NN	_	18	nn	_	_
18	molecule	_	NN	NN	_	15	pobj	_	_
19	important	_	JJ	JJ	_	18	amod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	atherogenesis	_	NN	NN	_	20	pobj	_	_

1	Human	_	JJ	JJ	_	2	amod	_	_
2	LDL	_	NN	NN	_	3	nsubj	_	_
3	induces	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	8	det	_	_
5	vascular	_	JJ	JJ	_	8	amod	_	_
6	cell	_	NN	NN	_	8	nn	_	_
7	adhesion	_	NN	NN	_	8	nn	_	_
8	molecule-1	_	NN	NN	_	3	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	VCAM-1	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	transcriptionally	_	RB	RB	_	3	advmod	_	_
13	with	_	IN	IN	_	3	prep	_	_
14	an	_	DT	DT	_	15	det	_	_
15	increase	_	NN	NN	_	13	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	mRNA	_	NN	NN	_	18	nn	_	_
18	levels	_	NNS	NNS	_	16	pobj	_	_
19	through	_	IN	IN	_	3	prep	_	_
20	activation	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	VCAM	_	NN	NN	_	24	nn	_	_
24	promoter	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	blocked	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	anti-VCAM	_	JJ	JJ	_	7	amod	_	_
7	antibodies	_	NNS	NNS	_	5	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	After	_	IN	IN	_	27	prep	_	_
2	a	_	DT	DT	_	4	det	_	_
3	2-day	_	JJ	JJ	_	4	amod	_	_
4	incubation	_	NN	NN	_	1	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	LDL	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	27	punct	_	_
8	the	_	DT	DT	_	9	det	_	_
9	binding	_	NN	NN	_	27	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	NF-kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	which	_	WDT	WDT	_	16	nsubjpass	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	believed	_	VBN	VBN	_	12	rcmod	_	_
17	to	_	TO	TO	_	22	aux	_	_
18	be	_	VB	VB	_	22	cop	_	_
19	a	_	DT	DT	_	22	det	_	_
20	key	_	JJ	JJ	_	22	amod	_	_
21	oxidative-stress	_	JJ	JJ	_	22	amod	_	_
22	sensor	_	NN	NN	_	16	xcomp	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	VCAM	_	NN	NN	_	25	nn	_	_
25	regulation	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	12	punct	_	_
27	remains	_	VBZ	VBZ	_	0	root	_	_
28	at	_	IN	IN	_	27	prep	_	_
29	basal	_	JJ	JJ	_	30	amod	_	_
30	level	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	27	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	18	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	activities	_	NNS	NNS	_	18	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	AP-1	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	GATA	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	18	punct	_	_
12	on	_	IN	IN	_	18	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	other	_	JJ	JJ	_	15	amod	_	_
15	hand	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	18	punct	_	_
17	are	_	VBP	VBP	_	18	auxpass	_	_
18	increased	_	VBN	VBN	_	0	root	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	LDL	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	18	punct	_	_

1	Thus	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	a	_	DT	DT	_	4	det	_	_
4	component	_	NN	NN	_	12	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	LDL-enhanced	_	JJ	JJ	_	8	amod	_	_
7	endothelial	_	JJ	JJ	_	8	amod	_	_
8	recruitment	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	monocytes	_	NNS	NNS	_	9	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	attributed	_	VBN	VBN	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	VCAM-1	_	JJ	JJ	_	15	amod	_	_
15	expression	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	which	_	WDT	WDT	_	18	nsubj	_	_
18	appears	_	VBZ	VBZ	_	15	rcmod	_	_
19	to	_	TO	TO	_	21	aux	_	_
20	be	_	VB	VB	_	21	auxpass	_	_
21	mediated	_	VBN	VBN	_	18	xcomp	_	_
22	through	_	IN	IN	_	21	prep	_	_
23	AP-1	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	GATA	_	NN	NN	_	23	conj	_	_
26	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	identify	_	VBP	VBP	_	0	root	_	_
4	LDL	_	NN	NN	_	3	dobj	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	a	_	DT	DT	_	7	det	_	_
7	VCAM-inducer	_	NN	NN	_	5	pobj	_	_
8	possibly	_	RB	RB	_	9	advmod	_	_
9	distinct	_	JJ	JJ	_	7	amod	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	cytokines	_	NNS	NNS	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	endotoxin	_	NN	NN	_	11	conj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Cloning	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	expression	_	NN	NN	_	1	conj	_	_
4	of	_	IN	IN	_	1	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	glucocorticoid	_	NN	NN	_	7	nn	_	_
7	receptor	_	NN	NN	_	4	pobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	squirrel	_	NN	NN	_	11	nn	_	_
11	monkey	_	NN	NN	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	Saimiri	_	FW	FW	_	15	nn	_	_
14	boliviensis	_	FW	FW	_	15	nn	_	_
15	boliviensis	_	FW	FW	_	11	dep	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	,	_	,	,	_	11	punct	_	_
18	a	_	DT	DT	_	20	det	_	_
19	glucocorticoid-resistant	_	JJ	JJ	_	20	amod	_	_
20	primate	_	NN	NN	_	11	appos	_	_
21	.	_	.	.	_	1	punct	_	_

1	New	_	JJ	JJ	_	3	amod	_	_
2	World	_	NN	NN	_	3	nn	_	_
3	primates	_	NNS	NNS	_	10	nsubj	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	squirrel	_	NN	NN	_	8	nn	_	_
8	monkey	_	NN	NN	_	5	pobj	_	_
9	have	_	VBP	VBP	_	10	aux	_	_
10	elevated	_	VBN	VBN	_	0	root	_	_
11	cortisol	_	NN	NN	_	12	nn	_	_
12	levels	_	NNS	NNS	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	glucocorticoid	_	NN	NN	_	15	nn	_	_
15	resistance	_	NN	NN	_	12	conj	_	_
16	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	shown	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	apparent	_	JJ	JJ	_	8	amod	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	affinity	_	NN	NN	_	19	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	glucocorticoid	_	NN	NN	_	12	nn	_	_
12	receptor	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	squirrel	_	NN	NN	_	16	nn	_	_
15	monkey	_	NN	NN	_	16	nn	_	_
16	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
17	is	_	VBZ	VBZ	_	19	cop	_	_
18	5-fold	_	RB	RB	_	19	advmod	_	_
19	lower	_	JJR	JJR	_	3	ccomp	_	_
20	than	_	IN	IN	_	19	prep	_	_
21	that	_	DT	DT	_	20	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	human	_	JJ	JJ	_	24	amod	_	_
24	lymphocytes	_	NNS	NNS	_	22	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
26	apparent	_	JJ	JJ	_	27	amod	_	_
27	Kd	_	NN	NN	_	19	dep	_	_
28	,	_	,	,	_	27	punct	_	_
29	20.9	_	CD	CD	_	27	appos	_	_
30	+/-	_	CC	CC	_	29	cc	_	_
31	1.8	_	CD	CD	_	29	conj	_	_
32	and	_	CC	CC	_	29	cc	_	_
33	4.3	_	CD	CD	_	29	conj	_	_
34	+/-	_	CC	CC	_	33	cc	_	_
35	0.2	_	CD	CD	_	33	conj	_	_
36	nmol/L	_	NN	NN	_	29	dep	_	_
37	,	_	,	,	_	27	punct	_	_
38	respectively	_	RB	RB	_	27	advmod	_	_
39	;	_	:	:	_	27	punct	_	_
40	n	_	NN	NN	_	27	dep	_	_
41	=	_	JJ	JJ	_	40	amod	_	_
42	3	_	CD	CD	_	41	dep	_	_
43	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
44	,	_	,	,	_	19	punct	_	_
45	consistent	_	JJ	JJ	_	19	advmod	_	_
46	with	_	IN	IN	_	45	prep	_	_
47	previous	_	JJ	JJ	_	48	amod	_	_
48	studies	_	NNS	NNS	_	46	pobj	_	_
49	in	_	IN	IN	_	48	prep	_	_
50	mononuclear	_	JJ	JJ	_	51	amod	_	_
51	leukocytes	_	NNS	NNS	_	49	pobj	_	_
52	isolated	_	VBN	VBN	_	51	vmod	_	_
53	from	_	IN	IN	_	52	prep	_	_
54	the	_	DT	DT	_	56	det	_	_
55	two	_	CD	CD	_	56	num	_	_
56	species	_	NNS	NNS	_	53	pobj	_	_
57	.	_	.	.	_	3	punct	_	_

1	As	_	IN	IN	_	19	prep	_	_
2	a	_	DT	DT	_	4	det	_	_
3	first	_	JJ	JJ	_	4	amod	_	_
4	step	_	NN	NN	_	1	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	understanding	_	VBG	VBG	_	5	pcomp	_	_
7	the	_	DT	DT	_	8	det	_	_
8	mechanism	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	decreased	_	VBN	VBN	_	12	amod	_	_
11	binding	_	NN	NN	_	12	nn	_	_
12	affinity	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	New	_	JJ	JJ	_	16	amod	_	_
15	World	_	NN	NN	_	16	nn	_	_
16	primates	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	19	punct	_	_
18	we	_	PRP	PRP	_	19	nsubj	_	_
19	used	_	VBD	VBD	_	0	root	_	_
20	reverse	_	JJ	JJ	_	21	amod	_	_
21	transcription-PCR	_	NN	NN	_	19	dobj	_	_
22	to	_	TO	TO	_	23	aux	_	_
23	clone	_	VB	VB	_	19	vmod	_	_
24	the	_	DT	DT	_	26	det	_	_
25	glucocorticoid	_	NN	NN	_	26	nn	_	_
26	receptor	_	NN	NN	_	23	dobj	_	_
27	from	_	IN	IN	_	23	prep	_	_
28	squirrel	_	NN	NN	_	30	nn	_	_
29	monkey	_	NN	NN	_	30	nn	_	_
30	liver	_	NN	NN	_	27	pobj	_	_
31	and	_	CC	CC	_	19	cc	_	_
32	have	_	VBP	VBP	_	33	aux	_	_
33	compared	_	VBN	VBN	_	19	conj	_	_
34	the	_	DT	DT	_	35	det	_	_
35	sequence	_	NN	NN	_	33	dobj	_	_
36	to	_	TO	TO	_	33	prep	_	_
37	receptor	_	NN	NN	_	38	nn	_	_
38	sequences	_	NNS	NNS	_	36	pobj	_	_
39	obtained	_	VBN	VBN	_	38	vmod	_	_
40	from	_	IN	IN	_	39	prep	_	_
41	owl	_	NN	NN	_	43	nn	_	_
42	monkey	_	NN	NN	_	43	nn	_	_
43	liver	_	NN	NN	_	40	pobj	_	_
44	,	_	,	,	_	43	punct	_	_
45	cotton-top	_	JJ	JJ	_	48	amod	_	_
46	tamarin	_	NN	NN	_	48	nn	_	_
47	B95-8	_	NN	NN	_	48	nn	_	_
48	cells	_	NNS	NNS	_	43	conj	_	_
49	,	_	,	,	_	43	punct	_	_
50	and	_	CC	CC	_	43	cc	_	_
51	human	_	JJ	JJ	_	52	amod	_	_
52	lymphocytes	_	NNS	NNS	_	43	conj	_	_
53	.	_	.	.	_	19	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	squirrel	_	NN	NN	_	3	nn	_	_
3	monkey	_	NN	NN	_	10	nsubj	_	_
4	glucocorticoid	_	NN	NN	_	5	nn	_	_
5	receptor	_	NN	NN	_	3	dep	_	_
6	is	_	VBZ	VBZ	_	10	cop	_	_
7	approximately	_	RB	RB	_	8	quantmod	_	_
8	97	_	CD	CD	_	9	num	_	_
9	%	_	NN	NN	_	10	npadvmod	_	_
10	identical	_	JJ	JJ	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	nucleotide	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	amino	_	NN	NN	_	16	nn	_	_
15	acid	_	NN	NN	_	16	nn	_	_
16	sequence	_	NN	NN	_	12	conj	_	_
17	to	_	TO	TO	_	10	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	human	_	JJ	JJ	_	20	amod	_	_
20	receptor	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	ligand-binding	_	JJ	JJ	_	3	amod	_	_
3	domain	_	NN	NN	_	15	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	amino	_	NN	NN	_	6	nn	_	_
6	acids	_	NNS	NNS	_	3	appos	_	_
7	528-777	_	CD	CD	_	6	num	_	_
8	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
9	of	_	IN	IN	_	3	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	squirrel	_	NN	NN	_	12	nn	_	_
12	monkey	_	NN	NN	_	9	pobj	_	_
13	glucocorticoid	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	12	dep	_	_
15	contains	_	VBZ	VBZ	_	0	root	_	_
16	four	_	CD	CD	_	19	num	_	_
17	amino	_	NN	NN	_	19	nn	_	_
18	acid	_	NN	NN	_	19	nn	_	_
19	differences	_	NNS	NNS	_	15	dobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	Ser551	_	NN	NN	_	19	dep	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	Thr	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	21	punct	_	_
25	Ser616	_	NN	NN	_	21	conj	_	_
26	to	_	TO	TO	_	25	prep	_	_
27	Ala	_	NN	NN	_	26	pobj	_	_
28	,	_	,	,	_	21	punct	_	_
29	Ala618	_	NN	NN	_	21	conj	_	_
30	to	_	TO	TO	_	29	prep	_	_
31	Ser	_	NN	NN	_	30	pobj	_	_
32	,	_	,	,	_	21	punct	_	_
33	and	_	CC	CC	_	21	cc	_	_
34	Ile761	_	NN	NN	_	21	conj	_	_
35	to	_	TO	TO	_	34	prep	_	_
36	Leu	_	NN	NN	_	35	pobj	_	_
37	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
38	,	_	,	,	_	19	punct	_	_
39	all	_	DT	DT	_	43	nsubj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	which	_	WDT	WDT	_	40	pobj	_	_
42	are	_	VBP	VBP	_	43	cop	_	_
43	present	_	JJ	JJ	_	19	rcmod	_	_
44	in	_	IN	IN	_	43	prep	_	_
45	owl	_	NN	NN	_	46	nn	_	_
46	monkey	_	NN	NN	_	44	pobj	_	_
47	and	_	CC	CC	_	46	cc	_	_
48	cotton-top	_	JJ	JJ	_	49	amod	_	_
49	tamarin	_	NN	NN	_	46	conj	_	_
50	receptors	_	NNS	NNS	_	46	dep	_	_
51	.	_	.	.	_	15	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	DNA-binding	_	JJ	JJ	_	3	amod	_	_
3	domain	_	NN	NN	_	11	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
5	amino	_	NN	NN	_	6	nn	_	_
6	acids	_	NNS	NNS	_	3	appos	_	_
7	421-486	_	CD	CD	_	6	num	_	_
8	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
9	is	_	VBZ	VBZ	_	11	auxpass	_	_
10	completely	_	RB	RB	_	11	advmod	_	_
11	conserved	_	VBN	VBN	_	0	root	_	_
12	among	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	12	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	squirrel	_	NN	NN	_	16	nn	_	_
16	monkey	_	NN	NN	_	13	conj	_	_
17	,	_	,	,	_	13	punct	_	_
18	owl	_	NN	NN	_	19	nn	_	_
19	monkey	_	NN	NN	_	13	conj	_	_
20	,	_	,	,	_	13	punct	_	_
21	and	_	CC	CC	_	13	cc	_	_
22	cotton-top	_	JJ	JJ	_	23	amod	_	_
23	tamarin	_	NN	NN	_	13	conj	_	_
24	receptors	_	NNS	NNS	_	13	dep	_	_
25	.	_	.	.	_	11	punct	_	_

1	Twenty-two	_	CD	CD	_	2	num	_	_
2	differences	_	NNS	NNS	_	8	nsubjpass	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	human	_	JJ	JJ	_	6	amod	_	_
6	sequence	_	NN	NN	_	3	pobj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	found	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	N-terminal	_	JJ	JJ	_	12	amod	_	_
12	region	_	NN	NN	_	9	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
14	amino	_	NN	NN	_	15	nn	_	_
15	acids	_	NNS	NNS	_	12	appos	_	_
16	1-421	_	CD	CD	_	15	num	_	_
17	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
18	of	_	IN	IN	_	12	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	squirrel	_	NN	NN	_	22	nn	_	_
21	monkey	_	NN	NN	_	22	nn	_	_
22	receptor	_	NN	NN	_	18	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	None	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	substitutions	_	NNS	NNS	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	ligand-binding	_	JJ	JJ	_	8	amod	_	_
8	domain	_	NN	NN	_	5	pobj	_	_
9	matched	_	VBD	VBD	_	0	root	_	_
10	mutations	_	NNS	NNS	_	9	dobj	_	_
11	known	_	VBN	VBN	_	10	vmod	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	influence	_	VB	VB	_	11	xcomp	_	_
14	binding	_	NN	NN	_	15	nn	_	_
15	affinity	_	NN	NN	_	13	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	other	_	JJ	JJ	_	18	amod	_	_
18	species	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	9	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	whether	_	IN	IN	_	9	mark	_	_
4	the	_	DT	DT	_	5	det	_	_
5	substitutions	_	NNS	NNS	_	9	nsubj	_	_
6	per	_	FW	FW	_	7	nn	_	_
7	se	_	FW	FW	_	5	advmod	_	_
8	were	_	VBD	VBD	_	9	cop	_	_
9	responsible	_	JJ	JJ	_	2	ccomp	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	decreased	_	VBN	VBN	_	12	amod	_	_
12	affinity	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	squirrel	_	NN	NN	_	15	nn	_	_
15	monkey	_	NN	NN	_	21	nsubjpass	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	human	_	JJ	JJ	_	19	amod	_	_
18	glucocorticoid	_	NN	NN	_	19	nn	_	_
19	receptors	_	NNS	NNS	_	15	conj	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	expressed	_	VBN	VBN	_	2	parataxis	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	28	det	_	_
24	TNT	_	NN	NN	_	28	nn	_	_
25	Coupled	_	JJ	JJ	_	28	amod	_	_
26	Reticulocyte	_	NN	NN	_	28	nn	_	_
27	Lysate	_	NN	NN	_	28	nn	_	_
28	System	_	NN	NN	_	22	pobj	_	_
29	.	_	.	.	_	2	punct	_	_

1	Expressions	_	NNS	NNS	_	25	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	2	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	squirrel	_	NN	NN	_	6	nn	_	_
6	monkey	_	NN	NN	_	3	conj	_	_
7	glucocorticoid	_	NN	NN	_	8	nn	_	_
8	receptors	_	NNS	NNS	_	3	dep	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	a	_	DT	DT	_	13	det	_	_
11	squirrel	_	NN	NN	_	13	nn	_	_
12	monkey	_	NN	NN	_	13	nn	_	_
13	receptor	_	NN	NN	_	3	conj	_	_
14	in	_	IN	IN	_	18	prep	_	_
15	which	_	WDT	WDT	_	14	pobj	_	_
16	Phe774	_	NN	NN	_	18	nsubjpass	_	_
17	was	_	VBD	VBD	_	18	auxpass	_	_
18	mutated	_	VBN	VBN	_	3	rcmod	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	Leu	_	NN	NN	_	19	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	F774L	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	were	_	VBD	VBD	_	25	cop	_	_
25	similar	_	JJ	JJ	_	0	root	_	_
26	.	_	.	.	_	25	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	expressed	_	VBN	VBN	_	14	advcl	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	TNT	_	NN	NN	_	6	nn	_	_
6	System	_	NN	NN	_	3	pobj	_	_
7	,	_	,	,	_	14	punct	_	_
8	squirrel	_	NN	NN	_	9	nn	_	_
9	monkey	_	NN	NN	_	14	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	human	_	JJ	JJ	_	13	amod	_	_
12	glucocorticoid	_	NN	NN	_	13	nn	_	_
13	receptors	_	NNS	NNS	_	9	conj	_	_
14	had	_	VBD	VBD	_	0	root	_	_
15	similar	_	JJ	JJ	_	19	amod	_	_
16	,	_	,	,	_	15	punct	_	_
17	high	_	JJ	JJ	_	15	dep	_	_
18	affinity	_	NN	NN	_	19	nn	_	_
19	binding	_	NN	NN	_	14	dobj	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	dexamethasone	_	NN	NN	_	20	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
23	apparent	_	JJ	JJ	_	24	amod	_	_
24	Kd	_	NN	NN	_	19	dep	_	_
25	,	_	,	,	_	24	punct	_	_
26	5.9	_	CD	CD	_	24	appos	_	_
27	+/-	_	CC	CC	_	26	cc	_	_
28	1.2	_	CD	CD	_	26	conj	_	_
29	and	_	CC	CC	_	26	cc	_	_
30	4.3	_	CD	CD	_	26	conj	_	_
31	+/-	_	CC	CC	_	30	cc	_	_
32	0.5	_	CD	CD	_	30	conj	_	_
33	nmol/L	_	NN	NN	_	26	dep	_	_
34	,	_	,	,	_	26	punct	_	_
35	respectively	_	RB	RB	_	26	advmod	_	_
36	;	_	:	:	_	24	punct	_	_
37	n	_	NN	NN	_	24	dep	_	_
38	=	_	JJ	JJ	_	37	amod	_	_
39	3	_	CD	CD	_	38	dep	_	_
40	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
41	,	_	,	,	_	14	punct	_	_
42	whereas	_	IN	IN	_	48	mark	_	_
43	the	_	DT	DT	_	47	det	_	_
44	squirrel	_	NN	NN	_	47	nn	_	_
45	monkey	_	NN	NN	_	47	nn	_	_
46	F774L	_	NN	NN	_	47	nn	_	_
47	receptor	_	NN	NN	_	48	nsubj	_	_
48	had	_	VBD	VBD	_	14	advcl	_	_
49	lower	_	JJR	JJR	_	51	amod	_	_
50	affinity	_	NN	NN	_	51	nn	_	_
51	binding	_	NN	NN	_	48	dobj	_	_
52	-LRB-	_	-LRB-	-LRB-	_	54	punct	_	_
53	apparent	_	JJ	JJ	_	54	amod	_	_
54	Kd	_	NN	NN	_	51	dep	_	_
55	,	_	,	,	_	54	punct	_	_
56	20.4	_	CD	CD	_	59	num	_	_
57	+/-	_	CC	CC	_	56	cc	_	_
58	2.0	_	CD	CD	_	56	conj	_	_
59	nmol/L	_	NN	NN	_	54	appos	_	_
60	;	_	:	:	_	54	punct	_	_
61	n	_	NN	NN	_	54	dep	_	_
62	=	_	JJ	JJ	_	61	amod	_	_
63	3	_	CD	CD	_	62	dep	_	_
64	-RRB-	_	-RRB-	-RRB-	_	54	punct	_	_
65	.	_	.	.	_	14	punct	_	_

1	Thus	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	substitutions	_	NNS	NNS	_	16	nsubj	_	_
4	within	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	ligand-binding	_	JJ	JJ	_	7	amod	_	_
7	domain	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	squirrel	_	NN	NN	_	11	nn	_	_
11	monkey	_	NN	NN	_	8	pobj	_	_
12	glucocorticoid	_	NN	NN	_	13	nn	_	_
13	receptor	_	NN	NN	_	11	dep	_	_
14	can	_	MD	MD	_	16	aux	_	_
15	not	_	RB	RB	_	16	neg	_	_
16	account	_	VB	VB	_	0	root	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	decreased	_	VBN	VBN	_	21	amod	_	_
20	binding	_	NN	NN	_	21	nn	_	_
21	affinity	_	NN	NN	_	17	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	these	_	DT	DT	_	24	det	_	_
24	receptors	_	NNS	NNS	_	22	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	squirrel	_	NN	NN	_	28	nn	_	_
27	monkey	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	16	punct	_	_

1	Rather	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	binding	_	NN	NN	_	5	nn	_	_
5	affinity	_	NN	NN	_	8	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	8	auxpass	_	_
7	probably	_	RB	RB	_	8	advmod	_	_
8	influenced	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	expression	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	cytosolic	_	JJ	JJ	_	14	amod	_	_
14	factors	_	NNS	NNS	_	12	pobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	affect	_	VBP	VBP	_	14	rcmod	_	_
17	glucocorticoid	_	NN	NN	_	18	nn	_	_
18	receptor	_	NN	NN	_	19	nn	_	_
19	function	_	NN	NN	_	16	dobj	_	_
20	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	NF-kappa	_	NN	NN	_	4	nn	_	_
3	B	_	NN	NN	_	4	nn	_	_
4	inhibitor	_	NN	NN	_	8	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	tepoxalin	_	NN	NN	_	4	appos	_	_
7	,	_	,	,	_	4	punct	_	_
8	suppresses	_	VBZ	VBZ	_	0	root	_	_
9	surface	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	adhesion	_	NN	NN	_	15	nn	_	_
15	molecules	_	NNS	NNS	_	11	pobj	_	_
16	CD62E	_	NN	NN	_	15	dep	_	_
17	,	_	,	,	_	16	punct	_	_
18	CD11b/CD18	_	NN	NN	_	16	conj	_	_
19	and	_	CC	CC	_	16	cc	_	_
20	CD106	_	NN	NN	_	16	conj	_	_
21	.	_	.	.	_	8	punct	_	_

1	Tepoxalin	_	NN	NN	_	13	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	6	det	_	_
4	dual	_	JJ	JJ	_	6	amod	_	_
5	enzyme	_	NN	NN	_	6	nn	_	_
6	inhibitor	_	NN	NN	_	1	appos	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	cyclooxygenase	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	5-lipoxygenase	_	NN	NN	_	8	conj	_	_
11	has	_	VBZ	VBZ	_	13	aux	_	_
12	been	_	VBN	VBN	_	13	auxpass	_	_
13	shown	_	VBN	VBN	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	inhibit	_	VB	VB	_	13	xcomp	_	_
16	T-cell	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	15	dobj	_	_
18	.	_	.	.	_	13	punct	_	_

1	Its	_	PRP$	PRP$	_	3	poss	_	_
2	immunosuppressive	_	JJ	JJ	_	3	amod	_	_
3	property	_	NN	NN	_	5	nsubj	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	distinct	_	JJ	JJ	_	0	root	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	cyclosporin	_	NN	NN	_	6	pobj	_	_
8	because	_	IN	IN	_	16	mark	_	_
9	only	_	RB	RB	_	10	advmod	_	_
10	tepoxalin	_	NN	NN	_	16	nsubj	_	_
11	,	_	,	,	_	10	punct	_	_
12	but	_	CC	CC	_	13	cc	_	_
13	not	_	RB	RB	_	10	cc	_	_
14	cyclosporin	_	NN	NN	_	10	conj	_	_
15	,	_	,	,	_	10	punct	_	_
16	suppresses	_	VBZ	VBZ	_	5	advcl	_	_
17	NF-kappa	_	NN	NN	_	19	nn	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	activation	_	NN	NN	_	16	dobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	tepoxalin	_	NN	NN	_	7	nsubj	_	_
6	selectively	_	RB	RB	_	7	advmod	_	_
7	inhibits	_	VBZ	VBZ	_	3	ccomp	_	_
8	intercellular	_	JJ	JJ	_	18	amod	_	_
9	adhesion	_	NN	NN	_	18	nn	_	_
10	molecule-1	_	NN	NN	_	18	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
12	ICAM-1	_	NN	NN	_	18	nn	_	_
13	,	_	,	,	_	18	punct	_	_
14	CD54	_	NN	NN	_	18	dep	_	_
15	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
16	/MAC-1	_	NN	NN	_	18	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	CD11b/CD18	_	NN	NN	_	20	npadvmod	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	dependent	_	JJ	JJ	_	21	amod	_	_
21	adhesion	_	NN	NN	_	7	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	polymorphonuclear	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	to	_	TO	TO	_	21	prep	_	_
26	IL-1	_	NN	NN	_	27	npadvmod	_	_
27	activated	_	JJ	JJ	_	32	amod	_	_
28	human	_	JJ	JJ	_	32	amod	_	_
29	umbilical	_	JJ	JJ	_	32	amod	_	_
30	vein	_	NN	NN	_	32	nn	_	_
31	endothelial	_	JJ	JJ	_	32	amod	_	_
32	cells	_	NNS	NNS	_	25	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mechanism	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	inhibition	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	related	_	JJ	JJ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	surface	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	several	_	JJ	JJ	_	15	amod	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	adhesion	_	NN	NN	_	15	nn	_	_
15	molecules	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	Flow	_	NN	NN	_	3	nn	_	_
2	cytometry	_	NN	NN	_	3	nn	_	_
3	analyses	_	NNS	NNS	_	29	nsubj	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	cultured	_	VBN	VBN	_	6	amod	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	that	_	WDT	WDT	_	9	nsubjpass	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	treated	_	VBN	VBN	_	6	rcmod	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	tepoxalin	_	NN	NN	_	10	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	antisense	_	JJ	JJ	_	14	amod	_	_
14	oligonucleotides	_	NNS	NNS	_	11	conj	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	P65/p50	_	NN	NN	_	18	nn	_	_
18	subunit	_	NN	NN	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	19	pobj	_	_
22	,	_	,	,	_	9	punct	_	_
23	and	_	CC	CC	_	9	cc	_	_
24	then	_	RB	RB	_	25	advmod	_	_
25	stimulated	_	VBN	VBN	_	9	conj	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	PMA	_	NN	NN	_	26	pobj	_	_
28	,	_	,	,	_	9	punct	_	_
29	revealed	_	VBD	VBD	_	0	root	_	_
30	a	_	DT	DT	_	32	det	_	_
31	reduced	_	VBN	VBN	_	32	amod	_	_
32	expression	_	NN	NN	_	29	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	CD11b/CD18	_	NN	NN	_	33	pobj	_	_
35	on	_	IN	IN	_	32	prep	_	_
36	monocytic	_	JJ	JJ	_	38	amod	_	_
37	HL60	_	NN	NN	_	38	nn	_	_
38	cells	_	NNS	NNS	_	35	pobj	_	_
39	,	_	,	,	_	32	punct	_	_
40	and	_	CC	CC	_	32	cc	_	_
41	endothelial	_	JJ	JJ	_	43	amod	_	_
42	adhesion	_	NN	NN	_	43	nn	_	_
43	molecule-1	_	NN	NN	_	32	conj	_	_
44	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
45	CD62E	_	NN	NN	_	43	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	and	_	CC	CC	_	43	cc	_	_
48	vascular	_	JJ	JJ	_	50	amod	_	_
49	adhesion	_	NN	NN	_	50	nn	_	_
50	molecule-1	_	NN	NN	_	43	conj	_	_
51	-LRB-	_	-LRB-	-LRB-	_	52	punct	_	_
52	CD106	_	NN	NN	_	50	appos	_	_
53	-RRB-	_	-RRB-	-RRB-	_	52	punct	_	_
54	on	_	IN	IN	_	43	prep	_	_
55	human	_	JJ	JJ	_	59	amod	_	_
56	umbilical	_	JJ	JJ	_	59	amod	_	_
57	vein	_	NN	NN	_	59	nn	_	_
58	endothelial	_	JJ	JJ	_	59	amod	_	_
59	cells	_	NNS	NNS	_	54	pobj	_	_
60	.	_	.	.	_	29	punct	_	_

1	Expression	_	NN	NN	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	other	_	JJ	JJ	_	5	amod	_	_
4	adhesion	_	NN	NN	_	5	nn	_	_
5	molecules	_	NNS	NNS	_	2	pobj	_	_
6	such	_	JJ	JJ	_	7	mwe	_	_
7	as	_	IN	IN	_	5	prep	_	_
8	lymphocyte	_	NN	NN	_	10	nn	_	_
9	function	_	NN	NN	_	10	nn	_	_
10	associated-antigen-1	_	NN	NN	_	7	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	CD11a/CD18	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	and	_	CC	CC	_	10	cc	_	_
15	CD54	_	NN	NN	_	10	conj	_	_
16	were	_	VBD	VBD	_	17	cop	_	_
17	unaffected	_	JJ	JJ	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	Tepoxalin	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	inhibited	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	secretion	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	11	det	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	npadvmod	_	_
10	regulated	_	JJ	JJ	_	11	amod	_	_
11	chemokine	_	NN	NN	_	6	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	IL-8	_	NN	NN	_	11	appos	_	_
14	,	_	,	,	_	11	punct	_	_
15	a	_	DT	DT	_	17	det	_	_
16	known	_	JJ	JJ	_	17	amod	_	_
17	inducer	_	NN	NN	_	11	appos	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	CD11b/CD18	_	NN	NN	_	20	nn	_	_
20	expression	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Thus	_	RB	RB	_	10	advmod	_	_
2	the	_	DT	DT	_	3	det	_	_
3	suppression	_	NN	NN	_	10	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	CD11b/CD18	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	pobj	_	_
7	by	_	IN	IN	_	3	prep	_	_
8	tepoxalin	_	NN	NN	_	7	pobj	_	_
9	may	_	MD	MD	_	10	aux	_	_
10	involve	_	VB	VB	_	0	root	_	_
11	IL-8	_	NN	NN	_	10	dobj	_	_
12	.	_	.	.	_	10	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	by	_	IN	IN	_	19	prep	_	_
6	inhibiting	_	VBG	VBG	_	5	pcomp	_	_
7	NF-kappa	_	NN	NN	_	9	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	dobj	_	_
10	,	_	,	,	_	19	punct	_	_
11	surface	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	19	nsubjpass	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	several	_	JJ	JJ	_	16	amod	_	_
15	adhesion	_	NN	NN	_	16	nn	_	_
16	molecules	_	NNS	NNS	_	13	pobj	_	_
17	can	_	MD	MD	_	19	aux	_	_
18	be	_	VB	VB	_	19	auxpass	_	_
19	modulated	_	VBN	VBN	_	3	ccomp	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	that	_	IN	IN	_	25	mark	_	_
22	tepoxalin	_	NN	NN	_	25	nsubj	_	_
23	may	_	MD	MD	_	25	aux	_	_
24	be	_	VB	VB	_	25	cop	_	_
25	useful	_	JJ	JJ	_	19	conj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	treating	_	VBG	VBG	_	26	pcomp	_	_
28	selected	_	VBN	VBN	_	31	amod	_	_
29	adhesion	_	NN	NN	_	30	npadvmod	_	_
30	mediated	_	JJ	JJ	_	31	amod	_	_
31	events	_	NNS	NNS	_	27	dobj	_	_
32	such	_	JJ	JJ	_	33	mwe	_	_
33	as	_	IN	IN	_	31	prep	_	_
34	leukocyte	_	NN	NN	_	35	nn	_	_
35	migration	_	NN	NN	_	33	pobj	_	_
36	or	_	CC	CC	_	35	cc	_	_
37	atherosclerotic	_	JJ	JJ	_	39	amod	_	_
38	plaque	_	NN	NN	_	39	nn	_	_
39	formation	_	NN	NN	_	35	conj	_	_
40	.	_	.	.	_	3	punct	_	_

1	Characterization	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	human	_	JJ	JJ	_	9	amod	_	_
5	platelet/endothelial	_	JJ	JJ	_	9	amod	_	_
6	cell	_	NN	NN	_	9	nn	_	_
7	adhesion	_	NN	NN	_	9	nn	_	_
8	molecule-1	_	NN	NN	_	9	nn	_	_
9	promoter	_	NN	NN	_	2	pobj	_	_
10	:	_	:	:	_	1	punct	_	_
11	identification	_	NN	NN	_	1	dep	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	GATA-2	_	NN	NN	_	16	nn	_	_
15	binding	_	NN	NN	_	16	nn	_	_
16	element	_	NN	NN	_	12	pobj	_	_
17	required	_	VBN	VBN	_	16	vmod	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	optimal	_	JJ	JJ	_	21	amod	_	_
20	transcriptional	_	JJ	JJ	_	19	dep	_	_
21	activity	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	1	punct	_	_

1	Platelet/endothelial	_	JJ	JJ	_	4	amod	_	_
2	cell	_	NN	NN	_	4	nn	_	_
3	adhesion	_	NN	NN	_	4	nn	_	_
4	molecule-1	_	NN	NN	_	11	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	PECAM-1	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	a	_	DT	DT	_	11	det	_	_
10	130-kD	_	JJ	JJ	_	11	amod	_	_
11	member	_	NN	NN	_	0	root	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	Ig	_	NN	NN	_	16	nn	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	superfamily	_	NN	NN	_	12	pobj	_	_
17	that	_	WDT	WDT	_	19	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	expressed	_	VBN	VBN	_	11	rcmod	_	_
20	on	_	IN	IN	_	19	prep	_	_
21	platelets	_	NNS	NNS	_	20	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	endothelial	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	21	conj	_	_
25	,	_	,	,	_	21	punct	_	_
26	and	_	CC	CC	_	21	cc	_	_
27	certain	_	JJ	JJ	_	29	amod	_	_
28	leukocyte	_	NN	NN	_	29	nn	_	_
29	subsets	_	NNS	NNS	_	21	conj	_	_
30	.	_	.	.	_	11	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	examine	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	factors	_	NNS	NNS	_	2	dobj	_	_
5	controlling	_	VBG	VBG	_	4	vmod	_	_
6	vascular-specific	_	JJ	JJ	_	7	amod	_	_
7	expression	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	PECAM-1	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	cloned	_	VBD	VBD	_	2	parataxis	_	_
13	the	_	DT	DT	_	15	det	_	_
14	5'-flanking	_	JJ	JJ	_	15	amod	_	_
15	region	_	NN	NN	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	PECAM-1	_	NN	NN	_	19	nn	_	_
19	gene	_	NN	NN	_	16	pobj	_	_
20	and	_	CC	CC	_	12	cc	_	_
21	analyzed	_	VBD	VBD	_	12	conj	_	_
22	its	_	PRP$	PRP$	_	24	poss	_	_
23	transcriptional	_	JJ	JJ	_	24	amod	_	_
24	activity	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	2	punct	_	_

1	5'-Rapid	_	JJ	JJ	_	2	amod	_	_
2	amplification	_	NN	NN	_	9	nn	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cDNA	_	NN	NN	_	5	nn	_	_
5	ends	_	NNS	NNS	_	3	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	5'-RACE	_	NNS	NNS	_	2	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	analysis	_	NN	NN	_	10	nsubj	_	_
10	showed	_	VBD	VBD	_	0	root	_	_
11	that	_	IN	IN	_	14	mark	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	initiation	_	NN	NN	_	14	nsubj	_	_
14	occurred	_	VBD	VBD	_	10	ccomp	_	_
15	at	_	IN	IN	_	14	prep	_	_
16	several	_	JJ	JJ	_	20	amod	_	_
17	closely	_	RB	RB	_	18	advmod	_	_
18	spaced	_	JJ	JJ	_	16	dep	_	_
19	nearby	_	NN	NN	_	20	nn	_	_
20	sites	_	NNS	NNS	_	15	pobj	_	_
21	originating	_	VBG	VBG	_	20	vmod	_	_
22	approximately	_	RB	RB	_	24	advmod	_	_
23	204	_	CD	CD	_	24	num	_	_
24	bp	_	NN	NN	_	26	npadvmod	_	_
25	upstream	_	RB	RB	_	24	advmod	_	_
26	from	_	IN	IN	_	21	prep	_	_
27	the	_	DT	DT	_	30	det	_	_
28	translation	_	NN	NN	_	30	nn	_	_
29	start	_	NN	NN	_	30	nn	_	_
30	site	_	NN	NN	_	26	pobj	_	_
31	.	_	.	.	_	10	punct	_	_

1	Analysis	_	NN	NN	_	15	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	sequence	_	NN	NN	_	2	pobj	_	_
5	immediately	_	RB	RB	_	6	advmod	_	_
6	upstream	_	JJ	JJ	_	4	advmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	transcription	_	NN	NN	_	11	nn	_	_
10	initiation	_	NN	NN	_	11	nn	_	_
11	site	_	NN	NN	_	7	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	TIS	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	showed	_	VBD	VBD	_	0	root	_	_
16	no	_	DT	DT	_	18	neg	_	_
17	canonical	_	JJ	JJ	_	18	amod	_	_
18	TATA	_	NN	NN	_	15	dobj	_	_
19	or	_	CC	CC	_	18	cc	_	_
20	CAAT	_	NN	NN	_	21	nn	_	_
21	elements	_	NNS	NNS	_	18	conj	_	_
22	,	_	,	,	_	15	punct	_	_
23	however	_	RB	RB	_	15	advmod	_	_
24	an	_	DT	DT	_	26	det	_	_
25	initiator	_	NN	NN	_	26	nn	_	_
26	element	_	NN	NN	_	32	nsubj	_	_
27	commonly	_	RB	RB	_	28	advmod	_	_
28	found	_	VBN	VBN	_	26	vmod	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	TATA-less	_	JJ	JJ	_	31	amod	_	_
31	promoters	_	NNS	NNS	_	29	pobj	_	_
32	encompassed	_	VBD	VBD	_	15	parataxis	_	_
33	the	_	DT	DT	_	34	det	_	_
34	TIS	_	NN	NN	_	32	dobj	_	_
35	.	_	.	.	_	15	punct	_	_

1	5'-serially	_	RB	RB	_	5	advmod	_	_
2	truncated	_	VBN	VBN	_	5	amod	_	_
3	PECAM-1	_	NN	NN	_	5	nn	_	_
4	promoter	_	NN	NN	_	5	nn	_	_
5	segments	_	NNS	NNS	_	13	nsubj	_	_
6	cloned	_	VBN	VBN	_	5	vmod	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	front	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	luciferase	_	NN	NN	_	12	nn	_	_
12	reporter	_	NN	NN	_	9	pobj	_	_
13	drove	_	VBD	VBD	_	0	root	_	_
14	transcription	_	NN	NN	_	13	dobj	_	_
15	in	_	IN	IN	_	13	prep	_	_
16	both	_	CC	CC	_	21	dep	_	_
17	a	_	DT	DT	_	21	det	_	_
18	lineage-	_	NN	NN	_	21	amod	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	orientation-specific	_	JJ	JJ	_	18	conj	_	_
21	manner	_	NN	NN	_	15	pobj	_	_
22	.	_	.	.	_	13	punct	_	_

1	Putative	_	JJ	JJ	_	4	amod	_	_
2	cis-acting	_	JJ	JJ	_	4	amod	_	_
3	control	_	NN	NN	_	4	nn	_	_
4	elements	_	NNS	NNS	_	11	nsubj	_	_
5	present	_	JJ	JJ	_	4	amod	_	_
6	within	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	300-bp	_	JJ	JJ	_	10	amod	_	_
9	core	_	NN	NN	_	10	nn	_	_
10	promoter	_	NN	NN	_	6	pobj	_	_
11	included	_	VBD	VBD	_	0	root	_	_
12	two	_	CD	CD	_	14	num	_	_
13	ets	_	NN	NN	_	14	nn	_	_
14	sites	_	NNS	NNS	_	11	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	an	_	DT	DT	_	18	det	_	_
17	Sp1	_	NN	NN	_	18	nn	_	_
18	site	_	NN	NN	_	14	conj	_	_
19	,	_	,	,	_	14	punct	_	_
20	tandem	_	JJ	JJ	_	22	amod	_	_
21	E-box	_	NN	NN	_	22	nn	_	_
22	domains	_	NNS	NNS	_	14	conj	_	_
23	,	_	,	,	_	14	punct	_	_
24	two	_	CD	CD	_	26	num	_	_
25	GATA-associated	_	JJ	JJ	_	26	amod	_	_
26	sites	_	NNS	NNS	_	14	conj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	CACCC	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	,	_	,	,	_	14	punct	_	_
31	an	_	DT	DT	_	34	det	_	_
32	AP-2	_	NN	NN	_	34	nn	_	_
33	binding	_	NN	NN	_	34	nn	_	_
34	site	_	NN	NN	_	14	conj	_	_
35	,	_	,	,	_	14	punct	_	_
36	and	_	CC	CC	_	14	cc	_	_
37	a	_	DT	DT	_	39	det	_	_
38	GATA	_	NN	NN	_	39	nn	_	_
39	element	_	NN	NN	_	14	conj	_	_
40	at	_	IN	IN	_	39	prep	_	_
41	-24	_	CD	CD	_	40	pobj	_	_
42	.	_	.	.	_	11	punct	_	_

1	Mutational	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	optimal	_	JJ	JJ	_	7	amod	_	_
6	transcriptional	_	JJ	JJ	_	5	dep	_	_
7	activity	_	NN	NN	_	8	nsubj	_	_
8	required	_	VBD	VBD	_	3	ccomp	_	_
9	the	_	DT	DT	_	11	det	_	_
10	GATA	_	NN	NN	_	11	nn	_	_
11	sequence	_	NN	NN	_	8	dobj	_	_
12	at	_	IN	IN	_	11	prep	_	_
13	position	_	NN	NN	_	12	pobj	_	_
14	-24	_	CD	CD	_	13	dep	_	_
15	,	_	,	,	_	3	punct	_	_
16	and	_	CC	CC	_	3	cc	_	_
17	gel-shift	_	JJ	JJ	_	18	amod	_	_
18	assays	_	NNS	NNS	_	20	nsubj	_	_
19	further	_	RB	RB	_	20	advmod	_	_
20	showed	_	VBD	VBD	_	3	conj	_	_
21	that	_	IN	IN	_	31	mark	_	_
22	the	_	DT	DT	_	25	det	_	_
23	GATA-2	_	NN	NN	_	25	nn	_	_
24	transcription	_	NN	NN	_	25	nn	_	_
25	factor	_	NN	NN	_	31	nsubj	_	_
26	,	_	,	,	_	25	punct	_	_
27	but	_	CC	CC	_	28	cc	_	_
28	not	_	RB	RB	_	25	cc	_	_
29	GATA-1	_	NN	NN	_	25	conj	_	_
30	,	_	,	,	_	25	punct	_	_
31	bound	_	VBD	VBD	_	20	ccomp	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	this	_	DT	DT	_	34	det	_	_
34	region	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	PECAM-1	_	NN	NN	_	38	nn	_	_
38	promoter	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	3	punct	_	_

1	Understanding	_	VBG	VBG	_	15	csubj	_	_
2	the	_	DT	DT	_	3	dep	_	_
3	cis-	_	JJ	JJ	_	1	dobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	transacting	_	VBG	VBG	_	6	amod	_	_
6	factors	_	NNS	NNS	_	3	conj	_	_
7	that	_	WDT	WDT	_	8	nsubj	_	_
8	regulate	_	VBP	VBP	_	3	rcmod	_	_
9	the	_	DT	DT	_	11	det	_	_
10	tissue-specific	_	JJ	JJ	_	11	amod	_	_
11	expression	_	NN	NN	_	8	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	PECAM-1	_	NN	NN	_	12	pobj	_	_
14	should	_	MD	MD	_	15	aux	_	_
15	increase	_	VB	VB	_	0	root	_	_
16	our	_	PRP$	PRP$	_	17	poss	_	_
17	understanding	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	mechanisms	_	NNS	NNS	_	18	pobj	_	_
21	by	_	IN	IN	_	27	prep	_	_
22	which	_	WDT	WDT	_	21	pobj	_	_
23	vascular-specific	_	JJ	JJ	_	25	amod	_	_
24	gene	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	27	nsubjpass	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	achieved	_	VBN	VBN	_	20	rcmod	_	_
28	.	_	.	.	_	15	punct	_	_

1	Rapid	_	JJ	JJ	_	3	amod	_	_
2	Ca2+-mediated	_	JJ	JJ	_	1	dep	_	_
3	activation	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	Rap1	_	NN	NN	_	4	pobj	_	_
6	in	_	IN	IN	_	3	prep	_	_
7	human	_	JJ	JJ	_	8	amod	_	_
8	platelets	_	NNS	NNS	_	6	pobj	_	_
9	.	_	.	.	_	3	punct	_	_

1	Rap1	_	NN	NN	_	7	nsubj	_	_
2	is	_	VBZ	VBZ	_	7	cop	_	_
3	a	_	DT	DT	_	7	det	_	_
4	small	_	JJ	JJ	_	7	amod	_	_
5	,	_	,	,	_	7	punct	_	_
6	Ras-like	_	JJ	JJ	_	7	amod	_	_
7	GTPase	_	NN	NN	_	0	root	_	_
8	whose	_	WP$	WP$	_	9	poss	_	_
9	function	_	NN	NN	_	15	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	regulation	_	NN	NN	_	9	conj	_	_
12	are	_	VBP	VBP	_	15	cop	_	_
13	still	_	RB	RB	_	15	advmod	_	_
14	largely	_	RB	RB	_	15	advmod	_	_
15	unknown	_	JJ	JJ	_	7	rcmod	_	_
16	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	developed	_	VBN	VBN	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	novel	_	JJ	JJ	_	6	amod	_	_
6	assay	_	NN	NN	_	3	dobj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	monitor	_	VB	VB	_	6	vmod	_	_
9	the	_	DT	DT	_	13	det	_	_
10	active	_	JJ	JJ	_	13	amod	_	_
11	,	_	,	,	_	13	punct	_	_
12	GTP-bound	_	JJ	JJ	_	13	amod	_	_
13	form	_	NN	NN	_	8	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	Rap1	_	NN	NN	_	14	pobj	_	_
16	based	_	VBN	VBN	_	8	prep	_	_
17	on	_	IN	IN	_	16	pcomp	_	_
18	the	_	DT	DT	_	20	det	_	_
19	differential	_	JJ	JJ	_	20	amod	_	_
20	affinity	_	NN	NN	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	Rap1GTP	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	Rap1GDP	_	NN	NN	_	22	conj	_	_
25	for	_	IN	IN	_	20	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	Rap	_	NN	NN	_	29	nn	_	_
28	binding	_	NN	NN	_	29	nn	_	_
29	domain	_	NN	NN	_	25	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	RalGDS	_	NN	NN	_	30	pobj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	RBD	_	NN	NN	_	29	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	.	_	.	.	_	3	punct	_	_

1	Stimulation	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	blood	_	NN	NN	_	4	nn	_	_
4	platelets	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	alpha-thrombin	_	NN	NN	_	5	pobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	other	_	JJ	JJ	_	10	amod	_	_
9	platelet	_	NN	NN	_	10	nn	_	_
10	activators	_	NNS	NNS	_	6	conj	_	_
11	caused	_	VBD	VBD	_	0	root	_	_
12	a	_	DT	DT	_	16	det	_	_
13	rapid	_	JJ	JJ	_	16	amod	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	strong	_	JJ	JJ	_	13	conj	_	_
16	induction	_	NN	NN	_	11	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	Rap1	_	NN	NN	_	17	pobj	_	_
19	that	_	WDT	WDT	_	20	nsubj	_	_
20	associated	_	VBD	VBD	_	16	rcmod	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	RBD	_	NN	NN	_	21	pobj	_	_
23	in	_	FW	FW	_	24	nn	_	_
24	vitro	_	FW	FW	_	20	advmod	_	_
25	.	_	.	.	_	11	punct	_	_

1	Binding	_	NN	NN	_	4	nsubj	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	RBD	_	NN	NN	_	2	pobj	_	_
4	increased	_	VBD	VBD	_	0	root	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	undetectable	_	JJ	JJ	_	7	amod	_	_
7	levels	_	NNS	NNS	_	5	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	resting	_	VBG	VBG	_	10	amod	_	_
10	platelets	_	NNS	NNS	_	8	pobj	_	_
11	to	_	TO	TO	_	4	prep	_	_
12	&gt;	_	JJR	JJR	_	13	quantmod	_	_
13	50	_	CD	CD	_	14	num	_	_
14	%	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	11	prep	_	_
16	total	_	JJ	JJ	_	17	amod	_	_
17	Rap1	_	NN	NN	_	15	pobj	_	_
18	within	_	IN	IN	_	4	prep	_	_
19	30	_	CD	CD	_	20	num	_	_
20	s	_	NN	NN	_	18	pobj	_	_
21	after	_	IN	IN	_	20	prep	_	_
22	stimulation	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	An	_	DT	DT	_	2	det	_	_
2	increase	_	NN	NN	_	10	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	intracellular	_	JJ	JJ	_	7	amod	_	_
6	Ca2+	_	NN	NN	_	7	nn	_	_
7	concentration	_	NN	NN	_	3	pobj	_	_
8	is	_	VBZ	VBZ	_	10	cop	_	_
9	both	_	CC	CC	_	10	preconj	_	_
10	necessary	_	JJ	JJ	_	0	root	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	sufficient	_	JJ	JJ	_	10	conj	_	_
13	for	_	IN	IN	_	10	prep	_	_
14	Rap1	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	13	pobj	_	_
16	since	_	IN	IN	_	19	mark	_	_
17	it	_	PRP	PRP	_	19	nsubjpass	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	induced	_	VBN	VBN	_	10	advcl	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	agents	_	NNS	NNS	_	20	pobj	_	_
22	that	_	WDT	WDT	_	23	nsubj	_	_
23	increase	_	VBP	VBP	_	21	rcmod	_	_
24	intracellular	_	JJ	JJ	_	25	amod	_	_
25	Ca2+	_	NN	NN	_	23	dobj	_	_
26	and	_	CC	CC	_	19	cc	_	_
27	inhibited	_	VBN	VBN	_	19	conj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	a	_	DT	DT	_	31	det	_	_
30	Ca2+-chelating	_	JJ	JJ	_	31	amod	_	_
31	agent	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	10	punct	_	_

1	Neither	_	CC	CC	_	2	preconj	_	_
2	inhibition	_	NN	NN	_	15	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	translocation	_	NN	NN	_	3	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Rap1	_	NN	NN	_	5	pobj	_	_
7	to	_	TO	TO	_	4	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	cytoskeleton	_	NN	NN	_	7	pobj	_	_
10	nor	_	CC	CC	_	2	cc	_	_
11	inhibition	_	NN	NN	_	2	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	platelet	_	NN	NN	_	14	nn	_	_
14	aggregation	_	NN	NN	_	12	pobj	_	_
15	affected	_	VBD	VBD	_	0	root	_	_
16	thrombin-induced	_	JJ	JJ	_	17	amod	_	_
17	activation	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	Rap1	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	15	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	18	punct	_	_
4	prostaglandin	_	NN	NN	_	5	nn	_	_
5	I2	_	NN	NN	_	18	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	PGI2	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	,	_	,	,	_	5	punct	_	_
10	a	_	DT	DT	_	13	det	_	_
11	strong	_	JJ	JJ	_	13	amod	_	_
12	negative	_	JJ	JJ	_	13	amod	_	_
13	regulator	_	NN	NN	_	5	appos	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	platelet	_	NN	NN	_	16	nn	_	_
16	function	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	5	punct	_	_
18	inhibited	_	VBD	VBD	_	0	root	_	_
19	agonist-induced	_	JJ	JJ	_	18	dobj	_	_
20	as	_	RB	RB	_	21	advmod	_	_
21	well	_	RB	RB	_	19	cc	_	_
22	as	_	IN	IN	_	21	mwe	_	_
23	Ca2+-induced	_	JJ	JJ	_	19	conj	_	_
24	activation	_	NN	NN	_	19	dep	_	_
25	of	_	IN	IN	_	19	prep	_	_
26	Rap1	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	18	punct	_	_

1	From	_	IN	IN	_	6	prep	_	_
2	our	_	PRP$	PRP$	_	3	poss	_	_
3	results	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	conclude	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	16	mark	_	_
8	Rap1	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	16	nsubj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	platelets	_	NNS	NNS	_	10	pobj	_	_
12	is	_	VBZ	VBZ	_	16	cop	_	_
13	an	_	DT	DT	_	16	det	_	_
14	important	_	JJ	JJ	_	16	amod	_	_
15	common	_	JJ	JJ	_	14	dep	_	_
16	event	_	NN	NN	_	6	ccomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	early	_	JJ	JJ	_	20	amod	_	_
19	agonist-induced	_	JJ	JJ	_	18	dep	_	_
20	signalling	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	16	punct	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	that	_	IN	IN	_	27	mark	_	_
24	this	_	DT	DT	_	25	det	_	_
25	activation	_	NN	NN	_	27	nsubjpass	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	mediated	_	VBN	VBN	_	16	conj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	an	_	DT	DT	_	33	det	_	_
30	increased	_	VBN	VBN	_	33	amod	_	_
31	intracellular	_	JJ	JJ	_	33	amod	_	_
32	Ca2+	_	NN	NN	_	33	nn	_	_
33	concentration	_	NN	NN	_	28	pobj	_	_
34	.	_	.	.	_	6	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	erythroid-specific	_	JJ	JJ	_	4	amod	_	_
4	genes	_	NNS	NNS	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	megakaryoblastic	_	JJ	JJ	_	7	amod	_	_
7	disorders	_	NNS	NNS	_	5	pobj	_	_
8	.	_	.	.	_	1	punct	_	_

1	Currently	_	RB	RB	_	2	advmod	_	_
2	available	_	JJ	JJ	_	3	amod	_	_
3	data	_	NNS	NNS	_	4	nsubj	_	_
4	indicate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	13	mark	_	_
6	erythroid	_	JJ	JJ	_	10	amod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	megakaryocytic	_	JJ	JJ	_	6	conj	_	_
9	differentiation	_	NN	NN	_	10	nn	_	_
10	pathways	_	NNS	NNS	_	13	nsubj	_	_
11	are	_	VBP	VBP	_	13	cop	_	_
12	closely	_	RB	RB	_	13	advmod	_	_
13	related	_	JJ	JJ	_	4	ccomp	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	each	_	DT	DT	_	16	det	_	_
16	other	_	JJ	JJ	_	14	pobj	_	_
17	,	_	,	,	_	13	punct	_	_
18	and	_	CC	CC	_	13	cc	_	_
19	there	_	EX	EX	_	21	expl	_	_
20	may	_	MD	MD	_	21	aux	_	_
21	exist	_	VB	VB	_	13	conj	_	_
22	progenitor	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	21	dobj	_	_
24	common	_	JJ	JJ	_	23	amod	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	those	_	DT	DT	_	28	det	_	_
27	two	_	CD	CD	_	28	num	_	_
28	lineages	_	NNS	NNS	_	25	pobj	_	_
29	may	_	MD	MD	_	21	dep	_	_
30	exist	_	VB	VB	_	21	dep	_	_
31	.	_	.	.	_	4	punct	_	_

1	Acute	_	JJ	JJ	_	3	amod	_	_
2	megakaryoblastic	_	JJ	JJ	_	3	amod	_	_
3	leukemia	_	NN	NN	_	19	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	AML-M7	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	transient	_	JJ	JJ	_	10	amod	_	_
9	myeloproliferative	_	JJ	JJ	_	10	amod	_	_
10	disorder	_	NN	NN	_	3	conj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	Down	_	NN	NN	_	14	poss	_	_
13	's	_	POS	POS	_	12	possessive	_	_
14	syndrome	_	NN	NN	_	11	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	TMD	_	NN	NN	_	10	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	are	_	VBP	VBP	_	19	auxpass	_	_
19	characterized	_	VBN	VBN	_	0	root	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	rapid	_	JJ	JJ	_	22	amod	_	_
22	growth	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	abnormal	_	JJ	JJ	_	26	amod	_	_
25	blast	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	23	pobj	_	_
27	which	_	WDT	WDT	_	28	nsubj	_	_
28	express	_	VBP	VBP	_	26	rcmod	_	_
29	megakaryocytic	_	JJ	JJ	_	30	amod	_	_
30	markers	_	NNS	NNS	_	28	dobj	_	_
31	.	_	.	.	_	19	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	blast	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	4	nsubj	_	_
4	express	_	VBP	VBP	_	0	root	_	_
5	lineage-specific	_	JJ	JJ	_	7	amod	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factors	_	NNS	NNS	_	4	dobj	_	_
8	such	_	JJ	JJ	_	9	mwe	_	_
9	as	_	IN	IN	_	7	prep	_	_
10	GATA-1	_	NN	NN	_	9	pobj	_	_
11	common	_	JJ	JJ	_	10	amod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	these	_	DT	DT	_	14	det	_	_
14	lineages	_	NNS	NNS	_	12	pobj	_	_
15	and	_	CC	CC	_	4	cc	_	_
16	frequently	_	RB	RB	_	17	advmod	_	_
17	express	_	VBP	VBP	_	4	conj	_	_
18	erythroid-specific	_	JJ	JJ	_	19	amod	_	_
19	mRNAs	_	NNS	NNS	_	17	dobj	_	_
20	such	_	JJ	JJ	_	21	mwe	_	_
21	as	_	IN	IN	_	19	prep	_	_
22	gamma-globin	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	erythroid	_	JJ	JJ	_	26	amod	_	_
25	delta-aminolevulinate	_	NN	NN	_	26	nn	_	_
26	synthase	_	NN	NN	_	22	conj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	ALAS-E	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	,	_	,	,	_	4	punct	_	_
31	indicating	_	VBG	VBG	_	4	vmod	_	_
32	that	_	IN	IN	_	42	mark	_	_
33	most	_	JJS	JJS	_	42	nsubj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	36	det	_	_
36	blasts	_	NNS	NNS	_	34	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	M7	_	NN	NN	_	41	nn	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	TMD	_	NN	NN	_	38	conj	_	_
41	cases	_	NNS	NNS	_	37	pobj	_	_
42	have	_	VBP	VBP	_	31	ccomp	_	_
43	erythroid	_	JJ	JJ	_	46	amod	_	_
44	and	_	CC	CC	_	43	cc	_	_
45	megakaryocytic	_	JJ	JJ	_	43	conj	_	_
46	phenotypes	_	NNS	NNS	_	42	dobj	_	_
47	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	blasts	_	NNS	NNS	_	11	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	M7	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	TMD	_	NN	NN	_	7	conj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	correspond	_	VB	VB	_	3	ccomp	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	progenitors	_	NNS	NNS	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	both	_	CC	CC	_	16	preconj	_	_
16	erythroid	_	JJ	JJ	_	19	amod	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	megakaryocytic	_	JJ	JJ	_	16	conj	_	_
19	lineages	_	NNS	NNS	_	14	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	NF-ATp	_	NN	NN	_	5	nsubj	_	_
3	is	_	VBZ	VBZ	_	5	cop	_	_
4	a	_	DT	DT	_	5	det	_	_
5	hallmark	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	unstimulated	_	JJ	JJ	_	9	amod	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	B-CLL	_	NN	NN	_	12	nn	_	_
12	patients	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	5	punct	_	_

1	B	_	NN	NN	_	2	nn	_	_
2	lymphocytes	_	NNS	NNS	_	17	nsubjpass	_	_
3	from	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	peripheral	_	JJ	JJ	_	6	amod	_	_
6	blood	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	patients	_	NNS	NNS	_	7	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	chronic	_	JJ	JJ	_	12	amod	_	_
11	lymphocytic	_	JJ	JJ	_	12	amod	_	_
12	leukaemia	_	NN	NN	_	9	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	CLL	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	analysed	_	VBN	VBN	_	0	root	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	nuclear	_	JJ	JJ	_	21	amod	_	_
21	presence	_	NN	NN	_	18	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	DNA	_	NN	NN	_	24	nn	_	_
24	binding	_	NN	NN	_	21	conj	_	_
25	of	_	IN	IN	_	21	prep	_	_
26	a	_	DT	DT	_	27	det	_	_
27	panel	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	transcription	_	NN	NN	_	30	nn	_	_
30	factors	_	NNS	NNS	_	28	pobj	_	_
31	which	_	WDT	WDT	_	33	nsubjpass	_	_
32	are	_	VBP	VBP	_	33	auxpass	_	_
33	involved	_	VBN	VBN	_	30	rcmod	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	gene	_	NN	NN	_	37	nn	_	_
37	control	_	NN	NN	_	34	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	lymphoid	_	JJ	JJ	_	40	amod	_	_
40	cells	_	NNS	NNS	_	38	pobj	_	_
41	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	following	_	JJ	JJ	_	4	amod	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factors	_	NNS	NNS	_	6	nsubjpass	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	studied	_	VBN	VBN	_	0	root	_	_
7	:	_	:	:	_	6	punct	_	_
8	the	_	DT	DT	_	10	det	_	_
9	Octamer	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	6	dobj	_	_
11	Oct-1	_	NN	NN	_	10	dep	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	Oct-2	_	NN	NN	_	11	conj	_	_
14	,	_	,	,	_	10	punct	_	_
15	members	_	NNS	NNS	_	10	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	AP-1	_	NN	NN	_	20	nn	_	_
19	factor	_	NN	NN	_	20	nn	_	_
20	family	_	NN	NN	_	16	pobj	_	_
21	,	_	,	,	_	10	punct	_	_
22	NF-AT	_	NN	NN	_	23	nn	_	_
23	factors	_	NNS	NNS	_	10	conj	_	_
24	,	_	,	,	_	23	punct	_	_
25	in	_	IN	IN	_	27	prep	_	_
26	particular	_	JJ	JJ	_	25	pobj	_	_
27	NF-ATp	_	NN	NN	_	23	appos	_	_
28	,	_	,	,	_	10	punct	_	_
29	and	_	CC	CC	_	10	cc	_	_
30	members	_	NNS	NNS	_	10	conj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	Rel/NF-kB	_	NN	NN	_	34	nn	_	_
34	family	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	23	mark	_	_
4	the	_	DT	DT	_	7	det	_	_
5	constitutive	_	JJ	JJ	_	7	amod	_	_
6	nuclear	_	JJ	JJ	_	7	amod	_	_
7	translocation	_	NN	NN	_	23	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	NF-ATp	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	a	_	DT	DT	_	12	det	_	_
12	member	_	NN	NN	_	9	appos	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	growing	_	VBG	VBG	_	16	amod	_	_
16	family	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NF-AT	_	NN	NN	_	19	nn	_	_
19	factors	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	9	punct	_	_
21	is	_	VBZ	VBZ	_	23	cop	_	_
22	a	_	DT	DT	_	23	det	_	_
23	hallmark	_	NN	NN	_	2	ccomp	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	nonstimulated	_	JJ	JJ	_	27	amod	_	_
26	B	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	24	pobj	_	_
28	from	_	IN	IN	_	27	prep	_	_
29	CLL	_	NN	NN	_	30	nn	_	_
30	patients	_	NNS	NNS	_	28	pobj	_	_
31	that	_	WDT	WDT	_	32	nsubj	_	_
32	distinguishes	_	VBZ	VBZ	_	23	rcmod	_	_
33	B-CLL	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	32	dobj	_	_
35	from	_	IN	IN	_	32	prep	_	_
36	'	_	``	``	_	40	punct	_	_
37	normal	_	JJ	JJ	_	40	amod	_	_
38	'	_	''	''	_	40	punct	_	_
39	B	_	NN	NN	_	40	nn	_	_
40	lymphocytes	_	NNS	NNS	_	35	pobj	_	_
41	.	_	.	.	_	2	punct	_	_

1	Constitutive	_	JJ	JJ	_	3	amod	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	appearance	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	observed	_	VBN	VBN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	NF-kB2/p52	_	NN	NN	_	7	pobj	_	_
9	.	_	.	.	_	6	punct	_	_

1	Constitutive	_	JJ	JJ	_	2	amod	_	_
2	binding	_	NN	NN	_	19	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	further	_	JJ	JJ	_	6	amod	_	_
5	factor	_	NN	NN	_	6	nn	_	_
6	proteins	_	NNS	NNS	_	3	pobj	_	_
7	to	_	TO	TO	_	2	prep	_	_
8	DNA	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	such	_	JJ	JJ	_	11	mwe	_	_
11	as	_	IN	IN	_	2	prep	_	_
12	JunD	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	c-Fos	_	NN	NN	_	12	conj	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	FosB	_	NN	NN	_	12	conj	_	_
17	,	_	,	,	_	2	punct	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	detected	_	VBN	VBN	_	0	root	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	several	_	JJ	JJ	_	22	amod	_	_
22	patients	_	NNS	NNS	_	20	pobj	_	_
23	whereas	_	IN	IN	_	40	mark	_	_
24	the	_	DT	DT	_	25	det	_	_
25	localisation	_	NN	NN	_	40	nsubj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	DNA	_	NN	NN	_	28	nn	_	_
28	binding	_	NN	NN	_	25	conj	_	_
29	of	_	IN	IN	_	25	prep	_	_
30	other	_	JJ	JJ	_	31	amod	_	_
31	factors	_	NNS	NNS	_	29	pobj	_	_
32	such	_	JJ	JJ	_	33	mwe	_	_
33	as	_	IN	IN	_	31	prep	_	_
34	c-Jun	_	NN	NN	_	33	pobj	_	_
35	,	_	,	,	_	34	punct	_	_
36	RelA/p65	_	NN	NN	_	34	conj	_	_
37	and	_	CC	CC	_	34	cc	_	_
38	c-Rel	_	NN	NN	_	34	conj	_	_
39	was	_	VBD	VBD	_	40	cop	_	_
40	unaltered	_	JJ	JJ	_	19	advcl	_	_
41	.	_	.	.	_	19	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	cop	_	_
3	remarkable	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	20	mark	_	_
5	in	_	IN	IN	_	20	prep	_	_
6	B-CLL	_	JJ	JJ	_	7	amod	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	the	_	DT	DT	_	10	det	_	_
9	nuclear	_	JJ	JJ	_	10	amod	_	_
10	appearance	_	NN	NN	_	20	nsubj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	DNA	_	NN	NN	_	13	nn	_	_
13	binding	_	NN	NN	_	10	conj	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	specific	_	JJ	JJ	_	17	amod	_	_
16	transcription	_	NN	NN	_	17	nn	_	_
17	factors	_	NNS	NNS	_	14	pobj	_	_
18	is	_	VBZ	VBZ	_	20	aux	_	_
19	dramatically	_	RB	RB	_	20	advmod	_	_
20	affected	_	JJ	JJ	_	3	ccomp	_	_
21	whereas	_	IN	IN	_	29	mark	_	_
22	other	_	JJ	JJ	_	23	amod	_	_
23	members	_	NNS	NNS	_	29	nsubj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	28	det	_	_
26	same	_	JJ	JJ	_	28	amod	_	_
27	factor	_	NN	NN	_	28	nn	_	_
28	family	_	NN	NN	_	24	pobj	_	_
29	remained	_	VBD	VBD	_	20	advcl	_	_
30	unaltered	_	JJ	JJ	_	29	acomp	_	_
31	in	_	IN	IN	_	29	prep	_	_
32	these	_	DT	DT	_	34	det	_	_
33	leukemic	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	31	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	It	_	PRP	PRP	_	2	nsubj	_	_
2	remains	_	VBZ	VBZ	_	0	root	_	_
3	to	_	TO	TO	_	5	aux	_	_
4	be	_	VB	VB	_	5	auxpass	_	_
5	shown	_	VBN	VBN	_	2	xcomp	_	_
6	which	_	WDT	WDT	_	8	det	_	_
7	molecular	_	JJ	JJ	_	8	amod	_	_
8	events	_	NNS	NNS	_	9	nsubj	_	_
9	lead	_	VBP	VBP	_	5	ccomp	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	specific	_	JJ	JJ	_	14	amod	_	_
13	'	_	``	``	_	14	punct	_	_
14	pre-activation	_	NN	NN	_	10	pobj	_	_
15	'	_	''	''	_	14	punct	_	_
16	,	_	,	,	_	14	punct	_	_
17	i.e.	_	FW	FW	_	20	advmod	_	_
18	constitutive	_	JJ	JJ	_	20	amod	_	_
19	nuclear	_	JJ	JJ	_	20	amod	_	_
20	translocation	_	NN	NN	_	14	appos	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	DNA	_	NN	NN	_	23	nn	_	_
23	binding	_	NN	NN	_	20	conj	_	_
24	,	_	,	,	_	14	punct	_	_
25	of	_	IN	IN	_	14	prep	_	_
26	these	_	DT	DT	_	27	det	_	_
27	members	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	NF-AT	_	NN	NN	_	35	nn	_	_
30	,	_	,	,	_	29	punct	_	_
31	NF-kB	_	NN	NN	_	29	conj	_	_
32	and	_	CC	CC	_	29	cc	_	_
33	AP-1	_	NN	NN	_	29	conj	_	_
34	factor	_	NN	NN	_	35	nn	_	_
35	families	_	NNS	NNS	_	28	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	Physical	_	JJ	JJ	_	4	amod	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	functional	_	JJ	JJ	_	1	conj	_	_
4	interaction	_	NN	NN	_	0	root	_	_
5	between	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	14	det	_	_
7	human	_	JJ	JJ	_	14	amod	_	_
8	T-cell	_	NN	NN	_	14	nn	_	_
9	lymphotropic	_	JJ	JJ	_	14	amod	_	_
10	virus	_	NN	NN	_	14	nn	_	_
11	type	_	NN	NN	_	14	nn	_	_
12	1	_	CD	CD	_	14	num	_	_
13	Tax1	_	NN	NN	_	14	nn	_	_
14	protein	_	NN	NN	_	5	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	19	det	_	_
17	CCAAT	_	NN	NN	_	19	nn	_	_
18	binding	_	NN	NN	_	19	nn	_	_
19	protein	_	NN	NN	_	14	conj	_	_
20	NF-Y	_	NN	NN	_	19	dep	_	_
21	.	_	.	.	_	4	punct	_	_

1	Tax1	_	NN	NN	_	20	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	potent	_	JJ	JJ	_	5	amod	_	_
5	activator	_	NN	NN	_	1	appos	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	11	amod	_	_
8	T-cell	_	NN	NN	_	11	nn	_	_
9	lymphotropic	_	JJ	JJ	_	11	amod	_	_
10	virus	_	NN	NN	_	11	nn	_	_
11	type	_	NN	NN	_	16	nn	_	_
12	1	_	CD	CD	_	11	num	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	HTLV-1	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	transcription	_	NN	NN	_	6	pobj	_	_
17	,	_	,	,	_	1	punct	_	_
18	has	_	VBZ	VBZ	_	20	aux	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	shown	_	VBN	VBN	_	0	root	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	modulate	_	VB	VB	_	20	xcomp	_	_
23	expression	_	NN	NN	_	22	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	many	_	JJ	JJ	_	27	amod	_	_
26	cellular	_	JJ	JJ	_	27	amod	_	_
27	genes	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	20	punct	_	_

1	Tax1	_	NN	NN	_	4	nsubj	_	_
2	does	_	VBZ	VBZ	_	4	aux	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	bind	_	VB	VB	_	0	root	_	_
5	DNA	_	NN	NN	_	4	dobj	_	_
6	directly	_	RB	RB	_	4	advmod	_	_
7	but	_	CC	CC	_	4	cc	_	_
8	regulates	_	VBZ	VBZ	_	4	conj	_	_
9	transcription	_	NN	NN	_	8	dobj	_	_
10	through	_	IN	IN	_	9	prep	_	_
11	protein-protein	_	JJ	JJ	_	12	amod	_	_
12	interactions	_	NNS	NNS	_	10	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	sequence-specific	_	JJ	JJ	_	16	amod	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factors	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	the	_	DT	DT	_	5	det	_	_
3	yeast	_	NN	NN	_	5	nn	_	_
4	two-hybrid	_	JJ	JJ	_	5	amod	_	_
5	system	_	NN	NN	_	1	dobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	screen	_	VB	VB	_	1	vmod	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	proteins	_	NNS	NNS	_	8	pobj	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	interact	_	VBP	VBP	_	9	rcmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	Tax1	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	1	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	isolated	_	VBD	VBD	_	1	parataxis	_	_
17	the	_	DT	DT	_	19	det	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	subunit	_	NN	NN	_	16	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	CCAAT	_	NN	NN	_	24	nn	_	_
23	binding	_	NN	NN	_	24	nn	_	_
24	protein	_	NN	NN	_	20	pobj	_	_
25	NF-Y	_	NN	NN	_	24	dep	_	_
26	from	_	IN	IN	_	16	prep	_	_
27	a	_	DT	DT	_	30	det	_	_
28	HeLa	_	NN	NN	_	30	nn	_	_
29	cDNA	_	NN	NN	_	30	nn	_	_
30	library	_	NN	NN	_	26	pobj	_	_
31	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	interaction	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	Tax1	_	NN	NN	_	3	pobj	_	_
5	with	_	IN	IN	_	2	prep	_	_
6	NF-YB	_	NN	NN	_	5	pobj	_	_
7	was	_	VBD	VBD	_	8	cop	_	_
8	specific	_	JJ	JJ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	that	_	IN	IN	_	14	mark	_	_
11	NF-YB	_	NN	NN	_	14	nsubj	_	_
12	did	_	VBD	VBD	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	interact	_	VB	VB	_	9	pcomp	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	variety	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	other	_	JJ	JJ	_	21	amod	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factors	_	NNS	NNS	_	18	pobj	_	_
22	,	_	,	,	_	17	punct	_	_
23	including	_	VBG	VBG	_	17	prep	_	_
24	human	_	JJ	JJ	_	27	amod	_	_
25	immunodeficiency	_	NN	NN	_	27	nn	_	_
26	virus	_	NN	NN	_	27	nn	_	_
27	Tat	_	NN	NN	_	23	pobj	_	_
28	,	_	,	,	_	27	punct	_	_
29	human	_	JJ	JJ	_	31	amod	_	_
30	papillomavirus	_	NN	NN	_	31	nn	_	_
31	E6	_	NN	NN	_	27	conj	_	_
32	,	_	,	,	_	27	punct	_	_
33	and	_	CC	CC	_	27	cc	_	_
34	Bicoid	_	NN	NN	_	27	conj	_	_
35	,	_	,	,	_	15	punct	_	_
36	or	_	CC	CC	_	15	cc	_	_
37	with	_	IN	IN	_	15	conj	_	_
38	the	_	DT	DT	_	46	det	_	_
39	M7	_	NN	NN	_	46	nn	_	_
40	-LRB-	_	-LRB-	-LRB-	_	46	punct	_	_
41	amino	_	NN	NN	_	46	nn	_	_
42	acids	_	NNS	NNS	_	46	nn	_	_
43	29CP-AS	_	NN	NN	_	46	nn	_	_
44	-RRB-	_	-RRB-	-RRB-	_	46	punct	_	_
45	Tax1	_	NN	NN	_	46	nn	_	_
46	mutant	_	NN	NN	_	37	pobj	_	_
47	.	_	.	.	_	8	punct	_	_

1	However	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	NF-YB	_	NN	NN	_	5	nsubj	_	_
4	did	_	VBD	VBD	_	5	aux	_	_
5	interact	_	VBP	VBP	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	C-terminal	_	JJ	JJ	_	10	amod	_	_
9	Tax1	_	NN	NN	_	10	nn	_	_
10	mutants	_	NNS	NNS	_	6	pobj	_	_
11	M22	_	NN	NN	_	10	dep	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	130TL-AS	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	and	_	CC	CC	_	11	cc	_	_
16	M47	_	NN	NN	_	11	conj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	319LL-RS	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	in	_	FW	FW	_	6	dep	_	_
6	vitro-translated	_	JJ	JJ	_	7	amod	_	_
7	NF-YB	_	NN	NN	_	9	nsubj	_	_
8	specifically	_	RB	RB	_	9	advmod	_	_
9	bound	_	VBD	VBD	_	3	ccomp	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	a	_	DT	DT	_	15	det	_	_
12	glutathione	_	NN	NN	_	15	nn	_	_
13	S-transferase-Tax1	_	NN	NN	_	15	nn	_	_
14	fusion	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	10	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Further	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	Tax1	_	NN	NN	_	4	nsubj	_	_
4	coimmunoprecipitated	_	VBD	VBD	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	NF-Y	_	NN	NN	_	5	pobj	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	nuclear	_	JJ	JJ	_	9	amod	_	_
9	extracts	_	NNS	NNS	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HTLV-1-transformed	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	4	punct	_	_
14	providing	_	VBG	VBG	_	4	xcomp	_	_
15	evidence	_	NN	NN	_	14	dobj	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	in	_	FW	FW	_	19	amod	_	_
18	vivo	_	FW	FW	_	17	dep	_	_
19	interaction	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	Tax1	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	NF-YB	_	NN	NN	_	21	conj	_	_
24	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	further	_	RB	RB	_	3	advmod	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	Tax1	_	NN	NN	_	7	nsubj	_	_
6	specifically	_	RB	RB	_	7	advmod	_	_
7	activated	_	VBD	VBD	_	3	ccomp	_	_
8	the	_	DT	DT	_	11	det	_	_
9	NF-Y-responsive	_	JJ	JJ	_	11	amod	_	_
10	DQbeta	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	7	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	as	_	RB	RB	_	14	advmod	_	_
14	well	_	RB	RB	_	11	cc	_	_
15	as	_	IN	IN	_	14	mwe	_	_
16	a	_	DT	DT	_	18	det	_	_
17	minimal	_	JJ	JJ	_	18	amod	_	_
18	promoter	_	NN	NN	_	11	conj	_	_
19	which	_	WDT	WDT	_	20	nsubj	_	_
20	contains	_	VBZ	VBZ	_	18	rcmod	_	_
21	only	_	RB	RB	_	24	advmod	_	_
22	the	_	DT	DT	_	24	det	_	_
23	Y-box	_	NN	NN	_	24	nn	_	_
24	element	_	NN	NN	_	20	dobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	10	punct	_	_
4	mutation	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	Y-box	_	NN	NN	_	8	nn	_	_
8	element	_	NN	NN	_	5	pobj	_	_
9	alone	_	RB	RB	_	4	advmod	_	_
10	abrogated	_	VBD	VBD	_	0	root	_	_
11	Tax1-mediated	_	JJ	JJ	_	12	amod	_	_
12	activation	_	NN	NN	_	10	dobj	_	_
13	.	_	.	.	_	10	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	indicate	_	VBP	VBP	_	1	parataxis	_	_
7	that	_	IN	IN	_	9	mark	_	_
8	Tax1	_	NN	NN	_	9	nsubj	_	_
9	interacts	_	VBZ	VBZ	_	6	ccomp	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	NF-Y	_	NN	NN	_	10	pobj	_	_
12	through	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	subunit	_	NN	NN	_	12	pobj	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	this	_	DT	DT	_	19	det	_	_
19	interaction	_	NN	NN	_	20	nsubj	_	_
20	results	_	VBZ	VBZ	_	9	conj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	activation	_	NN	NN	_	21	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	30	det	_	_
25	major	_	JJ	JJ	_	30	amod	_	_
26	histocompatibility	_	NN	NN	_	30	nn	_	_
27	complex	_	NN	NN	_	30	nn	_	_
28	class	_	NN	NN	_	30	nn	_	_
29	II	_	CD	CD	_	30	num	_	_
30	promoter	_	NN	NN	_	23	pobj	_	_
31	.	_	.	.	_	1	punct	_	_

1	Through	_	IN	IN	_	15	prep	_	_
2	activation	_	NN	NN	_	1	pobj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	other	_	JJ	JJ	_	7	amod	_	_
7	NF-Y	_	NN	NN	_	4	conj	_	_
8	driven	_	JJ	JJ	_	7	amod	_	_
9	promoters	_	NNS	NNS	_	7	dep	_	_
10	,	_	,	,	_	15	punct	_	_
11	the	_	DT	DT	_	13	det	_	_
12	Tax1-NF-Y	_	NN	NN	_	13	nn	_	_
13	interaction	_	NN	NN	_	15	nsubj	_	_
14	may	_	MD	MD	_	15	aux	_	_
15	play	_	VB	VB	_	0	root	_	_
16	a	_	DT	DT	_	18	det	_	_
17	critical	_	JJ	JJ	_	18	amod	_	_
18	role	_	NN	NN	_	15	dobj	_	_
19	in	_	IN	IN	_	15	prep	_	_
20	causing	_	VBG	VBG	_	19	pcomp	_	_
21	cellular	_	JJ	JJ	_	22	amod	_	_
22	transformation	_	NN	NN	_	20	dobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	HTLV-1	_	NN	NN	_	25	nn	_	_
25	pathogenesis	_	NN	NN	_	22	conj	_	_
26	.	_	.	.	_	15	punct	_	_

1	Cloning	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	9	det	_	_
4	novel	_	JJ	JJ	_	9	amod	_	_
5	human	_	JJ	JJ	_	9	amod	_	_
6	myeloid-cell-specific	_	JJ	JJ	_	9	amod	_	_
7	C/EBP-epsilon	_	NN	NN	_	9	nn	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	2	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Chicken	_	NN	NN	_	4	nn	_	_
2	NF-M	_	NN	NN	_	4	nn	_	_
3	transcription	_	NN	NN	_	4	nn	_	_
4	factor	_	NN	NN	_	15	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	in	_	IN	IN	_	4	prep	_	_
7	cooperation	_	NN	NN	_	6	pobj	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	either	_	CC	CC	_	10	preconj	_	_
10	c-Myb	_	NN	NN	_	8	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	v-Myb	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	4	punct	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	active	_	JJ	JJ	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	combinatorial	_	JJ	JJ	_	19	amod	_	_
19	activation	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	myeloid-cell-specific	_	JJ	JJ	_	22	amod	_	_
22	genes	_	NNS	NNS	_	20	pobj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	heterologous	_	JJ	JJ	_	26	amod	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	types	_	NNS	NNS	_	23	pobj	_	_
27	,	_	,	,	_	26	punct	_	_
28	such	_	JJ	JJ	_	29	mwe	_	_
29	as	_	IN	IN	_	26	prep	_	_
30	embryonic	_	JJ	JJ	_	31	amod	_	_
31	fibroblasts	_	NNS	NNS	_	29	pobj	_	_
32	.	_	.	.	_	15	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	humans	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	similar	_	JJ	JJ	_	5	amod	_	_
5	effects	_	NNS	NNS	_	7	nsubjpass	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	observed	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	homologous	_	JJ	JJ	_	10	amod	_	_
10	members	_	NNS	NNS	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	18	det	_	_
13	CCAAT/enhancer-binding	_	JJ	JJ	_	18	amod	_	_
14	protein	_	NN	NN	_	18	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	C/EBP	_	NN	NN	_	18	nn	_	_
17	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
18	family	_	NN	NN	_	11	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	transcriptional	_	JJ	JJ	_	21	amod	_	_
21	regulators	_	NNS	NNS	_	19	pobj	_	_
22	,	_	,	,	_	10	punct	_	_
23	especially	_	RB	RB	_	26	advmod	_	_
24	the	_	DT	DT	_	26	det	_	_
25	human	_	JJ	JJ	_	26	amod	_	_
26	homolog	_	NN	NN	_	10	appos	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	chicken	_	NN	NN	_	29	nn	_	_
29	NF-M	_	NN	NN	_	27	pobj	_	_
30	,	_	,	,	_	26	punct	_	_
31	C/EBP-beta	_	NN	NN	_	26	appos	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	NF-IL6	_	NN	NN	_	31	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	.	_	.	.	_	7	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	NF-IL6	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	expressed	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	10	det	_	_
10	variety	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	nonmyeloid	_	JJ	JJ	_	14	amod	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	types	_	NNS	NNS	_	11	pobj	_	_
15	and	_	CC	CC	_	7	cc	_	_
16	is	_	VBZ	VBZ	_	18	cop	_	_
17	strongly	_	RB	RB	_	18	advmod	_	_
18	inducible	_	JJ	JJ	_	7	conj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	response	_	NN	NN	_	19	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	inflammatory	_	JJ	JJ	_	23	amod	_	_
23	stimuli	_	NNS	NNS	_	21	pobj	_	_
24	,	_	,	,	_	18	punct	_	_
25	making	_	VBG	VBG	_	18	xcomp	_	_
26	it	_	PRP	PRP	_	29	nsubj	_	_
27	an	_	DT	DT	_	29	det	_	_
28	unlikely	_	JJ	JJ	_	29	amod	_	_
29	candidate	_	NN	NN	_	25	xcomp	_	_
30	to	_	TO	TO	_	31	aux	_	_
31	have	_	VB	VB	_	29	vmod	_	_
32	an	_	DT	DT	_	34	det	_	_
33	exclusive	_	JJ	JJ	_	34	amod	_	_
34	role	_	NN	NN	_	31	dobj	_	_
35	as	_	IN	IN	_	34	prep	_	_
36	a	_	DT	DT	_	39	det	_	_
37	combinatorial	_	JJ	JJ	_	39	amod	_	_
38	differentiation	_	NN	NN	_	39	nn	_	_
39	switch	_	NN	NN	_	35	pobj	_	_
40	during	_	IN	IN	_	31	prep	_	_
41	myelopoiesis	_	NN	NN	_	40	pobj	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	human	_	JJ	JJ	_	44	amod	_	_
44	cells	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	7	punct	_	_

1	By	_	IN	IN	_	31	prep	_	_
2	using	_	VBG	VBG	_	1	pcomp	_	_
3	a	_	DT	DT	_	6	det	_	_
4	reverse	_	JJ	JJ	_	5	amod	_	_
5	transcription-PCR-based	_	JJ	JJ	_	6	amod	_	_
6	approach	_	NN	NN	_	2	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	a	_	DT	DT	_	9	det	_	_
9	set	_	NN	NN	_	6	conj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	primers	_	NNS	NNS	_	10	pobj	_	_
12	specific	_	JJ	JJ	_	11	amod	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	DNA-binding	_	JJ	JJ	_	16	amod	_	_
16	domains	_	NNS	NNS	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	highly	_	RB	RB	_	19	advmod	_	_
19	homologous	_	JJ	JJ	_	20	amod	_	_
20	members	_	NNS	NNS	_	17	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	C/EBP	_	NN	NN	_	24	nn	_	_
24	family	_	NN	NN	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	transcriptional	_	JJ	JJ	_	27	amod	_	_
27	regulators	_	NNS	NNS	_	25	pobj	_	_
28	,	_	,	,	_	31	punct	_	_
29	we	_	PRP	PRP	_	31	nsubj	_	_
30	have	_	VBP	VBP	_	31	aux	_	_
31	cloned	_	VBN	VBN	_	0	root	_	_
32	a	_	DT	DT	_	35	det	_	_
33	novel	_	JJ	JJ	_	35	amod	_	_
34	human	_	JJ	JJ	_	35	amod	_	_
35	gene	_	NN	NN	_	31	dobj	_	_
36	encoding	_	VBG	VBG	_	35	vmod	_	_
37	a	_	DT	DT	_	38	det	_	_
38	member	_	NN	NN	_	36	dobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	the	_	DT	DT	_	43	det	_	_
41	C/EBP	_	NN	NN	_	43	nn	_	_
42	gene	_	NN	NN	_	43	nn	_	_
43	family	_	NN	NN	_	39	pobj	_	_
44	,	_	,	,	_	35	punct	_	_
45	identified	_	VBN	VBN	_	35	vmod	_	_
46	as	_	IN	IN	_	45	prep	_	_
47	the	_	DT	DT	_	49	det	_	_
48	human	_	JJ	JJ	_	49	amod	_	_
49	homolog	_	NN	NN	_	46	pobj	_	_
50	of	_	IN	IN	_	49	prep	_	_
51	CRP1	_	NN	NN	_	50	pobj	_	_
52	,	_	,	,	_	49	punct	_	_
53	C/EBP-epsilon	_	NN	NN	_	49	appos	_	_
54	.	_	.	.	_	31	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	1.2-kb	_	JJ	JJ	_	3	amod	_	_
3	cDNA	_	NN	NN	_	9	nsubjpass	_	_
4	encoding	_	VBG	VBG	_	3	vmod	_	_
5	full-length	_	JJ	JJ	_	7	amod	_	_
6	human	_	JJ	JJ	_	7	amod	_	_
7	C/EBP-epsilon	_	NN	NN	_	4	dobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	cloned	_	VBN	VBN	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	a	_	DT	DT	_	16	det	_	_
12	promyelocyte-late	_	JJ	JJ	_	16	amod	_	_
13	myeloblast-derived	_	JJ	JJ	_	16	amod	_	_
14	lambda	_	NN	NN	_	16	nn	_	_
15	gt11	_	NN	NN	_	16	nn	_	_
16	library	_	NN	NN	_	10	pobj	_	_
17	.	_	.	.	_	9	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	cDNA	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	genomic	_	JJ	JJ	_	5	conj	_	_
8	clones	_	NNS	NNS	_	5	dep	_	_
9	indicated	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	11	det	_	_
11	presence	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	two	_	CD	CD	_	14	num	_	_
14	exons	_	NNS	NNS	_	12	pobj	_	_
15	encoding	_	VBG	VBG	_	14	vmod	_	_
16	a	_	DT	DT	_	17	det	_	_
17	protein	_	NN	NN	_	15	dobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	an	_	DT	DT	_	22	det	_	_
20	apparent	_	JJ	JJ	_	22	amod	_	_
21	molecular	_	JJ	JJ	_	22	amod	_	_
22	mass	_	NN	NN	_	18	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	32	_	CD	CD	_	25	num	_	_
25	kDa	_	NN	NN	_	23	pobj	_	_
26	and	_	CC	CC	_	22	cc	_	_
27	a	_	DT	DT	_	28	det	_	_
28	pI	_	NN	NN	_	22	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	9.5	_	CD	CD	_	29	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	Primer	_	NN	NN	_	3	nn	_	_
2	extension	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	C/EBP-epsilon	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	4	pobj	_	_
7	detected	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	13	det	_	_
9	single	_	JJ	JJ	_	13	amod	_	_
10	major	_	JJ	JJ	_	13	amod	_	_
11	transcription	_	NN	NN	_	13	nn	_	_
12	start	_	NN	NN	_	13	nn	_	_
13	site	_	NN	NN	_	7	dobj	_	_
14	approximately	_	RB	RB	_	15	quantmod	_	_
15	200	_	CD	CD	_	16	num	_	_
16	bp	_	NN	NN	_	17	npadvmod	_	_
17	upstream	_	RB	RB	_	13	advmod	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	start	_	NN	NN	_	21	nn	_	_
21	codon	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	putative	_	JJ	JJ	_	4	amod	_	_
3	promoter	_	NN	NN	_	4	nn	_	_
4	area	_	NN	NN	_	6	nsubj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	similar	_	JJ	JJ	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	those	_	DT	DT	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	several	_	JJ	JJ	_	12	amod	_	_
11	other	_	JJ	JJ	_	12	amod	_	_
12	myeloid-cell-specific	_	JJ	JJ	_	13	amod	_	_
13	genes	_	NNS	NNS	_	9	pobj	_	_
14	in	_	IN	IN	_	6	prep	_	_
15	that	_	IN	IN	_	17	mark	_	_
16	it	_	PRP	PRP	_	17	nsubj	_	_
17	contains	_	VBZ	VBZ	_	14	pcomp	_	_
18	no	_	DT	DT	_	20	neg	_	_
19	TATAAA	_	NN	NN	_	20	nn	_	_
20	box	_	NN	NN	_	17	dobj	_	_
21	but	_	CC	CC	_	17	cc	_	_
22	has	_	VBZ	VBZ	_	17	conj	_	_
23	a	_	DT	DT	_	24	det	_	_
24	number	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	purine-rich	_	JJ	JJ	_	27	amod	_	_
27	stretches	_	NNS	NNS	_	25	pobj	_	_
28	with	_	IN	IN	_	24	prep	_	_
29	multiple	_	JJ	JJ	_	30	amod	_	_
30	sites	_	NNS	NNS	_	28	pobj	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	factors	_	NNS	NNS	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	37	det	_	_
36	Ets	_	NN	NN	_	37	nn	_	_
37	family	_	NN	NN	_	34	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	transcriptional	_	JJ	JJ	_	40	amod	_	_
40	regulators	_	NNS	NNS	_	38	pobj	_	_
41	.	_	.	.	_	6	punct	_	_

1	Northern	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analyses	_	NNS	NNS	_	4	nsubj	_	_
4	indicated	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	10	det	_	_
6	highly	_	RB	RB	_	7	advmod	_	_
7	restricted	_	JJ	JJ	_	10	amod	_	_
8	mRNA	_	NN	NN	_	10	nn	_	_
9	expression	_	NN	NN	_	10	nn	_	_
10	pattern	_	NN	NN	_	4	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	with	_	IN	IN	_	10	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	strongest	_	JJS	JJS	_	15	amod	_	_
15	expression	_	NN	NN	_	16	nsubj	_	_
16	occurring	_	VBG	VBG	_	12	pcomp	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	promyelocyte	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	late-myeloblast-like	_	JJ	JJ	_	18	conj	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	lines	_	NNS	NNS	_	18	dep	_	_
23	.	_	.	.	_	4	punct	_	_

1	Western	_	NN	NN	_	2	nn	_	_
2	blot	_	NN	NN	_	24	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	immunoprecipitation	_	NN	NN	_	2	conj	_	_
5	studies	_	NNS	NNS	_	2	dep	_	_
6	using	_	VBG	VBG	_	2	vmod	_	_
7	rabbit	_	NN	NN	_	9	nn	_	_
8	anti-C/EBP-epsilon	_	JJ	JJ	_	9	amod	_	_
9	antibodies	_	NNS	NNS	_	6	dobj	_	_
10	raised	_	VBN	VBN	_	9	vmod	_	_
11	against	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	N-terminal	_	JJ	JJ	_	14	amod	_	_
14	portion	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	C/EBP-epsilon	_	NN	NN	_	15	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
18	amino	_	NN	NN	_	19	nn	_	_
19	acids	_	NNS	NNS	_	14	appos	_	_
20	1	_	CD	CD	_	19	num	_	_
21	to	_	TO	TO	_	19	dep	_	_
22	115	_	CD	CD	_	19	num	_	_
23	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
24	showed	_	VBD	VBD	_	0	root	_	_
25	that	_	IN	IN	_	31	mark	_	_
26	C/EBP-epsilon	_	NN	NN	_	31	nsubj	_	_
27	is	_	VBZ	VBZ	_	31	cop	_	_
28	a	_	DT	DT	_	31	det	_	_
29	32-kDa	_	JJ	JJ	_	31	amod	_	_
30	nuclear	_	JJ	JJ	_	31	amod	_	_
31	phosphoprotein	_	NN	NN	_	24	ccomp	_	_
32	.	_	.	.	_	24	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	C/EBP-epsilon	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	5	nsubj	_	_
5	exhibited	_	VBD	VBD	_	0	root	_	_
6	strong	_	JJ	JJ	_	9	amod	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	specific	_	JJ	JJ	_	6	conj	_	_
9	binding	_	NN	NN	_	5	dobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	double-stranded	_	JJ	JJ	_	16	amod	_	_
12	DNA	_	NN	NN	_	16	nn	_	_
13	containing	_	VBG	VBG	_	16	amod	_	_
14	consensus	_	NN	NN	_	16	nn	_	_
15	C/EBP	_	NN	NN	_	16	nn	_	_
16	sites	_	NNS	NNS	_	10	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Cotransfection	_	NN	NN	_	23	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	dep	_	_
4	C/EBP-epsilon	_	NN	NN	_	2	pobj	_	_
5	sense	_	NN	NN	_	4	dep	_	_
6	and	_	CC	CC	_	4	cc	_	_
7	antisense	_	JJ	JJ	_	4	conj	_	_
8	expression	_	NN	NN	_	9	nn	_	_
9	constructs	_	NNS	NNS	_	4	dep	_	_
10	together	_	RB	RB	_	11	advmod	_	_
11	with	_	IN	IN	_	1	prep	_	_
12	chloramphenicol	_	NN	NN	_	15	nn	_	_
13	acetyltransferase	_	NN	NN	_	15	nn	_	_
14	reporter	_	NN	NN	_	15	nn	_	_
15	vectors	_	NNS	NNS	_	11	pobj	_	_
16	containing	_	VBG	VBG	_	15	vmod	_	_
17	myeloid-cell-specific	_	JJ	JJ	_	18	amod	_	_
18	c-mim	_	NN	NN	_	16	dobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	human	_	JJ	JJ	_	21	amod	_	_
21	myeloperoxidase	_	JJ	JJ	_	18	conj	_	_
22	promoters	_	NNS	NNS	_	18	dep	_	_
23	suggested	_	VBD	VBD	_	0	root	_	_
24	a	_	DT	DT	_	25	det	_	_
25	role	_	NN	NN	_	23	dobj	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	C/EBP-epsilon	_	NN	NN	_	26	pobj	_	_
28	transcription	_	NN	NN	_	29	nn	_	_
29	factor	_	NN	NN	_	27	dep	_	_
30	in	_	IN	IN	_	25	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	regulation	_	NN	NN	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	a	_	DT	DT	_	35	det	_	_
35	subset	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	myeloid-cell-specific	_	JJ	JJ	_	38	amod	_	_
38	genes	_	NNS	NNS	_	36	pobj	_	_
39	.	_	.	.	_	23	punct	_	_

1	Transient	_	JJ	JJ	_	2	amod	_	_
2	tranfection	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	7	det	_	_
5	promyelocyte	_	NN	NN	_	7	nn	_	_
6	cell	_	NN	NN	_	7	nn	_	_
7	line	_	NN	NN	_	3	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	NB4	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	with	_	IN	IN	_	2	prep	_	_
12	a	_	DT	DT	_	15	det	_	_
13	C/EBP-epsilon	_	NN	NN	_	15	nn	_	_
14	expression	_	NN	NN	_	15	nn	_	_
15	plasmid	_	NN	NN	_	11	pobj	_	_
16	increased	_	VBD	VBD	_	0	root	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	growth	_	NN	NN	_	16	dobj	_	_
19	by	_	IN	IN	_	16	prep	_	_
20	sevenfold	_	RB	RB	_	19	pobj	_	_
21	,	_	,	,	_	16	punct	_	_
22	while	_	IN	IN	_	25	mark	_	_
23	antisense	_	JJ	JJ	_	24	amod	_	_
24	C/EBP-epsilon	_	NN	NN	_	25	nsubj	_	_
25	caused	_	VBD	VBD	_	16	advcl	_	_
26	a	_	DT	DT	_	28	det	_	_
27	fivefold	_	JJ	JJ	_	28	amod	_	_
28	decrease	_	NN	NN	_	25	dobj	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	clonal	_	JJ	JJ	_	31	amod	_	_
31	growth	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	these	_	DT	DT	_	34	det	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	16	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	ferritin	_	NN	NN	_	7	nn	_	_
6	heavy-chain	_	JJ	JJ	_	7	amod	_	_
7	gene	_	NN	NN	_	3	pobj	_	_
8	:	_	:	:	_	2	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	activity	_	NN	NN	_	18	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	CCAAT	_	NN	NN	_	16	nn	_	_
14	binding	_	NN	NN	_	16	nn	_	_
15	factor	_	NN	NN	_	16	nn	_	_
16	NF-Y	_	NN	NN	_	11	pobj	_	_
17	is	_	VBZ	VBZ	_	18	auxpass	_	_
18	modulated	_	VBN	VBN	_	2	dep	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	heme-treated	_	JJ	JJ	_	23	amod	_	_
21	Friend	_	NN	NN	_	23	nn	_	_
22	leukemia	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	19	pobj	_	_
24	and	_	CC	CC	_	19	cc	_	_
25	during	_	IN	IN	_	19	conj	_	_
26	monocyte-to-macrophage	_	JJ	JJ	_	27	amod	_	_
27	differentiation	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	ferritin	_	NN	NN	_	5	nn	_	_
3	H-chain	_	JJ	JJ	_	5	amod	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	promoter	_	NN	NN	_	6	nn	_	_
6	regulation	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	analyzed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	heme-treated	_	JJ	JJ	_	13	amod	_	_
11	Friend	_	NN	NN	_	13	nn	_	_
12	leukemia	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	9	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	FLCs	_	NNS	NNS	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	and	_	CC	CC	_	9	cc	_	_
18	during	_	IN	IN	_	9	conj	_	_
19	monocyte-to-macrophage	_	JJ	JJ	_	20	amod	_	_
20	differentiation	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	majority	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	lines	_	NNS	NNS	_	4	pobj	_	_
7	studied	_	VBN	VBN	_	6	vmod	_	_
8	,	_	,	,	_	15	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	regulation	_	NN	NN	_	15	nsubjpass	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	ferritin	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	pobj	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	exerted	_	VBN	VBN	_	0	root	_	_
16	mostly	_	RB	RB	_	17	advmod	_	_
17	at	_	IN	IN	_	15	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	translational	_	JJ	JJ	_	20	amod	_	_
20	level	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	15	punct	_	_

1	However	_	RB	RB	_	33	advmod	_	_
2	,	_	,	,	_	33	punct	_	_
3	in	_	IN	IN	_	33	prep	_	_
4	differentiating	_	VBG	VBG	_	6	amod	_	_
5	erythroid	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	which	_	WDT	WDT	_	10	nsubj	_	_
9	must	_	MD	MD	_	10	aux	_	_
10	incorporate	_	VB	VB	_	6	rcmod	_	_
11	high	_	JJ	JJ	_	12	amod	_	_
12	levels	_	NNS	NNS	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	iron	_	NN	NN	_	13	pobj	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	sustain	_	VB	VB	_	10	xcomp	_	_
17	hemoglobin	_	NN	NN	_	18	nn	_	_
18	synthesis	_	NN	NN	_	16	dobj	_	_
19	,	_	,	,	_	3	punct	_	_
20	and	_	CC	CC	_	3	cc	_	_
21	in	_	IN	IN	_	3	conj	_	_
22	macrophages	_	NNS	NNS	_	21	pobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	which	_	WDT	WDT	_	26	nsubjpass	_	_
25	are	_	VBP	VBP	_	26	auxpass	_	_
26	involved	_	VBN	VBN	_	22	rcmod	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	iron	_	NN	NN	_	29	nn	_	_
29	storage	_	NN	NN	_	27	pobj	_	_
30	,	_	,	,	_	33	punct	_	_
31	transcriptional	_	JJ	JJ	_	32	amod	_	_
32	regulation	_	NN	NN	_	33	nsubj	_	_
33	seemed	_	VBD	VBD	_	0	root	_	_
34	to	_	TO	TO	_	38	aux	_	_
35	be	_	VB	VB	_	38	cop	_	_
36	a	_	DT	DT	_	38	det	_	_
37	relevant	_	JJ	JJ	_	38	amod	_	_
38	mechanism	_	NN	NN	_	33	xcomp	_	_
39	.	_	.	.	_	33	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	30	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	minimum	_	JJ	JJ	_	7	amod	_	_
7	region	_	NN	NN	_	30	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	ferritin	_	NN	NN	_	12	nn	_	_
11	H-gene	_	NN	NN	_	12	nn	_	_
12	promoter	_	NN	NN	_	8	pobj	_	_
13	that	_	WDT	WDT	_	15	nsubj	_	_
14	is	_	VBZ	VBZ	_	15	cop	_	_
15	able	_	JJ	JJ	_	12	rcmod	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	confer	_	VB	VB	_	15	xcomp	_	_
18	transcriptional	_	JJ	JJ	_	19	amod	_	_
19	regulation	_	NN	NN	_	17	dobj	_	_
20	by	_	IN	IN	_	17	prep	_	_
21	heme	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	FLCs	_	NNS	NNS	_	22	pobj	_	_
24	to	_	TO	TO	_	17	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	reporter	_	NN	NN	_	27	nn	_	_
27	gene	_	NN	NN	_	24	pobj	_	_
28	is	_	VBZ	VBZ	_	30	cop	_	_
29	77	_	CD	CD	_	30	num	_	_
30	nucleotides	_	NNS	NNS	_	2	ccomp	_	_
31	upstream	_	JJ	JJ	_	30	amod	_	_
32	of	_	IN	IN	_	30	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	TATA	_	NN	NN	_	35	nn	_	_
35	box	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	cis	_	JJ	JJ	_	3	amod	_	_
3	element	_	NN	NN	_	4	nsubj	_	_
4	binds	_	VBZ	VBZ	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	protein	_	NN	NN	_	7	nn	_	_
7	complex	_	NN	NN	_	4	dobj	_	_
8	referred	_	VBN	VBN	_	7	vmod	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	as	_	IN	IN	_	8	prep	_	_
11	HRF	_	NN	NN	_	10	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
13	heme-responsive	_	JJ	JJ	_	14	amod	_	_
14	factor	_	NN	NN	_	11	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	11	punct	_	_
17	which	_	WDT	WDT	_	20	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	20	auxpass	_	_
19	greatly	_	RB	RB	_	20	advmod	_	_
20	enhanced	_	VBN	VBN	_	11	rcmod	_	_
21	both	_	CC	CC	_	22	preconj	_	_
22	in	_	IN	IN	_	20	prep	_	_
23	heme-treated	_	JJ	JJ	_	24	amod	_	_
24	FLCs	_	NNS	NNS	_	22	pobj	_	_
25	and	_	CC	CC	_	22	cc	_	_
26	during	_	IN	IN	_	22	conj	_	_
27	monocyte-to-macrophage	_	JJ	JJ	_	28	amod	_	_
28	differentiation	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	CCAAT	_	NN	NN	_	3	nn	_	_
3	element	_	NN	NN	_	18	nsubj	_	_
4	present	_	JJ	JJ	_	3	amod	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	reverse	_	JJ	JJ	_	7	amod	_	_
7	orientation	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	this	_	DT	DT	_	11	det	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	ferritin	_	NN	NN	_	16	nn	_	_
15	H-chain	_	JJ	JJ	_	16	amod	_	_
16	gene	_	NN	NN	_	12	pobj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	necessary	_	JJ	JJ	_	0	root	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	binding	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	19	cc	_	_
22	for	_	IN	IN	_	19	conj	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	activity	_	NN	NN	_	22	pobj	_	_
25	,	_	,	,	_	18	punct	_	_
26	since	_	IN	IN	_	32	mark	_	_
27	a	_	DT	DT	_	30	det	_	_
28	single	_	JJ	JJ	_	30	amod	_	_
29	point	_	NN	NN	_	30	nn	_	_
30	mutation	_	NN	NN	_	32	nsubj	_	_
31	is	_	VBZ	VBZ	_	32	cop	_	_
32	able	_	JJ	JJ	_	18	advcl	_	_
33	to	_	TO	TO	_	34	aux	_	_
34	abolish	_	VB	VB	_	32	xcomp	_	_
35	the	_	DT	DT	_	36	det	_	_
36	binding	_	NN	NN	_	34	dobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	HRF	_	NN	NN	_	37	pobj	_	_
39	and	_	CC	CC	_	36	cc	_	_
40	the	_	DT	DT	_	42	det	_	_
41	transcriptional	_	JJ	JJ	_	42	amod	_	_
42	activity	_	NN	NN	_	36	conj	_	_
43	in	_	IN	IN	_	42	prep	_	_
44	transfected	_	VBN	VBN	_	45	amod	_	_
45	cells	_	NNS	NNS	_	43	pobj	_	_
46	.	_	.	.	_	18	punct	_	_

1	By	_	IN	IN	_	9	prep	_	_
2	competition	_	NN	NN	_	3	nn	_	_
3	experiments	_	NNS	NNS	_	1	pobj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	supershift	_	NN	NN	_	6	nn	_	_
6	assays	_	NNS	NNS	_	3	conj	_	_
7	,	_	,	,	_	9	punct	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	identified	_	VBD	VBD	_	0	root	_	_
10	the	_	DT	DT	_	12	det	_	_
11	induced	_	VBN	VBN	_	12	amod	_	_
12	HRF	_	NN	NN	_	9	dobj	_	_
13	as	_	IN	IN	_	9	prep	_	_
14	containing	_	VBG	VBG	_	13	pcomp	_	_
15	at	_	IN	IN	_	20	advmod	_	_
16	least	_	JJS	JJS	_	15	pobj	_	_
17	the	_	DT	DT	_	20	det	_	_
18	ubiquitous	_	JJ	JJ	_	20	amod	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	factor	_	NN	NN	_	14	dobj	_	_
21	NF-Y	_	NN	NN	_	20	dep	_	_
22	.	_	.	.	_	9	punct	_	_

1	NF-Y	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	formed	_	VBN	VBN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	three	_	CD	CD	_	6	num	_	_
6	subunits	_	NNS	NNS	_	4	pobj	_	_
7	,	_	,	,	_	6	punct	_	_
8	A	_	DT	DT	_	6	appos	_	_
9	,	_	,	,	_	8	punct	_	_
10	B	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	C	_	NN	NN	_	8	conj	_	_
14	,	_	,	,	_	6	punct	_	_
15	all	_	DT	DT	_	19	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	which	_	WDT	WDT	_	16	pobj	_	_
18	are	_	VBP	VBP	_	19	cop	_	_
19	necessary	_	JJ	JJ	_	6	rcmod	_	_
20	for	_	IN	IN	_	19	prep	_	_
21	DNA	_	NN	NN	_	22	nn	_	_
22	binding	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	Cotransfection	_	NN	NN	_	11	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	transdominant	_	JJ	JJ	_	6	amod	_	_
5	negative	_	JJ	JJ	_	6	amod	_	_
6	mutant	_	NN	NN	_	2	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	NF-YA	_	NN	NN	_	10	nn	_	_
10	subunit	_	NN	NN	_	7	pobj	_	_
11	abolishes	_	VBZ	VBZ	_	0	root	_	_
12	the	_	DT	DT	_	14	det	_	_
13	transcriptional	_	JJ	JJ	_	14	amod	_	_
14	activation	_	NN	NN	_	11	dobj	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	heme	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	11	punct	_	_
18	indicating	_	VBG	VBG	_	11	vmod	_	_
19	that	_	IN	IN	_	21	mark	_	_
20	NF-Y	_	NN	NN	_	21	nsubj	_	_
21	plays	_	VBZ	VBZ	_	18	ccomp	_	_
22	an	_	DT	DT	_	24	det	_	_
23	essential	_	JJ	JJ	_	24	amod	_	_
24	role	_	NN	NN	_	21	dobj	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	this	_	DT	DT	_	27	det	_	_
27	activation	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	11	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	observed	_	VBN	VBN	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	differential	_	JJ	JJ	_	7	amod	_	_
7	expression	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	NF-YA	_	NN	NN	_	11	nn	_	_
11	subunit	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	heme-treated	_	JJ	JJ	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	control	_	JJ	JJ	_	13	conj	_	_
16	FLCs	_	NNS	NNS	_	13	dep	_	_
17	and	_	CC	CC	_	12	cc	_	_
18	during	_	IN	IN	_	12	conj	_	_
19	monocyte-to-macrophage	_	JJ	JJ	_	20	amod	_	_
20	differentiation	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	4	punct	_	_

1	Characterization	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	mutant	_	JJ	JJ	_	6	amod	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	line	_	NN	NN	_	2	pobj	_	_
7	that	_	WDT	WDT	_	10	nsubj	_	_
8	does	_	VBZ	VBZ	_	10	aux	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	activate	_	VB	VB	_	6	rcmod	_	_
11	NF-kappaB	_	NN	NN	_	10	dobj	_	_
12	in	_	IN	IN	_	10	prep	_	_
13	response	_	NN	NN	_	12	pobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	multiple	_	JJ	JJ	_	16	amod	_	_
16	stimuli	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Numerous	_	JJ	JJ	_	2	amod	_	_
2	genes	_	NNS	NNS	_	17	nsubjpass	_	_
3	required	_	VBN	VBN	_	2	vmod	_	_
4	during	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	dep	_	_
6	immune	_	JJ	JJ	_	4	pobj	_	_
7	or	_	CC	CC	_	6	cc	_	_
8	inflammation	_	NN	NN	_	6	conj	_	_
9	response	_	NN	NN	_	6	dep	_	_
10	as	_	RB	RB	_	11	advmod	_	_
11	well	_	RB	RB	_	6	cc	_	_
12	as	_	IN	IN	_	11	mwe	_	_
13	the	_	DT	DT	_	15	det	_	_
14	adhesion	_	NN	NN	_	15	nn	_	_
15	process	_	NN	NN	_	6	conj	_	_
16	are	_	VBP	VBP	_	17	auxpass	_	_
17	regulated	_	VBN	VBN	_	0	root	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	nuclear	_	JJ	JJ	_	21	amod	_	_
20	factor	_	NN	NN	_	21	nn	_	_
21	kappaB	_	NN	NN	_	18	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	NF-kappaB	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	.	_	.	.	_	17	punct	_	_

1	Associated	_	VBN	VBN	_	0	root	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	its	_	PRP$	PRP$	_	4	poss	_	_
4	inhibitor	_	NN	NN	_	2	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	I	_	NN	NN	_	7	nn	_	_
7	kappaB	_	NN	NN	_	4	appos	_	_
8	,	_	,	,	_	1	punct	_	_
9	NF-kappaB	_	NN	NN	_	10	nsubj	_	_
10	resides	_	VBZ	VBZ	_	1	parataxis	_	_
11	as	_	IN	IN	_	10	prep	_	_
12	an	_	DT	DT	_	14	det	_	_
13	inactive	_	JJ	JJ	_	14	amod	_	_
14	form	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	10	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	cytoplasm	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	1	punct	_	_

1	Upon	_	IN	IN	_	10	prep	_	_
2	stimulation	_	NN	NN	_	1	pobj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	various	_	JJ	JJ	_	5	amod	_	_
5	agents	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	I	_	NN	NN	_	8	nn	_	_
8	kappaB	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	proteolyzed	_	VBN	VBN	_	0	root	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	NF-kappaB	_	NN	NN	_	13	nsubj	_	_
13	translocates	_	VBZ	VBZ	_	10	conj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	nucleus	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	16	punct	_	_
18	where	_	WRB	WRB	_	20	advmod	_	_
19	it	_	PRP	PRP	_	20	nsubj	_	_
20	activates	_	VBZ	VBZ	_	16	rcmod	_	_
21	its	_	PRP$	PRP$	_	23	poss	_	_
22	target	_	NN	NN	_	23	nn	_	_
23	genes	_	NNS	NNS	_	20	dobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transduction	_	NN	NN	_	3	nn	_	_
3	pathways	_	NNS	NNS	_	10	nsubj	_	_
4	that	_	WDT	WDT	_	5	nsubj	_	_
5	lead	_	VBP	VBP	_	3	rcmod	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	I	_	NN	NN	_	8	nn	_	_
8	kappaB	_	NN	NN	_	9	nn	_	_
9	inactivation	_	NN	NN	_	6	pobj	_	_
10	remain	_	VBP	VBP	_	0	root	_	_
11	poorly	_	RB	RB	_	10	advmod	_	_
12	understood	_	VBN	VBN	_	10	acomp	_	_
13	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	characterized	_	VBN	VBN	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	cellular	_	JJ	JJ	_	10	amod	_	_
10	mutant	_	NN	NN	_	7	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	the	_	DT	DT	_	18	det	_	_
13	70/Z3-derived	_	JJ	JJ	_	18	amod	_	_
14	1.3E2	_	NN	NN	_	18	nn	_	_
15	murine	_	JJ	JJ	_	18	amod	_	_
16	pre-B	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	line	_	NN	NN	_	10	appos	_	_
19	,	_	,	,	_	10	punct	_	_
20	that	_	WDT	WDT	_	23	nsubj	_	_
21	does	_	VBZ	VBZ	_	23	aux	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	activate	_	VB	VB	_	10	rcmod	_	_
24	NF-kappaB	_	NN	NN	_	23	dobj	_	_
25	in	_	IN	IN	_	23	prep	_	_
26	response	_	NN	NN	_	25	pobj	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	several	_	JJ	JJ	_	29	amod	_	_
29	stimuli	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	26	mark	_	_
4	upon	_	IN	IN	_	26	prep	_	_
5	stimulation	_	NN	NN	_	4	pobj	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	lipopolysaccharide	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	Taxol	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	7	punct	_	_
11	phorbol	_	NN	NN	_	13	nn	_	_
12	myristate	_	NN	NN	_	13	nn	_	_
13	acetate	_	NN	NN	_	7	conj	_	_
14	,	_	,	,	_	7	punct	_	_
15	interleukin-1	_	NN	NN	_	7	conj	_	_
16	,	_	,	,	_	7	punct	_	_
17	or	_	CC	CC	_	7	cc	_	_
18	double-stranded	_	JJ	JJ	_	19	amod	_	_
19	RNA	_	NN	NN	_	7	conj	_	_
20	,	_	,	,	_	26	punct	_	_
21	I	_	NN	NN	_	23	nn	_	_
22	kappaB	_	NN	NN	_	23	nn	_	_
23	alpha	_	NN	NN	_	26	nsubjpass	_	_
24	is	_	VBZ	VBZ	_	26	auxpass	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	degraded	_	VBN	VBN	_	2	ccomp	_	_
27	,	_	,	,	_	26	punct	_	_
28	as	_	IN	IN	_	26	prep	_	_
29	a	_	DT	DT	_	30	det	_	_
30	result	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	an	_	DT	DT	_	33	det	_	_
33	absence	_	NN	NN	_	31	pobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	induced	_	VBN	VBN	_	36	amod	_	_
36	phosphorylation	_	NN	NN	_	34	pobj	_	_
37	on	_	IN	IN	_	36	prep	_	_
38	serines	_	NNS	NNS	_	37	pobj	_	_
39	32	_	CD	CD	_	38	dep	_	_
40	and	_	CC	CC	_	38	cc	_	_
41	36	_	CD	CD	_	38	conj	_	_
42	.	_	.	.	_	2	punct	_	_

1	Neither	_	CC	CC	_	3	preconj	_	_
2	a	_	DT	DT	_	3	det	_	_
3	mutation	_	NN	NN	_	27	nsubj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	I	_	NN	NN	_	7	nn	_	_
6	kappaB	_	NN	NN	_	7	nn	_	_
7	alpha	_	NN	NN	_	4	pobj	_	_
8	nor	_	CC	CC	_	3	cc	_	_
9	a	_	DT	DT	_	10	det	_	_
10	mutation	_	NN	NN	_	3	conj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	p50	_	NN	NN	_	11	pobj	_	_
13	or	_	CC	CC	_	12	cc	_	_
14	relA	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	the	_	DT	DT	_	19	det	_	_
17	two	_	CD	CD	_	19	num	_	_
18	major	_	JJ	JJ	_	19	amod	_	_
19	subunits	_	NNS	NNS	_	12	appos	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	NF-kappaB	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	this	_	DT	DT	_	25	det	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	line	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	3	punct	_	_
27	accounts	_	VBZ	VBZ	_	0	root	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	this	_	DT	DT	_	31	det	_	_
30	phosphorylation	_	NN	NN	_	31	nn	_	_
31	defect	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	27	punct	_	_

1	As	_	RB	RB	_	4	advmod	_	_
2	well	_	RB	RB	_	4	advmod	_	_
3	as	_	IN	IN	_	4	mark	_	_
4	culminating	_	VBG	VBG	_	28	dep	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	inducible	_	JJ	JJ	_	8	amod	_	_
8	phosphorylation	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	I	_	NN	NN	_	11	nn	_	_
11	kappaB	_	NN	NN	_	12	nn	_	_
12	alpha	_	NN	NN	_	9	pobj	_	_
13	on	_	IN	IN	_	8	prep	_	_
14	serines	_	NNS	NNS	_	13	pobj	_	_
15	32	_	CD	CD	_	14	dep	_	_
16	and	_	CC	CC	_	14	cc	_	_
17	36	_	CD	CD	_	14	conj	_	_
18	,	_	,	,	_	28	punct	_	_
19	all	_	PDT	PDT	_	21	predet	_	_
20	the	_	DT	DT	_	21	det	_	_
21	stimuli	_	NNS	NNS	_	28	nsubj	_	_
22	that	_	WDT	WDT	_	24	nsubj	_	_
23	are	_	VBP	VBP	_	24	cop	_	_
24	inactive	_	JJ	JJ	_	21	rcmod	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	1.3E2	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	exhibit	_	VBP	VBP	_	0	root	_	_
29	a	_	DT	DT	_	30	det	_	_
30	sensitivity	_	NN	NN	_	28	dobj	_	_
31	to	_	TO	TO	_	30	prep	_	_
32	the	_	DT	DT	_	33	det	_	_
33	antioxidant	_	JJ	JJ	_	31	pobj	_	_
34	pyrrolidine	_	NN	NN	_	35	nn	_	_
35	dithiocarbamate	_	NN	NN	_	33	dep	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	PDTC	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	.	_	.	.	_	28	punct	_	_

1	In	_	IN	IN	_	18	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	18	punct	_	_
4	stimuli	_	NNS	NNS	_	18	nsubj	_	_
5	such	_	JJ	JJ	_	6	mwe	_	_
6	as	_	IN	IN	_	4	prep	_	_
7	hyperosmotic	_	JJ	JJ	_	8	amod	_	_
8	shock	_	NN	NN	_	6	pobj	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	phosphatase	_	NN	NN	_	11	nn	_	_
11	inhibitors	_	NNS	NNS	_	8	conj	_	_
12	,	_	,	,	_	8	punct	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	use	_	VBP	VBP	_	8	rcmod	_	_
15	PDTC-insensitive	_	JJ	JJ	_	16	amod	_	_
16	pathways	_	NNS	NNS	_	14	dobj	_	_
17	,	_	,	,	_	4	punct	_	_
18	induce	_	VBP	VBP	_	0	root	_	_
19	I	_	NN	NN	_	20	nn	_	_
20	kappaB	_	NN	NN	_	22	nn	_	_
21	alpha	_	NN	NN	_	22	nn	_	_
22	degradation	_	NN	NN	_	18	dobj	_	_
23	in	_	IN	IN	_	18	prep	_	_
24	1.3E2	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	18	punct	_	_

1	Analysis	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	redox	_	JJ	JJ	_	5	amod	_	_
5	status	_	NN	NN	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	1.3E2	_	NN	NN	_	6	pobj	_	_
8	does	_	VBZ	VBZ	_	10	aux	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	reveal	_	VB	VB	_	0	root	_	_
11	any	_	DT	DT	_	12	det	_	_
12	difference	_	NN	NN	_	10	dobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	wild-type	_	JJ	JJ	_	15	amod	_	_
15	70Z/3	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	the	_	DT	DT	_	17	det	_	_
6	human	_	JJ	JJ	_	17	amod	_	_
7	T-cell	_	NN	NN	_	17	nn	_	_
8	leukemia	_	NN	NN	_	17	nn	_	_
9	virus	_	NN	NN	_	17	nn	_	_
10	type	_	NN	NN	_	17	nn	_	_
11	1	_	CD	CD	_	17	num	_	_
12	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
13	HTLV-1	_	NN	NN	_	17	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
15	-derived	_	JJ	JJ	_	17	amod	_	_
16	Tax	_	NN	NN	_	17	nn	_	_
17	trans-activator	_	NN	NN	_	18	nsubj	_	_
18	induces	_	VBZ	VBZ	_	3	ccomp	_	_
19	NF-kappaB	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	18	dobj	_	_
21	in	_	IN	IN	_	18	prep	_	_
22	1.3E2	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	18	punct	_	_
24	suggesting	_	VBG	VBG	_	18	vmod	_	_
25	that	_	IN	IN	_	31	mark	_	_
26	this	_	DT	DT	_	28	det	_	_
27	viral	_	JJ	JJ	_	28	amod	_	_
28	protein	_	NN	NN	_	31	nsubj	_	_
29	does	_	VBZ	VBZ	_	31	aux	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	operate	_	VB	VB	_	24	ccomp	_	_
32	via	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	defective	_	JJ	JJ	_	35	amod	_	_
35	pathway	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	3	punct	_	_

1	Finally	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	show	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	25	mark	_	_
6	two	_	CD	CD	_	10	num	_	_
7	other	_	JJ	JJ	_	10	amod	_	_
8	I	_	NN	NN	_	10	nn	_	_
9	kappaB	_	NN	NN	_	10	nn	_	_
10	molecules	_	NNS	NNS	_	25	nsubjpass	_	_
11	,	_	,	,	_	10	punct	_	_
12	I	_	NN	NN	_	14	nn	_	_
13	kappaB	_	NN	NN	_	14	nn	_	_
14	beta	_	NN	NN	_	10	appos	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	the	_	DT	DT	_	21	det	_	_
17	recently	_	RB	RB	_	18	advmod	_	_
18	identified	_	VBN	VBN	_	21	amod	_	_
19	I	_	NN	NN	_	21	nn	_	_
20	kappaB	_	NN	NN	_	21	nn	_	_
21	epsilon	_	NN	NN	_	14	conj	_	_
22	,	_	,	,	_	10	punct	_	_
23	are	_	VBP	VBP	_	25	auxpass	_	_
24	not	_	RB	RB	_	25	neg	_	_
25	degraded	_	VBN	VBN	_	4	ccomp	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	30	det	_	_
28	1.3E2	_	NN	NN	_	30	nn	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	line	_	NN	NN	_	26	pobj	_	_
31	following	_	VBG	VBG	_	25	prep	_	_
32	stimulation	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	4	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	1.3E2	_	NN	NN	_	10	nsubj	_	_
6	is	_	VBZ	VBZ	_	10	cop	_	_
7	a	_	DT	DT	_	10	det	_	_
8	cellular	_	JJ	JJ	_	10	amod	_	_
9	transduction	_	NN	NN	_	10	nn	_	_
10	mutant	_	NN	NN	_	3	ccomp	_	_
11	exhibiting	_	VBG	VBG	_	10	vmod	_	_
12	a	_	DT	DT	_	13	det	_	_
13	defect	_	NN	NN	_	11	dobj	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	a	_	DT	DT	_	16	det	_	_
16	step	_	NN	NN	_	14	pobj	_	_
17	that	_	WDT	WDT	_	19	nsubjpass	_	_
18	is	_	VBZ	VBZ	_	19	auxpass	_	_
19	required	_	VBN	VBN	_	16	rcmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	several	_	JJ	JJ	_	22	amod	_	_
22	different	_	JJ	JJ	_	23	amod	_	_
23	stimuli	_	NNS	NNS	_	20	pobj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	activate	_	VB	VB	_	19	xcomp	_	_
26	NF-kappaB	_	NN	NN	_	25	dobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	this	_	DT	DT	_	5	det	_	_
5	analysis	_	NN	NN	_	6	nsubj	_	_
6	suggests	_	VBZ	VBZ	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	common	_	JJ	JJ	_	9	amod	_	_
9	step	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	signaling	_	NN	NN	_	13	nn	_	_
13	pathways	_	NNS	NNS	_	10	pobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	trigger	_	VBP	VBP	_	13	rcmod	_	_
16	I	_	NN	NN	_	18	nn	_	_
17	kappaB	_	NN	NN	_	18	nn	_	_
18	alpha	_	NN	NN	_	15	dobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	I	_	NN	NN	_	22	nn	_	_
21	kappaB	_	NN	NN	_	22	nn	_	_
22	beta	_	NN	NN	_	18	conj	_	_
23	,	_	,	,	_	18	punct	_	_
24	and	_	CC	CC	_	18	cc	_	_
25	I	_	NN	NN	_	27	nn	_	_
26	kappaB	_	NN	NN	_	27	nn	_	_
27	epsilon	_	NN	NN	_	18	conj	_	_
28	degradation	_	NN	NN	_	18	dep	_	_
29	.	_	.	.	_	6	punct	_	_

1	Transcription	_	NN	NN	_	7	nsubj	_	_
2	mediated	_	VBN	VBN	_	1	vmod	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	NFAT	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	7	cop	_	_
6	highly	_	RB	RB	_	7	advmod	_	_
7	inducible	_	JJ	JJ	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	effector	_	NN	NN	_	8	pobj	_	_
10	CD4+	_	JJ	JJ	_	17	amod	_	_
11	T	_	NN	NN	_	17	nn	_	_
12	helper	_	NN	NN	_	17	nn	_	_
13	2	_	CD	CD	_	17	num	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	Th2	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	cells	_	NNS	NNS	_	9	dep	_	_
18	but	_	CC	CC	_	8	cc	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	in	_	IN	IN	_	8	conj	_	_
21	Th1	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	.	_	.	.	_	7	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	factors	_	NNS	NNS	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	NFAT	_	NN	NN	_	6	nn	_	_
6	family	_	NN	NN	_	3	pobj	_	_
7	play	_	VBP	VBP	_	0	root	_	_
8	an	_	DT	DT	_	10	det	_	_
9	important	_	JJ	JJ	_	10	amod	_	_
10	role	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	regulating	_	VBG	VBG	_	11	pcomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	expression	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	several	_	JJ	JJ	_	18	amod	_	_
17	cytokine	_	NN	NN	_	18	nn	_	_
18	genes	_	NNS	NNS	_	15	pobj	_	_
19	during	_	IN	IN	_	14	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	immune	_	JJ	JJ	_	22	amod	_	_
22	response	_	NN	NN	_	19	pobj	_	_
23	,	_	,	,	_	7	punct	_	_
24	such	_	JJ	JJ	_	25	mwe	_	_
25	as	_	IN	IN	_	7	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	genes	_	NNS	NNS	_	25	pobj	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	interleukin	_	NN	NN	_	28	pobj	_	_
30	2	_	CD	CD	_	29	num	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	IL-2	_	NN	NN	_	29	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	and	_	CC	CC	_	29	cc	_	_
35	IL-4	_	NN	NN	_	29	conj	_	_
36	,	_	,	,	_	27	punct	_	_
37	among	_	IN	IN	_	27	prep	_	_
38	others	_	NNS	NNS	_	37	pobj	_	_
39	.	_	.	.	_	7	punct	_	_

1	Upon	_	IN	IN	_	13	prep	_	_
2	antigen	_	NN	NN	_	3	nn	_	_
3	stimulation	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	13	punct	_	_
5	precursor	_	NN	NN	_	13	nsubj	_	_
6	CD4+	_	JJ	JJ	_	12	amod	_	_
7	T	_	NN	NN	_	12	nn	_	_
8	helper	_	NN	NN	_	12	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	pTh	_	NN	NN	_	12	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
12	cells	_	NNS	NNS	_	5	dep	_	_
13	proliferate	_	VBP	VBP	_	0	root	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	differentiate	_	VBP	VBP	_	13	conj	_	_
16	into	_	IN	IN	_	15	prep	_	_
17	two	_	CD	CD	_	18	num	_	_
18	populations	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	effector	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	eTh1	_	NN	NN	_	18	dep	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	eTh2	_	NN	NN	_	23	conj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
27	,	_	,	,	_	15	punct	_	_
28	each	_	DT	DT	_	29	det	_	_
29	one	_	NN	NN	_	30	nsubj	_	_
30	expressing	_	VBG	VBG	_	15	dep	_	_
31	a	_	DT	DT	_	33	det	_	_
32	specific	_	JJ	JJ	_	33	amod	_	_
33	pattern	_	NN	NN	_	30	dobj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	cytokines	_	NNS	NNS	_	34	pobj	_	_
36	that	_	WDT	WDT	_	37	nsubj	_	_
37	distinguishes	_	VBZ	VBZ	_	33	rcmod	_	_
38	them	_	PRP	PRP	_	37	dobj	_	_
39	from	_	IN	IN	_	37	prep	_	_
40	their	_	PRP$	PRP$	_	41	poss	_	_
41	precursors	_	NNS	NNS	_	39	pobj	_	_
42	.	_	.	.	_	13	punct	_	_

1	eTh2	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	6	nsubj	_	_
3	are	_	VBP	VBP	_	6	cop	_	_
4	the	_	DT	DT	_	6	det	_	_
5	major	_	JJ	JJ	_	6	amod	_	_
6	source	_	NN	NN	_	0	root	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	IL-4	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	6	punct	_	_
10	while	_	IN	IN	_	14	mark	_	_
11	gamma	_	NN	NN	_	12	nn	_	_
12	interferon	_	NN	NN	_	14	nsubjpass	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	produced	_	VBN	VBN	_	6	advcl	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	eTh1	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	we	_	PRP	PRP	_	4	nsubj	_	_
3	have	_	VBP	VBP	_	4	aux	_	_
4	used	_	VBN	VBN	_	0	root	_	_
5	reporter	_	NN	NN	_	7	nn	_	_
6	transgenic	_	JJ	JJ	_	7	amod	_	_
7	mice	_	NNS	NNS	_	4	dobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	show	_	VB	VB	_	4	xcomp	_	_
10	that	_	IN	IN	_	20	mark	_	_
11	DNA	_	NN	NN	_	12	nn	_	_
12	binding	_	NN	NN	_	20	nsubjpass	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	activities	_	NNS	NNS	_	12	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	NFAT	_	NN	NN	_	16	pobj	_	_
18	are	_	VBP	VBP	_	20	auxpass	_	_
19	transiently	_	RB	RB	_	20	advmod	_	_
20	induced	_	VBN	VBN	_	9	ccomp	_	_
21	during	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	differentiation	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	pTh	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	24	pobj	_	_
27	into	_	IN	IN	_	23	prep	_	_
28	either	_	CC	CC	_	29	preconj	_	_
29	eTh1	_	NN	NN	_	27	pobj	_	_
30	or	_	CC	CC	_	29	cc	_	_
31	eTh2	_	NN	NN	_	32	nn	_	_
32	cells	_	NNS	NNS	_	29	conj	_	_
33	to	_	TO	TO	_	34	aux	_	_
34	mediate	_	VB	VB	_	20	xcomp	_	_
35	the	_	DT	DT	_	36	det	_	_
36	expression	_	NN	NN	_	34	dobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	IL-2	_	NN	NN	_	37	pobj	_	_
39	as	_	IN	IN	_	34	prep	_	_
40	a	_	DT	DT	_	43	det	_	_
41	common	_	JJ	JJ	_	43	amod	_	_
42	growth	_	NN	NN	_	43	nn	_	_
43	factor	_	NN	NN	_	39	pobj	_	_
44	in	_	IN	IN	_	43	prep	_	_
45	both	_	CC	CC	_	46	dep	_	_
46	pathways	_	NNS	NNS	_	44	pobj	_	_
47	.	_	.	.	_	4	punct	_	_

1	However	_	RB	RB	_	29	advmod	_	_
2	,	_	,	,	_	29	punct	_	_
3	although	_	IN	IN	_	9	mark	_	_
4	NFAT	_	NN	NN	_	6	nn	_	_
5	DNA	_	NN	NN	_	6	nn	_	_
6	binding	_	NN	NN	_	9	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	9	auxpass	_	_
8	similarly	_	RB	RB	_	9	advmod	_	_
9	induced	_	VBN	VBN	_	29	dep	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	eTh1	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	eTh2	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	conj	_	_
16	upon	_	IN	IN	_	9	prep	_	_
17	antigen	_	NN	NN	_	18	nn	_	_
18	stimulation	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	29	punct	_	_
20	only	_	RB	RB	_	23	advmod	_	_
21	the	_	DT	DT	_	23	det	_	_
22	NFAT	_	NN	NN	_	23	nn	_	_
23	complexes	_	NNS	NNS	_	29	nsubj	_	_
24	present	_	JJ	JJ	_	23	amod	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	eTh2	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	are	_	VBP	VBP	_	29	cop	_	_
29	able	_	JJ	JJ	_	0	root	_	_
30	to	_	TO	TO	_	31	aux	_	_
31	mediate	_	VB	VB	_	29	xcomp	_	_
32	high-level	_	JJ	JJ	_	33	amod	_	_
33	transcription	_	NN	NN	_	31	dobj	_	_
34	,	_	,	,	_	29	punct	_	_
35	and	_	CC	CC	_	29	cc	_	_
36	relatively	_	RB	RB	_	37	advmod	_	_
37	little	_	JJ	JJ	_	40	amod	_	_
38	NFAT	_	NN	NN	_	40	nn	_	_
39	transcriptional	_	JJ	JJ	_	40	amod	_	_
40	activity	_	NN	NN	_	42	nsubjpass	_	_
41	was	_	VBD	VBD	_	42	auxpass	_	_
42	induced	_	VBN	VBN	_	29	conj	_	_
43	in	_	IN	IN	_	42	prep	_	_
44	eTh1	_	NN	NN	_	45	nn	_	_
45	cells	_	NNS	NNS	_	43	pobj	_	_
46	.	_	.	.	_	29	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	activated	_	VBN	VBN	_	6	amod	_	_
5	pTh	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	,	_	,	,	_	13	punct	_	_
8	neither	_	CC	CC	_	9	preconj	_	_
9	eTh1	_	NN	NN	_	13	nsubj	_	_
10	nor	_	CC	CC	_	9	cc	_	_
11	eTh2	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	9	conj	_	_
13	produced	_	VBD	VBD	_	0	root	_	_
14	significant	_	JJ	JJ	_	15	amod	_	_
15	IL-2	_	NN	NN	_	13	dobj	_	_
16	upon	_	IN	IN	_	13	prep	_	_
17	stimulation	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	but	_	CC	CC	_	13	cc	_	_
20	the	_	DT	DT	_	22	det	_	_
21	high	_	JJ	JJ	_	22	amod	_	_
22	levels	_	NNS	NNS	_	28	nsubj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	NFAT	_	NN	NN	_	26	nn	_	_
25	transcriptional	_	JJ	JJ	_	26	amod	_	_
26	activities	_	NNS	NNS	_	23	pobj	_	_
27	directly	_	RB	RB	_	28	advmod	_	_
28	correlate	_	VBP	VBP	_	13	conj	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	IL-4	_	NN	NN	_	32	nn	_	_
32	production	_	NN	NN	_	29	pobj	_	_
33	induced	_	VBN	VBN	_	32	vmod	_	_
34	in	_	IN	IN	_	33	prep	_	_
35	response	_	NN	NN	_	34	pobj	_	_
36	to	_	TO	TO	_	35	prep	_	_
37	antigen	_	NN	NN	_	38	nn	_	_
38	stimulation	_	NN	NN	_	36	pobj	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	eTh2	_	NN	NN	_	41	nn	_	_
41	cells	_	NNS	NNS	_	39	pobj	_	_
42	.	_	.	.	_	13	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	activated	_	VBN	VBN	_	6	amod	_	_
6	NFAT	_	NN	NN	_	8	nsubjpass	_	_
7	is	_	VBZ	VBZ	_	8	auxpass	_	_
8	involved	_	VBN	VBN	_	3	ccomp	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	effector	_	NN	NN	_	12	nn	_	_
12	function	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	eTh2	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	that	_	IN	IN	_	32	mark	_	_
18	the	_	DT	DT	_	19	det	_	_
19	failure	_	NN	NN	_	32	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	eTh1	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	20	pobj	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	produce	_	VB	VB	_	19	vmod	_	_
25	IL-4	_	NN	NN	_	24	dobj	_	_
26	in	_	IN	IN	_	24	prep	_	_
27	response	_	NN	NN	_	26	pobj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	an	_	DT	DT	_	30	det	_	_
30	antigen	_	NN	NN	_	28	pobj	_	_
31	is	_	VBZ	VBZ	_	32	cop	_	_
32	due	_	JJ	JJ	_	8	conj	_	_
33	,	_	,	,	_	32	punct	_	_
34	at	_	IN	IN	_	32	advmod	_	_
35	least	_	JJS	JJS	_	34	pobj	_	_
36	partially	_	RB	RB	_	34	advmod	_	_
37	,	_	,	,	_	32	punct	_	_
38	to	_	TO	TO	_	32	prep	_	_
39	a	_	DT	DT	_	40	det	_	_
40	failure	_	NN	NN	_	38	pobj	_	_
41	to	_	TO	TO	_	42	aux	_	_
42	induce	_	VB	VB	_	40	vmod	_	_
43	high-level	_	JJ	JJ	_	44	amod	_	_
44	transcription	_	NN	NN	_	42	dobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	the	_	DT	DT	_	48	det	_	_
47	IL-4	_	NN	NN	_	48	nn	_	_
48	gene	_	NN	NN	_	45	pobj	_	_
49	by	_	IN	IN	_	44	prep	_	_
50	NFAT	_	NN	NN	_	49	pobj	_	_
51	.	_	.	.	_	3	punct	_	_

1	Regulation	_	NN	NN	_	9	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NFAT	_	NN	NN	_	2	pobj	_	_
4	could	_	MD	MD	_	9	aux	_	_
5	be	_	VB	VB	_	9	cop	_	_
6	therefore	_	RB	RB	_	9	advmod	_	_
7	a	_	DT	DT	_	9	det	_	_
8	critical	_	JJ	JJ	_	9	amod	_	_
9	element	_	NN	NN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	polarization	_	NN	NN	_	10	pobj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	eTh1	_	NN	NN	_	13	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	eTh2	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	9	punct	_	_

1	Constitutive	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p50	_	NN	NN	_	5	nn	_	_
5	homodimer	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	freshly	_	RB	RB	_	10	advmod	_	_
8	isolated	_	VBN	VBN	_	10	amod	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	monocytes	_	NNS	NNS	_	6	pobj	_	_
11	decreases	_	VBZ	VBZ	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	in	_	FW	FW	_	12	pobj	_	_
14	vitro	_	FW	FW	_	13	dep	_	_
15	and	_	CC	CC	_	13	cc	_	_
16	in	_	FW	FW	_	13	conj	_	_
17	vivo	_	FW	FW	_	16	dep	_	_
18	differentiation	_	NN	NN	_	13	dep	_	_
19	:	_	:	:	_	11	punct	_	_
20	a	_	DT	DT	_	22	det	_	_
21	possible	_	JJ	JJ	_	22	amod	_	_
22	mechanism	_	NN	NN	_	11	dep	_	_
23	influencing	_	VBG	VBG	_	22	vmod	_	_
24	human	_	JJ	JJ	_	27	amod	_	_
25	immunodeficiency	_	NN	NN	_	27	nn	_	_
26	virus	_	NN	NN	_	27	nn	_	_
27	replication	_	NN	NN	_	23	dobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	monocytes	_	NNS	NNS	_	28	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	mature	_	JJ	JJ	_	32	amod	_	_
32	macrophages	_	NNS	NNS	_	29	conj	_	_
33	.	_	.	.	_	11	punct	_	_

1	Human	_	JJ	JJ	_	4	amod	_	_
2	immunodeficiency	_	NN	NN	_	4	nn	_	_
3	virus	_	NN	NN	_	4	nn	_	_
4	type	_	NN	NN	_	9	nsubj	_	_
5	1	_	CD	CD	_	4	num	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	HIV-1	_	NN	NN	_	4	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	replicates	_	VBZ	VBZ	_	0	root	_	_
10	more	_	RBR	RBR	_	11	advmod	_	_
11	efficiently	_	RB	RB	_	9	advmod	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vitro	_	FW	FW	_	11	advmod	_	_
14	in	_	IN	IN	_	11	prep	_	_
15	differentiated	_	VBN	VBN	_	16	amod	_	_
16	macrophages	_	NNS	NNS	_	14	pobj	_	_
17	than	_	IN	IN	_	11	prep	_	_
18	in	_	IN	IN	_	17	pcomp	_	_
19	freshly	_	RB	RB	_	21	advmod	_	_
20	isolated	_	VBN	VBN	_	21	amod	_	_
21	monocytes	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	investigated	_	VBD	VBD	_	0	root	_	_
3	whether	_	IN	IN	_	8	mark	_	_
4	this	_	DT	DT	_	8	nsubjpass	_	_
5	may	_	MD	MD	_	8	aux	_	_
6	be	_	VB	VB	_	8	auxpass	_	_
7	partly	_	RB	RB	_	8	advmod	_	_
8	explained	_	VBN	VBN	_	2	ccomp	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	changes	_	NNS	NNS	_	9	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	expression	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NF-kappaB	_	NN	NN	_	13	pobj	_	_
15	with	_	IN	IN	_	10	prep	_	_
16	monocyte	_	NN	NN	_	17	nn	_	_
17	differentiation	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrated	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	12	mark	_	_
4	constitutive	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	12	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NF-kappaB	_	NN	NN	_	6	pobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	primary	_	JJ	JJ	_	11	amod	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	monocytes	_	NNS	NNS	_	8	pobj	_	_
12	changed	_	VBD	VBD	_	2	ccomp	_	_
13	significantly	_	RB	RB	_	12	advmod	_	_
14	with	_	IN	IN	_	12	prep	_	_
15	differentiation	_	NN	NN	_	14	pobj	_	_
16	in	_	FW	FW	_	15	amod	_	_
17	vitro	_	FW	FW	_	16	dep	_	_
18	to	_	TO	TO	_	15	prep	_	_
19	monocyte-derived	_	JJ	JJ	_	20	amod	_	_
20	macrophages	_	NNS	NNS	_	18	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	MDMs	_	NNS	NNS	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	and	_	CC	CC	_	15	cc	_	_
25	differentiation	_	NN	NN	_	15	conj	_	_
26	in	_	FW	FW	_	25	amod	_	_
27	vivo	_	FW	FW	_	26	dep	_	_
28	to	_	TO	TO	_	25	prep	_	_
29	alveolar	_	JJ	JJ	_	30	amod	_	_
30	macrophages	_	NNS	NNS	_	28	pobj	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	AMs	_	NNS	NNS	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	.	_	.	.	_	2	punct	_	_

1	Freshly	_	RB	RB	_	3	advmod	_	_
2	isolated	_	VBN	VBN	_	3	amod	_	_
3	monocytes	_	NNS	NNS	_	5	nsubj	_	_
4	constitutively	_	RB	RB	_	5	advmod	_	_
5	expressed	_	VBD	VBD	_	0	root	_	_
6	high	_	JJ	JJ	_	7	amod	_	_
7	levels	_	NNS	NNS	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	transcriptionally	_	RB	RB	_	12	advmod	_	_
10	inactive	_	JJ	JJ	_	12	amod	_	_
11	p50	_	NN	NN	_	12	nn	_	_
12	homodimer	_	NN	NN	_	8	pobj	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	decreased	_	VBD	VBD	_	7	rcmod	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	time	_	NN	NN	_	15	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	culture	_	NN	NN	_	17	pobj	_	_
19	in	_	IN	IN	_	14	prep	_	_
20	favor	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	25	dep	_	_
23	transcriptionally	_	RB	RB	_	24	advmod	_	_
24	active	_	JJ	JJ	_	25	amod	_	_
25	p50/p65	_	NN	NN	_	21	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	p50/RelB	_	NN	NN	_	25	conj	_	_
28	heterodimers	_	NNS	NNS	_	25	dep	_	_
29	.	_	.	.	_	5	punct	_	_

1	As	_	IN	IN	_	7	prep	_	_
2	in	_	IN	IN	_	1	pcomp	_	_
3	MDMs	_	NNS	NNS	_	2	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	AMs	_	NNS	NNS	_	7	nsubj	_	_
6	constitutively	_	RB	RB	_	7	advmod	_	_
7	expressed	_	VBD	VBD	_	0	root	_	_
8	p50/p65	_	NN	NN	_	7	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	p50/RelB	_	NN	NN	_	8	conj	_	_
11	although	_	IN	IN	_	12	mark	_	_
12	at	_	IN	IN	_	7	advcl	_	_
13	lower	_	JJR	JJR	_	14	amod	_	_
14	levels	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	7	punct	_	_

1	HIV	_	NN	NN	_	2	nn	_	_
2	infection	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	fresh	_	JJ	JJ	_	5	amod	_	_
5	monocytes	_	NNS	NNS	_	3	pobj	_	_
6	failed	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	induce	_	VB	VB	_	6	xcomp	_	_
9	p50/p65	_	NN	NN	_	8	dobj	_	_
10	as	_	IN	IN	_	11	mark	_	_
11	seen	_	VBN	VBN	_	6	advcl	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	MDMs	_	NNS	NNS	_	12	pobj	_	_
14	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	replacement	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p50	_	NN	NN	_	5	nn	_	_
5	homodimers	_	NNS	NNS	_	3	pobj	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	transcriptionally	_	RB	RB	_	8	advmod	_	_
8	active	_	JJ	JJ	_	9	amod	_	_
9	heterodimers	_	NNS	NNS	_	6	pobj	_	_
10	following	_	VBG	VBG	_	2	prep	_	_
11	time	_	NN	NN	_	10	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	culture	_	NN	NN	_	12	pobj	_	_
14	may	_	MD	MD	_	16	aux	_	_
15	partially	_	RB	RB	_	16	advmod	_	_
16	explain	_	VB	VB	_	0	root	_	_
17	the	_	DT	DT	_	19	det	_	_
18	progressive	_	JJ	JJ	_	19	amod	_	_
19	increase	_	NN	NN	_	16	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	susceptibility	_	NN	NN	_	20	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	monocytes	_	NNS	NNS	_	22	pobj	_	_
24	to	_	TO	TO	_	21	prep	_	_
25	HIV	_	NN	NN	_	26	nn	_	_
26	infection	_	NN	NN	_	24	pobj	_	_
27	during	_	IN	IN	_	21	prep	_	_
28	in	_	FW	FW	_	30	amod	_	_
29	vitro	_	FW	FW	_	28	dep	_	_
30	culture	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	16	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	change	_	NN	NN	_	13	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	NF-kappaB	_	NN	NN	_	5	nn	_	_
5	components	_	NNS	NNS	_	3	pobj	_	_
6	with	_	IN	IN	_	2	prep	_	_
7	monocyte	_	NN	NN	_	8	nn	_	_
8	differentiation	_	NN	NN	_	6	pobj	_	_
9	in	_	FW	FW	_	8	amod	_	_
10	vivo	_	FW	FW	_	9	dep	_	_
11	may	_	MD	MD	_	13	aux	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	explain	_	VB	VB	_	0	root	_	_
14	the	_	DT	DT	_	17	det	_	_
15	different	_	JJ	JJ	_	17	amod	_	_
16	transcriptional	_	JJ	JJ	_	15	dep	_	_
17	activities	_	NNS	NNS	_	13	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	these	_	DT	DT	_	21	det	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	populations	_	NNS	NNS	_	18	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	HIV-infected	_	JJ	JJ	_	24	amod	_	_
24	individuals	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	Identification	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	nucleotide	_	NN	NN	_	4	nn	_	_
4	sequences	_	NNS	NNS	_	2	pobj	_	_
5	that	_	WDT	WDT	_	6	nsubj	_	_
6	regulate	_	VBP	VBP	_	4	rcmod	_	_
7	transcription	_	NN	NN	_	6	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	MCF13	_	NN	NN	_	13	nn	_	_
11	murine	_	JJ	JJ	_	13	amod	_	_
12	leukemia	_	NN	NN	_	13	nn	_	_
13	virus	_	NN	NN	_	8	pobj	_	_
14	long	_	JJ	JJ	_	16	amod	_	_
15	terminal	_	JJ	JJ	_	16	amod	_	_
16	repeat	_	NN	NN	_	13	dep	_	_
17	in	_	IN	IN	_	7	prep	_	_
18	activated	_	VBN	VBN	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	region	_	NN	NN	_	24	nsubj	_	_
3	downstream	_	JJ	JJ	_	2	advmod	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	enhancer	_	NN	NN	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	DEN	_	NN	NN	_	3	dep	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	of	_	IN	IN	_	3	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	long	_	JJ	JJ	_	14	amod	_	_
13	terminal	_	JJ	JJ	_	14	amod	_	_
14	repeat	_	NN	NN	_	10	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	22	det	_	_
17	mink	_	NN	NN	_	19	npadvmod	_	_
18	cell	_	NN	NN	_	19	npadvmod	_	_
19	focus-forming	_	JJ	JJ	_	22	amod	_	_
20	murine	_	JJ	JJ	_	19	dep	_	_
21	leukemia	_	NN	NN	_	22	nn	_	_
22	virus	_	NN	NN	_	15	pobj	_	_
23	is	_	VBZ	VBZ	_	24	cop	_	_
24	important	_	JJ	JJ	_	0	root	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	viral	_	JJ	JJ	_	27	amod	_	_
27	pathogenicity	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	24	punct	_	_

1	Another	_	DT	DT	_	3	det	_	_
2	important	_	JJ	JJ	_	3	amod	_	_
3	activity	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	DEN	_	NN	NN	_	4	pobj	_	_
6	is	_	VBZ	VBZ	_	8	cop	_	_
7	its	_	PRP$	PRP$	_	8	poss	_	_
8	control	_	NN	NN	_	0	root	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	transcription	_	NN	NN	_	9	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	activated	_	VBN	VBN	_	14	amod	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	,	_	,	,	_	8	punct	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	we	_	PRP	PRP	_	19	nsubj	_	_
18	have	_	VBP	VBP	_	19	aux	_	_
19	determined	_	VBN	VBN	_	8	conj	_	_
20	that	_	IN	IN	_	25	mark	_	_
21	an	_	DT	DT	_	23	det	_	_
22	NF-kappaB	_	NN	NN	_	23	nn	_	_
23	site	_	NN	NN	_	25	nsubj	_	_
24	is	_	VBZ	VBZ	_	25	cop	_	_
25	critical	_	JJ	JJ	_	19	ccomp	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	this	_	DT	DT	_	28	det	_	_
28	activity	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	8	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	NF-kappaB	_	NN	NN	_	2	pobj	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	4	dep	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	a	_	DT	DT	_	11	det	_	_
9	T-lymphocytic	_	JJ	JJ	_	11	amod	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	line	_	NN	NN	_	7	pobj	_	_
12	by	_	IN	IN	_	1	prep	_	_
13	hypochlorous	_	JJ	JJ	_	14	amod	_	_
14	acid	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	1	punct	_	_

1	Reactive	_	JJ	JJ	_	3	amod	_	_
2	oxygen	_	NN	NN	_	3	nn	_	_
3	species	_	NNS	NNS	_	11	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	ROS	_	NNS	NNS	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	such	_	JJ	JJ	_	8	mwe	_	_
8	as	_	IN	IN	_	3	prep	_	_
9	hydrogen	_	NN	NN	_	10	nn	_	_
10	peroxide	_	NN	NN	_	8	pobj	_	_
11	serve	_	VBP	VBP	_	0	root	_	_
12	as	_	IN	IN	_	11	prep	_	_
13	second	_	JJ	JJ	_	14	amod	_	_
14	messengers	_	NNS	NNS	_	12	pobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	induction	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	transcription	_	NN	NN	_	21	nn	_	_
21	factor	_	NN	NN	_	18	pobj	_	_
22	NF-kappaB	_	NN	NN	_	21	dep	_	_
23	,	_	,	,	_	15	punct	_	_
24	and	_	CC	CC	_	15	cc	_	_
25	hence	_	RB	RB	_	26	advmod	_	_
26	in	_	IN	IN	_	15	conj	_	_
27	the	_	DT	DT	_	28	dep	_	_
28	activation	_	NN	NN	_	26	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	replication	_	NN	NN	_	28	conj	_	_
31	of	_	IN	IN	_	28	prep	_	_
32	human	_	JJ	JJ	_	35	amod	_	_
33	immunodeficiency	_	NN	NN	_	35	nn	_	_
34	virus	_	NN	NN	_	35	nn	_	_
35	type	_	NN	NN	_	31	pobj	_	_
36	1	_	CD	CD	_	35	num	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	HIV-1	_	NN	NN	_	35	appos	_	_
39	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
40	in	_	IN	IN	_	28	prep	_	_
41	human	_	JJ	JJ	_	42	amod	_	_
42	cells	_	NNS	NNS	_	40	pobj	_	_
43	.	_	.	.	_	11	punct	_	_

1	During	_	IN	IN	_	9	prep	_	_
2	inflammatory	_	JJ	JJ	_	3	amod	_	_
3	reactions	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	9	punct	_	_
5	many	_	JJ	JJ	_	7	amod	_	_
6	oxidative	_	JJ	JJ	_	7	amod	_	_
7	species	_	NNS	NNS	_	9	nsubjpass	_	_
8	are	_	VBP	VBP	_	9	auxpass	_	_
9	produced	_	VBN	VBN	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	one	_	CD	CD	_	16	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	which	_	WDT	WDT	_	12	pobj	_	_
14	is	_	VBZ	VBZ	_	16	cop	_	_
15	hypochlorous	_	JJ	JJ	_	16	amod	_	_
16	acid	_	NN	NN	_	9	dep	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	HOCl	_	NN	NN	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	,	_	,	,	_	16	punct	_	_
21	which	_	WDT	WDT	_	23	nsubj	_	_
22	is	_	VBZ	VBZ	_	23	cop	_	_
23	responsible	_	JJ	JJ	_	16	rcmod	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	microbicidal	_	JJ	JJ	_	27	amod	_	_
27	effects	_	NNS	NNS	_	24	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	activated	_	VBN	VBN	_	32	amod	_	_
30	human	_	JJ	JJ	_	32	amod	_	_
31	polymorphonuclear	_	JJ	JJ	_	32	amod	_	_
32	leukocytes	_	NNS	NNS	_	28	pobj	_	_
33	.	_	.	.	_	9	punct	_	_

1	Treatment	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	6	det	_	_
4	T-lymphocytic	_	JJ	JJ	_	6	amod	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	line	_	NN	NN	_	2	pobj	_	_
7	with	_	IN	IN	_	1	prep	_	_
8	micromolar	_	JJ	JJ	_	9	amod	_	_
9	concentrations	_	NNS	NNS	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HOCl	_	NN	NN	_	10	pobj	_	_
12	promoted	_	VBD	VBD	_	0	root	_	_
13	the	_	DT	DT	_	14	det	_	_
14	appearance	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	transcription	_	NN	NN	_	17	nn	_	_
17	factor	_	NN	NN	_	15	pobj	_	_
18	NF-kappaB	_	NN	NN	_	17	dep	_	_
19	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
20	the	_	DT	DT	_	22	det	_	_
21	heterodimer	_	NN	NN	_	22	nn	_	_
22	p50/p65	_	NN	NN	_	17	dep	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	in	_	IN	IN	_	14	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	nucleus	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	,	_	,	,	_	14	punct	_	_
31	even	_	RB	RB	_	32	advmod	_	_
32	in	_	IN	IN	_	14	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	absence	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	de	_	FW	FW	_	39	amod	_	_
37	novo	_	FW	FW	_	36	dep	_	_
38	protein	_	NN	NN	_	39	nn	_	_
39	synthesis	_	NN	NN	_	35	pobj	_	_
40	.	_	.	.	_	12	punct	_	_

1	Western	_	NN	NN	_	3	nn	_	_
2	blot	_	NN	NN	_	3	nn	_	_
3	analysis	_	NN	NN	_	12	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	NF-kappaB	_	NN	NN	_	8	nn	_	_
7	inhibitory	_	JJ	JJ	_	8	amod	_	_
8	subunits	_	NNS	NNS	_	4	pobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	IkappaB	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	demonstrated	_	VBD	VBD	_	0	root	_	_
13	that	_	IN	IN	_	21	mark	_	_
14	both	_	CC	CC	_	16	preconj	_	_
15	IkappaB-alpha	_	NN	NN	_	16	nn	_	_
16	proteolysis	_	NN	NN	_	21	nsubjpass	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	p105	_	NN	NN	_	19	nn	_	_
19	processing	_	NN	NN	_	16	conj	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	induced	_	VBN	VBN	_	12	ccomp	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	treatment	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	NF-kappaB	_	NN	NN	_	2	nn	_	_
2	activation	_	NN	NN	_	5	nsubj	_	_
3	was	_	VBD	VBD	_	5	cop	_	_
4	very	_	RB	RB	_	5	advmod	_	_
5	effective	_	JJ	JJ	_	0	root	_	_
6	when	_	WRB	WRB	_	9	advmod	_	_
7	cells	_	NNS	NNS	_	9	nsubjpass	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	subjected	_	VBN	VBN	_	5	advcl	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	hyperthermia	_	NN	NN	_	10	pobj	_	_
12	before	_	IN	IN	_	14	mark	_	_
13	being	_	VBG	VBG	_	14	auxpass	_	_
14	treated	_	VBN	VBN	_	9	advcl	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	HOCl	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Various	_	JJ	JJ	_	2	amod	_	_
2	antioxidants	_	NNS	NNS	_	15	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	2	prep	_	_
6	pyrrolidine	_	NN	NN	_	7	nn	_	_
7	dithiocarbamate	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	p-bromophenacyl-bromide	_	NN	NN	_	7	conj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	nordihydroguaiaretic	_	JJ	JJ	_	12	amod	_	_
12	acid	_	NN	NN	_	7	conj	_	_
13	could	_	MD	MD	_	15	aux	_	_
14	strongly	_	RB	RB	_	15	advmod	_	_
15	reduce	_	VB	VB	_	0	root	_	_
16	NF-kappaB	_	NN	NN	_	17	nn	_	_
17	translocation	_	NN	NN	_	15	dobj	_	_
18	,	_	,	,	_	15	punct	_	_
19	demonstrating	_	VBG	VBG	_	15	vmod	_	_
20	the	_	DT	DT	_	21	det	_	_
21	importance	_	NN	NN	_	19	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	oxidative	_	JJ	JJ	_	24	amod	_	_
24	species	_	NNS	NNS	_	22	pobj	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	transduction	_	NN	NN	_	28	nn	_	_
28	mechanism	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	15	punct	_	_

1	Moreover	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	ACH-2	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	10	nsubj	_	_
5	treated	_	VBN	VBN	_	4	vmod	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	HOCl	_	NN	NN	_	6	pobj	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	H2O2	_	NN	NN	_	7	conj	_	_
10	released	_	VBD	VBD	_	0	root	_	_
11	tumour	_	NN	NN	_	13	nn	_	_
12	necrosis	_	NN	NN	_	13	nn	_	_
13	factor-alpha	_	NN	NN	_	10	dobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	TNF-alpha	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	in	_	IN	IN	_	10	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	supernatants	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	importance	_	NN	NN	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	TNF-alpha	_	NN	NN	_	5	nn	_	_
5	release	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	NF-kappaB	_	NN	NN	_	8	nn	_	_
8	induction	_	NN	NN	_	6	pobj	_	_
9	by	_	IN	IN	_	5	prep	_	_
10	HOCl	_	NN	NN	_	9	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	H2O2	_	NN	NN	_	10	conj	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	demonstrated	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	fact	_	NN	NN	_	15	pobj	_	_
18	that	_	IN	IN	_	29	mark	_	_
19	:	_	:	:	_	29	punct	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	1	_	LS	LS	_	29	dep	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	the	_	DT	DT	_	25	det	_	_
24	nuclear	_	JJ	JJ	_	25	amod	_	_
25	appearance	_	NN	NN	_	29	nsubjpass	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	NF-kappaB	_	NN	NN	_	26	pobj	_	_
28	was	_	VBD	VBD	_	29	auxpass	_	_
29	promoted	_	VBN	VBN	_	17	dep	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	untreated	_	JJ	JJ	_	32	amod	_	_
32	cells	_	NNS	NNS	_	30	pobj	_	_
33	;	_	:	:	_	29	punct	_	_
34	and	_	CC	CC	_	29	cc	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	2	_	LS	LS	_	44	dep	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	synergism	_	NN	NN	_	44	nsubjpass	_	_
39	between	_	IN	IN	_	38	prep	_	_
40	TNF-alpha	_	NN	NN	_	39	pobj	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	HOCl	_	NN	NN	_	40	conj	_	_
43	was	_	VBD	VBD	_	44	auxpass	_	_
44	detected	_	VBN	VBN	_	29	conj	_	_
45	.	_	.	.	_	14	punct	_	_

1	Collectively	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	suggest	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	HOCl	_	NN	NN	_	10	nsubjpass	_	_
8	should	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	considered	_	VBN	VBN	_	5	ccomp	_	_
11	as	_	IN	IN	_	10	prep	_	_
12	an	_	DT	DT	_	14	det	_	_
13	oxidative	_	JJ	JJ	_	14	amod	_	_
14	species	_	NNS	NNS	_	11	pobj	_	_
15	capable	_	JJ	JJ	_	14	amod	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	inducing	_	VBG	VBG	_	16	pcomp	_	_
18	NF-kappaB	_	NN	NN	_	17	dobj	_	_
19	in	_	IN	IN	_	17	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	T-lymphocytic	_	JJ	JJ	_	23	amod	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	line	_	NN	NN	_	19	pobj	_	_
24	through	_	IN	IN	_	17	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	transduction	_	NN	NN	_	27	nn	_	_
27	mechanism	_	NN	NN	_	24	pobj	_	_
28	involving	_	VBG	VBG	_	27	vmod	_	_
29	ROS	_	NNS	NNS	_	28	dobj	_	_
30	,	_	,	,	_	17	punct	_	_
31	and	_	CC	CC	_	17	cc	_	_
32	having	_	VBG	VBG	_	17	conj	_	_
33	a	_	DT	DT	_	35	det	_	_
34	long-distance	_	JJ	JJ	_	35	amod	_	_
35	effect	_	NN	NN	_	32	dobj	_	_
36	through	_	IN	IN	_	32	prep	_	_
37	subsequent	_	JJ	JJ	_	39	amod	_	_
38	TNF-alpha	_	NN	NN	_	39	nn	_	_
39	release	_	NN	NN	_	36	pobj	_	_
40	.	_	.	.	_	5	punct	_	_

1	NF-kappa	_	NN	NN	_	3	nn	_	_
2	B-independent	_	JJ	JJ	_	3	amod	_	_
3	suppression	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	HIV	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	pobj	_	_
7	by	_	IN	IN	_	3	prep	_	_
8	ascorbic	_	JJ	JJ	_	9	amod	_	_
9	acid	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	3	punct	_	_

1	Ascorbic	_	JJ	JJ	_	2	amod	_	_
2	acid	_	NN	NN	_	11	nsubjpass	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	ascorbate	_	NN	NN	_	2	dep	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	vitamin	_	NN	NN	_	7	nn	_	_
7	C	_	NN	NN	_	4	conj	_	_
8	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
9	has	_	VBZ	VBZ	_	11	aux	_	_
10	been	_	VBN	VBN	_	11	auxpass	_	_
11	shown	_	VBN	VBN	_	0	root	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	suppress	_	VB	VB	_	11	xcomp	_	_
14	the	_	DT	DT	_	15	det	_	_
15	induction	_	NN	NN	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	HIV	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	15	prep	_	_
19	latently	_	RB	RB	_	23	advmod	_	_
20	infected	_	JJ	JJ	_	23	amod	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	lymphocytic	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	18	pobj	_	_
24	following	_	VBG	VBG	_	13	prep	_	_
25	stimulation	_	NN	NN	_	24	pobj	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	a	_	DT	DT	_	29	det	_	_
28	tumor	_	NN	NN	_	29	nn	_	_
29	promoter	_	NN	NN	_	26	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	PMA	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	and	_	CC	CC	_	29	cc	_	_
34	inflammatory	_	JJ	JJ	_	35	amod	_	_
35	cytokine	_	NN	NN	_	29	conj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	TNF-alpha	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	.	_	.	.	_	11	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	assess	_	VB	VB	_	0	root	_	_
3	whether	_	IN	IN	_	7	mark	_	_
4	this	_	DT	DT	_	5	det	_	_
5	inhibition	_	NN	NN	_	7	nsubjpass	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	mediated	_	VBN	VBN	_	2	ccomp	_	_
8	via	_	IN	IN	_	7	prep	_	_
9	modulation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	cellular	_	JJ	JJ	_	14	amod	_	_
13	transcription	_	NN	NN	_	14	nn	_	_
14	factor	_	NN	NN	_	10	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	NF-kappa	_	NN	NN	_	17	nn	_	_
17	B	_	NN	NN	_	14	appos	_	_
18	,	_	,	,	_	2	punct	_	_
19	we	_	PRP	PRP	_	20	nsubj	_	_
20	carried	_	VBD	VBD	_	2	parataxis	_	_
21	out	_	RP	RP	_	20	prt	_	_
22	gel	_	NN	NN	_	24	nn	_	_
23	shift	_	NN	NN	_	24	nn	_	_
24	analysis	_	NN	NN	_	20	dobj	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	nuclear	_	JJ	JJ	_	27	amod	_	_
27	extracts	_	NNS	NNS	_	25	pobj	_	_
28	prepared	_	VBN	VBN	_	27	vmod	_	_
29	under	_	IN	IN	_	28	prep	_	_
30	different	_	JJ	JJ	_	31	amod	_	_
31	conditions	_	NNS	NNS	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	cell	_	NN	NN	_	34	nn	_	_
34	stimulation	_	NN	NN	_	32	pobj	_	_
35	in	_	IN	IN	_	28	prep	_	_
36	the	_	DT	DT	_	37	dep	_	_
37	presence	_	NN	NN	_	35	pobj	_	_
38	or	_	CC	CC	_	37	cc	_	_
39	absence	_	NN	NN	_	37	conj	_	_
40	of	_	IN	IN	_	37	prep	_	_
41	ascorbate	_	NN	NN	_	40	pobj	_	_
42	,	_	,	,	_	41	punct	_	_
43	N-acetylcysteine	_	NN	NN	_	41	conj	_	_
44	-LRB-	_	-LRB-	-LRB-	_	45	punct	_	_
45	NAC	_	NN	NN	_	43	appos	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	,	_	,	,	_	41	punct	_	_
48	or	_	CC	CC	_	41	cc	_	_
49	zidovudine	_	NN	NN	_	41	conj	_	_
50	-LRB-	_	-LRB-	-LRB-	_	51	punct	_	_
51	AZT	_	NN	NN	_	49	appos	_	_
52	-RRB-	_	-RRB-	-RRB-	_	51	punct	_	_
53	.	_	.	.	_	2	punct	_	_

1	Pretreatment	_	NN	NN	_	22	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	ACH-2	_	NN	NN	_	5	nn	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	NAC	_	NN	NN	_	6	pobj	_	_
8	followed	_	VBN	VBN	_	1	vmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	stimulation	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	PMA	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	TNF-alpha	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	or	_	CC	CC	_	12	cc	_	_
17	hydrogen	_	NN	NN	_	18	nn	_	_
18	peroxide	_	NN	NN	_	12	conj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	H2O2	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	resulted	_	VBD	VBD	_	0	root	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	strong	_	JJ	JJ	_	25	amod	_	_
25	suppression	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	NF-kappa	_	NN	NN	_	28	nn	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	activation	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	22	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	neither	_	CC	CC	_	5	preconj	_	_
5	ascorbate	_	NN	NN	_	8	nsubj	_	_
6	nor	_	CC	CC	_	5	cc	_	_
7	AZT	_	NN	NN	_	5	conj	_	_
8	affected	_	VBD	VBD	_	0	root	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	activity	_	NN	NN	_	8	dobj	_	_
12	under	_	IN	IN	_	8	prep	_	_
13	all	_	DT	DT	_	16	det	_	_
14	three	_	CD	CD	_	16	num	_	_
15	induction	_	NN	NN	_	16	nn	_	_
16	conditions	_	NNS	NNS	_	12	pobj	_	_
17	in	_	IN	IN	_	8	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	ACH-2	_	NN	NN	_	21	nn	_	_
20	cell	_	NN	NN	_	21	nn	_	_
21	line	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	8	punct	_	_

1	Ascorbate	_	NN	NN	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	AZT	_	NN	NN	_	1	conj	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	had	_	VBD	VBD	_	0	root	_	_
6	no	_	DT	DT	_	7	neg	_	_
7	effect	_	NN	NN	_	5	dobj	_	_
8	on	_	IN	IN	_	5	prep	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	8	pobj	_	_
12	following	_	VBG	VBG	_	5	prep	_	_
13	TNF-alpha-	_	NN	NN	_	12	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	PMA-induced	_	JJ	JJ	_	13	conj	_	_
16	stimulation	_	NN	NN	_	13	dep	_	_
17	of	_	IN	IN	_	13	prep	_	_
18	U1	_	NN	NN	_	20	nn	_	_
19	promonocytic	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	mechanism	_	NN	NN	_	15	nsubjpass	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	HIV	_	NN	NN	_	10	nn	_	_
10	inhibition	_	NN	NN	_	8	pobj	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	ascorbate	_	NN	NN	_	11	pobj	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	mediated	_	VBN	VBN	_	3	ccomp	_	_
16	via	_	IN	IN	_	15	prep	_	_
17	NF-kappa	_	NN	NN	_	18	nn	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	inhibition	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	15	punct	_	_
21	unlike	_	IN	IN	_	15	prep	_	_
22	that	_	DT	DT	_	21	pobj	_	_
23	seen	_	VBN	VBN	_	22	vmod	_	_
24	with	_	IN	IN	_	23	prep	_	_
25	other	_	JJ	JJ	_	26	amod	_	_
26	antioxidants	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Egr-1/RelA	_	NN	NN	_	4	nn	_	_
4	synergy	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	distinguishing	_	VBG	VBG	_	5	pcomp	_	_
7	T	_	NN	NN	_	9	nn	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	6	dobj	_	_
10	from	_	IN	IN	_	6	prep	_	_
11	tumor	_	NN	NN	_	16	nn	_	_
12	necrosis	_	NN	NN	_	16	nn	_	_
13	factor-alpha-induced	_	JJ	JJ	_	16	amod	_	_
14	NF-kappa	_	NN	NN	_	15	nn	_	_
15	B1	_	NN	NN	_	16	nn	_	_
16	transcription	_	NN	NN	_	10	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	NF-kappa	_	NN	NN	_	2	nn	_	_
2	B	_	NN	NN	_	7	nsubj	_	_
3	is	_	VBZ	VBZ	_	7	cop	_	_
4	an	_	DT	DT	_	7	det	_	_
5	important	_	JJ	JJ	_	7	amod	_	_
6	transcription	_	NN	NN	_	7	nn	_	_
7	factor	_	NN	NN	_	0	root	_	_
8	required	_	VBN	VBN	_	7	vmod	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	T	_	NN	NN	_	12	nn	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	proliferation	_	NN	NN	_	9	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	other	_	JJ	JJ	_	16	amod	_	_
15	immunological	_	JJ	JJ	_	16	amod	_	_
16	functions	_	NNS	NNS	_	12	conj	_	_
17	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	NF-kappa	_	NN	NN	_	4	nn	_	_
3	B1	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	5	nsubj	_	_
5	encodes	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	105-kD	_	JJ	JJ	_	8	amod	_	_
8	protein	_	NN	NN	_	5	dobj	_	_
9	that	_	WDT	WDT	_	12	nsubj	_	_
10	is	_	VBZ	VBZ	_	12	cop	_	_
11	the	_	DT	DT	_	12	det	_	_
12	precursor	_	NN	NN	_	8	rcmod	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	p50	_	NN	NN	_	16	nn	_	_
16	component	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	5	punct	_	_

1	Previously	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	we	_	PRP	PRP	_	7	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	others	_	NNS	NNS	_	3	conj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	demonstrated	_	VBN	VBN	_	0	root	_	_
8	that	_	IN	IN	_	11	mark	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	11	nsubj	_	_
11	regulates	_	VBZ	VBZ	_	7	ccomp	_	_
12	the	_	DT	DT	_	15	det	_	_
13	NF-kappa	_	NN	NN	_	15	nn	_	_
14	B1	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	11	dobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	manuscript	_	NN	NN	_	1	pobj	_	_
4	we	_	PRP	PRP	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	investigated	_	VBN	VBN	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	molecular	_	JJ	JJ	_	9	amod	_	_
9	mechanisms	_	NNS	NNS	_	6	dobj	_	_
10	by	_	IN	IN	_	28	prep	_	_
11	which	_	WDT	WDT	_	10	pobj	_	_
12	T	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	lines	_	NNS	NNS	_	28	nsubj	_	_
15	stimulated	_	VBN	VBN	_	14	vmod	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	phorbol	_	NN	NN	_	19	nn	_	_
18	12-myristate	_	NN	NN	_	19	nn	_	_
19	13-acetate	_	NN	NN	_	16	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	PMA	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	and	_	CC	CC	_	19	cc	_	_
24	phytohemagglutin	_	NN	NN	_	19	conj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	PHA	_	NN	NN	_	24	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	display	_	VBP	VBP	_	9	rcmod	_	_
29	significantly	_	RB	RB	_	30	advmod	_	_
30	higher	_	JJR	JJR	_	31	amod	_	_
31	levels	_	NNS	NNS	_	28	dobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	NF-kappa	_	NN	NN	_	34	nn	_	_
34	B1	_	NN	NN	_	35	nn	_	_
35	encoding	_	NN	NN	_	32	pobj	_	_
36	transcripts	_	NNS	NNS	_	35	dep	_	_
37	than	_	IN	IN	_	31	prep	_	_
38	cells	_	NNS	NNS	_	37	pobj	_	_
39	stimulated	_	VBN	VBN	_	38	vmod	_	_
40	with	_	IN	IN	_	39	prep	_	_
41	tumor	_	NN	NN	_	43	nn	_	_
42	necrosis	_	NN	NN	_	43	nn	_	_
43	factor-alpha	_	NN	NN	_	40	pobj	_	_
44	,	_	,	,	_	28	punct	_	_
45	despite	_	IN	IN	_	28	prep	_	_
46	the	_	DT	DT	_	47	det	_	_
47	fact	_	NN	NN	_	45	pobj	_	_
48	that	_	IN	IN	_	51	mark	_	_
49	both	_	DT	DT	_	50	det	_	_
50	stimuli	_	NNS	NNS	_	51	nsubj	_	_
51	activate	_	VBP	VBP	_	47	ccomp	_	_
52	NF-kappa	_	NN	NN	_	53	nn	_	_
53	B	_	NN	NN	_	51	dobj	_	_
54	.	_	.	.	_	6	punct	_	_

1	Characterization	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	NF-kappa	_	NN	NN	_	6	nn	_	_
5	B1	_	NN	NN	_	6	nn	_	_
6	promoter	_	NN	NN	_	2	pobj	_	_
7	identified	_	VBD	VBD	_	0	root	_	_
8	an	_	DT	DT	_	10	det	_	_
9	Egr-1	_	NN	NN	_	10	nn	_	_
10	site	_	NN	NN	_	7	dobj	_	_
11	which	_	WDT	WDT	_	13	nsubjpass	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	found	_	VBN	VBN	_	10	rcmod	_	_
14	to	_	TO	TO	_	16	aux	_	_
15	be	_	VB	VB	_	16	cop	_	_
16	essential	_	JJ	JJ	_	13	xcomp	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	both	_	CC	CC	_	21	dep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	PMA/PHA-mediated	_	JJ	JJ	_	21	amod	_	_
21	induction	_	NN	NN	_	17	pobj	_	_
22	as	_	RB	RB	_	23	advmod	_	_
23	well	_	RB	RB	_	21	cc	_	_
24	as	_	IN	IN	_	23	mwe	_	_
25	the	_	DT	DT	_	27	det	_	_
26	synergistic	_	JJ	JJ	_	27	amod	_	_
27	activation	_	NN	NN	_	21	conj	_	_
28	observed	_	VBN	VBN	_	27	vmod	_	_
29	after	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	expression	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	RelA	_	NN	NN	_	35	nn	_	_
35	subunit	_	NN	NN	_	32	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	NF-kappa	_	NN	NN	_	38	nn	_	_
38	B	_	NN	NN	_	36	pobj	_	_
39	and	_	CC	CC	_	35	cc	_	_
40	Egr-1	_	NN	NN	_	35	conj	_	_
41	.	_	.	.	_	7	punct	_	_

1	Furthermore	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	Egr-1	_	NN	NN	_	4	nn	_	_
4	induction	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	required	_	VBN	VBN	_	0	root	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	endogenous	_	JJ	JJ	_	12	amod	_	_
9	NF-kappa	_	NN	NN	_	10	nn	_	_
10	B1	_	NN	NN	_	12	nn	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	7	pobj	_	_
13	,	_	,	,	_	6	punct	_	_
14	since	_	IN	IN	_	24	mark	_	_
15	PMA/PHA-stimulated	_	JJ	JJ	_	18	amod	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	lines	_	NNS	NNS	_	24	nsubjpass	_	_
19	expressing	_	VBG	VBG	_	18	vmod	_	_
20	antisense	_	JJ	JJ	_	22	amod	_	_
21	Egr-1	_	NN	NN	_	22	nn	_	_
22	RNA	_	NN	NN	_	19	dobj	_	_
23	were	_	VBD	VBD	_	24	auxpass	_	_
24	inhibited	_	VBN	VBN	_	6	advcl	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	their	_	PRP$	PRP$	_	27	poss	_	_
27	ability	_	NN	NN	_	25	pobj	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	upregulate	_	VB	VB	_	27	vmod	_	_
30	NF-kappa	_	NN	NN	_	32	nn	_	_
31	B1	_	NN	NN	_	32	nn	_	_
32	transcription	_	NN	NN	_	29	dobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	17	mark	_	_
5	transcriptional	_	JJ	JJ	_	6	amod	_	_
6	synergy	_	NN	NN	_	17	nsubj	_	_
7	mediated	_	VBN	VBN	_	6	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	activation	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	Egr-1	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	NF-kappa	_	NN	NN	_	15	nn	_	_
15	B	_	NN	NN	_	12	conj	_	_
16	may	_	MD	MD	_	17	aux	_	_
17	have	_	VBP	VBP	_	3	ccomp	_	_
18	important	_	JJ	JJ	_	19	amod	_	_
19	ramifications	_	NNS	NNS	_	17	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	development	_	NN	NN	_	20	pobj	_	_
24	by	_	IN	IN	_	17	prep	_	_
25	upregulating	_	VBG	VBG	_	24	pcomp	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B1	_	NN	NN	_	29	nn	_	_
28	gene	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	25	dobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	synthesis	_	NN	NN	_	0	root	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	immunogenicity	_	NN	NN	_	2	conj	_	_
5	of	_	IN	IN	_	2	prep	_	_
6	varicella-zoster	_	NN	NN	_	9	nn	_	_
7	virus	_	NN	NN	_	9	nn	_	_
8	glycoprotein	_	NN	NN	_	9	nn	_	_
9	E	_	NN	NN	_	5	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	immediate-early	_	JJ	JJ	_	12	amod	_	_
12	protein	_	NN	NN	_	9	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	IE62	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	expressed	_	VBN	VBN	_	9	vmod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	recombinant	_	JJ	JJ	_	21	amod	_	_
19	herpes	_	NN	NN	_	21	nn	_	_
20	simplex	_	NN	NN	_	21	nn	_	_
21	virus-1	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	evaluate	_	VB	VB	_	30	dep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	conditions	_	NNS	NNS	_	4	dobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	optimal	_	JJ	JJ	_	9	amod	_	_
9	expression	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	immunogenicity	_	NN	NN	_	9	conj	_	_
12	of	_	IN	IN	_	9	prep	_	_
13	varicella-zoster	_	JJ	JJ	_	18	amod	_	_
14	virus	_	NN	NN	_	18	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
16	VZV	_	NN	NN	_	18	nn	_	_
17	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
18	proteins	_	NNS	NNS	_	12	pobj	_	_
19	in	_	IN	IN	_	9	prep	_	_
20	a	_	DT	DT	_	27	det	_	_
21	herpes	_	NN	NN	_	23	nn	_	_
22	simplex	_	NN	NN	_	23	nn	_	_
23	virus-1	_	NN	NN	_	27	nn	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	HSV-1	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	vector	_	NN	NN	_	19	pobj	_	_
28	,	_	,	,	_	30	punct	_	_
29	we	_	PRP	PRP	_	30	nsubj	_	_
30	selected	_	VBD	VBD	_	0	root	_	_
31	the	_	DT	DT	_	34	det	_	_
32	VZV	_	NN	NN	_	34	nn	_	_
33	glycoprotein	_	NN	NN	_	34	nn	_	_
34	E	_	NN	NN	_	30	dobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	gE	_	NN	NN	_	34	appos	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	,	_	,	,	_	34	punct	_	_
39	encoded	_	VBN	VBN	_	34	vmod	_	_
40	by	_	IN	IN	_	39	prep	_	_
41	ORF	_	NN	NN	_	40	pobj	_	_
42	68	_	CD	CD	_	41	num	_	_
43	and	_	CC	CC	_	41	cc	_	_
44	the	_	DT	DT	_	46	det	_	_
45	VZV	_	NN	NN	_	46	nn	_	_
46	product	_	NN	NN	_	41	conj	_	_
47	of	_	IN	IN	_	46	prep	_	_
48	ORF	_	NN	NN	_	47	pobj	_	_
49	62	_	CD	CD	_	48	num	_	_
50	,	_	,	,	_	46	punct	_	_
51	an	_	DT	DT	_	55	det	_	_
52	immediate-early	_	JJ	JJ	_	55	amod	_	_
53	major	_	JJ	JJ	_	55	amod	_	_
54	tegument	_	NN	NN	_	55	nn	_	_
55	protein	_	NN	NN	_	46	appos	_	_
56	-LRB-	_	-LRB-	-LRB-	_	57	punct	_	_
57	IE62	_	NN	NN	_	55	appos	_	_
58	-RRB-	_	-RRB-	-RRB-	_	57	punct	_	_
59	.	_	.	.	_	30	punct	_	_

1	Three	_	CD	CD	_	3	num	_	_
2	HSV/VZV	_	NN	NN	_	3	nn	_	_
3	recombinants	_	NNS	NNS	_	5	nsubjpass	_	_
4	were	_	VBD	VBD	_	5	auxpass	_	_
5	generated	_	VBN	VBN	_	0	root	_	_
6	:	_	:	:	_	5	punct	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	1	_	LS	LS	_	21	dep	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	VZV	_	NN	NN	_	14	nn	_	_
11	gE	_	NN	NN	_	14	nn	_	_
12	protein	_	NN	NN	_	14	nn	_	_
13	coding	_	NN	NN	_	14	nn	_	_
14	sequences	_	NNS	NNS	_	21	nsubjpass	_	_
15	along	_	IN	IN	_	14	prep	_	_
16	with	_	IN	IN	_	15	pcomp	_	_
17	the	_	DT	DT	_	19	det	_	_
18	promoter	_	NN	NN	_	19	nn	_	_
19	region	_	NN	NN	_	16	pobj	_	_
20	were	_	VBD	VBD	_	21	auxpass	_	_
21	inserted	_	VBN	VBN	_	5	parataxis	_	_
22	into	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	29	det	_	_
24	thymidine	_	NN	NN	_	29	nn	_	_
25	kinase	_	NN	NN	_	29	nn	_	_
26	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
27	TK	_	NN	NN	_	29	nn	_	_
28	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
29	gene	_	NN	NN	_	22	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	HSV-1	_	NN	NN	_	33	nn	_	_
32	strain	_	NN	NN	_	33	nn	_	_
33	KOS	_	NN	NN	_	30	pobj	_	_
34	;	_	:	:	_	21	punct	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	2	_	LS	LS	_	47	dep	_	_
37	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
38	VZV	_	NN	NN	_	39	nn	_	_
39	gE	_	NN	NN	_	47	nsubjpass	_	_
40	expressed	_	VBN	VBN	_	39	vmod	_	_
41	from	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	45	det	_	_
43	HSV-1	_	NN	NN	_	45	nn	_	_
44	ICP4	_	NN	NN	_	45	nn	_	_
45	promoter	_	NN	NN	_	41	pobj	_	_
46	was	_	VBD	VBD	_	47	auxpass	_	_
47	inserted	_	VBN	VBN	_	21	conj	_	_
48	into	_	IN	IN	_	47	prep	_	_
49	the	_	DT	DT	_	55	det	_	_
50	glycoprotein	_	NN	NN	_	55	nn	_	_
51	C	_	NN	NN	_	55	nn	_	_
52	-LRB-	_	-LRB-	-LRB-	_	55	punct	_	_
53	gC	_	NN	NN	_	55	nn	_	_
54	-RRB-	_	-RRB-	-RRB-	_	55	punct	_	_
55	gene	_	NN	NN	_	48	pobj	_	_
56	of	_	IN	IN	_	55	prep	_	_
57	HSV-1	_	NN	NN	_	59	nn	_	_
58	strain	_	NN	NN	_	59	nn	_	_
59	F	_	NN	NN	_	56	pobj	_	_
60	;	_	:	:	_	21	punct	_	_
61	and	_	CC	CC	_	21	cc	_	_
62	-LRB-	_	-LRB-	-LRB-	_	63	punct	_	_
63	3	_	LS	LS	_	79	dep	_	_
64	-RRB-	_	-RRB-	-RRB-	_	63	punct	_	_
65	VZV	_	NN	NN	_	69	nn	_	_
66	IE62	_	NN	NN	_	69	nn	_	_
67	protein	_	NN	NN	_	69	nn	_	_
68	coding	_	NN	NN	_	69	nn	_	_
69	sequences	_	NNS	NNS	_	79	nsubjpass	_	_
70	under	_	IN	IN	_	69	prep	_	_
71	the	_	DT	DT	_	72	det	_	_
72	control	_	NN	NN	_	70	pobj	_	_
73	of	_	IN	IN	_	72	prep	_	_
74	the	_	DT	DT	_	77	det	_	_
75	HSV-1	_	NN	NN	_	77	nn	_	_
76	ICP4	_	NN	NN	_	77	nn	_	_
77	promoter	_	NN	NN	_	73	pobj	_	_
78	were	_	VBD	VBD	_	79	auxpass	_	_
79	inserted	_	VBN	VBN	_	21	conj	_	_
80	into	_	IN	IN	_	79	prep	_	_
81	the	_	DT	DT	_	83	det	_	_
82	gC	_	NN	NN	_	83	nn	_	_
83	gene	_	NN	NN	_	80	pobj	_	_
84	of	_	IN	IN	_	83	prep	_	_
85	HSV-1	_	NN	NN	_	87	nn	_	_
86	strain	_	NN	NN	_	87	nn	_	_
87	F	_	NN	NN	_	84	pobj	_	_
88	.	_	.	.	_	5	punct	_	_

1	Immunoblot	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	10	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	immunoperoxidase	_	NN	NN	_	5	nn	_	_
5	staining	_	NN	NN	_	2	conj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	infected	_	JJ	JJ	_	9	amod	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	monolayers	_	NNS	NNS	_	6	pobj	_	_
10	demonstrated	_	VBD	VBD	_	0	root	_	_
11	vector	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	VZV	_	NN	NN	_	15	nn	_	_
15	proteins	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	10	punct	_	_

1	Following	_	VBG	VBG	_	19	prep	_	_
2	intracranial	_	JJ	JJ	_	3	amod	_	_
3	inoculation	_	NN	NN	_	1	pobj	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	mice	_	NNS	NNS	_	4	pobj	_	_
6	,	_	,	,	_	19	punct	_	_
7	both	_	CC	CC	_	9	preconj	_	_
8	VZV	_	NN	NN	_	9	nn	_	_
9	gE-HSV	_	NN	NN	_	19	nsubj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	TK	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	VZV	_	NN	NN	_	15	nn	_	_
15	IE62-HSV	_	NN	NN	_	9	conj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	gC	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	induced	_	VBD	VBD	_	0	root	_	_
20	an	_	DT	DT	_	22	det	_	_
21	IgG	_	NN	NN	_	22	nn	_	_
22	response	_	NN	NN	_	19	dobj	_	_
23	against	_	IN	IN	_	19	prep	_	_
24	VZV	_	NN	NN	_	25	nn	_	_
25	gE	_	NN	NN	_	23	pobj	_	_
26	or	_	CC	CC	_	25	cc	_	_
27	VZV	_	NN	NN	_	28	nn	_	_
28	IE62	_	NN	NN	_	25	conj	_	_
29	.	_	.	.	_	19	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	tested	_	VBN	VBN	_	29	advcl	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	cytotoxicity	_	NN	NN	_	5	nn	_	_
5	assays	_	NNS	NNS	_	3	pobj	_	_
6	using	_	VBG	VBG	_	5	vmod	_	_
7	T-lymphocytes	_	NNS	NNS	_	6	dobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	VZV	_	NN	NN	_	12	nn	_	_
10	immune	_	JJ	JJ	_	12	amod	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	donors	_	NNS	NNS	_	8	pobj	_	_
13	,	_	,	,	_	29	punct	_	_
14	the	_	DT	DT	_	15	det	_	_
15	range	_	NN	NN	_	29	nsubj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	precursor	_	NN	NN	_	18	nn	_	_
18	frequencies	_	NNS	NNS	_	16	pobj	_	_
19	for	_	IN	IN	_	18	prep	_	_
20	T-lymphocytes	_	NNS	NNS	_	19	pobj	_	_
21	that	_	WDT	WDT	_	22	nsubj	_	_
22	recognized	_	VBD	VBD	_	20	rcmod	_	_
23	VZV	_	NN	NN	_	24	nn	_	_
24	gE	_	NN	NN	_	22	dobj	_	_
25	or	_	CC	CC	_	24	cc	_	_
26	VZV	_	NN	NN	_	27	nn	_	_
27	IE62	_	NN	NN	_	24	conj	_	_
28	was	_	VBD	VBD	_	29	cop	_	_
29	similar	_	JJ	JJ	_	0	root	_	_
30	whether	_	IN	IN	_	34	mark	_	_
31	these	_	DT	DT	_	32	det	_	_
32	proteins	_	NNS	NNS	_	34	nsubjpass	_	_
33	were	_	VBD	VBD	_	34	auxpass	_	_
34	expressed	_	VBN	VBN	_	29	ccomp	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	HSV-1	_	NN	NN	_	35	pobj	_	_
37	or	_	CC	CC	_	36	cc	_	_
38	a	_	DT	DT	_	40	det	_	_
39	vaccinia	_	NN	NN	_	40	nn	_	_
40	vector	_	NN	NN	_	36	conj	_	_
41	.	_	.	.	_	29	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	experiments	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	HSV-1	_	NN	NN	_	9	nsubj	_	_
6	is	_	VBZ	VBZ	_	9	cop	_	_
7	a	_	DT	DT	_	9	det	_	_
8	competent	_	JJ	JJ	_	9	amod	_	_
9	vector	_	NN	NN	_	3	ccomp	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	expression	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	these	_	DT	DT	_	15	det	_	_
14	VZV	_	NN	NN	_	15	nn	_	_
15	proteins	_	NNS	NNS	_	12	pobj	_	_
16	and	_	CC	CC	_	3	cc	_	_
17	support	_	VBP	VBP	_	3	conj	_	_
18	the	_	DT	DT	_	19	det	_	_
19	feasibility	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	engineering	_	VBG	VBG	_	20	pcomp	_	_
22	a	_	DT	DT	_	24	det	_	_
23	combined	_	JJ	JJ	_	24	amod	_	_
24	vaccine	_	NN	NN	_	21	dobj	_	_
25	for	_	IN	IN	_	24	prep	_	_
26	these	_	DT	DT	_	29	det	_	_
27	closely	_	RB	RB	_	28	advmod	_	_
28	related	_	JJ	JJ	_	29	amod	_	_
29	alpha-herpesviruses	_	NNS	NNS	_	25	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	-LSB-	_	-LRB-	-LRB-	_	2	punct	_	_
2	Correlation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	lymphocytic	_	JJ	JJ	_	5	amod	_	_
5	infiltration	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	tumor	_	NN	NN	_	8	nn	_	_
8	tissue	_	NN	NN	_	6	pobj	_	_
9	with	_	IN	IN	_	2	prep	_	_
10	the	_	DT	DT	_	11	dep	_	_
11	hormonal	_	JJ	JJ	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	metabolic	_	JJ	JJ	_	11	conj	_	_
14	state	_	NN	NN	_	11	dep	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	patients	_	NNS	NNS	_	15	pobj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	breast	_	NN	NN	_	19	nn	_	_
19	cancer	_	NN	NN	_	17	pobj	_	_
20	-RSB-	_	-RRB-	-RRB-	_	2	punct	_	_

1	Lymphocyte	_	NN	NN	_	2	nn	_	_
2	infiltration	_	NN	NN	_	6	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	tumor	_	NN	NN	_	3	pobj	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	studied	_	VBN	VBN	_	0	root	_	_
7	vis-a-vis	_	FW	FW	_	6	prep	_	_
8	hormone	_	NN	NN	_	10	nn	_	_
9	metabolic	_	JJ	JJ	_	10	amod	_	_
10	status	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	tumor	_	NN	NN	_	15	nn	_	_
13	tissue	_	NN	NN	_	15	nn	_	_
14	hormone	_	NN	NN	_	15	nn	_	_
15	sensitivity	_	NN	NN	_	10	conj	_	_
16	and	_	CC	CC	_	10	cc	_	_
17	tobacco	_	NN	NN	_	18	nn	_	_
18	smoking	_	NN	NN	_	10	conj	_	_
19	,	_	,	,	_	6	punct	_	_
20	in	_	IN	IN	_	6	prep	_	_
21	113	_	CD	CD	_	24	num	_	_
22	breast	_	NN	NN	_	24	nn	_	_
23	cancer	_	NN	NN	_	24	nn	_	_
24	patients	_	NNS	NNS	_	20	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	aged	_	JJ	JJ	_	24	amod	_	_
27	25-77	_	CD	CD	_	26	dep	_	_
28	.	_	.	.	_	6	punct	_	_

1	On	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	average	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	no	_	DT	DT	_	6	neg	_	_
6	correlation	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	established	_	VBN	VBN	_	0	root	_	_
9	between	_	IN	IN	_	8	prep	_	_
10	degree	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	lymphocyte	_	NN	NN	_	13	nn	_	_
13	infiltration	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	breast	_	NN	NN	_	16	nn	_	_
16	tumor	_	NN	NN	_	14	pobj	_	_
17	and	_	CC	CC	_	10	cc	_	_
18	age	_	NN	NN	_	10	conj	_	_
19	and	_	CC	CC	_	10	cc	_	_
20	menopause	_	NN	NN	_	21	nn	_	_
21	onset	_	NN	NN	_	10	conj	_	_
22	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	smoking	_	NN	NN	_	4	nn	_	_
3	menopausal	_	JJ	JJ	_	4	amod	_	_
4	patients	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	lymphocyte	_	NN	NN	_	7	nn	_	_
7	infiltration	_	NN	NN	_	9	nsubjpass	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	found	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	be	_	VB	VB	_	12	cop	_	_
12	higher	_	JJR	JJR	_	9	xcomp	_	_
13	than	_	IN	IN	_	12	prep	_	_
14	in	_	IN	IN	_	13	pcomp	_	_
15	non-smokers	_	NNS	NNS	_	14	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	p	_	NN	NN	_	15	dep	_	_
18	&lt;	_	JJR	JJR	_	17	amod	_	_
19	0.05	_	CD	CD	_	18	dep	_	_
20	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
21	.	_	.	.	_	9	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	direct	_	JJ	JJ	_	5	amod	_	_
5	correlation	_	NN	NN	_	2	nsubj	_	_
6	between	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	rate	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	lymphocyte	_	NN	NN	_	11	nn	_	_
11	infiltration	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	8	cc	_	_
13	the	_	DT	DT	_	14	det	_	_
14	level	_	NN	NN	_	8	conj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	progesterone	_	NN	NN	_	17	nn	_	_
17	receptors	_	NNS	NNS	_	15	pobj	_	_
18	in	_	IN	IN	_	8	prep	_	_
19	tumor	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	Some	_	DT	DT	_	2	det	_	_
2	subgroups	_	NNS	NNS	_	3	nsubj	_	_
3	displayed	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	direct	_	JJ	JJ	_	6	amod	_	_
6	correlation	_	NN	NN	_	3	dobj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	infiltration	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	sex-binding	_	JJ	JJ	_	11	amod	_	_
11	globulin	_	NN	NN	_	8	conj	_	_
12	,	_	,	,	_	11	punct	_	_
13	cholesterol	_	NN	NN	_	11	appos	_	_
14	,	_	,	,	_	11	punct	_	_
15	luteinizing	_	JJ	JJ	_	16	amod	_	_
16	hormone	_	NN	NN	_	11	appos	_	_
17	in	_	IN	IN	_	11	prep	_	_
18	blood	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	8	punct	_	_
20	and	_	CC	CC	_	8	cc	_	_
21	lean	_	JJ	JJ	_	23	amod	_	_
22	body	_	NN	NN	_	23	nn	_	_
23	mass	_	NN	NN	_	8	conj	_	_
24	.	_	.	.	_	3	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	was	_	VBD	VBD	_	3	auxpass	_	_
3	matched	_	VBN	VBN	_	0	root	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	an	_	DT	DT	_	7	det	_	_
6	inverse	_	JJ	JJ	_	7	amod	_	_
7	correlation	_	NN	NN	_	4	pobj	_	_
8	between	_	IN	IN	_	7	prep	_	_
9	lymphocyte	_	NN	NN	_	10	nn	_	_
10	infiltration	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	blood-thyroid	_	JJ	JJ	_	14	amod	_	_
13	hormone	_	NN	NN	_	14	nn	_	_
14	concentration	_	NN	NN	_	10	conj	_	_
15	,	_	,	,	_	14	punct	_	_
16	urine	_	NN	NN	_	17	nn	_	_
17	catecholamines	_	NNS	NNS	_	14	conj	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	free	_	JJ	JJ	_	21	amod	_	_
20	cortisol	_	NN	NN	_	21	nn	_	_
21	excretion	_	NN	NN	_	14	conj	_	_
22	and	_	CC	CC	_	14	cc	_	_
23	fat/lean	_	JJ	JJ	_	26	amod	_	_
24	body	_	NN	NN	_	26	nn	_	_
25	mass	_	NN	NN	_	26	nn	_	_
26	ratio	_	NN	NN	_	14	conj	_	_
27	.	_	.	.	_	3	punct	_	_

1	Considering	_	VBG	VBG	_	22	prep	_	_
2	the	_	DT	DT	_	1	pobj	_	_
3	abovesaid	_	VBN	VBN	_	2	amod	_	_
4	as	_	RB	RB	_	5	advmod	_	_
5	well	_	RB	RB	_	2	cc	_	_
6	as	_	IN	IN	_	5	mwe	_	_
7	the	_	DT	DT	_	9	det	_	_
8	lymphocyte	_	NN	NN	_	9	nn	_	_
9	ability	_	NN	NN	_	2	conj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	perform	_	VB	VB	_	9	vmod	_	_
12	the	_	DT	DT	_	14	det	_	_
13	dual	_	JJ	JJ	_	14	amod	_	_
14	function	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	immunocytes	_	NNS	NNS	_	15	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	hormonocytes	_	NNS	NNS	_	16	conj	_	_
19	,	_	,	,	_	22	punct	_	_
20	it	_	PRP	PRP	_	22	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	suggested	_	VBN	VBN	_	0	root	_	_
23	that	_	IN	IN	_	28	mark	_	_
24	the	_	DT	DT	_	25	det	_	_
25	results	_	NNS	NNS	_	28	nsubjpass	_	_
26	may	_	MD	MD	_	28	aux	_	_
27	be	_	VB	VB	_	28	auxpass	_	_
28	used	_	VBN	VBN	_	22	ccomp	_	_
29	in	_	IN	IN	_	28	prep	_	_
30	both	_	CC	CC	_	32	preconj	_	_
31	the	_	DT	DT	_	32	det	_	_
32	study	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	lymphocyte	_	NN	NN	_	35	nn	_	_
35	infiltration	_	NN	NN	_	33	pobj	_	_
36	and	_	CC	CC	_	32	cc	_	_
37	research	_	NN	NN	_	32	conj	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	means	_	NNS	NNS	_	38	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	its	_	PRP$	PRP$	_	42	poss	_	_
42	control	_	NN	NN	_	40	pobj	_	_
43	.	_	.	.	_	22	punct	_	_

1	Thymocytes	_	NNS	NNS	_	2	nsubj	_	_
2	control	_	VBP	VBP	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	CD4	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	2	dobj	_	_
6	differently	_	RB	RB	_	2	advmod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	mature	_	JJ	JJ	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	lymphocytes	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	analyzed	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	activity	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	enhancer	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	the	_	DT	DT	_	10	det	_	_
10	promoter	_	NN	NN	_	7	conj	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	the	_	DT	DT	_	13	det	_	_
13	silencer	_	NN	NN	_	7	conj	_	_
14	of	_	IN	IN	_	7	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	CD4	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	14	pobj	_	_
19	during	_	IN	IN	_	4	prep	_	_
20	T	_	NN	NN	_	22	nn	_	_
21	cell	_	NN	NN	_	22	nn	_	_
22	development	_	NN	NN	_	19	pobj	_	_
23	using	_	VBG	VBG	_	2	xcomp	_	_
24	transgenic	_	JJ	JJ	_	25	amod	_	_
25	mice	_	NNS	NNS	_	23	dobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	Immunofluorescence	_	NN	NN	_	2	nn	_	_
2	studies	_	NNS	NNS	_	18	nsubj	_	_
3	on	_	IN	IN	_	2	prep	_	_
4	thymic	_	JJ	JJ	_	5	amod	_	_
5	populations	_	NNS	NNS	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	mice	_	NNS	NNS	_	6	pobj	_	_
8	carrying	_	VBG	VBG	_	7	vmod	_	_
9	transgenes	_	NNS	NNS	_	8	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	various	_	JJ	JJ	_	12	amod	_	_
12	combinations	_	NNS	NNS	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	these	_	DT	DT	_	17	det	_	_
15	regulatory	_	JJ	JJ	_	17	amod	_	_
16	DNA	_	NN	NN	_	17	nn	_	_
17	elements	_	NNS	NNS	_	13	pobj	_	_
18	revealed	_	VBD	VBD	_	0	root	_	_
19	that	_	IN	IN	_	21	mark	_	_
20	thymocytes	_	NNS	NNS	_	21	nsubj	_	_
21	control	_	VBP	VBP	_	18	ccomp	_	_
22	the	_	DT	DT	_	24	det	_	_
23	CD4	_	NN	NN	_	24	nn	_	_
24	gene	_	NN	NN	_	21	dobj	_	_
25	in	_	IN	IN	_	21	prep	_	_
26	a	_	DT	DT	_	28	det	_	_
27	different	_	JJ	JJ	_	28	amod	_	_
28	manner	_	NN	NN	_	25	pobj	_	_
29	than	_	IN	IN	_	28	prep	_	_
30	mature	_	JJ	JJ	_	33	amod	_	_
31	peripheral	_	JJ	JJ	_	33	amod	_	_
32	T	_	NN	NN	_	33	nn	_	_
33	lymphocytes	_	NNS	NNS	_	29	pobj	_	_
34	.	_	.	.	_	18	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	5'-positive	_	JJ	JJ	_	4	amod	_	_
3	regulatory	_	JJ	JJ	_	4	amod	_	_
4	unit	_	NN	NN	_	17	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	consisting	_	VBG	VBG	_	4	vmod	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	promoter	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	the	_	DT	DT	_	13	det	_	_
12	5'	_	JJ	JJ	_	13	amod	_	_
13	enhancer	_	NN	NN	_	9	conj	_	_
14	,	_	,	,	_	4	punct	_	_
15	is	_	VBZ	VBZ	_	17	cop	_	_
16	already	_	RB	RB	_	17	advmod	_	_
17	active	_	JJ	JJ	_	0	root	_	_
18	at	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	24	det	_	_
20	CD4-CD8-double-negative	_	JJ	JJ	_	24	amod	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	DN	_	JJ	JJ	_	20	dep	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	stage	_	NN	NN	_	18	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	development	_	NN	NN	_	25	pobj	_	_
27	.	_	.	.	_	17	punct	_	_

1	However	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	its	_	PRP$	PRP$	_	4	poss	_	_
4	activity	_	NN	NN	_	5	nsubj	_	_
5	becomes	_	VBZ	VBZ	_	0	root	_	_
6	lower	_	JJR	JJR	_	5	acomp	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	double-positive	_	JJ	JJ	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	a	_	DT	DT	_	12	det	_	_
12	fraction	_	NN	NN	_	9	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	18	det	_	_
15	CD4+	_	JJ	JJ	_	18	amod	_	_
16	CD8int/-	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	population	_	NN	NN	_	13	pobj	_	_
19	,	_	,	,	_	5	punct	_	_
20	indicating	_	VBG	VBG	_	5	xcomp	_	_
21	that	_	IN	IN	_	41	mark	_	_
22	an	_	DT	DT	_	24	det	_	_
23	additional	_	JJ	JJ	_	24	amod	_	_
24	enhancer	_	NN	NN	_	41	nsubjpass	_	_
25	,	_	,	,	_	24	punct	_	_
26	located	_	JJ	JJ	_	24	amod	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	either	_	CC	CC	_	30	preconj	_	_
29	the	_	DT	DT	_	30	det	_	_
30	first	_	JJ	JJ	_	27	pobj	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	the	_	DT	DT	_	33	det	_	_
33	third	_	JJ	JJ	_	30	conj	_	_
34	intron	_	NN	NN	_	30	dep	_	_
35	of	_	IN	IN	_	30	prep	_	_
36	the	_	DT	DT	_	38	det	_	_
37	CD4	_	NN	NN	_	38	nn	_	_
38	gene	_	NN	NN	_	35	pobj	_	_
39	,	_	,	,	_	24	punct	_	_
40	is	_	VBZ	VBZ	_	41	auxpass	_	_
41	required	_	VBN	VBN	_	20	ccomp	_	_
42	for	_	IN	IN	_	41	prep	_	_
43	CD4	_	NN	NN	_	44	nn	_	_
44	gene	_	NN	NN	_	45	nn	_	_
45	expression	_	NN	NN	_	42	pobj	_	_
46	in	_	IN	IN	_	45	prep	_	_
47	this	_	DT	DT	_	48	det	_	_
48	population	_	NN	NN	_	46	pobj	_	_
49	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	other	_	JJ	JJ	_	5	amod	_	_
3	studied	_	VBN	VBN	_	5	amod	_	_
4	regulatory	_	JJ	JJ	_	5	amod	_	_
5	element	_	NN	NN	_	10	nsubj	_	_
6	is	_	VBZ	VBZ	_	10	cop	_	_
7	the	_	DT	DT	_	10	det	_	_
8	minimal	_	JJ	JJ	_	10	amod	_	_
9	CD4	_	NN	NN	_	10	nn	_	_
10	silencer	_	NN	NN	_	0	root	_	_
11	which	_	WDT	WDT	_	12	nsubj	_	_
12	inhibits	_	VBZ	VBZ	_	10	rcmod	_	_
13	CD4	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	15	nn	_	_
15	expression	_	NN	NN	_	12	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	peripheral	_	JJ	JJ	_	20	amod	_	_
18	CD8	_	NN	NN	_	20	nn	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	lymphocytes	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	10	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	silencer	_	NN	NN	_	4	nsubj	_	_
3	is	_	VBZ	VBZ	_	4	cop	_	_
4	inactive	_	JJ	JJ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	most	_	RBS	RBS	_	10	advmod	_	_
8	immature	_	JJ	JJ	_	10	amod	_	_
9	DN	_	JJ	JJ	_	10	amod	_	_
10	thymocytes	_	NNS	NNS	_	5	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	which	_	WDT	WDT	_	14	nsubj	_	_
13	probably	_	RB	RB	_	14	advmod	_	_
14	use	_	VBP	VBP	_	10	rcmod	_	_
15	a	_	DT	DT	_	18	det	_	_
16	distinct	_	JJ	JJ	_	18	amod	_	_
17	silencer	_	NN	NN	_	18	nn	_	_
18	mechanism	_	NN	NN	_	14	dobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	down-regulate	_	VB	VB	_	14	xcomp	_	_
21	CD4	_	NN	NN	_	22	nn	_	_
22	gene	_	NN	NN	_	23	nn	_	_
23	expression	_	NN	NN	_	20	dobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Unexpectedly	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	CD4	_	NN	NN	_	5	nn	_	_
5	silencer	_	NN	NN	_	8	nsubj	_	_
6	is	_	VBZ	VBZ	_	8	cop	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	active	_	JJ	JJ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	CD4+	_	JJ	JJ	_	12	amod	_	_
11	CD8int/-	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	thymus	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	8	punct	_	_
17	implying	_	VBG	VBG	_	8	xcomp	_	_
18	that	_	IN	IN	_	23	mark	_	_
19	an	_	DT	DT	_	20	det	_	_
20	anti-silencer	_	NN	NN	_	23	nsubjpass	_	_
21	may	_	MD	MD	_	23	aux	_	_
22	be	_	VB	VB	_	23	auxpass	_	_
23	required	_	VBN	VBN	_	17	ccomp	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	resume	_	VB	VB	_	23	xcomp	_	_
26	CD4	_	NN	NN	_	27	nn	_	_
27	expression	_	NN	NN	_	25	dobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	this	_	DT	DT	_	31	det	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	population	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	8	punct	_	_

1	Altogether	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	CD4	_	NN	NN	_	5	nn	_	_
5	gene	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	regulated	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	several	_	JJ	JJ	_	10	amod	_	_
10	positive	_	JJ	JJ	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	negative	_	JJ	JJ	_	10	conj	_	_
13	regulatory	_	JJ	JJ	_	14	amod	_	_
14	mechanisms	_	NNS	NNS	_	10	dep	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	come	_	VBP	VBP	_	10	rcmod	_	_
17	into	_	IN	IN	_	16	prep	_	_
18	play	_	NN	NN	_	17	pobj	_	_
19	in	_	IN	IN	_	16	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	developmentally	_	RB	RB	_	22	advmod	_	_
22	coordinated	_	VBN	VBN	_	23	amod	_	_
23	manner	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	7	punct	_	_

1	Heat-shock	_	NN	NN	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	cadmium	_	NN	NN	_	4	nn	_	_
4	chloride	_	NN	NN	_	1	conj	_	_
5	increase	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	8	dep	_	_
7	vimentin	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	5	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	protein	_	NN	NN	_	8	conj	_	_
11	levels	_	NNS	NNS	_	8	dep	_	_
12	in	_	IN	IN	_	8	prep	_	_
13	U-937	_	NN	NN	_	16	nn	_	_
14	human	_	JJ	JJ	_	16	amod	_	_
15	promonocytic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	12	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Heat-shock	_	NN	NN	_	24	nsubj	_	_
2	for	_	IN	IN	_	1	prep	_	_
3	2	_	CD	CD	_	4	num	_	_
4	hours	_	NNS	NNS	_	2	pobj	_	_
5	at	_	IN	IN	_	1	prep	_	_
6	42	_	CD	CD	_	8	num	_	_
7	degrees	_	NNS	NNS	_	8	nn	_	_
8	C	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	1	punct	_	_
10	or	_	CC	CC	_	1	cc	_	_
11	the	_	DT	DT	_	12	det	_	_
12	administration	_	NN	NN	_	1	conj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	3	_	CD	CD	_	15	num	_	_
15	hours	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	12	prep	_	_
17	100	_	CD	CD	_	20	dep	_	_
18	or	_	CC	CC	_	17	cc	_	_
19	150	_	CD	CD	_	17	conj	_	_
20	microM	_	NN	NN	_	22	dep	_	_
21	cadmium	_	NN	NN	_	22	nn	_	_
22	chloride	_	NN	NN	_	16	pobj	_	_
23	,	_	,	,	_	1	punct	_	_
24	inhibited	_	VBD	VBD	_	0	root	_	_
25	the	_	DT	DT	_	28	det	_	_
26	subsequent	_	JJ	JJ	_	28	amod	_	_
27	proliferation	_	NN	NN	_	28	nn	_	_
28	activity	_	NN	NN	_	24	dobj	_	_
29	,	_	,	,	_	24	punct	_	_
30	induced	_	VBD	VBD	_	24	conj	_	_
31	the	_	DT	DT	_	32	det	_	_
32	expression	_	NN	NN	_	30	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	functional	_	JJ	JJ	_	36	amod	_	_
35	differentiation	_	NN	NN	_	36	nn	_	_
36	markers	_	NNS	NNS	_	33	pobj	_	_
37	,	_	,	,	_	24	punct	_	_
38	and	_	CC	CC	_	24	cc	_	_
39	caused	_	VBD	VBD	_	24	conj	_	_
40	an	_	DT	DT	_	41	det	_	_
41	increase	_	NN	NN	_	39	dobj	_	_
42	in	_	IN	IN	_	41	prep	_	_
43	the	_	DT	DT	_	44	det	_	_
44	amount	_	NN	NN	_	42	pobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	the	_	DT	DT	_	49	det	_	_
47	stress-responsive	_	JJ	JJ	_	49	amod	_	_
48	HSP70	_	NN	NN	_	49	nn	_	_
49	protein	_	NN	NN	_	45	pobj	_	_
50	in	_	IN	IN	_	49	prep	_	_
51	U-937	_	NN	NN	_	54	nn	_	_
52	human	_	JJ	JJ	_	54	amod	_	_
53	promonocytic	_	JJ	JJ	_	54	amod	_	_
54	cells	_	NNS	NNS	_	50	pobj	_	_
55	.	_	.	.	_	24	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	both	_	CC	CC	_	5	preconj	_	_
5	heat	_	NN	NN	_	8	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	cadmium	_	NN	NN	_	5	conj	_	_
8	produced	_	VBD	VBD	_	0	root	_	_
9	an	_	DT	DT	_	10	det	_	_
10	increase	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	amount	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	intermediate	_	JJ	JJ	_	18	amod	_	_
17	filament	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	14	pobj	_	_
19	vimentin	_	NN	NN	_	18	dep	_	_
20	,	_	,	,	_	8	punct	_	_
21	as	_	IN	IN	_	22	mark	_	_
22	determined	_	VBN	VBN	_	8	advcl	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	immunoblot	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	immunofluorescence	_	NN	NN	_	24	conj	_	_
27	assays	_	NNS	NNS	_	24	dep	_	_
28	.	_	.	.	_	8	punct	_	_

1	By	_	IN	IN	_	13	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	13	punct	_	_
4	the	_	DT	DT	_	5	det	_	_
5	amounts	_	NNS	NNS	_	13	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	actin	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	beta-tubulin	_	NN	NN	_	7	conj	_	_
10	were	_	VBD	VBD	_	13	auxpass	_	_
11	not	_	RB	RB	_	13	neg	_	_
12	significantly	_	RB	RB	_	13	advmod	_	_
13	altered	_	VBN	VBN	_	0	root	_	_
14	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	amount	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	vimentin	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	also	_	RB	RB	_	8	advmod	_	_
8	increased	_	VBN	VBN	_	0	root	_	_
9	during	_	IN	IN	_	8	prep	_	_
10	recovery	_	NN	NN	_	9	pobj	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	stress	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	8	punct	_	_
14	indicating	_	VBG	VBG	_	8	vmod	_	_
15	that	_	IN	IN	_	21	mark	_	_
16	vimentin	_	NN	NN	_	17	nn	_	_
17	expression	_	NN	NN	_	21	nsubjpass	_	_
18	was	_	VBD	VBD	_	21	auxpass	_	_
19	not	_	RB	RB	_	21	neg	_	_
20	exclusively	_	RB	RB	_	21	advmod	_	_
21	regulated	_	VBN	VBN	_	14	ccomp	_	_
22	at	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	protein	_	NN	NN	_	25	nn	_	_
25	level	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	8	punct	_	_

1	Although	_	IN	IN	_	3	mark	_	_
2	cadmium	_	NN	NN	_	3	nsubj	_	_
3	caused	_	VBD	VBD	_	20	advcl	_	_
4	an	_	DT	DT	_	8	det	_	_
5	early	_	JJ	JJ	_	8	amod	_	_
6	,	_	,	,	_	5	punct	_	_
7	transient	_	JJ	JJ	_	5	dep	_	_
8	stimulation	_	NN	NN	_	3	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	c-jun	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	c-fos	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	8	conj	_	_
14	and	_	CC	CC	_	8	cc	_	_
15	AP-1	_	NN	NN	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	8	conj	_	_
18	,	_	,	,	_	20	punct	_	_
19	heat-shock	_	NN	NN	_	20	nsubj	_	_
20	failed	_	VBD	VBD	_	0	root	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	alter	_	VB	VB	_	20	xcomp	_	_
23	both	_	CC	CC	_	25	preconj	_	_
24	protooncogene	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	22	dobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	transcription	_	NN	NN	_	29	nn	_	_
28	factor	_	NN	NN	_	29	nn	_	_
29	binding	_	NN	NN	_	25	conj	_	_
30	,	_	,	,	_	20	punct	_	_
31	indicating	_	VBG	VBG	_	20	xcomp	_	_
32	that	_	IN	IN	_	40	mark	_	_
33	the	_	DT	DT	_	36	det	_	_
34	stress-induced	_	JJ	JJ	_	36	amod	_	_
35	vimentin	_	NN	NN	_	36	nn	_	_
36	increase	_	NN	NN	_	40	nsubj	_	_
37	was	_	VBD	VBD	_	40	cop	_	_
38	not	_	RB	RB	_	40	neg	_	_
39	the	_	DT	DT	_	40	det	_	_
40	result	_	NN	NN	_	31	ccomp	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	AP-1-mediated	_	JJ	JJ	_	44	amod	_	_
43	transcriptional	_	JJ	JJ	_	44	amod	_	_
44	activation	_	NN	NN	_	41	pobj	_	_
45	.	_	.	.	_	20	punct	_	_

1	Finally	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	it	_	PRP	PRP	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	observed	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	19	mark	_	_
7	the	_	DT	DT	_	8	det	_	_
8	rate	_	NN	NN	_	19	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	decay	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	vimentin	_	NN	NN	_	13	nn	_	_
13	mRNA	_	NN	NN	_	11	pobj	_	_
14	upon	_	IN	IN	_	10	prep	_	_
15	actinomycin	_	NN	NN	_	17	nn	_	_
16	D	_	NN	NN	_	17	nn	_	_
17	administration	_	NN	NN	_	14	pobj	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	decreased	_	VBN	VBN	_	5	ccomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	heat-	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	cadmium-pretreated	_	JJ	JJ	_	21	conj	_	_
24	cells	_	NNS	NNS	_	21	dep	_	_
25	in	_	IN	IN	_	19	prep	_	_
26	comparison	_	NN	NN	_	25	pobj	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	untreated	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	stress	_	NN	NN	_	6	nn	_	_
6	treatments	_	NNS	NNS	_	7	nsubj	_	_
7	cause	_	VBP	VBP	_	3	ccomp	_	_
8	an	_	DT	DT	_	9	det	_	_
9	increase	_	NN	NN	_	7	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	vimentin	_	NN	NN	_	12	nn	_	_
12	levels	_	NNS	NNS	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	promonocytic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	,	_	,	,	_	3	punct	_	_
17	which	_	WDT	WDT	_	20	nsubjpass	_	_
18	may	_	MD	MD	_	20	aux	_	_
19	be	_	VB	VB	_	20	auxpass	_	_
20	explained	_	VBN	VBN	_	3	ccomp	_	_
21	at	_	IN	IN	_	23	advmod	_	_
22	least	_	JJS	JJS	_	21	pobj	_	_
23	in	_	IN	IN	_	20	prep	_	_
24	part	_	NN	NN	_	23	pobj	_	_
25	by	_	IN	IN	_	20	prep	_	_
26	transcript	_	NN	NN	_	27	nn	_	_
27	stabilization	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Jak1	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	required	_	VBN	VBN	_	0	root	_	_
5	for	_	IN	IN	_	4	prep	_	_
6	mediating	_	VBG	VBG	_	5	pcomp	_	_
7	interleukin-4-induced	_	JJ	JJ	_	9	amod	_	_
8	tyrosine	_	NN	NN	_	9	nn	_	_
9	phosphorylation	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	insulin	_	NN	NN	_	13	nn	_	_
12	receptor	_	NN	NN	_	13	nn	_	_
13	substrate	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	Stat6	_	NN	NN	_	13	conj	_	_
16	signaling	_	NN	NN	_	17	nn	_	_
17	molecules	_	NNS	NNS	_	15	dep	_	_
18	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	Jak1	_	NN	NN	_	14	nsubjpass	_	_
3	,	_	,	,	_	2	punct	_	_
4	Jak2	_	NN	NN	_	2	conj	_	_
5	,	_	,	,	_	2	punct	_	_
6	Jak3	_	NN	NN	_	2	conj	_	_
7	,	_	,	,	_	2	punct	_	_
8	and	_	CC	CC	_	2	cc	_	_
9	Fes	_	NN	NN	_	2	conj	_	_
10	tyrosine	_	NN	NN	_	11	nn	_	_
11	kinases	_	NNS	NNS	_	2	dep	_	_
12	have	_	VBP	VBP	_	14	aux	_	_
13	been	_	VBN	VBN	_	14	auxpass	_	_
14	demonstrated	_	VBN	VBN	_	0	root	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	undergo	_	VB	VB	_	14	xcomp	_	_
17	tyrosine	_	NN	NN	_	18	nn	_	_
18	phosphorylation	_	NN	NN	_	16	dobj	_	_
19	in	_	IN	IN	_	16	prep	_	_
20	response	_	NN	NN	_	19	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	interleukin	_	NN	NN	_	24	nn	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	IL	_	NN	NN	_	27	nn	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	-4	_	CD	CD	_	24	num	_	_
27	stimulation	_	NN	NN	_	21	pobj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	different	_	JJ	JJ	_	31	amod	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	systems	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	14	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	it	_	PRP	PRP	_	6	nsubj	_	_
4	is	_	VBZ	VBZ	_	6	cop	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	clear	_	JJ	JJ	_	0	root	_	_
7	which	_	WDT	WDT	_	16	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	if	_	IN	IN	_	10	mark	_	_
10	any	_	DT	DT	_	7	dep	_	_
11	,	_	,	,	_	7	punct	_	_
12	of	_	IN	IN	_	7	prep	_	_
13	these	_	DT	DT	_	14	det	_	_
14	kinases	_	NNS	NNS	_	12	pobj	_	_
15	are	_	VBP	VBP	_	16	cop	_	_
16	responsible	_	JJ	JJ	_	6	ccomp	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	initiating	_	VBG	VBG	_	17	pcomp	_	_
19	IL-4-induced	_	JJ	JJ	_	21	amod	_	_
20	tyrosine	_	NN	NN	_	21	nn	_	_
21	phosphorylation	_	NN	NN	_	18	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	intracellular	_	JJ	JJ	_	24	amod	_	_
24	substrates	_	NNS	NNS	_	22	pobj	_	_
25	in	_	FW	FW	_	26	nn	_	_
26	vivo	_	FW	FW	_	18	advmod	_	_
27	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	8	punct	_	_
6	we	_	PRP	PRP	_	8	nsubj	_	_
7	have	_	VBP	VBP	_	8	aux	_	_
8	utilized	_	VBN	VBN	_	0	root	_	_
9	a	_	DT	DT	_	14	det	_	_
10	mutant	_	JJ	JJ	_	14	amod	_	_
11	Jak1-deficient	_	JJ	JJ	_	14	amod	_	_
12	HeLa	_	NN	NN	_	14	nn	_	_
13	cell	_	NN	NN	_	14	nn	_	_
14	line	_	NN	NN	_	8	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	E1C3	_	NN	NN	_	14	appos	_	_
17	,	_	,	,	_	14	punct	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	its	_	PRP$	PRP$	_	22	poss	_	_
20	parental	_	JJ	JJ	_	22	amod	_	_
21	Jak1-expressing	_	JJ	JJ	_	22	amod	_	_
22	counterpart	_	NN	NN	_	14	conj	_	_
23	,	_	,	,	_	22	punct	_	_
24	1D4	_	NN	NN	_	22	appos	_	_
25	,	_	,	,	_	8	punct	_	_
26	to	_	TO	TO	_	27	aux	_	_
27	analyze	_	VB	VB	_	8	xcomp	_	_
28	the	_	DT	DT	_	29	det	_	_
29	role	_	NN	NN	_	27	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	Jak1	_	NN	NN	_	30	pobj	_	_
32	in	_	IN	IN	_	29	prep	_	_
33	mediating	_	VBG	VBG	_	32	pcomp	_	_
34	IL-4-induced	_	JJ	JJ	_	37	amod	_	_
35	tyrosine	_	NN	NN	_	37	nn	_	_
36	phosphorylation	_	NN	NN	_	37	nn	_	_
37	events	_	NNS	NNS	_	33	dobj	_	_
38	.	_	.	.	_	8	punct	_	_

1	IL-4	_	NN	NN	_	2	nn	_	_
2	treatment	_	NN	NN	_	4	nsubj	_	_
3	rapidly	_	RB	RB	_	4	advmod	_	_
4	induced	_	VBD	VBD	_	0	root	_	_
5	tyrosine	_	NN	NN	_	6	nn	_	_
6	phosphorylation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	insulin	_	NN	NN	_	12	nn	_	_
9	receptor	_	NN	NN	_	12	nn	_	_
10	substrate	_	NN	NN	_	12	nn	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	IRS	_	NN	NN	_	7	pobj	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	-1	_	CD	CD	_	12	num	_	_
15	and	_	CC	CC	_	12	cc	_	_
16	IRS-2	_	NN	NN	_	12	conj	_	_
17	in	_	IN	IN	_	4	prep	_	_
18	1D4	_	NN	NN	_	17	pobj	_	_
19	but	_	CC	CC	_	17	cc	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	in	_	IN	IN	_	17	conj	_	_
22	E1C3	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	IL-4-mediated	_	JJ	JJ	_	3	amod	_	_
2	tyrosine	_	NN	NN	_	3	nn	_	_
3	phosphorylation	_	NN	NN	_	7	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	Stat6	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	pronounced	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	1D4	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	,	_	,	,	_	7	punct	_	_
12	while	_	IN	IN	_	18	mark	_	_
13	no	_	DT	DT	_	16	neg	_	_
14	IL-4-induced	_	JJ	JJ	_	16	amod	_	_
15	Stat6	_	NN	NN	_	16	nn	_	_
16	phosphorylation	_	NN	NN	_	18	nsubjpass	_	_
17	was	_	VBD	VBD	_	18	auxpass	_	_
18	detected	_	VBN	VBN	_	7	advcl	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	E1C3	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	7	punct	_	_

1	IL-4	_	NN	NN	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	induced	_	VBD	VBD	_	0	root	_	_
4	Stat6	_	NN	NN	_	7	nn	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	3	dobj	_	_
8	from	_	IN	IN	_	3	prep	_	_
9	lysates	_	NNS	NNS	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	1D4	_	NN	NN	_	10	pobj	_	_
12	but	_	CC	CC	_	13	cc	_	_
13	not	_	RB	RB	_	11	cc	_	_
14	E1C3	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	11	conj	_	_
16	utilizing	_	VBG	VBG	_	3	xcomp	_	_
17	a	_	DT	DT	_	25	det	_	_
18	radiolabeled	_	VBN	VBN	_	25	amod	_	_
19	immunoglobulin	_	NN	NN	_	25	nn	_	_
20	heavy	_	JJ	JJ	_	25	amod	_	_
21	chain	_	NN	NN	_	25	nn	_	_
22	germline	_	NN	NN	_	25	nn	_	_
23	epsilon	_	NN	NN	_	25	nn	_	_
24	promotor	_	NN	NN	_	25	nn	_	_
25	sequence	_	NN	NN	_	16	dobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	Iepsilon	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	in	_	IN	IN	_	16	prep	_	_
30	an	_	DT	DT	_	34	det	_	_
31	electrophoretic	_	JJ	JJ	_	34	amod	_	_
32	mobility	_	NN	NN	_	34	nn	_	_
33	shift	_	NN	NN	_	34	nn	_	_
34	assay	_	NN	NN	_	29	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	Reconstitution	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	Jak1	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	E1C3	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	5	pobj	_	_
8	restored	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	10	det	_	_
10	ability	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	IL-4	_	NN	NN	_	11	pobj	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	induce	_	VB	VB	_	10	vmod	_	_
15	IRS	_	NN	NN	_	14	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	Stat6	_	NN	NN	_	15	conj	_	_
18	tyrosine	_	NN	NN	_	19	nn	_	_
19	phosphorylation	_	NN	NN	_	15	dep	_	_
20	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	Jak1	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	required	_	VBN	VBN	_	4	ccomp	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	mediating	_	VBG	VBG	_	10	pcomp	_	_
12	tyrosine	_	NN	NN	_	13	nn	_	_
13	phosphorylation	_	NN	NN	_	11	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	activation	_	NN	NN	_	13	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	crucial	_	JJ	JJ	_	18	amod	_	_
18	molecules	_	NNS	NNS	_	16	pobj	_	_
19	involved	_	VBN	VBN	_	18	vmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	IL-4	_	NN	NN	_	23	nn	_	_
22	signal	_	NN	NN	_	23	nn	_	_
23	transduction	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	Immune	_	JJ	JJ	_	2	amod	_	_
2	hyperactivation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	HIV-1-infected	_	JJ	JJ	_	6	amod	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	3	pobj	_	_
7	mediated	_	VBN	VBN	_	2	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	Tat	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	the	_	DT	DT	_	13	det	_	_
12	CD28	_	NN	NN	_	13	nn	_	_
13	pathway	_	NN	NN	_	9	conj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Human	_	JJ	JJ	_	3	amod	_	_
2	immunodeficiency	_	NN	NN	_	3	nn	_	_
3	virus-type	_	NN	NN	_	8	nn	_	_
4	1	_	CD	CD	_	3	num	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	HIV-1	_	NN	NN	_	3	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	infection	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	characterized	_	VBN	VBN	_	0	root	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	a	_	DT	DT	_	14	det	_	_
13	chronic	_	JJ	JJ	_	14	amod	_	_
14	state	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	immune	_	JJ	JJ	_	17	amod	_	_
17	hyperactivation	_	NN	NN	_	15	pobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	patients	_	NNS	NNS	_	18	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	Infection	_	NN	NN	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	6	amod	_	_
4	peripheral	_	JJ	JJ	_	6	amod	_	_
5	blood	_	NN	NN	_	6	nn	_	_
6	lymphocytes	_	NNS	NNS	_	2	pobj	_	_
7	with	_	IN	IN	_	1	prep	_	_
8	HIV-1	_	NN	NN	_	7	pobj	_	_
9	in	_	FW	FW	_	10	nn	_	_
10	vitro	_	FW	FW	_	1	advmod	_	_
11	resulted	_	VBD	VBD	_	0	root	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	increased	_	VBN	VBN	_	18	amod	_	_
14	interleukin-2	_	NN	NN	_	18	nn	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	IL-2	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	secretion	_	NN	NN	_	12	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	response	_	NN	NN	_	19	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	T	_	NN	NN	_	24	nn	_	_
23	cell	_	NN	NN	_	24	nn	_	_
24	activation	_	NN	NN	_	21	pobj	_	_
25	via	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	dep	_	_
27	CD3	_	NN	NN	_	25	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	CD28	_	NN	NN	_	27	conj	_	_
30	receptors	_	NNS	NNS	_	27	dep	_	_
31	.	_	.	.	_	11	punct	_	_

1	Expression	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	HIV-1	_	NN	NN	_	5	nn	_	_
5	transactivator	_	NN	NN	_	2	pobj	_	_
6	Tat	_	NN	NN	_	5	dep	_	_
7	recapitulated	_	VBD	VBD	_	0	root	_	_
8	this	_	DT	DT	_	9	det	_	_
9	phenotype	_	NN	NN	_	7	dobj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	associated	_	VBN	VBN	_	7	conj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	increased	_	VBN	VBN	_	16	amod	_	_
15	IL-2	_	NN	NN	_	16	nn	_	_
16	secretion	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	response	_	NN	NN	_	17	pobj	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	costimulation	_	NN	NN	_	19	pobj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	CD3	_	NN	NN	_	21	pobj	_	_
23	plus	_	CC	CC	_	22	cc	_	_
24	CD28	_	NN	NN	_	22	conj	_	_
25	.	_	.	.	_	7	punct	_	_

1	IL-2	_	NN	NN	_	2	nn	_	_
2	superinduction	_	NN	NN	_	5	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	Tat	_	NN	NN	_	3	pobj	_	_
5	occurred	_	VBD	VBD	_	0	root	_	_
6	at	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	transcriptional	_	JJ	JJ	_	9	amod	_	_
9	level	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	5	punct	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	mediated	_	VBN	VBN	_	5	conj	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	CD28-responsive	_	JJ	JJ	_	16	amod	_	_
16	element	_	NN	NN	_	13	pobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	IL-2	_	NN	NN	_	20	nn	_	_
20	promoter	_	NN	NN	_	17	pobj	_	_
21	,	_	,	,	_	5	punct	_	_
22	and	_	CC	CC	_	5	cc	_	_
23	was	_	VBD	VBD	_	25	cop	_	_
24	exclusively	_	RB	RB	_	25	advmod	_	_
25	dependent	_	JJ	JJ	_	5	conj	_	_
26	on	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	30	det	_	_
28	29	_	CD	CD	_	30	num	_	_
29	amino	_	NN	NN	_	30	nn	_	_
30	acids	_	NNS	NNS	_	26	pobj	_	_
31	encoded	_	VBN	VBN	_	30	vmod	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	37	det	_	_
34	second	_	JJ	JJ	_	37	amod	_	_
35	exon	_	NN	NN	_	37	nn	_	_
36	of	_	IN	IN	_	37	amod	_	_
37	Tat	_	NN	NN	_	32	pobj	_	_
38	.	_	.	.	_	5	punct	_	_

1	c-Rel	_	NN	NN	_	4	nsubj	_	_
2	is	_	VBZ	VBZ	_	4	cop	_	_
3	a	_	DT	DT	_	4	det	_	_
4	target	_	NN	NN	_	0	root	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	pentoxifylline-mediated	_	JJ	JJ	_	7	amod	_	_
7	inhibition	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	T	_	NN	NN	_	11	nn	_	_
10	lymphocyte	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	8	pobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	possible	_	JJ	JJ	_	4	amod	_	_
3	clinical	_	JJ	JJ	_	2	dep	_	_
4	use	_	NN	NN	_	25	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	methyl	_	NN	NN	_	8	nn	_	_
8	xanthine	_	NN	NN	_	5	pobj	_	_
9	derivative	_	JJ	JJ	_	8	amod	_	_
10	,	_	,	,	_	8	punct	_	_
11	pentoxifylline	_	NN	NN	_	8	appos	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	PF	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	,	_	,	,	_	4	punct	_	_
16	for	_	IN	IN	_	4	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	treatment	_	NN	NN	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	T	_	NN	NN	_	22	nn	_	_
21	cell-dependent	_	JJ	JJ	_	22	amod	_	_
22	diseases	_	NNS	NNS	_	19	pobj	_	_
23	is	_	VBZ	VBZ	_	25	aux	_	_
24	being	_	VBG	VBG	_	25	auxpass	_	_
25	noted	_	VBN	VBN	_	0	root	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	increasing	_	VBG	VBG	_	28	amod	_	_
28	interest	_	NN	NN	_	26	pobj	_	_
29	.	_	.	.	_	25	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	paper	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	studied	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	molecular	_	JJ	JJ	_	9	amod	_	_
9	consequences	_	NNS	NNS	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	PF	_	NN	NN	_	12	nn	_	_
12	treatment	_	NN	NN	_	10	pobj	_	_
13	during	_	IN	IN	_	9	prep	_	_
14	lymphocyte	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	12	mark	_	_
4	in	_	IN	IN	_	12	prep	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	cells	_	NNS	NNS	_	4	pobj	_	_
7	,	_	,	,	_	12	punct	_	_
8	anti-CD3-induced	_	JJ	JJ	_	10	amod	_	_
9	c-Rel	_	NN	NN	_	10	nn	_	_
10	expression	_	NN	NN	_	12	nsubjpass	_	_
11	was	_	VBD	VBD	_	12	auxpass	_	_
12	blocked	_	VBN	VBN	_	2	ccomp	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	PF	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	12	punct	_	_
16	whereas	_	IN	IN	_	27	mark	_	_
17	the	_	DT	DT	_	18	det	_	_
18	induction	_	NN	NN	_	27	nsubjpass	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	other	_	JJ	JJ	_	23	amod	_	_
21	NF-kappaB	_	NN	NN	_	23	nn	_	_
22	family	_	NN	NN	_	23	nn	_	_
23	members	_	NNS	NNS	_	19	pobj	_	_
24	was	_	VBD	VBD	_	27	auxpass	_	_
25	not	_	RB	RB	_	27	neg	_	_
26	significantly	_	RB	RB	_	27	advmod	_	_
27	affected	_	VBN	VBN	_	12	advcl	_	_
28	.	_	.	.	_	2	punct	_	_

1	However	_	RB	RB	_	19	advmod	_	_
2	,	_	,	,	_	19	punct	_	_
3	induction	_	NN	NN	_	19	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	NF-AT	_	NN	NN	_	4	pobj	_	_
6	,	_	,	,	_	3	punct	_	_
7	which	_	WDT	WDT	_	8	nsubj	_	_
8	has	_	VBZ	VBZ	_	3	rcmod	_	_
9	the	_	DT	DT	_	12	det	_	_
10	same	_	JJ	JJ	_	12	amod	_	_
11	signaling	_	NN	NN	_	12	nn	_	_
12	requirements	_	NNS	NNS	_	8	dobj	_	_
13	as	_	IN	IN	_	12	prep	_	_
14	c-Rel	_	NN	NN	_	15	nn	_	_
15	induction	_	NN	NN	_	13	pobj	_	_
16	,	_	,	,	_	3	punct	_	_
17	was	_	VBD	VBD	_	19	auxpass	_	_
18	not	_	RB	RB	_	19	neg	_	_
19	inhibited	_	VBN	VBN	_	0	root	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	PF	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	19	punct	_	_

1	Among	_	IN	IN	_	14	prep	_	_
2	genes	_	NNS	NNS	_	1	pobj	_	_
3	that	_	WDT	WDT	_	4	nsubj	_	_
4	respond	_	VBP	VBP	_	2	rcmod	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	these	_	DT	DT	_	8	det	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	14	punct	_	_
10	IL-2	_	NN	NN	_	11	nn	_	_
11	mRNA	_	NN	NN	_	12	nn	_	_
12	induction	_	NN	NN	_	14	nsubjpass	_	_
13	was	_	VBD	VBD	_	14	auxpass	_	_
14	suppressed	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	PF	_	NN	NN	_	15	pobj	_	_
17	,	_	,	,	_	14	punct	_	_
18	whereas	_	IN	IN	_	28	mark	_	_
19	IL-2R	_	NN	NN	_	24	nn	_	_
20	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
21	alpha	_	NN	NN	_	24	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
23	chain	_	NN	NN	_	24	nn	_	_
24	mRNA	_	NN	NN	_	25	nn	_	_
25	induction	_	NN	NN	_	28	nsubjpass	_	_
26	was	_	VBD	VBD	_	28	auxpass	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	affected	_	VBN	VBN	_	14	advcl	_	_
29	.	_	.	.	_	14	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	implicated	_	VBD	VBD	_	0	root	_	_
4	c-Rel	_	NN	NN	_	3	dobj	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	an	_	DT	DT	_	8	det	_	_
7	IL-2	_	NN	NN	_	8	nn	_	_
8	promoter	_	NN	NN	_	5	pobj	_	_
9	factor	_	IN	IN	_	8	amod	_	_
10	,	_	,	,	_	8	punct	_	_
11	for	_	IN	IN	_	16	prep	_	_
12	which	_	WDT	WDT	_	11	pobj	_	_
13	experimental	_	JJ	JJ	_	14	amod	_	_
14	support	_	NN	NN	_	16	nsubjpass	_	_
15	was	_	VBD	VBD	_	16	auxpass	_	_
16	obtained	_	VBN	VBN	_	8	rcmod	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	transient	_	JJ	JJ	_	20	amod	_	_
19	transfection	_	NN	NN	_	20	nn	_	_
20	experiments	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	observation	_	NN	NN	_	3	pobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	T	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	14	punct	_	_
10	c-Rel	_	NN	NN	_	11	nn	_	_
11	induction	_	NN	NN	_	14	nsubjpass	_	_
12	was	_	VBD	VBD	_	14	auxpass	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	blocked	_	VBN	VBN	_	0	root	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	PF	_	NN	NN	_	15	pobj	_	_
17	in	_	IN	IN	_	14	prep	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	greater	_	JJR	JJR	_	3	amod	_	_
3	selectivity	_	NN	NN	_	19	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	PF	_	NN	NN	_	4	pobj	_	_
6	,	_	,	,	_	3	punct	_	_
7	compared	_	VBN	VBN	_	3	prep	_	_
8	with	_	IN	IN	_	7	pcomp	_	_
9	FK506	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	3	punct	_	_
11	at	_	IN	IN	_	3	prep	_	_
12	both	_	CC	CC	_	14	preconj	_	_
13	the	_	DT	DT	_	14	dep	_	_
14	molecular	_	JJ	JJ	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	cellular	_	JJ	JJ	_	14	conj	_	_
17	levels	_	NNS	NNS	_	14	dep	_	_
18	may	_	MD	MD	_	19	aux	_	_
19	prove	_	VB	VB	_	0	root	_	_
20	advantageous	_	JJ	JJ	_	19	acomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	manipulating	_	VBG	VBG	_	21	pcomp	_	_
23	T	_	NN	NN	_	25	nn	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	responses	_	NNS	NNS	_	22	dobj	_	_
26	in	_	FW	FW	_	27	nn	_	_
27	vivo	_	FW	FW	_	25	advmod	_	_
28	.	_	.	.	_	19	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	T	_	NN	NN	_	4	nn	_	_
3	cell-specific	_	JJ	JJ	_	4	amod	_	_
4	enhancer	_	NN	NN	_	10	nsubjpass	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	interleukin-3	_	NN	NN	_	8	nn	_	_
8	locus	_	NN	NN	_	5	pobj	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	activated	_	VBN	VBN	_	0	root	_	_
11	cooperatively	_	RB	RB	_	10	advmod	_	_
12	by	_	IN	IN	_	10	prep	_	_
13	Oct	_	NN	NN	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	NFAT	_	NN	NN	_	13	conj	_	_
16	elements	_	NNS	NNS	_	13	dep	_	_
17	within	_	IN	IN	_	13	prep	_	_
18	a	_	DT	DT	_	21	det	_	_
19	DNase	_	NN	NN	_	21	nn	_	_
20	I-hypersensitive	_	JJ	JJ	_	21	amod	_	_
21	site	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	10	punct	_	_

1	Interleukin-3	_	NN	NN	_	7	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-3	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	is	_	VBZ	VBZ	_	7	cop	_	_
6	a	_	DT	DT	_	7	det	_	_
7	cytokine	_	NN	NN	_	0	root	_	_
8	that	_	WDT	WDT	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	expressed	_	VBN	VBN	_	7	rcmod	_	_
11	primarily	_	RB	RB	_	12	advmod	_	_
12	in	_	IN	IN	_	10	prep	_	_
13	activated	_	VBN	VBN	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	identified	_	VBD	VBD	_	0	root	_	_
4	an	_	DT	DT	_	8	det	_	_
5	inducible	_	JJ	JJ	_	8	amod	_	_
6	T	_	NN	NN	_	8	nn	_	_
7	cell-specific	_	JJ	JJ	_	8	amod	_	_
8	enhancer	_	NN	NN	_	3	dobj	_	_
9	14	_	CD	CD	_	10	num	_	_
10	kb	_	NN	NN	_	11	npadvmod	_	_
11	upstream	_	RB	RB	_	8	advmod	_	_
12	of	_	IN	IN	_	8	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	IL-3	_	NN	NN	_	15	nn	_	_
15	gene	_	NN	NN	_	12	pobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	responded	_	VBD	VBD	_	8	rcmod	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	activation	_	NN	NN	_	18	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	receptor	_	NN	NN	_	25	nn	_	_
24	signaling	_	NN	NN	_	25	nn	_	_
25	pathways	_	NNS	NNS	_	20	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	IL-3	_	NN	NN	_	3	nn	_	_
3	enhancer	_	NN	NN	_	4	nsubj	_	_
4	spanned	_	VBD	VBD	_	0	root	_	_
5	an	_	DT	DT	_	11	det	_	_
6	inducible	_	JJ	JJ	_	11	amod	_	_
7	cyclosporin	_	NN	NN	_	11	nn	_	_
8	A-sensitive	_	JJ	JJ	_	11	amod	_	_
9	DNase	_	NN	NN	_	11	nn	_	_
10	I-hypersensitive	_	JJ	JJ	_	11	amod	_	_
11	site	_	NN	NN	_	4	dobj	_	_
12	found	_	VBN	VBN	_	11	vmod	_	_
13	only	_	RB	RB	_	14	advmod	_	_
14	in	_	IN	IN	_	12	prep	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	4	punct	_	_

1	Four	_	CD	CD	_	3	num	_	_
2	NFAT-like	_	JJ	JJ	_	3	amod	_	_
3	elements	_	NNS	NNS	_	4	nsubj	_	_
4	exist	_	VBP	VBP	_	0	root	_	_
5	within	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	enhancer	_	NN	NN	_	5	pobj	_	_
8	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	two	_	CD	CD	_	6	num	_	_
3	most	_	RBS	RBS	_	4	advmod	_	_
4	active	_	JJ	JJ	_	6	amod	_	_
5	NFAT-like	_	JJ	JJ	_	6	amod	_	_
6	elements	_	NNS	NNS	_	8	nsubj	_	_
7	were	_	VBD	VBD	_	8	cop	_	_
8	located	_	JJ	JJ	_	0	root	_	_
9	at	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	center	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	DNase	_	NN	NN	_	16	nn	_	_
15	I-hypersensitive	_	JJ	JJ	_	16	amod	_	_
16	site	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	One	_	CD	CD	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	5	det	_	_
4	NFAT-like	_	JJ	JJ	_	5	amod	_	_
5	elements	_	NNS	NNS	_	2	pobj	_	_
6	encompassed	_	VBD	VBD	_	0	root	_	_
7	overlapping	_	VBG	VBG	_	8	amod	_	_
8	Oct-	_	NN	NN	_	6	dobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	NFATp/c-binding	_	JJ	JJ	_	8	conj	_	_
11	sites	_	NNS	NNS	_	8	dep	_	_
12	,	_	,	,	_	8	punct	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	functioned	_	VBD	VBD	_	8	rcmod	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	highly	_	RB	RB	_	18	advmod	_	_
18	synergistic	_	JJ	JJ	_	19	amod	_	_
19	manner	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	suggest	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	15	mark	_	_
4	the	_	DT	DT	_	8	det	_	_
5	T	_	NN	NN	_	8	nn	_	_
6	cell-	_	NN	NN	_	8	nn	_	_
7	specific	_	JJ	JJ	_	8	amod	_	_
8	expression	_	NN	NN	_	15	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	IL-3	_	NN	NN	_	12	nn	_	_
12	gene	_	NN	NN	_	9	pobj	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	partly	_	RB	RB	_	15	advmod	_	_
15	controlled	_	VBN	VBN	_	2	ccomp	_	_
16	through	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	18	det	_	_
18	enhancer	_	NN	NN	_	16	pobj	_	_
19	by	_	IN	IN	_	15	prep	_	_
20	cooperation	_	NN	NN	_	19	pobj	_	_
21	between	_	IN	IN	_	20	prep	_	_
22	Oct	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	NFAT	_	NN	NN	_	22	conj	_	_
25	family	_	NN	NN	_	26	nn	_	_
26	proteins	_	NNS	NNS	_	22	dep	_	_
27	.	_	.	.	_	2	punct	_	_

1	TRAMP	_	NN	NN	_	0	root	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	6	det	_	_
4	novel	_	JJ	JJ	_	6	amod	_	_
5	apoptosis-mediating	_	JJ	JJ	_	6	amod	_	_
6	receptor	_	NN	NN	_	1	appos	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	sequence	_	NN	NN	_	9	nn	_	_
9	homology	_	NN	NN	_	7	pobj	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	tumor	_	NN	NN	_	14	nn	_	_
12	necrosis	_	NN	NN	_	14	nn	_	_
13	factor	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	10	pobj	_	_
15	1	_	CD	CD	_	14	num	_	_
16	and	_	CC	CC	_	14	cc	_	_
17	Fas	_	NN	NN	_	14	conj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	Apo-1/CD95	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	1	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	novel	_	JJ	JJ	_	3	amod	_	_
3	member	_	NN	NN	_	20	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	13	det	_	_
6	tumor	_	NN	NN	_	13	nn	_	_
7	necrosis	_	NN	NN	_	13	nn	_	_
8	factor	_	NN	NN	_	13	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
10	TNF	_	NN	NN	_	13	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
12	receptor	_	NN	NN	_	13	nn	_	_
13	family	_	NN	NN	_	4	pobj	_	_
14	,	_	,	,	_	3	punct	_	_
15	designated	_	VBN	VBN	_	3	vmod	_	_
16	TRAMP	_	NN	NN	_	15	dep	_	_
17	,	_	,	,	_	3	punct	_	_
18	has	_	VBZ	VBZ	_	20	aux	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	identified	_	VBN	VBN	_	0	root	_	_
21	.	_	.	.	_	20	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	structural	_	JJ	JJ	_	3	amod	_	_
3	organization	_	NN	NN	_	14	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	11	det	_	_
6	393	_	CD	CD	_	11	num	_	_
7	amino	_	NN	NN	_	11	nn	_	_
8	acid	_	NN	NN	_	11	nn	_	_
9	long	_	JJ	JJ	_	11	amod	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	TRAMP	_	NN	NN	_	4	pobj	_	_
12	is	_	VBZ	VBZ	_	14	cop	_	_
13	most	_	RBS	RBS	_	14	advmod	_	_
14	homologous	_	JJ	JJ	_	0	root	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	TNF	_	NN	NN	_	17	nn	_	_
17	receptor	_	NN	NN	_	15	pobj	_	_
18	1	_	CD	CD	_	17	num	_	_
19	.	_	.	.	_	14	punct	_	_

1	TRAMP	_	NN	NN	_	4	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	4	auxpass	_	_
3	abundantly	_	RB	RB	_	4	advmod	_	_
4	expressed	_	VBN	VBN	_	0	root	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	thymocytes	_	NNS	NNS	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	lymphocytes	_	NNS	NNS	_	6	conj	_	_
9	.	_	.	.	_	4	punct	_	_

1	Its	_	PRP$	PRP$	_	3	poss	_	_
2	extracellular	_	JJ	JJ	_	3	amod	_	_
3	domain	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	composed	_	VBN	VBN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	four	_	CD	CD	_	9	num	_	_
8	cysteine-rich	_	JJ	JJ	_	9	amod	_	_
9	domains	_	NNS	NNS	_	6	pobj	_	_
10	,	_	,	,	_	5	punct	_	_
11	and	_	CC	CC	_	5	cc	_	_
12	the	_	DT	DT	_	14	det	_	_
13	cytoplasmic	_	JJ	JJ	_	14	amod	_	_
14	region	_	NN	NN	_	15	nsubj	_	_
15	contains	_	VBZ	VBZ	_	5	conj	_	_
16	a	_	DT	DT	_	18	det	_	_
17	death	_	NN	NN	_	18	nn	_	_
18	domain	_	NN	NN	_	15	dobj	_	_
19	known	_	VBN	VBN	_	18	vmod	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	signal	_	NN	NN	_	22	nn	_	_
22	apoptosis	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	5	punct	_	_

1	Overexpression	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TRAMP	_	NN	NN	_	2	pobj	_	_
4	leads	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	two	_	CD	CD	_	8	num	_	_
7	major	_	JJ	JJ	_	8	amod	_	_
8	responses	_	NNS	NNS	_	5	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	NF-kappaB	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	8	appos	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	apoptosis	_	NN	NN	_	11	conj	_	_
14	.	_	.	.	_	4	punct	_	_

1	TRAMP-induced	_	JJ	JJ	_	3	amod	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	death	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	inhibited	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	an	_	DT	DT	_	8	det	_	_
8	inhibitor	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	ICE-like	_	JJ	JJ	_	11	amod	_	_
11	proteases	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	6	punct	_	_
13	but	_	CC	CC	_	6	cc	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	by	_	IN	IN	_	6	conj	_	_
16	Bcl-2	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	TRAMP	_	NN	NN	_	7	nsubj	_	_
5	does	_	VBZ	VBZ	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	appear	_	VB	VB	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	interact	_	VB	VB	_	7	xcomp	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	any	_	DT	DT	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	known	_	JJ	JJ	_	16	amod	_	_
15	apoptosis-inducing	_	JJ	JJ	_	16	amod	_	_
16	ligands	_	NNS	NNS	_	12	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	TNF	_	NN	NN	_	20	nn	_	_
20	family	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	Regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	tissue	_	NN	NN	_	6	nn	_	_
5	factor	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	2	pobj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	human	_	JJ	JJ	_	10	amod	_	_
9	monocytic	_	JJ	JJ	_	10	amod	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Role	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	AP-1	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	NF-kappa	_	NN	NN	_	6	nn	_	_
6	B/Rel	_	NN	NN	_	3	conj	_	_
7	,	_	,	,	_	3	punct	_	_
8	and	_	CC	CC	_	3	cc	_	_
9	Sp1	_	NN	NN	_	3	conj	_	_
10	proteins	_	NNS	NNS	_	3	dep	_	_
11	in	_	IN	IN	_	1	prep	_	_
12	uninduced	_	JJ	JJ	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	lipopolysaccharide-induced	_	JJ	JJ	_	12	conj	_	_
15	expression	_	NN	NN	_	12	dep	_	_
16	.	_	.	.	_	1	punct	_	_

1	Tissue	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	TF	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	expression	_	NN	NN	_	13	nsubj	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	peripheral	_	JJ	JJ	_	10	amod	_	_
9	blood	_	NN	NN	_	10	nn	_	_
10	monocytes	_	NNS	NNS	_	7	pobj	_	_
11	during	_	IN	IN	_	6	prep	_	_
12	sepsis	_	NN	NN	_	11	pobj	_	_
13	initiates	_	VBZ	VBZ	_	0	root	_	_
14	intravascular	_	JJ	JJ	_	15	amod	_	_
15	thrombosis	_	NN	NN	_	13	dobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	Bacterial	_	JJ	JJ	_	2	amod	_	_
2	lipopolysaccharide	_	NN	NN	_	7	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	LPS	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	rapidly	_	RB	RB	_	7	advmod	_	_
7	induces	_	VBZ	VBZ	_	0	root	_	_
8	TF	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	transcription	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	monocytes	_	NNS	NNS	_	11	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	human	_	JJ	JJ	_	4	amod	_	_
3	TF	_	NN	NN	_	4	nn	_	_
4	promoter	_	NN	NN	_	5	nsubj	_	_
5	contains	_	VBZ	VBZ	_	0	root	_	_
6	binding	_	VBG	VBG	_	7	amod	_	_
7	sites	_	NNS	NNS	_	5	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	transcription	_	NN	NN	_	11	nn	_	_
11	factors	_	NNS	NNS	_	8	pobj	_	_
12	AP-1	_	NN	NN	_	11	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	c-Rel/p65	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	Egr-1	_	NN	NN	_	12	conj	_	_
17	,	_	,	,	_	12	punct	_	_
18	and	_	CC	CC	_	12	cc	_	_
19	Sp1	_	NN	NN	_	12	conj	_	_
20	.	_	.	.	_	5	punct	_	_

1	NF-kappa	_	NN	NN	_	3	nn	_	_
2	B/Rel	_	NN	NN	_	3	nn	_	_
3	proteins	_	NNS	NNS	_	6	nsubjpass	_	_
4	have	_	VBP	VBP	_	6	aux	_	_
5	been	_	VBN	VBN	_	6	auxpass	_	_
6	shown	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	9	aux	_	_
8	physically	_	RB	RB	_	9	advmod	_	_
9	interact	_	VB	VB	_	6	xcomp	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	AP-1	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	Sp1	_	NN	NN	_	12	conj	_	_
15	proteins	_	NNS	NNS	_	12	dep	_	_
16	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	study	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	investigated	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	role	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	these	_	DT	DT	_	12	det	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	uninduced	_	JJ	JJ	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	LPS-induced	_	JJ	JJ	_	14	conj	_	_
17	TF	_	NN	NN	_	18	nn	_	_
18	gene	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	14	dep	_	_
20	in	_	IN	IN	_	14	prep	_	_
21	human	_	JJ	JJ	_	24	amod	_	_
22	monocytic	_	JJ	JJ	_	24	amod	_	_
23	THP-1	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	20	pobj	_	_
25	.	_	.	.	_	6	punct	_	_

1	Deletional	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	indicated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	five	_	CD	CD	_	7	num	_	_
6	Sp1	_	NN	NN	_	7	nn	_	_
7	sites	_	NNS	NNS	_	8	nsubj	_	_
8	mediated	_	VBD	VBD	_	3	ccomp	_	_
9	basal	_	JJ	JJ	_	10	amod	_	_
10	expression	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	uninduced	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	two	_	CD	CD	_	4	num	_	_
3	AP-1	_	NN	NN	_	4	nn	_	_
4	sites	_	NNS	NNS	_	5	nsubj	_	_
5	bound	_	VBD	VBD	_	0	root	_	_
6	c-Fos/c-Jun	_	NN	NN	_	7	nn	_	_
7	heterodimers	_	NNS	NNS	_	5	dobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	both	_	CC	CC	_	10	preconj	_	_
10	unstimulated	_	JJ	JJ	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	LPS-stimulated	_	JJ	JJ	_	10	conj	_	_
13	cells	_	NNS	NNS	_	10	dep	_	_
14	.	_	.	.	_	5	punct	_	_

1	Maximal	_	JJ	JJ	_	3	amod	_	_
2	LPS	_	NN	NN	_	3	nn	_	_
3	induction	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	TF	_	NN	NN	_	7	nn	_	_
7	promoter	_	NN	NN	_	4	pobj	_	_
8	required	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	12	det	_	_
10	two	_	CD	CD	_	12	num	_	_
11	AP-1	_	NN	NN	_	12	nn	_	_
12	sites	_	NNS	NNS	_	8	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	the	_	DT	DT	_	17	det	_	_
15	kappa	_	NN	NN	_	17	nn	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	site	_	NN	NN	_	12	conj	_	_
18	within	_	IN	IN	_	12	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	LPS	_	NN	NN	_	22	nn	_	_
21	response	_	NN	NN	_	22	nn	_	_
22	element	_	NN	NN	_	18	pobj	_	_
23	.	_	.	.	_	8	punct	_	_

1	Disruption	_	NN	NN	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	conserved	_	VBN	VBN	_	5	amod	_	_
5	spacing	_	NN	NN	_	2	pobj	_	_
6	between	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	proximal	_	JJ	JJ	_	10	amod	_	_
9	AP-1	_	NN	NN	_	10	nn	_	_
10	site	_	NN	NN	_	6	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	the	_	DT	DT	_	15	det	_	_
13	kappa	_	NN	NN	_	15	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	site	_	NN	NN	_	10	conj	_	_
16	abolished	_	VBD	VBD	_	0	root	_	_
17	LPS	_	NN	NN	_	18	nn	_	_
18	induction	_	NN	NN	_	16	dobj	_	_
19	.	_	.	.	_	16	punct	_	_

1	Replacement	_	NN	NN	_	12	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	6	det	_	_
4	two	_	CD	CD	_	6	num	_	_
5	AP-1	_	NN	NN	_	6	nn	_	_
6	sites	_	NNS	NNS	_	2	pobj	_	_
7	with	_	IN	IN	_	1	prep	_	_
8	intrinsically	_	RB	RB	_	9	advmod	_	_
9	bent	_	JJ	JJ	_	10	amod	_	_
10	DNA	_	NN	NN	_	7	pobj	_	_
11	partially	_	RB	RB	_	12	advmod	_	_
12	restored	_	VBD	VBD	_	0	root	_	_
13	LPS	_	NN	NN	_	14	nn	_	_
14	induction	_	NN	NN	_	12	dobj	_	_
15	,	_	,	,	_	12	punct	_	_
16	suggesting	_	VBG	VBG	_	12	vmod	_	_
17	an	_	DT	DT	_	20	det	_	_
18	additional	_	JJ	JJ	_	20	amod	_	_
19	structural	_	JJ	JJ	_	18	dep	_	_
20	role	_	NN	NN	_	16	dobj	_	_
21	for	_	IN	IN	_	16	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	AP-1	_	NN	NN	_	24	nn	_	_
24	sites	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	12	punct	_	_

1	Synergistic	_	JJ	JJ	_	2	amod	_	_
2	transactivation	_	NN	NN	_	27	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	LPS	_	NN	NN	_	7	nn	_	_
6	response	_	NN	NN	_	7	nn	_	_
7	element	_	NN	NN	_	3	pobj	_	_
8	in	_	IN	IN	_	2	prep	_	_
9	Drosophila	_	FW	FW	_	11	nn	_	_
10	Schneider	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	8	pobj	_	_
12	by	_	IN	IN	_	2	prep	_	_
13	coexpression	_	NN	NN	_	12	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	c-Fos	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	c-Jun	_	NN	NN	_	15	conj	_	_
18	,	_	,	,	_	15	punct	_	_
19	c-Rel	_	NN	NN	_	15	conj	_	_
20	,	_	,	,	_	15	punct	_	_
21	and	_	CC	CC	_	15	cc	_	_
22	p65	_	NN	NN	_	15	conj	_	_
23	or	_	CC	CC	_	22	cc	_	_
24	c-Jun	_	NN	NN	_	22	conj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	p65	_	NN	NN	_	24	conj	_	_
27	required	_	VBD	VBD	_	0	root	_	_
28	the	_	DT	DT	_	30	det	_	_
29	transactivation	_	NN	NN	_	30	nn	_	_
30	domains	_	NNS	NNS	_	27	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	c-Jun	_	NN	NN	_	31	pobj	_	_
33	and	_	CC	CC	_	32	cc	_	_
34	p65	_	NN	NN	_	32	conj	_	_
35	.	_	.	.	_	27	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	c-Fos/c-Jun	_	NN	NN	_	11	nsubj	_	_
6	,	_	,	,	_	5	punct	_	_
7	c-Rel/p65	_	NN	NN	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	Sp1	_	NN	NN	_	5	conj	_	_
11	regulate	_	VBP	VBP	_	3	ccomp	_	_
12	TF	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	monocytic	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	AML1a	_	NN	NN	_	5	nsubj	_	_
2	but	_	CC	CC	_	3	cc	_	_
3	not	_	RB	RB	_	1	cc	_	_
4	AML1b	_	NN	NN	_	1	conj	_	_
5	inhibits	_	VBZ	VBZ	_	0	root	_	_
6	erythroid	_	JJ	JJ	_	7	amod	_	_
7	differentiation	_	NN	NN	_	5	dobj	_	_
8	induced	_	VBN	VBN	_	7	vmod	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	sodium	_	NN	NN	_	11	nn	_	_
11	butyrate	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	5	cc	_	_
13	enhances	_	VBZ	VBZ	_	5	conj	_	_
14	the	_	DT	DT	_	16	det	_	_
15	megakaryocytic	_	JJ	JJ	_	16	amod	_	_
16	differentiation	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	K562	_	NN	NN	_	20	nn	_	_
19	leukemia	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	AML1	_	NN	NN	_	3	nsubj	_	_
2	may	_	MD	MD	_	3	aux	_	_
3	play	_	VB	VB	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	role	_	NN	NN	_	3	dobj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	growth	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	differentiation	_	NN	NN	_	7	conj	_	_
10	of	_	IN	IN	_	7	prep	_	_
11	cells	_	NNS	NNS	_	10	pobj	_	_
12	along	_	IN	IN	_	11	prep	_	_
13	erythroid	_	JJ	JJ	_	12	pobj	_	_
14	and/or	_	CC	CC	_	13	cc	_	_
15	megakaryocytic	_	JJ	JJ	_	13	conj	_	_
16	lineages	_	NNS	NNS	_	13	dep	_	_
17	,	_	,	,	_	3	punct	_	_
18	because	_	IN	IN	_	27	mark	_	_
19	a	_	DT	DT	_	21	det	_	_
20	significant	_	JJ	JJ	_	21	amod	_	_
21	level	_	NN	NN	_	27	nsubjpass	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	25	det	_	_
24	AML1	_	NN	NN	_	25	nn	_	_
25	gene	_	NN	NN	_	22	pobj	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	expressed	_	VBN	VBN	_	3	advcl	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	these	_	DT	DT	_	30	det	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	overexpressed	_	VBD	VBD	_	0	root	_	_
3	AML1a	_	NN	NN	_	2	dobj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	without	_	IN	IN	_	3	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	transcription-activating	_	JJ	JJ	_	8	amod	_	_
8	domain	_	NN	NN	_	5	pobj	_	_
9	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
10	and	_	CC	CC	_	3	cc	_	_
11	AML1b	_	NN	NN	_	3	conj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	with	_	IN	IN	_	11	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	domain	_	NN	NN	_	13	pobj	_	_
16	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
17	proteins	_	NNS	NNS	_	3	dep	_	_
18	in	_	IN	IN	_	2	prep	_	_
19	K562	_	NN	NN	_	21	nn	_	_
20	leukemia	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	which	_	WDT	WDT	_	26	nsubjpass	_	_
24	can	_	MD	MD	_	26	aux	_	_
25	be	_	VB	VB	_	26	auxpass	_	_
26	induced	_	VBN	VBN	_	21	rcmod	_	_
27	to	_	TO	TO	_	28	aux	_	_
28	differentiate	_	VB	VB	_	26	xcomp	_	_
29	into	_	IN	IN	_	28	prep	_	_
30	hemoglobin-producing	_	JJ	JJ	_	31	amod	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	megakaryocytes	_	NNS	NNS	_	31	conj	_	_
34	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	AML1a-transfected	_	JJ	JJ	_	4	amod	_	_
3	K562	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	5	nsubj	_	_
5	had	_	VBD	VBD	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	reduced	_	VBN	VBN	_	8	amod	_	_
8	capacity	_	NN	NN	_	5	dobj	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	differentiate	_	VB	VB	_	8	vmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	presence	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	sodium	_	NN	NN	_	16	nn	_	_
16	n-butyrate	_	NN	NN	_	14	pobj	_	_
17	but	_	CC	CC	_	11	cc	_	_
18	not	_	RB	RB	_	19	neg	_	_
19	in	_	IN	IN	_	11	conj	_	_
20	the	_	DT	DT	_	21	det	_	_
21	presence	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	other	_	JJ	JJ	_	24	amod	_	_
24	inducers	_	NNS	NNS	_	22	pobj	_	_
25	,	_	,	,	_	24	punct	_	_
26	such	_	JJ	JJ	_	27	mwe	_	_
27	as	_	IN	IN	_	24	prep	_	_
28	hemin	_	NN	NN	_	27	pobj	_	_
29	,	_	,	,	_	28	punct	_	_
30	1-beta-D-arabinofuranosylcytosine	_	NN	NN	_	28	conj	_	_
31	,	_	,	,	_	28	punct	_	_
32	and	_	CC	CC	_	28	cc	_	_
33	herbimycin	_	NN	NN	_	34	nn	_	_
34	A	_	NN	NN	_	28	conj	_	_
35	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	AML1	_	NN	NN	_	4	nn	_	_
3	antisense	_	JJ	JJ	_	4	amod	_	_
4	oligodeoxynucleotide	_	NN	NN	_	10	nsubj	_	_
5	but	_	CC	CC	_	6	cc	_	_
6	not	_	RB	RB	_	4	cc	_	_
7	the	_	DT	DT	_	9	det	_	_
8	sense	_	NN	NN	_	9	nn	_	_
9	oligomer	_	NN	NN	_	4	conj	_	_
10	recovered	_	VBD	VBD	_	0	root	_	_
11	its	_	PRP$	PRP$	_	13	poss	_	_
12	differentiation-inducing	_	JJ	JJ	_	13	amod	_	_
13	capacity	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	presence	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	butyrate	_	NN	NN	_	17	pobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	On	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	other	_	JJ	JJ	_	4	amod	_	_
4	hand	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	AML1b	_	NN	NN	_	7	nsubj	_	_
7	conferred	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	11	det	_	_
9	similar	_	JJ	JJ	_	11	amod	_	_
10	differentiation-inducing	_	JJ	JJ	_	9	dep	_	_
11	capacity	_	NN	NN	_	7	dobj	_	_
12	upon	_	IN	IN	_	7	prep	_	_
13	K562	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	transfected	_	VBN	VBN	_	14	vmod	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	vector	_	NN	NN	_	16	pobj	_	_
18	alone	_	RB	RB	_	17	advmod	_	_
19	.	_	.	.	_	7	punct	_	_

1	AML1a	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	associated	_	VBN	VBN	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	enhanced	_	VBN	VBN	_	7	amod	_	_
7	sensitivity	_	NN	NN	_	5	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	megakaryocytic	_	JJ	JJ	_	10	amod	_	_
10	differentiation	_	NN	NN	_	8	pobj	_	_
11	induced	_	VBN	VBN	_	10	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	phorbol	_	NN	NN	_	14	nn	_	_
14	ester	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	8	mark	_	_
6	AML1	_	NN	NN	_	7	nn	_	_
7	proteins	_	NNS	NNS	_	8	nsubj	_	_
8	play	_	VBP	VBP	_	4	ccomp	_	_
9	a	_	DT	DT	_	10	det	_	_
10	role	_	NN	NN	_	8	dobj	_	_
11	in	_	IN	IN	_	8	prep	_	_
12	erythroid	_	JJ	JJ	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	megakaryocytic	_	JJ	JJ	_	12	conj	_	_
15	differentiation	_	NN	NN	_	12	dep	_	_
16	.	_	.	.	_	3	punct	_	_

1	Differentiation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	U-937	_	NN	NN	_	5	nn	_	_
4	promonocytic	_	JJ	JJ	_	5	amod	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	etoposide	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	ICRF-193	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	7	punct	_	_
11	two	_	CD	CD	_	16	num	_	_
12	antitumour	_	JJ	JJ	_	16	amod	_	_
13	DNA	_	NN	NN	_	14	nn	_	_
14	topoisomerase	_	NN	NN	_	16	nn	_	_
15	II	_	CD	CD	_	14	num	_	_
16	inhibitors	_	NNS	NNS	_	7	appos	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	different	_	JJ	JJ	_	19	amod	_	_
19	mechanisms	_	NNS	NNS	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	action	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	compared	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	action	_	NN	NN	_	3	dobj	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	U-937	_	NN	NN	_	11	nn	_	_
8	human	_	JJ	JJ	_	11	amod	_	_
9	promonocytic	_	JJ	JJ	_	11	amod	_	_
10	leukemia	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	6	pobj	_	_
12	of	_	IN	IN	_	5	prep	_	_
13	two	_	CD	CD	_	17	num	_	_
14	DNA	_	NN	NN	_	15	nn	_	_
15	topoisomerase	_	NN	NN	_	17	nn	_	_
16	II	_	CD	CD	_	15	num	_	_
17	inhibitors	_	NNS	NNS	_	12	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	namely	_	RB	RB	_	22	advmod	_	_
20	the	_	DT	DT	_	22	det	_	_
21	epipodophyllotoxin	_	NN	NN	_	22	nn	_	_
22	etoposide	_	NN	NN	_	17	appos	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	the	_	DT	DT	_	26	det	_	_
25	bisdioxopiperazine	_	NN	NN	_	26	nn	_	_
26	ICRF-193	_	NN	NN	_	22	conj	_	_
27	.	_	.	.	_	3	punct	_	_

1	One	_	CD	CD	_	2	number	_	_
2	hour	_	NN	NN	_	3	amod	_	_
3	pulse-treatment	_	NN	NN	_	8	nsubj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	3	_	CD	CD	_	6	number	_	_
6	microM	_	NN	NN	_	7	amod	_	_
7	etoposide	_	NN	NN	_	4	pobj	_	_
8	caused	_	VBD	VBD	_	0	root	_	_
9	topoisomerase	_	NN	NN	_	10	npadvmod	_	_
10	associated	_	JJ	JJ	_	14	amod	_	_
11	,	_	,	,	_	10	punct	_	_
12	primary	_	JJ	JJ	_	10	dep	_	_
13	DNA	_	NN	NN	_	14	nn	_	_
14	breakage	_	NN	NN	_	8	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	which	_	WDT	WDT	_	19	nsubjpass	_	_
17	was	_	VBD	VBD	_	19	auxpass	_	_
18	rapidly	_	RB	RB	_	19	advmod	_	_
19	followed	_	VBN	VBN	_	14	rcmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	apoptosis	_	NN	NN	_	20	pobj	_	_
22	.	_	.	.	_	8	punct	_	_

1	By	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	effects	_	NNS	NNS	_	8	nsubjpass	_	_
6	were	_	VBD	VBD	_	8	auxpass	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	upon	_	IN	IN	_	8	prep	_	_
10	pulse-treatment	_	NN	NN	_	9	pobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	6	_	CD	CD	_	13	number	_	_
13	microM	_	NN	NN	_	14	amod	_	_
14	ICRF-193	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	However	_	RB	RB	_	20	advmod	_	_
2	,	_	,	,	_	20	punct	_	_
3	continuous	_	JJ	JJ	_	4	amod	_	_
4	treatments	_	NNS	NNS	_	20	nsubj	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	subcytotoxic	_	JJ	JJ	_	7	amod	_	_
7	concentrations	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	etoposide	_	NN	NN	_	8	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	0.15	_	CD	CD	_	12	num	_	_
12	microM	_	NN	NN	_	9	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	and	_	CC	CC	_	9	cc	_	_
15	ICRF-193	_	NN	NN	_	9	conj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
17	0.3	_	CD	CD	_	18	num	_	_
18	microM	_	NN	NN	_	15	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	produced	_	VBD	VBD	_	0	root	_	_
21	several	_	JJ	JJ	_	22	amod	_	_
22	similar	_	JJ	JJ	_	23	amod	_	_
23	effects	_	NNS	NNS	_	20	dobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	namely	_	RB	RB	_	28	advmod	_	_
26	decreased	_	VBN	VBN	_	28	amod	_	_
27	cell	_	NN	NN	_	28	nn	_	_
28	proliferation	_	NN	NN	_	23	appos	_	_
29	,	_	,	,	_	28	punct	_	_
30	accumulation	_	NN	NN	_	28	conj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	cells	_	NNS	NNS	_	31	pobj	_	_
33	at	_	IN	IN	_	30	prep	_	_
34	G2	_	NN	NN	_	33	pobj	_	_
35	,	_	,	,	_	28	punct	_	_
36	increase	_	NN	NN	_	28	conj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	mass	_	NN	NN	_	37	pobj	_	_
40	,	_	,	,	_	28	punct	_	_
41	and	_	CC	CC	_	28	cc	_	_
42	induction	_	NN	NN	_	28	conj	_	_
43	of	_	IN	IN	_	42	prep	_	_
44	differentiation	_	NN	NN	_	43	pobj	_	_
45	.	_	.	.	_	20	punct	_	_

1	Under	_	IN	IN	_	6	prep	_	_
2	these	_	DT	DT	_	3	det	_	_
3	conditions	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	etoposide	_	NN	NN	_	6	nsubj	_	_
6	produced	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	biphasic	_	JJ	JJ	_	9	amod	_	_
9	activation	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	protein	_	NN	NN	_	13	nn	_	_
12	kinase	_	NN	NN	_	13	nn	_	_
13	C	_	NN	NN	_	10	pobj	_	_
14	,	_	,	,	_	9	punct	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	consisted	_	VBD	VBD	_	9	rcmod	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	an	_	DT	DT	_	21	det	_	_
19	early	_	JJ	JJ	_	21	amod	_	_
20	transient	_	JJ	JJ	_	19	dep	_	_
21	activation	_	NN	NN	_	17	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	from	_	IN	IN	_	21	prep	_	_
24	hours	_	NNS	NNS	_	23	pobj	_	_
25	1	_	CD	CD	_	27	number	_	_
26	to	_	TO	TO	_	27	dep	_	_
27	6	_	CD	CD	_	24	num	_	_
28	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
29	of	_	IN	IN	_	21	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	membrane-bound	_	JJ	JJ	_	32	amod	_	_
32	enzyme	_	NN	NN	_	29	pobj	_	_
33	followed	_	VBN	VBN	_	21	vmod	_	_
34	by	_	IN	IN	_	33	prep	_	_
35	a	_	DT	DT	_	37	det	_	_
36	later	_	JJ	JJ	_	37	amod	_	_
37	activation	_	NN	NN	_	34	pobj	_	_
38	-LRB-	_	-LRB-	-LRB-	_	39	punct	_	_
39	hour	_	NN	NN	_	37	appos	_	_
40	48	_	CD	CD	_	39	num	_	_
41	-RRB-	_	-RRB-	-RRB-	_	39	punct	_	_
42	of	_	IN	IN	_	37	prep	_	_
43	the	_	DT	DT	_	46	dep	_	_
44	total	_	JJ	JJ	_	46	amod	_	_
45	,	_	,	,	_	46	punct	_	_
46	membrane-bound	_	JJ	JJ	_	42	pobj	_	_
47	and	_	CC	CC	_	46	cc	_	_
48	cytosolic	_	JJ	JJ	_	46	conj	_	_
49	enzyme	_	NN	NN	_	46	dep	_	_
50	.	_	.	.	_	6	punct	_	_

1	By	_	IN	IN	_	6	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	ICRF-193	_	NN	NN	_	6	nsubj	_	_
5	only	_	RB	RB	_	6	advmod	_	_
6	provoked	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	late	_	JJ	JJ	_	9	amod	_	_
9	activation	_	NN	NN	_	6	dobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	from	_	IN	IN	_	9	prep	_	_
12	hours	_	NNS	NNS	_	11	pobj	_	_
13	72	_	CD	CD	_	15	number	_	_
14	to	_	TO	TO	_	15	dep	_	_
15	96	_	CD	CD	_	12	num	_	_
16	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
17	of	_	IN	IN	_	9	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	total	_	JJ	JJ	_	20	amod	_	_
20	enzyme	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	When	_	WRB	WRB	_	2	advmod	_	_
2	used	_	VBN	VBN	_	10	advcl	_	_
3	at	_	IN	IN	_	2	prep	_	_
4	differentiation-inducing	_	JJ	JJ	_	5	amod	_	_
5	concentrations	_	NNS	NNS	_	3	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	both	_	DT	DT	_	9	det	_	_
8	topoisomerase	_	NN	NN	_	9	nn	_	_
9	inhibitors	_	NNS	NNS	_	10	nsubj	_	_
10	caused	_	VBD	VBD	_	0	root	_	_
11	a	_	DT	DT	_	13	det	_	_
12	great	_	JJ	JJ	_	13	amod	_	_
13	stimulation	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	AP-1	_	NN	NN	_	17	nn	_	_
16	binding	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	13	punct	_	_
19	with	_	IN	IN	_	13	prep	_	_
20	maximum	_	JJ	JJ	_	21	amod	_	_
21	value	_	NN	NN	_	19	pobj	_	_
22	at	_	IN	IN	_	21	prep	_	_
23	hour	_	NN	NN	_	22	pobj	_	_
24	12	_	CD	CD	_	23	num	_	_
25	in	_	IN	IN	_	22	dep	_	_
26	etoposide-treated	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	and	_	CC	CC	_	22	cc	_	_
29	at	_	IN	IN	_	22	conj	_	_
30	hour	_	NN	NN	_	29	pobj	_	_
31	48	_	CD	CD	_	30	num	_	_
32	in	_	IN	IN	_	22	dep	_	_
33	ICRF-193-treated	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	10	punct	_	_

1	By	_	IN	IN	_	19	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	19	punct	_	_
4	the	_	DT	DT	_	6	det	_	_
5	binding	_	NN	NN	_	6	nn	_	_
6	activity	_	NN	NN	_	19	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	NF-kappa	_	NN	NN	_	11	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	B	_	NN	NN	_	7	pobj	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	EGR-1	_	NN	NN	_	11	conj	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factors	_	NNS	NNS	_	11	dep	_	_
17	was	_	VBD	VBD	_	19	auxpass	_	_
18	little	_	RB	RB	_	19	advmod	_	_
19	affected	_	VBN	VBN	_	0	root	_	_
20	.	_	.	.	_	19	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	concluded	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	topoisomerase	_	NN	NN	_	7	nn	_	_
6	II	_	CD	CD	_	7	num	_	_
7	inhibitors	_	NNS	NNS	_	9	nsubj	_	_
8	may	_	MD	MD	_	9	aux	_	_
9	induce	_	VB	VB	_	3	ccomp	_	_
10	the	_	DT	DT	_	11	det	_	_
11	differentiation	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	promonocytic	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	9	punct	_	_
16	independently	_	RB	RB	_	9	advmod	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	their	_	PRP$	PRP$	_	19	poss	_	_
19	capacity	_	NN	NN	_	17	pobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	cause	_	VB	VB	_	19	vmod	_	_
22	DNA	_	NN	NN	_	24	nn	_	_
23	strand	_	NN	NN	_	24	nn	_	_
24	breaks	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	there	_	EX	EX	_	4	expl	_	_
4	are	_	VBP	VBP	_	0	root	_	_
5	other	_	JJ	JJ	_	6	amod	_	_
6	effects	_	NNS	NNS	_	4	nsubj	_	_
7	,	_	,	,	_	6	punct	_	_
8	such	_	JJ	JJ	_	9	mwe	_	_
9	as	_	IN	IN	_	6	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	early	_	JJ	JJ	_	12	amod	_	_
12	activation	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	protein	_	NN	NN	_	16	nn	_	_
15	kinase	_	NN	NN	_	16	nn	_	_
16	C	_	NN	NN	_	13	pobj	_	_
17	,	_	,	,	_	6	punct	_	_
18	which	_	WDT	WDT	_	21	nsubjpass	_	_
19	are	_	VBP	VBP	_	21	auxpass	_	_
20	probably	_	RB	RB	_	21	advmod	_	_
21	derived	_	VBN	VBN	_	6	rcmod	_	_
22	from	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	production	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	primary	_	JJ	JJ	_	28	amod	_	_
27	DNA	_	NN	NN	_	28	nn	_	_
28	breakage	_	NN	NN	_	25	pobj	_	_
29	by	_	IN	IN	_	24	prep	_	_
30	some	_	DT	DT	_	32	det	_	_
31	anti-topoisomerase	_	JJ	JJ	_	32	amod	_	_
32	drugs	_	NNS	NNS	_	29	pobj	_	_
33	.	_	.	.	_	4	punct	_	_

1	Nuclear	_	JJ	JJ	_	2	amod	_	_
2	Rel-A	_	NN	NN	_	9	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	c-Rel	_	NN	NN	_	2	conj	_	_
5	protein	_	NN	NN	_	6	nn	_	_
6	complexes	_	NNS	NNS	_	2	dep	_	_
7	are	_	VBP	VBP	_	9	auxpass	_	_
8	differentially	_	RB	RB	_	9	advmod	_	_
9	distributed	_	VBN	VBN	_	0	root	_	_
10	within	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	thymocytes	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	Nuclear	_	JJ	JJ	_	9	amod	_	_
2	factor-kappa	_	NN	NN	_	9	nn	_	_
3	B	_	NN	NN	_	9	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
5	NF-kappa	_	NN	NN	_	9	nn	_	_
6	B	_	NN	NN	_	9	nn	_	_
7	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
8	/Rel	_	NN	NN	_	9	nn	_	_
9	proteins	_	NNS	NNS	_	13	nsubj	_	_
10	are	_	VBP	VBP	_	13	cop	_	_
11	inducible	_	JJ	JJ	_	13	amod	_	_
12	transcriptional	_	JJ	JJ	_	13	amod	_	_
13	regulators	_	NNS	NNS	_	0	root	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	numerous	_	JJ	JJ	_	17	amod	_	_
16	cellular	_	JJ	JJ	_	17	amod	_	_
17	genes	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	13	punct	_	_

1	They	_	PRP	PRP	_	4	nsubj	_	_
2	are	_	VBP	VBP	_	4	cop	_	_
3	particularly	_	RB	RB	_	4	advmod	_	_
4	abundant	_	JJ	JJ	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	lymphoid	_	JJ	JJ	_	7	amod	_	_
7	tissues	_	NNS	NNS	_	5	pobj	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	are	_	VBP	VBP	_	10	auxpass	_	_
10	thought	_	VBN	VBN	_	4	conj	_	_
11	to	_	TO	TO	_	13	aux	_	_
12	be	_	VB	VB	_	13	cop	_	_
13	critical	_	JJ	JJ	_	10	xcomp	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	transcription	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	genes	_	NNS	NNS	_	17	pobj	_	_
19	involved	_	VBN	VBN	_	18	vmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	immune	_	JJ	JJ	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	inflammatory	_	JJ	JJ	_	21	conj	_	_
24	responses	_	NNS	NNS	_	21	dep	_	_
25	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	reported	_	VBN	VBN	_	0	root	_	_
4	previously	_	RB	RB	_	3	advmod	_	_
5	that	_	IN	IN	_	12	mark	_	_
6	a	_	DT	DT	_	10	det	_	_
7	nuclear	_	JJ	JJ	_	10	amod	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	12	nsubj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	present	_	JJ	JJ	_	3	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	freshly	_	RB	RB	_	15	advmod	_	_
15	extracted	_	VBN	VBN	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	thymocytes	_	NNS	NNS	_	13	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	absence	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	in	_	FW	FW	_	24	amod	_	_
23	vitro	_	FW	FW	_	22	dep	_	_
24	treatment	_	NN	NN	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	these	_	DT	DT	_	27	det	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	report	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	identified	_	VBD	VBD	_	0	root	_	_
8	NF-kappa	_	NN	NN	_	10	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	proteins	_	NNS	NNS	_	7	dobj	_	_
11	extracted	_	VBN	VBN	_	10	vmod	_	_
12	from	_	IN	IN	_	11	prep	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	thymocyte	_	NN	NN	_	15	nn	_	_
15	nuclei	_	NNS	NNS	_	12	pobj	_	_
16	as	_	IN	IN	_	7	prep	_	_
17	being	_	VBG	VBG	_	18	cop	_	_
18	p50/p65	_	NN	NN	_	16	pcomp	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	p50/c-Rel	_	NN	NN	_	18	conj	_	_
21	complexes	_	NNS	NNS	_	18	dep	_	_
22	.	_	.	.	_	7	punct	_	_

1	Immunochemical	_	JJ	JJ	_	11	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	immunofluorescent	_	JJ	JJ	_	1	conj	_	_
4	staining	_	NN	NN	_	1	dep	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	thymus	_	NN	NN	_	7	nn	_	_
7	sections	_	NNS	NNS	_	5	pobj	_	_
8	using	_	VBG	VBG	_	4	vmod	_	_
9	specific	_	JJ	JJ	_	10	amod	_	_
10	Abs	_	NNS	NNS	_	8	dobj	_	_
11	allowed	_	VBD	VBD	_	0	root	_	_
12	visualization	_	NN	NN	_	11	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	nuclear	_	JJ	JJ	_	17	amod	_	_
15	NF-kappa	_	NN	NN	_	17	nn	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	proteins	_	NNS	NNS	_	13	pobj	_	_
18	in	_	IN	IN	_	12	prep	_	_
19	both	_	CC	CC	_	20	preconj	_	_
20	thymocytes	_	NNS	NNS	_	18	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	nonthymocyte	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	20	conj	_	_
24	.	_	.	.	_	11	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	detection	_	NN	NN	_	3	nsubj	_	_
3	suggested	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	preferential	_	JJ	JJ	_	6	amod	_	_
6	activation	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	p50/c-Rel	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	6	prep	_	_
10	medullary	_	JJ	JJ	_	11	amod	_	_
11	thymocytes	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	3	punct	_	_
13	whereas	_	IN	IN	_	16	mark	_	_
14	p50/p65	_	NN	NN	_	16	nsubj	_	_
15	was	_	VBD	VBD	_	16	cop	_	_
16	present	_	JJ	JJ	_	3	advcl	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	both	_	CC	CC	_	19	preconj	_	_
19	cortical	_	JJ	JJ	_	17	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	medullary	_	JJ	JJ	_	19	conj	_	_
22	regions	_	NNS	NNS	_	19	dep	_	_
23	of	_	IN	IN	_	19	prep	_	_
24	human	_	JJ	JJ	_	26	amod	_	_
25	thymus	_	NN	NN	_	26	nn	_	_
26	lobules	_	NNS	NNS	_	23	pobj	_	_
27	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	intensity	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	p65	_	NN	NN	_	7	nn	_	_
7	labeling	_	NN	NN	_	5	pobj	_	_
8	was	_	VBD	VBD	_	10	cop	_	_
9	much	_	RB	RB	_	10	advmod	_	_
10	higher	_	JJR	JJR	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	several	_	JJ	JJ	_	13	amod	_	_
13	thymocytes	_	NNS	NNS	_	11	pobj	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	medulla	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	10	punct	_	_

1	p65	_	NN	NN	_	9	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	p50	_	NN	NN	_	1	conj	_	_
4	,	_	,	,	_	1	punct	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	c-Rel	_	NN	NN	_	1	conj	_	_
7	activities	_	NNS	NNS	_	1	dep	_	_
8	were	_	VBD	VBD	_	9	auxpass	_	_
9	found	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	CD4-	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	CD8-positive	_	JJ	JJ	_	12	conj	_	_
15	thymocytes	_	NNS	NNS	_	12	dep	_	_
16	.	_	.	.	_	9	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	p65	_	NN	NN	_	9	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	c-Rel	_	NN	NN	_	5	conj	_	_
8	complexes	_	NNS	NNS	_	5	dep	_	_
9	play	_	VBP	VBP	_	3	ccomp	_	_
10	distinct	_	JJ	JJ	_	11	amod	_	_
11	roles	_	NNS	NNS	_	9	dobj	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	that	_	IN	IN	_	22	mark	_	_
17	both	_	DT	DT	_	18	det	_	_
18	forms	_	NNS	NNS	_	22	nsubj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	NF-kappa	_	NN	NN	_	21	nn	_	_
21	B	_	NN	NN	_	19	pobj	_	_
22	play	_	VBP	VBP	_	9	conj	_	_
23	critical	_	JJ	JJ	_	24	amod	_	_
24	roles	_	NNS	NNS	_	22	dobj	_	_
25	during	_	IN	IN	_	22	prep	_	_
26	late	_	JJ	JJ	_	27	amod	_	_
27	stages	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	intrathymic	_	JJ	JJ	_	31	amod	_	_
31	maturation	_	NN	NN	_	28	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	T	_	NN	NN	_	34	nn	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	Alteration	_	NN	NN	_	16	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	5	det	_	_
4	single	_	JJ	JJ	_	5	amod	_	_
5	serine	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	basic	_	JJ	JJ	_	9	amod	_	_
9	domain	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	Epstein-Barr	_	JJ	JJ	_	15	amod	_	_
13	virus	_	NN	NN	_	15	nn	_	_
14	ZEBRA	_	NN	NN	_	15	nn	_	_
15	protein	_	NN	NN	_	10	pobj	_	_
16	separates	_	VBZ	VBZ	_	0	root	_	_
17	its	_	PRP$	PRP$	_	18	poss	_	_
18	functions	_	NNS	NNS	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	transcriptional	_	JJ	JJ	_	21	amod	_	_
21	activation	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	disruption	_	NN	NN	_	21	conj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	latency	_	NN	NN	_	24	pobj	_	_
26	.	_	.	.	_	16	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	ZEBRA	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	10	nsubj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	Epstein-Barr	_	JJ	JJ	_	6	amod	_	_
6	virus	_	NN	NN	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	EBV	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	activates	_	VBZ	VBZ	_	0	root	_	_
11	a	_	DT	DT	_	12	det	_	_
12	switch	_	NN	NN	_	10	dobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	latent	_	JJ	JJ	_	13	pobj	_	_
16	to	_	TO	TO	_	12	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	lytic	_	JJ	JJ	_	20	amod	_	_
19	expression	_	NN	NN	_	20	nn	_	_
20	program	_	NN	NN	_	16	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	virus	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	10	punct	_	_

1	ZEBRA	_	NN	NN	_	16	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	4	det	_	_
4	member	_	NN	NN	_	1	appos	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	bZIP	_	NN	NN	_	8	nn	_	_
8	family	_	NN	NN	_	5	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	DNA-binding	_	JJ	JJ	_	11	amod	_	_
11	proteins	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	1	punct	_	_
13	is	_	VBZ	VBZ	_	16	cop	_	_
14	a	_	DT	DT	_	16	det	_	_
15	transcriptional	_	JJ	JJ	_	16	amod	_	_
16	activator	_	NN	NN	_	0	root	_	_
17	capable	_	JJ	JJ	_	16	amod	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	inducing	_	VBG	VBG	_	18	pcomp	_	_
20	expression	_	NN	NN	_	19	dobj	_	_
21	from	_	IN	IN	_	19	prep	_	_
22	viral	_	JJ	JJ	_	25	amod	_	_
23	lytic	_	JJ	JJ	_	25	amod	_	_
24	cycle	_	NN	NN	_	25	nn	_	_
25	promoters	_	NNS	NNS	_	21	pobj	_	_
26	.	_	.	.	_	16	punct	_	_

1	It	_	PRP	PRP	_	5	nsubjpass	_	_
2	had	_	VBD	VBD	_	5	aux	_	_
3	previously	_	RB	RB	_	5	advmod	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	thought	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	14	mark	_	_
7	ZEBRA	_	NN	NN	_	9	poss	_	_
8	's	_	POS	POS	_	7	possessive	_	_
9	capacity	_	NN	NN	_	14	nsubj	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	disrupt	_	VB	VB	_	9	vmod	_	_
12	EBV	_	NN	NN	_	13	nn	_	_
13	latency	_	NN	NN	_	11	dobj	_	_
14	resided	_	VBD	VBD	_	5	ccomp	_	_
15	primarily	_	RB	RB	_	16	advmod	_	_
16	in	_	IN	IN	_	14	prep	_	_
17	its	_	PRP$	PRP$	_	18	poss	_	_
18	ability	_	NN	NN	_	16	pobj	_	_
19	to	_	TO	TO	_	20	aux	_	_
20	activate	_	VB	VB	_	18	vmod	_	_
21	transcription	_	NN	NN	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	genes	_	NNS	NNS	_	22	pobj	_	_
24	that	_	WDT	WDT	_	25	nsubj	_	_
25	encode	_	VBP	VBP	_	23	rcmod	_	_
26	products	_	NNS	NNS	_	25	dobj	_	_
27	required	_	VBN	VBN	_	26	vmod	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	lytic	_	JJ	JJ	_	30	amod	_	_
30	replication	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	generated	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	point	_	NN	NN	_	5	nn	_	_
5	mutant	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	ZEBRA	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	5	punct	_	_
9	Z	_	NN	NN	_	11	nn	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	S186A	_	NN	NN	_	5	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	,	_	,	,	_	5	punct	_	_
14	that	_	WDT	WDT	_	17	nsubj	_	_
15	was	_	VBD	VBD	_	17	cop	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	impaired	_	JJ	JJ	_	5	rcmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	its	_	PRP$	PRP$	_	20	poss	_	_
20	ability	_	NN	NN	_	18	pobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	activate	_	VB	VB	_	20	vmod	_	_
23	transcription	_	NN	NN	_	22	dobj	_	_
24	;	_	:	:	_	2	punct	_	_
25	however	_	RB	RB	_	29	advmod	_	_
26	,	_	,	,	_	29	punct	_	_
27	this	_	DT	DT	_	28	det	_	_
28	mutation	_	NN	NN	_	29	nsubj	_	_
29	abolished	_	VBD	VBD	_	2	parataxis	_	_
30	its	_	PRP$	PRP$	_	31	poss	_	_
31	ability	_	NN	NN	_	29	dobj	_	_
32	to	_	TO	TO	_	33	aux	_	_
33	initiate	_	VB	VB	_	31	vmod	_	_
34	the	_	DT	DT	_	37	det	_	_
35	viral	_	JJ	JJ	_	37	amod	_	_
36	lytic	_	JJ	JJ	_	35	dep	_	_
37	cascade	_	NN	NN	_	33	dobj	_	_
38	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	mutant	_	NN	NN	_	16	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	containing	_	VBG	VBG	_	2	vmod	_	_
5	a	_	DT	DT	_	7	det	_	_
6	serine-to-alanine	_	JJ	JJ	_	7	amod	_	_
7	substitution	_	NN	NN	_	4	dobj	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	DNA-binding	_	JJ	JJ	_	11	amod	_	_
11	domain	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	protein	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	bound	_	VBD	VBD	_	0	root	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	several	_	JJ	JJ	_	21	amod	_	_
19	known	_	JJ	JJ	_	21	amod	_	_
20	ZEBRA-binding	_	JJ	JJ	_	21	amod	_	_
21	sites	_	NNS	NNS	_	17	pobj	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	activated	_	VBD	VBD	_	16	conj	_	_
24	transcription	_	NN	NN	_	23	dobj	_	_
25	from	_	IN	IN	_	23	prep	_	_
26	reporters	_	NNS	NNS	_	25	pobj	_	_
27	bearing	_	VBG	VBG	_	26	vmod	_	_
28	known	_	JJ	JJ	_	30	amod	_	_
29	ZEBRA-responsive	_	JJ	JJ	_	30	amod	_	_
30	promoters	_	NNS	NNS	_	27	dobj	_	_
31	but	_	CC	CC	_	16	cc	_	_
32	did	_	VBD	VBD	_	34	aux	_	_
33	not	_	RB	RB	_	34	neg	_	_
34	disrupt	_	VB	VB	_	16	conj	_	_
35	latency	_	NN	NN	_	34	dobj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	EBV-infected	_	JJ	JJ	_	39	amod	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	lines	_	NNS	NNS	_	36	pobj	_	_
40	.	_	.	.	_	16	punct	_	_

1	Therefore	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	initiation	_	NN	NN	_	13	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	8	det	_	_
6	EBV	_	NN	NN	_	8	nn	_	_
7	lytic	_	JJ	JJ	_	8	amod	_	_
8	cycle	_	NN	NN	_	4	pobj	_	_
9	by	_	IN	IN	_	3	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	ZEBRA	_	NN	NN	_	12	nn	_	_
12	protein	_	NN	NN	_	9	pobj	_	_
13	requires	_	VBZ	VBZ	_	0	root	_	_
14	a	_	DT	DT	_	15	det	_	_
15	function	_	NN	NN	_	13	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	addition	_	NN	NN	_	16	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	transcriptional	_	JJ	JJ	_	20	amod	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	;	_	:	:	_	13	punct	_	_
22	a	_	DT	DT	_	23	det	_	_
23	change	_	NN	NN	_	35	nsubj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	serine	_	NN	NN	_	24	pobj	_	_
26	186	_	CD	CD	_	25	num	_	_
27	to	_	TO	TO	_	23	prep	_	_
28	alanine	_	NN	NN	_	27	pobj	_	_
29	in	_	IN	IN	_	23	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	DNA-binding	_	JJ	JJ	_	32	amod	_	_
32	domain	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	ZEBRA	_	NN	NN	_	33	pobj	_	_
35	abolished	_	VBD	VBD	_	13	parataxis	_	_
36	this	_	DT	DT	_	38	det	_	_
37	additional	_	JJ	JJ	_	38	amod	_	_
38	function	_	NN	NN	_	35	dobj	_	_
39	and	_	CC	CC	_	35	cc	_	_
40	uncovered	_	VBD	VBD	_	35	conj	_	_
41	a	_	DT	DT	_	43	det	_	_
42	new	_	JJ	JJ	_	43	amod	_	_
43	role	_	NN	NN	_	40	dobj	_	_
44	for	_	IN	IN	_	43	prep	_	_
45	the	_	DT	DT	_	47	det	_	_
46	ZEBRA	_	NN	NN	_	47	nn	_	_
47	protein	_	NN	NN	_	44	pobj	_	_
48	in	_	IN	IN	_	40	prep	_	_
49	disruption	_	NN	NN	_	48	pobj	_	_
50	of	_	IN	IN	_	49	prep	_	_
51	EBV	_	NN	NN	_	52	nn	_	_
52	latency	_	NN	NN	_	50	pobj	_	_
53	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	additional	_	JJ	JJ	_	3	amod	_	_
3	function	_	NN	NN	_	16	nsubj	_	_
4	that	_	WDT	WDT	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	required	_	VBN	VBN	_	3	rcmod	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	initiation	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	14	det	_	_
11	lytic	_	JJ	JJ	_	14	amod	_	_
12	viral	_	JJ	JJ	_	11	dep	_	_
13	life	_	NN	NN	_	14	nn	_	_
14	cycle	_	NN	NN	_	9	pobj	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	likely	_	JJ	JJ	_	0	root	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	require	_	VB	VB	_	16	xcomp	_	_
19	phosphorylation	_	NN	NN	_	18	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	serine	_	NN	NN	_	20	pobj	_	_
22	186	_	CD	CD	_	21	num	_	_
23	of	_	IN	IN	_	21	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	ZEBRA	_	NN	NN	_	26	nn	_	_
26	protein	_	NN	NN	_	23	pobj	_	_
27	,	_	,	,	_	19	punct	_	_
28	which	_	WDT	WDT	_	30	nsubj	_	_
29	may	_	MD	MD	_	30	aux	_	_
30	influence	_	VB	VB	_	19	rcmod	_	_
31	either	_	CC	CC	_	33	preconj	_	_
32	DNA	_	NN	NN	_	33	nn	_	_
33	recognition	_	NN	NN	_	30	dobj	_	_
34	or	_	CC	CC	_	33	cc	_	_
35	transcriptional	_	JJ	JJ	_	36	amod	_	_
36	activation	_	NN	NN	_	33	conj	_	_
37	of	_	IN	IN	_	33	prep	_	_
38	lytic	_	JJ	JJ	_	40	amod	_	_
39	viral	_	JJ	JJ	_	40	amod	_	_
40	promoters	_	NNS	NNS	_	37	pobj	_	_
41	in	_	IN	IN	_	33	prep	_	_
42	a	_	DT	DT	_	45	det	_	_
43	chromatinized	_	VBN	VBN	_	45	amod	_	_
44	viral	_	JJ	JJ	_	45	amod	_	_
45	episome	_	NN	NN	_	41	pobj	_	_
46	.	_	.	.	_	16	punct	_	_

1	Redox	_	NN	NN	_	2	nn	_	_
2	regulation	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	8	det	_	_
5	mitogen-activated	_	JJ	JJ	_	7	amod	_	_
6	protein	_	NN	NN	_	7	nn	_	_
7	kinase	_	NN	NN	_	8	nn	_	_
8	pathway	_	NN	NN	_	3	pobj	_	_
9	during	_	IN	IN	_	2	prep	_	_
10	lymphocyte	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	an	_	DT	DT	_	7	det	_	_
6	obligatory	_	JJ	JJ	_	7	amod	_	_
7	requirement	_	NN	NN	_	4	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	intracellular	_	JJ	JJ	_	10	amod	_	_
10	reactive	_	JJ	JJ	_	13	amod	_	_
11	oxygen	_	NN	NN	_	13	nn	_	_
12	species	_	NNS	NNS	_	13	nn	_	_
13	generation	_	NN	NN	_	8	pobj	_	_
14	during	_	IN	IN	_	13	prep	_	_
15	T	_	NN	NN	_	17	nn	_	_
16	lymphocyte	_	NN	NN	_	17	nn	_	_
17	activation	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	4	punct	_	_
19	and	_	CC	CC	_	4	cc	_	_
20	have	_	VBP	VBP	_	21	aux	_	_
21	proposed	_	VBN	VBN	_	4	conj	_	_
22	that	_	IN	IN	_	28	mark	_	_
23	intracellular	_	JJ	JJ	_	24	amod	_	_
24	reactive	_	JJ	JJ	_	26	amod	_	_
25	oxygen	_	NN	NN	_	26	nn	_	_
26	species	_	NNS	NNS	_	28	nsubj	_	_
27	may	_	MD	MD	_	28	aux	_	_
28	act	_	VB	VB	_	21	ccomp	_	_
29	as	_	IN	IN	_	28	prep	_	_
30	signalling	_	NN	NN	_	31	nn	_	_
31	agents	_	NNS	NNS	_	29	pobj	_	_
32	in	_	IN	IN	_	28	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	regulation	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	certain	_	JJ	JJ	_	37	amod	_	_
37	cellular	_	JJ	JJ	_	38	amod	_	_
38	processes	_	NNS	NNS	_	35	pobj	_	_
39	,	_	,	,	_	38	punct	_	_
40	for	_	IN	IN	_	38	prep	_	_
41	example	_	NN	NN	_	40	pobj	_	_
42	,	_	,	,	_	38	punct	_	_
43	during	_	IN	IN	_	38	prep	_	_
44	cell	_	NN	NN	_	46	nn	_	_
45	cycle	_	NN	NN	_	46	nn	_	_
46	entry	_	NN	NN	_	43	pobj	_	_
47	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	test	_	VB	VB	_	0	root	_	_
3	this	_	DT	DT	_	4	det	_	_
4	hypothesis	_	NN	NN	_	2	dobj	_	_
5	,	_	,	,	_	2	punct	_	_
6	we	_	PRP	PRP	_	9	nsubjpass	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	interested	_	VBN	VBN	_	2	parataxis	_	_
10	to	_	TO	TO	_	11	aux	_	_
11	determine	_	VB	VB	_	9	xcomp	_	_
12	which	_	WP	WP	_	22	nsubjpass	_	_
13	,	_	,	,	_	22	punct	_	_
14	if	_	IN	IN	_	15	mark	_	_
15	any	_	DT	DT	_	22	dep	_	_
16	,	_	,	,	_	22	punct	_	_
17	cell	_	NN	NN	_	20	nn	_	_
18	cycle	_	NN	NN	_	20	nn	_	_
19	entry	_	NN	NN	_	20	nn	_	_
20	events	_	NNS	NNS	_	22	dep	_	_
21	are	_	VBP	VBP	_	22	auxpass	_	_
22	affected	_	VBN	VBN	_	11	advcl	_	_
23	by	_	IN	IN	_	22	prep	_	_
24	oxidative	_	JJ	JJ	_	25	amod	_	_
25	signalling	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	earlier	_	JJR	JJR	_	3	amod	_	_
3	studies	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	have	_	VBP	VBP	_	7	aux	_	_
7	identified	_	VBN	VBN	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	transcription	_	NN	NN	_	10	nn	_	_
10	factors	_	NNS	NNS	_	7	dobj	_	_
11	NF-kappa	_	NN	NN	_	12	nn	_	_
12	B	_	NN	NN	_	10	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	AP-1	_	NN	NN	_	12	conj	_	_
15	as	_	IN	IN	_	7	prep	_	_
16	molecular	_	JJ	JJ	_	17	amod	_	_
17	targets	_	NNS	NNS	_	15	pobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	oxidative	_	JJ	JJ	_	21	amod	_	_
20	signalling	_	NN	NN	_	21	nn	_	_
21	processes	_	NNS	NNS	_	18	pobj	_	_
22	during	_	IN	IN	_	17	prep	_	_
23	cell	_	NN	NN	_	25	nn	_	_
24	cycle	_	NN	NN	_	25	nn	_	_
25	entry	_	NN	NN	_	22	pobj	_	_
26	,	_	,	,	_	7	punct	_	_
27	and	_	CC	CC	_	7	cc	_	_
28	have	_	VBP	VBP	_	29	aux	_	_
29	shown	_	VBN	VBN	_	7	conj	_	_
30	that	_	IN	IN	_	34	mark	_	_
31	oxidative	_	JJ	JJ	_	32	amod	_	_
32	signalling	_	NN	NN	_	34	nsubjpass	_	_
33	is	_	VBZ	VBZ	_	34	auxpass	_	_
34	involved	_	VBN	VBN	_	29	ccomp	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	37	det	_	_
37	regulation	_	NN	NN	_	35	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	early	_	JJ	JJ	_	40	amod	_	_
40	changes	_	NNS	NNS	_	38	pobj	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	gene	_	NN	NN	_	43	nn	_	_
43	expression	_	NN	NN	_	41	pobj	_	_
44	during	_	IN	IN	_	40	prep	_	_
45	the	_	DT	DT	_	50	det	_	_
46	G0	_	NN	NN	_	50	nn	_	_
47	to	_	TO	TO	_	46	prep	_	_
48	G1	_	NN	NN	_	47	pobj	_	_
49	phase	_	NN	NN	_	50	nn	_	_
50	transition	_	NN	NN	_	44	pobj	_	_
51	.	_	.	.	_	7	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	extend	_	VB	VB	_	0	root	_	_
3	these	_	DT	DT	_	5	det	_	_
4	initial	_	JJ	JJ	_	5	amod	_	_
5	observations	_	NNS	NNS	_	2	dobj	_	_
6	,	_	,	,	_	2	punct	_	_
7	we	_	PRP	PRP	_	9	nsubj	_	_
8	have	_	VBP	VBP	_	9	aux	_	_
9	examined	_	VBN	VBN	_	2	parataxis	_	_
10	the	_	DT	DT	_	11	det	_	_
11	effect	_	NN	NN	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	antioxidant	_	JJ	JJ	_	14	amod	_	_
14	treatment	_	NN	NN	_	12	pobj	_	_
15	on	_	IN	IN	_	11	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	activity	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	mitogen-activated	_	JJ	JJ	_	22	amod	_	_
21	protein	_	NN	NN	_	22	nn	_	_
22	kinases	_	NNS	NNS	_	18	pobj	_	_
23	erk1	_	NN	NN	_	22	dep	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	erk2	_	NN	NN	_	23	conj	_	_
26	,	_	,	,	_	9	punct	_	_
27	as	_	IN	IN	_	9	prep	_	_
28	members	_	NNS	NNS	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	a	_	DT	DT	_	33	det	_	_
31	signal	_	NN	NN	_	33	nn	_	_
32	transduction	_	NN	NN	_	33	nn	_	_
33	pathway	_	NN	NN	_	29	pobj	_	_
34	known	_	VBN	VBN	_	33	vmod	_	_
35	to	_	TO	TO	_	37	aux	_	_
36	directly	_	RB	RB	_	37	advmod	_	_
37	regulate	_	VB	VB	_	34	xcomp	_	_
38	transcription	_	NN	NN	_	40	nn	_	_
39	factor	_	NN	NN	_	40	nn	_	_
40	function	_	NN	NN	_	37	dobj	_	_
41	.	_	.	.	_	2	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	as	_	IN	IN	_	1	prep	_	_
3	a	_	DT	DT	_	4	det	_	_
4	probe	_	NN	NN	_	2	pobj	_	_
5	cysteamine	_	NN	NN	_	1	dobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	an	_	DT	DT	_	9	det	_	_
8	aminothiol	_	NN	NN	_	9	nn	_	_
9	compound	_	NN	NN	_	5	appos	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	antioxidant	_	JJ	JJ	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	antiproliferative	_	JJ	JJ	_	12	conj	_	_
15	activity	_	NN	NN	_	12	dep	_	_
16	,	_	,	,	_	1	punct	_	_
17	we	_	PRP	PRP	_	19	nsubj	_	_
18	have	_	VBP	VBP	_	19	aux	_	_
19	identified	_	VBN	VBN	_	1	parataxis	_	_
20	erk2	_	NN	NN	_	19	dobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	a	_	DT	DT	_	24	det	_	_
23	key	_	JJ	JJ	_	24	amod	_	_
24	element	_	NN	NN	_	20	appos	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	MAP	_	NN	NN	_	29	nn	_	_
28	kinase	_	NN	NN	_	29	nn	_	_
29	pathway	_	NN	NN	_	25	pobj	_	_
30	,	_	,	,	_	19	punct	_	_
31	as	_	IN	IN	_	19	prep	_	_
32	being	_	VBG	VBG	_	33	cop	_	_
33	responsive	_	JJ	JJ	_	31	pcomp	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	oxidative	_	JJ	JJ	_	36	amod	_	_
36	signalling	_	NN	NN	_	34	pobj	_	_
37	during	_	IN	IN	_	33	prep	_	_
38	lymphocyte	_	NN	NN	_	39	nn	_	_
39	activation	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	1	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	further	_	JJ	JJ	_	5	amod	_	_
5	evidence	_	NN	NN	_	3	dobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	suggest	_	VB	VB	_	5	vmod	_	_
8	a	_	DT	DT	_	9	det	_	_
9	role	_	NN	NN	_	7	dobj	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	intracellular	_	JJ	JJ	_	12	amod	_	_
12	oxidant	_	JJ	JJ	_	13	amod	_	_
13	generation	_	NN	NN	_	10	pobj	_	_
14	as	_	IN	IN	_	9	prep	_	_
15	a	_	DT	DT	_	17	det	_	_
16	regulatory	_	JJ	JJ	_	17	amod	_	_
17	mechanism	_	NN	NN	_	14	pobj	_	_
18	during	_	IN	IN	_	9	prep	_	_
19	cell	_	NN	NN	_	21	nn	_	_
20	cycle	_	NN	NN	_	21	nn	_	_
21	entry	_	NN	NN	_	18	pobj	_	_
22	,	_	,	,	_	3	punct	_	_
23	and	_	CC	CC	_	3	cc	_	_
24	establish	_	VBP	VBP	_	3	conj	_	_
25	a	_	DT	DT	_	26	det	_	_
26	link	_	NN	NN	_	24	dobj	_	_
27	between	_	IN	IN	_	26	prep	_	_
28	oxidative	_	JJ	JJ	_	29	amod	_	_
29	signalling	_	NN	NN	_	27	pobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	other	_	JJ	JJ	_	32	amod	_	_
32	aspects	_	NNS	NNS	_	29	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	37	det	_	_
35	intracellular	_	JJ	JJ	_	37	amod	_	_
36	signalling	_	NN	NN	_	37	nn	_	_
37	network	_	NN	NN	_	33	pobj	_	_
38	that	_	WDT	WDT	_	40	nsubjpass	_	_
39	is	_	VBZ	VBZ	_	40	auxpass	_	_
40	activated	_	VBN	VBN	_	37	rcmod	_	_
41	in	_	IN	IN	_	40	prep	_	_
42	response	_	NN	NN	_	41	pobj	_	_
43	to	_	TO	TO	_	42	prep	_	_
44	mitogenic	_	JJ	JJ	_	45	amod	_	_
45	stimulation	_	NN	NN	_	43	pobj	_	_
46	.	_	.	.	_	3	punct	_	_

1	Common	_	JJ	JJ	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	distinct	_	JJ	JJ	_	1	conj	_	_
4	intracellular	_	JJ	JJ	_	6	amod	_	_
5	signaling	_	NN	NN	_	6	nn	_	_
6	pathways	_	NNS	NNS	_	1	dep	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	neutrophils	_	NNS	NNS	_	7	pobj	_	_
10	utilized	_	VBN	VBN	_	1	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	platelet	_	NN	NN	_	14	nn	_	_
13	activating	_	NN	NN	_	14	nn	_	_
14	factor	_	NN	NN	_	11	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	FMLP	_	NN	NN	_	14	conj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Stimulation	_	NN	NN	_	15	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	human	_	JJ	JJ	_	4	amod	_	_
4	neutrophils	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	chemoattractants	_	NNS	NNS	_	5	pobj	_	_
7	FMLP	_	NN	NN	_	6	dep	_	_
8	or	_	CC	CC	_	7	cc	_	_
9	platelet	_	NN	NN	_	11	nn	_	_
10	activating	_	NN	NN	_	11	nn	_	_
11	factor	_	NN	NN	_	7	conj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	PAF	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	results	_	VBZ	VBZ	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	different	_	JJ	JJ	_	21	amod	_	_
18	but	_	CC	CC	_	17	cc	_	_
19	overlapping	_	VBG	VBG	_	17	conj	_	_
20	functional	_	JJ	JJ	_	21	amod	_	_
21	responses	_	NNS	NNS	_	16	pobj	_	_
22	.	_	.	.	_	15	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	questioned	_	VBD	VBD	_	0	root	_	_
3	whether	_	IN	IN	_	7	mark	_	_
4	these	_	DT	DT	_	5	det	_	_
5	differences	_	NNS	NNS	_	7	nsubj	_	_
6	might	_	MD	MD	_	7	aux	_	_
7	reflect	_	VB	VB	_	2	ccomp	_	_
8	patterns	_	NNS	NNS	_	7	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	intracellular	_	JJ	JJ	_	12	amod	_	_
11	signal	_	NN	NN	_	12	nn	_	_
12	transduction	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	2	punct	_	_

1	Stimulation	_	NN	NN	_	7	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	either	_	CC	CC	_	4	preconj	_	_
4	PAF	_	NN	NN	_	2	pobj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	FMLP	_	NN	NN	_	4	conj	_	_
7	resulted	_	VBD	VBD	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	equivalent	_	JJ	JJ	_	10	amod	_	_
10	phosphorylation	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	activation	_	NN	NN	_	10	conj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	21	det	_	_
15	mitogen-activated	_	JJ	JJ	_	21	amod	_	_
16	protein	_	NN	NN	_	21	nn	_	_
17	kinase	_	NN	NN	_	21	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	MAPk	_	NN	NN	_	21	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
21	homologue	_	NN	NN	_	13	pobj	_	_
22	38-kD	_	JJ	JJ	_	25	amod	_	_
23	murine	_	JJ	JJ	_	25	amod	_	_
24	MAP	_	NN	NN	_	25	nn	_	_
25	kinase	_	NN	NN	_	21	dep	_	_
26	homologous	_	JJ	JJ	_	25	amod	_	_
27	to	_	TO	TO	_	26	prep	_	_
28	HOG-1	_	NN	NN	_	32	nn	_	_
29	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
30	p38	_	NN	NN	_	32	nn	_	_
31	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
32	MAPk	_	NN	NN	_	27	pobj	_	_
33	.	_	.	.	_	7	punct	_	_

1	Neither	_	CC	CC	_	2	preconj	_	_
2	FMLP	_	NN	NN	_	5	nsubj	_	_
3	nor	_	CC	CC	_	2	cc	_	_
4	PAF	_	NN	NN	_	2	conj	_	_
5	activated	_	VBD	VBD	_	0	root	_	_
6	c-jun	_	NN	NN	_	8	nn	_	_
7	NH2-terminal	_	JJ	JJ	_	8	amod	_	_
8	MAPk	_	NN	NN	_	5	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	JNKs	_	NNS	NNS	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	.	_	.	.	_	5	punct	_	_

1	Under	_	IN	IN	_	10	prep	_	_
2	identical	_	JJ	JJ	_	3	amod	_	_
3	conditions	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	10	punct	_	_
5	FMLP	_	NN	NN	_	10	nsubj	_	_
6	but	_	CC	CC	_	7	cc	_	_
7	not	_	RB	RB	_	5	cc	_	_
8	PAF	_	NN	NN	_	5	conj	_	_
9	,	_	,	,	_	5	punct	_	_
10	resulted	_	VBD	VBD	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	significant	_	JJ	JJ	_	18	amod	_	_
13	p42/44	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	ERK	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	MAPk	_	NN	NN	_	18	nn	_	_
18	activation	_	NN	NN	_	11	pobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	FMLP	_	NN	NN	_	5	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	PAF	_	NN	NN	_	2	conj	_	_
5	activated	_	VBD	VBD	_	0	root	_	_
6	MAP	_	NN	NN	_	8	nn	_	_
7	kinase	_	NN	NN	_	8	nn	_	_
8	kinase-3	_	NN	NN	_	5	dobj	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	MKK3	_	NN	NN	_	8	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	,	_	,	,	_	8	punct	_	_
13	a	_	DT	DT	_	15	det	_	_
14	known	_	JJ	JJ	_	15	amod	_	_
15	activator	_	NN	NN	_	8	appos	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	p38	_	NN	NN	_	18	nn	_	_
18	MAPk	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	5	punct	_	_

1	Both	_	CC	CC	_	5	preconj	_	_
2	MAP	_	NN	NN	_	5	nn	_	_
3	ERK	_	NN	NN	_	5	nn	_	_
4	kinase	_	NN	NN	_	5	nn	_	_
5	kinase-1	_	NN	NN	_	12	nsubjpass	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	MEKK1	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	Raf	_	NN	NN	_	5	conj	_	_
11	are	_	VBP	VBP	_	12	auxpass	_	_
12	activated	_	VBN	VBN	_	0	root	_	_
13	strongly	_	RB	RB	_	14	advmod	_	_
14	by	_	IN	IN	_	12	prep	_	_
15	FMLP	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	14	punct	_	_
17	but	_	CC	CC	_	14	cc	_	_
18	minimally	_	RB	RB	_	19	advmod	_	_
19	by	_	IN	IN	_	14	conj	_	_
20	PAF	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	12	punct	_	_

1	Pertussis	_	NN	NN	_	2	nn	_	_
2	toxin	_	NN	NN	_	3	nsubj	_	_
3	blocked	_	VBD	VBD	_	0	root	_	_
4	FMLP-induced	_	JJ	JJ	_	5	amod	_	_
5	activation	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	13	det	_	_
8	p42/44	_	NN	NN	_	12	nn	_	_
9	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
10	ERK	_	NN	NN	_	12	nn	_	_
11	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
12	MAPk	_	NN	NN	_	13	nn	_	_
13	cascade	_	NN	NN	_	6	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	but	_	CC	CC	_	16	cc	_	_
16	not	_	RB	RB	_	5	cc	_	_
17	that	_	DT	DT	_	5	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	p38	_	NN	NN	_	20	nn	_	_
20	MAPk	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	specific	_	JJ	JJ	_	5	amod	_	_
3	p38	_	NN	NN	_	4	nn	_	_
4	MAPk	_	NN	NN	_	5	nn	_	_
5	inhibitor	_	NN	NN	_	10	nsubj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	SK&amp;F	_	NN	NN	_	5	appos	_	_
8	86002	_	CD	CD	_	7	num	_	_
9	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
10	blocked	_	VBD	VBD	_	0	root	_	_
11	superoxide	_	NN	NN	_	13	nn	_	_
12	anion	_	NN	NN	_	13	nn	_	_
13	production	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	response	_	NN	NN	_	14	pobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	FMLP	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	10	cc	_	_
19	reduced	_	VBD	VBD	_	10	conj	_	_
20	adhesion	_	NN	NN	_	19	dobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	chemotaxis	_	NN	NN	_	20	conj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	response	_	NN	NN	_	23	pobj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	PAF	_	NN	NN	_	25	pobj	_	_
27	or	_	CC	CC	_	26	cc	_	_
28	FMLP	_	NN	NN	_	26	conj	_	_
29	.	_	.	.	_	10	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	distinct	_	JJ	JJ	_	5	amod	_	_
5	patterns	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	intracellular	_	JJ	JJ	_	8	amod	_	_
8	signaling	_	NN	NN	_	6	pobj	_	_
9	for	_	IN	IN	_	5	prep	_	_
10	two	_	CD	CD	_	11	num	_	_
11	chemoattractants	_	NNS	NNS	_	9	pobj	_	_
12	and	_	CC	CC	_	3	cc	_	_
13	suggest	_	VBP	VBP	_	3	conj	_	_
14	that	_	IN	IN	_	22	mark	_	_
15	selective	_	JJ	JJ	_	16	amod	_	_
16	activation	_	NN	NN	_	22	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	intracellular	_	JJ	JJ	_	20	amod	_	_
19	signaling	_	NN	NN	_	20	nn	_	_
20	cascades	_	NNS	NNS	_	17	pobj	_	_
21	may	_	MD	MD	_	22	aux	_	_
22	underlie	_	VB	VB	_	13	ccomp	_	_
23	different	_	JJ	JJ	_	24	amod	_	_
24	patterns	_	NNS	NNS	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	functional	_	JJ	JJ	_	27	amod	_	_
27	responses	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	3	punct	_	_

1	Selective	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	an	_	DT	DT	_	7	det	_	_
5	interleukin-12	_	NN	NN	_	7	nn	_	_
6	receptor	_	NN	NN	_	7	nn	_	_
7	component	_	NN	NN	_	3	pobj	_	_
8	by	_	IN	IN	_	2	prep	_	_
9	human	_	JJ	JJ	_	13	amod	_	_
10	T	_	NN	NN	_	13	nn	_	_
11	helper	_	NN	NN	_	13	nn	_	_
12	1	_	CD	CD	_	13	num	_	_
13	cells	_	NNS	NNS	_	8	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	Interleukin-12	_	NN	NN	_	17	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-12	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	,	_	,	,	_	1	punct	_	_
6	a	_	DT	DT	_	8	det	_	_
7	heterodimeric	_	JJ	JJ	_	8	amod	_	_
8	cytokine	_	NN	NN	_	1	appos	_	_
9	produced	_	VBN	VBN	_	8	vmod	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	activated	_	VBN	VBN	_	12	amod	_	_
12	monocytes	_	NNS	NNS	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	dendritic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	12	conj	_	_
16	,	_	,	,	_	1	punct	_	_
17	plays	_	VBZ	VBZ	_	0	root	_	_
18	a	_	DT	DT	_	20	det	_	_
19	crucial	_	JJ	JJ	_	20	amod	_	_
20	role	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	17	prep	_	_
22	regulating	_	VBG	VBG	_	21	pcomp	_	_
23	interferon	_	NN	NN	_	27	nn	_	_
24	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
25	IFN	_	NN	NN	_	27	nn	_	_
26	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
27	-gamma	_	NN	NN	_	28	nn	_	_
28	production	_	NN	NN	_	22	dobj	_	_
29	and	_	CC	CC	_	21	cc	_	_
30	in	_	IN	IN	_	21	conj	_	_
31	the	_	DT	DT	_	32	det	_	_
32	generation	_	NN	NN	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	IFN-gamma-producing	_	JJ	JJ	_	41	amod	_	_
35	T	_	NN	NN	_	41	nn	_	_
36	helper	_	NN	NN	_	41	nn	_	_
37	1	_	CD	CD	_	41	num	_	_
38	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
39	Th1	_	NN	NN	_	41	nn	_	_
40	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
41	cells	_	NNS	NNS	_	33	pobj	_	_
42	.	_	.	.	_	17	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	28	mark	_	_
5	the	_	DT	DT	_	13	det	_	_
6	IL-12	_	NN	NN	_	13	nn	_	_
7	receptor	_	NN	NN	_	13	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
9	IL-12R	_	NN	NN	_	13	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
11	beta	_	NN	NN	_	13	nn	_	_
12	2	_	CD	CD	_	13	num	_	_
13	subunit	_	NN	NN	_	28	nsubjpass	_	_
14	,	_	,	,	_	13	punct	_	_
15	a	_	DT	DT	_	18	dep	_	_
16	recently	_	RB	RB	_	18	advmod	_	_
17	cloned	_	VBN	VBN	_	18	amod	_	_
18	binding	_	NN	NN	_	13	appos	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	signal	_	NN	NN	_	21	nn	_	_
21	transducing	_	NN	NN	_	18	conj	_	_
22	component	_	NN	NN	_	18	dep	_	_
23	of	_	IN	IN	_	18	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	IL-12R	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	13	punct	_	_
27	is	_	VBZ	VBZ	_	28	auxpass	_	_
28	expressed	_	VBN	VBN	_	3	ccomp	_	_
29	on	_	IN	IN	_	28	prep	_	_
30	human	_	JJ	JJ	_	31	amod	_	_
31	Th1	_	NN	NN	_	29	pobj	_	_
32	but	_	CC	CC	_	33	cc	_	_
33	not	_	RB	RB	_	31	cc	_	_
34	Th2	_	NN	NN	_	31	conj	_	_
35	clones	_	NNS	NNS	_	31	dep	_	_
36	and	_	CC	CC	_	28	cc	_	_
37	is	_	VBZ	VBZ	_	38	auxpass	_	_
38	induced	_	VBN	VBN	_	28	conj	_	_
39	during	_	IN	IN	_	38	prep	_	_
40	differentiation	_	NN	NN	_	39	pobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	human	_	JJ	JJ	_	44	amod	_	_
43	naive	_	JJ	JJ	_	44	amod	_	_
44	cells	_	NNS	NNS	_	41	pobj	_	_
45	along	_	IN	IN	_	44	prep	_	_
46	the	_	DT	DT	_	47	det	_	_
47	Th1	_	NN	NN	_	45	pobj	_	_
48	but	_	CC	CC	_	49	cc	_	_
49	not	_	RB	RB	_	47	cc	_	_
50	the	_	DT	DT	_	51	det	_	_
51	Th2	_	NN	NN	_	47	conj	_	_
52	pathway	_	NN	NN	_	47	dep	_	_
53	.	_	.	.	_	3	punct	_	_

1	IL-12	_	NN	NN	_	10	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	type	_	NN	NN	_	1	conj	_	_
4	I	_	CD	CD	_	3	num	_	_
5	but	_	CC	CC	_	6	cc	_	_
6	not	_	RB	RB	_	3	cc	_	_
7	type	_	NN	NN	_	3	conj	_	_
8	II	_	CD	CD	_	7	num	_	_
9	interferons	_	NNS	NNS	_	3	dep	_	_
10	induce	_	VBP	VBP	_	0	root	_	_
11	expression	_	NN	NN	_	10	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	IL-12R	_	NN	NN	_	17	nn	_	_
15	beta	_	NN	NN	_	17	nn	_	_
16	2	_	CD	CD	_	17	num	_	_
17	chain	_	NN	NN	_	12	pobj	_	_
18	during	_	IN	IN	_	11	prep	_	_
19	in	_	FW	FW	_	23	amod	_	_
20	vitro	_	FW	FW	_	19	dep	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	differentiation	_	NN	NN	_	18	pobj	_	_
24	after	_	IN	IN	_	23	prep	_	_
25	antigen	_	NN	NN	_	27	nn	_	_
26	receptor	_	NN	NN	_	27	nn	_	_
27	triggering	_	NN	NN	_	24	pobj	_	_
28	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	dep	_	_
2	selective	_	JJ	JJ	_	3	amod	_	_
3	expression	_	NN	NN	_	13	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	regulation	_	NN	NN	_	3	conj	_	_
6	of	_	IN	IN	_	3	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	IL-12R	_	NN	NN	_	11	nn	_	_
9	beta	_	NN	NN	_	11	nn	_	_
10	2	_	CD	CD	_	11	num	_	_
11	subunit	_	NN	NN	_	6	pobj	_	_
12	may	_	MD	MD	_	13	aux	_	_
13	help	_	VB	VB	_	0	root	_	_
14	to	_	TO	TO	_	15	aux	_	_
15	understand	_	VB	VB	_	13	xcomp	_	_
16	the	_	DT	DT	_	17	det	_	_
17	basis	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	Th1/Th2	_	NN	NN	_	20	nn	_	_
20	differentiation	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	13	cc	_	_
22	may	_	MD	MD	_	23	aux	_	_
23	provide	_	VB	VB	_	13	conj	_	_
24	therapeutic	_	JJ	JJ	_	25	amod	_	_
25	options	_	NNS	NNS	_	23	dobj	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	altering	_	VBG	VBG	_	26	pcomp	_	_
28	the	_	DT	DT	_	30	det	_	_
29	Th1/Th2	_	NN	NN	_	30	nn	_	_
30	balance	_	NN	NN	_	27	dobj	_	_
31	in	_	IN	IN	_	27	prep	_	_
32	several	_	JJ	JJ	_	34	amod	_	_
33	immuno-pathological	_	JJ	JJ	_	34	amod	_	_
34	conditions	_	NNS	NNS	_	31	pobj	_	_
35	such	_	JJ	JJ	_	36	mwe	_	_
36	as	_	IN	IN	_	34	prep	_	_
37	autoimmune	_	JJ	JJ	_	38	amod	_	_
38	diseases	_	NNS	NNS	_	36	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	allergies	_	NNS	NNS	_	38	conj	_	_
41	.	_	.	.	_	13	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factor	_	NN	NN	_	2	pobj	_	_
6	NF-kappaB	_	NN	NN	_	5	dep	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	lipopolysaccharide-stimulated	_	JJ	JJ	_	10	amod	_	_
9	U937	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	During	_	IN	IN	_	13	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	course	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	serious	_	JJ	JJ	_	7	amod	_	_
6	bacterial	_	JJ	JJ	_	5	dep	_	_
7	infections	_	NNS	NNS	_	4	pobj	_	_
8	,	_	,	,	_	13	punct	_	_
9	lipopolysaccharide	_	NN	NN	_	13	nsubj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	LPS	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	interacts	_	VBZ	VBZ	_	0	root	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	monocyte/macrophage	_	NN	NN	_	16	nn	_	_
16	receptors	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	13	punct	_	_
18	resulting	_	VBG	VBG	_	13	xcomp	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	generation	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	inflammatory	_	JJ	JJ	_	24	amod	_	_
24	cytokines	_	NNS	NNS	_	22	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	5	nsubj	_	_
3	NF-kappaB	_	NN	NN	_	2	dep	_	_
4	is	_	VBZ	VBZ	_	5	cop	_	_
5	crucial	_	JJ	JJ	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	activating	_	VBG	VBG	_	6	pcomp	_	_
8	the	_	DT	DT	_	9	det	_	_
9	transcription	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	genes	_	NNS	NNS	_	10	pobj	_	_
12	encoding	_	VBG	VBG	_	11	vmod	_	_
13	proinflammatory	_	JJ	JJ	_	14	amod	_	_
14	cytokines	_	NNS	NNS	_	12	dobj	_	_
15	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	paper	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	22	mark	_	_
8	the	_	DT	DT	_	9	det	_	_
9	activation	_	NN	NN	_	22	nsubj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	NF-kappaB	_	NN	NN	_	10	pobj	_	_
12	by	_	IN	IN	_	9	prep	_	_
13	LPS	_	NN	NN	_	12	pobj	_	_
14	in	_	IN	IN	_	9	prep	_	_
15	a	_	DT	DT	_	18	det	_	_
16	promonocytic	_	JJ	JJ	_	18	amod	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	line	_	NN	NN	_	14	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	U937	_	NN	NN	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	followed	_	VBD	VBD	_	6	ccomp	_	_
23	a	_	DT	DT	_	26	det	_	_
24	rather	_	RB	RB	_	25	advmod	_	_
25	slow	_	JJ	JJ	_	26	amod	_	_
26	kinetics	_	NN	NN	_	22	dobj	_	_
27	,	_	,	,	_	22	punct	_	_
28	depending	_	VBG	VBG	_	22	prep	_	_
29	on	_	IN	IN	_	28	pcomp	_	_
30	the	_	DT	DT	_	31	det	_	_
31	rate	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	IkappaB-alpha	_	NN	NN	_	35	nn	_	_
34	inhibitor	_	NN	NN	_	35	nn	_	_
35	hydrolysis	_	NN	NN	_	32	pobj	_	_
36	.	_	.	.	_	6	punct	_	_

1	No	_	DT	DT	_	2	neg	_	_
2	degradation	_	NN	NN	_	9	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	p105	_	NN	NN	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	p100	_	NN	NN	_	4	conj	_	_
7	inhibitors	_	NNS	NNS	_	4	dep	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	observed	_	VBN	VBN	_	0	root	_	_
10	under	_	IN	IN	_	9	prep	_	_
11	these	_	DT	DT	_	12	det	_	_
12	conditions	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transduction	_	NN	NN	_	3	nn	_	_
3	pathway	_	NN	NN	_	11	nsubj	_	_
4	leading	_	VBG	VBG	_	3	vmod	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	NF-kappaB	_	NN	NN	_	7	nn	_	_
7	activation	_	NN	NN	_	5	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	U937	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	involved	_	VBD	VBD	_	0	root	_	_
12	the	_	DT	DT	_	14	det	_	_
13	intracellular	_	JJ	JJ	_	14	amod	_	_
14	generation	_	NN	NN	_	11	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	reactive	_	JJ	JJ	_	18	amod	_	_
17	oxygen	_	NN	NN	_	18	nn	_	_
18	species	_	NNS	NNS	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	ROS	_	NNS	NNS	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	,	_	,	,	_	11	punct	_	_
23	as	_	IN	IN	_	24	mark	_	_
24	demonstrated	_	VBN	VBN	_	11	advcl	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	29	det	_	_
27	concomitant	_	JJ	JJ	_	29	amod	_	_
28	inhibitory	_	JJ	JJ	_	27	dep	_	_
29	effects	_	NNS	NNS	_	25	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	antioxidants	_	NNS	NNS	_	30	pobj	_	_
32	on	_	IN	IN	_	29	prep	_	_
33	NF-kappaB	_	NN	NN	_	34	nn	_	_
34	activation	_	NN	NN	_	32	pobj	_	_
35	and	_	CC	CC	_	29	cc	_	_
36	the	_	DT	DT	_	37	det	_	_
37	emission	_	NN	NN	_	29	conj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	a	_	DT	DT	_	41	det	_	_
40	fluorescent	_	JJ	JJ	_	41	amod	_	_
41	probe	_	NN	NN	_	38	pobj	_	_
42	reacting	_	VBG	VBG	_	41	vmod	_	_
43	intracellularly	_	RB	RB	_	42	advmod	_	_
44	with	_	IN	IN	_	42	prep	_	_
45	hydrogen	_	NN	NN	_	46	nn	_	_
46	peroxide	_	NN	NN	_	44	pobj	_	_
47	.	_	.	.	_	11	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	ROS	_	NNS	NNS	_	3	nn	_	_
3	pathway	_	NN	NN	_	6	nsubjpass	_	_
4	was	_	VBD	VBD	_	6	auxpass	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	characterized	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	use	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	other	_	JJ	JJ	_	12	amod	_	_
12	inhibitors	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	finding	_	NN	NN	_	3	nsubj	_	_
3	indicates	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	phospholipase	_	NN	NN	_	6	nn	_	_
6	A2	_	NN	NN	_	11	nsubjpass	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	5-lipoxygenase	_	NN	NN	_	6	conj	_	_
9	are	_	VBP	VBP	_	11	auxpass	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	involved	_	VBN	VBN	_	3	ccomp	_	_
12	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	NF-kappaB	_	NN	NN	_	6	nn	_	_
5	activation	_	NN	NN	_	6	nn	_	_
6	pathway	_	NN	NN	_	17	nsubj	_	_
7	involving	_	VBG	VBG	_	6	vmod	_	_
8	the	_	DT	DT	_	10	det	_	_
9	acidic	_	JJ	JJ	_	10	amod	_	_
10	sphingomyelinase	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	endolysosomial	_	JJ	JJ	_	14	amod	_	_
14	membrane	_	NN	NN	_	11	pobj	_	_
15	did	_	VBD	VBD	_	17	aux	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	seem	_	VB	VB	_	0	root	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	participate	_	VB	VB	_	17	xcomp	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	LPS-induced	_	JJ	JJ	_	24	amod	_	_
23	NF-kappaB	_	NN	NN	_	24	nn	_	_
24	activation	_	NN	NN	_	20	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	U937	_	NN	NN	_	27	nn	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	17	punct	_	_

1	Detection	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	adenovirus	_	NN	NN	_	4	nn	_	_
4	DNA	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	peripheral	_	JJ	JJ	_	9	amod	_	_
7	blood	_	NN	NN	_	9	nn	_	_
8	mononuclear	_	JJ	JJ	_	9	amod	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	by	_	IN	IN	_	1	prep	_	_
11	polymerase	_	NN	NN	_	14	nn	_	_
12	chain	_	NN	NN	_	14	nn	_	_
13	reaction	_	NN	NN	_	14	nn	_	_
14	assay	_	NN	NN	_	10	pobj	_	_
15	.	_	.	.	_	1	punct	_	_

1	Adenovirus	_	NN	NN	_	3	nsubj	_	_
2	can	_	MD	MD	_	3	aux	_	_
3	establish	_	VB	VB	_	0	root	_	_
4	persistent	_	JJ	JJ	_	5	amod	_	_
5	infections	_	NNS	NNS	_	3	dobj	_	_
6	which	_	WDT	WDT	_	8	nsubj	_	_
7	may	_	MD	MD	_	8	aux	_	_
8	reactivate	_	VB	VB	_	5	rcmod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	cause	_	VB	VB	_	8	conj	_	_
11	disease	_	NN	NN	_	8	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	immunocompromised	_	JJ	JJ	_	14	amod	_	_
14	hosts	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	Lymphocytes	_	NNS	NNS	_	4	nsubjpass	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	been	_	VBN	VBN	_	4	auxpass	_	_
4	postulated	_	VBN	VBN	_	0	root	_	_
5	to	_	TO	TO	_	6	aux	_	_
6	serve	_	VB	VB	_	4	xcomp	_	_
7	as	_	IN	IN	_	6	prep	_	_
8	a	_	DT	DT	_	9	det	_	_
9	site	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	adenoviral	_	JJ	JJ	_	12	amod	_	_
12	persistence	_	NN	NN	_	10	pobj	_	_
13	based	_	VBN	VBN	_	6	prep	_	_
14	upon	_	IN	IN	_	13	pcomp	_	_
15	the	_	DT	DT	_	16	det	_	_
16	ability	_	NN	NN	_	14	pobj	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	isolate	_	VB	VB	_	16	dep	_	_
19	adenovirus	_	NN	NN	_	18	dobj	_	_
20	from	_	IN	IN	_	18	prep	_	_
21	tonsils	_	NNS	NNS	_	20	pobj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	detect	_	VB	VB	_	18	conj	_	_
25	adenovirus	_	NN	NN	_	26	nn	_	_
26	DNA	_	NN	NN	_	24	dobj	_	_
27	by	_	IN	IN	_	18	prep	_	_
28	Southern	_	NN	NN	_	30	nn	_	_
29	blot	_	NN	NN	_	30	nn	_	_
30	hybridization	_	NN	NN	_	27	pobj	_	_
31	in	_	IN	IN	_	18	prep	_	_
32	peripheral	_	JJ	JJ	_	35	amod	_	_
33	blood	_	NN	NN	_	35	nn	_	_
34	mononuclear	_	JJ	JJ	_	35	amod	_	_
35	cells	_	NNS	NNS	_	31	pobj	_	_
36	-LRB-	_	-LRB-	-LRB-	_	37	punct	_	_
37	PBMC	_	NN	NN	_	35	appos	_	_
38	-RRB-	_	-RRB-	-RRB-	_	37	punct	_	_
39	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	test	_	VB	VB	_	0	root	_	_
3	this	_	DT	DT	_	4	det	_	_
4	hypothesis	_	NN	NN	_	2	dobj	_	_
5	,	_	,	,	_	2	punct	_	_
6	a	_	DT	DT	_	13	det	_	_
7	more	_	RBR	RBR	_	8	advmod	_	_
8	sensitive	_	JJ	JJ	_	13	amod	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	specific	_	JJ	JJ	_	8	conj	_	_
11	polymerase	_	NN	NN	_	13	nn	_	_
12	chain	_	NN	NN	_	13	nn	_	_
13	reaction	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	PCR	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	assay	_	NN	NN	_	19	nsubjpass	_	_
18	was	_	VBD	VBD	_	19	auxpass	_	_
19	developed	_	VBN	VBN	_	2	parataxis	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	detect	_	VB	VB	_	19	xcomp	_	_
22	adenovirus	_	NN	NN	_	23	nn	_	_
23	DNA	_	NN	NN	_	21	dobj	_	_
24	.	_	.	.	_	2	punct	_	_

1	Two	_	CD	CD	_	2	num	_	_
2	sets	_	NNS	NNS	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	nested	_	VBD	VBD	_	5	amod	_	_
5	primers	_	NNS	NNS	_	3	pobj	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	designed	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	conserved	_	VBN	VBN	_	10	amod	_	_
10	sequences	_	NNS	NNS	_	8	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	adenovirus	_	NN	NN	_	11	pobj	_	_
14	E1A	_	NN	NN	_	13	dep	_	_
15	and	_	CC	CC	_	13	cc	_	_
16	hexon	_	NN	NN	_	13	conj	_	_
17	genes	_	NNS	NNS	_	13	dep	_	_
18	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	E1A	_	NN	NN	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	hexon	_	NN	NN	_	2	conj	_	_
5	primers	_	NNS	NNS	_	2	dep	_	_
6	amplified	_	VBD	VBD	_	0	root	_	_
7	DNA	_	NN	NN	_	6	dobj	_	_
8	from	_	IN	IN	_	7	prep	_	_
9	representative	_	JJ	JJ	_	11	amod	_	_
10	adenoviral	_	JJ	JJ	_	9	dep	_	_
11	serotypes	_	NNS	NNS	_	8	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	all	_	DT	DT	_	16	det	_	_
14	six	_	CD	CD	_	16	num	_	_
15	adenoviral	_	JJ	JJ	_	16	amod	_	_
16	groups	_	NNS	NNS	_	12	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	A-F	_	NNS	NNS	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	.	_	.	.	_	6	punct	_	_

1	Both	_	DT	DT	_	2	det	_	_
2	primers	_	NNS	NNS	_	3	nsubj	_	_
3	detected	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	6	det	_	_
5	single	_	JJ	JJ	_	6	amod	_	_
6	copy	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	adenovirus	_	NN	NN	_	12	nn	_	_
10	type	_	NN	NN	_	12	nn	_	_
11	2	_	CD	CD	_	12	num	_	_
12	genome	_	NN	NN	_	7	pobj	_	_
13	but	_	CC	CC	_	3	cc	_	_
14	were	_	VBD	VBD	_	16	cop	_	_
15	less	_	RBR	RBR	_	16	advmod	_	_
16	sensitive	_	JJ	JJ	_	3	conj	_	_
17	for	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	group	_	NN	NN	_	21	nn	_	_
20	B	_	NN	NN	_	21	nn	_	_
21	type	_	NN	NN	_	17	pobj	_	_
22	35	_	CD	CD	_	21	num	_	_
23	.	_	.	.	_	3	punct	_	_

1	None	_	NN	NN	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	33	_	CD	CD	_	5	num	_	_
4	PBMC	_	NN	NN	_	5	nn	_	_
5	specimens	_	NNS	NNS	_	2	pobj	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	healthy	_	JJ	JJ	_	8	amod	_	_
8	adults	_	NNS	NNS	_	6	pobj	_	_
9	and	_	CC	CC	_	1	cc	_	_
10	only	_	RB	RB	_	11	advmod	_	_
11	one	_	CD	CD	_	1	conj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	40	_	CD	CD	_	15	num	_	_
14	pediatric	_	JJ	JJ	_	15	amod	_	_
15	samples	_	NNS	NNS	_	12	pobj	_	_
16	was	_	VBD	VBD	_	17	cop	_	_
17	positive	_	JJ	JJ	_	0	root	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	at	_	IN	IN	_	17	dep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	low	_	JJ	JJ	_	22	amod	_	_
22	level	_	NN	NN	_	19	pobj	_	_
23	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
24	for	_	IN	IN	_	17	prep	_	_
25	adenovirus	_	NN	NN	_	26	nn	_	_
26	DNA	_	NN	NN	_	24	pobj	_	_
27	by	_	IN	IN	_	17	prep	_	_
28	nested	_	JJ	JJ	_	30	amod	_	_
29	PCR	_	NN	NN	_	30	nn	_	_
30	assay	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	15	prep	_	_
2	comparison	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	15	punct	_	_
4	PBMC	_	NN	NN	_	15	nsubj	_	_
5	from	_	IN	IN	_	4	prep	_	_
6	two	_	CD	CD	_	7	num	_	_
7	children	_	NNS	NNS	_	5	pobj	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	fatal	_	JJ	JJ	_	11	amod	_	_
10	adenoviral	_	JJ	JJ	_	9	dep	_	_
11	infection	_	NN	NN	_	8	pobj	_	_
12	were	_	VBD	VBD	_	15	cop	_	_
13	both	_	RB	RB	_	15	advmod	_	_
14	strongly	_	RB	RB	_	15	advmod	_	_
15	positive	_	JJ	JJ	_	0	root	_	_
16	for	_	IN	IN	_	15	prep	_	_
17	adenovirus	_	NN	NN	_	18	nn	_	_
18	DNA	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	15	punct	_	_

1	It	_	PRP	PRP	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	concluded	_	VBN	VBN	_	0	root	_	_
4	that	_	IN	IN	_	18	mark	_	_
5	,	_	,	,	_	18	punct	_	_
6	in	_	IN	IN	_	18	prep	_	_
7	contrast	_	NN	NN	_	6	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	previous	_	JJ	JJ	_	11	amod	_	_
11	study	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	18	punct	_	_
13	PBMC	_	NN	NN	_	18	nsubj	_	_
14	are	_	VBP	VBP	_	18	cop	_	_
15	not	_	RB	RB	_	18	neg	_	_
16	a	_	DT	DT	_	18	det	_	_
17	common	_	JJ	JJ	_	18	amod	_	_
18	site	_	NN	NN	_	3	ccomp	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	persistent	_	JJ	JJ	_	24	amod	_	_
21	group	_	NN	NN	_	24	nn	_	_
22	C	_	NN	NN	_	24	nn	_	_
23	adenoviral	_	JJ	JJ	_	24	amod	_	_
24	infection	_	NN	NN	_	19	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	assay	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	PBMC	_	NN	NN	_	5	pobj	_	_
7	by	_	IN	IN	_	4	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	adenovirus-specific	_	JJ	JJ	_	10	amod	_	_
10	PCR	_	NN	NN	_	7	pobj	_	_
11	may	_	MD	MD	_	12	aux	_	_
12	help	_	VB	VB	_	0	root	_	_
13	detect	_	VB	VB	_	12	ccomp	_	_
14	early	_	JJ	JJ	_	16	amod	_	_
15	invasive	_	JJ	JJ	_	14	dep	_	_
16	disease	_	NN	NN	_	13	dobj	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	warrants	_	VBZ	VBZ	_	13	conj	_	_
19	further	_	JJ	JJ	_	20	amod	_	_
20	evaluation	_	NN	NN	_	18	dobj	_	_
21	.	_	.	.	_	12	punct	_	_

1	Control	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NFATx1	_	NN	NN	_	5	nn	_	_
4	nuclear	_	JJ	JJ	_	5	amod	_	_
5	translocation	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	calcineurin-regulated	_	JJ	JJ	_	10	amod	_	_
9	inhibitory	_	JJ	JJ	_	10	amod	_	_
10	domain	_	NN	NN	_	6	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	7	det	_	_
2	nuclear	_	JJ	JJ	_	7	amod	_	_
3	factor	_	NN	NN	_	7	nn	_	_
4	of	_	IN	IN	_	7	amod	_	_
5	activated	_	VBN	VBN	_	7	amod	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	11	nsubj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	NFAT	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	regulates	_	VBZ	VBZ	_	0	root	_	_
12	cytokine	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	11	dobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	through	_	IN	IN	_	11	prep	_	_
19	cis-acting	_	JJ	JJ	_	20	amod	_	_
20	elements	_	NNS	NNS	_	18	pobj	_	_
21	located	_	JJ	JJ	_	20	amod	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	promoters	_	NNS	NNS	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	several	_	JJ	JJ	_	28	amod	_	_
27	cytokine	_	NN	NN	_	28	nn	_	_
28	genes	_	NNS	NNS	_	25	pobj	_	_
29	.	_	.	.	_	11	punct	_	_

1	NFATx1	_	NN	NN	_	16	nsubj	_	_
2	,	_	,	,	_	1	punct	_	_
3	which	_	WDT	WDT	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	preferentially	_	RB	RB	_	6	advmod	_	_
6	expressed	_	VBN	VBN	_	1	rcmod	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	thymus	_	NN	NN	_	7	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	peripheral	_	JJ	JJ	_	13	amod	_	_
12	blood	_	NN	NN	_	13	nn	_	_
13	leukocytes	_	NNS	NNS	_	9	conj	_	_
14	,	_	,	,	_	1	punct	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	one	_	CD	CD	_	0	root	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	four	_	CD	CD	_	19	num	_	_
19	members	_	NNS	NNS	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	NFAT	_	NN	NN	_	23	nn	_	_
23	family	_	NN	NN	_	20	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	transcription	_	NN	NN	_	26	nn	_	_
26	factors	_	NNS	NNS	_	24	pobj	_	_
27	.	_	.	.	_	16	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	performed	_	VBN	VBN	_	0	root	_	_
4	domain	_	NN	NN	_	5	nn	_	_
5	analysis	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NFATx1	_	NN	NN	_	6	pobj	_	_
8	by	_	IN	IN	_	3	prep	_	_
9	examining	_	VBG	VBG	_	8	pcomp	_	_
10	the	_	DT	DT	_	11	det	_	_
11	effects	_	NNS	NNS	_	9	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	deletion	_	NN	NN	_	14	nn	_	_
14	mutations	_	NNS	NNS	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	found	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	14	mark	_	_
4	NFATx1	_	NN	NN	_	14	nsubj	_	_
5	DNA	_	NN	NN	_	7	nn	_	_
6	binding	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	4	dep	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	interaction	_	NN	NN	_	4	conj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	AP-1	_	NN	NN	_	12	nn	_	_
12	polypeptides	_	NNS	NNS	_	10	pobj	_	_
13	were	_	VBD	VBD	_	14	cop	_	_
14	dependent	_	JJ	JJ	_	2	ccomp	_	_
15	on	_	IN	IN	_	14	prep	_	_
16	its	_	PRP$	PRP$	_	20	poss	_	_
17	central	_	JJ	JJ	_	20	amod	_	_
18	Rel	_	NN	NN	_	20	nn	_	_
19	similarity	_	NN	NN	_	20	nn	_	_
20	region	_	NN	NN	_	15	pobj	_	_
21	and	_	CC	CC	_	14	cc	_	_
22	that	_	IN	IN	_	26	mark	_	_
23	transcriptional	_	JJ	JJ	_	24	amod	_	_
24	activation	_	NN	NN	_	26	nsubjpass	_	_
25	was	_	VBD	VBD	_	26	auxpass	_	_
26	reduced	_	VBN	VBN	_	14	conj	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	deletions	_	NNS	NNS	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	either	_	CC	CC	_	33	preconj	_	_
31	its	_	PRP$	PRP$	_	33	poss	_	_
32	N-terminal	_	JJ	JJ	_	33	amod	_	_
33	domain	_	NN	NN	_	29	pobj	_	_
34	or	_	CC	CC	_	33	cc	_	_
35	its	_	PRP$	PRP$	_	37	poss	_	_
36	C-terminal	_	JJ	JJ	_	37	amod	_	_
37	domain	_	NN	NN	_	33	conj	_	_
38	,	_	,	,	_	2	punct	_	_
39	suggesting	_	VBG	VBG	_	2	xcomp	_	_
40	the	_	DT	DT	_	41	det	_	_
41	presence	_	NN	NN	_	39	dobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	intrinsic	_	JJ	JJ	_	46	amod	_	_
44	transcriptional	_	JJ	JJ	_	46	amod	_	_
45	activation	_	NN	NN	_	46	nn	_	_
46	motifs	_	NNS	NNS	_	42	pobj	_	_
47	in	_	IN	IN	_	41	prep	_	_
48	both	_	DT	DT	_	49	det	_	_
49	regions	_	NNS	NNS	_	47	pobj	_	_
50	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	identified	_	VBD	VBD	_	0	root	_	_
4	a	_	DT	DT	_	7	det	_	_
5	potent	_	JJ	JJ	_	7	amod	_	_
6	inhibitory	_	JJ	JJ	_	7	amod	_	_
7	sequence	_	NN	NN	_	3	dobj	_	_
8	within	_	IN	IN	_	7	prep	_	_
9	its	_	PRP$	PRP$	_	11	poss	_	_
10	N-terminal	_	JJ	JJ	_	11	amod	_	_
11	domain	_	NN	NN	_	8	pobj	_	_
12	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	10	mark	_	_
4	the	_	DT	DT	_	5	det	_	_
5	inactivation	_	NN	NN	_	10	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	inhibition	_	NN	NN	_	6	pobj	_	_
9	was	_	VBD	VBD	_	10	cop	_	_
10	dependent	_	JJ	JJ	_	2	ccomp	_	_
11	on	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activity	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	calcineurin	_	NN	NN	_	14	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	a	_	DT	DT	_	19	det	_	_
18	calcium-calmodulin-dependent	_	JJ	JJ	_	19	amod	_	_
19	phosphatase	_	NN	NN	_	15	appos	_	_
20	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	also	_	RB	RB	_	3	advmod	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	calcineurin	_	NN	NN	_	6	nsubj	_	_
6	associated	_	VBD	VBD	_	3	ccomp	_	_
7	with	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	N-terminal	_	JJ	JJ	_	10	amod	_	_
10	domain	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	NFATx1	_	NN	NN	_	11	pobj	_	_
13	at	_	IN	IN	_	6	prep	_	_
14	multiple	_	JJ	JJ	_	16	amod	_	_
15	docking	_	NN	NN	_	16	nn	_	_
16	sites	_	NNS	NNS	_	13	pobj	_	_
17	and	_	CC	CC	_	6	cc	_	_
18	caused	_	VBD	VBD	_	6	conj	_	_
19	a	_	DT	DT	_	20	det	_	_
20	reduction	_	NN	NN	_	18	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	size	_	NN	NN	_	21	pobj	_	_
23	,	_	,	,	_	20	punct	_	_
24	indicative	_	JJ	JJ	_	20	amod	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	dephosphorylation	_	NN	NN	_	25	pobj	_	_
27	,	_	,	,	_	20	punct	_	_
28	in	_	IN	IN	_	20	prep	_	_
29	NFATx1	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	mapped	_	VBN	VBN	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	inhibitory	_	JJ	JJ	_	6	amod	_	_
6	activity	_	NN	NN	_	3	dobj	_	_
7	to	_	TO	TO	_	3	prep	_	_
8	less	_	JJR	JJR	_	7	pobj	_	_
9	than	_	IN	IN	_	8	amod	_	_
10	60	_	CD	CD	_	11	num	_	_
11	residues	_	NNS	NNS	_	8	dep	_	_
12	,	_	,	,	_	8	punct	_	_
13	containing	_	VBG	VBG	_	8	vmod	_	_
14	motifs	_	NNS	NNS	_	13	dobj	_	_
15	that	_	WDT	WDT	_	17	nsubjpass	_	_
16	are	_	VBP	VBP	_	17	auxpass	_	_
17	conserved	_	VBN	VBN	_	14	rcmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	all	_	DT	DT	_	21	det	_	_
20	NFAT	_	NN	NN	_	21	nn	_	_
21	proteins	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Finally	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	that	_	IN	IN	_	14	mark	_	_
6	deletion	_	NN	NN	_	14	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	NFATx1	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	6	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	mapped	_	VBN	VBN	_	13	amod	_	_
12	60	_	CD	CD	_	13	num	_	_
13	residues	_	NNS	NNS	_	9	pobj	_	_
14	leads	_	VBZ	VBZ	_	4	ccomp	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	its	_	PRP$	PRP$	_	18	poss	_	_
17	nuclear	_	JJ	JJ	_	18	amod	_	_
18	translocation	_	NN	NN	_	15	pobj	_	_
19	independent	_	JJ	JJ	_	18	amod	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	calcium	_	NN	NN	_	22	nn	_	_
22	signaling	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	support	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	model	_	NN	NN	_	3	dobj	_	_
6	proposing	_	VBG	VBG	_	5	vmod	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	the	_	DT	DT	_	10	det	_	_
9	N-terminal	_	JJ	JJ	_	10	amod	_	_
10	domain	_	NN	NN	_	11	nsubj	_	_
11	confers	_	VBZ	VBZ	_	6	ccomp	_	_
12	calcium-signaling	_	JJ	JJ	_	13	amod	_	_
13	dependence	_	NN	NN	_	11	dobj	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	NFATx1	_	NN	NN	_	17	nn	_	_
16	transactivation	_	NN	NN	_	17	nn	_	_
17	activity	_	NN	NN	_	14	pobj	_	_
18	by	_	IN	IN	_	11	prep	_	_
19	regulating	_	VBG	VBG	_	18	pcomp	_	_
20	its	_	PRP$	PRP$	_	22	poss	_	_
21	intracellular	_	JJ	JJ	_	22	amod	_	_
22	localization	_	NN	NN	_	19	dobj	_	_
23	through	_	IN	IN	_	19	prep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	protein	_	NN	NN	_	26	nn	_	_
26	module	_	NN	NN	_	23	pobj	_	_
27	that	_	WDT	WDT	_	28	nsubj	_	_
28	associates	_	VBZ	VBZ	_	26	rcmod	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	calcineurin	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	28	cc	_	_
32	is	_	VBZ	VBZ	_	34	cop	_	_
33	a	_	DT	DT	_	34	det	_	_
34	target	_	NN	NN	_	28	conj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	its	_	PRP$	PRP$	_	38	poss	_	_
37	phosphatase	_	NN	NN	_	38	nn	_	_
38	activity	_	NN	NN	_	35	pobj	_	_
39	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	PMLRARalpha	_	NN	NN	_	3	nn	_	_
3	transgene	_	NN	NN	_	4	nsubj	_	_
4	initiates	_	VBZ	VBZ	_	0	root	_	_
5	murine	_	JJ	JJ	_	8	amod	_	_
6	acute	_	JJ	JJ	_	8	amod	_	_
7	promyelocytic	_	JJ	JJ	_	8	amod	_	_
8	leukemia	_	NN	NN	_	4	dobj	_	_
9	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	malignant	_	JJ	JJ	_	3	amod	_	_
3	cells	_	NNS	NNS	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	acute	_	JJ	JJ	_	7	amod	_	_
6	promyelocytic	_	JJ	JJ	_	7	amod	_	_
7	leukemia	_	NN	NN	_	4	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	APL	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	contain	_	VBP	VBP	_	0	root	_	_
12	a	_	DT	DT	_	15	det	_	_
13	reciprocal	_	JJ	JJ	_	15	amod	_	_
14	chromosomal	_	JJ	JJ	_	13	dep	_	_
15	translocation	_	NN	NN	_	11	dobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	fuses	_	VBZ	VBZ	_	15	rcmod	_	_
18	the	_	DT	DT	_	21	det	_	_
19	promyelocytic	_	JJ	JJ	_	21	amod	_	_
20	leukemia	_	NN	NN	_	21	nn	_	_
21	gene	_	NN	NN	_	17	dobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	PML	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	with	_	IN	IN	_	17	prep	_	_
26	the	_	DT	DT	_	31	det	_	_
27	retinoic	_	JJ	JJ	_	31	amod	_	_
28	acid	_	NN	NN	_	31	nn	_	_
29	receptor	_	NN	NN	_	31	nn	_	_
30	alpha	_	NN	NN	_	31	nn	_	_
31	gene	_	NN	NN	_	25	pobj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
33	RAR	_	NN	NN	_	34	nn	_	_
34	alpha	_	NN	NN	_	31	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	.	_	.	.	_	11	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	test	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	hypothesis	_	NN	NN	_	2	dobj	_	_
5	that	_	IN	IN	_	10	mark	_	_
6	the	_	DT	DT	_	9	det	_	_
7	chimera	_	NN	NN	_	9	nn	_	_
8	PMLRAR	_	NN	NN	_	9	nn	_	_
9	alpha	_	NN	NN	_	10	nsubj	_	_
10	plays	_	VBZ	VBZ	_	4	ccomp	_	_
11	a	_	DT	DT	_	12	det	_	_
12	role	_	NN	NN	_	10	dobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	leukemogenesis	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	2	punct	_	_
16	we	_	PRP	PRP	_	17	nsubj	_	_
17	expressed	_	VBD	VBD	_	2	parataxis	_	_
18	a	_	DT	DT	_	21	det	_	_
19	PMLRAR	_	NN	NN	_	21	nn	_	_
20	alpha	_	NN	NN	_	21	nn	_	_
21	cDNA	_	NN	NN	_	17	dobj	_	_
22	in	_	IN	IN	_	17	prep	_	_
23	myeloid	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	transgenic	_	JJ	JJ	_	27	amod	_	_
27	mice	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	2	punct	_	_

1	PMLRAR	_	NN	NN	_	4	nn	_	_
2	alpha	_	NN	NN	_	4	nn	_	_
3	transgenic	_	JJ	JJ	_	4	amod	_	_
4	mice	_	NNS	NNS	_	5	nsubj	_	_
5	exhibited	_	VBD	VBD	_	0	root	_	_
6	impaired	_	JJ	JJ	_	8	amod	_	_
7	neutrophil	_	NN	NN	_	8	nn	_	_
8	maturation	_	NN	NN	_	5	dobj	_	_
9	early	_	RB	RB	_	10	advmod	_	_
10	in	_	IN	IN	_	8	prep	_	_
11	life	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	8	punct	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	progressed	_	VBD	VBD	_	8	rcmod	_	_
15	at	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	low	_	JJ	JJ	_	18	amod	_	_
18	frequency	_	NN	NN	_	15	pobj	_	_
19	over	_	IN	IN	_	14	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	course	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	several	_	JJ	JJ	_	24	amod	_	_
24	months	_	NNS	NNS	_	22	pobj	_	_
25	to	_	TO	TO	_	21	prep	_	_
26	overt	_	JJ	JJ	_	27	amod	_	_
27	APL	_	NN	NN	_	25	pobj	_	_
28	.	_	.	.	_	5	punct	_	_

1	Both	_	CC	CC	_	4	preconj	_	_
2	the	_	DT	DT	_	4	det	_	_
3	preleukemic	_	JJ	JJ	_	4	amod	_	_
4	state	_	NN	NN	_	10	nsubjpass	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	the	_	DT	DT	_	7	det	_	_
7	leukemia	_	NN	NN	_	4	conj	_	_
8	could	_	MD	MD	_	10	aux	_	_
9	be	_	VB	VB	_	10	auxpass	_	_
10	transplanted	_	VBN	VBN	_	0	root	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	nontransgenic	_	JJ	JJ	_	13	amod	_	_
13	mice	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	10	punct	_	_
15	and	_	CC	CC	_	10	cc	_	_
16	the	_	DT	DT	_	18	det	_	_
17	transplanted	_	VBN	VBN	_	18	amod	_	_
18	preleukemia	_	NN	NN	_	20	nsubj	_	_
19	could	_	MD	MD	_	20	aux	_	_
20	progress	_	VB	VB	_	10	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	APL	_	NN	NN	_	21	pobj	_	_
23	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	APL	_	NN	NN	_	3	nsubj	_	_
3	recapitulated	_	VBD	VBD	_	0	root	_	_
4	features	_	NNS	NNS	_	3	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	human	_	JJ	JJ	_	8	amod	_	_
8	disease	_	NN	NN	_	5	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	including	_	VBG	VBG	_	4	prep	_	_
11	a	_	DT	DT	_	12	det	_	_
12	response	_	NN	NN	_	10	pobj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	retinoic	_	JJ	JJ	_	15	amod	_	_
15	acid	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	Retinoic	_	JJ	JJ	_	2	amod	_	_
2	acid	_	NN	NN	_	3	nsubj	_	_
3	caused	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	leukemic	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	3	dobj	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	differentiate	_	VB	VB	_	3	xcomp	_	_
9	in	_	FW	FW	_	10	nn	_	_
10	vitro	_	FW	FW	_	8	advmod	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	in	_	FW	FW	_	13	nn	_	_
13	vivo	_	FW	FW	_	10	conj	_	_
14	,	_	,	,	_	3	punct	_	_
15	eliciting	_	VBG	VBG	_	3	xcomp	_	_
16	remissions	_	NNS	NNS	_	15	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	both	_	CC	CC	_	21	preconj	_	_
19	the	_	DT	DT	_	21	det	_	_
20	preleukemic	_	JJ	JJ	_	21	amod	_	_
21	state	_	NN	NN	_	17	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	APL	_	NN	NN	_	21	conj	_	_
24	in	_	IN	IN	_	21	prep	_	_
25	mice	_	NNS	NNS	_	24	pobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	PMLRAR	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	7	nsubj	_	_
7	impairs	_	VBZ	VBZ	_	3	ccomp	_	_
8	neutrophil	_	NN	NN	_	9	nn	_	_
9	differentiation	_	NN	NN	_	7	dobj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	initiates	_	VBZ	VBZ	_	7	conj	_	_
12	the	_	DT	DT	_	13	det	_	_
13	development	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	APL	_	NN	NN	_	14	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	transgenic	_	JJ	JJ	_	3	amod	_	_
3	mice	_	NNS	NNS	_	6	nsubj	_	_
4	described	_	VBN	VBN	_	3	vmod	_	_
5	here	_	RB	RB	_	4	advmod	_	_
6	provide	_	VBP	VBP	_	0	root	_	_
7	an	_	DT	DT	_	10	det	_	_
8	apparently	_	RB	RB	_	9	advmod	_	_
9	accurate	_	JJ	JJ	_	10	amod	_	_
10	model	_	NN	NN	_	6	dobj	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	13	amod	_	_
13	APL	_	NN	NN	_	11	pobj	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	includes	_	VBZ	VBZ	_	10	rcmod	_	_
16	clear	_	JJ	JJ	_	17	amod	_	_
17	evidence	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	tumor	_	NN	NN	_	20	nn	_	_
20	progression	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	model	_	NN	NN	_	5	nsubj	_	_
3	should	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	useful	_	JJ	JJ	_	0	root	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	exploring	_	VBG	VBG	_	6	pcomp	_	_
8	the	_	DT	DT	_	10	det	_	_
9	molecular	_	JJ	JJ	_	10	amod	_	_
10	pathogenesis	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	APL	_	NN	NN	_	11	pobj	_	_
13	and	_	CC	CC	_	10	cc	_	_
14	the	_	DT	DT	_	15	det	_	_
15	mechanisms	_	NNS	NNS	_	10	conj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	therapeutic	_	JJ	JJ	_	19	amod	_	_
19	response	_	NN	NN	_	16	pobj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	retinoic	_	JJ	JJ	_	22	amod	_	_
22	acid	_	NN	NN	_	20	pobj	_	_
23	,	_	,	,	_	6	punct	_	_
24	as	_	RB	RB	_	25	advmod	_	_
25	well	_	RB	RB	_	6	cc	_	_
26	as	_	IN	IN	_	25	mwe	_	_
27	for	_	IN	IN	_	6	conj	_	_
28	preclinical	_	JJ	JJ	_	29	amod	_	_
29	studies	_	NNS	NNS	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	therapeutic	_	JJ	JJ	_	32	amod	_	_
32	regimens	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	5	punct	_	_

1	Signal	_	NN	NN	_	2	nn	_	_
2	transducer	_	NN	NN	_	12	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	activator	_	NN	NN	_	6	nn	_	_
5	of	_	IN	IN	_	6	amod	_	_
6	transcription-3	_	NN	NN	_	2	conj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	STAT3	_	NN	NN	_	2	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	is	_	VBZ	VBZ	_	12	auxpass	_	_
11	constitutively	_	RB	RB	_	12	advmod	_	_
12	activated	_	VBN	VBN	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	normal	_	JJ	JJ	_	18	amod	_	_
15	,	_	,	,	_	18	punct	_	_
16	self-renewing	_	JJ	JJ	_	18	amod	_	_
17	B-1	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	13	pobj	_	_
19	but	_	CC	CC	_	12	cc	_	_
20	only	_	RB	RB	_	21	advmod	_	_
21	inducibly	_	RB	RB	_	22	advmod	_	_
22	expressed	_	VBN	VBN	_	12	conj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	conventional	_	JJ	JJ	_	26	amod	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	lymphocytes	_	NNS	NNS	_	23	pobj	_	_
27	-LSB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	see	_	VB	VB	_	12	parataxis	_	_
29	comments	_	NNS	NNS	_	28	dobj	_	_
30	-RSB-	_	-RRB-	-RRB-	_	28	punct	_	_

1	Cytokine	_	NN	NN	_	6	nn	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	growth	_	NN	NN	_	5	nn	_	_
4	factor	_	NN	NN	_	5	nn	_	_
5	receptor	_	NN	NN	_	1	conj	_	_
6	engagement	_	NN	NN	_	7	nsubj	_	_
7	leads	_	VBZ	VBZ	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	the	_	DT	DT	_	11	dep	_	_
10	rapid	_	JJ	JJ	_	11	amod	_	_
11	phosphorylation	_	NN	NN	_	8	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	activation	_	NN	NN	_	11	conj	_	_
14	of	_	IN	IN	_	11	prep	_	_
15	latent	_	JJ	JJ	_	19	amod	_	_
16	,	_	,	,	_	19	punct	_	_
17	cytosolic	_	JJ	JJ	_	19	amod	_	_
18	signal	_	NN	NN	_	19	nn	_	_
19	transducers	_	NNS	NNS	_	14	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	activators	_	NNS	NNS	_	27	nn	_	_
22	of	_	IN	IN	_	27	amod	_	_
23	transcription	_	NN	NN	_	27	nn	_	_
24	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
25	STAT	_	NN	NN	_	27	nn	_	_
26	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
27	proteins	_	NNS	NNS	_	19	conj	_	_
28	,	_	,	,	_	11	punct	_	_
29	which	_	WDT	WDT	_	31	nsubj	_	_
30	then	_	RB	RB	_	31	advmod	_	_
31	translocate	_	VBP	VBP	_	11	rcmod	_	_
32	to	_	TO	TO	_	31	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	nucleus	_	NN	NN	_	32	pobj	_	_
35	where	_	WRB	WRB	_	37	advmod	_	_
36	they	_	PRP	PRP	_	37	nsubj	_	_
37	regulate	_	VBP	VBP	_	34	rcmod	_	_
38	transcriptional	_	JJ	JJ	_	39	amod	_	_
39	events	_	NNS	NNS	_	37	dobj	_	_
40	from	_	IN	IN	_	39	prep	_	_
41	specific	_	JJ	JJ	_	43	amod	_	_
42	promoter	_	NN	NN	_	43	nn	_	_
43	sequences	_	NNS	NNS	_	40	pobj	_	_
44	.	_	.	.	_	7	punct	_	_

1	STAT3	_	NN	NN	_	2	nn	_	_
2	expression	_	NN	NN	_	7	nsubjpass	_	_
3	in	_	IN	IN	_	7	prep	_	_
4	particular	_	JJ	JJ	_	3	pobj	_	_
5	has	_	VBZ	VBZ	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	associated	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	Abl	_	NN	NN	_	15	nn	_	_
10	,	_	,	,	_	9	punct	_	_
11	Src	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	HTLV-1	_	NN	NN	_	9	conj	_	_
15	transformation	_	NN	NN	_	8	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	normal	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	7	punct	_	_

1	B-1	_	NN	NN	_	2	nn	_	_
2	lymphocytes	_	NNS	NNS	_	8	nsubj	_	_
3	are	_	VBP	VBP	_	8	cop	_	_
4	self-renewing	_	JJ	JJ	_	8	amod	_	_
5	,	_	,	,	_	8	punct	_	_
6	CD5+	_	JJ	JJ	_	8	amod	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	0	root	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	display	_	VBP	VBP	_	8	rcmod	_	_
11	a	_	DT	DT	_	12	det	_	_
12	propensity	_	NN	NN	_	10	dobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	malignant	_	JJ	JJ	_	15	amod	_	_
15	transformation	_	NN	NN	_	13	pobj	_	_
16	and	_	CC	CC	_	10	cc	_	_
17	are	_	VBP	VBP	_	20	cop	_	_
18	the	_	DT	DT	_	20	det	_	_
19	normal	_	JJ	JJ	_	20	amod	_	_
20	counterpart	_	NN	NN	_	10	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	human	_	JJ	JJ	_	25	amod	_	_
23	chronic	_	JJ	JJ	_	25	amod	_	_
24	lymphocytic	_	JJ	JJ	_	25	amod	_	_
25	leukemias	_	NNS	NNS	_	21	pobj	_	_
26	.	_	.	.	_	8	punct	_	_

1	Further	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	B-1	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	6	nsubjpass	_	_
5	are	_	VBP	VBP	_	6	auxpass	_	_
6	characterized	_	VBN	VBN	_	0	root	_	_
7	by	_	IN	IN	_	6	prep	_	_
8	aberrant	_	JJ	JJ	_	10	amod	_	_
9	intracellular	_	JJ	JJ	_	10	amod	_	_
10	signaling	_	NN	NN	_	7	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	including	_	VBG	VBG	_	10	prep	_	_
13	hyperresponsiveness	_	NN	NN	_	12	pobj	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	phorbol	_	NN	NN	_	18	nn	_	_
16	ester	_	NN	NN	_	18	nn	_	_
17	PKC	_	NN	NN	_	18	nn	_	_
18	agonists	_	NNS	NNS	_	14	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	B-1	_	NN	NN	_	6	nn	_	_
6	lymphocytes	_	NNS	NNS	_	8	nsubj	_	_
7	constitutively	_	RB	RB	_	8	advmod	_	_
8	express	_	VBP	VBP	_	3	ccomp	_	_
9	nuclear	_	JJ	JJ	_	11	amod	_	_
10	activated	_	VBN	VBN	_	11	amod	_	_
11	STAT3	_	NN	NN	_	8	dobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	which	_	WDT	WDT	_	16	nsubjpass	_	_
14	is	_	VBZ	VBZ	_	16	auxpass	_	_
15	not	_	RB	RB	_	16	neg	_	_
16	expressed	_	VBN	VBN	_	11	rcmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	unmanipulated	_	JJ	JJ	_	23	amod	_	_
19	conventional	_	JJ	JJ	_	23	amod	_	_
20	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	B-2	_	NN	NN	_	23	nn	_	_
22	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
23	lymphocytes	_	NNS	NNS	_	17	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	7	punct	_	_
4	STAT3	_	NN	NN	_	5	nn	_	_
5	activation	_	NN	NN	_	7	nsubjpass	_	_
6	is	_	VBZ	VBZ	_	7	auxpass	_	_
7	induced	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	B-2	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	after	_	IN	IN	_	7	prep	_	_
12	antigen	_	NN	NN	_	14	nn	_	_
13	receptor	_	NN	NN	_	14	nn	_	_
14	engagement	_	NN	NN	_	11	pobj	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	delayed	_	JJ	JJ	_	18	amod	_	_
18	fashion	_	NN	NN	_	15	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	after	_	IN	IN	_	15	dep	_	_
21	3	_	CD	CD	_	22	num	_	_
22	h	_	NN	NN	_	20	pobj	_	_
23	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
24	.	_	.	.	_	7	punct	_	_

1	Induction	_	NN	NN	_	5	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	STAT3	_	NN	NN	_	2	pobj	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	inhibited	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	both	_	CC	CC	_	12	preconj	_	_
8	the	_	DT	DT	_	12	det	_	_
9	serine/threonine	_	NN	NN	_	12	nn	_	_
10	protein	_	NN	NN	_	12	nn	_	_
11	kinase	_	NN	NN	_	12	nn	_	_
12	inhibitor	_	NN	NN	_	6	pobj	_	_
13	H-7	_	NN	NN	_	12	dep	_	_
14	and	_	CC	CC	_	12	cc	_	_
15	the	_	DT	DT	_	17	det	_	_
16	immunosuppressive	_	JJ	JJ	_	17	amod	_	_
17	drug	_	NN	NN	_	12	conj	_	_
18	rapamycin	_	NN	NN	_	17	dep	_	_
19	and	_	CC	CC	_	5	cc	_	_
20	requires	_	VBZ	VBZ	_	5	conj	_	_
21	de	_	FW	FW	_	24	amod	_	_
22	novo	_	FW	FW	_	21	dep	_	_
23	protein	_	NN	NN	_	24	nn	_	_
24	synthesis	_	NN	NN	_	20	dobj	_	_
25	,	_	,	,	_	20	punct	_	_
26	demonstrating	_	VBG	VBG	_	20	vmod	_	_
27	novel	_	JJ	JJ	_	28	amod	_	_
28	coupling	_	NN	NN	_	26	dobj	_	_
29	between	_	IN	IN	_	28	prep	_	_
30	sIg	_	NN	NN	_	29	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	STAT	_	NN	NN	_	33	nn	_	_
33	proteins	_	NNS	NNS	_	30	conj	_	_
34	that	_	WDT	WDT	_	35	nsubj	_	_
35	differs	_	VBZ	VBZ	_	28	rcmod	_	_
36	from	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	classical	_	JJ	JJ	_	39	amod	_	_
39	paradigm	_	NN	NN	_	36	pobj	_	_
40	for	_	IN	IN	_	39	prep	_	_
41	STAT	_	NN	NN	_	42	nn	_	_
42	induction	_	NN	NN	_	40	pobj	_	_
43	by	_	IN	IN	_	42	prep	_	_
44	cytokine	_	NN	NN	_	45	nn	_	_
45	receptors	_	NNS	NNS	_	43	pobj	_	_
46	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	inability	_	NN	NN	_	27	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	prolonged	_	JJ	JJ	_	5	amod	_	_
5	stimulation	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	conventional	_	JJ	JJ	_	9	amod	_	_
8	B-2	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	6	pobj	_	_
10	with	_	IN	IN	_	5	prep	_	_
11	anti-Ig	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	a	_	DT	DT	_	14	det	_	_
14	treatment	_	NN	NN	_	5	appos	_	_
15	sufficient	_	JJ	JJ	_	14	amod	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	induce	_	VB	VB	_	15	dep	_	_
18	CD5	_	NN	NN	_	19	nn	_	_
19	expression	_	NN	NN	_	17	dobj	_	_
20	,	_	,	,	_	17	punct	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	result	_	VB	VB	_	17	dep	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	sustained	_	JJ	JJ	_	26	amod	_	_
25	STAT3	_	NN	NN	_	26	nn	_	_
26	activation	_	NN	NN	_	23	pobj	_	_
27	suggests	_	VBZ	VBZ	_	0	root	_	_
28	that	_	IN	IN	_	34	mark	_	_
29	STAT3	_	NN	NN	_	34	nsubj	_	_
30	is	_	VBZ	VBZ	_	34	cop	_	_
31	a	_	DT	DT	_	34	det	_	_
32	specific	_	JJ	JJ	_	34	amod	_	_
33	nuclear	_	JJ	JJ	_	34	amod	_	_
34	marker	_	NN	NN	_	27	ccomp	_	_
35	for	_	IN	IN	_	34	prep	_	_
36	B-1	_	NN	NN	_	37	nn	_	_
37	cells	_	NNS	NNS	_	35	pobj	_	_
38	.	_	.	.	_	27	punct	_	_

1	Thus	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	STAT3	_	NN	NN	_	5	nsubj	_	_
4	may	_	MD	MD	_	5	aux	_	_
5	play	_	VB	VB	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	role	_	NN	NN	_	5	dobj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	B	_	NN	NN	_	13	nn	_	_
10	cell	_	NN	NN	_	13	nn	_	_
11	antigen-specific	_	JJ	JJ	_	13	amod	_	_
12	signaling	_	NN	NN	_	13	nn	_	_
13	responses	_	NNS	NNS	_	8	pobj	_	_
14	,	_	,	,	_	5	punct	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	its	_	PRP$	PRP$	_	18	poss	_	_
17	constitutive	_	JJ	JJ	_	18	amod	_	_
18	activation	_	NN	NN	_	20	nsubjpass	_	_
19	is	_	VBZ	VBZ	_	20	auxpass	_	_
20	associated	_	VBN	VBN	_	5	conj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	normal	_	JJ	JJ	_	25	amod	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	population	_	NN	NN	_	21	pobj	_	_
26	exhibiting	_	VBG	VBG	_	25	vmod	_	_
27	intrinsic	_	JJ	JJ	_	29	amod	_	_
28	proliferative	_	JJ	JJ	_	29	amod	_	_
29	behavior	_	NN	NN	_	26	dobj	_	_
30	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	T	_	NN	NN	_	5	nn	_	_
3	cell	_	NN	NN	_	5	nn	_	_
4	activation	_	NN	NN	_	5	nn	_	_
5	factor	_	NN	NN	_	8	nsubj	_	_
6	NF-ATc	_	NN	NN	_	5	dep	_	_
7	positively	_	RB	RB	_	8	advmod	_	_
8	regulates	_	VBZ	VBZ	_	0	root	_	_
9	HIV-1	_	NN	NN	_	8	dobj	_	_
10	replication	_	NN	NN	_	9	dep	_	_
11	and	_	CC	CC	_	9	cc	_	_
12	gene	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	9	conj	_	_
14	in	_	IN	IN	_	9	prep	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Clinical	_	JJ	JJ	_	2	amod	_	_
2	deterioration	_	NN	NN	_	14	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	human	_	JJ	JJ	_	7	amod	_	_
5	immunodeficiency	_	NN	NN	_	7	nn	_	_
6	virus	_	NN	NN	_	7	nn	_	_
7	type	_	NN	NN	_	12	nn	_	_
8	1	_	CD	CD	_	7	num	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	HIV-1	_	NN	NN	_	7	appos	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	infection	_	NN	NN	_	3	pobj	_	_
13	is	_	VBZ	VBZ	_	14	auxpass	_	_
14	associated	_	VBN	VBN	_	0	root	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	increased	_	VBN	VBN	_	17	amod	_	_
17	levels	_	NNS	NNS	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	viral	_	JJ	JJ	_	20	amod	_	_
20	replication	_	NN	NN	_	18	pobj	_	_
21	and	_	CC	CC	_	17	cc	_	_
22	burden	_	NN	NN	_	17	conj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	dep	_	_
25	peripheral	_	JJ	JJ	_	26	amod	_	_
26	blood	_	NN	NN	_	23	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	lymphoid	_	JJ	JJ	_	29	amod	_	_
29	organs	_	NNS	NNS	_	26	conj	_	_
30	.	_	.	.	_	14	punct	_	_

1	T	_	NN	NN	_	3	nn	_	_
2	cell	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	11	nsubj	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	ensuing	_	JJ	JJ	_	8	amod	_	_
6	cellular	_	JJ	JJ	_	8	amod	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	activation	_	NN	NN	_	3	conj	_	_
9	can	_	MD	MD	_	11	aux	_	_
10	be	_	VB	VB	_	11	cop	_	_
11	critical	_	JJ	JJ	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	HIV-1	_	NN	NN	_	14	nn	_	_
14	replication	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	hypothesis	_	NN	NN	_	20	nsubj	_	_
3	that	_	IN	IN	_	15	mark	_	_
4	the	_	DT	DT	_	10	det	_	_
5	nuclear	_	JJ	JJ	_	10	amod	_	_
6	factor	_	NN	NN	_	10	nn	_	_
7	of	_	IN	IN	_	10	amod	_	_
8	activated	_	VBN	VBN	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	15	nsubj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	NF-AT	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	may	_	MD	MD	_	15	aux	_	_
15	influence	_	VB	VB	_	2	ccomp	_	_
16	HIV-1	_	NN	NN	_	17	nn	_	_
17	replication	_	NN	NN	_	15	dobj	_	_
18	is	_	VBZ	VBZ	_	20	cop	_	_
19	therefore	_	RB	RB	_	20	advmod	_	_
20	compelling	_	JJ	JJ	_	0	root	_	_
21	given	_	VBN	VBN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	tight	_	JJ	JJ	_	24	amod	_	_
24	correlation	_	NN	NN	_	21	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	HIV-1	_	NN	NN	_	28	nn	_	_
27	transcriptional	_	JJ	JJ	_	28	amod	_	_
28	induction	_	NN	NN	_	25	pobj	_	_
29	to	_	TO	TO	_	24	prep	_	_
30	T	_	NN	NN	_	32	nn	_	_
31	cell	_	NN	NN	_	32	nn	_	_
32	activation	_	NN	NN	_	29	pobj	_	_
33	.	_	.	.	_	20	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	12	mark	_	_
4	certain	_	JJ	JJ	_	10	amod	_	_
5	NF-AT	_	NN	NN	_	10	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
7	Rel	_	NN	NN	_	10	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
9	family	_	NN	NN	_	10	nn	_	_
10	members	_	NNS	NNS	_	12	nsubj	_	_
11	productively	_	RB	RB	_	12	advmod	_	_
12	bind	_	VBP	VBP	_	2	ccomp	_	_
13	the	_	DT	DT	_	16	det	_	_
14	kappaB	_	NN	NN	_	16	nn	_	_
15	regulatory	_	JJ	JJ	_	16	amod	_	_
16	elements	_	NNS	NNS	_	12	dobj	_	_
17	,	_	,	,	_	12	punct	_	_
18	synergize	_	VBP	VBP	_	12	conj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	NF-kappaB	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	Tat	_	NN	NN	_	20	conj	_	_
23	in	_	IN	IN	_	20	prep	_	_
24	transcriptional	_	JJ	JJ	_	25	amod	_	_
25	activation	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	HIV-1	_	NN	NN	_	26	pobj	_	_
28	,	_	,	,	_	12	punct	_	_
29	and	_	CC	CC	_	12	cc	_	_
30	enhance	_	VBP	VBP	_	12	conj	_	_
31	HIV-1	_	NN	NN	_	32	nn	_	_
32	replication	_	NN	NN	_	30	dobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	T	_	NN	NN	_	35	nn	_	_
35	cells	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	2	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	link	_	VBP	VBP	_	0	root	_	_
4	regulatory	_	JJ	JJ	_	5	amod	_	_
5	factors	_	NNS	NNS	_	3	dobj	_	_
6	critical	_	JJ	JJ	_	5	amod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	T	_	NN	NN	_	10	nn	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	commitment	_	NN	NN	_	7	pobj	_	_
11	directly	_	RB	RB	_	3	advmod	_	_
12	to	_	TO	TO	_	3	prep	_	_
13	HIV-1	_	NN	NN	_	14	nn	_	_
14	replication	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	ALY	_	NN	NN	_	12	nsubjpass	_	_
2	,	_	,	,	_	1	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	context-dependent	_	JJ	JJ	_	5	amod	_	_
5	coactivator	_	NN	NN	_	1	appos	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	LEF-1	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	AML-1	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	1	punct	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	required	_	VBN	VBN	_	0	root	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	TCRalpha	_	NN	NN	_	15	nn	_	_
15	enhancer	_	NN	NN	_	16	nn	_	_
16	function	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	12	punct	_	_

1	LEF-1	_	NN	NN	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	a	_	DT	DT	_	5	det	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factor	_	NN	NN	_	0	root	_	_
6	that	_	WDT	WDT	_	7	nsubj	_	_
7	participates	_	VBZ	VBZ	_	5	rcmod	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	regulation	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	20	det	_	_
13	T-cell	_	NN	NN	_	20	nn	_	_
14	receptor	_	NN	NN	_	20	nn	_	_
15	alpha	_	NN	NN	_	20	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
17	TCR	_	NN	NN	_	20	nn	_	_
18	alpha	_	NN	NN	_	20	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
20	enhancer	_	NN	NN	_	11	pobj	_	_
21	by	_	IN	IN	_	7	prep	_	_
22	facilitating	_	VBG	VBG	_	21	pcomp	_	_
23	the	_	DT	DT	_	24	det	_	_
24	assembly	_	NN	NN	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	multiple	_	JJ	JJ	_	27	amod	_	_
27	proteins	_	NNS	NNS	_	25	pobj	_	_
28	into	_	IN	IN	_	22	prep	_	_
29	a	_	DT	DT	_	31	det	_	_
30	higher	_	JJR	JJR	_	31	amod	_	_
31	order	_	NN	NN	_	28	pobj	_	_
32	nucleoprotein	_	NN	NN	_	33	nn	_	_
33	complex	_	NN	NN	_	31	dep	_	_
34	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	function	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	LEF-1	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	dependent	_	JJ	JJ	_	0	root	_	_
7	,	_	,	,	_	6	punct	_	_
8	in	_	IN	IN	_	6	prep	_	_
9	part	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	6	punct	_	_
11	on	_	IN	IN	_	6	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	HMG	_	NN	NN	_	14	nn	_	_
14	domain	_	NN	NN	_	11	pobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	induces	_	VBZ	VBZ	_	14	rcmod	_	_
17	a	_	DT	DT	_	19	det	_	_
18	sharp	_	JJ	JJ	_	19	amod	_	_
19	bend	_	NN	NN	_	16	dobj	_	_
20	in	_	IN	IN	_	16	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	DNA	_	NN	NN	_	23	nn	_	_
23	helix	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	11	punct	_	_
25	and	_	CC	CC	_	11	cc	_	_
26	on	_	IN	IN	_	11	conj	_	_
27	an	_	DT	DT	_	29	det	_	_
28	activation	_	NN	NN	_	29	nn	_	_
29	domain	_	NN	NN	_	26	pobj	_	_
30	that	_	WDT	WDT	_	31	nsubj	_	_
31	stimulates	_	VBZ	VBZ	_	29	rcmod	_	_
32	transcription	_	NN	NN	_	31	dobj	_	_
33	only	_	RB	RB	_	34	advmod	_	_
34	in	_	IN	IN	_	31	prep	_	_
35	a	_	DT	DT	_	37	det	_	_
36	specific	_	JJ	JJ	_	37	amod	_	_
37	context	_	NN	NN	_	34	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	other	_	JJ	JJ	_	41	amod	_	_
40	enhancer-binding	_	JJ	JJ	_	41	amod	_	_
41	proteins	_	NNS	NNS	_	38	pobj	_	_
42	.	_	.	.	_	6	punct	_	_

1	With	_	IN	IN	_	16	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	aim	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	gaining	_	VBG	VBG	_	4	pcomp	_	_
6	insight	_	NN	NN	_	5	dobj	_	_
7	into	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	function	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	context-dependent	_	JJ	JJ	_	13	amod	_	_
12	activation	_	NN	NN	_	13	nn	_	_
13	domains	_	NNS	NNS	_	10	pobj	_	_
14	,	_	,	,	_	16	punct	_	_
15	we	_	PRP	PRP	_	16	nsubj	_	_
16	cloned	_	VBD	VBD	_	0	root	_	_
17	ALY	_	NN	NN	_	16	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	a	_	DT	DT	_	22	det	_	_
20	novel	_	JJ	JJ	_	22	amod	_	_
21	LEF-1-interacting	_	JJ	JJ	_	22	amod	_	_
22	protein	_	NN	NN	_	17	appos	_	_
23	.	_	.	.	_	16	punct	_	_

1	ALY	_	NN	NN	_	8	nsubj	_	_
2	is	_	VBZ	VBZ	_	8	cop	_	_
3	a	_	DT	DT	_	8	det	_	_
4	ubiquitously	_	RB	RB	_	5	advmod	_	_
5	expressed	_	VBN	VBN	_	8	amod	_	_
6	,	_	,	,	_	5	punct	_	_
7	nuclear	_	JJ	JJ	_	5	dep	_	_
8	protein	_	NN	NN	_	0	root	_	_
9	that	_	WDT	WDT	_	11	nsubj	_	_
10	specifically	_	RB	RB	_	11	advmod	_	_
11	associates	_	VBZ	VBZ	_	8	rcmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	activation	_	NN	NN	_	15	nn	_	_
15	domains	_	NNS	NNS	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	LEF-1	_	NN	NN	_	16	pobj	_	_
18	and	_	CC	CC	_	17	cc	_	_
19	AML-1	_	NN	NN	_	17	conj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
21	CBF	_	NN	NN	_	22	nn	_	_
22	alpha2	_	NN	NN	_	15	dep	_	_
23	,	_	,	,	_	22	punct	_	_
24	PEBP2	_	NN	NN	_	25	nn	_	_
25	alpha	_	NN	NN	_	27	nn	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	B	_	NN	NN	_	22	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	,	_	,	,	_	8	punct	_	_
30	which	_	WDT	WDT	_	34	nsubj	_	_
31	is	_	VBZ	VBZ	_	34	cop	_	_
32	another	_	DT	DT	_	34	det	_	_
33	protein	_	NN	NN	_	34	nn	_	_
34	component	_	NN	NN	_	8	rcmod	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	the	_	DT	DT	_	40	det	_	_
37	TCR	_	NN	NN	_	40	nn	_	_
38	alpha	_	NN	NN	_	40	nn	_	_
39	enhancer	_	NN	NN	_	40	nn	_	_
40	complex	_	NN	NN	_	35	pobj	_	_
41	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	ALY	_	NN	NN	_	6	nsubj	_	_
5	can	_	MD	MD	_	6	aux	_	_
6	increase	_	VB	VB	_	0	root	_	_
7	DNA	_	NN	NN	_	8	nn	_	_
8	binding	_	NN	NN	_	6	dobj	_	_
9	by	_	IN	IN	_	6	prep	_	_
10	both	_	CC	CC	_	11	preconj	_	_
11	LEF-1	_	NN	NN	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	AML	_	NN	NN	_	14	nn	_	_
14	proteins	_	NNS	NNS	_	11	conj	_	_
15	.	_	.	.	_	6	punct	_	_

1	Overexpression	_	NN	NN	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	ALY	_	NN	NN	_	2	pobj	_	_
4	stimulates	_	VBZ	VBZ	_	0	root	_	_
5	the	_	DT	DT	_	6	det	_	_
6	activity	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	12	det	_	_
9	TCR	_	NN	NN	_	12	nn	_	_
10	alpha	_	NN	NN	_	12	nn	_	_
11	enhancer	_	NN	NN	_	12	nn	_	_
12	complex	_	NN	NN	_	7	pobj	_	_
13	reconstituted	_	VBN	VBN	_	12	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	transfected	_	VBN	VBN	_	18	amod	_	_
16	nonlymphoid	_	JJ	JJ	_	18	amod	_	_
17	HeLa	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	14	pobj	_	_
19	,	_	,	,	_	4	punct	_	_
20	whereas	_	IN	IN	_	28	mark	_	_
21	down-regulation	_	NN	NN	_	28	nsubj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	ALY	_	NN	NN	_	22	pobj	_	_
24	by	_	IN	IN	_	21	prep	_	_
25	anti-sense	_	JJ	JJ	_	26	amod	_	_
26	oligonucleotides	_	NNS	NNS	_	24	pobj	_	_
27	virtually	_	RB	RB	_	28	advmod	_	_
28	eliminates	_	VBZ	VBZ	_	4	advcl	_	_
29	TCR	_	NN	NN	_	31	nn	_	_
30	alpha	_	NN	NN	_	31	nn	_	_
31	enhancer	_	NN	NN	_	32	nn	_	_
32	activity	_	NN	NN	_	28	dobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	T	_	NN	NN	_	35	nn	_	_
35	cells	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	Similar	_	JJ	JJ	_	7	advmod	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	LEF-1	_	NN	NN	_	2	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	ALY	_	NN	NN	_	7	nsubj	_	_
6	can	_	MD	MD	_	7	aux	_	_
7	stimulate	_	VB	VB	_	0	root	_	_
8	transcription	_	NN	NN	_	7	dobj	_	_
9	in	_	IN	IN	_	7	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	context	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	TCR	_	NN	NN	_	16	nn	_	_
15	alpha	_	NN	NN	_	16	nn	_	_
16	enhancer	_	NN	NN	_	12	pobj	_	_
17	but	_	CC	CC	_	21	cc	_	_
18	apparently	_	RB	RB	_	21	dep	_	_
19	not	_	RB	RB	_	21	dep	_	_
20	when	_	WRB	WRB	_	21	advmod	_	_
21	tethered	_	VBN	VBN	_	7	parataxis	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	DNA	_	NN	NN	_	22	pobj	_	_
24	through	_	IN	IN	_	21	prep	_	_
25	an	_	DT	DT	_	28	det	_	_
26	heterologous	_	JJ	JJ	_	28	amod	_	_
27	DNA-binding	_	JJ	JJ	_	28	amod	_	_
28	domain	_	NN	NN	_	24	pobj	_	_
29	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	ALY	_	NN	NN	_	5	nsubj	_	_
5	mediates	_	VBZ	VBZ	_	2	ccomp	_	_
6	context-dependent	_	JJ	JJ	_	8	amod	_	_
7	transcriptional	_	JJ	JJ	_	6	dep	_	_
8	activation	_	NN	NN	_	5	dobj	_	_
9	by	_	IN	IN	_	5	prep	_	_
10	facilitating	_	VBG	VBG	_	9	pcomp	_	_
11	the	_	DT	DT	_	13	det	_	_
12	functional	_	JJ	JJ	_	13	amod	_	_
13	collaboration	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	multiple	_	JJ	JJ	_	16	amod	_	_
16	proteins	_	NNS	NNS	_	14	pobj	_	_
17	in	_	IN	IN	_	10	prep	_	_
18	the	_	DT	DT	_	22	det	_	_
19	TCR	_	NN	NN	_	22	nn	_	_
20	alpha	_	NN	NN	_	22	nn	_	_
21	enhancer	_	NN	NN	_	22	nn	_	_
22	complex	_	NN	NN	_	17	pobj	_	_
23	.	_	.	.	_	2	punct	_	_

1	Differentiation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	T-helper	_	NN	NN	_	4	nn	_	_
4	lymphocytes	_	NNS	NNS	_	2	pobj	_	_
5	:	_	:	:	_	1	punct	_	_
6	selective	_	JJ	JJ	_	7	amod	_	_
7	regulation	_	NN	NN	_	1	dep	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	members	_	NNS	NNS	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	STAT	_	NN	NN	_	13	nn	_	_
13	family	_	NN	NN	_	10	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	transcription	_	NN	NN	_	16	nn	_	_
16	factors	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Interleukin-4	_	NN	NN	_	10	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-4	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	and	_	CC	CC	_	1	cc	_	_
6	interleukin-12	_	NN	NN	_	1	conj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	IL-12	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	control	_	VBP	VBP	_	0	root	_	_
11	the	_	DT	DT	_	12	det	_	_
12	differentiation	_	NN	NN	_	10	dobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	T-helper	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	10	punct	_	_

1	Here	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	summarize	_	VBP	VBP	_	0	root	_	_
4	studies	_	NNS	NNS	_	3	dobj	_	_
5	which	_	WDT	WDT	_	6	nsubj	_	_
6	investigate	_	VBP	VBP	_	4	rcmod	_	_
7	the	_	DT	DT	_	8	det	_	_
8	mechanism	_	NN	NN	_	6	dobj	_	_
9	by	_	IN	IN	_	14	prep	_	_
10	which	_	WDT	WDT	_	9	pobj	_	_
11	these	_	DT	DT	_	12	det	_	_
12	cytokines	_	NNS	NNS	_	14	nsubj	_	_
13	selectively	_	RB	RB	_	14	advmod	_	_
14	reprogramme	_	VBP	VBP	_	8	rcmod	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	expression	_	NN	NN	_	14	dobj	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	T-lymphocytes	_	NNS	NNS	_	17	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	Cytokine	_	NN	NN	_	2	nn	_	_
2	stimulation	_	NN	NN	_	3	nsubj	_	_
3	leads	_	VBZ	VBZ	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	phosphorylation	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	specific	_	JJ	JJ	_	10	amod	_	_
9	tyrosine	_	NN	NN	_	10	nn	_	_
10	residues	_	NNS	NNS	_	7	pobj	_	_
11	within	_	IN	IN	_	6	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	intracellular	_	JJ	JJ	_	14	amod	_	_
14	domain	_	NN	NN	_	11	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	corresponding	_	JJ	JJ	_	19	amod	_	_
18	cytokine	_	NN	NN	_	19	nn	_	_
19	receptor	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	phosphotyrosines	_	NNS	NNS	_	3	nsubj	_	_
3	serve	_	VBP	VBP	_	0	root	_	_
4	as	_	IN	IN	_	3	prep	_	_
5	docking	_	NN	NN	_	6	nn	_	_
6	sites	_	NNS	NNS	_	4	pobj	_	_
7	for	_	IN	IN	_	6	prep	_	_
8	latent	_	JJ	JJ	_	12	amod	_	_
9	,	_	,	,	_	12	punct	_	_
10	cytoplasmic	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	7	pobj	_	_
13	known	_	VBN	VBN	_	12	vmod	_	_
14	as	_	IN	IN	_	13	prep	_	_
15	signal	_	NN	NN	_	16	nn	_	_
16	transducers	_	NNS	NNS	_	14	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	activators	_	NNS	NNS	_	24	nn	_	_
19	of	_	IN	IN	_	24	amod	_	_
20	transcription	_	NN	NN	_	24	nn	_	_
21	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
22	Stat	_	NN	NN	_	24	nn	_	_
23	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
24	proteins	_	NNS	NNS	_	16	conj	_	_
25	.	_	.	.	_	3	punct	_	_

1	Receptor/Stat	_	NN	NN	_	2	nn	_	_
2	interaction	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	mediated	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	13	det	_	_
7	src	_	NN	NN	_	13	nn	_	_
8	homology	_	NN	NN	_	13	nn	_	_
9	2	_	CD	CD	_	13	num	_	_
10	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
11	SH2	_	NN	NN	_	13	nn	_	_
12	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
13	domain	_	NN	NN	_	5	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	corresponding	_	JJ	JJ	_	18	amod	_	_
17	Stat	_	NN	NN	_	18	nn	_	_
18	protein	_	NN	NN	_	14	pobj	_	_
19	.	_	.	.	_	4	punct	_	_

1	Although	_	IN	IN	_	13	mark	_	_
2	Stat	_	NN	NN	_	13	nsubj	_	_
3	binding	_	VBG	VBG	_	2	vmod	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	intracellular	_	JJ	JJ	_	7	amod	_	_
7	domain	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	cytokine	_	NN	NN	_	11	nn	_	_
11	receptor	_	NN	NN	_	8	pobj	_	_
12	strongly	_	RB	RB	_	13	advmod	_	_
13	depends	_	VBZ	VBZ	_	27	advcl	_	_
14	on	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	phosphotyrosine	_	NN	NN	_	17	nn	_	_
17	residue	_	NN	NN	_	14	pobj	_	_
18	,	_	,	,	_	27	punct	_	_
19	the	_	DT	DT	_	20	det	_	_
20	recruitment	_	NN	NN	_	27	nsubjpass	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	25	det	_	_
23	specific	_	JJ	JJ	_	25	amod	_	_
24	Stat	_	NN	NN	_	25	nn	_	_
25	protein	_	NN	NN	_	21	pobj	_	_
26	is	_	VBZ	VBZ	_	27	auxpass	_	_
27	dictated	_	VBN	VBN	_	0	root	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	amino	_	NN	NN	_	31	nn	_	_
30	acid	_	NN	NN	_	31	nn	_	_
31	residues	_	NNS	NNS	_	28	pobj	_	_
32	C-terminal	_	JJ	JJ	_	31	amod	_	_
33	to	_	TO	TO	_	27	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	phosphotyrosine	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	27	punct	_	_

1	Specific	_	JJ	JJ	_	3	amod	_	_
2	docking	_	NN	NN	_	3	nn	_	_
3	sites	_	NNS	NNS	_	10	nsubjpass	_	_
4	within	_	IN	IN	_	3	prep	_	_
5	individual	_	JJ	JJ	_	7	amod	_	_
6	cytokine	_	NN	NN	_	7	nn	_	_
7	receptors	_	NNS	NNS	_	4	pobj	_	_
8	have	_	VBP	VBP	_	10	aux	_	_
9	been	_	VBN	VBN	_	10	auxpass	_	_
10	identified	_	VBN	VBN	_	0	root	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	almost	_	RB	RB	_	13	advmod	_	_
13	all	_	DT	DT	_	15	amod	_	_
14	Stat	_	NN	NN	_	15	nn	_	_
15	proteins	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	10	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	direct	_	JJ	JJ	_	3	amod	_	_
3	coupling	_	NN	NN	_	10	nsubj	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	cytokine	_	NN	NN	_	6	nn	_	_
6	receptor	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	transcription	_	NN	NN	_	9	nn	_	_
9	factor	_	NN	NN	_	6	conj	_	_
10	helps	_	VBZ	VBZ	_	0	root	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	explain	_	VB	VB	_	10	xcomp	_	_
13	how	_	WRB	WRB	_	14	advmod	_	_
14	different	_	JJ	JJ	_	15	amod	_	_
15	cytokines	_	NNS	NNS	_	16	nsubj	_	_
16	elicit	_	VBP	VBP	_	12	ccomp	_	_
17	distinct	_	JJ	JJ	_	18	amod	_	_
18	patterns	_	NNS	NNS	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	10	punct	_	_

1	Cell-to-cell	_	JJ	JJ	_	2	amod	_	_
2	contact	_	NN	NN	_	3	nsubj	_	_
3	activates	_	VBZ	VBZ	_	0	root	_	_
4	the	_	DT	DT	_	7	det	_	_
5	long	_	JJ	JJ	_	7	amod	_	_
6	terminal	_	JJ	JJ	_	7	amod	_	_
7	repeat	_	NN	NN	_	3	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	immunodeficiency	_	NN	NN	_	11	nn	_	_
11	virus	_	NN	NN	_	8	pobj	_	_
12	1	_	CD	CD	_	11	num	_	_
13	through	_	IN	IN	_	3	prep	_	_
14	its	_	PRP$	PRP$	_	16	poss	_	_
15	kappaB	_	NN	NN	_	16	nn	_	_
16	motif	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	Cell-to-cell	_	JJ	JJ	_	2	amod	_	_
2	contact	_	NN	NN	_	15	nsubj	_	_
3	between	_	IN	IN	_	2	prep	_	_
4	peripheral	_	JJ	JJ	_	6	amod	_	_
5	blood	_	NN	NN	_	6	nn	_	_
6	lymphocytes	_	NNS	NNS	_	3	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	transfected	_	VBN	VBN	_	14	amod	_	_
9	human	_	JJ	JJ	_	14	amod	_	_
10	colonic	_	JJ	JJ	_	14	amod	_	_
11	carcinoma	_	NN	NN	_	14	nn	_	_
12	cell	_	NN	NN	_	14	nn	_	_
13	line	_	NN	NN	_	14	nn	_	_
14	HT29	_	NN	NN	_	6	conj	_	_
15	activates	_	VBZ	VBZ	_	0	root	_	_
16	transcription	_	NN	NN	_	15	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	long	_	JJ	JJ	_	21	amod	_	_
20	terminal	_	JJ	JJ	_	21	amod	_	_
21	repeats	_	NNS	NNS	_	17	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	LTR	_	NNS	NNS	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	of	_	IN	IN	_	21	prep	_	_
26	human	_	JJ	JJ	_	28	amod	_	_
27	immunodeficiency	_	NN	NN	_	28	nn	_	_
28	virus	_	NN	NN	_	25	pobj	_	_
29	.	_	.	.	_	15	punct	_	_

1	HIV-1	_	NN	NN	_	2	nn	_	_
2	LTR	_	NNS	NNS	_	3	nn	_	_
3	transcription	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	controlled	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	9	det	_	_
8	complex	_	JJ	JJ	_	9	amod	_	_
9	array	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	virus-encoded	_	JJ	JJ	_	10	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	cellular	_	JJ	JJ	_	11	conj	_	_
14	proteins	_	NNS	NNS	_	11	dep	_	_
15	.	_	.	.	_	5	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	various	_	JJ	JJ	_	3	amod	_	_
3	constructs	_	NNS	NNS	_	1	dobj	_	_
4	expressing	_	VBG	VBG	_	3	vmod	_	_
5	a	_	DT	DT	_	8	det	_	_
6	lacZ	_	NN	NN	_	8	nn	_	_
7	reporter	_	NN	NN	_	8	nn	_	_
8	gene	_	NN	NN	_	4	dobj	_	_
9	under	_	IN	IN	_	4	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	control	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	intact	_	JJ	JJ	_	12	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	three	_	CD	CD	_	14	conj	_	_
17	deleted	_	JJ	JJ	_	16	amod	_	_
18	forms	_	NNS	NNS	_	14	dep	_	_
19	of	_	IN	IN	_	14	prep	_	_
20	HIV-1	_	NN	NN	_	21	nn	_	_
21	LTR	_	NNS	NNS	_	19	pobj	_	_
22	,	_	,	,	_	1	punct	_	_
23	we	_	PRP	PRP	_	24	nsubj	_	_
24	obtained	_	VBD	VBD	_	1	parataxis	_	_
25	evidence	_	NN	NN	_	24	dobj	_	_
26	that	_	IN	IN	_	37	mark	_	_
27	the	_	DT	DT	_	30	det	_	_
28	kappaB	_	NN	NN	_	30	nn	_	_
29	regulatory	_	JJ	JJ	_	30	amod	_	_
30	elements	_	NNS	NNS	_	37	nsubjpass	_	_
31	located	_	JJ	JJ	_	30	amod	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	U3	_	NN	NN	_	35	nn	_	_
35	region	_	NN	NN	_	32	pobj	_	_
36	are	_	VBP	VBP	_	37	auxpass	_	_
37	involved	_	VBN	VBN	_	25	ccomp	_	_
38	in	_	IN	IN	_	37	prep	_	_
39	cell-to-cell	_	JJ	JJ	_	40	amod	_	_
40	activation	_	NN	NN	_	38	pobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	HIV-1	_	NN	NN	_	43	nn	_	_
43	LTR	_	NNS	NNS	_	41	pobj	_	_
44	.	_	.	.	_	1	punct	_	_

1	Cell-to-cell	_	JJ	JJ	_	2	amod	_	_
2	contact	_	NN	NN	_	3	nsubj	_	_
3	activates	_	VBZ	VBZ	_	0	root	_	_
4	in	_	FW	FW	_	6	amod	_	_
5	vitro	_	FW	FW	_	4	dep	_	_
6	binding	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	16	det	_	_
9	nuclear	_	JJ	JJ	_	16	amod	_	_
10	factor	_	NN	NN	_	16	nn	_	_
11	kappaB	_	NN	NN	_	16	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
13	NF-kappaB	_	NN	NN	_	16	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
15	p50/p65	_	NN	NN	_	16	nn	_	_
16	heterodimer	_	NN	NN	_	7	pobj	_	_
17	to	_	TO	TO	_	6	prep	_	_
18	an	_	DT	DT	_	21	det	_	_
19	HIV-1	_	NN	NN	_	21	nn	_	_
20	kappaB	_	NN	NN	_	21	nn	_	_
21	oligonucleotide	_	NN	NN	_	17	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Cell-to-cell	_	JJ	JJ	_	3	amod	_	_
2	contact	_	NN	NN	_	3	nn	_	_
3	activation	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	NF-kappaB	_	NN	NN	_	4	pobj	_	_
6	was	_	VBD	VBD	_	9	auxpass	_	_
7	only	_	RB	RB	_	8	advmod	_	_
8	partially	_	RB	RB	_	9	advmod	_	_
9	inhibited	_	VBN	VBN	_	0	root	_	_
10	by	_	IN	IN	_	9	prep	_	_
11	100	_	CD	CD	_	12	number	_	_
12	microM	_	NN	NN	_	14	amod	_	_
13	pyrrolidine	_	NN	NN	_	14	nn	_	_
14	dithiocarbamate	_	NN	NN	_	10	pobj	_	_
15	and	_	CC	CC	_	9	cc	_	_
16	was	_	VBD	VBD	_	18	auxpass	_	_
17	not	_	RB	RB	_	18	neg	_	_
18	correlated	_	VBN	VBN	_	9	conj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	significant	_	JJ	JJ	_	22	amod	_	_
22	decrease	_	NN	NN	_	19	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	cellular	_	JJ	JJ	_	27	amod	_	_
25	inhibitor	_	NN	NN	_	27	nn	_	_
26	kappaB	_	NN	NN	_	27	nn	_	_
27	alpha	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	NF-kappaB	_	NN	NN	_	3	nn	_	_
2	nuclear	_	JJ	JJ	_	3	amod	_	_
3	activation	_	NN	NN	_	6	nsubj	_	_
4	was	_	VBD	VBD	_	6	cop	_	_
5	not	_	RB	RB	_	6	neg	_	_
6	detectable	_	JJ	JJ	_	0	root	_	_
7	before	_	IN	IN	_	6	prep	_	_
8	1	_	CD	CD	_	9	num	_	_
9	h	_	NN	NN	_	7	pobj	_	_
10	after	_	IN	IN	_	9	prep	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	contact	_	NN	NN	_	10	pobj	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	was	_	VBD	VBD	_	15	cop	_	_
15	dependent	_	JJ	JJ	_	6	conj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	protein	_	NN	NN	_	18	nn	_	_
18	synthesis	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	6	punct	_	_

1	Lineage-	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	stage-specific	_	JJ	JJ	_	1	conj	_	_
4	expression	_	NN	NN	_	1	dep	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	runt	_	NN	NN	_	8	nn	_	_
7	box	_	NN	NN	_	8	nn	_	_
8	polypeptides	_	NNS	NNS	_	5	pobj	_	_
9	in	_	IN	IN	_	1	prep	_	_
10	primitive	_	JJ	JJ	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	definitive	_	JJ	JJ	_	10	conj	_	_
13	hematopoiesis	_	NN	NN	_	10	dep	_	_
14	.	_	.	.	_	1	punct	_	_

1	Translocations	_	NNS	NNS	_	9	nsubjpass	_	_
2	involving	_	VBG	VBG	_	1	vmod	_	_
3	the	_	DT	DT	_	6	det	_	_
4	human	_	JJ	JJ	_	6	amod	_	_
5	CBFA2	_	NN	NN	_	6	nn	_	_
6	locus	_	NN	NN	_	2	dobj	_	_
7	have	_	VBP	VBP	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	associated	_	VBN	VBN	_	0	root	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	leukemia	_	NN	NN	_	10	pobj	_	_
12	.	_	.	.	_	9	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	gene	_	NN	NN	_	11	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	originally	_	RB	RB	_	5	advmod	_	_
5	named	_	VBN	VBN	_	2	vmod	_	_
6	AML1	_	NN	NN	_	5	dep	_	_
7	,	_	,	,	_	2	punct	_	_
8	is	_	VBZ	VBZ	_	11	cop	_	_
9	a	_	DT	DT	_	11	det	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	homologue	_	NN	NN	_	0	root	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	Drosophila	_	FW	FW	_	16	nn	_	_
15	gene	_	NN	NN	_	16	nn	_	_
16	runt	_	NN	NN	_	12	pobj	_	_
17	that	_	WDT	WDT	_	18	nsubj	_	_
18	controls	_	VBZ	VBZ	_	16	rcmod	_	_
19	early	_	JJ	JJ	_	20	amod	_	_
20	events	_	NNS	NNS	_	18	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	fly	_	NN	NN	_	23	nn	_	_
23	embryogenesis	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	clarify	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	role	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	mammalian	_	JJ	JJ	_	8	amod	_	_
7	runt	_	NN	NN	_	8	nn	_	_
8	products	_	NNS	NNS	_	5	pobj	_	_
9	in	_	IN	IN	_	4	prep	_	_
10	normal	_	JJ	JJ	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	leukemic	_	JJ	JJ	_	10	conj	_	_
13	hematopoiesis	_	NN	NN	_	10	dep	_	_
14	,	_	,	,	_	2	punct	_	_
15	we	_	PRP	PRP	_	17	nsubj	_	_
16	have	_	VBP	VBP	_	17	aux	_	_
17	studied	_	VBN	VBN	_	2	parataxis	_	_
18	their	_	PRP$	PRP$	_	19	poss	_	_
19	pattern	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	expression	_	NN	NN	_	20	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	mouse	_	NN	NN	_	25	nn	_	_
24	hematopoietic	_	JJ	JJ	_	25	amod	_	_
25	tissues	_	NNS	NNS	_	22	pobj	_	_
26	in	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	28	det	_	_
28	adult	_	JJ	JJ	_	26	pobj	_	_
29	and	_	CC	CC	_	22	cc	_	_
30	during	_	IN	IN	_	22	conj	_	_
31	ontogeny	_	NN	NN	_	30	pobj	_	_
32	using	_	VBG	VBG	_	17	xcomp	_	_
33	an	_	DT	DT	_	36	det	_	_
34	anti-runt	_	JJ	JJ	_	36	amod	_	_
35	box	_	NN	NN	_	36	nn	_	_
36	antiserum	_	NN	NN	_	32	dobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	adult	_	JJ	JJ	_	5	amod	_	_
4	bone	_	NN	NN	_	5	nn	_	_
5	marrow	_	NN	NN	_	1	pobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	we	_	PRP	PRP	_	8	nsubj	_	_
8	found	_	VBD	VBD	_	0	root	_	_
9	expression	_	NN	NN	_	8	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	runt	_	NN	NN	_	12	nn	_	_
12	polypeptides	_	NNS	NNS	_	10	pobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	differentiating	_	VBG	VBG	_	16	amod	_	_
15	myeloid	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	and	_	CC	CC	_	13	cc	_	_
18	in	_	IN	IN	_	13	conj	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	lymphocytes	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	Within	_	IN	IN	_	9	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	erythroid	_	JJ	JJ	_	4	amod	_	_
4	lineage	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	9	punct	_	_
6	runt	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	9	nsubj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	biphasic	_	JJ	JJ	_	0	root	_	_
10	,	_	,	,	_	9	punct	_	_
11	clearly	_	RB	RB	_	12	advmod	_	_
12	present	_	JJ	JJ	_	9	dep	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	erythroblasts	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	early	_	JJ	JJ	_	19	amod	_	_
18	blood	_	NN	NN	_	19	nn	_	_
19	islands	_	NNS	NNS	_	16	pobj	_	_
20	and	_	CC	CC	_	16	cc	_	_
21	of	_	IN	IN	_	16	conj	_	_
22	the	_	DT	DT	_	24	det	_	_
23	fetal	_	JJ	JJ	_	24	amod	_	_
24	liver	_	NN	NN	_	21	pobj	_	_
25	,	_	,	,	_	9	punct	_	_
26	but	_	CC	CC	_	9	cc	_	_
27	absent	_	JJ	JJ	_	9	conj	_	_
28	in	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	30	det	_	_
30	adult	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	Biochemical	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	12	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	Western	_	NN	NN	_	5	nn	_	_
5	blotting	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	fetal	_	JJ	JJ	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	adult	_	JJ	JJ	_	7	conj	_	_
10	hematopoietic	_	JJ	JJ	_	11	amod	_	_
11	populations	_	NNS	NNS	_	7	dep	_	_
12	shows	_	VBZ	VBZ	_	0	root	_	_
13	several	_	JJ	JJ	_	15	amod	_	_
14	runt	_	JJ	JJ	_	15	amod	_	_
15	isoforms	_	NNS	NNS	_	12	dobj	_	_
16	.	_	.	.	_	12	punct	_	_

1	At	_	IN	IN	_	3	advmod	_	_
2	least	_	JJS	JJS	_	1	pobj	_	_
3	one	_	CD	CD	_	6	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	them	_	PRP	PRP	_	4	pobj	_	_
6	appears	_	VBZ	VBZ	_	0	root	_	_
7	to	_	TO	TO	_	10	aux	_	_
8	be	_	VB	VB	_	10	cop	_	_
9	myeloid	_	JJ	JJ	_	10	amod	_	_
10	specific	_	JJ	JJ	_	6	xcomp	_	_
11	.	_	.	.	_	6	punct	_	_

1	Cytokine	_	NN	NN	_	3	nn	_	_
2	signal	_	NN	NN	_	3	nn	_	_
3	networks	_	NNS	NNS	_	0	root	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	a	_	DT	DT	_	7	det	_	_
6	new	_	JJ	JJ	_	7	amod	_	_
7	era	_	NN	NN	_	3	conj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	biomedical	_	JJ	JJ	_	10	amod	_	_
10	research	_	NN	NN	_	8	pobj	_	_
11	.	_	.	.	_	3	punct	_	_

1	Elucidation	_	NN	NN	_	18	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	biochemical	_	JJ	JJ	_	5	amod	_	_
5	nature	_	NN	NN	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	signal	_	NN	NN	_	10	nn	_	_
9	transduction	_	NN	NN	_	10	nn	_	_
10	pathway	_	NN	NN	_	6	pobj	_	_
11	that	_	WDT	WDT	_	12	nsubj	_	_
12	regulate	_	VBP	VBP	_	10	rcmod	_	_
13	transcription	_	NN	NN	_	12	dobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	replication	_	NN	NN	_	13	conj	_	_
16	is	_	VBZ	VBZ	_	18	cop	_	_
17	the	_	DT	DT	_	18	det	_	_
18	focus	_	NN	NN	_	0	root	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	attention	_	NN	NN	_	19	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	molecular	_	JJ	JJ	_	23	amod	_	_
23	biology	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	18	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	research	_	NN	NN	_	4	nsubj	_	_
3	may	_	MD	MD	_	4	aux	_	_
4	make	_	VB	VB	_	0	root	_	_
5	feasible	_	JJ	JJ	_	6	amod	_	_
6	manipulation	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	growth	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	differentiation	_	NN	NN	_	8	conj	_	_
11	of	_	IN	IN	_	8	prep	_	_
12	mammalian	_	JJ	JJ	_	13	amod	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	,	_	,	,	_	6	punct	_	_
15	which	_	WDT	WDT	_	19	nsubj	_	_
16	in	_	IN	IN	_	19	prep	_	_
17	turn	_	NN	NN	_	16	pobj	_	_
18	would	_	MD	MD	_	19	aux	_	_
19	have	_	VB	VB	_	6	rcmod	_	_
20	profound	_	JJ	JJ	_	21	amod	_	_
21	implication	_	NN	NN	_	19	dobj	_	_
22	in	_	IN	IN	_	19	prep	_	_
23	biomedical	_	JJ	JJ	_	24	amod	_	_
24	research	_	NN	NN	_	22	pobj	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	cell	_	NN	NN	_	25	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	gene	_	NN	NN	_	26	conj	_	_
29	therapy	_	NN	NN	_	26	dep	_	_
30	,	_	,	,	_	24	punct	_	_
31	and	_	CC	CC	_	24	cc	_	_
32	development	_	NN	NN	_	24	conj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	pharmaceutical	_	JJ	JJ	_	35	amod	_	_
35	products	_	NNS	NNS	_	33	pobj	_	_
36	.	_	.	.	_	4	punct	_	_

1	Cytokines	_	NNS	NNS	_	2	nsubj	_	_
2	control	_	VBP	VBP	_	0	root	_	_
3	growth	_	NN	NN	_	2	dobj	_	_
4	,	_	,	,	_	3	punct	_	_
5	differentiation	_	NN	NN	_	3	conj	_	_
6	,	_	,	,	_	3	punct	_	_
7	death	_	NN	NN	_	3	conj	_	_
8	,	_	,	,	_	3	punct	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	function	_	NN	NN	_	3	conj	_	_
11	of	_	IN	IN	_	3	prep	_	_
12	cells	_	NNS	NNS	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	lymphocytic	_	JJ	JJ	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	hemopoietic	_	JJ	JJ	_	14	appos	_	_
17	systems	_	NNS	NNS	_	14	dep	_	_
18	,	_	,	,	_	2	punct	_	_
19	and	_	CC	CC	_	2	cc	_	_
20	together	_	RB	RB	_	21	advmod	_	_
21	with	_	IN	IN	_	2	conj	_	_
22	nerve	_	JJ	JJ	_	23	amod	_	_
23	cells	_	NNS	NNS	_	21	pobj	_	_
24	provide	_	VBP	VBP	_	2	dep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	pertinent	_	JJ	JJ	_	27	amod	_	_
27	model	_	NN	NN	_	24	dobj	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	study	_	VB	VB	_	27	vmod	_	_
30	intercellular	_	JJ	JJ	_	31	amod	_	_
31	communications	_	NNS	NNS	_	29	dobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	intercellular	_	JJ	JJ	_	35	amod	_	_
34	signal	_	NN	NN	_	35	nn	_	_
35	networks	_	NNS	NNS	_	31	conj	_	_
36	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	review	_	NN	NN	_	3	nsubj	_	_
3	outlines	_	VBZ	VBZ	_	0	root	_	_
4	general	_	JJ	JJ	_	5	amod	_	_
5	features	_	NNS	NNS	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	signal	_	NN	NN	_	8	nn	_	_
8	transduction	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	3	cc	_	_
10	several	_	JJ	JJ	_	11	amod	_	_
11	aspects	_	NNS	NNS	_	16	nsubjpass	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	cytokine	_	NN	NN	_	14	nn	_	_
14	networks	_	NNS	NNS	_	12	pobj	_	_
15	are	_	VBP	VBP	_	16	auxpass	_	_
16	discussed	_	VBN	VBN	_	3	conj	_	_
17	with	_	IN	IN	_	16	prep	_	_
18	emphasis	_	NN	NN	_	17	pobj	_	_
19	on	_	IN	IN	_	18	prep	_	_
20	:	_	:	:	_	3	punct	_	_
21	transcriptional	_	JJ	JJ	_	22	amod	_	_
22	regulation	_	NN	NN	_	3	dep	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	Th1	_	NN	NN	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	Th2-specific	_	JJ	JJ	_	24	conj	_	_
27	cytokine	_	NN	NN	_	28	nn	_	_
28	genes	_	NNS	NNS	_	24	dep	_	_
29	in	_	IN	IN	_	22	prep	_	_
30	T	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	29	pobj	_	_
32	,	_	,	,	_	22	punct	_	_
33	the	_	DT	DT	_	34	det	_	_
34	roles	_	NNS	NNS	_	22	conj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	cytokines	_	NNS	NNS	_	35	pobj	_	_
37	and	_	CC	CC	_	36	cc	_	_
38	their	_	PRP$	PRP$	_	39	poss	_	_
39	receptors	_	NNS	NNS	_	36	conj	_	_
40	in	_	IN	IN	_	34	prep	_	_
41	growth	_	NN	NN	_	40	pobj	_	_
42	and	_	CC	CC	_	41	cc	_	_
43	differentiation	_	NN	NN	_	41	conj	_	_
44	of	_	IN	IN	_	41	prep	_	_
45	hemopoietic	_	JJ	JJ	_	46	amod	_	_
46	cells	_	NNS	NNS	_	44	pobj	_	_
47	,	_	,	,	_	22	punct	_	_
48	and	_	CC	CC	_	22	cc	_	_
49	the	_	DT	DT	_	50	det	_	_
50	manipulation	_	NN	NN	_	22	conj	_	_
51	of	_	IN	IN	_	50	prep	_	_
52	cytokine	_	NN	NN	_	53	nn	_	_
53	networks	_	NNS	NNS	_	51	pobj	_	_
54	.	_	.	.	_	3	punct	_	_

1	Nuclear	_	JJ	JJ	_	3	amod	_	_
2	factor-kappa	_	NN	NN	_	3	nn	_	_
3	B	_	NN	NN	_	5	nsubj	_	_
4	potently	_	RB	RB	_	5	advmod	_	_
5	up-regulates	_	VBZ	VBZ	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	promoter	_	NN	NN	_	8	nn	_	_
8	activity	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	RANTES	_	NN	NN	_	9	pobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	a	_	DT	DT	_	13	det	_	_
13	chemokine	_	NN	NN	_	10	appos	_	_
14	that	_	WDT	WDT	_	15	nsubj	_	_
15	blocks	_	VBZ	VBZ	_	13	rcmod	_	_
16	HIV	_	NN	NN	_	17	nn	_	_
17	infection	_	NN	NN	_	15	dobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	complex	_	JJ	JJ	_	3	amod	_	_
3	network	_	NN	NN	_	14	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	cytokines	_	NNS	NNS	_	4	pobj	_	_
6	that	_	WDT	WDT	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	involved	_	VBN	VBN	_	5	rcmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	inflammatory	_	JJ	JJ	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	immunoregulatory	_	JJ	JJ	_	10	conj	_	_
13	responses	_	NNS	NNS	_	10	dep	_	_
14	plays	_	VBZ	VBZ	_	0	root	_	_
15	a	_	DT	DT	_	17	det	_	_
16	critical	_	JJ	JJ	_	17	amod	_	_
17	role	_	NN	NN	_	14	dobj	_	_
18	in	_	IN	IN	_	14	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	pathogenesis	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	HIV	_	NN	NN	_	23	nn	_	_
23	infection	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	14	punct	_	_

1	RANTES	_	NN	NN	_	16	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
3	regulated	_	VBN	VBN	_	9	amod	_	_
4	upon	_	IN	IN	_	9	amod	_	_
5	activation	_	NN	NN	_	9	nn	_	_
6	,	_	,	,	_	9	punct	_	_
7	normal	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cell	_	NN	NN	_	1	appos	_	_
10	expressed	_	VBN	VBN	_	9	amod	_	_
11	and	_	CC	CC	_	9	cc	_	_
12	secreted	_	VBN	VBN	_	9	conj	_	_
13	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
14	is	_	VBZ	VBZ	_	16	cop	_	_
15	a	_	DT	DT	_	16	det	_	_
16	cytokine	_	NN	NN	_	0	root	_	_
17	that	_	WDT	WDT	_	18	nsubj	_	_
18	belongs	_	VBZ	VBZ	_	16	rcmod	_	_
19	to	_	TO	TO	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	beta-chemokine	_	NN	NN	_	22	nn	_	_
22	family	_	NN	NN	_	19	pobj	_	_
23	;	_	:	:	_	16	punct	_	_
24	it	_	PRP	PRP	_	26	nsubj	_	_
25	is	_	VBZ	VBZ	_	26	cop	_	_
26	chemoattractant	_	JJ	JJ	_	16	parataxis	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	CD4+/CD45RO	_	JJ	JJ	_	30	amod	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	27	pobj	_	_
31	,	_	,	,	_	26	punct	_	_
32	it	_	PRP	PRP	_	34	nsubjpass	_	_
33	is	_	VBZ	VBZ	_	34	auxpass	_	_
34	produced	_	VBN	VBN	_	26	parataxis	_	_
35	by	_	IN	IN	_	34	prep	_	_
36	various	_	JJ	JJ	_	38	amod	_	_
37	cell	_	NN	NN	_	38	nn	_	_
38	types	_	NNS	NNS	_	35	pobj	_	_
39	including	_	VBG	VBG	_	38	prep	_	_
40	CD8+	_	JJ	JJ	_	39	pobj	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	CD4+	_	JJ	JJ	_	40	conj	_	_
43	T	_	NN	NN	_	44	nn	_	_
44	cells	_	NNS	NNS	_	40	dep	_	_
45	as	_	RB	RB	_	46	advmod	_	_
46	well	_	RB	RB	_	40	cc	_	_
47	as	_	IN	IN	_	46	mwe	_	_
48	monocytes/macrophages	_	NNS	NNS	_	40	conj	_	_
49	,	_	,	,	_	34	punct	_	_
50	and	_	CC	CC	_	34	cc	_	_
51	has	_	VBZ	VBZ	_	54	aux	_	_
52	recently	_	RB	RB	_	54	advmod	_	_
53	been	_	VBN	VBN	_	54	auxpass	_	_
54	shown	_	VBN	VBN	_	34	conj	_	_
55	to	_	TO	TO	_	56	aux	_	_
56	suppress	_	VB	VB	_	54	xcomp	_	_
57	replication	_	NN	NN	_	56	dobj	_	_
58	of	_	IN	IN	_	57	prep	_	_
59	macrophage-tropic	_	JJ	JJ	_	60	amod	_	_
60	strains	_	NNS	NNS	_	58	pobj	_	_
61	of	_	IN	IN	_	60	prep	_	_
62	HIV	_	NN	NN	_	61	pobj	_	_
63	in	_	IN	IN	_	57	prep	_	_
64	CD4+	_	JJ	JJ	_	66	amod	_	_
65	T	_	NN	NN	_	66	nn	_	_
66	cells	_	NNS	NNS	_	63	pobj	_	_
67	.	_	.	.	_	16	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	investigate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	molecular	_	JJ	JJ	_	5	amod	_	_
5	mechanisms	_	NNS	NNS	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	RANTES	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	6	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	the	_	DT	DT	_	13	det	_	_
11	RANTES	_	NN	NN	_	13	nn	_	_
12	promoter	_	NN	NN	_	13	nn	_	_
13	region	_	NN	NN	_	15	nsubjpass	_	_
14	was	_	VBD	VBD	_	15	auxpass	_	_
15	analyzed	_	VBN	VBN	_	2	parataxis	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	transient	_	JJ	JJ	_	18	amod	_	_
18	expression	_	NN	NN	_	16	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	gel-mobility	_	JJ	JJ	_	21	amod	_	_
21	shift	_	NN	NN	_	18	conj	_	_
22	assays	_	NNS	NNS	_	18	dep	_	_
23	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	11	mark	_	_
4	:	_	:	:	_	11	punct	_	_
5	1	_	LS	LS	_	11	dep	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	RANTES	_	NN	NN	_	9	nn	_	_
8	promoter	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	11	nsubjpass	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	up-regulated	_	VBN	VBN	_	2	ccomp	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	PMA	_	NN	NN	_	12	pobj	_	_
14	plus	_	CC	CC	_	13	cc	_	_
15	ionomycin	_	NN	NN	_	13	conj	_	_
16	,	_	,	,	_	13	punct	_	_
17	coexpression	_	NN	NN	_	13	conj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	p65	_	NN	NN	_	21	nn	_	_
21	subunit	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	nuclear	_	JJ	JJ	_	29	amod	_	_
24	factor	_	NN	NN	_	29	nn	_	_
25	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
26	NF	_	NN	NN	_	29	nn	_	_
27	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
28	-kappa	_	NN	NN	_	29	nn	_	_
29	B	_	NN	NN	_	22	pobj	_	_
30	,	_	,	,	_	13	punct	_	_
31	the	_	DT	DT	_	33	det	_	_
32	proinflammatory	_	JJ	JJ	_	33	amod	_	_
33	cytokines	_	NNS	NNS	_	13	conj	_	_
34	TNF-alpha	_	NN	NN	_	33	dep	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	IL-1	_	NN	NN	_	37	nn	_	_
37	beta	_	NN	NN	_	34	conj	_	_
38	,	_	,	,	_	13	punct	_	_
39	and	_	CC	CC	_	13	cc	_	_
40	the	_	DT	DT	_	43	det	_	_
41	CD28	_	NN	NN	_	43	nn	_	_
42	costimulatory	_	JJ	JJ	_	43	amod	_	_
43	pathway	_	NN	NN	_	13	conj	_	_
44	;	_	:	:	_	11	punct	_	_
45	2	_	LS	LS	_	51	dep	_	_
46	-RRB-	_	-RRB-	-RRB-	_	45	punct	_	_
47	the	_	DT	DT	_	50	det	_	_
48	RANTES	_	NN	NN	_	50	nn	_	_
49	promoter	_	NN	NN	_	50	nn	_	_
50	region	_	NN	NN	_	51	nsubj	_	_
51	contains	_	VBZ	VBZ	_	11	conj	_	_
52	four	_	CD	CD	_	56	num	_	_
53	NF-kappa	_	NN	NN	_	56	nn	_	_
54	B	_	NN	NN	_	56	nn	_	_
55	binding	_	NN	NN	_	56	nn	_	_
56	sites	_	NNS	NNS	_	51	dobj	_	_
57	at	_	IN	IN	_	51	prep	_	_
58	positions	_	NNS	NNS	_	57	pobj	_	_
59	-30	_	CD	CD	_	58	dep	_	_
60	,	_	,	,	_	58	punct	_	_
61	-44	_	CD	CD	_	58	conj	_	_
62	,	_	,	,	_	58	punct	_	_
63	-213	_	CD	CD	_	58	conj	_	_
64	,	_	,	,	_	58	punct	_	_
65	and	_	CC	CC	_	58	cc	_	_
66	-579	_	CD	CD	_	58	conj	_	_
67	relative	_	JJ	JJ	_	58	amod	_	_
68	to	_	TO	TO	_	67	prep	_	_
69	the	_	DT	DT	_	72	det	_	_
70	transcription	_	NN	NN	_	72	nn	_	_
71	start	_	NN	NN	_	72	nn	_	_
72	site	_	NN	NN	_	68	pobj	_	_
73	;	_	:	:	_	11	punct	_	_
74	3	_	LS	LS	_	93	dep	_	_
75	-RRB-	_	-RRB-	-RRB-	_	74	punct	_	_
76	one	_	CD	CD	_	77	num	_	_
77	site	_	NN	NN	_	93	nsubj	_	_
78	-LRB-	_	-LRB-	-LRB-	_	79	punct	_	_
79	-213	_	CD	CD	_	77	appos	_	_
80	-RRB-	_	-RRB-	-RRB-	_	79	punct	_	_
81	is	_	VBZ	VBZ	_	93	cop	_	_
82	an	_	DT	DT	_	93	det	_	_
83	NF-AT	_	NN	NN	_	93	nn	_	_
84	-LRB-	_	-LRB-	-LRB-	_	93	punct	_	_
85	nuclear	_	JJ	JJ	_	93	amod	_	_
86	factor	_	NN	NN	_	93	nn	_	_
87	of	_	IN	IN	_	93	amod	_	_
88	activated	_	VBN	VBN	_	93	amod	_	_
89	T	_	NN	NN	_	93	nn	_	_
90	cells	_	NNS	NNS	_	93	nn	_	_
91	-RRB-	_	-RRB-	-RRB-	_	93	punct	_	_
92	binding	_	NN	NN	_	93	nn	_	_
93	site	_	NN	NN	_	11	conj	_	_
94	that	_	WDT	WDT	_	96	nsubj	_	_
95	also	_	RB	RB	_	96	advmod	_	_
96	has	_	VBZ	VBZ	_	93	rcmod	_	_
97	weak	_	JJ	JJ	_	98	amod	_	_
98	affinity	_	NN	NN	_	96	dobj	_	_
99	to	_	TO	TO	_	98	prep	_	_
100	NF-kappa	_	NN	NN	_	101	nn	_	_
101	B	_	NN	NN	_	99	pobj	_	_
102	,	_	,	,	_	93	punct	_	_
103	and	_	CC	CC	_	93	cc	_	_
104	the	_	DT	DT	_	107	det	_	_
105	most	_	RBS	RBS	_	106	advmod	_	_
106	distal	_	JJ	JJ	_	107	amod	_	_
107	site	_	NN	NN	_	112	nsubj	_	_
108	-LRB-	_	-LRB-	-LRB-	_	109	punct	_	_
109	-579	_	CD	CD	_	107	appos	_	_
110	-RRB-	_	-RRB-	-RRB-	_	109	punct	_	_
111	also	_	RB	RB	_	112	advmod	_	_
112	serves	_	VBZ	VBZ	_	93	conj	_	_
113	as	_	IN	IN	_	112	prep	_	_
114	a	_	DT	DT	_	116	det	_	_
115	CD28-responsive	_	JJ	JJ	_	116	amod	_	_
116	element	_	NN	NN	_	113	pobj	_	_
117	;	_	:	:	_	11	punct	_	_
118	and	_	CC	CC	_	11	cc	_	_
119	4	_	LS	LS	_	144	dep	_	_
120	-RRB-	_	-RRB-	-RRB-	_	119	punct	_	_
121	mutation	_	NN	NN	_	144	nsubj	_	_
122	on	_	IN	IN	_	121	prep	_	_
123	any	_	DT	DT	_	122	pobj	_	_
124	of	_	IN	IN	_	123	prep	_	_
125	those	_	DT	DT	_	128	det	_	_
126	NF-kappa	_	NN	NN	_	128	nn	_	_
127	B	_	NN	NN	_	128	nn	_	_
128	sites	_	NNS	NNS	_	124	pobj	_	_
129	or	_	CC	CC	_	121	cc	_	_
130	coexpression	_	NN	NN	_	121	conj	_	_
131	of	_	IN	IN	_	130	prep	_	_
132	I	_	NN	NN	_	135	nn	_	_
133	kappa	_	NN	NN	_	135	nn	_	_
134	B	_	NN	NN	_	135	nn	_	_
135	alpha	_	NN	NN	_	131	pobj	_	_
136	-LRB-	_	-LRB-	-LRB-	_	141	punct	_	_
137	cytoplasmic	_	JJ	JJ	_	141	amod	_	_
138	inhibitor	_	NN	NN	_	141	nn	_	_
139	of	_	IN	IN	_	141	amod	_	_
140	NF-kappa	_	NN	NN	_	141	nn	_	_
141	B	_	NN	NN	_	135	appos	_	_
142	-RRB-	_	-RRB-	-RRB-	_	141	punct	_	_
143	markedly	_	RB	RB	_	144	advmod	_	_
144	reduced	_	VBD	VBD	_	11	conj	_	_
145	the	_	DT	DT	_	147	det	_	_
146	promoter	_	NN	NN	_	147	nn	_	_
147	activity	_	NN	NN	_	144	dobj	_	_
148	.	_	.	.	_	2	punct	_	_

1	Thus	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	NF-kappa	_	NN	NN	_	4	nn	_	_
4	B	_	NN	NN	_	16	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	a	_	DT	DT	_	9	det	_	_
7	potent	_	JJ	JJ	_	9	amod	_	_
8	transcriptional	_	JJ	JJ	_	7	dep	_	_
9	activator	_	NN	NN	_	4	appos	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	HIV	_	NN	NN	_	12	nn	_	_
12	expression	_	NN	NN	_	10	pobj	_	_
13	,	_	,	,	_	4	punct	_	_
14	is	_	VBZ	VBZ	_	16	auxpass	_	_
15	also	_	RB	RB	_	16	advmod	_	_
16	involved	_	VBN	VBN	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	expression	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	RANTES	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	21	punct	_	_
23	a	_	DT	DT	_	24	det	_	_
24	chemokine	_	NN	NN	_	21	appos	_	_
25	that	_	WDT	WDT	_	26	nsubj	_	_
26	blocks	_	VBZ	VBZ	_	24	rcmod	_	_
27	infection	_	NN	NN	_	26	dobj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	macrophage-tropic	_	JJ	JJ	_	30	amod	_	_
30	strains	_	NNS	NNS	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	HIV	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	16	punct	_	_

1	Response	_	NN	NN	_	0	root	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	intranasal	_	JJ	JJ	_	5	amod	_	_
4	fluticasone	_	NN	NN	_	5	nn	_	_
5	propionate	_	NN	NN	_	2	pobj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	perennial	_	JJ	JJ	_	8	amod	_	_
8	allergic	_	JJ	JJ	_	9	amod	_	_
9	rhinitis	_	NN	NN	_	6	pobj	_	_
10	not	_	RB	RB	_	11	neg	_	_
11	associated	_	VBN	VBN	_	1	vmod	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	glucocorticoid	_	NN	NN	_	14	nn	_	_
14	receptor	_	NN	NN	_	15	nn	_	_
15	characteristics	_	NNS	NNS	_	12	pobj	_	_
16	.	_	.	.	_	1	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	4	det	_	_
4	reduction	_	NN	NN	_	12	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	symptoms	_	NNS	NNS	_	5	pobj	_	_
7	due	_	JJ	JJ	_	4	amod	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	treatment	_	NN	NN	_	8	pobj	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	corticosteroids	_	NNS	NNS	_	10	pobj	_	_
12	varies	_	VBZ	VBZ	_	1	dep	_	_
13	among	_	IN	IN	_	12	prep	_	_
14	patients	_	NNS	NNS	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	perennial	_	JJ	JJ	_	17	amod	_	_
17	rhinitis	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	12	punct	_	_

1	Most	_	JJS	JJS	_	2	amod	_	_
2	patients	_	NNS	NNS	_	4	nsubj	_	_
3	will	_	MD	MD	_	4	aux	_	_
4	respond	_	VB	VB	_	0	root	_	_
5	but	_	CC	CC	_	4	cc	_	_
6	a	_	DT	DT	_	8	det	_	_
7	few	_	JJ	JJ	_	8	amod	_	_
8	patients	_	NNS	NNS	_	9	nsubj	_	_
9	respond	_	VBP	VBP	_	4	conj	_	_
10	less	_	RBR	RBR	_	9	advmod	_	_
11	to	_	TO	TO	_	9	prep	_	_
12	these	_	DT	DT	_	13	det	_	_
13	drugs	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	4	punct	_	_

1	OBJECTIVE	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	To	_	TO	TO	_	4	aux	_	_
4	investigate	_	VB	VB	_	1	dep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	association	_	NN	NN	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	reduction	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	symptoms	_	NNS	NNS	_	9	pobj	_	_
11	due	_	JJ	JJ	_	8	amod	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	glucocorticoids	_	NNS	NNS	_	12	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	glucocorticoid	_	NN	NN	_	16	nn	_	_
16	receptor	_	NN	NN	_	17	nn	_	_
17	characteristics	_	NNS	NNS	_	13	conj	_	_
18	in	_	IN	IN	_	8	prep	_	_
19	patients	_	NNS	NNS	_	18	pobj	_	_
20	with	_	IN	IN	_	19	prep	_	_
21	perennial	_	JJ	JJ	_	22	amod	_	_
22	allergic	_	JJ	JJ	_	23	amod	_	_
23	rhinitis	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	4	punct	_	_
25	in	_	FW	FW	_	30	amod	_	_
26	vitro	_	FW	FW	_	25	dep	_	_
27	glucocorticoid	_	NN	NN	_	28	nn	_	_
28	receptor	_	NN	NN	_	30	nn	_	_
29	binding	_	NN	NN	_	30	nn	_	_
30	studies	_	NNS	NNS	_	32	nsubjpass	_	_
31	were	_	VBD	VBD	_	32	auxpass	_	_
32	performed	_	VBN	VBN	_	4	parataxis	_	_
33	with	_	IN	IN	_	32	prep	_	_
34	peripheral	_	JJ	JJ	_	37	amod	_	_
35	blood	_	NN	NN	_	37	nn	_	_
36	mononuclear	_	JJ	JJ	_	37	amod	_	_
37	cells	_	NNS	NNS	_	33	pobj	_	_
38	using	_	VBG	VBG	_	32	xcomp	_	_
39	dexamethasone	_	NN	NN	_	38	dobj	_	_
40	and	_	CC	CC	_	32	cc	_	_
41	in	_	FW	FW	_	43	amod	_	_
42	vitro	_	FW	FW	_	41	dep	_	_
43	production	_	NN	NN	_	47	nsubjpass	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	mediators	_	NNS	NNS	_	44	pobj	_	_
46	were	_	VBD	VBD	_	47	auxpass	_	_
47	measured	_	VBN	VBN	_	32	conj	_	_
48	.	_	.	.	_	1	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	During	_	IN	IN	_	34	prep	_	_
4	a	_	DT	DT	_	8	det	_	_
5	double-blind	_	JJ	JJ	_	6	amod	_	_
6	placebo-controlled	_	JJ	JJ	_	8	amod	_	_
7	crossover	_	JJ	JJ	_	8	amod	_	_
8	study	_	NN	NN	_	3	pobj	_	_
9	,	_	,	,	_	34	punct	_	_
10	200	_	CD	CD	_	11	number	_	_
11	micrograms	_	NNS	NNS	_	16	amod	_	_
12	fluticasone	_	NN	NN	_	16	nn	_	_
13	propionate	_	JJ	JJ	_	16	amod	_	_
14	aqueous	_	JJ	JJ	_	16	amod	_	_
15	nasal	_	JJ	JJ	_	16	amod	_	_
16	spray	_	NN	NN	_	34	nsubjpass	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	in	_	IN	IN	_	16	prep	_	_
19	the	_	DT	DT	_	22	det	_	_
20	active	_	JJ	JJ	_	22	amod	_	_
21	treatment	_	NN	NN	_	22	nn	_	_
22	period	_	NN	NN	_	18	pobj	_	_
23	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
24	and	_	CC	CC	_	16	cc	_	_
25	placebo	_	NN	NN	_	16	conj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	in	_	IN	IN	_	25	prep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	placebo	_	NN	NN	_	31	nn	_	_
30	treatment	_	NN	NN	_	31	nn	_	_
31	period	_	NN	NN	_	27	pobj	_	_
32	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
33	were	_	VBD	VBD	_	34	auxpass	_	_
34	administered	_	VBN	VBN	_	1	dep	_	_
35	twice	_	RB	RB	_	36	advmod	_	_
36	daily	_	RB	RB	_	34	advmod	_	_
37	for	_	IN	IN	_	34	prep	_	_
38	2	_	CD	CD	_	39	num	_	_
39	weeks	_	NNS	NNS	_	37	pobj	_	_
40	to	_	TO	TO	_	34	prep	_	_
41	22	_	CD	CD	_	42	num	_	_
42	patients	_	NNS	NNS	_	40	pobj	_	_
43	allergic	_	JJ	JJ	_	42	amod	_	_
44	to	_	TO	TO	_	43	prep	_	_
45	house	_	NN	NN	_	47	nn	_	_
46	dust	_	NN	NN	_	47	nn	_	_
47	mite	_	NN	NN	_	44	pobj	_	_
48	.	_	.	.	_	1	punct	_	_

1	At	_	IN	IN	_	10	prep	_	_
2	the	_	DT	DT	_	3	det	_	_
3	end	_	NN	NN	_	1	pobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	both	_	DT	DT	_	7	det	_	_
6	treatment	_	NN	NN	_	7	nn	_	_
7	periods	_	NNS	NNS	_	4	pobj	_	_
8	symptoms	_	NNS	NNS	_	10	nsubjpass	_	_
9	were	_	VBD	VBD	_	10	auxpass	_	_
10	scored	_	VBN	VBN	_	0	root	_	_
11	after	_	IN	IN	_	10	prep	_	_
12	allergen	_	NN	NN	_	13	nn	_	_
13	provocation	_	NN	NN	_	11	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	100	_	CD	CD	_	13	dep	_	_
16	,	_	,	,	_	15	punct	_	_
17	1000	_	CD	CD	_	15	amod	_	_
18	,	_	,	,	_	15	punct	_	_
19	10000	_	CD	CD	_	15	amod	_	_
20	BU/mL	_	NN	NN	_	15	dep	_	_
21	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
22	and	_	CC	CC	_	11	cc	_	_
23	during	_	IN	IN	_	11	conj	_	_
24	the	_	DT	DT	_	26	det	_	_
25	9.5	_	CD	CD	_	26	num	_	_
26	hours	_	NNS	NNS	_	23	pobj	_	_
27	after	_	IN	IN	_	26	prep	_	_
28	this	_	DT	DT	_	29	det	_	_
29	challenge	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	10	punct	_	_

1	Receptor	_	NN	NN	_	3	nn	_	_
2	binding	_	NN	NN	_	3	nn	_	_
3	studies	_	NNS	NNS	_	7	nsubjpass	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	dexamethasone	_	NN	NN	_	4	pobj	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	performed	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	peripheral	_	JJ	JJ	_	12	amod	_	_
10	blood	_	NN	NN	_	12	nn	_	_
11	mononuclear	_	JJ	JJ	_	12	amod	_	_
12	cells	_	NNS	NNS	_	8	pobj	_	_
13	.	_	.	.	_	7	punct	_	_

1	Leukotriene	_	NN	NN	_	2	nn	_	_
2	B4	_	NN	NN	_	23	nsubjpass	_	_
3	produced	_	VBN	VBN	_	2	vmod	_	_
4	by	_	IN	IN	_	3	prep	_	_
5	monocytes	_	NNS	NNS	_	4	pobj	_	_
6	in	_	FW	FW	_	7	nn	_	_
7	vitro	_	FW	FW	_	3	advmod	_	_
8	and	_	CC	CC	_	2	cc	_	_
9	soluble	_	JJ	JJ	_	11	amod	_	_
10	interleukin-2	_	NN	NN	_	11	nn	_	_
11	receptor	_	NN	NN	_	2	conj	_	_
12	released	_	VBN	VBN	_	11	vmod	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
15	in	_	FW	FW	_	16	nn	_	_
16	vitro	_	FW	FW	_	12	advmod	_	_
17	and	_	CC	CC	_	2	cc	_	_
18	cortisol	_	NN	NN	_	19	nn	_	_
19	levels	_	NNS	NNS	_	2	conj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	plasma	_	NN	NN	_	20	pobj	_	_
22	were	_	VBD	VBD	_	23	auxpass	_	_
23	determined	_	VBN	VBN	_	0	root	_	_
24	.	_	.	.	_	23	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	No	_	DT	DT	_	6	neg	_	_
4	significant	_	JJ	JJ	_	6	amod	_	_
5	partial	_	JJ	JJ	_	4	dep	_	_
6	correlations	_	NNS	NNS	_	65	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	number	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	17	det	_	_
12	peripheral	_	JJ	JJ	_	17	amod	_	_
13	blood	_	NN	NN	_	17	nn	_	_
14	mononuclear	_	JJ	JJ	_	17	amod	_	_
15	cell	_	NN	NN	_	17	nn	_	_
16	glucocorticoid	_	NN	NN	_	17	nn	_	_
17	receptors	_	NNS	NNS	_	10	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
19	6821	_	CD	CD	_	23	num	_	_
20	+/-	_	CC	CC	_	19	cc	_	_
21	5669	_	CD	CD	_	19	conj	_	_
22	binding	_	VBG	VBG	_	23	amod	_	_
23	sites	_	NNS	NNS	_	9	dep	_	_
24	per	_	IN	IN	_	23	prep	_	_
25	cell	_	NN	NN	_	24	pobj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
27	and	_	CC	CC	_	9	cc	_	_
28	the	_	DT	DT	_	29	det	_	_
29	affinity	_	NN	NN	_	9	conj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	Kd	_	NN	NN	_	29	dep	_	_
32	:	_	:	:	_	31	punct	_	_
33	16.5	_	CD	CD	_	36	num	_	_
34	+/-	_	CC	CC	_	33	cc	_	_
35	13.51	_	CD	CD	_	33	conj	_	_
36	nmol/L	_	NN	NN	_	31	dep	_	_
37	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
38	for	_	IN	IN	_	29	prep	_	_
39	the	_	DT	DT	_	41	det	_	_
40	glucocorticoid	_	NN	NN	_	41	nn	_	_
41	receptors	_	NNS	NNS	_	38	pobj	_	_
42	with	_	IN	IN	_	6	prep	_	_
43	the	_	DT	DT	_	45	det	_	_
44	symptom	_	NN	NN	_	45	nn	_	_
45	score	_	NN	NN	_	42	pobj	_	_
46	-LRB-	_	-LRB-	-LRB-	_	47	punct	_	_
47	placebo	_	NN	NN	_	45	dep	_	_
48	:	_	:	:	_	47	punct	_	_
49	4.3	_	CD	CD	_	52	num	_	_
50	+/-	_	CC	CC	_	49	cc	_	_
51	2.45	_	CD	CD	_	49	conj	_	_
52	pts	_	NNS	NNS	_	47	dep	_	_
53	;	_	:	:	_	47	punct	_	_
54	fluticasone	_	NN	NN	_	47	dep	_	_
55	:	_	:	:	_	54	punct	_	_
56	2.4	_	CD	CD	_	59	num	_	_
57	+/-	_	CC	CC	_	56	cc	_	_
58	1.55	_	CD	CD	_	56	conj	_	_
59	pts	_	NNS	NNS	_	54	dep	_	_
60	-RRB-	_	-RRB-	-RRB-	_	47	punct	_	_
61	after	_	IN	IN	_	45	prep	_	_
62	active	_	JJ	JJ	_	63	amod	_	_
63	treatment	_	NN	NN	_	61	pobj	_	_
64	were	_	VBD	VBD	_	65	auxpass	_	_
65	found	_	VBN	VBN	_	1	dep	_	_
66	.	_	.	.	_	1	punct	_	_

1	Also	_	RB	RB	_	59	advmod	_	_
2	no	_	DT	DT	_	5	neg	_	_
3	significant	_	JJ	JJ	_	5	amod	_	_
4	partial	_	JJ	JJ	_	3	dep	_	_
5	correlations	_	NNS	NNS	_	59	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	levels	_	NNS	NNS	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	leukotriene	_	NN	NN	_	11	nn	_	_
11	B4	_	NN	NN	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
13	45.6	_	CD	CD	_	17	dep	_	_
14	+/-	_	CC	CC	_	13	cc	_	_
15	105.3	_	CD	CD	_	13	conj	_	_
16	ng/10-LRB-6-RRB-	_	CD	CD	_	13	number	_	_
17	cells	_	NNS	NNS	_	11	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	produced	_	VBN	VBN	_	11	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	monocytes	_	NNS	NNS	_	20	pobj	_	_
22	in	_	FW	FW	_	23	nn	_	_
23	vitro	_	FW	FW	_	19	advmod	_	_
24	,	_	,	,	_	11	punct	_	_
25	soluble	_	JJ	JJ	_	27	amod	_	_
26	interleukin-2	_	NN	NN	_	27	nn	_	_
27	receptor	_	NN	NN	_	11	appos	_	_
28	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
29	734	_	CD	CD	_	33	dep	_	_
30	+/-	_	CC	CC	_	29	cc	_	_
31	237	_	CD	CD	_	29	conj	_	_
32	ng/10-LRB-6-RRB-	_	CD	CD	_	29	number	_	_
33	cells	_	NNS	NNS	_	27	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	released	_	VBN	VBN	_	27	vmod	_	_
36	by	_	IN	IN	_	35	prep	_	_
37	lymphocytes	_	NNS	NNS	_	36	pobj	_	_
38	in	_	FW	FW	_	39	nn	_	_
39	vitro	_	FW	FW	_	35	advmod	_	_
40	and	_	CC	CC	_	8	cc	_	_
41	cortisol	_	NN	NN	_	42	nn	_	_
42	levels	_	NNS	NNS	_	8	conj	_	_
43	-LRB-	_	-LRB-	-LRB-	_	47	punct	_	_
44	571	_	CD	CD	_	47	num	_	_
45	+/-	_	CC	CC	_	44	cc	_	_
46	236	_	CD	CD	_	44	conj	_	_
47	ng/mL	_	NN	NN	_	42	appos	_	_
48	-RRB-	_	-RRB-	-RRB-	_	47	punct	_	_
49	in	_	IN	IN	_	42	prep	_	_
50	plasma	_	NN	NN	_	49	pobj	_	_
51	with	_	IN	IN	_	5	prep	_	_
52	the	_	DT	DT	_	54	det	_	_
53	symptom	_	NN	NN	_	54	nn	_	_
54	score	_	NN	NN	_	51	pobj	_	_
55	after	_	IN	IN	_	54	prep	_	_
56	active	_	JJ	JJ	_	57	amod	_	_
57	treatment	_	NN	NN	_	55	pobj	_	_
58	were	_	VBD	VBD	_	59	auxpass	_	_
59	found	_	VBN	VBN	_	0	root	_	_
60	.	_	.	.	_	59	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	4	det	_	_
4	reduction	_	NN	NN	_	24	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	symptoms	_	NNS	NNS	_	5	pobj	_	_
7	due	_	JJ	JJ	_	4	amod	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	topical	_	JJ	JJ	_	11	amod	_	_
10	fluticasone	_	NN	NN	_	11	nn	_	_
11	propionate	_	NN	NN	_	8	pobj	_	_
12	in	_	IN	IN	_	4	prep	_	_
13	patients	_	NNS	NNS	_	12	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	rhinitis	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	allergy	_	NN	NN	_	15	conj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	house	_	NN	NN	_	21	nn	_	_
20	dust	_	NN	NN	_	21	nn	_	_
21	mite	_	NN	NN	_	18	pobj	_	_
22	is	_	VBZ	VBZ	_	24	auxpass	_	_
23	not	_	RB	RB	_	24	neg	_	_
24	correlated	_	VBN	VBN	_	1	dep	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	characteristics	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	the	_	DT	DT	_	31	det	_	_
30	glucocorticoid	_	NN	NN	_	31	nn	_	_
31	receptor	_	NN	NN	_	28	pobj	_	_
32	.	_	.	.	_	1	punct	_	_

1	HIV	_	NN	NN	_	4	nsubj	_	_
2	does	_	VBZ	VBZ	_	4	aux	_	_
3	not	_	RB	RB	_	4	neg	_	_
4	replicate	_	VB	VB	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	naive	_	JJ	JJ	_	9	amod	_	_
7	CD4	_	NN	NN	_	9	nn	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	stimulated	_	VBN	VBN	_	9	vmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	CD3/CD28	_	NN	NN	_	11	pobj	_	_
13	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	20	mark	_	_
8	the	_	DT	DT	_	12	det	_	_
9	T	_	NN	NN	_	12	nn	_	_
10	cell	_	NN	NN	_	12	nn	_	_
11	tropic	_	JJ	JJ	_	12	amod	_	_
12	strain	_	NN	NN	_	20	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HIV	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	12	punct	_	_
16	LAI	_	NN	NN	_	12	appos	_	_
17	,	_	,	,	_	12	punct	_	_
18	does	_	VBZ	VBZ	_	20	aux	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	replicate	_	VB	VB	_	6	ccomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	naive	_	JJ	JJ	_	25	amod	_	_
23	CD4	_	NN	NN	_	25	nn	_	_
24	T	_	NN	NN	_	25	nn	_	_
25	cells	_	NNS	NNS	_	21	pobj	_	_
26	stimulated	_	VBN	VBN	_	25	vmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	cross-linking	_	JJ	JJ	_	27	pcomp	_	_
29	CD3	_	NN	NN	_	28	dobj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	CD28	_	NN	NN	_	29	conj	_	_
32	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	LAI	_	NN	NN	_	5	nsubj	_	_
5	replicates	_	VBZ	VBZ	_	0	root	_	_
6	well	_	RB	RB	_	5	advmod	_	_
7	in	_	IN	IN	_	5	prep	_	_
8	memory	_	NN	NN	_	11	nn	_	_
9	CD4	_	NN	NN	_	11	nn	_	_
10	T	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	7	pobj	_	_
12	stimulated	_	VBN	VBN	_	11	vmod	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	same	_	JJ	JJ	_	16	amod	_	_
16	way	_	NN	NN	_	13	pobj	_	_
17	.	_	.	.	_	5	punct	_	_

1	Unlike	_	IN	IN	_	8	prep	_	_
2	this	_	DT	DT	_	5	det	_	_
3	physiologically	_	RB	RB	_	4	advmod	_	_
4	relevant	_	JJ	JJ	_	5	amod	_	_
5	stimulation	_	NN	NN	_	1	pobj	_	_
6	,	_	,	,	_	8	punct	_	_
7	PHA	_	NN	NN	_	8	nsubj	_	_
8	stimulates	_	VBZ	VBZ	_	0	root	_	_
9	productive	_	JJ	JJ	_	11	amod	_	_
10	LAI	_	NN	NN	_	11	nn	_	_
11	replication	_	NN	NN	_	8	dobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	both	_	CC	CC	_	14	preconj	_	_
14	naive	_	JJ	JJ	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	memory	_	NN	NN	_	14	conj	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	14	dep	_	_
19	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	4	nsubjpass	_	_
3	were	_	VBD	VBD	_	4	auxpass	_	_
4	conducted	_	VBN	VBN	_	0	root	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	highly	_	RB	RB	_	7	advmod	_	_
7	purified	_	VBN	VBN	_	11	amod	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	FACS-isolated	_	JJ	JJ	_	7	dep	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	subsets	_	NNS	NNS	_	5	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	CD4	_	NN	NN	_	15	nn	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	12	pobj	_	_
16	identified	_	VBN	VBN	_	11	vmod	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	expression	_	NN	NN	_	17	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	both	_	CC	CC	_	21	preconj	_	_
21	CD45RA	_	NN	NN	_	19	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	CD62L	_	NN	NN	_	21	conj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Remixing	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	purified	_	VBN	VBN	_	5	amod	_	_
4	T	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	13	mark	_	_
8	naive	_	JJ	JJ	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	13	nsubj	_	_
11	do	_	VBP	VBP	_	13	aux	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	suppress	_	VB	VB	_	6	ccomp	_	_
14	LAI	_	NN	NN	_	15	nn	_	_
15	replication	_	NN	NN	_	13	dobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	memory	_	NN	NN	_	19	nn	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	16	pobj	_	_
20	and	_	CC	CC	_	13	cc	_	_
21	that	_	IN	IN	_	27	mark	_	_
22	memory	_	NN	NN	_	24	nn	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	27	nsubj	_	_
25	do	_	VBP	VBP	_	27	aux	_	_
26	not	_	RB	RB	_	27	neg	_	_
27	restore	_	VB	VB	_	13	conj	_	_
28	LAI	_	NN	NN	_	29	nn	_	_
29	expression	_	NN	NN	_	27	dobj	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	naive	_	JJ	JJ	_	33	amod	_	_
32	T	_	NN	NN	_	33	nn	_	_
33	cells	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	suppression	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	productive	_	JJ	JJ	_	6	amod	_	_
5	LAI	_	NN	NN	_	6	nn	_	_
6	replication	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	naive	_	JJ	JJ	_	10	amod	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	7	pobj	_	_
11	is	_	VBZ	VBZ	_	13	cop	_	_
12	not	_	RB	RB	_	13	neg	_	_
13	due	_	JJ	JJ	_	0	root	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	differential	_	JJ	JJ	_	16	amod	_	_
16	expression	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	viral	_	JJ	JJ	_	19	amod	_	_
19	coreceptors	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	13	punct	_	_
21	nor	_	CC	CC	_	13	cc	_	_
22	is	_	VBZ	VBZ	_	24	cop	_	_
23	it	_	PRP	PRP	_	24	nsubj	_	_
24	due	_	JJ	JJ	_	13	conj	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	inhibition	_	NN	NN	_	25	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	activation	_	NN	NN	_	27	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	important	_	JJ	JJ	_	32	amod	_	_
32	HIV	_	NN	NN	_	29	pobj	_	_
33	transcription	_	NN	NN	_	34	nn	_	_
34	factors	_	NNS	NNS	_	32	dep	_	_
35	,	_	,	,	_	32	punct	_	_
36	nuclear	_	JJ	JJ	_	37	amod	_	_
37	factor-kappaB	_	NN	NN	_	32	appos	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	activator	_	NN	NN	_	40	nn	_	_
40	protein-1	_	NN	NN	_	37	conj	_	_
41	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	inherent	_	JJ	JJ	_	3	amod	_	_
3	resistance	_	NN	NN	_	22	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	naive	_	JJ	JJ	_	7	amod	_	_
6	T	_	NN	NN	_	7	nn	_	_
7	cells	_	NNS	NNS	_	4	pobj	_	_
8	to	_	TO	TO	_	3	prep	_	_
9	productive	_	JJ	JJ	_	11	amod	_	_
10	HIV	_	NN	NN	_	11	nn	_	_
11	infection	_	NN	NN	_	8	pobj	_	_
12	,	_	,	,	_	3	punct	_	_
13	coupled	_	VBN	VBN	_	3	vmod	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	their	_	PRP$	PRP$	_	17	poss	_	_
16	proliferative	_	JJ	JJ	_	17	amod	_	_
17	advantage	_	NN	NN	_	14	pobj	_	_
18	as	_	IN	IN	_	19	mark	_	_
19	demonstrated	_	VBN	VBN	_	13	advcl	_	_
20	here	_	RB	RB	_	19	advmod	_	_
21	,	_	,	,	_	3	punct	_	_
22	provides	_	VBZ	VBZ	_	0	root	_	_
23	a	_	DT	DT	_	25	det	_	_
24	sound	_	JJ	JJ	_	25	amod	_	_
25	basis	_	NN	NN	_	22	dobj	_	_
26	for	_	IN	IN	_	25	prep	_	_
27	proposed	_	JJ	JJ	_	29	amod	_	_
28	clinical	_	JJ	JJ	_	27	dep	_	_
29	therapies	_	NNS	NNS	_	26	pobj	_	_
30	using	_	VBG	VBG	_	29	vmod	_	_
31	ex	_	FW	FW	_	33	amod	_	_
32	vivo	_	FW	FW	_	31	dep	_	_
33	expansion	_	NN	NN	_	30	dobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	reinfusion	_	NN	NN	_	33	conj	_	_
36	of	_	IN	IN	_	33	prep	_	_
37	CD4	_	NN	NN	_	39	nn	_	_
38	T	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	36	pobj	_	_
40	from	_	IN	IN	_	39	prep	_	_
41	HIV-infected	_	JJ	JJ	_	42	amod	_	_
42	adults	_	NNS	NNS	_	40	pobj	_	_
43	.	_	.	.	_	22	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Pax-5	_	NN	NN	_	3	nn	_	_
3	gene	_	NN	NN	_	6	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	6	auxpass	_	_
5	alternatively	_	RB	RB	_	6	advmod	_	_
6	spliced	_	VBN	VBN	_	0	root	_	_
7	during	_	IN	IN	_	6	prep	_	_
8	B-cell	_	NN	NN	_	9	nn	_	_
9	development	_	NN	NN	_	7	pobj	_	_
10	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	transcription	_	NN	NN	_	4	nn	_	_
3	factor	_	NN	NN	_	4	nn	_	_
4	Pax-5	_	NN	NN	_	6	nsubjpass	_	_
5	is	_	VBZ	VBZ	_	6	auxpass	_	_
6	expressed	_	VBN	VBN	_	0	root	_	_
7	during	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	early	_	JJ	JJ	_	10	amod	_	_
10	stages	_	NNS	NNS	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	B-cell	_	NN	NN	_	13	nn	_	_
13	differentiation	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	6	cc	_	_
15	influences	_	VBZ	VBZ	_	6	conj	_	_
16	the	_	DT	DT	_	17	det	_	_
17	expression	_	NN	NN	_	15	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	several	_	JJ	JJ	_	21	amod	_	_
20	B-cell-specific	_	JJ	JJ	_	21	amod	_	_
21	genes	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	19	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	existing	_	VBG	VBG	_	6	amod	_	_
6	isoform	_	NN	NN	_	3	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	Pax-5	_	NN	NN	_	6	dep	_	_
9	,	_	,	,	_	8	punct	_	_
10	which	_	WDT	WDT	_	14	dobj	_	_
11	we	_	PRP	PRP	_	13	nsubj	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	named	_	VBN	VBN	_	8	rcmod	_	_
14	Pax-5a	_	NN	NN	_	13	xcomp	_	_
15	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
16	,	_	,	,	_	19	punct	_	_
17	we	_	PRP	PRP	_	19	nsubj	_	_
18	have	_	VBP	VBP	_	19	aux	_	_
19	isolated	_	VBN	VBN	_	0	root	_	_
20	three	_	CD	CD	_	22	num	_	_
21	new	_	JJ	JJ	_	22	amod	_	_
22	isoforms	_	NNS	NNS	_	19	dobj	_	_
23	,	_	,	,	_	22	punct	_	_
24	Pax-5b	_	NN	NN	_	22	appos	_	_
25	,	_	,	,	_	24	punct	_	_
26	Pax-5d	_	NN	NN	_	24	conj	_	_
27	,	_	,	,	_	24	punct	_	_
28	and	_	CC	CC	_	24	cc	_	_
29	Pax-5e	_	NN	NN	_	24	conj	_	_
30	,	_	,	,	_	19	punct	_	_
31	from	_	IN	IN	_	19	prep	_	_
32	murine	_	JJ	JJ	_	33	amod	_	_
33	spleen	_	NN	NN	_	31	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	B-lymphoid	_	JJ	JJ	_	37	amod	_	_
36	cell	_	NN	NN	_	37	nn	_	_
37	lines	_	NNS	NNS	_	33	conj	_	_
38	using	_	VBG	VBG	_	19	xcomp	_	_
39	library	_	NN	NN	_	40	nn	_	_
40	screenings	_	NNS	NNS	_	38	dobj	_	_
41	and	_	CC	CC	_	40	cc	_	_
42	polymerase	_	NN	NN	_	45	nn	_	_
43	chain	_	NN	NN	_	45	nn	_	_
44	reaction	_	NN	NN	_	45	nn	_	_
45	amplification	_	NN	NN	_	40	conj	_	_
46	.	_	.	.	_	19	punct	_	_

1	Isoforms	_	NNS	NNS	_	6	nsubj	_	_
2	Pax-5b	_	NN	NN	_	1	dep	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	Pax-5e	_	NN	NN	_	2	conj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	spliced	_	VBN	VBN	_	0	root	_	_
7	out	_	RP	RP	_	6	prt	_	_
8	their	_	PRP$	PRP$	_	10	poss	_	_
9	second	_	JJ	JJ	_	10	amod	_	_
10	exon	_	NN	NN	_	6	dobj	_	_
11	,	_	,	,	_	6	punct	_	_
12	resulting	_	VBG	VBG	_	6	vmod	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	proteins	_	NNS	NNS	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	only	_	RB	RB	_	20	advmod	_	_
17	a	_	DT	DT	_	20	det	_	_
18	partial	_	JJ	JJ	_	20	amod	_	_
19	DNA-binding	_	JJ	JJ	_	20	amod	_	_
20	domain	_	NN	NN	_	15	pobj	_	_
21	.	_	.	.	_	6	punct	_	_

1	Isoforms	_	NNS	NNS	_	6	nsubj	_	_
2	Pax-5d	_	NN	NN	_	1	dep	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	Pax-5e	_	NN	NN	_	2	conj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	deleted	_	VBN	VBN	_	0	root	_	_
7	the	_	DT	DT	_	8	det	_	_
8	3'-region	_	NN	NN	_	6	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	encodes	_	VBZ	VBZ	_	8	rcmod	_	_
12	the	_	DT	DT	_	14	det	_	_
13	transactivating	_	VBG	VBG	_	14	amod	_	_
14	domain	_	NN	NN	_	11	dobj	_	_
15	,	_	,	,	_	6	punct	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	replaced	_	VBN	VBN	_	6	conj	_	_
18	it	_	PRP	PRP	_	17	dobj	_	_
19	with	_	IN	IN	_	17	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	novel	_	JJ	JJ	_	22	amod	_	_
22	sequence	_	NN	NN	_	19	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	existence	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	alternative	_	JJ	JJ	_	6	amod	_	_
5	Pax-5	_	NN	NN	_	6	nn	_	_
6	transcripts	_	NNS	NNS	_	3	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	confirmed	_	VBN	VBN	_	0	root	_	_
9	using	_	VBG	VBG	_	8	xcomp	_	_
10	RNase	_	NN	NN	_	12	nn	_	_
11	protection	_	NN	NN	_	12	nn	_	_
12	assays	_	NNS	NNS	_	9	dobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	Furthermore	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	Pax-5a	_	NN	NN	_	8	nsubjpass	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	Pax-5b	_	NN	NN	_	6	nn	_	_
6	proteins	_	NNS	NNS	_	3	conj	_	_
7	were	_	VBD	VBD	_	8	auxpass	_	_
8	detected	_	VBN	VBN	_	0	root	_	_
9	using	_	VBG	VBG	_	8	xcomp	_	_
10	Western	_	NN	NN	_	12	nn	_	_
11	blot	_	NN	NN	_	12	nn	_	_
12	analysis	_	NN	NN	_	9	dobj	_	_
13	.	_	.	.	_	8	punct	_	_

1	Pax-5a	_	NN	NN	_	3	nsubj	_	_
2	was	_	VBD	VBD	_	3	cop	_	_
3	detectable	_	JJ	JJ	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	pro-	_	JJ	JJ	_	4	pobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	pre-	_	JJ	JJ	_	5	conj	_	_
8	,	_	,	,	_	5	punct	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	mature	_	JJ	JJ	_	5	conj	_	_
11	B-cell	_	NN	NN	_	12	nn	_	_
12	lines	_	NNS	NNS	_	5	dep	_	_
13	,	_	,	,	_	4	punct	_	_
14	but	_	CC	CC	_	4	cc	_	_
15	not	_	RB	RB	_	16	neg	_	_
16	in	_	IN	IN	_	4	conj	_	_
17	two	_	CD	CD	_	18	num	_	_
18	plasmacytomas	_	NNS	NNS	_	16	pobj	_	_
19	;	_	:	:	_	3	punct	_	_
20	Pax-5b	_	NN	NN	_	22	nsubjpass	_	_
21	was	_	VBD	VBD	_	22	auxpass	_	_
22	shown	_	VBN	VBN	_	3	parataxis	_	_
23	to	_	TO	TO	_	25	aux	_	_
24	be	_	VB	VB	_	25	cop	_	_
25	present	_	JJ	JJ	_	22	xcomp	_	_
26	at	_	IN	IN	_	25	prep	_	_
27	low	_	JJ	JJ	_	28	amod	_	_
28	levels	_	NNS	NNS	_	26	pobj	_	_
29	in	_	IN	IN	_	25	prep	_	_
30	mature	_	JJ	JJ	_	32	amod	_	_
31	B-cell	_	NN	NN	_	32	nn	_	_
32	lines	_	NNS	NNS	_	29	pobj	_	_
33	and	_	CC	CC	_	29	cc	_	_
34	,	_	,	,	_	29	punct	_	_
35	unexpectedly	_	RB	RB	_	29	conj	_	_
36	,	_	,	,	_	29	punct	_	_
37	in	_	IN	IN	_	29	conj	_	_
38	one	_	CD	CD	_	41	num	_	_
39	plasma	_	NN	NN	_	41	nn	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	line	_	NN	NN	_	37	pobj	_	_
42	,	_	,	,	_	29	punct	_	_
43	but	_	CC	CC	_	29	cc	_	_
44	not	_	RB	RB	_	45	neg	_	_
45	in	_	IN	IN	_	29	conj	_	_
46	pro-B-cell	_	JJ	JJ	_	45	pobj	_	_
47	or	_	CC	CC	_	46	cc	_	_
48	T-cell	_	NN	NN	_	46	conj	_	_
49	lines	_	NNS	NNS	_	46	dep	_	_
50	.	_	.	.	_	3	punct	_	_

1	Mobility	_	NN	NN	_	3	nn	_	_
2	shift	_	NN	NN	_	3	nn	_	_
3	assays	_	NNS	NNS	_	4	nsubj	_	_
4	showed	_	VBD	VBD	_	0	root	_	_
5	that	_	IN	IN	_	20	mark	_	_
6	in	_	FW	FW	_	7	nn	_	_
7	vitro	_	FW	FW	_	9	advmod	_	_
8	translated	_	VBN	VBN	_	9	amod	_	_
9	Pax-5a	_	NN	NN	_	20	nsubj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	Pax-5d	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	but	_	CC	CC	_	14	cc	_	_
14	not	_	RB	RB	_	9	cc	_	_
15	Pax-5b	_	NN	NN	_	9	conj	_	_
16	or	_	CC	CC	_	15	cc	_	_
17	Pax-5e	_	NN	NN	_	15	conj	_	_
18	,	_	,	,	_	9	punct	_	_
19	could	_	MD	MD	_	20	aux	_	_
20	interact	_	VB	VB	_	4	ccomp	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	a	_	DT	DT	_	26	det	_	_
23	B-cell-specific	_	JJ	JJ	_	26	amod	_	_
24	activator	_	NN	NN	_	26	nn	_	_
25	protein-binding	_	JJ	JJ	_	26	amod	_	_
26	site	_	NN	NN	_	21	pobj	_	_
27	on	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	blk	_	NN	NN	_	30	nn	_	_
30	promoter	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	this	_	DT	DT	_	3	det	_	_
3	assay	_	NN	NN	_	1	dobj	_	_
4	,	_	,	,	_	1	punct	_	_
5	we	_	PRP	PRP	_	7	nsubj	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	showed	_	VBD	VBD	_	1	parataxis	_	_
8	that	_	IN	IN	_	11	mark	_	_
9	Pax-5d	_	NN	NN	_	11	nsubj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	present	_	JJ	JJ	_	7	ccomp	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	nuclear	_	JJ	JJ	_	14	amod	_	_
14	extracts	_	NNS	NNS	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	some	_	DT	DT	_	15	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
18	but	_	CC	CC	_	20	cc	_	_
19	not	_	RB	RB	_	20	neg	_	_
20	all	_	DT	DT	_	16	dep	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	B-lymphoid	_	JJ	JJ	_	23	amod	_	_
23	lines	_	NNS	NNS	_	16	dep	_	_
24	and	_	CC	CC	_	11	cc	_	_
25	interacts	_	VBZ	VBZ	_	11	conj	_	_
26	with	_	IN	IN	_	25	prep	_	_
27	the	_	DT	DT	_	31	det	_	_
28	B-cell-specific	_	JJ	JJ	_	31	amod	_	_
29	activator	_	NN	NN	_	31	nn	_	_
30	protein-binding	_	JJ	JJ	_	31	amod	_	_
31	site	_	NN	NN	_	26	pobj	_	_
32	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	pattern	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	differential	_	JJ	JJ	_	5	amod	_	_
5	expression	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	alternatively	_	RB	RB	_	10	advmod	_	_
8	spliced	_	VBN	VBN	_	10	amod	_	_
9	Pax-5	_	NN	NN	_	10	nn	_	_
10	isoforms	_	NNS	NNS	_	6	pobj	_	_
11	suggests	_	VBZ	VBZ	_	0	root	_	_
12	that	_	IN	IN	_	19	mark	_	_
13	they	_	PRP	PRP	_	19	nsubj	_	_
14	may	_	MD	MD	_	19	aux	_	_
15	be	_	VB	VB	_	19	cop	_	_
16	important	_	JJ	JJ	_	19	amod	_	_
17	regulators	_	NNS	NNS	_	19	nn	_	_
18	of	_	IN	IN	_	19	amod	_	_
19	transcription	_	NN	NN	_	11	ccomp	_	_
20	during	_	IN	IN	_	19	prep	_	_
21	B-cell	_	NN	NN	_	22	nn	_	_
22	maturation	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	11	punct	_	_

1	Oxidant-regulation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	expression	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	chronically	_	RB	RB	_	8	advmod	_	_
8	inflamed	_	JJ	JJ	_	9	amod	_	_
9	intestine	_	NN	NN	_	5	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	is	_	VBZ	VBZ	_	3	aux	_	_
3	becoming	_	VBG	VBG	_	0	root	_	_
4	increasingly	_	RB	RB	_	5	advmod	_	_
5	apparent	_	JJ	JJ	_	3	acomp	_	_
6	that	_	IN	IN	_	28	mark	_	_
7	the	_	DT	DT	_	10	det	_	_
8	chronic	_	JJ	JJ	_	10	amod	_	_
9	gut	_	NN	NN	_	10	nn	_	_
10	inflammation	_	NN	NN	_	28	nsubjpass	_	_
11	observed	_	VBN	VBN	_	10	vmod	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	17	det	_	_
14	idiopathic	_	JJ	JJ	_	15	amod	_	_
15	inflammatory	_	JJ	JJ	_	17	amod	_	_
16	bowel	_	NN	NN	_	17	nn	_	_
17	diseases	_	NNS	NNS	_	12	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	e.g.	_	FW	FW	_	21	prep	_	_
20	ulcerative	_	JJ	JJ	_	21	amod	_	_
21	colitis	_	NN	NN	_	17	dep	_	_
22	,	_	,	,	_	21	punct	_	_
23	Crohn	_	NN	NN	_	25	poss	_	_
24	's	_	POS	POS	_	25	possessive	_	_
25	disease	_	NN	NN	_	21	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
27	is	_	VBZ	VBZ	_	28	auxpass	_	_
28	associated	_	VBN	VBN	_	3	ccomp	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	enhanced	_	VBN	VBN	_	31	amod	_	_
31	production	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	leukocyte-derived	_	JJ	JJ	_	34	amod	_	_
34	oxidants	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	3	punct	_	_

1	Oxidants	_	NNS	NNS	_	7	nsubjpass	_	_
2	such	_	JJ	JJ	_	3	mwe	_	_
3	as	_	IN	IN	_	1	prep	_	_
4	hydrogen	_	NN	NN	_	5	nn	_	_
5	peroxide	_	NN	NN	_	3	pobj	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	known	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	activate	_	VB	VB	_	7	xcomp	_	_
10	certain	_	JJ	JJ	_	12	amod	_	_
11	transcription	_	NN	NN	_	12	nn	_	_
12	factors	_	NNS	NNS	_	9	dobj	_	_
13	such	_	JJ	JJ	_	14	mwe	_	_
14	as	_	IN	IN	_	12	prep	_	_
15	nuclear	_	JJ	JJ	_	19	amod	_	_
16	transcription	_	NN	NN	_	19	nn	_	_
17	factor	_	NN	NN	_	19	nn	_	_
18	kappa	_	NN	NN	_	19	nn	_	_
19	beta	_	NN	NN	_	14	pobj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Nuclear	_	JJ	JJ	_	4	amod	_	_
2	transcription	_	NN	NN	_	4	nn	_	_
3	factor	_	NN	NN	_	4	nn	_	_
4	kB	_	NN	NN	_	13	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
6	NF-kappa	_	NN	NN	_	7	nn	_	_
7	B	_	NN	NN	_	4	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	is	_	VBZ	VBZ	_	13	cop	_	_
10	a	_	DT	DT	_	13	det	_	_
11	ubiquitous	_	JJ	JJ	_	13	amod	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factor	_	NN	NN	_	0	root	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	pleiotropic	_	JJ	JJ	_	16	amod	_	_
16	regulator	_	NN	NN	_	13	conj	_	_
17	of	_	IN	IN	_	13	prep	_	_
18	numerous	_	JJ	JJ	_	19	amod	_	_
19	genes	_	NNS	NNS	_	17	pobj	_	_
20	involved	_	VBN	VBN	_	19	vmod	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	23	dep	_	_
23	immune	_	JJ	JJ	_	21	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	inflammatory	_	JJ	JJ	_	23	conj	_	_
26	responses	_	NNS	NNS	_	23	dep	_	_
27	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	3	det	_	_
2	transcription	_	NN	NN	_	3	nn	_	_
3	factor	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	activated	_	VBN	VBN	_	0	root	_	_
6	via	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	dep	_	_
8	selective	_	JJ	JJ	_	9	amod	_	_
9	phosphorylation	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	ubiquination	_	NN	NN	_	9	conj	_	_
12	and	_	CC	CC	_	9	cc	_	_
13	degradation	_	NN	NN	_	9	conj	_	_
14	of	_	IN	IN	_	9	prep	_	_
15	its	_	PRP$	PRP$	_	18	poss	_	_
16	inhibitor	_	NN	NN	_	18	nn	_	_
17	protein	_	NN	NN	_	18	nn	_	_
18	I-kB	_	NN	NN	_	14	pobj	_	_
19	thereby	_	RB	RB	_	20	advmod	_	_
20	allowing	_	VBG	VBG	_	5	xcomp	_	_
21	translocation	_	NN	NN	_	20	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	22	pobj	_	_
25	into	_	IN	IN	_	21	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	nucleus	_	NN	NN	_	25	pobj	_	_
28	where	_	WRB	WRB	_	30	advmod	_	_
29	it	_	PRP	PRP	_	30	nsubj	_	_
30	upregulates	_	VBZ	VBZ	_	27	rcmod	_	_
31	the	_	DT	DT	_	32	det	_	_
32	transcription	_	NN	NN	_	30	dobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	a	_	DT	DT	_	35	det	_	_
35	variety	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	adhesion	_	NN	NN	_	38	nn	_	_
38	molecules	_	NNS	NNS	_	36	pobj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
40	e.g.	_	FW	FW	_	41	prep	_	_
41	ICAM-1	_	NN	NN	_	38	dep	_	_
42	,	_	,	,	_	41	punct	_	_
43	VCAM-1	_	NN	NN	_	41	appos	_	_
44	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
45	,	_	,	,	_	38	punct	_	_
46	cytokines	_	NNS	NNS	_	38	conj	_	_
47	-LRB-	_	-LRB-	-LRB-	_	48	punct	_	_
48	TNF	_	NN	NN	_	46	dep	_	_
49	,	_	,	,	_	48	punct	_	_
50	IL-1	_	NN	NN	_	48	appos	_	_
51	,	_	,	,	_	48	punct	_	_
52	IL-6	_	NN	NN	_	48	appos	_	_
53	-RRB-	_	-RRB-	-RRB-	_	48	punct	_	_
54	and	_	CC	CC	_	38	cc	_	_
55	enzymes	_	NNS	NNS	_	38	conj	_	_
56	-LRB-	_	-LRB-	-LRB-	_	57	punct	_	_
57	iNOS	_	NN	NN	_	55	appos	_	_
58	-RRB-	_	-RRB-	-RRB-	_	57	punct	_	_
59	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	proteolytic	_	JJ	JJ	_	3	amod	_	_
3	degradation	_	NN	NN	_	11	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	9	det	_	_
6	post-translationally	_	RB	RB	_	7	advmod	_	_
7	modified	_	VBN	VBN	_	9	amod	_	_
8	I-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	4	pobj	_	_
10	is	_	VBZ	VBZ	_	11	auxpass	_	_
11	known	_	VBN	VBN	_	0	root	_	_
12	to	_	TO	TO	_	14	aux	_	_
13	be	_	VB	VB	_	14	auxpass	_	_
14	mediated	_	VBN	VBN	_	11	xcomp	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	26S	_	NN	NN	_	19	nn	_	_
18	proteasome	_	NN	NN	_	19	nn	_	_
19	complex	_	NN	NN	_	15	pobj	_	_
20	.	_	.	.	_	11	punct	_	_

1	Based	_	VBN	VBN	_	9	prep	_	_
2	upon	_	IN	IN	_	1	pcomp	_	_
3	work	_	NN	NN	_	2	pobj	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	our	_	PRP$	PRP$	_	6	poss	_	_
6	laboratory	_	NN	NN	_	4	pobj	_	_
7	,	_	,	,	_	9	punct	_	_
8	we	_	PRP	PRP	_	9	nsubj	_	_
9	propose	_	VBP	VBP	_	0	root	_	_
10	that	_	IN	IN	_	16	mark	_	_
11	inhibition	_	NN	NN	_	16	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	NF-kappa	_	NN	NN	_	14	nn	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	activation	_	NN	NN	_	12	pobj	_	_
16	produces	_	VBZ	VBZ	_	9	ccomp	_	_
17	significant	_	JJ	JJ	_	20	amod	_	_
18	anti	_	JJ	JJ	_	19	amod	_	_
19	inflammatory	_	JJ	JJ	_	17	dep	_	_
20	activity	_	NN	NN	_	16	dobj	_	_
21	which	_	WDT	WDT	_	24	nsubjpass	_	_
22	may	_	MD	MD	_	24	aux	_	_
23	be	_	VB	VB	_	24	auxpass	_	_
24	mediated	_	VBN	VBN	_	20	rcmod	_	_
25	by	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	inhibition	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	transcription	_	NN	NN	_	28	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	certain	_	JJ	JJ	_	33	amod	_	_
32	pro-inflammatory	_	JJ	JJ	_	33	amod	_	_
33	mediators	_	NNS	NNS	_	30	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	adhesion	_	NN	NN	_	36	nn	_	_
36	molecules	_	NNS	NNS	_	33	conj	_	_
37	.	_	.	.	_	9	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	LAZ3/BCL6	_	NN	NN	_	2	pobj	_	_
4	in	_	IN	IN	_	1	prep	_	_
5	follicular	_	JJ	JJ	_	6	amod	_	_
6	center	_	NN	NN	_	11	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	FC	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	4	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	reactive	_	JJ	JJ	_	15	amod	_	_
14	lymph	_	NN	NN	_	15	nn	_	_
15	nodes	_	NNS	NNS	_	12	pobj	_	_
16	and	_	CC	CC	_	11	cc	_	_
17	FC-derived	_	JJ	JJ	_	19	amod	_	_
18	non-Hodgkin	_	JJ	JJ	_	19	amod	_	_
19	lymphomas	_	NNS	NNS	_	11	conj	_	_
20	.	_	.	.	_	1	punct	_	_

1	Chromosomal	_	JJ	JJ	_	2	amod	_	_
2	translocation	_	NN	NN	_	16	nsubjpass	_	_
3	resulting	_	VBG	VBG	_	2	vmod	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	abnormal	_	JJ	JJ	_	6	amod	_	_
6	expression	_	NN	NN	_	4	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	LAZ3/BCL6	_	NN	NN	_	10	nn	_	_
10	gene	_	NN	NN	_	7	pobj	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	B	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	has	_	VBZ	VBZ	_	16	aux	_	_
15	been	_	VBN	VBN	_	16	auxpass	_	_
16	implicated	_	VBN	VBN	_	0	root	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	tumorigenesis	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	non-Hodgkin	_	JJ	JJ	_	22	amod	_	_
22	lymphoma	_	NN	NN	_	20	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	NHL	_	NN	NN	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	.	_	.	.	_	16	punct	_	_

1	Therefore	_	RB	RB	_	3	advmod	_	_
2	we	_	PRP	PRP	_	3	nsubj	_	_
3	studied	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	6	det	_	_
5	expression	_	NN	NN	_	6	nn	_	_
6	pattern	_	NN	NN	_	3	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	LAZ3/BCL6	_	NN	NN	_	7	pobj	_	_
9	by	_	IN	IN	_	3	prep	_	_
10	in	_	FW	FW	_	12	amod	_	_
11	situ	_	FW	FW	_	10	dep	_	_
12	hybridization	_	NN	NN	_	9	pobj	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	synthetic	_	JJ	JJ	_	16	amod	_	_
15	oligonucleotide	_	NN	NN	_	16	nn	_	_
16	probes	_	NNS	NNS	_	13	pobj	_	_
17	in	_	IN	IN	_	3	prep	_	_
18	frozen	_	VBN	VBN	_	20	amod	_	_
19	tissue	_	NN	NN	_	20	nn	_	_
20	sections	_	NNS	NNS	_	17	pobj	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	five	_	CD	CD	_	25	num	_	_
23	reactive	_	JJ	JJ	_	25	amod	_	_
24	lymph	_	NN	NN	_	25	nn	_	_
25	nodes	_	NNS	NNS	_	21	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	38	_	CD	CD	_	29	num	_	_
28	B	_	NN	NN	_	29	nn	_	_
29	cell	_	NN	NN	_	25	conj	_	_
30	and	_	CC	CC	_	29	cc	_	_
31	non-B	_	JJ	JJ	_	32	amod	_	_
32	NHL	_	NN	NN	_	29	conj	_	_
33	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	5	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	5	punct	_	_
4	we	_	PRP	PRP	_	5	nsubj	_	_
5	investigated	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	expression	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	LAZ3/BCL6	_	NN	NN	_	8	pobj	_	_
10	by	_	IN	IN	_	5	prep	_	_
11	Northern	_	NN	NN	_	13	nn	_	_
12	blot	_	NN	NN	_	13	nn	_	_
13	analysis	_	NN	NN	_	10	pobj	_	_
14	on	_	IN	IN	_	5	prep	_	_
15	multiple	_	JJ	JJ	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	tissues	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	LAZ3/BCL6	_	NN	NN	_	3	nn	_	_
3	transcript	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	found	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	variety	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	tissues	_	NNS	NNS	_	9	pobj	_	_
11	,	_	,	,	_	8	punct	_	_
12	including	_	VBG	VBG	_	8	prep	_	_
13	skeletal	_	JJ	JJ	_	14	amod	_	_
14	muscle	_	NN	NN	_	12	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	peripheral	_	JJ	JJ	_	18	amod	_	_
17	blood	_	NN	NN	_	18	nn	_	_
18	leukocytes	_	NNS	NNS	_	14	appos	_	_
19	,	_	,	,	_	6	punct	_	_
20	and	_	CC	CC	_	6	cc	_	_
21	weakly	_	RB	RB	_	22	advmod	_	_
22	in	_	IN	IN	_	6	conj	_	_
23	normal	_	JJ	JJ	_	25	amod	_	_
24	lymph	_	NN	NN	_	25	nn	_	_
25	nodes	_	NNS	NNS	_	22	pobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	10	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	tumor	_	NN	NN	_	4	nn	_	_
4	samples	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	10	punct	_	_
6	expression	_	NN	NN	_	10	nsubjpass	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	LAZ3/BCL6	_	NN	NN	_	7	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	observed	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	68	_	CD	CD	_	13	num	_	_
13	%	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	all	_	DT	DT	_	18	det	_	_
16	B	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	NHL	_	NN	NN	_	14	pobj	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	none	_	NN	NN	_	13	conj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	non-B	_	JJ	JJ	_	24	amod	_	_
24	lymphomas	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	10	punct	_	_

1	All	_	DT	DT	_	2	det	_	_
2	cases	_	NNS	NNS	_	12	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	follicular	_	JJ	JJ	_	3	pobj	_	_
5	,	_	,	,	_	4	punct	_	_
6	mixed	_	JJ	JJ	_	7	amod	_	_
7	small	_	JJ	JJ	_	4	appos	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	large	_	JJ	JJ	_	7	conj	_	_
10	cell	_	NN	NN	_	11	nn	_	_
11	lymphomas	_	NNS	NNS	_	7	dep	_	_
12	showed	_	VBD	VBD	_	0	root	_	_
13	LAZ3/BCL6	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	12	dobj	_	_
15	confined	_	VBN	VBN	_	14	vmod	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	neoplastic	_	JJ	JJ	_	19	amod	_	_
19	follicles	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	12	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	follicular	_	JJ	JJ	_	4	amod	_	_
3	expression	_	NN	NN	_	4	nn	_	_
4	pattern	_	NN	NN	_	7	nsubjpass	_	_
5	was	_	VBD	VBD	_	7	auxpass	_	_
6	also	_	RB	RB	_	7	advmod	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	all	_	DT	DT	_	13	det	_	_
10	non-malignant	_	JJ	JJ	_	13	amod	_	_
11	reactive	_	JJ	JJ	_	10	dep	_	_
12	lymph	_	NN	NN	_	13	nn	_	_
13	nodes	_	NNS	NNS	_	8	pobj	_	_
14	.	_	.	.	_	7	punct	_	_

1	Hence	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	expression	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	LAZ3/BCL6	_	NN	NN	_	5	pobj	_	_
7	does	_	VBZ	VBZ	_	9	aux	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	correlate	_	VB	VB	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	malignancy	_	NN	NN	_	10	pobj	_	_
12	,	_	,	,	_	9	punct	_	_
13	but	_	CC	CC	_	9	cc	_	_
14	reflects	_	VBZ	VBZ	_	9	conj	_	_
15	the	_	DT	DT	_	16	det	_	_
16	origin	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	B	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	germinal	_	JJ	JJ	_	23	amod	_	_
23	centers	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	Estrogen	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	progesterone	_	NN	NN	_	4	nn	_	_
4	receptors	_	NNS	NNS	_	1	conj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	vernal	_	JJ	JJ	_	7	amod	_	_
7	keratoconjunctivitis	_	NN	NN	_	5	pobj	_	_
8	.	_	.	.	_	1	punct	_	_

1	PURPOSE	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Sex-related	_	JJ	JJ	_	4	amod	_	_
4	influences	_	NNS	NNS	_	7	nsubjpass	_	_
5	have	_	VBP	VBP	_	7	aux	_	_
6	been	_	VBN	VBN	_	7	auxpass	_	_
7	implicated	_	VBN	VBN	_	1	dep	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	pathogenesis	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	vernal	_	JJ	JJ	_	13	amod	_	_
13	keratoconjunctivitis	_	NN	NN	_	11	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	VKC	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	,	_	,	,	_	13	punct	_	_
18	an	_	DT	DT	_	21	det	_	_
19	allergic	_	JJ	JJ	_	20	amod	_	_
20	eosinophilic	_	JJ	JJ	_	21	amod	_	_
21	disease	_	NN	NN	_	13	appos	_	_
22	.	_	.	.	_	7	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	4	det	_	_
4	authors	_	NNS	NNS	_	5	nsubj	_	_
5	evaluated	_	VBD	VBD	_	1	dep	_	_
6	tarsal	_	JJ	JJ	_	5	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	bulbar	_	JJ	JJ	_	6	conj	_	_
9	conjunctival	_	JJ	JJ	_	10	amod	_	_
10	biopsies	_	NNS	NNS	_	6	dep	_	_
11	from	_	IN	IN	_	6	prep	_	_
12	seven	_	CD	CD	_	13	num	_	_
13	patients	_	NNS	NNS	_	11	pobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	severe	_	JJ	JJ	_	18	amod	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	symptomatic	_	JJ	JJ	_	15	conj	_	_
18	VKC	_	NN	NN	_	14	pobj	_	_
19	for	_	IN	IN	_	5	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	presence	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	estrogen	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	progesterone	_	NN	NN	_	26	nn	_	_
26	receptors	_	NNS	NNS	_	23	conj	_	_
27	by	_	IN	IN	_	5	prep	_	_
28	using	_	VBG	VBG	_	27	pcomp	_	_
29	monoclonal	_	JJ	JJ	_	30	amod	_	_
30	antibodies	_	NNS	NNS	_	28	dobj	_	_
31	with	_	IN	IN	_	28	prep	_	_
32	a	_	DT	DT	_	34	det	_	_
33	peroxidase-antiperoxidase	_	JJ	JJ	_	34	amod	_	_
34	technique	_	NN	NN	_	31	pobj	_	_
35	.	_	.	.	_	1	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Both	_	CC	CC	_	5	preconj	_	_
4	the	_	DT	DT	_	5	dep	_	_
5	epithelium	_	NN	NN	_	28	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	subepithelium	_	NN	NN	_	5	conj	_	_
8	of	_	IN	IN	_	5	prep	_	_
9	the	_	DT	DT	_	10	dep	_	_
10	tarsal	_	JJ	JJ	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	bulbar	_	JJ	JJ	_	10	conj	_	_
13	conjunctiva	_	NN	NN	_	10	dep	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	patients	_	NNS	NNS	_	14	pobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	VKC	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	5	punct	_	_
19	but	_	CC	CC	_	20	cc	_	_
20	not	_	RB	RB	_	5	cc	_	_
21	those	_	DT	DT	_	5	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	four	_	CD	CD	_	26	num	_	_
24	nonatopic	_	JJ	JJ	_	26	amod	_	_
25	control	_	JJ	JJ	_	26	amod	_	_
26	subjects	_	NNS	NNS	_	22	pobj	_	_
27	,	_	,	,	_	5	punct	_	_
28	showed	_	VBD	VBD	_	1	dep	_	_
29	intense	_	JJ	JJ	_	31	amod	_	_
30	positive	_	JJ	JJ	_	29	dep	_	_
31	staining	_	NN	NN	_	28	dobj	_	_
32	for	_	IN	IN	_	31	prep	_	_
33	estrogen	_	NN	NN	_	32	pobj	_	_
34	and	_	CC	CC	_	33	cc	_	_
35	progesterone	_	NN	NN	_	36	nn	_	_
36	receptors	_	NNS	NNS	_	33	conj	_	_
37	.	_	.	.	_	1	punct	_	_

1	Immunofluorescence	_	NN	NN	_	2	nn	_	_
2	colocalization	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	both	_	CC	CC	_	5	preconj	_	_
5	estrogen	_	NN	NN	_	3	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	progesterone	_	NN	NN	_	8	nn	_	_
8	receptors	_	NNS	NNS	_	5	conj	_	_
9	with	_	IN	IN	_	2	prep	_	_
10	eosinophil	_	NN	NN	_	12	nn	_	_
11	cationic	_	JJ	JJ	_	12	amod	_	_
12	protein	_	NN	NN	_	9	pobj	_	_
13	showed	_	VBD	VBD	_	0	root	_	_
14	that	_	IN	IN	_	22	mark	_	_
15	approximately	_	RB	RB	_	16	quantmod	_	_
16	70	_	CD	CD	_	17	num	_	_
17	%	_	NN	NN	_	22	nsubj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	positive	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	were	_	VBD	VBD	_	22	cop	_	_
22	eosinophils	_	NNS	NNS	_	13	ccomp	_	_
23	.	_	.	.	_	13	punct	_	_

1	CONCLUSIONS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Sexual	_	JJ	JJ	_	4	amod	_	_
4	hormones	_	NNS	NNS	_	11	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	through	_	IN	IN	_	4	prep	_	_
7	their	_	PRP$	PRP$	_	8	poss	_	_
8	receptors	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	influence	_	VB	VB	_	1	dep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	activity	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	eosinophils	_	NNS	NNS	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	patients	_	NNS	NNS	_	16	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	VKC	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	1	punct	_	_

1	Use	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	new	_	JJ	JJ	_	5	amod	_	_
4	biologic	_	JJ	JJ	_	3	dep	_	_
5	markers	_	NNS	NNS	_	2	pobj	_	_
6	in	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	ovulation	_	NN	NN	_	9	nn	_	_
9	induction	_	NN	NN	_	6	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	Biological	_	JJ	JJ	_	2	amod	_	_
2	markers	_	NNS	NNS	_	15	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	ovulation	_	NN	NN	_	3	pobj	_	_
5	,	_	,	,	_	2	punct	_	_
6	after	_	IN	IN	_	2	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	great	_	JJ	JJ	_	6	pobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	past	_	NN	NN	_	9	pobj	_	_
12	,	_	,	,	_	2	punct	_	_
13	have	_	VBP	VBP	_	15	aux	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	fallen	_	VBN	VBN	_	0	root	_	_
16	into	_	IN	IN	_	15	prep	_	_
17	disuse	_	NN	NN	_	16	pobj	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	large	_	JJ	JJ	_	21	amod	_	_
21	diffusion	_	NN	NN	_	18	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	biochemical	_	JJ	JJ	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	biophysical	_	JJ	JJ	_	23	conj	_	_
26	ones	_	NNS	NNS	_	23	dep	_	_
27	.	_	.	.	_	15	punct	_	_

1	However	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	real	_	JJ	JJ	_	5	amod	_	_
5	effect	_	NN	NN	_	12	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	hormones	_	NNS	NNS	_	6	pobj	_	_
8	involved	_	VBN	VBN	_	7	vmod	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	ovulation	_	NN	NN	_	9	pobj	_	_
11	is	_	VBZ	VBZ	_	12	auxpass	_	_
12	expressed	_	VBN	VBN	_	0	root	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	biological	_	JJ	JJ	_	15	amod	_	_
15	modifications	_	NNS	NNS	_	13	pobj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	target	_	NN	NN	_	18	nn	_	_
18	tissues	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	12	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	explore	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	modifications	_	NNS	NNS	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	reproductive	_	JJ	JJ	_	9	amod	_	_
8	target	_	NN	NN	_	9	nn	_	_
9	tissues	_	NNS	NNS	_	5	pobj	_	_
10	as	_	IN	IN	_	2	prep	_	_
11	ovulation	_	NN	NN	_	12	nn	_	_
12	markers	_	NNS	NNS	_	10	pobj	_	_
13	we	_	PRP	PRP	_	14	nsubj	_	_
14	studied	_	VBD	VBD	_	2	parataxis	_	_
15	the	_	DT	DT	_	16	det	_	_
16	behaviour	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	Albuminemia	_	NN	NN	_	17	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	Platelet	_	NN	NN	_	21	nn	_	_
21	Factor	_	NN	NN	_	18	appos	_	_
22	IV	_	CD	CD	_	21	num	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	as	_	IN	IN	_	21	prep	_	_
25	indicator	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	Platelet	_	NN	NN	_	28	nn	_	_
28	Aggregation	_	NN	NN	_	26	pobj	_	_
29	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
30	,	_	,	,	_	18	punct	_	_
31	Type	_	NN	NN	_	34	nn	_	_
32	II	_	CD	CD	_	34	num	_	_
33	estrogenic	_	JJ	JJ	_	34	amod	_	_
34	receptors	_	NNS	NNS	_	18	appos	_	_
35	in	_	IN	IN	_	18	prep	_	_
36	42	_	CD	CD	_	39	num	_	_
37	ovulation	_	NN	NN	_	38	npadvmod	_	_
38	induced	_	JJ	JJ	_	39	amod	_	_
39	women	_	NNS	NNS	_	35	pobj	_	_
40	,	_	,	,	_	39	punct	_	_
41	undergoing	_	VBG	VBG	_	39	vmod	_	_
42	our	_	PRP$	PRP$	_	43	poss	_	_
43	observation	_	NN	NN	_	41	dobj	_	_
44	.	_	.	.	_	2	punct	_	_

1	33	_	CD	CD	_	4	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	them	_	PRP	PRP	_	2	pobj	_	_
4	had	_	VBD	VBD	_	0	root	_	_
5	ovulation	_	NN	NN	_	4	dobj	_	_
6	and	_	CC	CC	_	4	cc	_	_
7	9	_	CD	CD	_	8	nsubj	_	_
8	developed	_	VBD	VBD	_	4	conj	_	_
9	a	_	DT	DT	_	11	det	_	_
10	LUF	_	NN	NN	_	11	nn	_	_
11	syndrome	_	NN	NN	_	8	dobj	_	_
12	,	_	,	,	_	4	punct	_	_
13	constituting	_	VBG	VBG	_	4	parataxis	_	_
14	two	_	CD	CD	_	16	num	_	_
15	biological	_	JJ	JJ	_	16	amod	_	_
16	models	_	NNS	NNS	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	an	_	DT	DT	_	20	det	_	_
19	opposite	_	JJ	JJ	_	20	amod	_	_
20	situation	_	NN	NN	_	17	pobj	_	_
21	for	_	IN	IN	_	13	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	three	_	CD	CD	_	24	num	_	_
24	markers	_	NNS	NNS	_	21	pobj	_	_
25	observed	_	VBN	VBN	_	24	vmod	_	_
26	.	_	.	.	_	4	punct	_	_

1	All	_	PDT	PDT	_	3	predet	_	_
2	the	_	DT	DT	_	3	det	_	_
3	markers	_	NNS	NNS	_	7	nsubj	_	_
4	considered	_	VBN	VBN	_	3	vmod	_	_
5	were	_	VBD	VBD	_	7	cop	_	_
6	sufficiently	_	RB	RB	_	7	advmod	_	_
7	sensitive	_	JJ	JJ	_	0	root	_	_
8	,	_	,	,	_	7	punct	_	_
9	but	_	CC	CC	_	7	cc	_	_
10	among	_	IN	IN	_	19	prep	_	_
11	them	_	PRP	PRP	_	10	pobj	_	_
12	,	_	,	,	_	19	punct	_	_
13	Platelet	_	NN	NN	_	14	nn	_	_
14	Factor	_	NN	NN	_	19	nsubj	_	_
15	IV	_	CD	CD	_	14	num	_	_
16	was	_	VBD	VBD	_	19	cop	_	_
17	the	_	DT	DT	_	19	det	_	_
18	most	_	RBS	RBS	_	19	advmod	_	_
19	reliable	_	JJ	JJ	_	7	conj	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	the	_	DT	DT	_	24	det	_	_
22	hormonal	_	JJ	JJ	_	23	amod	_	_
23	ovulatory	_	JJ	JJ	_	24	amod	_	_
24	situation	_	NN	NN	_	20	pobj	_	_
25	.	_	.	.	_	7	punct	_	_

1	Induction	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	relA	_	NN	NN	_	5	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	p65	_	NN	NN	_	2	pobj	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	and	_	CC	CC	_	5	cc	_	_
8	I	_	NN	NN	_	12	nn	_	_
9	kappa	_	NN	NN	_	12	nn	_	_
10	B	_	NN	NN	_	12	nn	_	_
11	alpha	_	NN	NN	_	12	nn	_	_
12	subunit	_	NN	NN	_	5	conj	_	_
13	expression	_	NN	NN	_	5	dep	_	_
14	during	_	IN	IN	_	1	prep	_	_
15	differentiation	_	NN	NN	_	14	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	human	_	JJ	JJ	_	20	amod	_	_
18	peripheral	_	JJ	JJ	_	20	amod	_	_
19	blood	_	NN	NN	_	20	nn	_	_
20	monocytes	_	NNS	NNS	_	16	pobj	_	_
21	to	_	TO	TO	_	15	prep	_	_
22	macrophages	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	1	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	evaluated	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	dep	_	_
4	expression	_	NN	NN	_	2	dobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	DNA	_	NN	NN	_	8	nn	_	_
7	binding	_	NN	NN	_	8	nn	_	_
8	activity	_	NN	NN	_	4	conj	_	_
9	of	_	IN	IN	_	4	prep	_	_
10	nuclear	_	JJ	JJ	_	17	amod	_	_
11	factor	_	NN	NN	_	17	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
13	NF	_	NN	NN	_	17	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
15	-kappa	_	NN	NN	_	17	nn	_	_
16	B	_	NN	NN	_	17	nn	_	_
17	subunits	_	NNS	NNS	_	9	pobj	_	_
18	in	_	IN	IN	_	4	prep	_	_
19	human	_	JJ	JJ	_	22	amod	_	_
20	peripheral	_	JJ	JJ	_	22	amod	_	_
21	blood	_	NN	NN	_	22	nn	_	_
22	monocytes	_	NNS	NNS	_	18	pobj	_	_
23	and	_	CC	CC	_	18	cc	_	_
24	in	_	IN	IN	_	18	conj	_	_
25	monocyte-derived	_	JJ	JJ	_	26	amod	_	_
26	macrophages	_	NNS	NNS	_	24	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	MDMs	_	NNS	NNS	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	.	_	.	.	_	2	punct	_	_

1	Constitutive	_	JJ	JJ	_	4	amod	_	_
2	DNA	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	activity	_	NN	NN	_	10	nsubjpass	_	_
5	consisting	_	VBG	VBG	_	4	vmod	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	p50	_	NN	NN	_	8	nn	_	_
8	homodimers	_	NNS	NNS	_	6	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	detected	_	VBN	VBN	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	extracts	_	NNS	NNS	_	11	pobj	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	both	_	DT	DT	_	17	det	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	types	_	NNS	NNS	_	14	pobj	_	_
18	.	_	.	.	_	10	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	additional	_	JJ	JJ	_	3	amod	_	_
3	complex	_	NN	NN	_	11	nsubj	_	_
4	composed	_	VBN	VBN	_	3	vmod	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	p50/RelA	_	NN	NN	_	10	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
8	p65	_	NN	NN	_	10	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
10	heterodimers	_	NNS	NNS	_	5	pobj	_	_
11	appeared	_	VBD	VBD	_	0	root	_	_
12	only	_	RB	RB	_	13	advmod	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	nuclear	_	JJ	JJ	_	15	amod	_	_
15	extracts	_	NNS	NNS	_	13	pobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	7-day	_	JJ	JJ	_	18	amod	_	_
18	MDMs	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	11	punct	_	_

1	Immunoblot	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	10	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	p50	_	NN	NN	_	7	nn	_	_
7	subunit	_	NN	NN	_	10	nsubjpass	_	_
8	was	_	VBD	VBD	_	10	auxpass	_	_
9	constitutively	_	RB	RB	_	10	advmod	_	_
10	expressed	_	VBN	VBN	_	3	ccomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	monocytes	_	NNS	NNS	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	MDMs	_	NNS	NNS	_	12	conj	_	_
15	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	the	_	DT	DT	_	9	det	_	_
5	RelA	_	NN	NN	_	9	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
7	p65	_	NN	NN	_	9	nn	_	_
8	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
9	subunit	_	NN	NN	_	12	nsubj	_	_
10	was	_	VBD	VBD	_	12	cop	_	_
11	barely	_	RB	RB	_	12	advmod	_	_
12	detectable	_	JJ	JJ	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	monocytes	_	NNS	NNS	_	13	pobj	_	_
15	,	_	,	,	_	12	punct	_	_
16	but	_	CC	CC	_	12	cc	_	_
17	its	_	PRP$	PRP$	_	18	poss	_	_
18	level	_	NN	NN	_	19	nsubj	_	_
19	increased	_	VBD	VBD	_	12	conj	_	_
20	markedly	_	RB	RB	_	19	advmod	_	_
21	in	_	IN	IN	_	19	prep	_	_
22	MDMs	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	12	punct	_	_

1	Analysis	_	NN	NN	_	8	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	RelA	_	NN	NN	_	7	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	p65	_	NN	NN	_	7	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
7	mRNA	_	NN	NN	_	2	pobj	_	_
8	revealed	_	VBD	VBD	_	0	root	_	_
9	that	_	IN	IN	_	20	mark	_	_
10	the	_	DT	DT	_	11	det	_	_
11	stability	_	NN	NN	_	20	nsubj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	RelA	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	p65	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	mRNA	_	NN	NN	_	12	pobj	_	_
18	was	_	VBD	VBD	_	20	cop	_	_
19	significantly	_	RB	RB	_	20	advmod	_	_
20	higher	_	JJR	JJR	_	8	ccomp	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	MDMs	_	NNS	NNS	_	21	pobj	_	_
23	,	_	,	,	_	20	punct	_	_
24	compared	_	VBN	VBN	_	20	prep	_	_
25	with	_	IN	IN	_	24	pcomp	_	_
26	monocytes	_	NNS	NNS	_	25	pobj	_	_
27	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	30	prep	_	_
2	MDMs	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	30	punct	_	_
4	an	_	DT	DT	_	5	det	_	_
5	upregulation	_	NN	NN	_	30	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	I	_	NN	NN	_	10	nn	_	_
8	kappa	_	NN	NN	_	10	nn	_	_
9	B	_	NN	NN	_	10	nn	_	_
10	alpha	_	NN	NN	_	11	nn	_	_
11	synthesis	_	NN	NN	_	6	pobj	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	5	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	the	_	DT	DT	_	16	det	_	_
16	appearance	_	NN	NN	_	5	conj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	22	det	_	_
19	novel	_	JJ	JJ	_	22	amod	_	_
20	M-LRB-r-RRB-	_	NN	NN	_	22	amod	_	_
21	40,000	_	CD	CD	_	20	number	_	_
22	form	_	NN	NN	_	17	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	I	_	NN	NN	_	27	nn	_	_
25	kappa	_	NN	NN	_	27	nn	_	_
26	B	_	NN	NN	_	27	nn	_	_
27	alpha	_	NN	NN	_	23	pobj	_	_
28	were	_	VBD	VBD	_	30	auxpass	_	_
29	also	_	RB	RB	_	30	advmod	_	_
30	observed	_	VBN	VBN	_	0	root	_	_
31	.	_	.	.	_	30	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	7	mark	_	_
5	macrophage	_	NN	NN	_	6	nn	_	_
6	differentiation	_	NN	NN	_	7	nsubj	_	_
7	results	_	VBZ	VBZ	_	3	ccomp	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	expression	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	active	_	JJ	JJ	_	17	amod	_	_
13	p50/RelA	_	NN	NN	_	17	nn	_	_
14	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
15	p65	_	NN	NN	_	17	nn	_	_
16	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
17	heterodimers	_	NNS	NNS	_	11	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	capacity	_	NN	NN	_	18	pobj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	activate	_	VB	VB	_	20	vmod	_	_
23	target	_	NN	NN	_	25	nn	_	_
24	gene	_	NN	NN	_	25	nn	_	_
25	expression	_	NN	NN	_	22	dobj	_	_
26	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	parallel	_	JJ	JJ	_	3	amod	_	_
3	induction	_	NN	NN	_	11	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	I	_	NN	NN	_	8	nn	_	_
6	kappa	_	NN	NN	_	8	nn	_	_
7	B	_	NN	NN	_	8	nn	_	_
8	alpha	_	NN	NN	_	9	nn	_	_
9	synthesis	_	NN	NN	_	4	pobj	_	_
10	may	_	MD	MD	_	11	aux	_	_
11	allow	_	VB	VB	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	continuous	_	JJ	JJ	_	15	amod	_	_
15	presence	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	a	_	DT	DT	_	19	det	_	_
18	cytoplasmic	_	JJ	JJ	_	19	amod	_	_
19	reservoir	_	NN	NN	_	16	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	p50/RelA	_	NN	NN	_	25	nn	_	_
22	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
23	p65	_	NN	NN	_	25	nn	_	_
24	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
25	complexes	_	NNS	NNS	_	20	pobj	_	_
26	that	_	WDT	WDT	_	29	nsubj	_	_
27	are	_	VBP	VBP	_	29	cop	_	_
28	readily	_	RB	RB	_	29	advmod	_	_
29	available	_	JJ	JJ	_	25	rcmod	_	_
30	for	_	IN	IN	_	29	prep	_	_
31	inducer-mediated	_	JJ	JJ	_	32	amod	_	_
32	stimulation	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	11	punct	_	_

1	Requirement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	prestimulated	_	JJ	JJ	_	6	amod	_	_
4	THP-1	_	NN	NN	_	6	nn	_	_
5	monocytic	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	2	pobj	_	_
7	for	_	IN	IN	_	1	prep	_	_
8	endothelial	_	JJ	JJ	_	9	amod	_	_
9	cell	_	NN	NN	_	10	nn	_	_
10	activation	_	NN	NN	_	7	pobj	_	_
11	.	_	.	.	_	1	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	TNF	_	NN	NN	_	4	nn	_	_
4	alpha	_	NN	NN	_	2	pobj	_	_
5	.	_	.	.	_	1	punct	_	_

1	Blood	_	NN	NN	_	2	nn	_	_
2	monocytes	_	NNS	NNS	_	4	nsubj	_	_
3	spontaneously	_	RB	RB	_	4	advmod	_	_
4	activate	_	VBP	VBP	_	0	root	_	_
5	endothelial	_	JJ	JJ	_	6	amod	_	_
6	cells	_	NNS	NNS	_	4	dobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	culture	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	leading	_	VBG	VBG	_	4	vmod	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	adhesion	_	NN	NN	_	11	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	monocytic	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	onto	_	IN	IN	_	12	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	endothelial	_	JJ	JJ	_	19	amod	_	_
19	surface	_	NN	NN	_	16	pobj	_	_
20	and	_	CC	CC	_	12	cc	_	_
21	overproduction	_	NN	NN	_	12	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	endothelial	_	JJ	JJ	_	24	amod	_	_
24	proteins	_	NNS	NNS	_	22	pobj	_	_
25	such	_	JJ	JJ	_	26	mwe	_	_
26	as	_	IN	IN	_	24	prep	_	_
27	von	_	NN	NN	_	29	nn	_	_
28	Willebrand	_	NN	NN	_	29	nn	_	_
29	factor	_	NN	NN	_	26	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	vWf	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	and	_	CC	CC	_	29	cc	_	_
34	plasminogen	_	NN	NN	_	37	nn	_	_
35	activator	_	NN	NN	_	37	nn	_	_
36	inhibitor	_	NN	NN	_	37	nn	_	_
37	type	_	NN	NN	_	29	conj	_	_
38	1	_	CD	CD	_	37	num	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	PAI-1	_	NN	NN	_	37	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	overcome	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	difficulty	_	NN	NN	_	2	dobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	obtaining	_	VBG	VBG	_	5	pcomp	_	_
7	quiescent	_	JJ	JJ	_	8	amod	_	_
8	monocytes	_	NNS	NNS	_	6	dobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	studied	_	VBD	VBD	_	2	parataxis	_	_
12	the	_	DT	DT	_	13	det	_	_
13	ability	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	promonocytic	_	JJ	JJ	_	17	amod	_	_
16	THP-1	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	to	_	TO	TO	_	19	aux	_	_
19	activate	_	VB	VB	_	13	vmod	_	_
20	endothelial	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	19	dobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	Lipopolysaccharide	_	NN	NN	_	5	npadvmod	_	_
2	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
3	LPS	_	NN	NN	_	5	npadvmod	_	_
4	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
5	-prestimulated	_	JJ	JJ	_	11	nsubjpass	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	untreated	_	JJ	JJ	_	5	conj	_	_
8	THP-1	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	dep	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	cocultured	_	VBN	VBN	_	0	root	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	resting	_	VBG	VBG	_	18	amod	_	_
14	human	_	JJ	JJ	_	18	amod	_	_
15	umbilical	_	JJ	JJ	_	18	amod	_	_
16	vein	_	NN	NN	_	18	nn	_	_
17	endothelial	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	12	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	HUVEC	_	NNS	NNS	_	18	appos	_	_
21	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
22	for	_	IN	IN	_	11	prep	_	_
23	3	_	CD	CD	_	26	num	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	24	_	CD	CD	_	23	conj	_	_
26	h	_	NN	NN	_	22	pobj	_	_
27	in	_	IN	IN	_	11	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	presence	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	colimycin	_	NN	NN	_	30	pobj	_	_
32	to	_	TO	TO	_	33	aux	_	_
33	neutralize	_	VB	VB	_	11	xcomp	_	_
34	LPS	_	NN	NN	_	35	nn	_	_
35	traces	_	NNS	NNS	_	33	dobj	_	_
36	.	_	.	.	_	11	punct	_	_

1	Addition	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	untreated	_	JJ	JJ	_	5	amod	_	_
4	THP-1	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	had	_	VBD	VBD	_	0	root	_	_
7	little	_	JJ	JJ	_	8	amod	_	_
8	effect	_	NN	NN	_	6	dobj	_	_
9	on	_	IN	IN	_	6	prep	_	_
10	HUVEC	_	NNS	NNS	_	11	nn	_	_
11	adhesiveness	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	Addition	_	NN	NN	_	7	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	prestimulated	_	JJ	JJ	_	5	amod	_	_
4	THP-1	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	2	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	followed	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	noticeable	_	JJ	JJ	_	11	amod	_	_
11	adhesion	_	NN	NN	_	8	pobj	_	_
12	after	_	IN	IN	_	7	prep	_	_
13	3	_	CD	CD	_	14	num	_	_
14	h	_	NN	NN	_	12	pobj	_	_
15	which	_	WDT	WDT	_	16	nsubj	_	_
16	reversed	_	VBD	VBD	_	7	dep	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	basal	_	JJ	JJ	_	19	amod	_	_
19	values	_	NNS	NNS	_	17	pobj	_	_
20	within	_	IN	IN	_	16	prep	_	_
21	24	_	CD	CD	_	22	num	_	_
22	h	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	7	punct	_	_

1	Under	_	IN	IN	_	15	prep	_	_
2	these	_	DT	DT	_	3	det	_	_
3	conditions	_	NNS	NNS	_	1	pobj	_	_
4	HUVEC	_	NNS	NNS	_	6	nn	_	_
5	adhesion	_	NN	NN	_	6	nn	_	_
6	molecules	_	NNS	NNS	_	15	nsubjpass	_	_
7	,	_	,	,	_	6	punct	_	_
8	E-selectin	_	NN	NN	_	6	appos	_	_
9	,	_	,	,	_	8	punct	_	_
10	VCAM-1	_	NN	NN	_	8	conj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	ICAM-1	_	NN	NN	_	8	conj	_	_
13	,	_	,	,	_	6	punct	_	_
14	were	_	VBD	VBD	_	15	auxpass	_	_
15	increased	_	VBN	VBN	_	0	root	_	_
16	at	_	IN	IN	_	15	prep	_	_
17	3	_	CD	CD	_	18	num	_	_
18	h	_	NN	NN	_	16	pobj	_	_
19	with	_	IN	IN	_	15	prep	_	_
20	only	_	RB	RB	_	21	advmod	_	_
21	ICAM-1	_	NN	NN	_	22	nsubj	_	_
22	remaining	_	VBG	VBG	_	19	pcomp	_	_
23	overexpressed	_	VBN	VBN	_	22	acomp	_	_
24	at	_	IN	IN	_	23	prep	_	_
25	24	_	CD	CD	_	26	num	_	_
26	h	_	NN	NN	_	24	pobj	_	_
27	.	_	.	.	_	15	punct	_	_

1	Diffusible	_	JJ	JJ	_	3	amod	_	_
2	endothelial	_	JJ	JJ	_	3	amod	_	_
3	proteins	_	NNS	NNS	_	17	nsubj	_	_
4	such	_	JJ	JJ	_	5	mwe	_	_
5	as	_	IN	IN	_	3	prep	_	_
6	soluble	_	JJ	JJ	_	7	amod	_	_
7	E-selectin	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	7	punct	_	_
9	PAI-1	_	NN	NN	_	7	conj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	vWf	_	NN	NN	_	7	conj	_	_
12	to	_	TO	TO	_	11	prep	_	_
13	a	_	DT	DT	_	15	det	_	_
14	minimal	_	JJ	JJ	_	15	amod	_	_
15	extent	_	NN	NN	_	12	pobj	_	_
16	,	_	,	,	_	3	punct	_	_
17	increased	_	VBD	VBD	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	supernatants	_	NNS	NNS	_	18	pobj	_	_
20	from	_	IN	IN	_	19	prep	_	_
21	HUVEC	_	NNS	NNS	_	20	pobj	_	_
22	cocultured	_	VBN	VBN	_	21	vmod	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	24	_	CD	CD	_	25	num	_	_
25	h	_	NN	NN	_	23	pobj	_	_
26	with	_	IN	IN	_	22	prep	_	_
27	prestimulated	_	JJ	JJ	_	29	amod	_	_
28	THP-1	_	NN	NN	_	29	nn	_	_
29	cells	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	17	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	those	_	DT	DT	_	3	det	_	_
3	cocultures	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	TNF	_	NN	NN	_	6	nn	_	_
6	alpha	_	NN	NN	_	7	nn	_	_
7	concentrations	_	NNS	NNS	_	8	nsubj	_	_
8	peaked	_	VBD	VBD	_	0	root	_	_
9	at	_	IN	IN	_	8	prep	_	_
10	3	_	CD	CD	_	11	num	_	_
11	h	_	NN	NN	_	9	pobj	_	_
12	whereas	_	IN	IN	_	15	mark	_	_
13	IL-1	_	NN	NN	_	15	nn	_	_
14	beta	_	NN	NN	_	15	nn	_	_
15	levels	_	NNS	NNS	_	8	advcl	_	_
16	progressively	_	RB	RB	_	15	advmod	_	_
17	rose	_	VBD	VBD	_	15	dep	_	_
18	until	_	IN	IN	_	17	prep	_	_
19	24	_	CD	CD	_	20	num	_	_
20	h	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	8	punct	_	_

1	Addition	_	NN	NN	_	7	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	an	_	DT	DT	_	6	det	_	_
4	anti-TNF	_	JJ	JJ	_	6	amod	_	_
5	alpha	_	NN	NN	_	6	nn	_	_
6	antibody	_	NN	NN	_	2	pobj	_	_
7	decreased	_	VBD	VBD	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	40	_	CD	CD	_	10	num	_	_
10	%	_	NN	NN	_	8	pobj	_	_
11	E-selectin	_	NN	NN	_	7	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	ICAM-1	_	NN	NN	_	11	conj	_	_
14	induction	_	NN	NN	_	11	dep	_	_
15	and	_	CC	CC	_	7	cc	_	_
16	suppressed	_	VBD	VBD	_	7	conj	_	_
17	PAI-1	_	NN	NN	_	18	nn	_	_
18	overproduction	_	NN	NN	_	16	dobj	_	_
19	with	_	IN	IN	_	16	prep	_	_
20	a	_	DT	DT	_	22	det	_	_
21	weak	_	JJ	JJ	_	22	amod	_	_
22	effect	_	NN	NN	_	19	pobj	_	_
23	on	_	IN	IN	_	22	prep	_	_
24	vWf	_	NN	NN	_	23	pobj	_	_
25	.	_	.	.	_	7	punct	_	_

1	An	_	DT	DT	_	4	det	_	_
2	anti-IL-1	_	JJ	JJ	_	4	amod	_	_
3	beta	_	NN	NN	_	4	nn	_	_
4	antibody	_	NN	NN	_	5	nsubj	_	_
5	had	_	VBD	VBD	_	0	root	_	_
6	negligible	_	JJ	JJ	_	7	amod	_	_
7	effects	_	NNS	NNS	_	5	dobj	_	_
8	on	_	IN	IN	_	5	prep	_	_
9	HUVEC	_	NNS	NNS	_	11	nn	_	_
10	adhesion	_	NN	NN	_	11	nn	_	_
11	molecules	_	NNS	NNS	_	8	pobj	_	_
12	,	_	,	,	_	11	punct	_	_
13	PAI-1	_	NN	NN	_	11	appos	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	vWf	_	NN	NN	_	13	conj	_	_
16	production	_	NN	NN	_	13	dep	_	_
17	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	evidence	_	NN	NN	_	3	dobj	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	promonocytic	_	JJ	JJ	_	8	amod	_	_
7	THP-1	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	9	nsubj	_	_
9	require	_	VBP	VBP	_	4	ccomp	_	_
10	prestimulation	_	NN	NN	_	9	dobj	_	_
11	in	_	IN	IN	_	14	mark	_	_
12	order	_	NN	NN	_	14	dep	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	activate	_	VB	VB	_	9	advcl	_	_
15	HUVEC	_	NNS	NNS	_	14	dobj	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	that	_	IN	IN	_	20	mark	_	_
18	TNF	_	NN	NN	_	19	nn	_	_
19	alpha	_	NN	NN	_	20	nsubj	_	_
20	contributes	_	VBZ	VBZ	_	9	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	this	_	DT	DT	_	23	det	_	_
23	phenomenon	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	3	punct	_	_

1	c-Jun	_	NN	NN	_	0	root	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	GST-pi	_	NN	NN	_	1	conj	_	_
4	expression	_	NN	NN	_	1	dep	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	human	_	JJ	JJ	_	8	amod	_	_
7	plasma	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	.	_	.	.	_	1	punct	_	_

1	Bone	_	NN	NN	_	3	nn	_	_
2	marrow	_	NN	NN	_	3	nn	_	_
3	samples	_	NNS	NNS	_	22	nsubjpass	_	_
4	from	_	IN	IN	_	3	prep	_	_
5	33	_	CD	CD	_	6	num	_	_
6	patients	_	NNS	NNS	_	4	pobj	_	_
7	affected	_	VBN	VBN	_	6	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	MM	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	MGUS	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	6	punct	_	_
13	and	_	CC	CC	_	6	cc	_	_
14	8	_	CD	CD	_	15	num	_	_
15	patients	_	NNS	NNS	_	6	conj	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	affected	_	VBN	VBN	_	15	vmod	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	lymphoproliferative	_	JJ	JJ	_	20	amod	_	_
20	diseases	_	NNS	NNS	_	18	pobj	_	_
21	were	_	VBD	VBD	_	22	auxpass	_	_
22	studied	_	VBN	VBN	_	0	root	_	_
23	for	_	IN	IN	_	22	prep	_	_
24	expression	_	NN	NN	_	23	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	c-Jun	_	NN	NN	_	25	pobj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
28	a	_	DT	DT	_	29	det	_	_
29	component	_	NN	NN	_	26	dep	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	transcription	_	NN	NN	_	33	nn	_	_
33	factor	_	NN	NN	_	30	pobj	_	_
34	AP-1	_	NN	NN	_	33	dep	_	_
35	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
36	and	_	CC	CC	_	26	cc	_	_
37	glutathione-S-transferase	_	NN	NN	_	38	nn	_	_
38	pi	_	NN	NN	_	26	conj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
40	GST-pi	_	NN	NN	_	38	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
42	using	_	VBG	VBG	_	22	xcomp	_	_
43	immunocytochemical	_	JJ	JJ	_	44	amod	_	_
44	methods	_	NNS	NNS	_	42	dobj	_	_
45	.	_	.	.	_	22	punct	_	_

1	A	_	DT	DT	_	5	det	_	_
2	high	_	JJ	JJ	_	5	amod	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	frequent	_	JJ	JJ	_	2	conj	_	_
5	expression	_	NN	NN	_	11	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	these	_	DT	DT	_	9	det	_	_
8	two	_	CD	CD	_	9	num	_	_
9	proteins	_	NNS	NNS	_	6	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	found	_	VBN	VBN	_	0	root	_	_
12	both	_	CC	CC	_	13	preconj	_	_
13	in	_	IN	IN	_	11	prep	_	_
14	MM	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	MGUS	_	NN	NN	_	14	conj	_	_
17	patients	_	NNS	NNS	_	14	dep	_	_
18	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
19	31/33	_	CD	CD	_	20	num	_	_
20	patients	_	NNS	NNS	_	14	dep	_	_
21	positive	_	JJ	JJ	_	20	amod	_	_
22	for	_	IN	IN	_	21	prep	_	_
23	c-Jun	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	29/33	_	CD	CD	_	26	num	_	_
26	patients	_	NNS	NNS	_	20	conj	_	_
27	positive	_	JJ	JJ	_	26	amod	_	_
28	for	_	IN	IN	_	27	prep	_	_
29	GST-pi	_	NN	NN	_	28	pobj	_	_
30	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
31	and	_	CC	CC	_	13	cc	_	_
32	in	_	IN	IN	_	13	conj	_	_
33	controls	_	NNS	NNS	_	32	pobj	_	_
34	not	_	RB	RB	_	35	neg	_	_
35	affected	_	VBN	VBN	_	33	vmod	_	_
36	by	_	IN	IN	_	35	prep	_	_
37	monoclonal	_	JJ	JJ	_	38	amod	_	_
38	gammopathy	_	NN	NN	_	36	pobj	_	_
39	-LRB-	_	-LRB-	-LRB-	_	41	punct	_	_
40	7/8	_	CD	CD	_	41	num	_	_
41	patients	_	NNS	NNS	_	33	dep	_	_
42	positive	_	JJ	JJ	_	41	amod	_	_
43	for	_	IN	IN	_	42	prep	_	_
44	both	_	CC	CC	_	45	preconj	_	_
45	c-Jun	_	NN	NN	_	43	pobj	_	_
46	and	_	CC	CC	_	45	cc	_	_
47	GST-pi	_	NN	NN	_	45	conj	_	_
48	-RRB-	_	-RRB-	-RRB-	_	41	punct	_	_
49	.	_	.	.	_	11	punct	_	_

1	No	_	DT	DT	_	4	neg	_	_
2	statistically	_	RB	RB	_	3	advmod	_	_
3	significant	_	JJ	JJ	_	4	amod	_	_
4	correlation	_	NN	NN	_	6	nsubjpass	_	_
5	was	_	VBD	VBD	_	6	auxpass	_	_
6	found	_	VBN	VBN	_	0	root	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	c-Jun-	_	NN	NN	_	7	pobj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	GST-pi-positive	_	JJ	JJ	_	8	conj	_	_
11	plasma	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	8	dep	_	_
13	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	6	det	_	_
5	two	_	CD	CD	_	6	num	_	_
6	proteins	_	NNS	NNS	_	3	pobj	_	_
7	was	_	VBD	VBD	_	9	cop	_	_
8	not	_	RB	RB	_	9	neg	_	_
9	related	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	clinical	_	JJ	JJ	_	10	pobj	_	_
12	or	_	CC	CC	_	11	cc	_	_
13	laboratory	_	NN	NN	_	11	conj	_	_
14	data	_	NNS	NNS	_	11	dep	_	_
15	.	_	.	.	_	9	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	seem	_	VBP	VBP	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	confirm	_	VB	VB	_	3	xcomp	_	_
6	a	_	DT	DT	_	8	det	_	_
7	possible	_	JJ	JJ	_	8	amod	_	_
8	role	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	transcriptional	_	JJ	JJ	_	12	amod	_	_
12	complex	_	NN	NN	_	9	pobj	_	_
13	AP-1	_	NN	NN	_	12	dep	_	_
14	in	_	IN	IN	_	8	prep	_	_
15	activating	_	VBG	VBG	_	14	pcomp	_	_
16	GST-pi	_	NN	NN	_	17	nn	_	_
17	promoter	_	NN	NN	_	15	dobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	human	_	JJ	JJ	_	21	amod	_	_
20	plasma	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	3	punct	_	_

1	Two	_	CD	CD	_	3	num	_	_
2	distinct	_	JJ	JJ	_	3	amod	_	_
3	pathways	_	NNS	NNS	_	13	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	interleukin-5	_	NN	NN	_	6	nn	_	_
6	synthesis	_	NN	NN	_	4	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	allergen-specific	_	JJ	JJ	_	11	amod	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	T-cell	_	NN	NN	_	11	nn	_	_
11	clones	_	NNS	NNS	_	7	pobj	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	suppressed	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	glucocorticoids	_	NNS	NNS	_	14	pobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	Glucocorticoids	_	NNS	NNS	_	8	nsubjpass	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	GC	_	NNS	NNS	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	have	_	VBP	VBP	_	8	aux	_	_
6	long	_	RB	RB	_	8	advmod	_	_
7	been	_	VBN	VBN	_	8	auxpass	_	_
8	used	_	VBN	VBN	_	0	root	_	_
9	as	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	13	det	_	_
11	most	_	RBS	RBS	_	12	advmod	_	_
12	effective	_	JJ	JJ	_	13	amod	_	_
13	agents	_	NNS	NNS	_	9	pobj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	treatment	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	allergic	_	JJ	JJ	_	19	amod	_	_
19	diseases	_	NNS	NNS	_	17	pobj	_	_
20	accompanied	_	VBN	VBN	_	19	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	eosinophilia	_	NN	NN	_	21	pobj	_	_
23	such	_	JJ	JJ	_	24	mwe	_	_
24	as	_	IN	IN	_	22	prep	_	_
25	chronic	_	JJ	JJ	_	26	amod	_	_
26	asthma	_	NN	NN	_	24	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	atopic	_	JJ	JJ	_	29	amod	_	_
29	dermatitis	_	NN	NN	_	26	conj	_	_
30	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	development	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	chronic	_	JJ	JJ	_	5	amod	_	_
5	eosinophilic	_	JJ	JJ	_	6	amod	_	_
6	inflammation	_	NN	NN	_	3	pobj	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	dependent	_	JJ	JJ	_	0	root	_	_
9	on	_	IN	IN	_	8	prep	_	_
10	interleukin-5	_	NN	NN	_	9	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	IL-5	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	,	_	,	,	_	10	punct	_	_
15	a	_	DT	DT	_	18	det	_	_
16	selective	_	JJ	JJ	_	18	amod	_	_
17	eosinophil-activating	_	JJ	JJ	_	18	amod	_	_
18	factor	_	NN	NN	_	10	appos	_	_
19	,	_	,	,	_	10	punct	_	_
20	produced	_	VBN	VBN	_	10	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	helper	_	NN	NN	_	24	nn	_	_
23	T	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	8	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	delineate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	regulatory	_	JJ	JJ	_	5	amod	_	_
5	mechanisms	_	NNS	NNS	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	IL-5	_	NN	NN	_	9	nn	_	_
9	synthesis	_	NN	NN	_	6	pobj	_	_
10	,	_	,	,	_	2	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	established	_	VBD	VBD	_	2	parataxis	_	_
13	allergen-specific	_	JJ	JJ	_	16	amod	_	_
14	CD4+	_	JJ	JJ	_	16	amod	_	_
15	T-cell	_	NN	NN	_	16	nn	_	_
16	clones	_	NNS	NNS	_	12	dobj	_	_
17	from	_	IN	IN	_	12	prep	_	_
18	asthmatic	_	JJ	JJ	_	19	amod	_	_
19	patients	_	NNS	NNS	_	17	pobj	_	_
20	.	_	.	.	_	2	punct	_	_

1	GC	_	NNS	NNS	_	3	nsubj	_	_
2	efficiently	_	RB	RB	_	3	advmod	_	_
3	suppressed	_	VBD	VBD	_	0	root	_	_
4	IL-5	_	NN	NN	_	5	nn	_	_
5	synthesis	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	T-cell	_	NN	NN	_	8	nn	_	_
8	clones	_	NNS	NNS	_	6	pobj	_	_
9	activated	_	VBN	VBN	_	5	vmod	_	_
10	via	_	IN	IN	_	9	prep	_	_
11	either	_	CC	CC	_	13	preconj	_	_
12	T-cell	_	NN	NN	_	13	nn	_	_
13	receptor	_	NN	NN	_	10	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	TCR	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	or	_	CC	CC	_	13	cc	_	_
18	IL-2	_	NN	NN	_	19	nn	_	_
19	receptor	_	NN	NN	_	13	conj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	IL-2R	_	NN	NN	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	.	_	.	.	_	3	punct	_	_

1	Induction	_	NN	NN	_	12	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	IL-5	_	NN	NN	_	4	nn	_	_
4	mRNA	_	NN	NN	_	2	pobj	_	_
5	upon	_	IN	IN	_	1	prep	_	_
6	TCR	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	IL-2R	_	NN	NN	_	6	conj	_	_
9	stimulation	_	NN	NN	_	6	dep	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	totally	_	RB	RB	_	12	advmod	_	_
12	inhibited	_	VBN	VBN	_	0	root	_	_
13	by	_	IN	IN	_	12	prep	_	_
14	dexamethasone	_	NN	NN	_	13	pobj	_	_
15	.	_	.	.	_	12	punct	_	_

1	Human	_	JJ	JJ	_	5	amod	_	_
2	IL-5	_	NN	NN	_	5	nn	_	_
3	promoter/enhancer-luciferase	_	NN	NN	_	5	nn	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	construct	_	NN	NN	_	11	nsubjpass	_	_
6	transfected	_	VBN	VBN	_	5	vmod	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	T-cell	_	NN	NN	_	9	nn	_	_
9	clones	_	NNS	NNS	_	7	pobj	_	_
10	was	_	VBD	VBD	_	11	auxpass	_	_
11	transcribed	_	VBN	VBN	_	0	root	_	_
12	on	_	IN	IN	_	11	prep	_	_
13	either	_	CC	CC	_	14	preconj	_	_
14	TCR	_	NN	NN	_	12	pobj	_	_
15	or	_	CC	CC	_	14	cc	_	_
16	IL-2R	_	NN	NN	_	14	conj	_	_
17	stimulation	_	NN	NN	_	14	dep	_	_
18	and	_	CC	CC	_	11	cc	_	_
19	was	_	VBD	VBD	_	21	auxpass	_	_
20	clearly	_	RB	RB	_	21	advmod	_	_
21	downregulated	_	VBN	VBN	_	11	conj	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	dexamethasone	_	NN	NN	_	22	pobj	_	_
24	,	_	,	,	_	11	punct	_	_
25	indicating	_	VBG	VBG	_	11	vmod	_	_
26	that	_	IN	IN	_	41	mark	_	_
27	the	_	DT	DT	_	33	det	_	_
28	approximately	_	RB	RB	_	33	advmod	_	_
29	500-bp	_	JJ	JJ	_	33	amod	_	_
30	human	_	JJ	JJ	_	33	amod	_	_
31	IL-5	_	NN	NN	_	33	nn	_	_
32	gene	_	NN	NN	_	33	nn	_	_
33	segment	_	NN	NN	_	41	nsubj	_	_
34	located	_	JJ	JJ	_	33	amod	_	_
35	5'	_	RB	RB	_	36	advmod	_	_
36	upstream	_	RB	RB	_	37	npadvmod	_	_
37	of	_	IN	IN	_	34	prep	_	_
38	the	_	DT	DT	_	40	det	_	_
39	coding	_	VBG	VBG	_	40	amod	_	_
40	region	_	NN	NN	_	37	pobj	_	_
41	contains	_	VBZ	VBZ	_	25	ccomp	_	_
42	activation-inducible	_	JJ	JJ	_	44	amod	_	_
43	enhancer	_	NN	NN	_	44	nn	_	_
44	elements	_	NNS	NNS	_	41	dobj	_	_
45	responsible	_	JJ	JJ	_	44	amod	_	_
46	for	_	IN	IN	_	45	prep	_	_
47	the	_	DT	DT	_	48	det	_	_
48	regulation	_	NN	NN	_	46	pobj	_	_
49	by	_	IN	IN	_	48	prep	_	_
50	GC	_	NNS	NNS	_	49	pobj	_	_
51	.	_	.	.	_	11	punct	_	_

1	Electrophoretic	_	JJ	JJ	_	5	amod	_	_
2	mobility	_	NN	NN	_	5	nn	_	_
3	shift	_	NN	NN	_	5	nn	_	_
4	assay	_	NN	NN	_	5	nn	_	_
5	analysis	_	NN	NN	_	6	nsubj	_	_
6	suggested	_	VBD	VBD	_	0	root	_	_
7	that	_	IN	IN	_	11	mark	_	_
8	AP-1	_	NN	NN	_	11	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	NF-kappaB	_	NN	NN	_	8	conj	_	_
11	are	_	VBP	VBP	_	6	ccomp	_	_
12	among	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	possible	_	JJ	JJ	_	15	amod	_	_
15	targets	_	NNS	NNS	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	GC	_	NNS	NNS	_	18	nn	_	_
18	actions	_	NNS	NNS	_	16	pobj	_	_
19	on	_	IN	IN	_	18	prep	_	_
20	TCR-stimulated	_	JJ	JJ	_	22	amod	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	19	pobj	_	_
23	.	_	.	.	_	6	punct	_	_

1	NF-AT	_	NN	NN	_	7	nsubjpass	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	NF-kappaB	_	NN	NN	_	1	conj	_	_
4	were	_	VBD	VBD	_	7	auxpass	_	_
5	not	_	RB	RB	_	7	neg	_	_
6	significantly	_	RB	RB	_	7	advmod	_	_
7	induced	_	VBN	VBN	_	0	root	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	IL-2	_	NN	NN	_	10	nn	_	_
10	stimulation	_	NN	NN	_	8	pobj	_	_
11	.	_	.	.	_	7	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	25	nsubj	_	_
3	showing	_	VBG	VBG	_	2	vmod	_	_
4	that	_	IN	IN	_	6	mark	_	_
5	GC	_	NNS	NNS	_	6	nsubj	_	_
6	suppressed	_	VBD	VBD	_	3	ccomp	_	_
7	IL-5	_	NN	NN	_	8	nn	_	_
8	production	_	NN	NN	_	6	dobj	_	_
9	by	_	IN	IN	_	6	prep	_	_
10	human	_	JJ	JJ	_	13	amod	_	_
11	CD4+	_	JJ	JJ	_	13	amod	_	_
12	T	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	9	pobj	_	_
14	activated	_	VBN	VBN	_	13	vmod	_	_
15	by	_	IN	IN	_	14	prep	_	_
16	two	_	CD	CD	_	18	num	_	_
17	distinct	_	JJ	JJ	_	18	amod	_	_
18	stimuli	_	NNS	NNS	_	15	pobj	_	_
19	,	_	,	,	_	18	punct	_	_
20	TCR	_	NN	NN	_	18	appos	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	IL-2R	_	NN	NN	_	20	conj	_	_
23	stimulation	_	NN	NN	_	20	dep	_	_
24	,	_	,	,	_	2	punct	_	_
25	underscore	_	VBP	VBP	_	0	root	_	_
26	the	_	DT	DT	_	27	det	_	_
27	efficacy	_	NN	NN	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	GC	_	NNS	NNS	_	28	pobj	_	_
30	in	_	IN	IN	_	27	prep	_	_
31	the	_	DT	DT	_	32	det	_	_
32	treatment	_	NN	NN	_	30	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	allergic	_	JJ	JJ	_	35	amod	_	_
35	diseases	_	NNS	NNS	_	33	pobj	_	_
36	via	_	IN	IN	_	32	prep	_	_
37	suppression	_	NN	NN	_	36	pobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	T-cell	_	NN	NN	_	41	nn	_	_
40	IL-5	_	NN	NN	_	41	nn	_	_
41	synthesis	_	NN	NN	_	38	pobj	_	_
42	.	_	.	.	_	25	punct	_	_

1	Experimental	_	JJ	JJ	_	2	amod	_	_
2	expression	_	NN	NN	_	0	root	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	mice	_	NNS	NNS	_	3	pobj	_	_
5	and	_	CC	CC	_	2	cc	_	_
6	spontaneous	_	JJ	JJ	_	7	amod	_	_
7	expression	_	NN	NN	_	2	conj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	human	_	JJ	JJ	_	10	amod	_	_
10	SLE	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	7	prep	_	_
12	polyomavirus	_	NN	NN	_	13	nn	_	_
13	T-antigen	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	molecular	_	JJ	JJ	_	3	amod	_	_
3	basis	_	NN	NN	_	0	root	_	_
4	for	_	IN	IN	_	3	prep	_	_
5	induction	_	NN	NN	_	4	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	antibodies	_	NNS	NNS	_	6	pobj	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	DNA	_	NN	NN	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	eukaryotic	_	JJ	JJ	_	13	amod	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	factors	_	NNS	NNS	_	9	conj	_	_
14	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	previously	_	RB	RB	_	4	advmod	_	_
4	demonstrated	_	VBN	VBN	_	0	root	_	_
5	that	_	IN	IN	_	14	mark	_	_
6	experimental	_	JJ	JJ	_	7	amod	_	_
7	expression	_	NN	NN	_	14	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	13	det	_	_
10	polyomavirus	_	NN	NN	_	13	nn	_	_
11	transcription	_	NN	NN	_	13	nn	_	_
12	factor	_	NN	NN	_	13	nn	_	_
13	T-antigen	_	NN	NN	_	8	pobj	_	_
14	has	_	VBZ	VBZ	_	4	ccomp	_	_
15	the	_	DT	DT	_	16	det	_	_
16	potential	_	NN	NN	_	14	dobj	_	_
17	to	_	TO	TO	_	18	aux	_	_
18	induce	_	VB	VB	_	16	vmod	_	_
19	anti-DNA	_	JJ	JJ	_	20	amod	_	_
20	antibodies	_	NNS	NNS	_	18	dobj	_	_
21	in	_	IN	IN	_	18	prep	_	_
22	mice	_	NNS	NNS	_	21	pobj	_	_
23	.	_	.	.	_	4	punct	_	_

1	Two	_	CD	CD	_	2	num	_	_
2	sets	_	NNS	NNS	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	independent	_	JJ	JJ	_	5	amod	_	_
5	evidences	_	NNS	NNS	_	3	pobj	_	_
6	are	_	VBP	VBP	_	7	auxpass	_	_
7	presented	_	VBN	VBN	_	0	root	_	_
8	here	_	RB	RB	_	7	advmod	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	demonstrate	_	VBP	VBP	_	7	dep	_	_
11	a	_	DT	DT	_	13	det	_	_
12	biological	_	JJ	JJ	_	13	amod	_	_
13	relevance	_	NN	NN	_	10	dobj	_	_
14	for	_	IN	IN	_	13	prep	_	_
15	this	_	DT	DT	_	16	det	_	_
16	model	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	7	punct	_	_

1	First	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	describe	_	VBP	VBP	_	0	root	_	_
5	results	_	NNS	NNS	_	4	dobj	_	_
6	demonstrating	_	VBG	VBG	_	5	vmod	_	_
7	that	_	IN	IN	_	13	mark	_	_
8	mice	_	NNS	NNS	_	13	nsubj	_	_
9	inoculated	_	VBN	VBN	_	8	vmod	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	T-antigen-expressing	_	JJ	JJ	_	12	amod	_	_
12	plasmids	_	NNS	NNS	_	10	pobj	_	_
13	produced	_	VBD	VBD	_	6	ccomp	_	_
14	antibodies	_	NNS	NNS	_	13	dobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	not	_	RB	RB	_	17	neg	_	_
17	only	_	RB	RB	_	18	preconj	_	_
18	to	_	TO	TO	_	14	prep	_	_
19	T-antigen	_	NN	NN	_	18	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	DNA	_	NN	NN	_	19	conj	_	_
22	,	_	,	,	_	18	punct	_	_
23	but	_	CC	CC	_	24	cc	_	_
24	also	_	RB	RB	_	18	cc	_	_
25	to	_	TO	TO	_	18	conj	_	_
26	the	_	DT	DT	_	30	det	_	_
27	DNA-binding	_	JJ	JJ	_	30	amod	_	_
28	eukaryotic	_	JJ	JJ	_	30	amod	_	_
29	transcription	_	NN	NN	_	30	nn	_	_
30	factors	_	NNS	NNS	_	25	pobj	_	_
31	TATA-binding	_	JJ	JJ	_	32	amod	_	_
32	protein	_	NN	NN	_	30	dep	_	_
33	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
34	TBP	_	NN	NN	_	32	appos	_	_
35	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
36	,	_	,	,	_	25	punct	_	_
37	and	_	CC	CC	_	25	cc	_	_
38	to	_	TO	TO	_	25	conj	_	_
39	the	_	DT	DT	_	41	det	_	_
40	cAMP-response-element-binding	_	JJ	JJ	_	41	amod	_	_
41	protein	_	NN	NN	_	38	pobj	_	_
42	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
43	CREB	_	NN	NN	_	41	appos	_	_
44	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
45	.	_	.	.	_	4	punct	_	_

1	Secondly	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	investigated	_	VBD	VBD	_	0	root	_	_
5	whether	_	IN	IN	_	8	mark	_	_
6	polyomavirus	_	NN	NN	_	7	nn	_	_
7	reactivation	_	NN	NN	_	8	nsubj	_	_
8	occurs	_	VBZ	VBZ	_	4	ccomp	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	SLE	_	NN	NN	_	11	nn	_	_
11	patients	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	8	punct	_	_
13	and	_	CC	CC	_	8	cc	_	_
14	whether	_	IN	IN	_	27	mark	_	_
15	antibodies	_	NNS	NNS	_	27	nsubjpass	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	T-antigen	_	NN	NN	_	16	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	DNA	_	NN	NN	_	17	appos	_	_
20	,	_	,	,	_	16	punct	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	to	_	TO	TO	_	16	conj	_	_
23	TBP	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	CREB	_	NN	NN	_	23	conj	_	_
26	are	_	VBP	VBP	_	27	auxpass	_	_
27	linked	_	VBN	VBN	_	8	conj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	such	_	JJ	JJ	_	30	amod	_	_
30	events	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	4	punct	_	_

1	Both	_	CC	CC	_	2	preconj	_	_
2	within	_	IN	IN	_	13	prep	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	among	_	IN	IN	_	2	conj	_	_
5	these	_	DT	DT	_	7	det	_	_
6	SLE	_	NN	NN	_	7	nn	_	_
7	patients	_	NNS	NNS	_	2	pobj	_	_
8	,	_	,	,	_	13	punct	_	_
9	frequent	_	JJ	JJ	_	11	amod	_	_
10	polyomavirus	_	NN	NN	_	11	nn	_	_
11	reactivations	_	NNS	NNS	_	13	nsubjpass	_	_
12	were	_	VBD	VBD	_	13	auxpass	_	_
13	observed	_	VBN	VBN	_	0	root	_	_
14	that	_	WDT	WDT	_	18	nsubjpass	_	_
15	could	_	MD	MD	_	18	aux	_	_
16	not	_	RB	RB	_	18	neg	_	_
17	be	_	VB	VB	_	18	auxpass	_	_
18	explained	_	VBN	VBN	_	13	dep	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	certain	_	JJ	JJ	_	21	amod	_	_
21	rearrangements	_	NNS	NNS	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	26	det	_	_
24	noncoding	_	JJ	JJ	_	26	amod	_	_
25	control	_	NN	NN	_	26	nn	_	_
26	regions	_	NNS	NNS	_	22	pobj	_	_
27	,	_	,	,	_	19	punct	_	_
28	nor	_	CC	CC	_	19	cc	_	_
29	by	_	IN	IN	_	19	conj	_	_
30	corticosteroid	_	NN	NN	_	31	nn	_	_
31	treatment	_	NN	NN	_	29	pobj	_	_
32	.	_	.	.	_	13	punct	_	_

1	Linked	_	VBN	VBN	_	0	root	_	_
2	to	_	TO	TO	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	events	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	1	punct	_	_
6	antibodies	_	NNS	NNS	_	17	nsubjpass	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	T-antigen	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	DNA	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	8	punct	_	_
12	TBP	_	NN	NN	_	8	conj	_	_
13	,	_	,	,	_	8	punct	_	_
14	and	_	CC	CC	_	8	cc	_	_
15	CREB	_	NN	NN	_	8	conj	_	_
16	were	_	VBD	VBD	_	17	auxpass	_	_
17	detected	_	VBN	VBN	_	1	parataxis	_	_
18	,	_	,	,	_	17	punct	_	_
19	identical	_	JJ	JJ	_	17	advmod	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	what	_	WP	WP	_	23	dobj	_	_
22	we	_	PRP	PRP	_	23	nsubj	_	_
23	observed	_	VBD	VBD	_	20	pcomp	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	mice	_	NNS	NNS	_	24	pobj	_	_
26	.	_	.	.	_	1	punct	_	_

1	Antibodies	_	NNS	NNS	_	6	nsubjpass	_	_
2	recognizing	_	VBG	VBG	_	1	vmod	_	_
3	double-stranded	_	JJ	JJ	_	4	amod	_	_
4	DNA	_	NN	NN	_	2	dobj	_	_
5	were	_	VBD	VBD	_	6	auxpass	_	_
6	confined	_	VBN	VBN	_	0	root	_	_
7	to	_	TO	TO	_	6	prep	_	_
8	patients	_	NNS	NNS	_	7	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	frequent	_	JJ	JJ	_	12	amod	_	_
11	polyomavirus	_	NN	NN	_	12	nn	_	_
12	reactivations	_	NNS	NNS	_	9	pobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	5	nsubj	_	_
3	described	_	VBN	VBN	_	2	vmod	_	_
4	here	_	RB	RB	_	3	advmod	_	_
5	indicate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	24	mark	_	_
7	cognate	_	JJ	JJ	_	8	amod	_	_
8	interaction	_	NN	NN	_	24	nsubj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	B	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	recognizing	_	VBG	VBG	_	11	vmod	_	_
13	DNA	_	NN	NN	_	12	dobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	DNA-associated	_	JJ	JJ	_	16	amod	_	_
16	proteins	_	NNS	NNS	_	13	conj	_	_
17	and	_	CC	CC	_	11	cc	_	_
18	T	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	11	conj	_	_
20	recognizing	_	VBG	VBG	_	19	vmod	_	_
21	T	_	NN	NN	_	22	nn	_	_
22	antigen	_	NN	NN	_	20	dobj	_	_
23	had	_	VBD	VBD	_	24	aux	_	_
24	taken	_	VBN	VBN	_	5	ccomp	_	_
25	place	_	NN	NN	_	24	dobj	_	_
26	as	_	IN	IN	_	24	prep	_	_
27	a	_	DT	DT	_	28	det	_	_
28	consequence	_	NN	NN	_	26	pobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	complex	_	JJ	JJ	_	31	amod	_	_
31	formation	_	NN	NN	_	29	pobj	_	_
32	between	_	IN	IN	_	31	prep	_	_
33	T	_	NN	NN	_	34	nn	_	_
34	ag	_	NN	NN	_	32	pobj	_	_
35	and	_	CC	CC	_	34	cc	_	_
36	DNA	_	NN	NN	_	34	conj	_	_
37	in	_	FW	FW	_	38	nn	_	_
38	vivo	_	FW	FW	_	31	advmod	_	_
39	in	_	IN	IN	_	24	prep	_	_
40	the	_	DT	DT	_	41	det	_	_
41	context	_	NN	NN	_	39	pobj	_	_
42	of	_	IN	IN	_	41	prep	_	_
43	polyomavirus	_	NN	NN	_	44	nn	_	_
44	reactivations	_	NNS	NNS	_	42	pobj	_	_
45	.	_	.	.	_	5	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	an	_	DT	DT	_	6	det	_	_
4	SAF-like	_	JJ	JJ	_	6	amod	_	_
5	transcription	_	NN	NN	_	6	nn	_	_
6	factor	_	NN	NN	_	2	pobj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	activation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	serum	_	NN	NN	_	14	nn	_	_
12	amyloid	_	NN	NN	_	14	nn	_	_
13	A	_	NN	NN	_	14	nn	_	_
14	gene	_	NN	NN	_	10	pobj	_	_
15	in	_	IN	IN	_	9	prep	_	_
16	monocyte/macrophage	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	15	pobj	_	_
18	by	_	IN	IN	_	9	prep	_	_
19	lipopolysaccharide	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	1	punct	_	_

1	Serum	_	NN	NN	_	3	nn	_	_
2	amyloid	_	NN	NN	_	3	nn	_	_
3	A	_	NN	NN	_	9	nsubjpass	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	SAA	_	NN	NN	_	3	appos	_	_
6	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	linked	_	VBN	VBN	_	0	root	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	atherosclerosis	_	NN	NN	_	10	pobj	_	_
12	because	_	IN	IN	_	13	mwe	_	_
13	of	_	IN	IN	_	9	prep	_	_
14	its	_	PRP$	PRP$	_	15	poss	_	_
15	ability	_	NN	NN	_	13	pobj	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	remodel	_	VB	VB	_	15	vmod	_	_
18	high-density	_	JJ	JJ	_	19	amod	_	_
19	lipoprotein	_	NN	NN	_	17	dobj	_	_
20	by	_	IN	IN	_	17	prep	_	_
21	the	_	DT	DT	_	22	det	_	_
22	depletion	_	NN	NN	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	apolipoprotein	_	NN	NN	_	25	nn	_	_
25	A1	_	NN	NN	_	23	pobj	_	_
26	,	_	,	,	_	15	punct	_	_
27	its	_	PRP$	PRP$	_	28	poss	_	_
28	ability	_	NN	NN	_	15	conj	_	_
29	to	_	TO	TO	_	30	aux	_	_
30	bind	_	VB	VB	_	28	vmod	_	_
31	cholesterol	_	NN	NN	_	30	dobj	_	_
32	,	_	,	,	_	15	punct	_	_
33	and	_	CC	CC	_	15	cc	_	_
34	its	_	PRP$	PRP$	_	35	poss	_	_
35	presence	_	NN	NN	_	15	conj	_	_
36	in	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	atherosclerotic	_	JJ	JJ	_	39	amod	_	_
39	plaques	_	NNS	NNS	_	36	pobj	_	_
40	of	_	IN	IN	_	39	prep	_	_
41	coronary	_	JJ	JJ	_	40	pobj	_	_
42	and	_	CC	CC	_	41	cc	_	_
43	carotid	_	JJ	JJ	_	41	conj	_	_
44	arteries	_	NNS	NNS	_	41	dep	_	_
45	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	investigated	_	VBD	VBD	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	induction	_	NN	NN	_	10	nn	_	_
10	mechanism	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	SAA	_	NN	NN	_	13	nn	_	_
13	gene	_	NN	NN	_	11	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	THP-1	_	NN	NN	_	17	nn	_	_
16	monocyte/macrophage	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	14	pobj	_	_
18	which	_	WDT	WDT	_	19	nsubj	_	_
19	play	_	VBP	VBP	_	17	rcmod	_	_
20	a	_	DT	DT	_	22	det	_	_
21	critical	_	JJ	JJ	_	22	amod	_	_
22	role	_	NN	NN	_	19	dobj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	development	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	atherosclerotic	_	JJ	JJ	_	29	amod	_	_
28	fatty	_	JJ	JJ	_	29	amod	_	_
29	streak	_	NN	NN	_	26	pobj	_	_
30	and	_	CC	CC	_	25	cc	_	_
31	plaque	_	NN	NN	_	32	nn	_	_
32	formation	_	NN	NN	_	25	conj	_	_
33	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	others	_	NNS	NNS	_	1	conj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	shown	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	SAA	_	NN	NN	_	8	nn	_	_
8	gene	_	NN	NN	_	10	nsubjpass	_	_
9	is	_	VBZ	VBZ	_	10	auxpass	_	_
10	induced	_	VBN	VBN	_	5	ccomp	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	monocyte/macrophage	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	by	_	IN	IN	_	10	prep	_	_
15	lipopolysaccharide	_	NN	NN	_	14	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	LPS	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	.	_	.	.	_	5	punct	_	_

1	By	_	IN	IN	_	7	prep	_	_
2	promoter	_	NN	NN	_	4	nn	_	_
3	function	_	NN	NN	_	4	nn	_	_
4	analysis	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	show	_	VBP	VBP	_	0	root	_	_
8	that	_	IN	IN	_	18	mark	_	_
9	the	_	DT	DT	_	12	det	_	_
10	SAA	_	NN	NN	_	12	nn	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	sequence	_	NN	NN	_	18	nsubj	_	_
13	between	_	IN	IN	_	12	prep	_	_
14	-280	_	CD	CD	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	-226	_	CD	CD	_	14	conj	_	_
17	can	_	MD	MD	_	18	aux	_	_
18	confer	_	VB	VB	_	7	ccomp	_	_
19	LPS	_	NN	NN	_	20	nn	_	_
20	responsiveness	_	NN	NN	_	18	dobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	Gel	_	NN	NN	_	5	nn	_	_
2	electrophoretic	_	JJ	JJ	_	5	amod	_	_
3	mobility	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	assay	_	NN	NN	_	6	nsubj	_	_
6	detected	_	VBD	VBD	_	0	root	_	_
7	an	_	DT	DT	_	10	det	_	_
8	induced	_	VBN	VBN	_	10	amod	_	_
9	DNA-binding	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	6	dobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	these	_	DT	DT	_	13	det	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	response	_	NN	NN	_	14	pobj	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	LPS	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	6	punct	_	_

1	Characterization	_	NN	NN	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	DNA-binding	_	JJ	JJ	_	5	amod	_	_
5	protein	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	UV	_	NN	NN	_	8	nn	_	_
8	cross-linking	_	NN	NN	_	6	pobj	_	_
9	,	_	,	,	_	1	punct	_	_
10	Southwestern	_	NN	NN	_	11	nn	_	_
11	blot	_	NN	NN	_	1	appos	_	_
12	,	_	,	,	_	11	punct	_	_
13	and	_	CC	CC	_	11	cc	_	_
14	antibody	_	JJ	JJ	_	15	amod	_	_
15	ablation/supershift	_	NN	NN	_	11	conj	_	_
16	assays	_	NNS	NNS	_	11	dep	_	_
17	revealed	_	VBD	VBD	_	0	root	_	_
18	that	_	IN	IN	_	21	mark	_	_
19	it	_	PRP	PRP	_	21	nsubj	_	_
20	is	_	VBZ	VBZ	_	21	cop	_	_
21	similar	_	JJ	JJ	_	17	ccomp	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	a	_	DT	DT	_	27	det	_	_
24	recently	_	RB	RB	_	25	advmod	_	_
25	reported	_	VBN	VBN	_	27	amod	_	_
26	nuclear	_	JJ	JJ	_	27	amod	_	_
27	factor	_	NN	NN	_	22	pobj	_	_
28	designated	_	VBN	VBN	_	27	vmod	_	_
29	SAF	_	NN	NN	_	28	dep	_	_
30	.	_	.	.	_	17	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	LPS-mediated	_	JJ	JJ	_	8	amod	_	_
6	SAA	_	NN	NN	_	8	nn	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	induction	_	NN	NN	_	14	nsubj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	monocyte/macrophage	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	9	pobj	_	_
12	is	_	VBZ	VBZ	_	14	cop	_	_
13	primarily	_	RB	RB	_	14	advmod	_	_
14	due	_	JJ	JJ	_	3	ccomp	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	induction	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	SAF	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Expression	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NFAT-family	_	NN	NN	_	4	nn	_	_
4	proteins	_	NNS	NNS	_	2	pobj	_	_
5	in	_	IN	IN	_	1	prep	_	_
6	normal	_	JJ	JJ	_	9	amod	_	_
7	human	_	JJ	JJ	_	9	amod	_	_
8	T	_	NN	NN	_	9	nn	_	_
9	cells	_	NNS	NNS	_	5	pobj	_	_
10	.	_	.	.	_	1	punct	_	_

1	NFAT	_	NN	NN	_	2	nn	_	_
2	proteins	_	NNS	NNS	_	3	nsubj	_	_
3	constitute	_	VBP	VBP	_	0	root	_	_
4	a	_	DT	DT	_	5	det	_	_
5	family	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	transcription	_	NN	NN	_	8	nn	_	_
8	factors	_	NNS	NNS	_	6	pobj	_	_
9	involved	_	VBN	VBN	_	5	vmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	mediating	_	VBG	VBG	_	10	pcomp	_	_
12	signal	_	NN	NN	_	13	nn	_	_
13	transduction	_	NN	NN	_	11	dobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Using	_	VBG	VBG	_	0	root	_	_
2	a	_	DT	DT	_	3	det	_	_
3	panel	_	NN	NN	_	1	dobj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	specific	_	JJ	JJ	_	6	amod	_	_
6	antisera	_	NNS	NNS	_	4	pobj	_	_
7	in	_	IN	IN	_	1	prep	_	_
8	immunoprecipitation	_	NN	NN	_	9	nn	_	_
9	assays	_	NNS	NNS	_	7	pobj	_	_
10	,	_	,	,	_	1	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	found	_	VBD	VBD	_	1	parataxis	_	_
13	that	_	IN	IN	_	21	mark	_	_
14	NFATp	_	NN	NN	_	21	nsubjpass	_	_
15	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
16	135	_	CD	CD	_	17	num	_	_
17	kDa	_	NN	NN	_	14	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	is	_	VBZ	VBZ	_	21	auxpass	_	_
20	constitutively	_	RB	RB	_	21	advmod	_	_
21	expressed	_	VBN	VBN	_	12	ccomp	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	normal	_	JJ	JJ	_	26	amod	_	_
24	human	_	JJ	JJ	_	26	amod	_	_
25	T	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	22	pobj	_	_
27	,	_	,	,	_	21	punct	_	_
28	while	_	IN	IN	_	40	mark	_	_
29	synthesis	_	NN	NN	_	40	nsubjpass	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	NFATc	_	NN	NN	_	30	pobj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	34	punct	_	_
33	predominant	_	JJ	JJ	_	34	amod	_	_
34	form	_	NN	NN	_	31	dep	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	86	_	CD	CD	_	37	num	_	_
37	kDa	_	NN	NN	_	35	pobj	_	_
38	-RRB-	_	-RRB-	-RRB-	_	34	punct	_	_
39	is	_	VBZ	VBZ	_	40	auxpass	_	_
40	induced	_	VBN	VBN	_	21	advcl	_	_
41	by	_	IN	IN	_	40	prep	_	_
42	ionomycin	_	NN	NN	_	43	nn	_	_
43	treatment	_	NN	NN	_	41	pobj	_	_
44	.	_	.	.	_	1	punct	_	_

1	NFAT4/x	_	NN	NN	_	5	nsubjpass	_	_
2	was	_	VBD	VBD	_	5	auxpass	_	_
3	very	_	RB	RB	_	4	advmod	_	_
4	weakly	_	RB	RB	_	5	advmod	_	_
5	expressed	_	VBN	VBN	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	unstimulated	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	5	punct	_	_
10	and	_	CC	CC	_	5	cc	_	_
11	its	_	PRP$	PRP$	_	12	poss	_	_
12	level	_	NN	NN	_	15	nsubj	_	_
13	did	_	VBD	VBD	_	15	aux	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	increase	_	VB	VB	_	5	conj	_	_
16	upon	_	IN	IN	_	15	prep	_	_
17	treatment	_	NN	NN	_	16	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	activating	_	VBG	VBG	_	20	amod	_	_
20	agents	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	NFAT3	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	5	nsubjpass	_	_
3	was	_	VBD	VBD	_	5	auxpass	_	_
4	not	_	RB	RB	_	5	neg	_	_
5	observed	_	VBN	VBN	_	0	root	_	_
6	under	_	IN	IN	_	5	prep	_	_
7	any	_	DT	DT	_	8	det	_	_
8	conditions	_	NNS	NNS	_	6	pobj	_	_
9	.	_	.	.	_	5	punct	_	_

1	Higher-molecular-weight	_	JJ	JJ	_	2	amod	_	_
2	species	_	NNS	NNS	_	14	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NFATc	_	NN	NN	_	3	pobj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	of	_	IN	IN	_	2	prep	_	_
7	110	_	CD	CD	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	140	_	CD	CD	_	7	conj	_	_
10	kDa	_	NN	NN	_	7	dep	_	_
11	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
12	were	_	VBD	VBD	_	14	auxpass	_	_
13	also	_	RB	RB	_	14	advmod	_	_
14	detected	_	VBN	VBN	_	0	root	_	_
15	.	_	.	.	_	14	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	9	punct	_	_
4	translation	_	NN	NN	_	9	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	NFATc	_	NN	NN	_	7	nn	_	_
7	mRNA	_	NN	NN	_	5	pobj	_	_
8	apparently	_	RB	RB	_	9	advmod	_	_
9	initiates	_	VBZ	VBZ	_	0	root	_	_
10	at	_	IN	IN	_	9	prep	_	_
11	two	_	CD	CD	_	14	num	_	_
12	different	_	JJ	JJ	_	14	amod	_	_
13	AUG	_	NN	NN	_	14	nn	_	_
14	codons	_	NNS	NNS	_	10	pobj	_	_
15	,	_	,	,	_	9	punct	_	_
16	giving	_	VBG	VBG	_	9	xcomp	_	_
17	rise	_	NN	NN	_	16	dobj	_	_
18	to	_	TO	TO	_	16	prep	_	_
19	proteins	_	NNS	NNS	_	18	pobj	_	_
20	that	_	WDT	WDT	_	21	nsubj	_	_
21	differ	_	VBP	VBP	_	19	rcmod	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	size	_	NN	NN	_	22	pobj	_	_
24	by	_	IN	IN	_	21	prep	_	_
25	36	_	CD	CD	_	27	num	_	_
26	amino	_	NN	NN	_	27	nn	_	_
27	acids	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	9	punct	_	_

1	Additional	_	JJ	JJ	_	3	amod	_	_
2	size	_	NN	NN	_	3	nn	_	_
3	heterogeneity	_	NN	NN	_	9	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	both	_	CC	CC	_	6	preconj	_	_
6	NFATc	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	NFATp	_	NN	NN	_	6	conj	_	_
9	results	_	VBZ	VBZ	_	0	root	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	phosphorylation	_	NN	NN	_	10	pobj	_	_
12	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	21	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	to	_	TO	TO	_	2	prep	_	_
4	ionomycin	_	NN	NN	_	5	nn	_	_
5	treatment	_	NN	NN	_	3	pobj	_	_
6	,	_	,	,	_	21	punct	_	_
7	exposure	_	NN	NN	_	21	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	cells	_	NNS	NNS	_	8	pobj	_	_
10	to	_	TO	TO	_	7	prep	_	_
11	phorbol	_	NN	NN	_	13	nn	_	_
12	myristate	_	NN	NN	_	13	nn	_	_
13	acetate	_	NN	NN	_	10	pobj	_	_
14	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	PMA	_	NN	NN	_	13	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	plus	_	CC	CC	_	13	cc	_	_
18	anti-CD28	_	NN	NN	_	13	conj	_	_
19	did	_	VBD	VBD	_	21	aux	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	induce	_	VB	VB	_	0	root	_	_
22	NFATc	_	NN	NN	_	21	dobj	_	_
23	,	_	,	,	_	21	punct	_	_
24	indicating	_	VBG	VBG	_	21	vmod	_	_
25	that	_	IN	IN	_	37	mark	_	_
26	under	_	IN	IN	_	37	prep	_	_
27	these	_	DT	DT	_	28	det	_	_
28	conditions	_	NNS	NNS	_	26	pobj	_	_
29	,	_	,	,	_	37	punct	_	_
30	interleukin-2	_	NN	NN	_	31	nn	_	_
31	synthesis	_	NN	NN	_	37	nsubj	_	_
32	by	_	IN	IN	_	31	prep	_	_
33	these	_	DT	DT	_	34	det	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	is	_	VBZ	VBZ	_	37	cop	_	_
36	apparently	_	RB	RB	_	37	advmod	_	_
37	independent	_	JJ	JJ	_	24	ccomp	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	NFATc	_	NN	NN	_	38	pobj	_	_
40	.	_	.	.	_	21	punct	_	_

1	In	_	IN	IN	_	14	prep	_	_
2	DNA	_	NN	NN	_	4	nn	_	_
3	binding	_	NN	NN	_	4	nn	_	_
4	assays	_	NNS	NNS	_	1	pobj	_	_
5	,	_	,	,	_	14	punct	_	_
6	both	_	CC	CC	_	7	preconj	_	_
7	PMA	_	NN	NN	_	14	nsubj	_	_
8	plus	_	CC	CC	_	7	cc	_	_
9	anti-CD28	_	NN	NN	_	7	conj	_	_
10	and	_	CC	CC	_	7	cc	_	_
11	PMA	_	NN	NN	_	7	conj	_	_
12	plus	_	CC	CC	_	11	cc	_	_
13	ionomycin	_	NN	NN	_	11	conj	_	_
14	resulted	_	VBD	VBD	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	nuclear	_	JJ	JJ	_	17	amod	_	_
17	NFAT	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	14	punct	_	_

1	Surprisingly	_	RB	RB	_	15	advmod	_	_
2	,	_	,	,	_	15	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	PMA-ionomycin-induced	_	JJ	JJ	_	5	amod	_	_
5	synthesis	_	NN	NN	_	15	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NFATc	_	NN	NN	_	6	pobj	_	_
8	that	_	WDT	WDT	_	10	nsubjpass	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	detected	_	VBN	VBN	_	5	rcmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	immunoprecipitation	_	NN	NN	_	11	pobj	_	_
13	was	_	VBD	VBD	_	15	auxpass	_	_
14	not	_	RB	RB	_	15	neg	_	_
15	mirrored	_	VBN	VBN	_	0	root	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	20	det	_	_
18	DNA	_	NN	NN	_	20	nn	_	_
19	binding	_	NN	NN	_	20	nn	_	_
20	assays	_	NNS	NNS	_	16	pobj	_	_
21	:	_	:	:	_	15	punct	_	_
22	nearly	_	RB	RB	_	23	advmod	_	_
23	all	_	DT	DT	_	28	nsubj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	activity	_	NN	NN	_	24	pobj	_	_
27	was	_	VBD	VBD	_	28	cop	_	_
28	due	_	JJ	JJ	_	15	parataxis	_	_
29	to	_	TO	TO	_	28	prep	_	_
30	NFATp	_	NN	NN	_	29	pobj	_	_
31	.	_	.	.	_	15	punct	_	_

1	This	_	DT	DT	_	5	nsubj	_	_
2	is	_	VBZ	VBZ	_	5	cop	_	_
3	the	_	DT	DT	_	5	det	_	_
4	first	_	JJ	JJ	_	5	amod	_	_
5	study	_	NN	NN	_	0	root	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	expression	_	NN	NN	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	all	_	DT	DT	_	11	det	_	_
10	family	_	NN	NN	_	11	nn	_	_
11	members	_	NNS	NNS	_	8	pobj	_	_
12	at	_	IN	IN	_	7	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	protein	_	NN	NN	_	15	nn	_	_
15	level	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	7	prep	_	_
17	normal	_	JJ	JJ	_	20	amod	_	_
18	human	_	JJ	JJ	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	High	_	JJ	JJ	_	2	amod	_	_
2	levels	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	DNA-binding	_	NN	NN	_	6	nn	_	_
6	activity	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	E2F	_	NN	NN	_	7	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	adult	_	JJ	JJ	_	12	amod	_	_
11	T-cell	_	NN	NN	_	12	nn	_	_
12	leukemia	_	NN	NN	_	9	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	human	_	JJ	JJ	_	20	amod	_	_
15	T-cell	_	NN	NN	_	20	nn	_	_
16	leukemia	_	NN	NN	_	20	nn	_	_
17	virus	_	NN	NN	_	20	nn	_	_
18	type	_	NN	NN	_	20	nn	_	_
19	I-infected	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	12	conj	_	_
21	:	_	:	:	_	2	punct	_	_
22	possible	_	JJ	JJ	_	23	amod	_	_
23	enhancement	_	NN	NN	_	2	dep	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	DNA-binding	_	NN	NN	_	24	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	E2F	_	NN	NN	_	26	pobj	_	_
28	by	_	IN	IN	_	23	prep	_	_
29	the	_	DT	DT	_	36	det	_	_
30	human	_	JJ	JJ	_	36	amod	_	_
31	T-cell	_	NN	NN	_	36	nn	_	_
32	leukemia	_	NN	NN	_	36	nn	_	_
33	virus	_	NN	NN	_	36	nn	_	_
34	I	_	CD	CD	_	36	num	_	_
35	transactivating	_	NN	NN	_	36	nn	_	_
36	protein	_	NN	NN	_	28	pobj	_	_
37	,	_	,	,	_	36	punct	_	_
38	Tax	_	NN	NN	_	36	appos	_	_
39	.	_	.	.	_	23	punct	_	_

1	Transcription	_	NN	NN	_	2	nn	_	_
2	factor	_	NN	NN	_	4	nsubj	_	_
3	E2F	_	NN	NN	_	2	dep	_	_
4	binds	_	VBZ	VBZ	_	0	root	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	cellular	_	JJ	JJ	_	7	amod	_	_
7	promoters	_	NNS	NNS	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	certain	_	JJ	JJ	_	10	amod	_	_
10	growth-	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	cell	_	NN	NN	_	10	conj	_	_
13	cycle-controlling	_	JJ	JJ	_	14	amod	_	_
14	genes	_	NNS	NNS	_	10	dep	_	_
15	and	_	CC	CC	_	4	cc	_	_
16	forms	_	VBZ	VBZ	_	4	conj	_	_
17	distinct	_	JJ	JJ	_	19	amod	_	_
18	heteromeric	_	JJ	JJ	_	19	amod	_	_
19	complexes	_	NNS	NNS	_	16	dobj	_	_
20	with	_	IN	IN	_	16	prep	_	_
21	other	_	JJ	JJ	_	23	amod	_	_
22	nuclear	_	JJ	JJ	_	23	amod	_	_
23	proteins	_	NNS	NNS	_	20	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	It	_	PRP	PRP	_	5	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	5	aux	_	_
3	therefore	_	RB	RB	_	5	advmod	_	_
4	been	_	VBN	VBN	_	5	auxpass	_	_
5	proposed	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	9	mark	_	_
7	E2F	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	involved	_	VBN	VBN	_	5	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	cellular	_	JJ	JJ	_	13	amod	_	_
12	proliferation	_	NN	NN	_	13	nn	_	_
13	control	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	5	punct	_	_

1	Human	_	JJ	JJ	_	5	amod	_	_
2	T-cell	_	NN	NN	_	5	nn	_	_
3	leukemia	_	NN	NN	_	5	nn	_	_
4	virus	_	NN	NN	_	5	nn	_	_
5	type	_	NN	NN	_	13	nsubj	_	_
6	I	_	CD	CD	_	5	num	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	HTLV-I	_	NN	NN	_	5	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	is	_	VBZ	VBZ	_	13	cop	_	_
11	an	_	DT	DT	_	13	det	_	_
12	etiological	_	JJ	JJ	_	13	amod	_	_
13	agent	_	NN	NN	_	0	root	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	adult	_	JJ	JJ	_	17	amod	_	_
16	T-cell	_	NN	NN	_	17	nn	_	_
17	leukemia	_	NN	NN	_	14	pobj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	ATL	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	by	_	IN	IN	_	2	prep	_	_
5	mobility-shift	_	NN	NN	_	6	nn	_	_
6	assay	_	NN	NN	_	4	pobj	_	_
7	that	_	IN	IN	_	12	mark	_	_
8	E2F-containing	_	JJ	JJ	_	10	amod	_	_
9	DNA-binding	_	JJ	JJ	_	10	amod	_	_
10	complexes	_	NNS	NNS	_	12	nsubjpass	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	detected	_	VBN	VBN	_	2	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	HTLV-I-infected	_	JJ	JJ	_	16	amod	_	_
15	T-cell	_	NN	NN	_	16	nn	_	_
16	lines	_	NNS	NNS	_	13	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	leukemic	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	16	conj	_	_
20	obtained	_	VBN	VBN	_	19	vmod	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	ATL	_	NN	NN	_	23	nn	_	_
23	patients	_	NNS	NNS	_	21	pobj	_	_
24	but	_	CC	CC	_	13	cc	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	in	_	IN	IN	_	13	conj	_	_
27	an	_	DT	DT	_	30	det	_	_
28	uninfected	_	JJ	JJ	_	30	amod	_	_
29	T-cell	_	NN	NN	_	30	nn	_	_
30	line	_	NN	NN	_	26	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	Jurkat	_	NN	NN	_	30	appos	_	_
33	,	_	,	,	_	30	punct	_	_
34	and	_	CC	CC	_	30	cc	_	_
35	normal	_	JJ	JJ	_	39	amod	_	_
36	peripheral	_	JJ	JJ	_	39	amod	_	_
37	blood	_	NN	NN	_	39	nn	_	_
38	mononuclear	_	JJ	JJ	_	39	amod	_	_
39	cells	_	NNS	NNS	_	30	conj	_	_
40	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	Tax	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	13	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	encoded	_	VBN	VBN	_	3	vmod	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	HTLV-I	_	NN	NN	_	6	pobj	_	_
8	,	_	,	,	_	3	punct	_	_
9	is	_	VBZ	VBZ	_	13	cop	_	_
10	a	_	DT	DT	_	13	det	_	_
11	potent	_	JJ	JJ	_	13	amod	_	_
12	transcription	_	NN	NN	_	13	nn	_	_
13	activator	_	NN	NN	_	0	root	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	viral	_	JJ	JJ	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	several	_	JJ	JJ	_	15	conj	_	_
18	cellular	_	JJ	JJ	_	19	amod	_	_
19	genes	_	NNS	NNS	_	15	dep	_	_
20	.	_	.	.	_	13	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	expression	_	NN	NN	_	8	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	Tax	_	NN	NN	_	5	pobj	_	_
7	can	_	MD	MD	_	8	aux	_	_
8	induce	_	VB	VB	_	2	ccomp	_	_
9	the	_	DT	DT	_	12	det	_	_
10	E2F-containing	_	JJ	JJ	_	12	amod	_	_
11	DNA-binding	_	JJ	JJ	_	12	amod	_	_
12	complexes	_	NNS	NNS	_	8	dobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	Jurkat	_	NN	NN	_	16	nn	_	_
15	T	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	Thus	_	RB	RB	_	16	advmod	_	_
2	,	_	,	,	_	16	punct	_	_
3	Tax	_	NN	NN	_	16	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	through	_	IN	IN	_	16	prep	_	_
6	enhancement	_	NN	NN	_	5	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	DNA-binding	_	NN	NN	_	10	nn	_	_
10	activity	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	E2F	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	16	punct	_	_
14	may	_	MD	MD	_	16	aux	_	_
15	be	_	VB	VB	_	16	cop	_	_
16	capable	_	JJ	JJ	_	0	root	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	regulating	_	VBG	VBG	_	17	pcomp	_	_
19	cellular	_	JJ	JJ	_	21	amod	_	_
20	gene	_	NN	NN	_	21	nn	_	_
21	expression	_	NN	NN	_	18	dobj	_	_
22	implicated	_	VBN	VBN	_	21	vmod	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	25	dep	_	_
25	proliferation	_	NN	NN	_	23	pobj	_	_
26	and	_	CC	CC	_	25	cc	_	_
27	transformation	_	NN	NN	_	25	conj	_	_
28	of	_	IN	IN	_	25	prep	_	_
29	T	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	in	_	IN	IN	_	18	prep	_	_
32	ATL	_	NN	NN	_	31	pobj	_	_
33	.	_	.	.	_	16	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	activity	_	NN	NN	_	5	nsubj	_	_
3	may	_	MD	MD	_	5	aux	_	_
4	be	_	VB	VB	_	5	cop	_	_
5	relevant	_	JJ	JJ	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	mechanisms	_	NNS	NNS	_	6	pobj	_	_
9	whereby	_	WRB	WRB	_	16	advmod	_	_
10	HTLV-I	_	NN	NN	_	16	nsubj	_	_
11	which	_	WDT	WDT	_	14	nsubj	_	_
12	does	_	VBZ	VBZ	_	14	aux	_	_
13	not	_	RB	RB	_	14	neg	_	_
14	contain	_	VB	VB	_	10	rcmod	_	_
15	oncogenes	_	NNS	NNS	_	14	dobj	_	_
16	induces	_	VBZ	VBZ	_	8	rcmod	_	_
17	neoplasia	_	NN	NN	_	16	dobj	_	_
18	.	_	.	.	_	5	punct	_	_

1	Oncogenic	_	JJ	JJ	_	2	amod	_	_
2	forms	_	NNS	NNS	_	17	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NOTCH1	_	NN	NN	_	3	pobj	_	_
5	lacking	_	VBG	VBG	_	2	vmod	_	_
6	either	_	CC	CC	_	10	preconj	_	_
7	the	_	DT	DT	_	10	det	_	_
8	primary	_	JJ	JJ	_	10	amod	_	_
9	binding	_	VBG	VBG	_	10	amod	_	_
10	site	_	NN	NN	_	5	dobj	_	_
11	for	_	IN	IN	_	10	prep	_	_
12	RBP-Jkappa	_	NN	NN	_	11	pobj	_	_
13	or	_	CC	CC	_	10	cc	_	_
14	nuclear	_	JJ	JJ	_	16	amod	_	_
15	localization	_	NN	NN	_	16	nn	_	_
16	sequences	_	NNS	NNS	_	10	conj	_	_
17	retain	_	VBP	VBP	_	0	root	_	_
18	the	_	DT	DT	_	19	det	_	_
19	ability	_	NN	NN	_	17	dobj	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	associate	_	VB	VB	_	19	vmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	RBP-Jkappa	_	NN	NN	_	22	pobj	_	_
24	and	_	CC	CC	_	21	cc	_	_
25	activate	_	VB	VB	_	21	conj	_	_
26	transcription	_	NN	NN	_	25	dobj	_	_
27	.	_	.	.	_	17	punct	_	_

1	Truncated	_	JJ	JJ	_	2	amod	_	_
2	forms	_	NNS	NNS	_	28	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	7	det	_	_
5	NOTCH1	_	NN	NN	_	7	nn	_	_
6	transmembrane	_	JJ	JJ	_	7	amod	_	_
7	receptor	_	NN	NN	_	3	pobj	_	_
8	engineered	_	VBN	VBN	_	2	vmod	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	resemble	_	VB	VB	_	8	xcomp	_	_
11	mutant	_	JJ	JJ	_	12	amod	_	_
12	forms	_	NNS	NNS	_	10	xcomp	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	NOTCH1	_	NN	NN	_	13	pobj	_	_
15	found	_	VBN	VBN	_	12	vmod	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	certain	_	JJ	JJ	_	18	amod	_	_
18	cases	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	human	_	JJ	JJ	_	23	amod	_	_
21	T	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	leukemia/lymphoma	_	NN	NN	_	19	pobj	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	T-ALL	_	NN	NN	_	23	appos	_	_
26	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
27	efficiently	_	RB	RB	_	28	advmod	_	_
28	induce	_	VBP	VBP	_	0	root	_	_
29	T-ALL	_	NN	NN	_	28	dobj	_	_
30	when	_	WRB	WRB	_	31	advmod	_	_
31	expressed	_	VBN	VBN	_	28	advcl	_	_
32	in	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	35	det	_	_
34	bone	_	NN	NN	_	35	nn	_	_
35	marrow	_	NN	NN	_	32	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	mice	_	NNS	NNS	_	36	pobj	_	_
38	.	_	.	.	_	28	punct	_	_

1	Unlike	_	IN	IN	_	35	prep	_	_
2	full-sized	_	JJ	JJ	_	3	amod	_	_
3	NOTCH1	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	35	punct	_	_
5	two	_	CD	CD	_	8	num	_	_
6	such	_	JJ	JJ	_	7	amod	_	_
7	truncated	_	JJ	JJ	_	8	amod	_	_
8	forms	_	NNS	NNS	_	35	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	protein	_	NN	NN	_	9	pobj	_	_
12	either	_	CC	CC	_	13	preconj	_	_
13	lacking	_	VBG	VBG	_	8	dep	_	_
14	a	_	DT	DT	_	16	det	_	_
15	major	_	JJ	JJ	_	16	amod	_	_
16	portion	_	NN	NN	_	13	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	extracellular	_	JJ	JJ	_	20	amod	_	_
20	domain	_	NN	NN	_	17	pobj	_	_
21	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
22	DeltaE	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	or	_	CC	CC	_	13	cc	_	_
25	consisting	_	VBG	VBG	_	13	conj	_	_
26	only	_	RB	RB	_	27	advmod	_	_
27	of	_	IN	IN	_	25	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	intracellular	_	JJ	JJ	_	30	amod	_	_
30	domain	_	NN	NN	_	27	pobj	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	ICN	_	NN	NN	_	30	appos	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	were	_	VBD	VBD	_	35	auxpass	_	_
35	found	_	VBN	VBN	_	0	root	_	_
36	to	_	TO	TO	_	37	aux	_	_
37	activate	_	VB	VB	_	35	xcomp	_	_
38	transcription	_	NN	NN	_	37	dobj	_	_
39	in	_	IN	IN	_	38	prep	_	_
40	cultured	_	VBN	VBN	_	41	amod	_	_
41	cells	_	NNS	NNS	_	39	pobj	_	_
42	,	_	,	,	_	37	punct	_	_
43	presumably	_	RB	RB	_	44	advmod	_	_
44	through	_	IN	IN	_	37	prep	_	_
45	RBP-Jkappa	_	NN	NN	_	47	nn	_	_
46	response	_	NN	NN	_	47	nn	_	_
47	elements	_	NNS	NNS	_	44	pobj	_	_
48	within	_	IN	IN	_	47	prep	_	_
49	DNA	_	NN	NN	_	48	pobj	_	_
50	.	_	.	.	_	35	punct	_	_

1	Both	_	CC	CC	_	3	dep	_	_
2	truncated	_	JJ	JJ	_	3	dep	_	_
3	forms	_	NNS	NNS	_	5	nsubj	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	bound	_	VBD	VBD	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	10	det	_	_
8	transcription	_	NN	NN	_	10	nn	_	_
9	factor	_	NN	NN	_	10	nn	_	_
10	RBP-Jkappa	_	NN	NN	_	6	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	extracts	_	NNS	NNS	_	11	pobj	_	_
13	prepared	_	VBN	VBN	_	12	vmod	_	_
14	from	_	IN	IN	_	13	prep	_	_
15	human	_	JJ	JJ	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	murine	_	JJ	JJ	_	15	conj	_	_
18	T-ALL	_	NN	NN	_	20	nn	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	lines	_	NNS	NNS	_	15	dep	_	_
21	.	_	.	.	_	5	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	activation	_	NN	NN	_	3	nsubj	_	_
3	required	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	presence	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	weak	_	JJ	JJ	_	10	amod	_	_
9	RBP-Jkappa-binding	_	JJ	JJ	_	10	amod	_	_
10	site	_	NN	NN	_	6	pobj	_	_
11	within	_	IN	IN	_	5	prep	_	_
12	the	_	DT	DT	_	16	det	_	_
13	NOTCH1	_	NN	NN	_	16	nn	_	_
14	ankyrin	_	NN	NN	_	16	nn	_	_
15	repeat	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	11	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	intracellular	_	JJ	JJ	_	20	amod	_	_
20	domain	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Unexpectedly	_	RB	RB	_	30	advmod	_	_
2	,	_	,	,	_	30	punct	_	_
3	a	_	DT	DT	_	8	det	_	_
4	second	_	JJ	JJ	_	8	amod	_	_
5	,	_	,	,	_	4	punct	_	_
6	stronger	_	JJR	JJR	_	4	dep	_	_
7	RBP-Jkappa-binding	_	JJ	JJ	_	8	amod	_	_
8	site	_	NN	NN	_	30	nsubjpass	_	_
9	,	_	,	,	_	8	punct	_	_
10	which	_	WDT	WDT	_	11	nsubj	_	_
11	lies	_	VBZ	VBZ	_	8	rcmod	_	_
12	within	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	intracellular	_	JJ	JJ	_	15	amod	_	_
15	domain	_	NN	NN	_	12	pobj	_	_
16	close	_	JJ	JJ	_	15	amod	_	_
17	to	_	TO	TO	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	transmembrane	_	JJ	JJ	_	20	amod	_	_
20	region	_	NN	NN	_	17	pobj	_	_
21	and	_	CC	CC	_	11	cc	_	_
22	significantly	_	RB	RB	_	23	advmod	_	_
23	augments	_	VBZ	VBZ	_	11	conj	_	_
24	association	_	NN	NN	_	23	dobj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	RBP-Jkappa	_	NN	NN	_	25	pobj	_	_
27	,	_	,	,	_	8	punct	_	_
28	was	_	VBD	VBD	_	30	auxpass	_	_
29	not	_	RB	RB	_	30	neg	_	_
30	needed	_	VBN	VBN	_	0	root	_	_
31	for	_	IN	IN	_	30	prep	_	_
32	oncogenesis	_	NN	NN	_	31	pobj	_	_
33	or	_	CC	CC	_	31	cc	_	_
34	for	_	IN	IN	_	31	conj	_	_
35	transcriptional	_	JJ	JJ	_	36	amod	_	_
36	activation	_	NN	NN	_	34	pobj	_	_
37	.	_	.	.	_	30	punct	_	_

1	While	_	IN	IN	_	3	mark	_	_
2	ICN	_	NN	NN	_	3	nsubj	_	_
3	appeared	_	VBD	VBD	_	10	advcl	_	_
4	primarily	_	RB	RB	_	5	advmod	_	_
5	in	_	IN	IN	_	3	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	nucleus	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	10	punct	_	_
9	DeltaE	_	NN	NN	_	10	nsubj	_	_
10	localized	_	VBD	VBD	_	0	root	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	cytoplasmic	_	JJ	JJ	_	11	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	nuclear	_	JJ	JJ	_	12	conj	_	_
15	membranes	_	NNS	NNS	_	12	dep	_	_
16	,	_	,	,	_	10	punct	_	_
17	suggesting	_	VBG	VBG	_	10	xcomp	_	_
18	that	_	IN	IN	_	23	mark	_	_
19	intranuclear	_	JJ	JJ	_	20	amod	_	_
20	localization	_	NN	NN	_	23	nsubj	_	_
21	is	_	VBZ	VBZ	_	23	cop	_	_
22	not	_	RB	RB	_	23	neg	_	_
23	essential	_	JJ	JJ	_	17	ccomp	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	oncogenesis	_	NN	NN	_	24	pobj	_	_
26	or	_	CC	CC	_	25	cc	_	_
27	transcriptional	_	JJ	JJ	_	28	amod	_	_
28	activation	_	NN	NN	_	25	conj	_	_
29	.	_	.	.	_	10	punct	_	_

1	In	_	IN	IN	_	13	prep	_	_
2	support	_	NN	NN	_	1	pobj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	interpretation	_	NN	NN	_	3	pobj	_	_
6	,	_	,	,	_	13	punct	_	_
7	mutation	_	NN	NN	_	13	nsubj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	putative	_	JJ	JJ	_	12	amod	_	_
10	nuclear	_	JJ	JJ	_	12	amod	_	_
11	localization	_	NN	NN	_	12	nn	_	_
12	sequences	_	NNS	NNS	_	8	pobj	_	_
13	decreased	_	VBD	VBD	_	0	root	_	_
14	nuclear	_	JJ	JJ	_	15	amod	_	_
15	localization	_	NN	NN	_	13	dobj	_	_
16	and	_	CC	CC	_	13	cc	_	_
17	increased	_	VBD	VBD	_	13	conj	_	_
18	transcriptional	_	JJ	JJ	_	19	amod	_	_
19	activation	_	NN	NN	_	17	dobj	_	_
20	by	_	IN	IN	_	13	prep	_	_
21	membrane-bound	_	JJ	JJ	_	22	amod	_	_
22	DeltaE	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	13	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	activation	_	NN	NN	_	12	nsubj	_	_
3	by	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	6	det	_	_
5	mutant	_	JJ	JJ	_	6	amod	_	_
6	form	_	NN	NN	_	3	pobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	membrane-bound	_	JJ	JJ	_	9	amod	_	_
9	DeltaE	_	NN	NN	_	7	pobj	_	_
10	was	_	VBD	VBD	_	12	cop	_	_
11	approximately	_	RB	RB	_	12	advmod	_	_
12	equivalent	_	JJ	JJ	_	0	root	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	that	_	DT	DT	_	13	pobj	_	_
15	produced	_	VBN	VBN	_	14	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	intranuclear	_	JJ	JJ	_	18	amod	_	_
18	ICN	_	NN	NN	_	16	pobj	_	_
19	.	_	.	.	_	12	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	5	nsubj	_	_
3	are	_	VBP	VBP	_	5	cop	_	_
4	most	_	RBS	RBS	_	5	advmod	_	_
5	consistent	_	JJ	JJ	_	0	root	_	_
6	with	_	IN	IN	_	5	prep	_	_
7	NOTCH1	_	NN	NN	_	8	nn	_	_
8	oncogenesis	_	NN	NN	_	6	pobj	_	_
9	and	_	CC	CC	_	5	cc	_	_
10	transcriptional	_	JJ	JJ	_	11	amod	_	_
11	activation	_	NN	NN	_	13	nsubj	_	_
12	being	_	VBG	VBG	_	13	cop	_	_
13	independent	_	JJ	JJ	_	5	conj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	association	_	NN	NN	_	14	pobj	_	_
16	with	_	IN	IN	_	15	prep	_	_
17	RBP-Jkappa	_	NN	NN	_	16	pobj	_	_
18	at	_	IN	IN	_	17	prep	_	_
19	promoter	_	NN	NN	_	20	nn	_	_
20	sites	_	NNS	NNS	_	18	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Activation	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	NF-kappaB	_	NN	NN	_	5	nn	_	_
5	pathway	_	NN	NN	_	2	pobj	_	_
6	by	_	IN	IN	_	1	prep	_	_
7	inflammatory	_	JJ	JJ	_	8	amod	_	_
8	stimuli	_	NNS	NNS	_	6	pobj	_	_
9	in	_	IN	IN	_	1	prep	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	neutrophils	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	Activated	_	VBN	VBN	_	2	amod	_	_
2	neutrophils	_	NNS	NNS	_	3	nsubj	_	_
3	have	_	VBP	VBP	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	ability	_	NN	NN	_	3	dobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	upregulate	_	VB	VB	_	5	dep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	expression	_	NN	NN	_	7	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	many	_	JJ	JJ	_	12	amod	_	_
12	genes	_	NNS	NNS	_	10	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	in	_	IN	IN	_	12	prep	_	_
15	particular	_	JJ	JJ	_	14	pobj	_	_
16	those	_	DT	DT	_	12	dep	_	_
17	encoding	_	VBG	VBG	_	16	vmod	_	_
18	cytokines	_	NNS	NNS	_	17	dobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	chemokines	_	NNS	NNS	_	18	conj	_	_
21	,	_	,	,	_	7	punct	_	_
22	and	_	CC	CC	_	7	cc	_	_
23	to	_	TO	TO	_	25	aux	_	_
24	subsequently	_	RB	RB	_	25	advmod	_	_
25	release	_	VB	VB	_	7	conj	_	_
26	the	_	DT	DT	_	28	det	_	_
27	corresponding	_	JJ	JJ	_	28	amod	_	_
28	proteins	_	NNS	NNS	_	25	dobj	_	_
29	.	_	.	.	_	3	punct	_	_

1	Although	_	IN	IN	_	4	mark	_	_
2	little	_	JJ	JJ	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	known	_	VBN	VBN	_	18	advcl	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	date	_	NN	NN	_	5	pobj	_	_
7	concerning	_	VBG	VBG	_	4	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	regulation	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	transcription	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	neutrophils	_	NNS	NNS	_	13	pobj	_	_
15	,	_	,	,	_	18	punct	_	_
16	it	_	PRP	PRP	_	18	nsubj	_	_
17	is	_	VBZ	VBZ	_	18	cop	_	_
18	noteworthy	_	JJ	JJ	_	0	root	_	_
19	that	_	IN	IN	_	24	mark	_	_
20	many	_	JJ	JJ	_	24	nsubj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	these	_	DT	DT	_	23	det	_	_
23	genes	_	NNS	NNS	_	21	pobj	_	_
24	depend	_	VBP	VBP	_	18	ccomp	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	the	_	DT	DT	_	27	det	_	_
27	activation	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	transcription	_	NN	NN	_	30	nn	_	_
30	factors	_	NNS	NNS	_	28	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	such	_	JJ	JJ	_	33	mwe	_	_
33	as	_	IN	IN	_	30	prep	_	_
34	NF-kappaB	_	NN	NN	_	33	pobj	_	_
35	,	_	,	,	_	24	punct	_	_
36	for	_	IN	IN	_	24	prep	_	_
37	inducible	_	JJ	JJ	_	38	amod	_	_
38	expression	_	NN	NN	_	36	pobj	_	_
39	.	_	.	.	_	18	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	therefore	_	RB	RB	_	3	advmod	_	_
3	investigated	_	VBD	VBD	_	0	root	_	_
4	whether	_	IN	IN	_	8	mark	_	_
5	NF-kappaB/Rel	_	NN	NN	_	6	nn	_	_
6	proteins	_	NNS	NNS	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	expressed	_	VBN	VBN	_	3	dep	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	human	_	JJ	JJ	_	11	amod	_	_
11	neutrophils	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	8	punct	_	_
13	as	_	RB	RB	_	14	advmod	_	_
14	well	_	RB	RB	_	8	cc	_	_
15	as	_	IN	IN	_	14	mwe	_	_
16	their	_	PRP$	PRP$	_	17	poss	_	_
17	fate	_	NN	NN	_	8	conj	_	_
18	on	_	IN	IN	_	17	prep	_	_
19	cell	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	18	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	report	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	17	mark	_	_
5	dimers	_	NNS	NNS	_	17	nsubj	_	_
6	consisting	_	VBG	VBG	_	5	vmod	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	p50	_	NN	NN	_	9	nn	_	_
9	NFkappaB1	_	NN	NN	_	7	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	p65	_	NN	NN	_	12	nn	_	_
12	RelA	_	NN	NN	_	9	conj	_	_
13	,	_	,	,	_	9	punct	_	_
14	and/or	_	CC	CC	_	9	cc	_	_
15	c-Rel	_	NN	NN	_	9	conj	_	_
16	are	_	VBP	VBP	_	17	cop	_	_
17	present	_	JJ	JJ	_	3	ccomp	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	neutrophils	_	NNS	NNS	_	18	pobj	_	_
20	and	_	CC	CC	_	17	cc	_	_
21	that	_	IN	IN	_	31	mark	_	_
22	the	_	DT	DT	_	24	det	_	_
23	greater	_	JJR	JJR	_	24	amod	_	_
24	part	_	NN	NN	_	31	nsubjpass	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	these	_	DT	DT	_	28	det	_	_
27	protein	_	NN	NN	_	28	nn	_	_
28	complexes	_	NNS	NNS	_	25	pobj	_	_
29	is	_	VBZ	VBZ	_	31	auxpass	_	_
30	physically	_	RB	RB	_	31	advmod	_	_
31	associated	_	VBN	VBN	_	17	conj	_	_
32	with	_	IN	IN	_	31	prep	_	_
33	cytoplasmic	_	JJ	JJ	_	34	amod	_	_
34	IkappaB-alpha	_	NN	NN	_	32	pobj	_	_
35	in	_	IN	IN	_	34	prep	_	_
36	resting	_	VBG	VBG	_	37	amod	_	_
37	cells	_	NNS	NNS	_	35	pobj	_	_
38	.	_	.	.	_	3	punct	_	_

1	Following	_	VBG	VBG	_	39	prep	_	_
2	neutrophil	_	NN	NN	_	3	nn	_	_
3	stimulation	_	NN	NN	_	1	pobj	_	_
4	with	_	IN	IN	_	3	prep	_	_
5	proinflammatory	_	JJ	JJ	_	6	amod	_	_
6	agonists	_	NNS	NNS	_	4	pobj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
8	such	_	JJ	JJ	_	9	mwe	_	_
9	as	_	IN	IN	_	6	prep	_	_
10	lipopolysaccharide	_	NN	NN	_	9	pobj	_	_
11	-LSB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	LPS	_	NN	NN	_	10	appos	_	_
13	-RSB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	,	_	,	,	_	10	punct	_	_
15	tumor	_	NN	NN	_	17	nn	_	_
16	necrosis	_	NN	NN	_	17	nn	_	_
17	factor-alpha	_	NN	NN	_	10	conj	_	_
18	-LSB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	TNF-alpha	_	NN	NN	_	17	appos	_	_
20	-RSB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	,	_	,	,	_	10	punct	_	_
22	and	_	CC	CC	_	10	cc	_	_
23	fMet-Leu-Phe	_	NN	NN	_	10	conj	_	_
24	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
25	that	_	WDT	WDT	_	26	nsubj	_	_
26	induce	_	VBP	VBP	_	6	rcmod	_	_
27	the	_	DT	DT	_	28	det	_	_
28	production	_	NN	NN	_	26	dobj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	cytokines	_	NNS	NNS	_	29	pobj	_	_
31	and	_	CC	CC	_	30	cc	_	_
32	chemokines	_	NNS	NNS	_	30	conj	_	_
33	in	_	IN	IN	_	26	prep	_	_
34	these	_	DT	DT	_	35	det	_	_
35	cells	_	NNS	NNS	_	33	pobj	_	_
36	,	_	,	,	_	39	punct	_	_
37	NF-kappaB/Rel	_	NN	NN	_	38	nn	_	_
38	proteins	_	NNS	NNS	_	39	nsubj	_	_
39	translocated	_	VBD	VBD	_	0	root	_	_
40	to	_	TO	TO	_	39	prep	_	_
41	nuclear	_	JJ	JJ	_	42	amod	_	_
42	fractions	_	NNS	NNS	_	40	pobj	_	_
43	,	_	,	,	_	39	punct	_	_
44	resulting	_	VBG	VBG	_	39	xcomp	_	_
45	in	_	IN	IN	_	44	prep	_	_
46	a	_	DT	DT	_	48	det	_	_
47	transient	_	JJ	JJ	_	48	amod	_	_
48	induction	_	NN	NN	_	45	pobj	_	_
49	of	_	IN	IN	_	48	prep	_	_
50	NF-kappaB	_	NN	NN	_	53	nn	_	_
51	DNA	_	NN	NN	_	53	nn	_	_
52	binding	_	NN	NN	_	53	nn	_	_
53	activity	_	NN	NN	_	49	pobj	_	_
54	,	_	,	,	_	44	punct	_	_
55	as	_	IN	IN	_	56	mark	_	_
56	determined	_	VBN	VBN	_	44	advcl	_	_
57	in	_	IN	IN	_	56	prep	_	_
58	gel	_	NN	NN	_	61	nn	_	_
59	mobility	_	NN	NN	_	61	nn	_	_
60	shift	_	NN	NN	_	61	nn	_	_
61	assays	_	NNS	NNS	_	57	pobj	_	_
62	.	_	.	.	_	39	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	onset	_	NN	NN	_	7	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	both	_	DT	DT	_	5	det	_	_
5	processes	_	NNS	NNS	_	3	pobj	_	_
6	was	_	VBD	VBD	_	7	auxpass	_	_
7	found	_	VBN	VBN	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	be	_	VB	VB	_	7	xcomp	_	_
10	closely	_	RB	RB	_	11	advmod	_	_
11	paralleled	_	VBN	VBN	_	9	dep	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	,	_	,	,	_	11	punct	_	_
14	and	_	CC	CC	_	11	cc	_	_
15	dependent	_	JJ	JJ	_	11	conj	_	_
16	on	_	IN	IN	_	15	prep	_	_
17	,	_	,	,	_	11	punct	_	_
18	IkappaB-alpha	_	NN	NN	_	19	nn	_	_
19	degradation	_	NN	NN	_	11	conj	_	_
20	.	_	.	.	_	7	punct	_	_

1	Proinflammatory	_	JJ	JJ	_	2	amod	_	_
2	neutrophil	_	NN	NN	_	3	nn	_	_
3	stimuli	_	NNS	NNS	_	5	nsubj	_	_
4	also	_	RB	RB	_	5	advmod	_	_
5	promoted	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	accumulation	_	NN	NN	_	5	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	IkappaB-alpha	_	NN	NN	_	11	nn	_	_
10	mRNA	_	NN	NN	_	11	nn	_	_
11	transcripts	_	NNS	NNS	_	8	pobj	_	_
12	,	_	,	,	_	5	punct	_	_
13	resulting	_	VBG	VBG	_	5	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	reexpression	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	20	det	_	_
19	IkappaB-alpha	_	NN	NN	_	20	nn	_	_
20	protein	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	6	prep	_	_
2	our	_	PRP$	PRP$	_	3	poss	_	_
3	knowledge	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	this	_	DT	DT	_	6	nsubj	_	_
6	constitutes	_	VBZ	VBZ	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	first	_	JJ	JJ	_	9	amod	_	_
9	indication	_	NN	NN	_	6	dobj	_	_
10	that	_	IN	IN	_	14	mark	_	_
11	NF-kappaB	_	NN	NN	_	12	nn	_	_
12	activation	_	NN	NN	_	14	nsubj	_	_
13	may	_	MD	MD	_	14	aux	_	_
14	underlie	_	VB	VB	_	9	ccomp	_	_
15	the	_	DT	DT	_	16	det	_	_
16	action	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	proinflammatory	_	JJ	JJ	_	19	amod	_	_
19	stimuli	_	NNS	NNS	_	17	pobj	_	_
20	towards	_	IN	IN	_	16	prep	_	_
21	human	_	JJ	JJ	_	24	amod	_	_
22	neutrophil	_	NN	NN	_	24	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	expression	_	NN	NN	_	20	pobj	_	_
25	and	_	CC	CC	_	14	cc	_	_
26	,	_	,	,	_	14	punct	_	_
27	as	_	IN	IN	_	28	mark	_	_
28	such	_	JJ	JJ	_	14	advcl	_	_
29	,	_	,	,	_	14	punct	_	_
30	adds	_	VBZ	VBZ	_	14	dep	_	_
31	a	_	DT	DT	_	33	det	_	_
32	new	_	JJ	JJ	_	33	amod	_	_
33	facet	_	NN	NN	_	30	dobj	_	_
34	to	_	TO	TO	_	33	prep	_	_
35	our	_	PRP$	PRP$	_	36	poss	_	_
36	understanding	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	neutrophil	_	NN	NN	_	39	nn	_	_
39	biology	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	6	punct	_	_

1	Glucocorticoid-resistance	_	NN	NN	_	7	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	peripheral-blood	_	JJ	JJ	_	4	amod	_	_
4	lymphocytes	_	NNS	NNS	_	2	pobj	_	_
5	does	_	VBZ	VBZ	_	7	aux	_	_
6	not	_	RB	RB	_	7	neg	_	_
7	correlate	_	VB	VB	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	number	_	NN	NN	_	8	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	affinity	_	NN	NN	_	10	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	glucocorticoid-receptors	_	NNS	NNS	_	12	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	chronic	_	JJ	JJ	_	18	amod	_	_
16	renal	_	JJ	JJ	_	18	amod	_	_
17	failure	_	NN	NN	_	18	nn	_	_
18	patients	_	NNS	NNS	_	14	pobj	_	_
19	.	_	.	.	_	7	punct	_	_

1	Glucocorticoid	_	NN	NN	_	5	nn	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	GC	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	resistance	_	NN	NN	_	16	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	patients	_	NNS	NNS	_	6	pobj	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	chronic	_	JJ	JJ	_	11	amod	_	_
10	renal	_	JJ	JJ	_	11	amod	_	_
11	failure	_	NN	NN	_	8	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	CRF	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	seriously	_	RB	RB	_	16	advmod	_	_
16	impairs	_	VBZ	VBZ	_	0	root	_	_
17	successive	_	JJ	JJ	_	19	amod	_	_
18	GC	_	NN	NN	_	19	nn	_	_
19	therapy	_	NN	NN	_	16	dobj	_	_
20	after	_	IN	IN	_	16	prep	_	_
21	renal	_	JJ	JJ	_	22	amod	_	_
22	transplantation	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	16	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	examined	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	relationship	_	NN	NN	_	2	dobj	_	_
5	between	_	IN	IN	_	4	prep	_	_
6	GC-receptor	_	NN	NN	_	10	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	GC-R	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	parameters	_	NNS	NNS	_	5	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	peripheral-blood	_	JJ	JJ	_	14	amod	_	_
13	mononuclear	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	PBMC	_	NN	NN	_	14	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	and	_	CC	CC	_	10	cc	_	_
19	PBMC	_	NN	NN	_	20	nn	_	_
20	resistance	_	NN	NN	_	10	conj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	GC	_	NN	NN	_	21	pobj	_	_
23	in	_	IN	IN	_	2	prep	_	_
24	21	_	CD	CD	_	26	num	_	_
25	CRF	_	NN	NN	_	26	nn	_	_
26	patients	_	NNS	NNS	_	23	pobj	_	_
27	and	_	CC	CC	_	26	cc	_	_
28	18	_	CD	CD	_	30	num	_	_
29	healthy	_	JJ	JJ	_	30	amod	_	_
30	subjects	_	NNS	NNS	_	26	conj	_	_
31	.	_	.	.	_	2	punct	_	_

1	Each	_	DT	DT	_	3	det	_	_
2	subject	_	NN	NN	_	3	nn	_	_
3	group	_	NN	NN	_	5	nsubjpass	_	_
4	was	_	VBD	VBD	_	5	auxpass	_	_
5	divided	_	VBN	VBN	_	0	root	_	_
6	into	_	IN	IN	_	5	prep	_	_
7	two	_	CD	CD	_	8	num	_	_
8	subgroups	_	NNS	NNS	_	6	pobj	_	_
9	according	_	VBG	VBG	_	8	prep	_	_
10	to	_	TO	TO	_	9	pcomp	_	_
11	PBMC	_	NN	NN	_	12	nn	_	_
12	sensitivity	_	NN	NN	_	10	pobj	_	_
13	to	_	TO	TO	_	12	prep	_	_
14	prednisolone	_	NN	NN	_	13	pobj	_	_
15	in	_	IN	IN	_	12	prep	_	_
16	a	_	DT	DT	_	19	det	_	_
17	mitogen	_	NN	NN	_	19	nn	_	_
18	assay	_	NN	NN	_	19	nn	_	_
19	procedure	_	NN	NN	_	15	pobj	_	_
20	;	_	:	:	_	5	punct	_	_
21	i.e.	_	FW	FW	_	5	prep	_	_
22	,	_	,	,	_	5	punct	_	_
23	sensitive	_	JJ	JJ	_	5	dep	_	_
24	-LRB-	_	-LRB-	-LRB-	_	25	punct	_	_
25	IC50	_	NN	NN	_	23	dep	_	_
26	&lt;	_	JJR	JJR	_	25	amod	_	_
27	381	_	CD	CD	_	28	num	_	_
28	ng/mL	_	NN	NN	_	26	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	25	punct	_	_
30	and	_	CC	CC	_	23	cc	_	_
31	resistant	_	JJ	JJ	_	23	conj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	IC50	_	NN	NN	_	31	dep	_	_
34	&gt;	_	JJR	JJR	_	33	amod	_	_
35	381	_	CD	CD	_	36	num	_	_
36	ng/mL	_	NN	NN	_	34	dep	_	_
37	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
38	groups	_	NNS	NNS	_	23	dep	_	_
39	.	_	.	.	_	5	punct	_	_

1	In	_	IN	IN	_	23	prep	_	_
2	healthy	_	JJ	JJ	_	3	amod	_	_
3	subjects	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	23	punct	_	_
5	the	_	DT	DT	_	6	det	_	_
6	mean	_	NN	NN	_	23	nsubj	_	_
7	GC-R	_	NN	NN	_	6	dep	_	_
8	Bmax	_	NN	NN	_	6	dep	_	_
9	and	_	CC	CC	_	6	cc	_	_
10	Kd	_	NN	NN	_	6	conj	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	quiescent	_	JJ	JJ	_	13	amod	_	_
13	PBMC	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	GC-sensitive	_	JJ	JJ	_	17	amod	_	_
17	group	_	NN	NN	_	14	pobj	_	_
18	were	_	VBD	VBD	_	23	cop	_	_
19	2.89	_	CD	CD	_	23	num	_	_
20	+/-	_	CC	CC	_	19	cc	_	_
21	1.23	_	CD	CD	_	19	conj	_	_
22	fmol/10-LRB-6-RRB-	_	NN	NN	_	23	nn	_	_
23	cells	_	NNS	NNS	_	0	root	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	4.00	_	CD	CD	_	28	num	_	_
26	+/-	_	CC	CC	_	25	cc	_	_
27	2.24	_	CD	CD	_	25	conj	_	_
28	nM	_	NN	NN	_	23	conj	_	_
29	,	_	,	,	_	23	punct	_	_
30	respectively	_	RB	RB	_	23	advmod	_	_
31	.	_	.	.	_	23	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	Bmax	_	NN	NN	_	7	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	these	_	DT	DT	_	5	det	_	_
5	subjects	_	NNS	NNS	_	3	pobj	_	_
6	significantly	_	RB	RB	_	7	advmod	_	_
7	increased	_	VBD	VBD	_	0	root	_	_
8	to	_	TO	TO	_	7	prep	_	_
9	6.61	_	CD	CD	_	8	pobj	_	_
10	+/-	_	CC	CC	_	9	cc	_	_
11	2.02	_	CD	CD	_	9	conj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
13	257.7	_	CD	CD	_	16	num	_	_
14	+/-	_	CC	CC	_	13	cc	_	_
15	107.8	_	CD	CD	_	13	conj	_	_
16	%	_	NN	NN	_	9	appos	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	after	_	IN	IN	_	7	prep	_	_
19	24	_	CD	CD	_	20	number	_	_
20	h	_	NN	NN	_	21	amod	_	_
21	stimulation	_	NN	NN	_	18	pobj	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	concanavalin	_	NN	NN	_	24	nn	_	_
24	A	_	NN	NN	_	22	pobj	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	p	_	NN	NN	_	21	dep	_	_
27	&lt;	_	JJR	JJR	_	26	amod	_	_
28	0.01	_	CD	CD	_	27	dep	_	_
29	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
30	,	_	,	,	_	7	punct	_	_
31	while	_	IN	IN	_	37	mark	_	_
32	the	_	DT	DT	_	34	det	_	_
33	Kd	_	NN	NN	_	34	nn	_	_
34	change	_	NN	NN	_	37	nsubj	_	_
35	was	_	VBD	VBD	_	37	cop	_	_
36	not	_	RB	RB	_	37	neg	_	_
37	significant	_	JJ	JJ	_	7	advcl	_	_
38	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	GC-R	_	NN	NN	_	18	nsubj	_	_
3	Bmax	_	NN	NN	_	2	dep	_	_
4	and	_	CC	CC	_	3	cc	_	_
5	Kd	_	NN	NN	_	3	conj	_	_
6	in	_	IN	IN	_	2	prep	_	_
7	quiescent	_	JJ	JJ	_	8	amod	_	_
8	PBMC	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	GC-resistant	_	JJ	JJ	_	12	amod	_	_
12	group	_	NN	NN	_	9	pobj	_	_
13	were	_	VBD	VBD	_	18	cop	_	_
14	5.33	_	CD	CD	_	18	num	_	_
15	+/-	_	CC	CC	_	14	cc	_	_
16	1.37	_	CD	CD	_	14	conj	_	_
17	fmol/10-LRB-6-RRB-	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	0	root	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	3.20	_	CD	CD	_	23	num	_	_
21	+/-	_	CC	CC	_	20	cc	_	_
22	1.39	_	CD	CD	_	20	conj	_	_
23	nM	_	NN	NN	_	18	conj	_	_
24	,	_	,	,	_	18	punct	_	_
25	respectively	_	RB	RB	_	18	advmod	_	_
26	.	_	.	.	_	18	punct	_	_

1	Both	_	DT	DT	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	these	_	DT	DT	_	4	det	_	_
4	parameters	_	NNS	NNS	_	2	pobj	_	_
5	,	_	,	,	_	1	punct	_	_
6	however	_	RB	RB	_	10	advmod	_	_
7	,	_	,	,	_	10	punct	_	_
8	did	_	VBD	VBD	_	10	aux	_	_
9	not	_	RB	RB	_	10	neg	_	_
10	change	_	VB	VB	_	0	root	_	_
11	significantly	_	RB	RB	_	10	advmod	_	_
12	after	_	IN	IN	_	10	prep	_	_
13	mitogen	_	NN	NN	_	14	nn	_	_
14	stimulation	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	10	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	6	det	_	_
4	significant	_	JJ	JJ	_	6	amod	_	_
5	negative	_	JJ	JJ	_	4	dep	_	_
6	correlation	_	NN	NN	_	2	nsubj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	IC50S	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	prednisolone	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	8	cc	_	_
12	increase-ratios	_	NN	NN	_	8	conj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
14	post/pre	_	JJ	JJ	_	15	amod	_	_
15	ratio	_	NN	NN	_	12	appos	_	_
16	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
17	of	_	IN	IN	_	12	prep	_	_
18	Bmax	_	NN	NN	_	17	pobj	_	_
19	after	_	IN	IN	_	2	prep	_	_
20	mitogen	_	NN	NN	_	21	nn	_	_
21	stimulation	_	NN	NN	_	19	pobj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	p	_	NN	NN	_	21	dep	_	_
24	&lt;	_	JJR	JJR	_	23	amod	_	_
25	0.05	_	CD	CD	_	24	dep	_	_
26	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
27	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	20	prep	_	_
2	CRF	_	NN	NN	_	3	nn	_	_
3	patients	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	20	punct	_	_
5	Bmax	_	NN	NN	_	20	nsubj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	Kd	_	NN	NN	_	5	conj	_	_
8	in	_	IN	IN	_	5	prep	_	_
9	quiescent	_	JJ	JJ	_	10	amod	_	_
10	PBMC	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	GC-sensitive	_	JJ	JJ	_	14	amod	_	_
14	group	_	NN	NN	_	11	pobj	_	_
15	were	_	VBD	VBD	_	20	cop	_	_
16	6.04	_	CD	CD	_	20	num	_	_
17	+/-	_	CC	CC	_	16	cc	_	_
18	2.35	_	CD	CD	_	16	conj	_	_
19	fmol/10-LRB-6-RRB-	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	0	root	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	3.49	_	CD	CD	_	25	num	_	_
23	+/-	_	CC	CC	_	22	cc	_	_
24	1.72	_	CD	CD	_	22	conj	_	_
25	nM	_	NN	NN	_	20	conj	_	_
26	,	_	,	,	_	20	punct	_	_
27	respectively	_	RB	RB	_	20	advmod	_	_
28	,	_	,	,	_	20	punct	_	_
29	while	_	IN	IN	_	42	mark	_	_
30	those	_	DT	DT	_	42	nsubj	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	PBMC	_	NN	NN	_	31	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	GC-resistant	_	JJ	JJ	_	36	amod	_	_
36	group	_	NN	NN	_	33	pobj	_	_
37	were	_	VBD	VBD	_	42	cop	_	_
38	5.13	_	CD	CD	_	42	num	_	_
39	+/-	_	CC	CC	_	38	cc	_	_
40	2.31	_	CD	CD	_	38	conj	_	_
41	fmol/10-LRB-6-RRB-	_	NN	NN	_	42	nn	_	_
42	cells	_	NNS	NNS	_	20	advcl	_	_
43	and	_	CC	CC	_	42	cc	_	_
44	4.04	_	CD	CD	_	47	num	_	_
45	+/-	_	CC	CC	_	44	cc	_	_
46	1.62	_	CD	CD	_	44	conj	_	_
47	nM	_	NN	NN	_	42	conj	_	_
48	,	_	,	,	_	42	punct	_	_
49	respectively	_	RB	RB	_	42	advmod	_	_
50	.	_	.	.	_	20	punct	_	_

1	The	_	DT	DT	_	2	dep	_	_
2	Bmax	_	NN	NN	_	8	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	Kd	_	NN	NN	_	2	conj	_	_
5	were	_	VBD	VBD	_	8	auxpass	_	_
6	not	_	RB	RB	_	8	neg	_	_
7	significantly	_	RB	RB	_	8	advmod	_	_
8	changed	_	VBN	VBN	_	0	root	_	_
9	after	_	IN	IN	_	8	prep	_	_
10	mitogen	_	NN	NN	_	11	nn	_	_
11	stimulation	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	both	_	DT	DT	_	14	det	_	_
14	subgroups	_	NNS	NNS	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	CRF	_	NN	NN	_	15	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	Moreover	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	in	_	IN	IN	_	10	prep	_	_
4	contrast	_	NN	NN	_	3	pobj	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	healthy	_	JJ	JJ	_	7	amod	_	_
7	subjects	_	NNS	NNS	_	5	pobj	_	_
8	,	_	,	,	_	10	punct	_	_
9	there	_	EX	EX	_	10	expl	_	_
10	was	_	VBD	VBD	_	0	root	_	_
11	no	_	DT	DT	_	12	neg	_	_
12	correlation	_	NN	NN	_	10	nsubj	_	_
13	between	_	IN	IN	_	12	prep	_	_
14	IC50	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	GC-R	_	NN	NN	_	17	nn	_	_
17	parameters	_	NNS	NNS	_	14	conj	_	_
18	in	_	IN	IN	_	10	prep	_	_
19	CRF	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	concluded	_	VBD	VBD	_	0	root	_	_
3	that	_	IN	IN	_	21	mark	_	_
4	,	_	,	,	_	21	punct	_	_
5	in	_	IN	IN	_	21	prep	_	_
6	healthy	_	JJ	JJ	_	7	amod	_	_
7	subjects	_	NNS	NNS	_	5	pobj	_	_
8	,	_	,	,	_	21	punct	_	_
9	decreased	_	VBN	VBN	_	11	amod	_	_
10	PBMC	_	NN	NN	_	11	nn	_	_
11	capacity	_	NN	NN	_	21	nsubjpass	_	_
12	to	_	TO	TO	_	13	aux	_	_
13	amplify	_	VB	VB	_	11	vmod	_	_
14	GC-R	_	NN	NN	_	15	nn	_	_
15	numbers	_	NNS	NNS	_	13	dobj	_	_
16	in	_	IN	IN	_	13	prep	_	_
17	response	_	NN	NN	_	16	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	mitogen	_	NN	NN	_	18	pobj	_	_
20	is	_	VBZ	VBZ	_	21	auxpass	_	_
21	correlated	_	VBN	VBN	_	2	ccomp	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	GC	_	NN	NN	_	24	nn	_	_
24	resistance	_	NN	NN	_	22	pobj	_	_
25	,	_	,	,	_	21	punct	_	_
26	whereas	_	IN	IN	_	35	mark	_	_
27	in	_	IN	IN	_	35	prep	_	_
28	CRF	_	NN	NN	_	29	nn	_	_
29	patients	_	NNS	NNS	_	27	pobj	_	_
30	the	_	DT	DT	_	32	det	_	_
31	resistant	_	JJ	JJ	_	32	amod	_	_
32	mechanism	_	NN	NN	_	35	nsubjpass	_	_
33	is	_	VBZ	VBZ	_	35	auxpass	_	_
34	not	_	RB	RB	_	35	neg	_	_
35	correlated	_	VBN	VBN	_	21	advcl	_	_
36	with	_	IN	IN	_	35	prep	_	_
37	GC-R	_	NN	NN	_	38	nn	_	_
38	parameters	_	NNS	NNS	_	36	pobj	_	_
39	.	_	.	.	_	2	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	unknown	_	JJ	JJ	_	3	amod	_	_
3	event	_	NN	NN	_	6	nsubjpass	_	_
4	might	_	MD	MD	_	6	aux	_	_
5	be	_	VB	VB	_	6	auxpass	_	_
6	involved	_	VBN	VBN	_	0	root	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	GC-resistance	_	NN	NN	_	7	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	CRF	_	NN	NN	_	9	pobj	_	_
11	.	_	.	.	_	6	punct	_	_

1	Significance	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	quantitative	_	JJ	JJ	_	4	amod	_	_
4	analysis	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	AML1/ETO	_	NN	NN	_	7	nn	_	_
7	transcripts	_	NNS	NNS	_	5	pobj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	peripheral	_	JJ	JJ	_	12	amod	_	_
10	blood	_	NN	NN	_	12	nn	_	_
11	stem	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	8	pobj	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	t-LRB-8;21-RRB-	_	NN	NN	_	17	nn	_	_
15	acute	_	JJ	JJ	_	17	amod	_	_
16	myelogenous	_	JJ	JJ	_	17	amod	_	_
17	leukemia	_	NN	NN	_	13	pobj	_	_
18	.	_	.	.	_	1	punct	_	_

1	Autologous	_	JJ	JJ	_	6	amod	_	_
2	peripheral	_	JJ	JJ	_	5	amod	_	_
3	blood	_	NN	NN	_	5	nn	_	_
4	stem	_	NN	NN	_	5	nn	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	transplantation	_	NN	NN	_	11	nsubj	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	PBSCT	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	is	_	VBZ	VBZ	_	11	aux	_	_
11	replacing	_	VBG	VBG	_	0	root	_	_
12	autologous	_	JJ	JJ	_	15	amod	_	_
13	bone	_	NN	NN	_	15	nn	_	_
14	marrow	_	NN	NN	_	15	nn	_	_
15	transplantation	_	NN	NN	_	11	dobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	BMT	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	in	_	IN	IN	_	11	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	treatment	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	leukemia	_	NN	NN	_	22	pobj	_	_
24	.	_	.	.	_	11	punct	_	_

1	One	_	CD	CD	_	11	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	potential	_	JJ	JJ	_	5	amod	_	_
5	advantages	_	NNS	NNS	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	autologous	_	JJ	JJ	_	8	amod	_	_
8	PBSCT	_	NN	NN	_	6	pobj	_	_
9	is	_	VBZ	VBZ	_	11	cop	_	_
10	the	_	DT	DT	_	11	det	_	_
11	possibility	_	NN	NN	_	0	root	_	_
12	that	_	IN	IN	_	22	mark	_	_
13	peripheral	_	JJ	JJ	_	16	amod	_	_
14	blood	_	NN	NN	_	16	nn	_	_
15	stem	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	22	nsubj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	PBSC	_	NNS	NNS	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	are	_	VBP	VBP	_	22	cop	_	_
21	less	_	RBR	RBR	_	22	advmod	_	_
22	likely	_	JJ	JJ	_	11	ccomp	_	_
23	to	_	TO	TO	_	25	aux	_	_
24	be	_	VB	VB	_	25	auxpass	_	_
25	contaminated	_	VBN	VBN	_	22	xcomp	_	_
26	by	_	IN	IN	_	25	prep	_	_
27	leukemic	_	JJ	JJ	_	28	amod	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	than	_	IN	IN	_	32	mark	_	_
30	bone	_	NN	NN	_	32	nn	_	_
31	marrow	_	NN	NN	_	32	nn	_	_
32	grafts	_	NNS	NNS	_	22	ccomp	_	_
33	.	_	.	.	_	11	punct	_	_

1	However	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	major	_	JJ	JJ	_	5	amod	_	_
5	problem	_	NN	NN	_	7	nsubj	_	_
6	still	_	RB	RB	_	7	advmod	_	_
7	remains	_	VBZ	VBZ	_	0	root	_	_
8	the	_	DT	DT	_	10	det	_	_
9	high	_	JJ	JJ	_	10	amod	_	_
10	incidence	_	NN	NN	_	7	xcomp	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	leukemic	_	JJ	JJ	_	13	amod	_	_
13	relapse	_	NN	NN	_	11	pobj	_	_
14	following	_	VBG	VBG	_	13	prep	_	_
15	autologous	_	JJ	JJ	_	16	amod	_	_
16	PBSCT	_	NN	NN	_	14	pobj	_	_
17	,	_	,	,	_	13	punct	_	_
18	which	_	WDT	WDT	_	21	nsubjpass	_	_
19	may	_	MD	MD	_	21	aux	_	_
20	be	_	VB	VB	_	21	auxpass	_	_
21	caused	_	VBN	VBN	_	13	rcmod	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	reinfusion	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	PBSC	_	NNS	NNS	_	25	pobj	_	_
27	contaminated	_	VBN	VBN	_	26	vmod	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	leukemic	_	JJ	JJ	_	30	amod	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	7	punct	_	_

1	Recently	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	we	_	PRP	PRP	_	5	nsubj	_	_
4	have	_	VBP	VBP	_	5	aux	_	_
5	developed	_	VBN	VBN	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	quantitative	_	JJ	JJ	_	8	amod	_	_
8	assay	_	NN	NN	_	5	dobj	_	_
9	using	_	VBG	VBG	_	8	vmod	_	_
10	competitive	_	JJ	JJ	_	15	amod	_	_
11	reverse	_	JJ	JJ	_	13	amod	_	_
12	transcriptase	_	NN	NN	_	13	nn	_	_
13	polymerase	_	NN	NN	_	15	nn	_	_
14	chain	_	NN	NN	_	15	nn	_	_
15	reaction	_	NN	NN	_	9	dobj	_	_
16	that	_	WDT	WDT	_	17	nsubj	_	_
17	estimates	_	VBZ	VBZ	_	15	rcmod	_	_
18	the	_	DT	DT	_	19	det	_	_
19	number	_	NN	NN	_	17	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	AML1/ETO	_	NN	NN	_	22	nn	_	_
22	transcripts	_	NNS	NNS	_	20	pobj	_	_
23	in	_	IN	IN	_	19	prep	_	_
24	t-LRB-8;21-RRB-	_	NN	NN	_	23	pobj	_	_
25	acute	_	JJ	JJ	_	27	amod	_	_
26	myelogenous	_	JJ	JJ	_	27	amod	_	_
27	leukemia	_	NN	NN	_	24	dep	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	AML	_	NN	NN	_	27	appos	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	,	_	,	,	_	5	punct	_	_
32	in	_	IN	IN	_	35	mark	_	_
33	order	_	NN	NN	_	35	dep	_	_
34	to	_	TO	TO	_	35	aux	_	_
35	determine	_	VB	VB	_	5	advcl	_	_
36	the	_	DT	DT	_	37	det	_	_
37	degree	_	NN	NN	_	35	dobj	_	_
38	of	_	IN	IN	_	37	prep	_	_
39	leukemic	_	JJ	JJ	_	41	amod	_	_
40	cell	_	NN	NN	_	41	nn	_	_
41	contamination	_	NN	NN	_	38	pobj	_	_
42	in	_	IN	IN	_	37	prep	_	_
43	PBSC	_	NNS	NNS	_	44	nn	_	_
44	harvests	_	NNS	NNS	_	42	pobj	_	_
45	,	_	,	,	_	35	punct	_	_
46	and	_	CC	CC	_	35	cc	_	_
47	to	_	TO	TO	_	48	aux	_	_
48	monitor	_	VB	VB	_	35	conj	_	_
49	minimal	_	JJ	JJ	_	51	amod	_	_
50	residual	_	JJ	JJ	_	51	amod	_	_
51	disease	_	NN	NN	_	48	dobj	_	_
52	-LRB-	_	-LRB-	-LRB-	_	53	punct	_	_
53	MRD	_	NN	NN	_	51	appos	_	_
54	-RRB-	_	-RRB-	-RRB-	_	53	punct	_	_
55	quantitatively	_	RB	RB	_	48	advmod	_	_
56	in	_	IN	IN	_	48	prep	_	_
57	patients	_	NNS	NNS	_	56	pobj	_	_
58	with	_	IN	IN	_	57	prep	_	_
59	t-LRB-8;21-RRB-	_	NN	NN	_	60	nn	_	_
60	AML	_	NN	NN	_	58	pobj	_	_
61	.	_	.	.	_	5	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	24	mark	_	_
5	although	_	IN	IN	_	13	mark	_	_
6	PBSC	_	NNS	NNS	_	7	nn	_	_
7	harvests	_	NNS	NNS	_	13	nsubjpass	_	_
8	collected	_	VBN	VBN	_	7	vmod	_	_
9	after	_	IN	IN	_	8	prep	_	_
10	consolidation	_	NN	NN	_	11	nn	_	_
11	chemotherapy	_	NN	NN	_	9	pobj	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	contaminated	_	VBN	VBN	_	24	advcl	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	leukemic	_	JJ	JJ	_	16	amod	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	,	_	,	,	_	24	punct	_	_
18	the	_	DT	DT	_	19	det	_	_
19	degree	_	NN	NN	_	24	nsubj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	leukemic	_	JJ	JJ	_	23	amod	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	contamination	_	NN	NN	_	20	pobj	_	_
24	decreases	_	VBZ	VBZ	_	3	ccomp	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	repeated	_	JJ	JJ	_	27	amod	_	_
27	cycles	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	chemotherapy	_	NN	NN	_	28	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	Furthermore	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	MRD	_	NN	NN	_	9	nsubj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	PBSC	_	NNS	NNS	_	7	nn	_	_
7	harvests	_	NNS	NNS	_	5	pobj	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	less	_	JJR	JJR	_	0	root	_	_
10	than	_	IN	IN	_	9	prep	_	_
11	in	_	IN	IN	_	10	pcomp	_	_
12	the	_	DT	DT	_	15	det	_	_
13	corresponding	_	JJ	JJ	_	15	amod	_	_
14	bone	_	NN	NN	_	15	nn	_	_
15	marrow	_	NN	NN	_	11	pobj	_	_
16	obtained	_	VBN	VBN	_	15	vmod	_	_
17	on	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	day	_	NN	NN	_	17	pobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	PBSC	_	NNS	NNS	_	23	nn	_	_
23	collection	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	9	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	appears	_	VBZ	VBZ	_	0	root	_	_
3	to	_	TO	TO	_	6	aux	_	_
4	be	_	VB	VB	_	6	cop	_	_
5	no	_	DT	DT	_	6	neg	_	_
6	relationship	_	NN	NN	_	2	nsubj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	number	_	NN	NN	_	7	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	AML1/ETO	_	NN	NN	_	12	nn	_	_
12	transcripts	_	NNS	NNS	_	10	pobj	_	_
13	found	_	VBN	VBN	_	12	vmod	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	infused	_	VBN	VBN	_	18	amod	_	_
17	PBSC	_	NNS	NNS	_	18	nn	_	_
18	harvests	_	NNS	NNS	_	14	pobj	_	_
19	and	_	CC	CC	_	9	cc	_	_
20	the	_	DT	DT	_	21	det	_	_
21	incidence	_	NN	NN	_	9	conj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	leukemic	_	JJ	JJ	_	24	amod	_	_
24	relapse	_	NN	NN	_	22	pobj	_	_
25	following	_	VBG	VBG	_	24	prep	_	_
26	autologous	_	JJ	JJ	_	27	amod	_	_
27	PBSCT	_	NNS	NNS	_	25	pobj	_	_
28	in	_	IN	IN	_	6	prep	_	_
29	our	_	PRP$	PRP$	_	30	poss	_	_
30	study	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	2	punct	_	_

1	However	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	a	_	DT	DT	_	5	det	_	_
4	substantial	_	JJ	JJ	_	5	amod	_	_
5	decrease	_	NN	NN	_	10	nsubjpass	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	AML1/ETO	_	NN	NN	_	8	nn	_	_
8	transcripts	_	NNS	NNS	_	6	pobj	_	_
9	was	_	VBD	VBD	_	10	auxpass	_	_
10	seen	_	VBN	VBN	_	0	root	_	_
11	following	_	VBG	VBG	_	10	prep	_	_
12	autologous	_	JJ	JJ	_	13	amod	_	_
13	PBSCT	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	10	punct	_	_

1	Thus	_	RB	RB	_	12	advmod	_	_
2	,	_	,	,	_	12	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	quantitative	_	JJ	JJ	_	5	amod	_	_
5	analysis	_	NN	NN	_	12	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	AML1/ETO	_	NN	NN	_	8	nn	_	_
8	transcripts	_	NNS	NNS	_	6	pobj	_	_
9	may	_	MD	MD	_	12	aux	_	_
10	be	_	VB	VB	_	12	cop	_	_
11	clinically	_	RB	RB	_	12	advmod	_	_
12	useful	_	JJ	JJ	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	patients	_	NNS	NNS	_	13	pobj	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	t-LRB-8;21-RRB-	_	NN	NN	_	17	nn	_	_
17	AML	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	12	punct	_	_

1	DNA	_	NN	NN	_	3	nn	_	_
2	methylation	_	NN	NN	_	3	nn	_	_
3	changes	_	NNS	NNS	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	hematologic	_	JJ	JJ	_	6	amod	_	_
6	malignancies	_	NNS	NNS	_	4	pobj	_	_
7	:	_	:	:	_	3	punct	_	_
8	biologic	_	JJ	JJ	_	3	dep	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	clinical	_	JJ	JJ	_	8	conj	_	_
11	implications	_	NNS	NNS	_	8	dep	_	_
12	.	_	.	.	_	3	punct	_	_

1	DNA	_	NN	NN	_	3	nn	_	_
2	methylation	_	NN	NN	_	3	nn	_	_
3	changes	_	NNS	NNS	_	4	nsubj	_	_
4	are	_	VBP	VBP	_	0	root	_	_
5	among	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	10	det	_	_
7	most	_	RBS	RBS	_	9	advmod	_	_
8	common	_	JJ	JJ	_	9	amod	_	_
9	detectable	_	JJ	JJ	_	10	amod	_	_
10	abnormalities	_	NNS	NNS	_	5	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	human	_	JJ	JJ	_	13	amod	_	_
13	neoplasia	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	4	punct	_	_

1	Hypermethylation	_	NN	NN	_	8	nsubj	_	_
2	within	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	promoters	_	NNS	NNS	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	selected	_	VBN	VBN	_	7	amod	_	_
7	genes	_	NNS	NNS	_	5	pobj	_	_
8	appears	_	VBZ	VBZ	_	0	root	_	_
9	to	_	TO	TO	_	12	aux	_	_
10	be	_	VB	VB	_	12	cop	_	_
11	especially	_	RB	RB	_	12	advmod	_	_
12	common	_	JJ	JJ	_	8	xcomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	all	_	DT	DT	_	15	det	_	_
15	types	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	human	_	JJ	JJ	_	19	amod	_	_
18	hematopoietic	_	JJ	JJ	_	19	amod	_	_
19	neoplasms	_	NNS	NNS	_	16	pobj	_	_
20	,	_	,	,	_	8	punct	_	_
21	and	_	CC	CC	_	8	cc	_	_
22	is	_	VBZ	VBZ	_	24	auxpass	_	_
23	usually	_	RB	RB	_	24	advmod	_	_
24	associated	_	VBN	VBN	_	8	conj	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	inactivation	_	NN	NN	_	25	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	32	det	_	_
29	involved	_	VBN	VBN	_	32	amod	_	_
30	gene	_	NN	NN	_	32	nn	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	s	_	NNS	NNS	_	27	pobj	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	.	_	.	.	_	8	punct	_	_

1	Such	_	JJ	JJ	_	3	amod	_	_
2	hypermethylation-associated	_	JJ	JJ	_	3	amod	_	_
3	silencing	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	gene	_	NN	NN	_	6	nn	_	_
6	expression	_	NN	NN	_	4	pobj	_	_
7	has	_	VBZ	VBZ	_	9	aux	_	_
8	been	_	VBN	VBN	_	9	auxpass	_	_
9	shown	_	VBN	VBN	_	0	root	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	several	_	JJ	JJ	_	12	amod	_	_
12	genes	_	NNS	NNS	_	10	pobj	_	_
13	regulating	_	VBG	VBG	_	12	vmod	_	_
14	the	_	DT	DT	_	15	dep	_	_
15	growth	_	NN	NN	_	13	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	differentiation	_	NN	NN	_	15	conj	_	_
18	of	_	IN	IN	_	15	prep	_	_
19	hematopoietic	_	JJ	JJ	_	20	amod	_	_
20	cells	_	NNS	NNS	_	18	pobj	_	_
21	,	_	,	,	_	20	punct	_	_
22	including	_	VBG	VBG	_	20	prep	_	_
23	the	_	DT	DT	_	29	det	_	_
24	estrogen	_	NN	NN	_	29	nn	_	_
25	receptor	_	NN	NN	_	29	nn	_	_
26	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
27	ER	_	NN	NN	_	29	nn	_	_
28	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
29	gene	_	NN	NN	_	22	pobj	_	_
30	,	_	,	,	_	29	punct	_	_
31	P15	_	NN	NN	_	29	conj	_	_
32	,	_	,	,	_	29	punct	_	_
33	P16	_	NN	NN	_	29	conj	_	_
34	and	_	CC	CC	_	29	cc	_	_
35	others	_	NNS	NNS	_	29	conj	_	_
36	.	_	.	.	_	9	punct	_	_

1	Hypermethylation	_	NN	NN	_	8	nsubj	_	_
2	within	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	4	det	_	_
4	promoters	_	NNS	NNS	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	some	_	DT	DT	_	7	det	_	_
7	genes	_	NNS	NNS	_	5	pobj	_	_
8	appear	_	VBP	VBP	_	0	root	_	_
9	to	_	TO	TO	_	13	aux	_	_
10	be	_	VB	VB	_	13	cop	_	_
11	an	_	DT	DT	_	13	det	_	_
12	early	_	JJ	JJ	_	13	amod	_	_
13	event	_	NN	NN	_	8	xcomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	pathogenesis	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	neoplasia	_	NN	NN	_	17	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	ER	_	NN	NN	_	18	dep	_	_
21	,	_	,	,	_	20	punct	_	_
22	P15	_	NN	NN	_	20	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
24	,	_	,	,	_	8	punct	_	_
25	while	_	IN	IN	_	28	mark	_	_
26	other	_	JJ	JJ	_	27	amod	_	_
27	genes	_	NNS	NNS	_	28	nsubj	_	_
28	seem	_	VBP	VBP	_	8	advcl	_	_
29	to	_	TO	TO	_	30	aux	_	_
30	become	_	VB	VB	_	28	xcomp	_	_
31	methylated	_	VBN	VBN	_	30	acomp	_	_
32	during	_	IN	IN	_	31	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	progression	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	leukemias	_	NNS	NNS	_	35	pobj	_	_
37	-LRB-	_	-LRB-	-LRB-	_	38	punct	_	_
38	HIC1	_	NN	NN	_	36	dep	_	_
39	,	_	,	,	_	38	punct	_	_
40	c-abl	_	NN	NN	_	38	appos	_	_
41	-RRB-	_	-RRB-	-RRB-	_	38	punct	_	_
42	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	high	_	JJ	JJ	_	3	amod	_	_
3	prevalence	_	NN	NN	_	7	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	promoter	_	NN	NN	_	6	nn	_	_
6	methylation	_	NN	NN	_	4	pobj	_	_
7	suggests	_	VBZ	VBZ	_	0	root	_	_
8	that	_	IN	IN	_	14	mark	_	_
9	this	_	DT	DT	_	11	det	_	_
10	molecular	_	JJ	JJ	_	11	amod	_	_
11	abnormality	_	NN	NN	_	14	nsubjpass	_	_
12	can	_	MD	MD	_	14	aux	_	_
13	be	_	VB	VB	_	14	auxpass	_	_
14	used	_	VBN	VBN	_	7	ccomp	_	_
15	to	_	TO	TO	_	16	aux	_	_
16	monitor	_	VB	VB	_	14	xcomp	_	_
17	disease	_	NN	NN	_	18	nn	_	_
18	activity	_	NN	NN	_	16	dobj	_	_
19	during	_	IN	IN	_	16	prep	_	_
20	therapy	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	new	_	JJ	JJ	_	5	amod	_	_
5	technology	_	NN	NN	_	6	nsubj	_	_
6	allows	_	VBZ	VBZ	_	0	root	_	_
7	the	_	DT	DT	_	9	det	_	_
8	sensitive	_	JJ	JJ	_	9	amod	_	_
9	identification	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	gene	_	NN	NN	_	12	nn	_	_
12	hypermethylation	_	NN	NN	_	10	pobj	_	_
13	in	_	IN	IN	_	9	prep	_	_
14	a	_	DT	DT	_	15	det	_	_
15	background	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	normal	_	JJ	JJ	_	18	amod	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	,	_	,	,	_	6	punct	_	_
20	suggesting	_	VBG	VBG	_	6	vmod	_	_
21	possible	_	JJ	JJ	_	23	amod	_	_
22	new	_	JJ	JJ	_	21	dep	_	_
23	strategies	_	NNS	NNS	_	20	dobj	_	_
24	for	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	detection	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	minimal	_	JJ	JJ	_	30	amod	_	_
29	residual	_	JJ	JJ	_	30	amod	_	_
30	disease	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	Finally	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	reactivation	_	NN	NN	_	18	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	tumor-suppressor	_	JJ	JJ	_	7	amod	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	expression	_	NN	NN	_	4	pobj	_	_
8	through	_	IN	IN	_	3	prep	_	_
9	pharmacologic	_	JJ	JJ	_	10	amod	_	_
10	inhibition	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	DNA	_	NN	NN	_	13	nn	_	_
13	methyltransferase	_	NN	NN	_	11	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	resultant	_	JJ	JJ	_	17	amod	_	_
16	DNA	_	NN	NN	_	17	nn	_	_
17	demethylation	_	NN	NN	_	13	conj	_	_
18	appears	_	VBZ	VBZ	_	0	root	_	_
19	to	_	TO	TO	_	24	aux	_	_
20	be	_	VB	VB	_	24	cop	_	_
21	a	_	DT	DT	_	24	det	_	_
22	promising	_	JJ	JJ	_	24	amod	_	_
23	new	_	JJ	JJ	_	22	dep	_	_
24	avenue	_	NN	NN	_	18	xcomp	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	therapy	_	NN	NN	_	25	pobj	_	_
27	in	_	IN	IN	_	24	prep	_	_
28	acute	_	JJ	JJ	_	29	amod	_	_
29	leukemia	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	18	punct	_	_

1	Transcriptional	_	JJ	JJ	_	2	amod	_	_
2	induction	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	collagenase-1	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	differentiated	_	VBN	VBN	_	11	amod	_	_
7	monocyte-like	_	JJ	JJ	_	11	amod	_	_
8	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
9	U937	_	NN	NN	_	11	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
11	cells	_	NNS	NNS	_	5	pobj	_	_
12	is	_	VBZ	VBZ	_	13	auxpass	_	_
13	regulated	_	VBN	VBN	_	0	root	_	_
14	by	_	IN	IN	_	13	prep	_	_
15	AP-1	_	NN	NN	_	14	pobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	an	_	DT	DT	_	20	det	_	_
18	upstream	_	JJ	JJ	_	20	amod	_	_
19	C/EBP-beta	_	NN	NN	_	20	nn	_	_
20	site	_	NN	NN	_	15	conj	_	_
21	.	_	.	.	_	13	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	report	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	6	punct	_	_
5	we	_	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	0	root	_	_
7	that	_	IN	IN	_	16	mark	_	_
8	the	_	DT	DT	_	10	det	_	_
9	AP-1	_	NN	NN	_	10	nn	_	_
10	site	_	NN	NN	_	16	nsubj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	a	_	DT	DT	_	15	det	_	_
13	distal	_	JJ	JJ	_	15	amod	_	_
14	promoter	_	NN	NN	_	15	nn	_	_
15	element	_	NN	NN	_	10	conj	_	_
16	regulate	_	VBP	VBP	_	6	ccomp	_	_
17	transcriptional	_	JJ	JJ	_	18	amod	_	_
18	induction	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	collagenase-1	_	NN	NN	_	19	pobj	_	_
21	during	_	IN	IN	_	16	prep	_	_
22	monocytic	_	JJ	JJ	_	23	amod	_	_
23	differentiation	_	NN	NN	_	21	pobj	_	_
24	.	_	.	.	_	6	punct	_	_

1	Chloramphenicol	_	NN	NN	_	4	nn	_	_
2	acetyltransferase	_	NN	NN	_	4	nn	_	_
3	expression	_	NN	NN	_	4	nn	_	_
4	constructs	_	NNS	NNS	_	16	nsubjpass	_	_
5	containing	_	VBG	VBG	_	4	vmod	_	_
6	regions	_	NNS	NNS	_	5	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	human	_	JJ	JJ	_	11	amod	_	_
10	collagenase-1	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	7	pobj	_	_
12	were	_	VBD	VBD	_	16	auxpass	_	_
13	stably	_	RB	RB	_	16	advmod	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	transiently	_	RB	RB	_	13	conj	_	_
16	transfected	_	VBN	VBN	_	0	root	_	_
17	into	_	IN	IN	_	16	prep	_	_
18	U937	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	17	pobj	_	_
20	,	_	,	,	_	16	punct	_	_
21	and	_	CC	CC	_	16	cc	_	_
22	reporter	_	NN	NN	_	23	nn	_	_
23	activity	_	NN	NN	_	25	nsubjpass	_	_
24	was	_	VBD	VBD	_	25	auxpass	_	_
25	assessed	_	VBN	VBN	_	16	conj	_	_
26	at	_	IN	IN	_	25	prep	_	_
27	various	_	JJ	JJ	_	28	amod	_	_
28	times	_	NNS	NNS	_	26	pobj	_	_
29	after	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	31	det	_	_
31	onset	_	NN	NN	_	29	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	phorbol	_	NN	NN	_	40	nn	_	_
34	12-myristate	_	NN	NN	_	40	nn	_	_
35	13-acetate	_	NN	NN	_	40	nn	_	_
36	-LRB-	_	-LRB-	-LRB-	_	40	punct	_	_
37	PMA	_	NN	NN	_	40	nn	_	_
38	-RRB-	_	-RRB-	-RRB-	_	40	punct	_	_
39	-mediated	_	JJ	JJ	_	40	amod	_	_
40	differentiation	_	NN	NN	_	32	pobj	_	_
41	.	_	.	.	_	16	punct	_	_

1	Rapid	_	JJ	JJ	_	4	amod	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	strong	_	JJ	JJ	_	1	conj	_	_
4	induction	_	NN	NN	_	9	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	promoter	_	NN	NN	_	7	nn	_	_
7	activity	_	NN	NN	_	5	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	lost	_	VBN	VBN	_	0	root	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	constructs	_	NNS	NNS	_	10	pobj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	a	_	DT	DT	_	16	det	_	_
14	mutant	_	JJ	JJ	_	16	amod	_	_
15	AP-1	_	NN	NN	_	16	nn	_	_
16	element	_	NN	NN	_	12	pobj	_	_
17	;	_	:	:	_	9	punct	_	_
18	however	_	RB	RB	_	29	advmod	_	_
19	,	_	,	,	_	29	punct	_	_
20	at	_	IN	IN	_	29	prep	_	_
21	16-96	_	CD	CD	_	22	num	_	_
22	h	_	NN	NN	_	23	amod	_	_
23	post-PMA	_	NN	NN	_	20	pobj	_	_
24	,	_	,	,	_	29	punct	_	_
25	the	_	DT	DT	_	28	det	_	_
26	mutant	_	JJ	JJ	_	28	amod	_	_
27	collagenase-1	_	NN	NN	_	28	nn	_	_
28	promoter	_	NN	NN	_	29	nsubj	_	_
29	displayed	_	VBD	VBD	_	9	parataxis	_	_
30	AP-1	_	NN	NN	_	31	npadvmod	_	_
31	independent	_	JJ	JJ	_	29	acomp	_	_
32	PMA-mediated	_	JJ	JJ	_	31	dep	_	_
33	transactivation	_	NN	NN	_	29	dep	_	_
34	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	AP-1	_	NN	NN	_	4	nn	_	_
3	mutant	_	JJ	JJ	_	4	amod	_	_
4	constructs	_	NNS	NNS	_	6	nsubj	_	_
5	also	_	RB	RB	_	6	advmod	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	delayed	_	VBN	VBN	_	9	amod	_	_
8	transcriptional	_	JJ	JJ	_	9	amod	_	_
9	activation	_	NN	NN	_	6	dobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	PMA-treated	_	JJ	JJ	_	12	amod	_	_
12	fibroblasts	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	6	punct	_	_

1	Western	_	NN	NN	_	5	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	supershift	_	NN	NN	_	1	conj	_	_
4	analyses	_	NNS	NNS	_	1	dep	_	_
5	indicated	_	VBD	VBD	_	0	root	_	_
6	that	_	IN	IN	_	13	mark	_	_
7	functional	_	JJ	JJ	_	8	amod	_	_
8	Jun	_	NN	NN	_	13	nsubj	_	_
9	and	_	CC	CC	_	8	cc	_	_
10	Fos	_	NN	NN	_	8	conj	_	_
11	proteins	_	NNS	NNS	_	8	dep	_	_
12	were	_	VBD	VBD	_	13	cop	_	_
13	present	_	JJ	JJ	_	5	ccomp	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	nuclear	_	JJ	JJ	_	16	amod	_	_
16	extracts	_	NNS	NNS	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	PMA-differentiated	_	JJ	JJ	_	20	amod	_	_
19	U937	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	.	_	.	.	_	5	punct	_	_

1	Promoter	_	NN	NN	_	3	nn	_	_
2	deletion	_	NN	NN	_	3	nn	_	_
3	constructs	_	NNS	NNS	_	4	nsubj	_	_
4	demonstrated	_	VBD	VBD	_	0	root	_	_
5	the	_	DT	DT	_	7	det	_	_
6	potential	_	JJ	JJ	_	7	amod	_	_
7	role	_	NN	NN	_	4	dobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	distal	_	JJ	JJ	_	11	amod	_	_
10	promoter	_	NN	NN	_	11	nn	_	_
11	sequences	_	NNS	NNS	_	8	pobj	_	_
12	in	_	IN	IN	_	7	prep	_	_
13	regulating	_	VBG	VBG	_	12	pcomp	_	_
14	collagenase-1	_	NN	NN	_	15	nn	_	_
15	transcription	_	NN	NN	_	13	dobj	_	_
16	.	_	.	.	_	4	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	Western	_	NN	NN	_	12	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	supershift	_	NN	NN	_	4	conj	_	_
7	,	_	,	,	_	4	punct	_	_
8	and	_	CC	CC	_	4	cc	_	_
9	promoter	_	NN	NN	_	10	nn	_	_
10	deletion	_	NN	NN	_	4	conj	_	_
11	analyses	_	NNS	NNS	_	4	dep	_	_
12	suggested	_	VBD	VBD	_	0	root	_	_
13	a	_	DT	DT	_	14	det	_	_
14	role	_	NN	NN	_	12	dobj	_	_
15	for	_	IN	IN	_	14	prep	_	_
16	CCAAT/enhancer-binding	_	JJ	JJ	_	22	amod	_	_
17	protein-beta	_	NN	NN	_	22	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
19	C/EBP-beta	_	NN	NN	_	22	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
21	binding	_	NN	NN	_	22	nn	_	_
22	site	_	NN	NN	_	15	pobj	_	_
23	between	_	IN	IN	_	22	prep	_	_
24	-2010	_	CD	CD	_	23	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	-1954	_	CD	CD	_	24	conj	_	_
27	in	_	IN	IN	_	14	prep	_	_
28	regulating	_	VBG	VBG	_	27	pcomp	_	_
29	transcription	_	NN	NN	_	28	dobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	collagenase-1	_	NN	NN	_	30	pobj	_	_
32	in	_	IN	IN	_	29	prep	_	_
33	monocytic	_	JJ	JJ	_	34	amod	_	_
34	cells	_	NNS	NNS	_	32	pobj	_	_
35	.	_	.	.	_	12	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	findings	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	16	mark	_	_
5	distinct	_	JJ	JJ	_	7	amod	_	_
6	regulatory	_	JJ	JJ	_	7	amod	_	_
7	elements	_	NNS	NNS	_	16	nsubj	_	_
8	,	_	,	,	_	7	punct	_	_
9	acting	_	VBG	VBG	_	7	vmod	_	_
10	somewhat	_	RB	RB	_	11	advmod	_	_
11	independently	_	RB	RB	_	9	advmod	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	each	_	DT	DT	_	14	det	_	_
14	other	_	JJ	JJ	_	12	pobj	_	_
15	,	_	,	,	_	7	punct	_	_
16	control	_	VBP	VBP	_	3	ccomp	_	_
17	expression	_	NN	NN	_	16	dobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	collagenase-1	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	our	_	PRP$	PRP$	_	5	poss	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	suggests	_	VBZ	VBZ	_	0	root	_	_
7	that	_	IN	IN	_	16	mark	_	_
8	the	_	DT	DT	_	11	det	_	_
9	rapid	_	JJ	JJ	_	11	amod	_	_
10	PMA-mediated	_	JJ	JJ	_	9	dep	_	_
11	induction	_	NN	NN	_	16	nsubjpass	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	collagenase-1	_	NN	NN	_	14	nn	_	_
14	transcription	_	NN	NN	_	12	pobj	_	_
15	is	_	VBZ	VBZ	_	16	auxpass	_	_
16	controlled	_	VBN	VBN	_	6	ccomp	_	_
17	by	_	IN	IN	_	16	prep	_	_
18	a	_	DT	DT	_	19	det	_	_
19	mechanism	_	NN	NN	_	17	pobj	_	_
20	distinct	_	JJ	JJ	_	19	amod	_	_
21	from	_	IN	IN	_	20	prep	_	_
22	that	_	DT	DT	_	21	pobj	_	_
23	regulating	_	VBG	VBG	_	22	vmod	_	_
24	the	_	DT	DT	_	26	det	_	_
25	sustained	_	JJ	JJ	_	26	amod	_	_
26	expression	_	NN	NN	_	23	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	this	_	DT	DT	_	29	det	_	_
29	proteinase	_	NN	NN	_	27	pobj	_	_
30	in	_	IN	IN	_	26	prep	_	_
31	activated	_	VBN	VBN	_	32	amod	_	_
32	macrophages	_	NNS	NNS	_	30	pobj	_	_
33	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	tumour	_	NN	NN	_	6	nn	_	_
3	associated	_	JJ	JJ	_	6	amod	_	_
4	cell	_	NN	NN	_	6	nn	_	_
5	surface	_	NN	NN	_	6	nn	_	_
6	antigen	_	NN	NN	_	9	nsubj	_	_
7	A6H	_	NN	NN	_	6	dep	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	costimulatory	_	JJ	JJ	_	0	root	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	CD4+	_	JJ	JJ	_	10	pobj	_	_
13	but	_	CC	CC	_	14	cc	_	_
14	not	_	RB	RB	_	12	cc	_	_
15	CD8+	_	JJ	JJ	_	12	conj	_	_
16	T	_	NN	NN	_	17	nn	_	_
17	cells	_	NNS	NNS	_	12	dep	_	_
18	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	A6H	_	NN	NN	_	4	nn	_	_
3	monoclonal	_	JJ	JJ	_	4	amod	_	_
4	antibody	_	NN	NN	_	8	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	mAb	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	recognizes	_	VBZ	VBZ	_	0	root	_	_
9	a	_	DT	DT	_	12	det	_	_
10	120,000-140,000	_	CD	CD	_	12	num	_	_
11	MW	_	NN	NN	_	12	nn	_	_
12	antigen	_	NN	NN	_	8	dobj	_	_
13	that	_	WDT	WDT	_	15	nsubjpass	_	_
14	is	_	VBZ	VBZ	_	15	auxpass	_	_
15	expressed	_	VBN	VBN	_	12	rcmod	_	_
16	at	_	IN	IN	_	15	prep	_	_
17	similar	_	JJ	JJ	_	18	amod	_	_
18	densities	_	NNS	NNS	_	16	pobj	_	_
19	on	_	IN	IN	_	15	prep	_	_
20	85-90	_	CD	CD	_	21	amod	_	_
21	%	_	NN	NN	_	19	pobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	human	_	JJ	JJ	_	24	amod	_	_
24	CD4+	_	JJ	JJ	_	22	pobj	_	_
25	and	_	CC	CC	_	24	cc	_	_
26	CD8+	_	JJ	JJ	_	24	conj	_	_
27	T	_	NN	NN	_	28	nn	_	_
28	cells	_	NNS	NNS	_	24	dep	_	_
29	and	_	CC	CC	_	19	cc	_	_
30	on	_	IN	IN	_	19	conj	_	_
31	renal	_	JJ	JJ	_	33	amod	_	_
32	cell	_	NN	NN	_	33	nn	_	_
33	carcinomas	_	NNS	NNS	_	30	pobj	_	_
34	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	binding	_	NN	NN	_	7	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	A6H	_	NN	NN	_	6	nn	_	_
6	mAb	_	NN	NN	_	3	pobj	_	_
7	induced	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	costimulatory	_	JJ	JJ	_	10	amod	_	_
10	signal	_	NN	NN	_	7	dobj	_	_
11	in	_	IN	IN	_	7	prep	_	_
12	anti-CD3	_	JJ	JJ	_	15	amod	_	_
13	activated	_	VBN	VBN	_	15	amod	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	11	pobj	_	_
16	.	_	.	.	_	7	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	present	_	JJ	JJ	_	4	amod	_	_
4	report	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	show	_	VBP	VBP	_	0	root	_	_
8	that	_	IN	IN	_	10	mark	_	_
9	A6H	_	NN	NN	_	10	nsubj	_	_
10	costimulated	_	VBD	VBD	_	7	ccomp	_	_
11	cell	_	NN	NN	_	12	nn	_	_
12	proliferation	_	NN	NN	_	10	dobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	cytokine	_	NN	NN	_	15	nn	_	_
15	production	_	NN	NN	_	12	conj	_	_
16	in	_	IN	IN	_	10	prep	_	_
17	purified	_	VBN	VBN	_	20	amod	_	_
18	CD4+	_	JJ	JJ	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	16	pobj	_	_
21	.	_	.	.	_	7	punct	_	_

1	Unexpectedly	_	RB	RB	_	7	advmod	_	_
2	,	_	,	,	_	7	punct	_	_
3	the	_	DT	DT	_	6	det	_	_
4	CD8+	_	JJ	JJ	_	6	amod	_	_
5	T-cell	_	NN	NN	_	6	nn	_	_
6	subpopulation	_	NN	NN	_	7	nsubj	_	_
7	failed	_	VBD	VBD	_	0	root	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	respond	_	VB	VB	_	7	xcomp	_	_
10	.	_	.	.	_	7	punct	_	_

1	CD4+	_	JJ	JJ	_	3	amod	_	_
2	T	_	NN	NN	_	3	nn	_	_
3	cells	_	NNS	NNS	_	9	nsubj	_	_
4	costimulated	_	VBN	VBN	_	3	vmod	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	A6H	_	NN	NN	_	8	nn	_	_
8	mAb	_	NN	NN	_	5	pobj	_	_
9	upregulated	_	VBD	VBD	_	0	root	_	_
10	CD80	_	NN	NN	_	9	dobj	_	_
11	,	_	,	,	_	10	punct	_	_
12	CD86	_	NN	NN	_	10	conj	_	_
13	,	_	,	,	_	10	punct	_	_
14	CD71	_	NN	NN	_	10	conj	_	_
15	,	_	,	,	_	10	punct	_	_
16	interleukin-2	_	NN	NN	_	21	nn	_	_
17	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
18	IL-2	_	NN	NN	_	21	nn	_	_
19	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
20	R	_	NN	NN	_	21	nn	_	_
21	alpha	_	NN	NN	_	10	conj	_	_
22	,	_	,	,	_	10	punct	_	_
23	IL-2R	_	NN	NN	_	24	nn	_	_
24	beta	_	NN	NN	_	10	conj	_	_
25	and	_	CC	CC	_	10	cc	_	_
26	IL-2R	_	NN	NN	_	27	nn	_	_
27	gamma	_	NN	NN	_	10	conj	_	_
28	,	_	,	,	_	9	punct	_	_
29	while	_	IN	IN	_	39	mark	_	_
30	no	_	DT	DT	_	32	neg	_	_
31	corresponding	_	JJ	JJ	_	32	amod	_	_
32	up-regulation	_	NN	NN	_	39	nsubjpass	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	these	_	DT	DT	_	37	det	_	_
35	cell	_	NN	NN	_	37	nn	_	_
36	surface	_	NN	NN	_	37	nn	_	_
37	molecules	_	NNS	NNS	_	33	pobj	_	_
38	was	_	VBD	VBD	_	39	auxpass	_	_
39	seen	_	VBN	VBN	_	9	advcl	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	CD8+	_	JJ	JJ	_	43	amod	_	_
42	T	_	NN	NN	_	43	nn	_	_
43	cells	_	NNS	NNS	_	40	pobj	_	_
44	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	4	mark	_	_
2	order	_	NN	NN	_	4	dep	_	_
3	to	_	TO	TO	_	4	aux	_	_
4	investigate	_	VB	VB	_	18	dep	_	_
5	the	_	DT	DT	_	6	det	_	_
6	nature	_	NN	NN	_	4	dobj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	A6H	_	NN	NN	_	10	nn	_	_
10	mAb	_	NN	NN	_	11	nn	_	_
11	costimulus	_	NN	NN	_	7	pobj	_	_
12	at	_	IN	IN	_	4	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	transcriptional	_	JJ	JJ	_	15	amod	_	_
15	level	_	NN	NN	_	12	pobj	_	_
16	we	_	PRP	PRP	_	18	nsubj	_	_
17	have	_	VBP	VBP	_	18	aux	_	_
18	examined	_	VBN	VBN	_	0	root	_	_
19	induction	_	NN	NN	_	18	dobj	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	23	det	_	_
22	transcription	_	NN	NN	_	23	nn	_	_
23	factors	_	NNS	NNS	_	20	pobj	_	_
24	OCT-1	_	NN	NN	_	23	dep	_	_
25	,	_	,	,	_	24	punct	_	_
26	AP-1	_	NN	NN	_	24	conj	_	_
27	and	_	CC	CC	_	24	cc	_	_
28	NF-kappa	_	NN	NN	_	29	nn	_	_
29	B	_	NN	NN	_	24	conj	_	_
30	which	_	WDT	WDT	_	32	nsubjpass	_	_
31	are	_	VBP	VBP	_	32	auxpass	_	_
32	known	_	VBN	VBN	_	23	rcmod	_	_
33	to	_	TO	TO	_	36	aux	_	_
34	be	_	VB	VB	_	36	cop	_	_
35	transcriptional	_	JJ	JJ	_	36	amod	_	_
36	regulators	_	NNS	NNS	_	32	xcomp	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	several	_	JJ	JJ	_	39	amod	_	_
39	cytokine	_	NN	NN	_	37	pobj	_	_
40	and	_	CC	CC	_	39	cc	_	_
41	cytokine	_	NN	NN	_	42	nn	_	_
42	receptor	_	NN	NN	_	39	conj	_	_
43	genes	_	NNS	NNS	_	39	dep	_	_
44	,	_	,	,	_	39	punct	_	_
45	including	_	VBG	VBG	_	39	prep	_	_
46	the	_	DT	DT	_	47	dep	_	_
47	IL-2	_	NN	NN	_	45	pobj	_	_
48	and	_	CC	CC	_	47	cc	_	_
49	IL-2R	_	NN	NN	_	47	conj	_	_
50	genes	_	NNS	NNS	_	47	dep	_	_
51	.	_	.	.	_	18	punct	_	_

1	Co-ligation	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	A6H	_	NN	NN	_	5	nn	_	_
5	antigen	_	NN	NN	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	the	_	DT	DT	_	9	det	_	_
8	CD3	_	NN	NN	_	9	nn	_	_
9	complex	_	NN	NN	_	5	conj	_	_
10	induced	_	VBD	VBD	_	0	root	_	_
11	expression	_	NN	NN	_	10	dobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	transcription	_	NN	NN	_	15	nn	_	_
15	factor	_	NN	NN	_	12	pobj	_	_
16	AP-1	_	NN	NN	_	15	dep	_	_
17	in	_	IN	IN	_	10	prep	_	_
18	CD4+	_	JJ	JJ	_	20	amod	_	_
19	T	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	17	pobj	_	_
21	,	_	,	,	_	10	punct	_	_
22	whereas	_	IN	IN	_	35	mark	_	_
23	no	_	DT	DT	_	24	neg	_	_
24	increase	_	NN	NN	_	35	nsubjpass	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	NF-kappa	_	NN	NN	_	27	nn	_	_
27	B	_	NN	NN	_	25	pobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	octamer-binding	_	JJ	JJ	_	33	amod	_	_
30	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
31	Oct	_	NN	NN	_	33	nn	_	_
32	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
33	proteins	_	NNS	NNS	_	27	conj	_	_
34	was	_	VBD	VBD	_	35	auxpass	_	_
35	seen	_	VBN	VBN	_	10	advcl	_	_
36	compared	_	VBN	VBN	_	35	prep	_	_
37	to	_	TO	TO	_	36	pcomp	_	_
38	T	_	NN	NN	_	39	nn	_	_
39	cells	_	NNS	NNS	_	37	pobj	_	_
40	stimulated	_	VBN	VBN	_	39	vmod	_	_
41	with	_	IN	IN	_	40	prep	_	_
42	anti-CD3	_	NN	NN	_	41	pobj	_	_
43	alone	_	RB	RB	_	42	advmod	_	_
44	.	_	.	.	_	10	punct	_	_

1	Furthermore	_	RB	RB	_	8	advmod	_	_
2	,	_	,	,	_	8	punct	_	_
3	no	_	DT	DT	_	4	neg	_	_
4	induction	_	NN	NN	_	8	nsubjpass	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	AP-1	_	NN	NN	_	5	pobj	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	seen	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	A6H	_	NN	NN	_	11	npadvmod	_	_
11	costimulated	_	JJ	JJ	_	14	amod	_	_
12	CD8+	_	JJ	JJ	_	14	amod	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	9	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggests	_	VBZ	VBZ	_	0	root	_	_
4	that	_	IN	IN	_	19	mark	_	_
5	both	_	CC	CC	_	7	dep	_	_
6	proximal	_	JJ	JJ	_	7	amod	_	_
7	steps	_	NNS	NNS	_	19	nsubj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	CD8+	_	JJ	JJ	_	11	amod	_	_
10	T-cell	_	NN	NN	_	11	nn	_	_
11	activation	_	NN	NN	_	8	pobj	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	7	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	the	_	DT	DT	_	17	det	_	_
16	later	_	JJ	JJ	_	17	amod	_	_
17	phases	_	NNS	NNS	_	7	conj	_	_
18	are	_	VBP	VBP	_	19	cop	_	_
19	unresponsive	_	JJ	JJ	_	3	ccomp	_	_
20	to	_	TO	TO	_	19	prep	_	_
21	A6H	_	NN	NN	_	22	nn	_	_
22	ligation	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	3	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	differences	_	NNS	NNS	_	18	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	A6H	_	NN	NN	_	6	nn	_	_
6	molecule	_	NN	NN	_	3	pobj	_	_
7	or	_	CC	CC	_	2	cc	_	_
8	distinct	_	JJ	JJ	_	9	amod	_	_
9	regulation	_	NN	NN	_	2	conj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	16	det	_	_
12	A6H	_	NN	NN	_	13	npadvmod	_	_
13	transduced	_	JJ	JJ	_	16	amod	_	_
14	AP-1	_	NN	NN	_	16	nn	_	_
15	activation	_	NN	NN	_	16	nn	_	_
16	pathway	_	NN	NN	_	10	pobj	_	_
17	may	_	MD	MD	_	18	aux	_	_
18	exist	_	VB	VB	_	0	root	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	CD4+	_	JJ	JJ	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	CD8+	_	JJ	JJ	_	20	conj	_	_
23	T	_	NN	NN	_	25	nn	_	_
24	cell	_	NN	NN	_	25	nn	_	_
25	subpopulations	_	NNS	NNS	_	20	dep	_	_
26	.	_	.	.	_	18	punct	_	_

1	Inhibitor	_	NN	NN	_	14	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IK	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	IFN-gamma	_	NN	NN	_	12	nn	_	_
7	induced	_	JJ	JJ	_	12	amod	_	_
8	HLA	_	NN	NN	_	11	nn	_	_
9	class	_	NN	NN	_	11	nn	_	_
10	II	_	CD	CD	_	11	num	_	_
11	antigens	_	NNS	NNS	_	12	nn	_	_
12	expression	_	NN	NN	_	5	pobj	_	_
13	also	_	RB	RB	_	14	advmod	_	_
14	inhibits	_	VBZ	VBZ	_	0	root	_	_
15	HLA	_	NN	NN	_	16	nn	_	_
16	class	_	NN	NN	_	19	nn	_	_
17	II	_	CD	CD	_	16	num	_	_
18	constitutive	_	JJ	JJ	_	19	amod	_	_
19	expression	_	NN	NN	_	14	dobj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	26	det	_	_
22	human	_	JJ	JJ	_	26	amod	_	_
23	Raji	_	NN	NN	_	26	nn	_	_
24	B	_	NN	NN	_	26	nn	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	line	_	NN	NN	_	20	pobj	_	_
27	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	14	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	major	_	JJ	JJ	_	12	amod	_	_
5	histocompatibility	_	NN	NN	_	12	nn	_	_
6	complex	_	NN	NN	_	12	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
8	MHC	_	NN	NN	_	12	nn	_	_
9	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
10	class	_	NN	NN	_	12	nn	_	_
11	II	_	CD	CD	_	12	num	_	_
12	antigens	_	NNS	NNS	_	3	pobj	_	_
13	is	_	VBZ	VBZ	_	14	cop	_	_
14	constitutive	_	JJ	JJ	_	0	root	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	professional	_	JJ	JJ	_	19	amod	_	_
17	antigen	_	NN	NN	_	19	nn	_	_
18	presenting	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	15	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	APCs	_	NNS	NNS	_	19	appos	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	but	_	CC	CC	_	14	cc	_	_
24	can	_	MD	MD	_	27	aux	_	_
25	also	_	RB	RB	_	27	advmod	_	_
26	be	_	VB	VB	_	27	auxpass	_	_
27	induced	_	VBN	VBN	_	14	conj	_	_
28	by	_	IN	IN	_	27	prep	_	_
29	interferon-gamma	_	NN	NN	_	28	pobj	_	_
30	-LRB-	_	-LRB-	-LRB-	_	31	punct	_	_
31	IFN-gamma	_	NN	NN	_	29	appos	_	_
32	-RRB-	_	-RRB-	-RRB-	_	31	punct	_	_
33	on	_	IN	IN	_	27	prep	_	_
34	the	_	DT	DT	_	35	det	_	_
35	majority	_	NN	NN	_	33	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	40	det	_	_
38	non	_	JJ	JJ	_	40	amod	_	_
39	professional	_	JJ	JJ	_	40	amod	_	_
40	APCs	_	NNS	NNS	_	36	pobj	_	_
41	-LRB-	_	-LRB-	-LRB-	_	43	punct	_	_
42	e.g.	_	FW	FW	_	43	prep	_	_
43	fibroblasts	_	NNS	NNS	_	40	appos	_	_
44	-RRB-	_	-RRB-	-RRB-	_	43	punct	_	_
45	.	_	.	.	_	14	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	characterised	_	VBN	VBN	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	new	_	JJ	JJ	_	7	amod	_	_
7	factor	_	NN	NN	_	4	dobj	_	_
8	called	_	VBN	VBN	_	7	vmod	_	_
9	IK	_	NN	NN	_	8	dep	_	_
10	which	_	WDT	WDT	_	14	nsubj	_	_
11	is	_	VBZ	VBZ	_	14	cop	_	_
12	an	_	DT	DT	_	14	det	_	_
13	efficient	_	JJ	JJ	_	14	amod	_	_
14	inhibitor	_	NN	NN	_	9	rcmod	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	IFN-gamma	_	NN	NN	_	17	nn	_	_
17	induction	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	MHC	_	NN	NN	_	22	nn	_	_
20	class	_	NN	NN	_	22	nn	_	_
21	II	_	CD	CD	_	22	num	_	_
22	antigens	_	NNS	NNS	_	23	nn	_	_
23	expression	_	NN	NN	_	18	pobj	_	_
24	.	_	.	.	_	4	punct	_	_

1	Here	_	RB	RB	_	4	advmod	_	_
2	,	_	,	,	_	4	punct	_	_
3	we	_	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	_	VBP	VBP	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	novel	_	JJ	JJ	_	7	amod	_	_
7	role	_	NN	NN	_	4	dobj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	IK	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	MHC	_	NN	NN	_	12	nn	_	_
12	class	_	NN	NN	_	14	nn	_	_
13	II	_	CD	CD	_	12	num	_	_
14	expression	_	NN	NN	_	10	pobj	_	_
15	since	_	IN	IN	_	27	mark	_	_
16	over-expression	_	NN	NN	_	27	nsubj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	this	_	DT	DT	_	19	det	_	_
19	protein	_	NN	NN	_	17	pobj	_	_
20	by	_	IN	IN	_	16	prep	_	_
21	stable	_	JJ	JJ	_	22	amod	_	_
22	transfection	_	NN	NN	_	20	pobj	_	_
23	into	_	IN	IN	_	22	prep	_	_
24	human	_	JJ	JJ	_	26	amod	_	_
25	B	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	23	pobj	_	_
27	led	_	VBD	VBD	_	4	advcl	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	a	_	DT	DT	_	31	det	_	_
30	total	_	JJ	JJ	_	31	amod	_	_
31	disappearance	_	NN	NN	_	28	pobj	_	_
32	of	_	IN	IN	_	31	prep	_	_
33	constitutive	_	JJ	JJ	_	38	amod	_	_
34	MHC	_	NN	NN	_	37	nn	_	_
35	class	_	NN	NN	_	37	nn	_	_
36	II	_	CD	CD	_	37	num	_	_
37	mRNA	_	NN	NN	_	38	nn	_	_
38	expression	_	NN	NN	_	32	pobj	_	_
39	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	class	_	NN	NN	_	4	nn	_	_
3	II	_	CD	CD	_	4	num	_	_
4	transactivator	_	NN	NN	_	9	nsubj	_	_
5	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
6	CIITA	_	NN	NN	_	4	appos	_	_
7	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	necessary	_	JJ	JJ	_	0	root	_	_
10	for	_	IN	IN	_	9	prep	_	_
11	both	_	CC	CC	_	12	preconj	_	_
12	constitutive	_	JJ	JJ	_	10	pobj	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	IFN-gamma	_	NN	NN	_	12	conj	_	_
15	induced	_	JJ	JJ	_	14	amod	_	_
16	MHC	_	NN	NN	_	17	nn	_	_
17	class	_	NN	NN	_	19	nn	_	_
18	II	_	CD	CD	_	17	num	_	_
19	expressions	_	NNS	NNS	_	12	dep	_	_
20	.	_	.	.	_	9	punct	_	_

1	Examination	_	NN	NN	_	10	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CIITA	_	NN	NN	_	4	nn	_	_
4	mRNA	_	NN	NN	_	2	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	IK	_	NN	NN	_	9	nn	_	_
7	stably	_	RB	RB	_	9	advmod	_	_
8	transfected	_	VBN	VBN	_	9	amod	_	_
9	clones	_	NNS	NNS	_	5	pobj	_	_
10	revealed	_	VBD	VBD	_	0	root	_	_
11	a	_	DT	DT	_	13	det	_	_
12	marked	_	JJ	JJ	_	13	amod	_	_
13	reduction	_	NN	NN	_	10	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	CIITA	_	NN	NN	_	16	nn	_	_
16	mRNA	_	NN	NN	_	17	nn	_	_
17	transcription	_	NN	NN	_	14	pobj	_	_
18	.	_	.	.	_	10	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	1	parataxis	_	_
6	that	_	IN	IN	_	10	mark	_	_
7	the	_	DT	DT	_	9	det	_	_
8	IK	_	NN	NN	_	9	nn	_	_
9	protein	_	NN	NN	_	10	nsubj	_	_
10	plays	_	VBZ	VBZ	_	5	ccomp	_	_
11	a	_	DT	DT	_	13	det	_	_
12	key	_	JJ	JJ	_	13	amod	_	_
13	role	_	NN	NN	_	10	dobj	_	_
14	in	_	IN	IN	_	10	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	constitutive	_	JJ	JJ	_	17	amod	_	_
17	expression	_	NN	NN	_	14	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	MHC	_	NN	NN	_	22	nn	_	_
20	class	_	NN	NN	_	22	nn	_	_
21	II	_	CD	CD	_	22	num	_	_
22	antigens	_	NNS	NNS	_	18	pobj	_	_
23	and	_	CC	CC	_	10	cc	_	_
24	that	_	IN	IN	_	29	mark	_	_
25	inhibition	_	NN	NN	_	29	nsubj	_	_
26	induced	_	VBN	VBN	_	25	vmod	_	_
27	by	_	IN	IN	_	26	prep	_	_
28	IK	_	NN	NN	_	27	pobj	_	_
29	is	_	VBZ	VBZ	_	10	conj	_	_
30	upstream	_	JJ	JJ	_	29	advmod	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	CIITA	_	NN	NN	_	31	pobj	_	_
33	in	_	IN	IN	_	29	prep	_	_
34	this	_	DT	DT	_	36	det	_	_
35	regulatory	_	JJ	JJ	_	36	amod	_	_
36	pathway	_	NN	NN	_	33	pobj	_	_
37	.	_	.	.	_	1	punct	_	_

1	Molecular	_	JJ	JJ	_	2	amod	_	_
2	actions	_	NNS	NNS	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	prolactin	_	NN	NN	_	3	pobj	_	_
5	in	_	IN	IN	_	2	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	immune	_	JJ	JJ	_	8	amod	_	_
8	system	_	NN	NN	_	5	pobj	_	_
9	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	immunoregulatory	_	JJ	JJ	_	3	nn	_	_
3	properties	_	NNS	NNS	_	13	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	prolactin	_	NN	NN	_	4	pobj	_	_
6	,	_	,	,	_	5	punct	_	_
7	a	_	DT	DT	_	10	det	_	_
8	pituitary	_	JJ	JJ	_	10	amod	_	_
9	peptide	_	NN	NN	_	10	nn	_	_
10	hormone	_	NN	NN	_	5	appos	_	_
11	,	_	,	,	_	3	punct	_	_
12	have	_	VBP	VBP	_	13	aux	_	_
13	received	_	VBN	VBN	_	0	root	_	_
14	renewed	_	JJ	JJ	_	15	amod	_	_
15	attention	_	NN	NN	_	13	dobj	_	_
16	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	prolactin	_	NN	NN	_	3	nn	_	_
3	receptor	_	NN	NN	_	15	nsubjpass	_	_
4	,	_	,	,	_	3	punct	_	_
5	a	_	DT	DT	_	6	det	_	_
6	member	_	NN	NN	_	3	appos	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	hematopoietin/cytokine	_	NN	NN	_	11	nn	_	_
10	receptor	_	NN	NN	_	11	nn	_	_
11	superfamily	_	NN	NN	_	7	pobj	_	_
12	,	_	,	,	_	3	punct	_	_
13	is	_	VBZ	VBZ	_	15	auxpass	_	_
14	ubiquitously	_	RB	RB	_	15	advmod	_	_
15	expressed	_	VBN	VBN	_	0	root	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	cells	_	NNS	NNS	_	16	pobj	_	_
18	in	_	IN	IN	_	15	prep	_	_
19	the	_	DT	DT	_	21	det	_	_
20	immune	_	JJ	JJ	_	21	amod	_	_
21	system	_	NN	NN	_	18	pobj	_	_
22	.	_	.	.	_	15	punct	_	_

1	Certain	_	JJ	JJ	_	2	amod	_	_
2	subpopulations	_	NNS	NNS	_	5	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	lymphocytes	_	NNS	NNS	_	3	pobj	_	_
5	synthesize	_	VBP	VBP	_	0	root	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	secrete	_	VBP	VBP	_	5	conj	_	_
8	biologically	_	RB	RB	_	9	advmod	_	_
9	active	_	JJ	JJ	_	10	amod	_	_
10	prolactin	_	NN	NN	_	5	dobj	_	_
11	,	_	,	,	_	5	punct	_	_
12	which	_	WDT	WDT	_	13	nsubj	_	_
13	suggests	_	VBZ	VBZ	_	5	dep	_	_
14	that	_	IN	IN	_	17	mark	_	_
15	prolactin	_	NN	NN	_	17	nsubj	_	_
16	can	_	MD	MD	_	17	aux	_	_
17	act	_	VB	VB	_	13	ccomp	_	_
18	as	_	IN	IN	_	17	prep	_	_
19	an	_	DT	DT	_	23	det	_	_
20	autocrine	_	NN	NN	_	23	amod	_	_
21	and/or	_	CC	CC	_	20	cc	_	_
22	paracrine	_	NN	NN	_	20	conj	_	_
23	factor	_	NN	NN	_	18	pobj	_	_
24	to	_	TO	TO	_	25	aux	_	_
25	modulate	_	VB	VB	_	17	xcomp	_	_
26	the	_	DT	DT	_	27	det	_	_
27	activities	_	NNS	NNS	_	25	dobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	cells	_	NNS	NNS	_	28	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	immune	_	JJ	JJ	_	33	amod	_	_
33	system	_	NN	NN	_	30	pobj	_	_
34	.	_	.	.	_	5	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	review	_	NN	NN	_	3	nsubj	_	_
3	focuses	_	VBZ	VBZ	_	0	root	_	_
4	on	_	IN	IN	_	3	prep	_	_
5	the	_	DT	DT	_	7	det	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	actions	_	NNS	NNS	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	prolactin	_	NN	NN	_	8	pobj	_	_
10	in	_	IN	IN	_	7	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	immune	_	JJ	JJ	_	13	amod	_	_
13	system	_	NN	NN	_	10	pobj	_	_
14	.	_	.	.	_	3	punct	_	_

1	Emphasis	_	NN	NN	_	3	nsubjpass	_	_
2	is	_	VBZ	VBZ	_	3	auxpass	_	_
3	given	_	VBN	VBN	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	recent	_	JJ	JJ	_	6	amod	_	_
6	information	_	NN	NN	_	4	pobj	_	_
7	about	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	10	det	_	_
9	molecular	_	JJ	JJ	_	10	amod	_	_
10	mechanisms	_	NNS	NNS	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	prolactin	_	NN	NN	_	15	nn	_	_
13	receptor	_	NN	NN	_	15	nn	_	_
14	signal	_	NN	NN	_	15	nn	_	_
15	transduction	_	NN	NN	_	11	pobj	_	_
16	,	_	,	,	_	10	punct	_	_
17	and	_	CC	CC	_	10	cc	_	_
18	the	_	DT	DT	_	20	det	_	_
19	signaling	_	VBG	VBG	_	20	amod	_	_
20	molecules	_	NNS	NNS	_	10	conj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	prolactin-inducible	_	JJ	JJ	_	24	amod	_	_
23	target	_	NN	NN	_	24	nn	_	_
24	genes	_	NNS	NNS	_	20	conj	_	_
25	that	_	WDT	WDT	_	26	nsubj	_	_
26	participate	_	VBP	VBP	_	20	rcmod	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	these	_	DT	DT	_	29	det	_	_
29	responses	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	9	prep	_	_
2	particular	_	JJ	JJ	_	1	pobj	_	_
3	,	_	,	,	_	9	punct	_	_
4	the	_	DT	DT	_	9	det	_	_
5	prolactin-inducible	_	JJ	JJ	_	9	amod	_	_
6	interferon	_	NN	NN	_	9	nn	_	_
7	regulatory	_	JJ	JJ	_	9	amod	_	_
8	factor-1	_	NN	NN	_	9	nn	_	_
9	gene	_	NN	NN	_	0	root	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	its	_	PRP$	PRP$	_	12	poss	_	_
12	roles	_	NNS	NNS	_	9	conj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	mediating	_	VBG	VBG	_	13	pcomp	_	_
15	diverse	_	JJ	JJ	_	17	amod	_	_
16	immune	_	JJ	JJ	_	15	dep	_	_
17	responses	_	NNS	NNS	_	14	dobj	_	_
18	.	_	.	.	_	9	punct	_	_

1	Spontaneous	_	JJ	JJ	_	2	amod	_	_
2	occurrence	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	early	_	JJ	JJ	_	8	amod	_	_
5	region	_	NN	NN	_	8	nn	_	_
6	1A	_	NN	NN	_	8	nn	_	_
7	reiteration	_	NN	NN	_	8	nn	_	_
8	mutants	_	NNS	NNS	_	3	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	type	_	NN	NN	_	12	nn	_	_
11	5	_	CD	CD	_	12	num	_	_
12	adenovirus	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	2	prep	_	_
14	persistently	_	RB	RB	_	17	advmod	_	_
15	infected	_	JJ	JJ	_	17	amod	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	T-lymphocytes	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Mutants	_	NNS	NNS	_	17	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	type	_	NN	NN	_	5	nn	_	_
4	5	_	CD	CD	_	5	num	_	_
5	adenovirus	_	NN	NN	_	2	pobj	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	Ad5	_	NN	NN	_	5	appos	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	with	_	IN	IN	_	1	prep	_	_
10	reiterated	_	VBN	VBN	_	12	amod	_	_
11	DNA	_	NN	NN	_	12	nn	_	_
12	sequences	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	E1a	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	13	pobj	_	_
17	appeared	_	VBD	VBD	_	0	root	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	a	_	DT	DT	_	23	det	_	_
20	human	_	JJ	JJ	_	23	amod	_	_
21	T-lymphocyte	_	NN	NN	_	23	nn	_	_
22	cell	_	NN	NN	_	23	nn	_	_
23	line	_	NN	NN	_	18	pobj	_	_
24	,	_	,	,	_	23	punct	_	_
25	Molt-4	_	NN	NN	_	23	appos	_	_
26	,	_	,	,	_	23	punct	_	_
27	persistently	_	RB	RB	_	28	advmod	_	_
28	infected	_	VBN	VBN	_	23	vmod	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	H5sub304	_	NN	NN	_	29	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	a	_	DT	DT	_	34	det	_	_
33	deletion/substitution	_	NN	NN	_	34	nn	_	_
34	mutant	_	NN	NN	_	30	appos	_	_
35	that	_	WDT	WDT	_	36	nsubj	_	_
36	has	_	VBZ	VBZ	_	34	rcmod	_	_
37	a	_	DT	DT	_	39	det	_	_
38	wild-type	_	JJ	JJ	_	39	amod	_	_
39	phenotype	_	NN	NN	_	36	dobj	_	_
40	in	_	IN	IN	_	36	prep	_	_
41	viral	_	JJ	JJ	_	42	amod	_	_
42	replication	_	NN	NN	_	40	pobj	_	_
43	.	_	.	.	_	17	punct	_	_

1	Endonuclease	_	NN	NN	_	2	nn	_	_
2	analyses	_	NNS	NNS	_	6	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	DNA	_	NN	NN	_	5	nn	_	_
5	sequencing	_	NN	NN	_	2	conj	_	_
6	revealed	_	VBD	VBD	_	0	root	_	_
7	DNA	_	NN	NN	_	8	nn	_	_
8	reiteration	_	NN	NN	_	6	dobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	each	_	DT	DT	_	11	det	_	_
11	mutant	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	four	_	CD	CD	_	5	num	_	_
4	representative	_	JJ	JJ	_	5	amod	_	_
5	mutants	_	NNS	NNS	_	1	pobj	_	_
6	investigated	_	VBN	VBN	_	5	vmod	_	_
7	,	_	,	,	_	12	punct	_	_
8	the	_	DT	DT	_	10	det	_	_
9	DNA	_	NN	NN	_	10	nn	_	_
10	reiterations	_	NNS	NNS	_	12	nsubj	_	_
11	all	_	DT	DT	_	12	advmod	_	_
12	started	_	VBD	VBD	_	0	root	_	_
13	within	_	IN	IN	_	12	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	six-base-pair	_	JJ	JJ	_	17	amod	_	_
16	consensus	_	NN	NN	_	17	nn	_	_
17	sequence	_	NN	NN	_	13	pobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	G	_	NN	NN	_	17	appos	_	_
20	-LRB-	_	-LRB-	-LRB-	_	22	punct	_	_
21	or	_	CC	CC	_	22	cc	_	_
22	C	_	NN	NN	_	19	appos	_	_
23	-RRB-	_	-RRB-	-RRB-	_	22	punct	_	_
24	CTGTG	_	NN	NN	_	19	dep	_	_
25	,	_	,	,	_	17	punct	_	_
26	located	_	JJ	JJ	_	17	amod	_	_
27	in	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	second	_	JJ	JJ	_	30	amod	_	_
30	exon	_	NN	NN	_	27	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	34	det	_	_
33	E1a	_	NN	NN	_	34	nn	_	_
34	region	_	NN	NN	_	31	pobj	_	_
35	-LRB-	_	-LRB-	-LRB-	_	36	punct	_	_
36	at	_	IN	IN	_	34	prep	_	_
37	nt	_	NN	NN	_	36	pobj	_	_
38	1333	_	CD	CD	_	37	dep	_	_
39	,	_	,	,	_	37	punct	_	_
40	1367	_	CD	CD	_	37	conj	_	_
41	,	_	,	,	_	37	punct	_	_
42	or	_	CC	CC	_	37	cc	_	_
43	1419	_	CD	CD	_	37	conj	_	_
44	-RRB-	_	-RRB-	-RRB-	_	36	punct	_	_
45	.	_	.	.	_	12	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	not	_	RB	RB	_	2	neg	_	_
4	any	_	DT	DT	_	6	det	_	_
5	DNA	_	NN	NN	_	6	nn	_	_
6	homology	_	NN	NN	_	2	nsubj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	9	det	_	_
9	breakpoints	_	NNS	NNS	_	7	pobj	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	second	_	JJ	JJ	_	13	amod	_	_
13	exon	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	9	cc	_	_
15	the	_	DT	DT	_	17	det	_	_
16	inserting	_	JJ	JJ	_	17	amod	_	_
17	sequences	_	NNS	NNS	_	9	conj	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	starting	_	VBG	VBG	_	17	dep	_	_
20	at	_	IN	IN	_	19	prep	_	_
21	nt	_	NN	NN	_	20	pobj	_	_
22	532	_	CD	CD	_	21	dep	_	_
23	,	_	,	,	_	21	punct	_	_
24	710	_	CD	CD	_	21	conj	_	_
25	,	_	,	,	_	21	punct	_	_
26	or	_	CC	CC	_	21	cc	_	_
27	792	_	CD	CD	_	21	conj	_	_
28	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
29	.	_	.	.	_	2	punct	_	_

1	Northern	_	NN	NN	_	2	nn	_	_
2	analyses	_	NNS	NNS	_	3	nsubj	_	_
3	suggested	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	15	mark	_	_
5	the	_	DT	DT	_	8	det	_	_
6	reiterated	_	VBN	VBN	_	8	amod	_	_
7	splicing	_	NN	NN	_	8	nn	_	_
8	sites	_	NNS	NNS	_	15	nsubjpass	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	representative	_	JJ	JJ	_	12	amod	_	_
12	mutants	_	NNS	NNS	_	9	pobj	_	_
13	were	_	VBD	VBD	_	15	auxpass	_	_
14	all	_	DT	DT	_	15	advmod	_	_
15	used	_	VBN	VBN	_	3	dep	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	RNA	_	NN	NN	_	18	nn	_	_
18	splicing	_	NN	NN	_	16	pobj	_	_
19	,	_	,	,	_	15	punct	_	_
20	and	_	CC	CC	_	15	cc	_	_
21	the	_	DT	DT	_	26	det	_	_
22	closest	_	JJS	JJS	_	26	amod	_	_
23	donor	_	NN	NN	_	26	nn	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	recipient	_	NN	NN	_	23	conj	_	_
26	joints	_	NNS	NNS	_	28	nsubjpass	_	_
27	were	_	VBD	VBD	_	28	auxpass	_	_
28	used	_	VBN	VBN	_	15	conj	_	_
29	most	_	RBS	RBS	_	30	advmod	_	_
30	frequently	_	RB	RB	_	28	advmod	_	_
31	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	imply	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	during	_	IN	IN	_	9	prep	_	_
6	persistent	_	JJ	JJ	_	7	amod	_	_
7	infection	_	NN	NN	_	5	pobj	_	_
8	Ad5	_	NN	NN	_	9	nsubj	_	_
9	underwent	_	VBD	VBD	_	3	ccomp	_	_
10	spontaneous	_	JJ	JJ	_	11	amod	_	_
11	mutations	_	NNS	NNS	_	9	dobj	_	_
12	by	_	IN	IN	_	9	prep	_	_
13	sequence-specific	_	JJ	JJ	_	14	amod	_	_
14	breakage	_	NN	NN	_	12	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	nonhomologous	_	JJ	JJ	_	20	amod	_	_
17	end-end	_	JJ	JJ	_	20	amod	_	_
18	joining	_	NN	NN	_	20	nn	_	_
19	recombination	_	NN	NN	_	20	nn	_	_
20	events	_	NNS	NNS	_	14	conj	_	_
21	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	4	det	_	_
2	E1a	_	NN	NN	_	4	nn	_	_
3	reiteration	_	NN	NN	_	4	nn	_	_
4	mutants	_	NNS	NNS	_	7	nsubjpass	_	_
5	could	_	MD	MD	_	7	aux	_	_
6	be	_	VB	VB	_	7	auxpass	_	_
7	propagated	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	HeLa	_	NN	NN	_	8	pobj	_	_
10	,	_	,	,	_	9	punct	_	_
11	A549	_	NN	NN	_	9	conj	_	_
12	,	_	,	,	_	9	punct	_	_
13	and	_	CC	CC	_	9	cc	_	_
14	KB	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	9	conj	_	_
16	;	_	:	:	_	7	punct	_	_
17	they	_	PRP	PRP	_	20	nsubj	_	_
18	were	_	VBD	VBD	_	20	cop	_	_
19	genetically	_	RB	RB	_	20	advmod	_	_
20	stable	_	JJ	JJ	_	7	parataxis	_	_
21	;	_	:	:	_	20	punct	_	_
22	and	_	CC	CC	_	20	cc	_	_
23	they	_	PRP	PRP	_	24	nsubj	_	_
24	killed	_	VBD	VBD	_	20	conj	_	_
25	CREF	_	NN	NN	_	26	nn	_	_
26	cells	_	NNS	NNS	_	24	dobj	_	_
27	at	_	IN	IN	_	24	prep	_	_
28	a	_	DT	DT	_	31	det	_	_
29	strikingly	_	RB	RB	_	30	advmod	_	_
30	high	_	JJ	JJ	_	31	amod	_	_
31	frequency	_	NN	NN	_	27	pobj	_	_
32	.	_	.	.	_	7	punct	_	_

1	Preliminary	_	JJ	JJ	_	2	amod	_	_
2	observations	_	NNS	NNS	_	3	nsubj	_	_
3	tend	_	VBP	VBP	_	0	root	_	_
4	to	_	TO	TO	_	5	aux	_	_
5	correlate	_	VB	VB	_	3	xcomp	_	_
6	this	_	DT	DT	_	9	det	_	_
7	CREF	_	NN	NN	_	9	nn	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	killing	_	NN	NN	_	5	dobj	_	_
10	with	_	IN	IN	_	5	prep	_	_
11	the	_	DT	DT	_	12	det	_	_
12	accumulation	_	NN	NN	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	early	_	JJ	JJ	_	17	amod	_	_
16	viral	_	JJ	JJ	_	17	amod	_	_
17	proteins	_	NNS	NNS	_	13	pobj	_	_
18	and/or	_	CC	CC	_	17	cc	_	_
19	viral	_	JJ	JJ	_	20	amod	_	_
20	DNA	_	NN	NN	_	17	conj	_	_
21	in	_	IN	IN	_	12	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	infected	_	JJ	JJ	_	24	amod	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	degree	_	NN	NN	_	8	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cell	_	NN	NN	_	5	nn	_	_
5	damage	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	observed	_	VBN	VBN	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	Ad5wt	_	NN	NN	_	9	pobj	_	_
11	or	_	CC	CC	_	10	cc	_	_
12	H5sub304	_	NN	NN	_	10	conj	_	_
13	infection	_	NN	NN	_	10	dep	_	_
14	of	_	IN	IN	_	10	prep	_	_
15	CREF	_	NN	NN	_	16	nn	_	_
16	cells	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	8	punct	_	_

1	The	_	DT	DT	_	4	det	_	_
2	observed	_	VBN	VBN	_	4	amod	_	_
3	E1a	_	NN	NN	_	4	nn	_	_
4	reiterations	_	NNS	NNS	_	5	nsubj	_	_
5	provide	_	VBP	VBP	_	0	root	_	_
6	a	_	DT	DT	_	7	det	_	_
7	model	_	NN	NN	_	5	dobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	gain	_	VB	VB	_	7	vmod	_	_
10	insight	_	NN	NN	_	9	dobj	_	_
11	into	_	IN	IN	_	10	prep	_	_
12	understanding	_	VBG	VBG	_	11	pcomp	_	_
13	the	_	DT	DT	_	15	det	_	_
14	evolutionary	_	JJ	JJ	_	15	amod	_	_
15	events	_	NNS	NNS	_	12	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	some	_	DT	DT	_	24	det	_	_
18	,	_	,	,	_	24	punct	_	_
19	if	_	IN	IN	_	20	mark	_	_
20	not	_	RB	RB	_	24	ccomp	_	_
21	all	_	DT	DT	_	20	dep	_	_
22	,	_	,	,	_	24	punct	_	_
23	adenovirus	_	NN	NN	_	24	dep	_	_
24	types	_	NNS	NNS	_	16	pobj	_	_
25	during	_	IN	IN	_	15	prep	_	_
26	many	_	JJ	JJ	_	27	amod	_	_
27	years	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	symbiotic	_	JJ	JJ	_	32	amod	_	_
30	,	_	,	,	_	29	punct	_	_
31	persistent	_	JJ	JJ	_	29	dep	_	_
32	relationship	_	NN	NN	_	28	pobj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	human	_	JJ	JJ	_	35	amod	_	_
35	tonsils	_	NNS	NNS	_	33	pobj	_	_
36	and	_	CC	CC	_	35	cc	_	_
37	adenoids	_	NNS	NNS	_	35	conj	_	_
38	and	_	CC	CC	_	35	cc	_	_
39	possibly	_	RB	RB	_	41	advmod	_	_
40	other	_	JJ	JJ	_	41	amod	_	_
41	lymphoid	_	JJ	JJ	_	42	amod	_	_
42	organs	_	NNS	NNS	_	35	conj	_	_
43	.	_	.	.	_	5	punct	_	_

1	Quantification	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	vitamin	_	NN	NN	_	6	nn	_	_
4	D	_	NN	NN	_	6	nn	_	_
5	receptor	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	2	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	competitive	_	JJ	JJ	_	11	amod	_	_
9	polymerase	_	NN	NN	_	11	nn	_	_
10	chain	_	NN	NN	_	11	nn	_	_
11	reaction	_	NN	NN	_	7	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	PBMC	_	NN	NN	_	12	pobj	_	_
14	:	_	:	:	_	1	punct	_	_
15	lack	_	NN	NN	_	1	dep	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	correspondence	_	NN	NN	_	16	pobj	_	_
18	with	_	IN	IN	_	17	prep	_	_
19	common	_	JJ	JJ	_	21	amod	_	_
20	allelic	_	JJ	JJ	_	21	amod	_	_
21	variants	_	NNS	NNS	_	18	pobj	_	_
22	.	_	.	.	_	1	punct	_	_

1	It	_	PRP	PRP	_	5	nsubjpass	_	_
2	has	_	VBZ	VBZ	_	5	aux	_	_
3	been	_	VBN	VBN	_	5	auxpass	_	_
4	recently	_	RB	RB	_	5	advmod	_	_
5	claimed	_	VBN	VBN	_	0	root	_	_
6	that	_	IN	IN	_	16	mark	_	_
7	polymorphism	_	NN	NN	_	16	nsubj	_	_
8	for	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	vitamin	_	NN	NN	_	12	nn	_	_
11	D	_	NN	NN	_	12	nn	_	_
12	receptor	_	NN	NN	_	8	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	VDR	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	influences	_	VBZ	VBZ	_	5	ccomp	_	_
17	several	_	JJ	JJ	_	18	amod	_	_
18	aspects	_	NNS	NNS	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	calcium	_	NN	NN	_	19	pobj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	bone	_	NN	NN	_	20	conj	_	_
23	metabolism	_	NN	NN	_	20	dep	_	_
24	.	_	.	.	_	5	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	evaluate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	5	det	_	_
4	physiologic	_	JJ	JJ	_	5	amod	_	_
5	plausibility	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	these	_	DT	DT	_	8	det	_	_
8	claims	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	2	punct	_	_
10	we	_	PRP	PRP	_	11	nsubj	_	_
11	compared	_	VBD	VBD	_	2	parataxis	_	_
12	the	_	DT	DT	_	13	det	_	_
13	abundance	_	NN	NN	_	11	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	VDR	_	NN	NN	_	17	nn	_	_
17	mRNA	_	NN	NN	_	14	pobj	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	peripheral	_	JJ	JJ	_	22	amod	_	_
20	blood	_	NN	NN	_	22	nn	_	_
21	mononuclear	_	JJ	JJ	_	22	amod	_	_
22	cells	_	NNS	NNS	_	18	pobj	_	_
23	-LRB-	_	-LRB-	-LRB-	_	24	punct	_	_
24	PBMCs	_	NNS	NNS	_	22	appos	_	_
25	-RRB-	_	-RRB-	-RRB-	_	24	punct	_	_
26	between	_	IN	IN	_	11	prep	_	_
27	different	_	JJ	JJ	_	29	amod	_	_
28	VDR	_	NN	NN	_	29	nn	_	_
29	genotypes	_	NNS	NNS	_	26	pobj	_	_
30	using	_	VBG	VBG	_	11	xcomp	_	_
31	a	_	DT	DT	_	38	det	_	_
32	quantitative	_	JJ	JJ	_	38	amod	_	_
33	reverse	_	JJ	JJ	_	38	amod	_	_
34	transcribed	_	VBN	VBN	_	38	amod	_	_
35	polymerase	_	NN	NN	_	38	nn	_	_
36	chain	_	NN	NN	_	38	nn	_	_
37	reaction-based	_	JJ	JJ	_	38	amod	_	_
38	method	_	NN	NN	_	30	dobj	_	_
39	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	method	_	NN	NN	_	4	nsubjpass	_	_
3	is	_	VBZ	VBZ	_	4	auxpass	_	_
4	based	_	VBN	VBN	_	0	root	_	_
5	on	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	coamplification	_	NN	NN	_	5	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	VDR	_	NN	NN	_	10	nn	_	_
10	cDNA	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	an	_	DT	DT	_	14	det	_	_
13	internal	_	JJ	JJ	_	14	amod	_	_
14	standard	_	NN	NN	_	10	conj	_	_
15	consisting	_	VBG	VBG	_	14	vmod	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	known	_	JJ	JJ	_	18	amod	_	_
18	concentrations	_	NNS	NNS	_	16	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	a	_	DT	DT	_	23	det	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	VDR	_	NN	NN	_	23	nn	_	_
23	CDNA	_	NN	NN	_	19	pobj	_	_
24	mutated	_	VBN	VBN	_	23	vmod	_	_
25	at	_	IN	IN	_	24	prep	_	_
26	a	_	DT	DT	_	29	det	_	_
27	BglII	_	NN	NN	_	29	nn	_	_
28	restriction	_	NN	NN	_	29	nn	_	_
29	site	_	NN	NN	_	25	pobj	_	_
30	;	_	:	:	_	4	punct	_	_
31	the	_	DT	DT	_	33	det	_	_
32	interassay	_	JJ	JJ	_	33	amod	_	_
33	coefficient	_	NN	NN	_	38	nsubj	_	_
34	of	_	IN	IN	_	33	prep	_	_
35	variation	_	NN	NN	_	34	pobj	_	_
36	is	_	VBZ	VBZ	_	38	cop	_	_
37	11	_	CD	CD	_	38	num	_	_
38	%	_	NN	NN	_	4	parataxis	_	_
39	.	_	.	.	_	4	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	validate	_	VB	VB	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	method	_	NN	NN	_	2	dobj	_	_
5	,	_	,	,	_	2	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	made	_	VBD	VBD	_	2	parataxis	_	_
8	use	_	NN	NN	_	7	dobj	_	_
9	of	_	IN	IN	_	7	prep	_	_
10	earlier	_	JJR	JJR	_	13	amod	_	_
11	receptor	_	NN	NN	_	13	nn	_	_
12	binding	_	NN	NN	_	13	nn	_	_
13	studies	_	NNS	NNS	_	9	pobj	_	_
14	indicating	_	VBG	VBG	_	13	vmod	_	_
15	that	_	IN	IN	_	27	mark	_	_
16	normal	_	JJ	JJ	_	18	amod	_	_
17	human	_	JJ	JJ	_	18	amod	_	_
18	monocytes	_	NNS	NNS	_	27	nsubj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	activated	_	VBN	VBN	_	18	conj	_	_
21	,	_	,	,	_	20	punct	_	_
22	but	_	CC	CC	_	20	cc	_	_
23	not	_	RB	RB	_	20	conj	_	_
24	resting	_	VBG	VBG	_	23	amod	_	_
25	,	_	,	,	_	20	punct	_	_
26	lymphocytes	_	NNS	NNS	_	20	conj	_	_
27	expressed	_	VBD	VBD	_	14	ccomp	_	_
28	the	_	DT	DT	_	29	det	_	_
29	VDR	_	NN	NN	_	27	dobj	_	_
30	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	concentration	_	NN	NN	_	11	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	VDR	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	3	pobj	_	_
7	was	_	VBD	VBD	_	11	cop	_	_
8	10-LRB--8-RRB-	_	CD	CD	_	10	number	_	_
9	to	_	TO	TO	_	10	dep	_	_
10	10-LRB--7-RRB-	_	CD	CD	_	11	num	_	_
11	g/g	_	NN	NN	_	0	root	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	total	_	JJ	JJ	_	14	amod	_	_
14	RNA	_	NN	NN	_	12	pobj	_	_
15	in	_	IN	IN	_	11	prep	_	_
16	cell-sorted	_	JJ	JJ	_	17	amod	_	_
17	monocytes	_	NNS	NNS	_	15	pobj	_	_
18	and	_	CC	CC	_	15	cc	_	_
19	in	_	IN	IN	_	15	conj	_	_
20	in	_	FW	FW	_	23	nn	_	_
21	vitro	_	FW	FW	_	23	nn	_	_
22	activated	_	VBN	VBN	_	23	amod	_	_
23	lymphocytes	_	NNS	NNS	_	19	pobj	_	_
24	,	_	,	,	_	11	punct	_	_
25	but	_	CC	CC	_	11	cc	_	_
26	only	_	RB	RB	_	27	quantmod	_	_
27	10-LRB--12-RRB-	_	CD	CD	_	28	num	_	_
28	g/g	_	NN	NN	_	11	conj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	total	_	JJ	JJ	_	31	amod	_	_
31	mRNA	_	NN	NN	_	29	pobj	_	_
32	in	_	IN	IN	_	28	prep	_	_
33	resting	_	VBG	VBG	_	34	amod	_	_
34	lymphocytes	_	NNS	NNS	_	32	pobj	_	_
35	,	_	,	,	_	11	punct	_	_
36	establishing	_	VBG	VBG	_	11	vmod	_	_
37	that	_	IN	IN	_	48	mark	_	_
38	the	_	DT	DT	_	40	det	_	_
39	VDR	_	NN	NN	_	40	nn	_	_
40	mRNA	_	NN	NN	_	48	nsubj	_	_
41	determined	_	VBN	VBN	_	40	vmod	_	_
42	by	_	IN	IN	_	41	prep	_	_
43	our	_	PRP$	PRP$	_	44	poss	_	_
44	method	_	NN	NN	_	42	pobj	_	_
45	in	_	IN	IN	_	44	prep	_	_
46	PBMCs	_	NNS	NNS	_	45	pobj	_	_
47	is	_	VBZ	VBZ	_	48	cop	_	_
48	due	_	JJ	JJ	_	36	ccomp	_	_
49	to	_	TO	TO	_	48	prep	_	_
50	constitutive	_	JJ	JJ	_	51	amod	_	_
51	expression	_	NN	NN	_	49	pobj	_	_
52	in	_	IN	IN	_	51	prep	_	_
53	monocytes	_	NNS	NNS	_	52	pobj	_	_
54	.	_	.	.	_	11	punct	_	_

1	Following	_	VBG	VBG	_	41	prep	_	_
2	an	_	DT	DT	_	5	det	_	_
3	initial	_	JJ	JJ	_	5	amod	_	_
4	genotype	_	NN	NN	_	5	nn	_	_
5	screening	_	NN	NN	_	1	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	85	_	CD	CD	_	9	num	_	_
8	normal	_	JJ	JJ	_	9	amod	_	_
9	volunteers	_	NNS	NNS	_	6	pobj	_	_
10	by	_	IN	IN	_	5	prep	_	_
11	polymerase	_	NN	NN	_	13	nn	_	_
12	chain	_	NN	NN	_	13	nn	_	_
13	reaction	_	NN	NN	_	10	pobj	_	_
14	or	_	CC	CC	_	13	cc	_	_
15	restriction	_	NN	NN	_	18	nn	_	_
16	fragment	_	NN	NN	_	18	nn	_	_
17	length	_	NN	NN	_	18	nn	_	_
18	polymorphism	_	NN	NN	_	19	nn	_	_
19	analysis	_	NN	NN	_	13	conj	_	_
20	,	_	,	,	_	41	punct	_	_
21	14	_	CD	CD	_	22	num	_	_
22	individuals	_	NNS	NNS	_	41	nsubjpass	_	_
23	with	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	26	det	_	_
25	Bb	_	NN	NN	_	26	nn	_	_
26	genotype	_	NN	NN	_	23	pobj	_	_
27	,	_	,	,	_	22	punct	_	_
28	12	_	CD	CD	_	22	conj	_	_
29	with	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	bb	_	NN	NN	_	32	nn	_	_
32	genotype	_	NN	NN	_	29	pobj	_	_
33	,	_	,	,	_	22	punct	_	_
34	and	_	CC	CC	_	22	cc	_	_
35	12	_	CD	CD	_	22	conj	_	_
36	with	_	IN	IN	_	35	prep	_	_
37	the	_	DT	DT	_	39	det	_	_
38	BB	_	NN	NN	_	39	nn	_	_
39	genotype	_	NN	NN	_	36	pobj	_	_
40	were	_	VBD	VBD	_	41	auxpass	_	_
41	selected	_	VBN	VBN	_	0	root	_	_
42	.	_	.	.	_	41	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	concentration	_	NN	NN	_	16	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	6	det	_	_
5	VDR	_	NN	NN	_	6	nn	_	_
6	mRNA	_	NN	NN	_	3	pobj	_	_
7	,	_	,	,	_	2	punct	_	_
8	corrected	_	VBN	VBN	_	2	vmod	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	number	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	monocytes	_	NNS	NNS	_	12	pobj	_	_
14	,	_	,	,	_	2	punct	_	_
15	was	_	VBD	VBD	_	16	cop	_	_
16	similar	_	JJ	JJ	_	0	root	_	_
17	among	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	21	det	_	_
19	three	_	CD	CD	_	21	num	_	_
20	genotype	_	NN	NN	_	21	nn	_	_
21	groups	_	NNS	NNS	_	17	pobj	_	_
22	,	_	,	,	_	16	punct	_	_
23	as	_	IN	IN	_	27	dep	_	_
24	were	_	VBD	VBD	_	27	dep	_	_
25	the	_	DT	DT	_	27	det	_	_
26	other	_	JJ	JJ	_	27	amod	_	_
27	variables	_	NNS	NNS	_	16	advcl	_	_
28	examined	_	VBN	VBN	_	27	vmod	_	_
29	:	_	:	:	_	16	punct	_	_
30	serum	_	NN	NN	_	31	nn	_	_
31	calcitriol	_	NN	NN	_	16	dep	_	_
32	,	_	,	,	_	31	punct	_	_
33	serum	_	NN	NN	_	34	nn	_	_
34	osteocalcin	_	NN	NN	_	31	conj	_	_
35	,	_	,	,	_	31	punct	_	_
36	and	_	CC	CC	_	31	cc	_	_
37	vertebral	_	NN	NN	_	31	conj	_	_
38	and	_	CC	CC	_	37	cc	_	_
39	hip	_	NN	NN	_	40	nn	_	_
40	bone	_	NN	NN	_	37	conj	_	_
41	density	_	NN	NN	_	37	dep	_	_
42	.	_	.	.	_	16	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	8	mark	_	_
4	VDR	_	NN	NN	_	5	nn	_	_
5	polymorphism	_	NN	NN	_	8	nsubj	_	_
6	does	_	VBZ	VBZ	_	8	aux	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	affect	_	VB	VB	_	2	ccomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	abundance	_	NN	NN	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	VDR	_	NN	NN	_	14	nn	_	_
14	mRNA	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	2	punct	_	_

1	HLA-DMA	_	NN	NN	_	6	nsubj	_	_
2	and	_	CC	CC	_	1	cc	_	_
3	HLA-DMB	_	NN	NN	_	1	conj	_	_
4	gene	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	1	dep	_	_
6	functions	_	VBZ	VBZ	_	0	root	_	_
7	through	_	IN	IN	_	6	prep	_	_
8	the	_	DT	DT	_	11	det	_	_
9	conserved	_	VBN	VBN	_	11	amod	_	_
10	S-X-Y	_	NN	NN	_	11	nn	_	_
11	region	_	NN	NN	_	7	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	MHC	_	NN	NN	_	6	nn	_	_
3	class	_	NN	NN	_	6	nn	_	_
4	II	_	CD	CD	_	6	num	_	_
5	homologous	_	JJ	JJ	_	6	amod	_	_
6	proteins	_	NNS	NNS	_	10	nsubj	_	_
7	HLA-DMA	_	NN	NN	_	6	dep	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	HLA-DMB	_	NN	NN	_	7	conj	_	_
10	function	_	VBP	VBP	_	0	root	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	loading	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	peptides	_	NNS	NNS	_	14	pobj	_	_
16	onto	_	IN	IN	_	13	prep	_	_
17	class	_	NN	NN	_	19	nn	_	_
18	II	_	CD	CD	_	19	num	_	_
19	molecules	_	NNS	NNS	_	16	pobj	_	_
20	.	_	.	.	_	10	punct	_	_

1	Like	_	IN	IN	_	10	prep	_	_
2	the	_	DT	DT	_	5	det	_	_
3	class	_	NN	NN	_	5	nn	_	_
4	II	_	CD	CD	_	5	num	_	_
5	genes	_	NNS	NNS	_	1	pobj	_	_
6	,	_	,	,	_	10	punct	_	_
7	the	_	DT	DT	_	9	det	_	_
8	HLA-DM	_	NN	NN	_	9	nn	_	_
9	genes	_	NNS	NNS	_	10	nsubj	_	_
10	contain	_	VBP	VBP	_	0	root	_	_
11	upstream	_	JJ	JJ	_	13	amod	_	_
12	regulatory	_	JJ	JJ	_	13	amod	_	_
13	sequences	_	NNS	NNS	_	10	dobj	_	_
14	similar	_	JJ	JJ	_	13	amod	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	the	_	DT	DT	_	19	det	_	_
17	S-X-Y	_	NN	NN	_	19	nn	_	_
18	regulatory	_	JJ	JJ	_	19	amod	_	_
19	region	_	NN	NN	_	15	pobj	_	_
20	as	_	RB	RB	_	21	advmod	_	_
21	well	_	RB	RB	_	13	cc	_	_
22	as	_	IN	IN	_	21	mwe	_	_
23	additional	_	JJ	JJ	_	25	amod	_	_
24	putative	_	JJ	JJ	_	25	amod	_	_
25	regulatory	_	JJ	JJ	_	26	amod	_	_
26	sites	_	NNS	NNS	_	13	conj	_	_
27	.	_	.	.	_	10	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	determine	_	VB	VB	_	0	root	_	_
3	whether	_	IN	IN	_	8	mark	_	_
4	the	_	DT	DT	_	6	det	_	_
5	DM	_	NN	NN	_	6	nn	_	_
6	genes	_	NNS	NNS	_	8	nsubjpass	_	_
7	are	_	VBP	VBP	_	8	auxpass	_	_
8	regulated	_	VBN	VBN	_	2	ccomp	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	similar	_	JJ	JJ	_	12	amod	_	_
12	manner	_	NN	NN	_	9	pobj	_	_
13	as	_	IN	IN	_	12	prep	_	_
14	class	_	NN	NN	_	16	nn	_	_
15	II	_	CD	CD	_	16	num	_	_
16	genes	_	NNS	NNS	_	13	pobj	_	_
17	,	_	,	,	_	2	punct	_	_
18	a	_	DT	DT	_	19	det	_	_
19	series	_	NN	NN	_	28	nsubjpass	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	in	_	FW	FW	_	20	pobj	_	_
22	vivo	_	FW	FW	_	21	dep	_	_
23	and	_	CC	CC	_	21	cc	_	_
24	in	_	FW	FW	_	21	conj	_	_
25	vitro	_	FW	FW	_	24	dep	_	_
26	analyses	_	NNS	NNS	_	21	dep	_	_
27	was	_	VBD	VBD	_	28	auxpass	_	_
28	performed	_	VBN	VBN	_	2	parataxis	_	_
29	.	_	.	.	_	2	punct	_	_

1	Deletion	_	NN	NN	_	2	nn	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	showed	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	11	mark	_	_
5	expression	_	NN	NN	_	11	nsubj	_	_
6	from	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	DM	_	NN	NN	_	9	nn	_	_
9	promoters	_	NNS	NNS	_	6	pobj	_	_
10	is	_	VBZ	VBZ	_	11	cop	_	_
11	dependent	_	JJ	JJ	_	3	ccomp	_	_
12	on	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	conserved	_	VBN	VBN	_	16	amod	_	_
15	S-X-Y	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	12	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	5	det	_	_
2	class	_	NN	NN	_	5	nn	_	_
3	II-specific	_	JJ	JJ	_	5	amod	_	_
4	transcription	_	NN	NN	_	5	nn	_	_
5	factors	_	NNS	NNS	_	11	nsubjpass	_	_
6	RFX	_	NN	NN	_	5	dep	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	CIITA	_	NN	NN	_	6	conj	_	_
9	are	_	VBP	VBP	_	11	auxpass	_	_
10	also	_	RB	RB	_	11	advmod	_	_
11	required	_	VBN	VBN	_	0	root	_	_
12	for	_	IN	IN	_	11	prep	_	_
13	expression	_	NN	NN	_	12	pobj	_	_
14	,	_	,	,	_	11	punct	_	_
15	as	_	IN	IN	_	22	mark	_	_
16	cell	_	NN	NN	_	17	nn	_	_
17	lines	_	NNS	NNS	_	22	nsubj	_	_
18	deficient	_	JJ	JJ	_	17	amod	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	these	_	DT	DT	_	21	det	_	_
21	factors	_	NNS	NNS	_	19	pobj	_	_
22	failed	_	VBD	VBD	_	11	advcl	_	_
23	to	_	TO	TO	_	24	aux	_	_
24	allow	_	VB	VB	_	22	xcomp	_	_
25	transcription	_	NN	NN	_	24	dobj	_	_
26	from	_	IN	IN	_	24	prep	_	_
27	the	_	DT	DT	_	29	det	_	_
28	DM	_	NN	NN	_	29	nn	_	_
29	promoters	_	NNS	NNS	_	26	pobj	_	_
30	.	_	.	.	_	11	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	in	_	FW	FW	_	7	amod	_	_
5	vivo	_	FW	FW	_	4	dep	_	_
6	footprint	_	NN	NN	_	7	nn	_	_
7	analysis	_	NN	NN	_	8	nsubj	_	_
8	showed	_	VBD	VBD	_	0	root	_	_
9	the	_	DT	DT	_	11	dep	_	_
10	putative	_	JJ	JJ	_	11	amod	_	_
11	X	_	NN	NN	_	8	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	Y	_	NN	NN	_	11	conj	_	_
14	boxes	_	NNS	NNS	_	11	dep	_	_
15	to	_	TO	TO	_	17	aux	_	_
16	be	_	VB	VB	_	17	auxpass	_	_
17	occupied	_	VBN	VBN	_	8	xcomp	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	transcription	_	NN	NN	_	20	nn	_	_
20	factors	_	NNS	NNS	_	18	pobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	wild-type	_	JJ	JJ	_	24	amod	_	_
23	B	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	21	pobj	_	_
25	,	_	,	,	_	21	punct	_	_
26	but	_	CC	CC	_	21	cc	_	_
27	not	_	RB	RB	_	28	neg	_	_
28	in	_	IN	IN	_	21	conj	_	_
29	RFX-deficient	_	JJ	JJ	_	31	amod	_	_
30	B	_	NN	NN	_	31	nn	_	_
31	cells	_	NNS	NNS	_	28	pobj	_	_
32	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	6	prep	_	_
2	astrocytes	_	NNS	NNS	_	1	pobj	_	_
3	,	_	,	,	_	6	punct	_	_
4	IFN-gamma	_	NN	NN	_	5	nn	_	_
5	treatment	_	NN	NN	_	6	nsubj	_	_
6	induced	_	VBD	VBD	_	0	root	_	_
7	increased	_	VBN	VBN	_	8	amod	_	_
8	occupancy	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	these	_	DT	DT	_	11	det	_	_
11	sites	_	NNS	NNS	_	9	pobj	_	_
12	.	_	.	.	_	6	punct	_	_

1	None	_	NN	NN	_	9	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	7	det	_	_
4	other	_	JJ	JJ	_	6	amod	_	_
5	putative	_	JJ	JJ	_	6	amod	_	_
6	regulatory	_	JJ	JJ	_	7	amod	_	_
7	sites	_	NNS	NNS	_	2	pobj	_	_
8	was	_	VBD	VBD	_	9	auxpass	_	_
9	occupied	_	VBN	VBN	_	0	root	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vivo	_	FW	FW	_	9	advmod	_	_
12	,	_	,	,	_	9	punct	_	_
13	indicating	_	VBG	VBG	_	9	vmod	_	_
14	that	_	IN	IN	_	19	mark	_	_
15	they	_	PRP	PRP	_	19	nsubj	_	_
16	may	_	MD	MD	_	19	aux	_	_
17	not	_	RB	RB	_	19	neg	_	_
18	be	_	VB	VB	_	19	cop	_	_
19	functional	_	JJ	JJ	_	13	ccomp	_	_
20	.	_	.	.	_	9	punct	_	_

1	Finally	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	gel	_	NN	NN	_	5	nn	_	_
4	shift	_	NN	NN	_	5	nn	_	_
5	analysis	_	NN	NN	_	6	nsubj	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	synergistic	_	JJ	JJ	_	9	amod	_	_
8	complex	_	JJ	JJ	_	9	amod	_	_
9	formation	_	NN	NN	_	6	dobj	_	_
10	between	_	IN	IN	_	9	prep	_	_
11	proteins	_	NNS	NNS	_	10	pobj	_	_
12	that	_	WDT	WDT	_	13	nsubj	_	_
13	bind	_	VBP	VBP	_	11	rcmod	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	putative	_	JJ	JJ	_	18	amod	_	_
17	X	_	NN	NN	_	18	nn	_	_
18	boxes	_	NNS	NNS	_	14	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	DM	_	NN	NN	_	22	nn	_	_
22	genes	_	NNS	NNS	_	19	pobj	_	_
23	,	_	,	,	_	6	punct	_	_
24	as	_	IN	IN	_	26	dep	_	_
25	is	_	VBZ	VBZ	_	26	auxpass	_	_
26	found	_	VBN	VBN	_	6	advcl	_	_
27	for	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	30	det	_	_
29	DRA	_	NN	NN	_	30	nn	_	_
30	gene	_	NN	NN	_	27	pobj	_	_
31	.	_	.	.	_	6	punct	_	_

1	Therefore	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	the	_	DT	DT	_	5	det	_	_
4	DM	_	NN	NN	_	5	nn	_	_
5	genes	_	NNS	NNS	_	6	nsubj	_	_
6	share	_	VBP	VBP	_	0	root	_	_
7	a	_	DT	DT	_	9	det	_	_
8	common	_	JJ	JJ	_	9	amod	_	_
9	mechanism	_	NN	NN	_	6	dobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	regulation	_	NN	NN	_	10	pobj	_	_
12	with	_	IN	IN	_	6	prep	_	_
13	the	_	DT	DT	_	16	det	_	_
14	class	_	NN	NN	_	16	nn	_	_
15	II	_	CD	CD	_	16	num	_	_
16	genes	_	NNS	NNS	_	12	pobj	_	_
17	.	_	.	.	_	6	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	enhancer-blocking	_	JJ	JJ	_	3	amod	_	_
3	element	_	NN	NN	_	0	root	_	_
4	between	_	IN	IN	_	3	prep	_	_
5	alpha	_	NN	NN	_	4	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	delta	_	NN	NN	_	5	conj	_	_
8	gene	_	NN	NN	_	9	nn	_	_
9	segments	_	NNS	NNS	_	5	dep	_	_
10	within	_	IN	IN	_	3	prep	_	_
11	the	_	DT	DT	_	17	det	_	_
12	human	_	JJ	JJ	_	17	amod	_	_
13	T	_	NN	NN	_	17	nn	_	_
14	cell	_	NN	NN	_	17	nn	_	_
15	receptor	_	NN	NN	_	17	nn	_	_
16	alpha/delta	_	NN	NN	_	17	nn	_	_
17	locus	_	NN	NN	_	10	pobj	_	_
18	.	_	.	.	_	3	punct	_	_

1	T	_	NN	NN	_	7	nn	_	_
2	cell	_	NN	NN	_	7	nn	_	_
3	receptor	_	NN	NN	_	7	nn	_	_
4	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
5	TCR	_	NN	NN	_	7	nn	_	_
6	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
7	alpha	_	NN	NN	_	13	nsubjpass	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	delta	_	NN	NN	_	7	conj	_	_
10	gene	_	NN	NN	_	11	nn	_	_
11	segments	_	NNS	NNS	_	7	dep	_	_
12	are	_	VBP	VBP	_	13	auxpass	_	_
13	organized	_	VBN	VBN	_	0	root	_	_
14	within	_	IN	IN	_	13	prep	_	_
15	a	_	DT	DT	_	18	det	_	_
16	single	_	JJ	JJ	_	18	amod	_	_
17	genetic	_	JJ	JJ	_	18	amod	_	_
18	locus	_	NN	NN	_	14	pobj	_	_
19	but	_	CC	CC	_	13	cc	_	_
20	are	_	VBP	VBP	_	22	auxpass	_	_
21	differentially	_	RB	RB	_	22	advmod	_	_
22	regulated	_	VBN	VBN	_	13	conj	_	_
23	during	_	IN	IN	_	22	prep	_	_
24	T	_	NN	NN	_	26	nn	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	development	_	NN	NN	_	23	pobj	_	_
27	.	_	.	.	_	13	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	enhancer-blocking	_	JJ	JJ	_	3	amod	_	_
3	element	_	NN	NN	_	14	nsubj	_	_
4	-LRB-	_	-LRB-	-LRB-	_	5	punct	_	_
5	BEAD-1	_	NN	NN	_	3	dep	_	_
6	,	_	,	,	_	5	punct	_	_
7	for	_	IN	IN	_	5	prep	_	_
8	blocking	_	VBG	VBG	_	7	pcomp	_	_
9	element	_	NN	NN	_	10	nn	_	_
10	alpha/delta	_	NN	NN	_	8	dobj	_	_
11	1	_	CD	CD	_	10	num	_	_
12	-RRB-	_	-RRB-	-RRB-	_	5	punct	_	_
13	was	_	VBD	VBD	_	14	cop	_	_
14	localized	_	JJ	JJ	_	0	root	_	_
15	to	_	TO	TO	_	14	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	2.0-kb	_	JJ	JJ	_	18	amod	_	_
18	region	_	NN	NN	_	15	pobj	_	_
19	3'	_	RB	RB	_	18	advmod	_	_
20	of	_	IN	IN	_	19	prep	_	_
21	TCR	_	NN	NN	_	24	nn	_	_
22	delta	_	NN	NN	_	24	nn	_	_
23	gene	_	NN	NN	_	24	nn	_	_
24	segments	_	NNS	NNS	_	20	pobj	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	5'	_	RB	RB	_	19	conj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	TCR	_	NN	NN	_	32	nn	_	_
29	alpha	_	NN	NN	_	32	nn	_	_
30	joining	_	NN	NN	_	32	nn	_	_
31	gene	_	NN	NN	_	32	nn	_	_
32	segments	_	NNS	NNS	_	27	pobj	_	_
33	within	_	IN	IN	_	18	prep	_	_
34	this	_	DT	DT	_	35	det	_	_
35	locus	_	NN	NN	_	33	pobj	_	_
36	.	_	.	.	_	14	punct	_	_

1	BEAD-1	_	NN	NN	_	2	nsubj	_	_
2	blocked	_	VBD	VBD	_	0	root	_	_
3	the	_	DT	DT	_	4	det	_	_
4	ability	_	NN	NN	_	2	dobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	the	_	DT	DT	_	9	det	_	_
7	TCR	_	NN	NN	_	9	nn	_	_
8	delta	_	NN	NN	_	9	nn	_	_
9	enhancer	_	NN	NN	_	5	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	Edelta	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	to	_	TO	TO	_	14	aux	_	_
14	activate	_	VB	VB	_	4	vmod	_	_
15	a	_	DT	DT	_	16	det	_	_
16	promoter	_	NN	NN	_	14	dobj	_	_
17	when	_	WRB	WRB	_	18	advmod	_	_
18	located	_	JJ	JJ	_	2	advcl	_	_
19	between	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	21	det	_	_
21	two	_	CD	CD	_	19	pobj	_	_
22	in	_	IN	IN	_	21	prep	_	_
23	a	_	DT	DT	_	25	det	_	_
24	chromatin-integrated	_	JJ	JJ	_	25	amod	_	_
25	construct	_	NN	NN	_	22	pobj	_	_
26	.	_	.	.	_	2	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	propose	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	5	mark	_	_
4	BEAD-1	_	NN	NN	_	5	nsubj	_	_
5	functions	_	VBZ	VBZ	_	2	ccomp	_	_
6	as	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	8	det	_	_
8	boundary	_	NN	NN	_	6	pobj	_	_
9	that	_	WDT	WDT	_	10	nsubj	_	_
10	separates	_	VBZ	VBZ	_	8	rcmod	_	_
11	the	_	DT	DT	_	14	det	_	_
12	TCR	_	NN	NN	_	14	nn	_	_
13	alpha/delta	_	NN	NN	_	14	nn	_	_
14	locus	_	NN	NN	_	10	dobj	_	_
15	into	_	IN	IN	_	10	prep	_	_
16	distinct	_	JJ	JJ	_	18	amod	_	_
17	regulatory	_	JJ	JJ	_	18	amod	_	_
18	domains	_	NNS	NNS	_	15	pobj	_	_
19	controlled	_	VBN	VBN	_	18	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	Edelta	_	NN	NN	_	20	pobj	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	the	_	DT	DT	_	26	det	_	_
24	TCR	_	NN	NN	_	26	nn	_	_
25	alpha	_	NN	NN	_	26	nn	_	_
26	enhancer	_	NN	NN	_	21	conj	_	_
27	,	_	,	,	_	5	punct	_	_
28	and	_	CC	CC	_	5	cc	_	_
29	that	_	IN	IN	_	31	mark	_	_
30	it	_	PRP	PRP	_	31	nsubj	_	_
31	prevents	_	VBZ	VBZ	_	5	conj	_	_
32	Edelta	_	NN	NN	_	31	dobj	_	_
33	from	_	IN	IN	_	31	prep	_	_
34	opening	_	VBG	VBG	_	33	pcomp	_	_
35	the	_	DT	DT	_	36	det	_	_
36	chromatin	_	NN	NN	_	34	dobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	43	det	_	_
39	TCR	_	NN	NN	_	40	nn	_	_
40	alpha	_	NN	NN	_	43	nn	_	_
41	joining	_	NN	NN	_	43	nn	_	_
42	gene	_	NN	NN	_	43	nn	_	_
43	segments	_	NNS	NNS	_	37	pobj	_	_
44	for	_	IN	IN	_	34	prep	_	_
45	VDJ	_	NN	NN	_	46	nn	_	_
46	recombination	_	NN	NN	_	44	pobj	_	_
47	at	_	IN	IN	_	31	prep	_	_
48	an	_	DT	DT	_	50	det	_	_
49	early	_	JJ	JJ	_	50	amod	_	_
50	stage	_	NN	NN	_	47	pobj	_	_
51	of	_	IN	IN	_	50	prep	_	_
52	T	_	NN	NN	_	54	nn	_	_
53	cell	_	NN	NN	_	54	nn	_	_
54	development	_	NN	NN	_	51	pobj	_	_
55	.	_	.	.	_	2	punct	_	_

1	Plasma	_	NN	NN	_	3	nn	_	_
2	sialyltransferase	_	NN	NN	_	3	nn	_	_
3	levels	_	NNS	NNS	_	0	root	_	_
4	in	_	IN	IN	_	3	prep	_	_
5	psychiatric	_	JJ	JJ	_	6	amod	_	_
6	disorders	_	NNS	NNS	_	4	pobj	_	_
7	as	_	IN	IN	_	3	prep	_	_
8	a	_	DT	DT	_	10	det	_	_
9	possible	_	JJ	JJ	_	10	amod	_	_
10	indicator	_	NN	NN	_	7	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	HPA	_	JJ	JJ	_	14	amod	_	_
13	axis	_	NN	NN	_	14	nn	_	_
14	function	_	NN	NN	_	11	pobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	dysfunction	_	NN	NN	_	29	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	the	_	DT	DT	_	5	det	_	_
5	regulation	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	12	det	_	_
8	hypothalamic-pituitary-adrenal	_	JJ	JJ	_	12	amod	_	_
9	-LRB-	_	-LRB-	-LRB-	_	10	punct	_	_
10	HPA	_	JJ	JJ	_	8	dep	_	_
11	-RRB-	_	-RRB-	-RRB-	_	10	punct	_	_
12	axis	_	NN	NN	_	6	pobj	_	_
13	,	_	,	,	_	2	punct	_	_
14	possibly	_	RB	RB	_	15	advmod	_	_
15	attributed	_	VBN	VBN	_	2	vmod	_	_
16	to	_	TO	TO	_	15	prep	_	_
17	a	_	DT	DT	_	18	det	_	_
18	change	_	NN	NN	_	16	pobj	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	glucocorticoid	_	NN	NN	_	21	nn	_	_
21	receptor	_	NN	NN	_	25	nn	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	GR	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	functionality	_	NN	NN	_	19	pobj	_	_
26	,	_	,	,	_	2	punct	_	_
27	has	_	VBZ	VBZ	_	29	aux	_	_
28	been	_	VBN	VBN	_	29	auxpass	_	_
29	implicated	_	VBN	VBN	_	0	root	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	depression	_	NN	NN	_	30	pobj	_	_
32	.	_	.	.	_	29	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	have	_	VBP	VBP	_	3	aux	_	_
3	measured	_	VBN	VBN	_	0	root	_	_
4	both	_	CC	CC	_	9	preconj	_	_
5	lymphocyte	_	NN	NN	_	6	nn	_	_
6	GR	_	NN	NN	_	9	nn	_	_
7	receptor	_	NN	NN	_	9	nn	_	_
8	binding	_	NN	NN	_	9	nn	_	_
9	parameters	_	NNS	NNS	_	3	dobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	plasma	_	NN	NN	_	13	nn	_	_
12	sialyltransferase	_	NN	NN	_	13	nn	_	_
13	activity	_	NN	NN	_	9	conj	_	_
14	,	_	,	,	_	3	punct	_	_
15	as	_	IN	IN	_	3	prep	_	_
16	a	_	DT	DT	_	18	det	_	_
17	biochemical	_	JJ	JJ	_	18	amod	_	_
18	marker	_	NN	NN	_	15	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	GR	_	NN	NN	_	21	nn	_	_
21	function	_	NN	NN	_	19	pobj	_	_
22	,	_	,	,	_	3	punct	_	_
23	in	_	IN	IN	_	3	prep	_	_
24	two	_	CD	CD	_	25	num	_	_
25	groups	_	NNS	NNS	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	patients	_	NNS	NNS	_	26	pobj	_	_
28	suffering	_	VBG	VBG	_	27	vmod	_	_
29	from	_	IN	IN	_	28	prep	_	_
30	depression	_	NN	NN	_	29	pobj	_	_
31	or	_	CC	CC	_	30	cc	_	_
32	schizophrenia	_	NN	NN	_	30	conj	_	_
33	and	_	CC	CC	_	23	cc	_	_
34	in	_	IN	IN	_	23	conj	_	_
35	a	_	DT	DT	_	36	det	_	_
36	group	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	age-	_	NN	NN	_	37	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	sex-matched	_	JJ	JJ	_	38	conj	_	_
41	controls	_	NNS	NNS	_	38	dep	_	_
42	.	_	.	.	_	3	punct	_	_

1	While	_	IN	IN	_	3	mark	_	_
2	there	_	EX	EX	_	3	expl	_	_
3	was	_	VBD	VBD	_	17	advcl	_	_
4	a	_	DT	DT	_	6	det	_	_
5	significant	_	JJ	JJ	_	6	amod	_	_
6	increase	_	NN	NN	_	3	nsubj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	plasma	_	NN	NN	_	10	nn	_	_
9	cortisol	_	NN	NN	_	10	nn	_	_
10	levels	_	NNS	NNS	_	7	pobj	_	_
11	in	_	IN	IN	_	3	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	depressed	_	JJ	JJ	_	14	amod	_	_
14	group	_	NN	NN	_	11	pobj	_	_
15	,	_	,	,	_	17	punct	_	_
16	there	_	EX	EX	_	17	expl	_	_
17	were	_	VBD	VBD	_	0	root	_	_
18	no	_	DT	DT	_	19	neg	_	_
19	changes	_	NNS	NNS	_	17	nsubj	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	the	_	DT	DT	_	25	det	_	_
22	lymphocyte	_	NN	NN	_	25	nn	_	_
23	GR	_	NN	NN	_	25	nn	_	_
24	binding	_	NN	NN	_	25	nn	_	_
25	parameters	_	NNS	NNS	_	20	pobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
27	K	_	NN	NN	_	29	nn	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	m	_	NN	NN	_	25	dep	_	_
30	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
31	and	_	CC	CC	_	29	cc	_	_
32	Bmax	_	NN	NN	_	29	conj	_	_
33	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
34	.	_	.	.	_	17	punct	_	_

1	There	_	EX	EX	_	2	expl	_	_
2	was	_	VBD	VBD	_	0	root	_	_
3	,	_	,	,	_	2	punct	_	_
4	however	_	RB	RB	_	2	advmod	_	_
5	,	_	,	,	_	2	punct	_	_
6	a	_	DT	DT	_	8	det	_	_
7	significant	_	JJ	JJ	_	8	amod	_	_
8	decrease	_	NN	NN	_	2	nsubj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	15	det	_	_
11	plasma	_	NN	NN	_	12	nn	_	_
12	sialyltransferase	_	NN	NN	_	15	nn	_	_
13	:	_	:	:	_	12	punct	_	_
14	cortisol	_	NN	NN	_	15	nn	_	_
15	ratio	_	NN	NN	_	9	pobj	_	_
16	in	_	IN	IN	_	2	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	depressed	_	JJ	JJ	_	19	amod	_	_
19	group	_	NN	NN	_	16	pobj	_	_
20	suggesting	_	VBG	VBG	_	2	xcomp	_	_
21	an	_	DT	DT	_	22	det	_	_
22	inability	_	NN	NN	_	20	dobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	the	_	DT	DT	_	27	det	_	_
25	raised	_	VBN	VBN	_	27	amod	_	_
26	cortisol	_	NN	NN	_	27	nn	_	_
27	levels	_	NNS	NNS	_	23	pobj	_	_
28	to	_	TO	TO	_	29	aux	_	_
29	induce	_	VB	VB	_	22	vmod	_	_
30	enzyme	_	NN	NN	_	31	nn	_	_
31	expression	_	NN	NN	_	29	dobj	_	_
32	and	_	CC	CC	_	2	cc	_	_
33	this	_	DT	DT	_	34	det	_	_
34	ratio	_	NN	NN	_	36	nsubj	_	_
35	may	_	MD	MD	_	36	aux	_	_
36	provide	_	VB	VB	_	2	conj	_	_
37	a	_	DT	DT	_	40	det	_	_
38	useful	_	JJ	JJ	_	40	amod	_	_
39	biochemical	_	JJ	JJ	_	38	dep	_	_
40	marker	_	NN	NN	_	36	dobj	_	_
41	of	_	IN	IN	_	40	prep	_	_
42	cortisol	_	NN	NN	_	44	nn	_	_
43	receptor	_	NN	NN	_	44	nn	_	_
44	function	_	NN	NN	_	41	pobj	_	_
45	.	_	.	.	_	2	punct	_	_

1	Although	_	IN	IN	_	3	mark	_	_
2	there	_	EX	EX	_	3	expl	_	_
3	was	_	VBD	VBD	_	25	advcl	_	_
4	an	_	DT	DT	_	5	det	_	_
5	increase	_	NN	NN	_	3	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	plasma	_	NN	NN	_	9	nn	_	_
9	activity	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	15	det	_	_
12	alpha	_	NN	NN	_	15	nn	_	_
13	2,6	_	CD	CD	_	15	num	_	_
14	sialyltransferase	_	NN	NN	_	15	nn	_	_
15	isozyme	_	NN	NN	_	10	pobj	_	_
16	in	_	IN	IN	_	3	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	schizophrenic	_	JJ	JJ	_	19	amod	_	_
19	group	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	25	punct	_	_
21	no	_	DT	DT	_	23	neg	_	_
22	other	_	JJ	JJ	_	23	amod	_	_
23	changes	_	NNS	NNS	_	25	nsubjpass	_	_
24	were	_	VBD	VBD	_	25	auxpass	_	_
25	determined	_	VBN	VBN	_	0	root	_	_
26	.	_	.	.	_	25	punct	_	_

1	Therefore	_	RB	RB	_	24	advmod	_	_
2	,	_	,	,	_	24	punct	_	_
3	while	_	IN	IN	_	11	mark	_	_
4	the	_	DT	DT	_	10	det	_	_
5	total	_	JJ	JJ	_	10	amod	_	_
6	plasma	_	NN	NN	_	7	nn	_	_
7	sialyltransferase	_	NN	NN	_	10	nn	_	_
8	:	_	:	:	_	10	punct	_	_
9	cortisol	_	NN	NN	_	10	nn	_	_
10	ratio	_	NN	NN	_	11	nsubj	_	_
11	reflects	_	VBZ	VBZ	_	24	dep	_	_
12	HPA	_	JJ	JJ	_	14	amod	_	_
13	axis	_	NN	NN	_	14	nn	_	_
14	function	_	NN	NN	_	11	dobj	_	_
15	,	_	,	,	_	24	punct	_	_
16	alterations	_	NNS	NNS	_	24	nsubjpass	_	_
17	in	_	IN	IN	_	16	prep	_	_
18	specific	_	JJ	JJ	_	20	amod	_	_
19	isozyme	_	NN	NN	_	20	nn	_	_
20	activity	_	NN	NN	_	17	pobj	_	_
21	may	_	MD	MD	_	24	aux	_	_
22	also	_	RB	RB	_	24	advmod	_	_
23	be	_	VB	VB	_	24	auxpass	_	_
24	associated	_	VBN	VBN	_	0	root	_	_
25	with	_	IN	IN	_	24	prep	_	_
26	other	_	JJ	JJ	_	29	amod	_	_
27	CNS	_	NN	NN	_	29	nn	_	_
28	disease	_	NN	NN	_	29	nn	_	_
29	states	_	NNS	NNS	_	25	pobj	_	_
30	.	_	.	.	_	24	punct	_	_

1	Involvement	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	N-terminal	_	JJ	JJ	_	5	amod	_	_
5	region	_	NN	NN	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	12	det	_	_
8	human	_	JJ	JJ	_	12	amod	_	_
9	mineralocorticoid	_	NN	NN	_	12	nn	_	_
10	receptor	_	NN	NN	_	12	nn	_	_
11	hormone-binding	_	JJ	JJ	_	12	amod	_	_
12	domain	_	NN	NN	_	6	pobj	_	_
13	in	_	IN	IN	_	1	prep	_	_
14	agonist	_	NN	NN	_	13	pobj	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	antagonist	_	NN	NN	_	14	conj	_	_
17	binding	_	NN	NN	_	14	dep	_	_
18	as	_	IN	IN	_	19	mark	_	_
19	revealed	_	VBN	VBN	_	1	dep	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	a	_	DT	DT	_	24	det	_	_
22	new	_	JJ	JJ	_	24	amod	_	_
23	monoclonal	_	JJ	JJ	_	24	amod	_	_
24	antibody	_	NN	NN	_	20	pobj	_	_
25	.	_	.	.	_	1	punct	_	_

1	To	_	TO	TO	_	2	aux	_	_
2	gain	_	VB	VB	_	0	root	_	_
3	a	_	DT	DT	_	5	det	_	_
4	better	_	JJR	JJR	_	5	amod	_	_
5	understanding	_	NN	NN	_	2	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	mechanism	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	binding	_	VBG	VBG	_	9	pcomp	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	human	_	JJ	JJ	_	15	amod	_	_
14	mineralocorticoid	_	NN	NN	_	15	nn	_	_
15	receptor	_	NN	NN	_	11	pobj	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	hMR	_	NN	NN	_	15	appos	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	,	_	,	,	_	2	punct	_	_
20	we	_	PRP	PRP	_	21	nsubj	_	_
21	developed	_	VBD	VBD	_	2	parataxis	_	_
22	a	_	DT	DT	_	25	det	_	_
23	new	_	JJ	JJ	_	25	amod	_	_
24	monoclonal	_	JJ	JJ	_	25	amod	_	_
25	antibody	_	NN	NN	_	21	dobj	_	_
26	-LRB-	_	-LRB-	-LRB-	_	27	punct	_	_
27	mAb	_	NN	NN	_	25	appos	_	_
28	-RRB-	_	-RRB-	-RRB-	_	27	punct	_	_
29	raised	_	VBN	VBN	_	25	vmod	_	_
30	against	_	IN	IN	_	29	prep	_	_
31	the	_	DT	DT	_	33	det	_	_
32	hormone-binding	_	JJ	JJ	_	33	amod	_	_
33	domain	_	NN	NN	_	30	pobj	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	HBD	_	NN	NN	_	33	appos	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	.	_	.	.	_	2	punct	_	_

1	For	_	IN	IN	_	7	prep	_	_
2	this	_	DT	DT	_	3	det	_	_
3	purpose	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	7	punct	_	_
5	mice	_	NNS	NNS	_	7	nsubjpass	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	immunized	_	VBN	VBN	_	0	root	_	_
8	with	_	IN	IN	_	7	prep	_	_
9	a	_	DT	DT	_	11	det	_	_
10	fusion	_	NN	NN	_	11	nn	_	_
11	protein	_	NN	NN	_	8	pobj	_	_
12	including	_	VBG	VBG	_	11	vmod	_	_
13	the	_	DT	DT	_	14	det	_	_
14	sequence	_	NN	NN	_	12	dobj	_	_
15	Thr729-Lys984	_	NN	NN	_	14	dep	_	_
16	of	_	IN	IN	_	14	prep	_	_
17	hMR	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	7	punct	_	_

1	After	_	IN	IN	_	8	prep	_	_
2	ELISA	_	NN	NN	_	3	nn	_	_
3	screening	_	NN	NN	_	1	pobj	_	_
4	,	_	,	,	_	8	punct	_	_
5	mAb	_	NN	NN	_	6	nn	_	_
6	18C7	_	NN	NN	_	8	nsubjpass	_	_
7	was	_	VBD	VBD	_	8	auxpass	_	_
8	selected	_	VBN	VBN	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	its	_	PRP$	PRP$	_	11	poss	_	_
11	specificity	_	NN	NN	_	9	pobj	_	_
12	towards	_	IN	IN	_	11	prep	_	_
13	the	_	DT	DT	_	14	det	_	_
14	HBD	_	NN	NN	_	12	pobj	_	_
15	.	_	.	.	_	8	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	antibody	_	NN	NN	_	3	nsubj	_	_
3	recognized	_	VBD	VBD	_	0	root	_	_
4	both	_	CC	CC	_	6	preconj	_	_
5	the	_	DT	DT	_	6	dep	_	_
6	denatured	_	VBN	VBN	_	3	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	native	_	JJ	JJ	_	10	amod	_	_
9	MR	_	NN	NN	_	10	nn	_	_
10	forms	_	NNS	NNS	_	6	conj	_	_
11	,	_	,	,	_	6	punct	_	_
12	as	_	RB	RB	_	13	advmod	_	_
13	well	_	RB	RB	_	6	cc	_	_
14	as	_	IN	IN	_	13	mwe	_	_
15	the	_	DT	DT	_	18	det	_	_
16	hetero-oligomeric	_	JJ	JJ	_	18	amod	_	_
17	MR	_	NN	NN	_	18	nn	_	_
18	form	_	NN	NN	_	6	conj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	the	_	DT	DT	_	23	det	_	_
21	transformed	_	JJ	JJ	_	23	amod	_	_
22	MR	_	NN	NN	_	23	nn	_	_
23	state	_	NN	NN	_	18	conj	_	_
24	.	_	.	.	_	3	punct	_	_

1	By	_	IN	IN	_	12	prep	_	_
2	using	_	VBG	VBG	_	1	pcomp	_	_
3	several	_	JJ	JJ	_	5	amod	_	_
4	HBD	_	NN	NN	_	5	nn	_	_
5	subfragments	_	NNS	NNS	_	2	dobj	_	_
6	,	_	,	,	_	12	punct	_	_
7	the	_	DT	DT	_	10	det	_	_
8	mAb	_	NN	NN	_	10	nn	_	_
9	18C7	_	NN	NN	_	10	nn	_	_
10	epitope	_	NN	NN	_	12	nsubj	_	_
11	was	_	VBD	VBD	_	12	cop	_	_
12	located	_	JJ	JJ	_	0	root	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	16	det	_	_
15	N-terminal	_	JJ	JJ	_	16	amod	_	_
16	region	_	NN	NN	_	13	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	HBD	_	NN	NN	_	17	pobj	_	_
20	from	_	IN	IN	_	12	prep	_	_
21	Thr729	_	NN	NN	_	23	nn	_	_
22	to	_	TO	TO	_	23	dep	_	_
23	Leu765	_	NN	NN	_	20	pobj	_	_
24	.	_	.	.	_	12	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	then	_	RB	RB	_	3	advmod	_	_
3	studied	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	effect	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	antibody	_	NN	NN	_	6	pobj	_	_
9	on	_	IN	IN	_	5	prep	_	_
10	aldosterone	_	NN	NN	_	9	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	progesterone	_	NN	NN	_	10	conj	_	_
13	binding	_	NN	NN	_	10	dep	_	_
14	to	_	TO	TO	_	10	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	hMR	_	NN	NN	_	14	pobj	_	_
17	.	_	.	.	_	3	punct	_	_

1	When	_	WRB	WRB	_	4	advmod	_	_
2	18C7	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	incubated	_	VBN	VBN	_	11	advcl	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	liganded	_	JJ	JJ	_	7	amod	_	_
7	MR	_	NN	NN	_	5	pobj	_	_
8	,	_	,	,	_	11	punct	_	_
9	it	_	PRP	PRP	_	11	nsubj	_	_
10	was	_	VBD	VBD	_	11	cop	_	_
11	able	_	JJ	JJ	_	0	root	_	_
12	to	_	TO	TO	_	14	aux	_	_
13	partly	_	RB	RB	_	14	advmod	_	_
14	displace	_	VB	VB	_	11	xcomp	_	_
15	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
16	20	_	CD	CD	_	17	num	_	_
17	%	_	NN	NN	_	14	dep	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	the	_	DT	DT	_	20	det	_	_
20	hormone	_	NN	NN	_	14	dobj	_	_
21	from	_	IN	IN	_	14	prep	_	_
22	its	_	PRP$	PRP$	_	24	poss	_	_
23	binding	_	VBG	VBG	_	24	amod	_	_
24	site	_	NN	NN	_	21	pobj	_	_
25	.	_	.	.	_	11	punct	_	_

1	When	_	WRB	WRB	_	4	advmod	_	_
2	18C7	_	NN	NN	_	4	nsubjpass	_	_
3	was	_	VBD	VBD	_	4	auxpass	_	_
4	incubated	_	VBN	VBN	_	14	advcl	_	_
5	with	_	IN	IN	_	4	prep	_	_
6	MR	_	NN	NN	_	5	pobj	_	_
7	before	_	IN	IN	_	4	prep	_	_
8	aldosterone	_	NN	NN	_	7	pobj	_	_
9	or	_	CC	CC	_	8	cc	_	_
10	progesterone	_	NN	NN	_	8	conj	_	_
11	,	_	,	,	_	14	punct	_	_
12	the	_	DT	DT	_	13	det	_	_
13	antibody	_	NN	NN	_	14	nsubj	_	_
14	inhibited	_	VBD	VBD	_	0	root	_	_
15	75-80	_	CD	CD	_	16	num	_	_
16	%	_	NN	NN	_	14	dobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	19	det	_	_
19	binding	_	NN	NN	_	17	pobj	_	_
20	.	_	.	.	_	14	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	effect	_	NN	NN	_	9	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	18C7	_	NN	NN	_	3	pobj	_	_
5	on	_	IN	IN	_	2	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	binding	_	NN	NN	_	5	pobj	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	similar	_	JJ	JJ	_	0	root	_	_
10	with	_	IN	IN	_	9	prep	_	_
11	both	_	DT	DT	_	12	det	_	_
12	hormones	_	NNS	NNS	_	10	pobj	_	_
13	.	_	.	.	_	9	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	sucrose	_	NN	NN	_	4	nn	_	_
3	gradient	_	JJ	JJ	_	4	amod	_	_
4	analysis	_	NN	NN	_	5	nsubj	_	_
5	indicated	_	VBD	VBD	_	0	root	_	_
6	the	_	DT	DT	_	8	det	_	_
7	simultaneous	_	JJ	JJ	_	8	amod	_	_
8	presence	_	NN	NN	_	5	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	two	_	CD	CD	_	11	num	_	_
11	kinds	_	NNS	NNS	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	receptor	_	NN	NN	_	14	nn	_	_
14	complexes	_	NNS	NNS	_	12	pobj	_	_
15	:	_	:	:	_	5	punct	_	_
16	the	_	DT	DT	_	18	det	_	_
17	steroid-MR	_	JJ	JJ	_	18	amod	_	_
18	complex	_	NN	NN	_	5	dep	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	the	_	DT	DT	_	22	det	_	_
21	antibody-MR	_	JJ	JJ	_	22	amod	_	_
22	complex	_	NN	NN	_	18	conj	_	_
23	.	_	.	.	_	5	punct	_	_

1	After	_	IN	IN	_	14	mark	_	_
2	its	_	PRP$	PRP$	_	4	poss	_	_
3	associated	_	VBN	VBN	_	4	amod	_	_
4	proteins	_	NNS	NNS	_	14	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	especially	_	RB	RB	_	10	advmod	_	_
7	the	_	DT	DT	_	10	det	_	_
8	heat-shock	_	JJ	JJ	_	10	amod	_	_
9	protein	_	NN	NN	_	10	nn	_	_
10	hsp90	_	NN	NN	_	4	appos	_	_
11	,	_	,	,	_	4	punct	_	_
12	had	_	VBD	VBD	_	14	aux	_	_
13	been	_	VBN	VBN	_	14	cop	_	_
14	cross-linked	_	JJ	JJ	_	24	advcl	_	_
15	with	_	IN	IN	_	14	prep	_	_
16	the	_	DT	DT	_	17	det	_	_
17	hMR	_	NN	NN	_	15	pobj	_	_
18	by	_	IN	IN	_	14	prep	_	_
19	dimethylpimelimidate	_	NN	NN	_	18	pobj	_	_
20	,	_	,	,	_	24	punct	_	_
21	18C7	_	NN	NN	_	24	nsubj	_	_
22	was	_	VBD	VBD	_	24	cop	_	_
23	still	_	RB	RB	_	24	advmod	_	_
24	able	_	JJ	JJ	_	0	root	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	react	_	VB	VB	_	24	xcomp	_	_
27	with	_	IN	IN	_	26	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	receptor	_	NN	NN	_	27	pobj	_	_
30	.	_	.	.	_	24	punct	_	_

1	Our	_	PRP$	PRP$	_	2	poss	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicated	_	VBD	VBD	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	the	_	DT	DT	_	6	det	_	_
6	epitope	_	NN	NN	_	12	nsubjpass	_	_
7	recognized	_	VBN	VBN	_	6	vmod	_	_
8	by	_	IN	IN	_	7	prep	_	_
9	18C7	_	NN	NN	_	8	pobj	_	_
10	was	_	VBD	VBD	_	12	auxpass	_	_
11	directly	_	RB	RB	_	12	advmod	_	_
12	implicated	_	VBN	VBN	_	3	ccomp	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	hormone	_	NN	NN	_	15	nn	_	_
15	binding	_	NN	NN	_	13	pobj	_	_
16	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	lack	_	NN	NN	_	30	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	steroid	_	NN	NN	_	5	nn	_	_
5	binding	_	NN	NN	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	HBD	_	NN	NN	_	8	nn	_	_
8	mutants	_	NNS	NNS	_	6	pobj	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	Thr729-Leu765	_	JJ	JJ	_	12	amod	_	_
12	sequence	_	NN	NN	_	9	pobj	_	_
13	deleted	_	VBN	VBN	_	12	vmod	_	_
14	-LSB-	_	-LRB-	-LRB-	_	15	punct	_	_
15	Jalaguier	_	NNP	NNP	_	2	dep	_	_
16	,	_	,	,	_	15	punct	_	_
17	Mesnier	_	NNP	NNP	_	15	conj	_	_
18	,	_	,	,	_	15	punct	_	_
19	Leger	_	NNP	NNP	_	15	conj	_	_
20	and	_	CC	CC	_	15	cc	_	_
21	Auzou	_	NNP	NNP	_	15	conj	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	1996	_	CD	CD	_	15	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	J.Steroid	_	NNP	NNP	_	26	nn	_	_
26	Biochem.Mol.Biol.57	_	NNP	NNP	_	15	dep	_	_
27	,	_	,	,	_	15	punct	_	_
28	43-50	_	CD	CD	_	15	amod	_	_
29	-RSB-	_	-RRB-	-RRB-	_	15	punct	_	_
30	supports	_	VBZ	VBZ	_	0	root	_	_
31	this	_	DT	DT	_	32	det	_	_
32	hypothesis	_	NN	NN	_	30	dobj	_	_
33	.	_	.	.	_	30	punct	_	_

1	Because	_	IN	IN	_	2	mwe	_	_
2	of	_	IN	IN	_	12	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	similar	_	JJ	JJ	_	5	amod	_	_
5	behaviours	_	NNS	NNS	_	2	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	aldosterone	_	NN	NN	_	6	pobj	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	progesterone	_	NN	NN	_	7	conj	_	_
10	,	_	,	,	_	12	punct	_	_
11	we	_	PRP	PRP	_	12	nsubj	_	_
12	conclude	_	VBP	VBP	_	0	root	_	_
13	that	_	IN	IN	_	23	mark	_	_
14	the	_	DT	DT	_	17	det	_	_
15	N-terminal	_	JJ	JJ	_	17	amod	_	_
16	Thr729-Leu765	_	JJ	JJ	_	17	amod	_	_
17	region	_	NN	NN	_	23	nsubjpass	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	HBD	_	NN	NN	_	18	pobj	_	_
21	is	_	VBZ	VBZ	_	23	auxpass	_	_
22	similarly	_	RB	RB	_	23	advmod	_	_
23	involved	_	VBN	VBN	_	12	ccomp	_	_
24	in	_	IN	IN	_	23	prep	_	_
25	the	_	DT	DT	_	26	det	_	_
26	binding	_	NN	NN	_	24	pobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	both	_	DT	DT	_	29	det	_	_
29	hormones	_	NNS	NNS	_	27	pobj	_	_
30	.	_	.	.	_	12	punct	_	_

1	Triggering	_	NN	NN	_	6	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	HLA-DR	_	NN	NN	_	4	nn	_	_
4	antigens	_	NNS	NNS	_	2	pobj	_	_
5	differentially	_	RB	RB	_	6	advmod	_	_
6	modulates	_	VBZ	VBZ	_	0	root	_	_
7	tumor	_	NN	NN	_	10	nn	_	_
8	necrosis	_	NN	NN	_	10	nn	_	_
9	factor	_	NN	NN	_	10	nn	_	_
10	alpha	_	NN	NN	_	11	nn	_	_
11	release	_	NN	NN	_	6	dobj	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	at	_	IN	IN	_	11	prep	_	_
16	distinct	_	JJ	JJ	_	17	amod	_	_
17	stage	_	NN	NN	_	15	pobj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	maturation	_	NN	NN	_	18	pobj	_	_
20	.	_	.	.	_	6	punct	_	_

1	Triggering	_	NN	NN	_	24	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	HLA	_	NN	NN	_	6	nn	_	_
4	class	_	NN	NN	_	6	nn	_	_
5	II	_	CD	CD	_	6	num	_	_
6	antigens	_	NNS	NNS	_	2	pobj	_	_
7	by	_	IN	IN	_	1	prep	_	_
8	the	_	DT	DT	_	15	det	_	_
9	anti-HLA-DR	_	JJ	JJ	_	15	amod	_	_
10	monoclonal	_	JJ	JJ	_	15	amod	_	_
11	antibody	_	NN	NN	_	15	nn	_	_
12	-LRB-	_	-LRB-	-LRB-	_	15	punct	_	_
13	mAb	_	NN	NN	_	15	nn	_	_
14	-RRB-	_	-RRB-	-RRB-	_	15	punct	_	_
15	L243	_	NN	NN	_	7	pobj	_	_
16	significantly	_	RB	RB	_	24	advmod	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	P	_	NN	NN	_	16	dep	_	_
19	&lt;	_	JJR	JJR	_	18	amod	_	_
20	0.05	_	CD	CD	_	19	dep	_	_
21	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
22	and	_	CC	CC	_	16	cc	_	_
23	differentially	_	RB	RB	_	16	conj	_	_
24	enhanced	_	VBD	VBD	_	0	root	_	_
25	the	_	DT	DT	_	26	det	_	_
26	release	_	NN	NN	_	24	dobj	_	_
27	of	_	IN	IN	_	26	prep	_	_
28	tumor	_	NN	NN	_	31	nn	_	_
29	necrosis	_	NN	NN	_	31	nn	_	_
30	factor	_	NN	NN	_	31	nn	_	_
31	alpha	_	NN	NN	_	27	pobj	_	_
32	-LRB-	_	-LRB-	-LRB-	_	33	punct	_	_
33	TNF-alpha	_	NN	NN	_	31	appos	_	_
34	-RRB-	_	-RRB-	-RRB-	_	33	punct	_	_
35	by	_	IN	IN	_	26	prep	_	_
36	the	_	DT	DT	_	40	det	_	_
37	non-Hodgkin	_	JJ	JJ	_	40	amod	_	_
38	's	_	POS	POS	_	40	possessive	_	_
39	lymphoma	_	NN	NN	_	40	nn	_	_
40	cells	_	NNS	NNS	_	35	pobj	_	_
41	Ri-I	_	NN	NN	_	40	dep	_	_
42	,	_	,	,	_	41	punct	_	_
43	Ci-I	_	NN	NN	_	41	conj	_	_
44	,	_	,	,	_	41	punct	_	_
45	and	_	CC	CC	_	41	cc	_	_
46	Sc-I	_	NN	NN	_	41	conj	_	_
47	,	_	,	,	_	40	punct	_	_
48	which	_	WDT	WDT	_	49	nsubj	_	_
49	are	_	VBP	VBP	_	40	rcmod	_	_
50	at	_	IN	IN	_	49	prep	_	_
51	a	_	DT	DT	_	53	det	_	_
52	distinct	_	JJ	JJ	_	53	amod	_	_
53	stage	_	NN	NN	_	50	pobj	_	_
54	of	_	IN	IN	_	53	prep	_	_
55	B-cell	_	NN	NN	_	56	nn	_	_
56	differentiation	_	NN	NN	_	54	pobj	_	_
57	,	_	,	,	_	35	punct	_	_
58	and	_	CC	CC	_	35	cc	_	_
59	by	_	IN	IN	_	35	conj	_	_
60	the	_	DT	DT	_	66	det	_	_
61	more	_	RBR	RBR	_	62	advmod	_	_
62	mature	_	JJ	JJ	_	66	amod	_	_
63	Burkitt	_	NN	NN	_	66	nn	_	_
64	lymphoma	_	NN	NN	_	66	nn	_	_
65	cell	_	NN	NN	_	66	nn	_	_
66	Raji	_	NN	NN	_	59	pobj	_	_
67	;	_	:	:	_	24	punct	_	_
68	in	_	IN	IN	_	74	prep	_	_
69	contrast	_	NN	NN	_	68	pobj	_	_
70	,	_	,	,	_	74	punct	_	_
71	it	_	PRP	PRP	_	74	nsubj	_	_
72	did	_	VBD	VBD	_	74	aux	_	_
73	not	_	RB	RB	_	74	neg	_	_
74	induce	_	VB	VB	_	24	parataxis	_	_
75	TNF-alpha	_	NN	NN	_	76	nn	_	_
76	release	_	NN	NN	_	74	dobj	_	_
77	by	_	IN	IN	_	76	prep	_	_
78	the	_	DT	DT	_	81	det	_	_
79	pre-B	_	JJ	JJ	_	81	amod	_	_
80	leukemia	_	NN	NN	_	81	nn	_	_
81	cells	_	NNS	NNS	_	77	pobj	_	_
82	Nalm-6	_	NN	NN	_	81	dep	_	_
83	and	_	CC	CC	_	82	cc	_	_
84	BV173	_	NN	NN	_	82	conj	_	_
85	.	_	.	.	_	24	punct	_	_

1	TNF-alpha	_	NN	NN	_	2	nn	_	_
2	release	_	NN	NN	_	3	nsubj	_	_
3	peaked	_	VBD	VBD	_	0	root	_	_
4	at	_	IN	IN	_	3	prep	_	_
5	24	_	CD	CD	_	6	num	_	_
6	h	_	NN	NN	_	4	pobj	_	_
7	and	_	CC	CC	_	3	cc	_	_
8	decreased	_	VBD	VBD	_	3	conj	_	_
9	thereafter	_	RB	RB	_	8	advmod	_	_
10	,	_	,	,	_	3	punct	_	_
11	and	_	CC	CC	_	3	cc	_	_
12	it	_	PRP	PRP	_	15	nsubjpass	_	_
13	was	_	VBD	VBD	_	15	auxpass	_	_
14	dose	_	NN	NN	_	15	npadvmod	_	_
15	dependent	_	JJ	JJ	_	3	conj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	preceded	_	VBN	VBN	_	15	conj	_	_
18	by	_	IN	IN	_	17	prep	_	_
19	an	_	DT	DT	_	20	det	_	_
20	increase	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	TNF-alpha	_	NN	NN	_	23	nn	_	_
23	mRNA	_	NN	NN	_	21	pobj	_	_
24	detectable	_	JJ	JJ	_	20	amod	_	_
25	after	_	IN	IN	_	24	prep	_	_
26	3	_	CD	CD	_	27	num	_	_
27	h	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	stimulation	_	NN	NN	_	28	pobj	_	_
30	with	_	IN	IN	_	29	prep	_	_
31	mAb	_	NN	NN	_	32	nn	_	_
32	L243	_	NN	NN	_	30	pobj	_	_
33	.	_	.	.	_	3	punct	_	_

1	Secreted	_	VBN	VBN	_	2	amod	_	_
2	TNF-alpha	_	NN	NN	_	3	nsubj	_	_
3	mediated	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	enhancement	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	nuclear	_	JJ	JJ	_	10	amod	_	_
8	factor	_	NN	NN	_	10	nn	_	_
9	kappa	_	NN	NN	_	10	nn	_	_
10	B	_	NN	NN	_	6	pobj	_	_
11	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	10	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	and	_	CC	CC	_	5	cc	_	_
16	activator	_	NN	NN	_	17	nn	_	_
17	protein-1	_	NN	NN	_	22	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	19	punct	_	_
19	AP-1	_	NN	NN	_	17	appos	_	_
20	-RRB-	_	-RRB-	-RRB-	_	19	punct	_	_
21	binding	_	NN	NN	_	22	nn	_	_
22	activity	_	NN	NN	_	5	conj	_	_
23	;	_	:	:	_	3	punct	_	_
24	in	_	IN	IN	_	41	prep	_	_
25	fact	_	NN	NN	_	24	pobj	_	_
26	,	_	,	,	_	41	punct	_	_
27	the	_	DT	DT	_	28	det	_	_
28	triggering	_	NN	NN	_	41	nsubj	_	_
29	of	_	IN	IN	_	28	prep	_	_
30	HLA-DR	_	NN	NN	_	31	nn	_	_
31	antigens	_	NNS	NNS	_	29	pobj	_	_
32	in	_	IN	IN	_	28	prep	_	_
33	the	_	DT	DT	_	34	det	_	_
34	presence	_	NN	NN	_	32	pobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	antihuman	_	JJ	JJ	_	38	amod	_	_
37	TNF-alpha-neutralizing	_	JJ	JJ	_	38	amod	_	_
38	antibodies	_	NNS	NNS	_	35	pobj	_	_
39	did	_	VBD	VBD	_	41	aux	_	_
40	not	_	RB	RB	_	41	neg	_	_
41	upregulate	_	VB	VB	_	3	parataxis	_	_
42	NF-kappa	_	NN	NN	_	43	nn	_	_
43	B	_	NN	NN	_	41	dobj	_	_
44	and	_	CC	CC	_	43	cc	_	_
45	AP-1	_	NN	NN	_	43	conj	_	_
46	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	released	_	VBN	VBN	_	5	amod	_	_
5	TNF-alpha	_	NN	NN	_	8	nsubj	_	_
6	was	_	VBD	VBD	_	8	cop	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	responsible	_	JJ	JJ	_	0	root	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	12	det	_	_
11	homotypic	_	JJ	JJ	_	12	amod	_	_
12	aggregation	_	NN	NN	_	9	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	Ri-I	_	NN	NN	_	13	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	Ci-I	_	NN	NN	_	14	conj	_	_
17	,	_	,	,	_	14	punct	_	_
18	Sc-I	_	NN	NN	_	14	conj	_	_
19	,	_	,	,	_	14	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	Raji	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	14	conj	_	_
23	induced	_	VBN	VBN	_	14	vmod	_	_
24	by	_	IN	IN	_	23	prep	_	_
25	mAb	_	NN	NN	_	26	nn	_	_
26	L243	_	NN	NN	_	24	pobj	_	_
27	,	_	,	,	_	8	punct	_	_
28	and	_	CC	CC	_	8	cc	_	_
29	it	_	PRP	PRP	_	32	nsubj	_	_
30	did	_	VBD	VBD	_	32	aux	_	_
31	not	_	RB	RB	_	32	neg	_	_
32	affect	_	VB	VB	_	8	conj	_	_
33	the	_	DT	DT	_	34	det	_	_
34	proliferation	_	NN	NN	_	32	dobj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	B	_	NN	NN	_	37	nn	_	_
37	cells	_	NNS	NNS	_	35	pobj	_	_
38	investigated	_	VBN	VBN	_	37	vmod	_	_
39	.	_	.	.	_	8	punct	_	_

1	Altogether	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	our	_	PRP$	PRP$	_	4	poss	_	_
4	data	_	NNS	NNS	_	5	nsubj	_	_
5	demonstrate	_	VBP	VBP	_	0	root	_	_
6	that	_	IN	IN	_	24	mark	_	_
7	:	_	:	:	_	24	punct	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	a	_	LS	LS	_	24	dep	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	the	_	DT	DT	_	12	det	_	_
12	ability	_	NN	NN	_	24	nsubj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	B	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	to	_	TO	TO	_	17	aux	_	_
17	release	_	VB	VB	_	12	vmod	_	_
18	TNF-alpha	_	NN	NN	_	17	dobj	_	_
19	after	_	IN	IN	_	17	prep	_	_
20	triggering	_	NN	NN	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	HLA-DR	_	NN	NN	_	23	nn	_	_
23	antigens	_	NNS	NNS	_	21	pobj	_	_
24	depends	_	VBZ	VBZ	_	5	ccomp	_	_
25	on	_	IN	IN	_	24	prep	_	_
26	their	_	PRP$	PRP$	_	27	poss	_	_
27	stage	_	NN	NN	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	differentiation	_	NN	NN	_	28	pobj	_	_
30	;	_	:	:	_	24	punct	_	_
31	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
32	b	_	LS	LS	_	38	dep	_	_
33	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
34	levels	_	NNS	NNS	_	38	nsubj	_	_
35	of	_	IN	IN	_	34	prep	_	_
36	released	_	VBN	VBN	_	37	amod	_	_
37	TNF-alpha	_	NN	NN	_	35	pobj	_	_
38	seem	_	VBP	VBP	_	24	conj	_	_
39	to	_	TO	TO	_	40	aux	_	_
40	correlate	_	VB	VB	_	38	xcomp	_	_
41	with	_	IN	IN	_	40	prep	_	_
42	the	_	DT	DT	_	43	det	_	_
43	stage	_	NN	NN	_	41	pobj	_	_
44	of	_	IN	IN	_	43	prep	_	_
45	B-cell	_	NN	NN	_	46	nn	_	_
46	maturation	_	NN	NN	_	44	pobj	_	_
47	but	_	CC	CC	_	38	cc	_	_
48	do	_	VBP	VBP	_	50	aux	_	_
49	not	_	RB	RB	_	50	neg	_	_
50	correlate	_	VB	VB	_	38	conj	_	_
51	with	_	IN	IN	_	50	prep	_	_
52	the	_	DT	DT	_	53	det	_	_
53	amounts	_	NNS	NNS	_	51	pobj	_	_
54	of	_	IN	IN	_	53	prep	_	_
55	cell	_	NN	NN	_	58	nn	_	_
56	surface	_	NN	NN	_	58	nn	_	_
57	HLA-DR	_	NN	NN	_	58	nn	_	_
58	antigens	_	NNS	NNS	_	54	pobj	_	_
59	;	_	:	:	_	24	punct	_	_
60	-LRB-	_	-LRB-	-LRB-	_	61	punct	_	_
61	c	_	LS	LS	_	65	dep	_	_
62	-RRB-	_	-RRB-	-RRB-	_	61	punct	_	_
63	secreted	_	VBN	VBN	_	64	amod	_	_
64	TNF-alpha	_	NN	NN	_	65	nsubj	_	_
65	regulates	_	VBZ	VBZ	_	24	conj	_	_
66	the	_	DT	DT	_	67	det	_	_
67	levels	_	NNS	NNS	_	65	dobj	_	_
68	of	_	IN	IN	_	67	prep	_	_
69	expression	_	NN	NN	_	68	pobj	_	_
70	of	_	IN	IN	_	69	prep	_	_
71	NF-kappa	_	NN	NN	_	72	nn	_	_
72	B	_	NN	NN	_	70	pobj	_	_
73	and	_	CC	CC	_	72	cc	_	_
74	AP-1	_	NN	NN	_	72	conj	_	_
75	by	_	IN	IN	_	65	prep	_	_
76	an	_	DT	DT	_	78	det	_	_
77	autocrine	_	JJ	JJ	_	78	amod	_	_
78	loop	_	NN	NN	_	75	pobj	_	_
79	;	_	:	:	_	24	punct	_	_
80	and	_	CC	CC	_	24	cc	_	_
81	-LRB-	_	-LRB-	-LRB-	_	82	punct	_	_
82	d	_	LS	LS	_	93	dep	_	_
83	-RRB-	_	-RRB-	-RRB-	_	82	punct	_	_
84	intracellular	_	JJ	JJ	_	85	amod	_	_
85	signals	_	NNS	NNS	_	93	nsubj	_	_
86	mediating	_	VBG	VBG	_	85	vmod	_	_
87	TNF-alpha	_	NN	NN	_	88	nn	_	_
88	release	_	NN	NN	_	86	dobj	_	_
89	by	_	IN	IN	_	88	prep	_	_
90	B	_	NN	NN	_	91	nn	_	_
91	cells	_	NNS	NNS	_	89	pobj	_	_
92	are	_	VBP	VBP	_	93	cop	_	_
93	distinct	_	JJ	JJ	_	24	conj	_	_
94	from	_	IN	IN	_	93	prep	_	_
95	those	_	DT	DT	_	94	pobj	_	_
96	regulating	_	VBG	VBG	_	95	vmod	_	_
97	homotypic	_	JJ	JJ	_	98	amod	_	_
98	aggregation	_	NN	NN	_	96	dobj	_	_
99	and	_	CC	CC	_	98	cc	_	_
100	proliferation	_	NN	NN	_	98	conj	_	_
101	.	_	.	.	_	5	punct	_	_

1	Immediate	_	JJ	JJ	_	2	amod	_	_
2	early	_	JJ	JJ	_	10	nsubj	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	early	_	JJ	JJ	_	7	amod	_	_
5	lytic	_	JJ	JJ	_	7	amod	_	_
6	cycle	_	NN	NN	_	7	nn	_	_
7	proteins	_	NNS	NNS	_	2	conj	_	_
8	are	_	VBP	VBP	_	10	cop	_	_
9	frequent	_	JJ	JJ	_	10	amod	_	_
10	targets	_	NNS	NNS	_	0	root	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	18	det	_	_
13	Epstein-Barr	_	JJ	JJ	_	14	amod	_	_
14	virus-induced	_	JJ	JJ	_	18	amod	_	_
15	cytotoxic	_	JJ	JJ	_	14	dep	_	_
16	T	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	response	_	NN	NN	_	11	pobj	_	_
19	.	_	.	.	_	10	punct	_	_

1	Epstein-Barr	_	JJ	JJ	_	2	amod	_	_
2	virus	_	NN	NN	_	12	nsubj	_	_
3	-LRB-	_	-LRB-	-LRB-	_	4	punct	_	_
4	EBV	_	NN	NN	_	2	appos	_	_
5	-RRB-	_	-RRB-	-RRB-	_	4	punct	_	_
6	,	_	,	,	_	2	punct	_	_
7	a	_	DT	DT	_	9	det	_	_
8	human	_	JJ	JJ	_	9	amod	_	_
9	gamma-herpesvirus	_	NN	NN	_	2	appos	_	_
10	,	_	,	,	_	2	punct	_	_
11	can	_	MD	MD	_	12	aux	_	_
12	establish	_	VB	VB	_	0	root	_	_
13	both	_	CC	CC	_	14	preconj	_	_
14	nonproductive	_	JJ	JJ	_	12	dobj	_	_
15	-LRB-	_	-LRB-	-LRB-	_	16	punct	_	_
16	latent	_	JJ	JJ	_	14	dep	_	_
17	-RRB-	_	-RRB-	-RRB-	_	16	punct	_	_
18	and	_	CC	CC	_	14	cc	_	_
19	productive	_	JJ	JJ	_	14	conj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	lytic	_	JJ	JJ	_	19	dep	_	_
22	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
23	infections	_	NNS	NNS	_	14	dep	_	_
24	.	_	.	.	_	12	punct	_	_

1	Although	_	IN	IN	_	17	mark	_	_
2	the	_	DT	DT	_	10	det	_	_
3	CD8+	_	JJ	JJ	_	10	amod	_	_
4	cytotoxic	_	JJ	JJ	_	6	amod	_	_
5	T	_	NN	NN	_	6	nn	_	_
6	lymphocyte	_	NN	NN	_	10	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	CTL	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	response	_	NN	NN	_	17	nsubjpass	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	latently	_	RB	RB	_	14	advmod	_	_
13	infected	_	JJ	JJ	_	14	amod	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	is	_	VBZ	VBZ	_	17	auxpass	_	_
16	well	_	RB	RB	_	17	advmod	_	_
17	characterized	_	VBN	VBN	_	22	advcl	_	_
18	,	_	,	,	_	22	punct	_	_
19	very	_	RB	RB	_	20	advmod	_	_
20	little	_	JJ	JJ	_	22	nsubjpass	_	_
21	is	_	VBZ	VBZ	_	22	auxpass	_	_
22	known	_	VBN	VBN	_	0	root	_	_
23	about	_	IN	IN	_	22	prep	_	_
24	T	_	NN	NN	_	26	nn	_	_
25	cell	_	NN	NN	_	26	nn	_	_
26	controls	_	NNS	NNS	_	23	pobj	_	_
27	over	_	IN	IN	_	26	prep	_	_
28	lytic	_	JJ	JJ	_	29	amod	_	_
29	infection	_	NN	NN	_	27	pobj	_	_
30	;	_	:	:	_	22	punct	_	_
31	this	_	DT	DT	_	32	det	_	_
32	imbalance	_	NN	NN	_	36	nsubj	_	_
33	in	_	IN	IN	_	32	prep	_	_
34	our	_	PRP$	PRP$	_	35	poss	_	_
35	understanding	_	NN	NN	_	33	pobj	_	_
36	belies	_	VBZ	VBZ	_	22	parataxis	_	_
37	the	_	DT	DT	_	38	det	_	_
38	importance	_	NN	NN	_	36	dobj	_	_
39	of	_	IN	IN	_	38	prep	_	_
40	virus-replicative	_	JJ	JJ	_	41	amod	_	_
41	lesions	_	NNS	NNS	_	39	pobj	_	_
42	in	_	IN	IN	_	38	prep	_	_
43	several	_	JJ	JJ	_	44	amod	_	_
44	aspects	_	NNS	NNS	_	42	pobj	_	_
45	of	_	IN	IN	_	44	prep	_	_
46	EBV	_	NN	NN	_	48	nn	_	_
47	disease	_	NN	NN	_	48	nn	_	_
48	pathogenesis	_	NN	NN	_	45	pobj	_	_
49	.	_	.	.	_	22	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	present	_	JJ	JJ	_	3	amod	_	_
3	work	_	NN	NN	_	4	nsubj	_	_
4	shows	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	17	mark	_	_
6	the	_	DT	DT	_	10	det	_	_
7	primary	_	JJ	JJ	_	10	amod	_	_
8	CD8+	_	JJ	JJ	_	10	amod	_	_
9	CTL	_	NN	NN	_	10	nn	_	_
10	response	_	NN	NN	_	17	nsubj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	EBV	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	infectious	_	JJ	JJ	_	16	amod	_	_
15	mononucleosis	_	NN	NN	_	16	nn	_	_
16	patients	_	NNS	NNS	_	13	pobj	_	_
17	contains	_	VBZ	VBZ	_	4	ccomp	_	_
18	multiple	_	JJ	JJ	_	21	amod	_	_
19	lytic	_	JJ	JJ	_	18	dep	_	_
20	antigen-specific	_	JJ	JJ	_	18	dep	_	_
21	reactivities	_	NNS	NNS	_	17	dobj	_	_
22	at	_	IN	IN	_	21	prep	_	_
23	levels	_	NNS	NNS	_	22	pobj	_	_
24	at	_	IN	IN	_	27	advmod	_	_
25	least	_	JJS	JJS	_	24	pobj	_	_
26	as	_	RB	RB	_	27	advmod	_	_
27	high	_	JJ	JJ	_	23	amod	_	_
28	as	_	IN	IN	_	27	prep	_	_
29	those	_	DT	DT	_	28	pobj	_	_
30	seen	_	VBN	VBN	_	29	vmod	_	_
31	against	_	IN	IN	_	30	prep	_	_
32	latent	_	JJ	JJ	_	33	amod	_	_
33	antigens	_	NNS	NNS	_	31	pobj	_	_
34	;	_	:	:	_	4	punct	_	_
35	similar	_	JJ	JJ	_	36	amod	_	_
36	reactivities	_	NNS	NNS	_	39	nsubj	_	_
37	are	_	VBP	VBP	_	39	cop	_	_
38	also	_	RB	RB	_	39	advmod	_	_
39	detectable	_	JJ	JJ	_	4	parataxis	_	_
40	in	_	IN	IN	_	39	prep	_	_
41	CTL	_	NN	NN	_	42	nn	_	_
42	memory	_	NN	NN	_	40	pobj	_	_
43	.	_	.	.	_	4	punct	_	_

1	Clonal	_	JJ	JJ	_	2	amod	_	_
2	analysis	_	NN	NN	_	3	nsubj	_	_
3	revealed	_	VBD	VBD	_	0	root	_	_
4	individual	_	JJ	JJ	_	5	amod	_	_
5	responses	_	NNS	NNS	_	3	dobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	two	_	CD	CD	_	11	num	_	_
9	immediate	_	JJ	JJ	_	11	amod	_	_
10	early	_	JJ	JJ	_	11	amod	_	_
11	proteins	_	NNS	NNS	_	6	pobj	_	_
12	BZLF1	_	NN	NN	_	11	dep	_	_
13	and	_	CC	CC	_	12	cc	_	_
14	BRLF1	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	6	punct	_	_
16	and	_	CC	CC	_	6	cc	_	_
17	to	_	TO	TO	_	6	conj	_	_
18	three	_	CD	CD	_	17	pobj	_	_
19	-LRB-	_	-LRB-	-LRB-	_	20	punct	_	_
20	BMLF1	_	NN	NN	_	18	dep	_	_
21	,	_	,	,	_	20	punct	_	_
22	BMRF1	_	NN	NN	_	20	conj	_	_
23	,	_	,	,	_	20	punct	_	_
24	and	_	CC	CC	_	20	cc	_	_
25	BALF2	_	NN	NN	_	20	conj	_	_
26	-RRB-	_	-RRB-	-RRB-	_	20	punct	_	_
27	of	_	IN	IN	_	6	dep	_	_
28	the	_	DT	DT	_	31	det	_	_
29	six	_	CD	CD	_	31	num	_	_
30	early	_	JJ	JJ	_	31	amod	_	_
31	proteins	_	NNS	NNS	_	27	pobj	_	_
32	tested	_	VBN	VBN	_	31	vmod	_	_
33	.	_	.	.	_	3	punct	_	_

1	In	_	IN	IN	_	17	prep	_	_
2	several	_	JJ	JJ	_	3	amod	_	_
3	cases	_	NNS	NNS	_	1	pobj	_	_
4	,	_	,	,	_	17	punct	_	_
5	the	_	DT	DT	_	7	det	_	_
6	peptide	_	NN	NN	_	7	nn	_	_
7	epitope	_	NN	NN	_	17	nsubjpass	_	_
8	and	_	CC	CC	_	7	cc	_	_
9	HLA-restricting	_	JJ	JJ	_	10	amod	_	_
10	determinant	_	NN	NN	_	7	conj	_	_
11	recognized	_	VBN	VBN	_	7	vmod	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	these	_	DT	DT	_	14	det	_	_
14	CTLs	_	NNS	NNS	_	12	pobj	_	_
15	has	_	VBZ	VBZ	_	17	aux	_	_
16	been	_	VBN	VBN	_	17	auxpass	_	_
17	defined	_	VBN	VBN	_	0	root	_	_
18	,	_	,	,	_	17	punct	_	_
19	one	_	CD	CD	_	21	num	_	_
20	unusual	_	JJ	JJ	_	21	amod	_	_
21	feature	_	NN	NN	_	24	nsubj	_	_
22	being	_	VBG	VBG	_	24	cop	_	_
23	the	_	DT	DT	_	24	det	_	_
24	number	_	NN	NN	_	17	ccomp	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	responses	_	NNS	NNS	_	25	pobj	_	_
27	restricted	_	JJ	JJ	_	26	amod	_	_
28	through	_	IN	IN	_	27	prep	_	_
29	HLA-C	_	NN	NN	_	30	nn	_	_
30	alleles	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	17	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	work	_	NN	NN	_	4	nsubj	_	_
3	strongly	_	RB	RB	_	4	advmod	_	_
4	suggests	_	VBZ	VBZ	_	0	root	_	_
5	that	_	IN	IN	_	9	mark	_	_
6	EBV-replicative	_	JJ	JJ	_	7	amod	_	_
7	lesions	_	NNS	NNS	_	9	nsubj	_	_
8	are	_	VBP	VBP	_	9	cop	_	_
9	subject	_	JJ	JJ	_	4	ccomp	_	_
10	to	_	TO	TO	_	9	prep	_	_
11	direct	_	JJ	JJ	_	13	amod	_	_
12	CTL	_	NN	NN	_	13	nn	_	_
13	control	_	NN	NN	_	10	pobj	_	_
14	in	_	FW	FW	_	15	nn	_	_
15	vivo	_	FW	FW	_	9	advmod	_	_
16	and	_	CC	CC	_	9	cc	_	_
17	that	_	IN	IN	_	27	mark	_	_
18	immediate	_	JJ	JJ	_	19	amod	_	_
19	early	_	JJ	JJ	_	27	nsubj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	early	_	JJ	JJ	_	19	conj	_	_
22	proteins	_	NNS	NNS	_	19	dep	_	_
23	are	_	VBP	VBP	_	27	cop	_	_
24	frequently	_	RB	RB	_	27	advmod	_	_
25	the	_	DT	DT	_	27	det	_	_
26	immunodominant	_	JJ	JJ	_	27	amod	_	_
27	targets	_	NNS	NNS	_	9	conj	_	_
28	.	_	.	.	_	4	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	contrasts	_	VBZ	VBZ	_	0	root	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	findings	_	NNS	NNS	_	3	pobj	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	alpha-	_	NN	NN	_	5	pobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	beta-herpesvirus	_	NN	NN	_	6	conj	_	_
9	systems	_	NNS	NNS	_	6	dep	_	_
10	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
11	herpes	_	NN	NN	_	12	nn	_	_
12	simplex	_	NN	NN	_	6	dep	_	_
13	,	_	,	,	_	12	punct	_	_
14	cytomegalovirus	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
16	where	_	WRB	WRB	_	26	advmod	_	_
17	viral	_	JJ	JJ	_	18	amod	_	_
18	interference	_	NN	NN	_	26	nsubj	_	_
19	with	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	antigen-processing	_	JJ	JJ	_	22	amod	_	_
22	pathway	_	NN	NN	_	19	pobj	_	_
23	during	_	IN	IN	_	18	prep	_	_
24	lytic	_	JJ	JJ	_	25	amod	_	_
25	infection	_	NN	NN	_	23	pobj	_	_
26	renders	_	VBZ	VBZ	_	6	rcmod	_	_
27	immediate	_	JJ	JJ	_	28	amod	_	_
28	early	_	JJ	JJ	_	34	nsubj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	early	_	JJ	JJ	_	28	conj	_	_
31	proteins	_	NNS	NNS	_	28	dep	_	_
32	much	_	RB	RB	_	33	advmod	_	_
33	less	_	RBR	RBR	_	34	advmod	_	_
34	immunogenic	_	JJ	JJ	_	26	xcomp	_	_
35	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	unique	_	JJ	JJ	_	3	amod	_	_
3	capacity	_	NN	NN	_	20	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	gamma-herpesvirus	_	NN	NN	_	4	pobj	_	_
6	to	_	TO	TO	_	7	aux	_	_
7	amplify	_	VB	VB	_	3	vmod	_	_
8	the	_	DT	DT	_	10	det	_	_
9	viral	_	JJ	JJ	_	10	amod	_	_
10	load	_	NN	NN	_	7	dobj	_	_
11	in	_	FW	FW	_	12	nn	_	_
12	vivo	_	FW	FW	_	7	advmod	_	_
13	through	_	IN	IN	_	7	prep	_	_
14	a	_	DT	DT	_	17	det	_	_
15	latent	_	JJ	JJ	_	17	amod	_	_
16	growth-transforming	_	JJ	JJ	_	15	dep	_	_
17	infection	_	NN	NN	_	13	pobj	_	_
18	may	_	MD	MD	_	20	aux	_	_
19	have	_	VB	VB	_	20	aux	_	_
20	rendered	_	VBN	VBN	_	0	root	_	_
21	these	_	DT	DT	_	22	det	_	_
22	agents	_	NNS	NNS	_	24	nsubj	_	_
23	less	_	RBR	RBR	_	24	advmod	_	_
24	dependent	_	JJ	JJ	_	20	xcomp	_	_
25	upon	_	IN	IN	_	24	prep	_	_
26	viral	_	JJ	JJ	_	27	amod	_	_
27	replication	_	NN	NN	_	25	pobj	_	_
28	as	_	IN	IN	_	20	prep	_	_
29	a	_	DT	DT	_	30	det	_	_
30	means	_	NN	NN	_	28	pobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	successfully	_	RB	RB	_	33	advmod	_	_
33	colonizing	_	VBG	VBG	_	31	pcomp	_	_
34	their	_	PRP$	PRP$	_	35	poss	_	_
35	hosts	_	NNS	NNS	_	33	dobj	_	_
36	.	_	.	.	_	20	punct	_	_

1	A	_	DT	DT	_	4	det	_	_
2	new	_	JJ	JJ	_	4	amod	_	_
3	mouse	_	NN	NN	_	4	nn	_	_
4	gene	_	NN	NN	_	17	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	SRG3	_	NN	NN	_	4	appos	_	_
7	,	_	,	,	_	4	punct	_	_
8	related	_	JJ	JJ	_	4	amod	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	SWI3	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	Saccharomyces	_	FW	FW	_	14	nn	_	_
14	cerevisiae	_	FW	FW	_	12	pobj	_	_
15	,	_	,	,	_	4	punct	_	_
16	is	_	VBZ	VBZ	_	17	auxpass	_	_
17	required	_	VBN	VBN	_	0	root	_	_
18	for	_	IN	IN	_	17	prep	_	_
19	apoptosis	_	NN	NN	_	18	pobj	_	_
20	induced	_	VBN	VBN	_	19	vmod	_	_
21	by	_	IN	IN	_	20	prep	_	_
22	glucocorticoids	_	NNS	NNS	_	21	pobj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	a	_	DT	DT	_	27	det	_	_
25	thymoma	_	NN	NN	_	27	nn	_	_
26	cell	_	NN	NN	_	27	nn	_	_
27	line	_	NN	NN	_	23	pobj	_	_
28	.	_	.	.	_	17	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	isolated	_	VBD	VBD	_	0	root	_	_
3	a	_	DT	DT	_	6	det	_	_
4	new	_	JJ	JJ	_	6	amod	_	_
5	mouse	_	NN	NN	_	6	nn	_	_
6	gene	_	NN	NN	_	2	dobj	_	_
7	that	_	WDT	WDT	_	10	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	10	auxpass	_	_
9	highly	_	RB	RB	_	10	advmod	_	_
10	expressed	_	VBN	VBN	_	6	rcmod	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	thymocytes	_	NNS	NNS	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	testis	_	NN	NN	_	12	conj	_	_
15	,	_	,	,	_	12	punct	_	_
16	and	_	CC	CC	_	12	cc	_	_
17	brain	_	NN	NN	_	12	conj	_	_
18	.	_	.	.	_	2	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	gene	_	NN	NN	_	6	nsubj	_	_
3	,	_	,	,	_	2	punct	_	_
4	SRG3	_	NN	NN	_	2	appos	_	_
5	,	_	,	,	_	2	punct	_	_
6	showed	_	VBD	VBD	_	0	root	_	_
7	a	_	DT	DT	_	10	det	_	_
8	significant	_	JJ	JJ	_	10	amod	_	_
9	sequence	_	NN	NN	_	10	nn	_	_
10	homology	_	NN	NN	_	6	dobj	_	_
11	to	_	TO	TO	_	10	prep	_	_
12	SWI3	_	NN	NN	_	11	pobj	_	_
13	,	_	,	,	_	12	punct	_	_
14	a	_	DT	DT	_	17	det	_	_
15	yeast	_	NN	NN	_	17	nn	_	_
16	transcriptional	_	JJ	JJ	_	17	amod	_	_
17	activator	_	NN	NN	_	12	appos	_	_
18	,	_	,	,	_	12	punct	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	its	_	PRP$	PRP$	_	23	poss	_	_
21	human	_	JJ	JJ	_	23	amod	_	_
22	homolog	_	NN	NN	_	23	nn	_	_
23	BAF155	_	NN	NN	_	12	conj	_	_
24	.	_	.	.	_	6	punct	_	_

1	SRG3	_	NN	NN	_	2	nsubj	_	_
2	encodes	_	VBZ	VBZ	_	0	root	_	_
3	1,100	_	CD	CD	_	5	num	_	_
4	amino	_	NN	NN	_	5	nn	_	_
5	acids	_	NNS	NNS	_	2	dobj	_	_
6	and	_	CC	CC	_	2	cc	_	_
7	has	_	VBZ	VBZ	_	2	conj	_	_
8	33-47	_	CD	CD	_	9	dep	_	_
9	%	_	NN	NN	_	10	dep	_	_
10	identity	_	NN	NN	_	7	dobj	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	SWI3	_	NN	NN	_	13	nn	_	_
13	protein	_	NN	NN	_	11	pobj	_	_
14	over	_	IN	IN	_	10	prep	_	_
15	three	_	CD	CD	_	16	num	_	_
16	regions	_	NNS	NNS	_	14	pobj	_	_
17	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	SRG3	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	4	nsubj	_	_
4	contains	_	VBZ	VBZ	_	0	root	_	_
5	an	_	DT	DT	_	8	det	_	_
6	acidic	_	JJ	JJ	_	8	amod	_	_
7	NH2	_	NN	NN	_	8	nn	_	_
8	terminus	_	NN	NN	_	4	dobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	a	_	DT	DT	_	14	det	_	_
11	myb-like	_	JJ	JJ	_	14	amod	_	_
12	DNA	_	NN	NN	_	14	nn	_	_
13	binding	_	NN	NN	_	14	nn	_	_
14	domain	_	NN	NN	_	8	conj	_	_
15	,	_	,	,	_	8	punct	_	_
16	a	_	DT	DT	_	18	det	_	_
17	leucine-zipper	_	JJ	JJ	_	18	amod	_	_
18	motif	_	NN	NN	_	8	conj	_	_
19	,	_	,	,	_	8	punct	_	_
20	and	_	CC	CC	_	8	cc	_	_
21	a	_	DT	DT	_	25	det	_	_
22	proline-	_	NN	NN	_	25	nn	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	glutamine-rich	_	JJ	JJ	_	22	conj	_	_
25	region	_	NN	NN	_	8	conj	_	_
26	at	_	IN	IN	_	25	prep	_	_
27	its	_	PRP$	PRP$	_	29	poss	_	_
28	COOH	_	NN	NN	_	29	nn	_	_
29	terminus	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	Rabbit	_	NN	NN	_	2	nn	_	_
2	antiserum	_	NN	NN	_	11	nsubj	_	_
3	raised	_	VBN	VBN	_	2	vmod	_	_
4	against	_	IN	IN	_	3	prep	_	_
5	a	_	DT	DT	_	7	det	_	_
6	COOH-terminal	_	JJ	JJ	_	7	amod	_	_
7	polypeptide	_	NN	NN	_	4	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	SRG3	_	NN	NN	_	8	pobj	_	_
11	recognized	_	VBD	VBD	_	0	root	_	_
12	a	_	DT	DT	_	13	det	_	_
13	protein	_	NN	NN	_	11	dobj	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	an	_	DT	DT	_	18	det	_	_
16	apparent	_	JJ	JJ	_	18	amod	_	_
17	molecular	_	JJ	JJ	_	18	amod	_	_
18	mass	_	NN	NN	_	14	pobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	155	_	CD	CD	_	21	num	_	_
21	kD	_	NN	NN	_	19	pobj	_	_
22	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	serum	_	NN	NN	_	4	nsubj	_	_
3	also	_	RB	RB	_	4	advmod	_	_
4	detected	_	VBD	VBD	_	0	root	_	_
5	a	_	DT	DT	_	7	det	_	_
6	170-kD	_	JJ	JJ	_	7	amod	_	_
7	protein	_	NN	NN	_	4	dobj	_	_
8	that	_	WDT	WDT	_	9	nsubj	_	_
9	seems	_	VBZ	VBZ	_	7	rcmod	_	_
10	to	_	TO	TO	_	14	aux	_	_
11	be	_	VB	VB	_	14	cop	_	_
12	a	_	DT	DT	_	14	det	_	_
13	mouse	_	NN	NN	_	14	nn	_	_
14	homologue	_	NN	NN	_	9	xcomp	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	17	amod	_	_
17	BAF170	_	NN	NN	_	15	pobj	_	_
18	.	_	.	.	_	4	punct	_	_

1	Immunoprecipitation	_	NN	NN	_	13	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cell	_	NN	NN	_	4	nn	_	_
4	extract	_	NN	NN	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	antiserum	_	NN	NN	_	5	pobj	_	_
8	against	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	mouse	_	NN	NN	_	11	nn	_	_
11	SRG3	_	NN	NN	_	8	pobj	_	_
12	also	_	RB	RB	_	13	advmod	_	_
13	brought	_	VBD	VBD	_	0	root	_	_
14	down	_	RP	RP	_	13	prt	_	_
15	a	_	DT	DT	_	17	det	_	_
16	195-kD	_	JJ	JJ	_	17	amod	_	_
17	protein	_	NN	NN	_	13	dobj	_	_
18	that	_	WDT	WDT	_	21	nsubjpass	_	_
19	could	_	MD	MD	_	21	aux	_	_
20	be	_	VB	VB	_	21	auxpass	_	_
21	recognized	_	VBN	VBN	_	17	rcmod	_	_
22	by	_	IN	IN	_	21	prep	_	_
23	an	_	DT	DT	_	24	det	_	_
24	antiserum	_	NN	NN	_	22	pobj	_	_
25	raised	_	VBN	VBN	_	24	vmod	_	_
26	against	_	IN	IN	_	25	prep	_	_
27	human	_	JJ	JJ	_	29	amod	_	_
28	SWI2	_	NN	NN	_	29	nn	_	_
29	protein	_	NN	NN	_	26	pobj	_	_
30	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	8	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	SRG3	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	8	nsubj	_	_
8	associates	_	VBZ	VBZ	_	3	ccomp	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	12	det	_	_
11	mouse	_	NN	NN	_	12	nn	_	_
12	SWI2	_	NN	NN	_	9	pobj	_	_
13	.	_	.	.	_	3	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	SRG3	_	NN	NN	_	3	nn	_	_
3	protein	_	NN	NN	_	5	nsubjpass	_	_
4	is	_	VBZ	VBZ	_	5	auxpass	_	_
5	expressed	_	VBN	VBN	_	0	root	_	_
6	about	_	RB	RB	_	8	quantmod	_	_
7	three	_	CD	CD	_	8	number	_	_
8	times	_	NNS	NNS	_	9	dep	_	_
9	higher	_	JJR	JJR	_	5	advmod	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	thymocytes	_	NNS	NNS	_	10	pobj	_	_
12	than	_	IN	IN	_	9	prep	_	_
13	in	_	IN	IN	_	12	pcomp	_	_
14	peripheral	_	JJ	JJ	_	15	amod	_	_
15	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	5	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	expression	_	NN	NN	_	17	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	anti-sense	_	JJ	JJ	_	5	amod	_	_
5	RNA	_	NN	NN	_	3	pobj	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	SRG3	_	NN	NN	_	8	nn	_	_
8	mRNA	_	NN	NN	_	6	pobj	_	_
9	in	_	IN	IN	_	2	prep	_	_
10	a	_	DT	DT	_	13	det	_	_
11	thymoma	_	NN	NN	_	13	nn	_	_
12	cell	_	NN	NN	_	13	nn	_	_
13	line	_	NN	NN	_	9	pobj	_	_
14	,	_	,	,	_	13	punct	_	_
15	S49.1	_	NN	NN	_	13	appos	_	_
16	,	_	,	,	_	2	punct	_	_
17	reduced	_	VBD	VBD	_	0	root	_	_
18	the	_	DT	DT	_	20	det	_	_
19	expression	_	NN	NN	_	20	nn	_	_
20	level	_	NN	NN	_	17	dobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	SRG3	_	NN	NN	_	24	nn	_	_
24	protein	_	NN	NN	_	21	pobj	_	_
25	,	_	,	,	_	17	punct	_	_
26	and	_	CC	CC	_	17	cc	_	_
27	decreased	_	VBD	VBD	_	17	conj	_	_
28	the	_	DT	DT	_	31	det	_	_
29	apoptotic	_	JJ	JJ	_	31	amod	_	_
30	cell	_	NN	NN	_	31	nn	_	_
31	death	_	NN	NN	_	27	dobj	_	_
32	induced	_	VBN	VBN	_	31	vmod	_	_
33	by	_	IN	IN	_	32	prep	_	_
34	glucocorticoids	_	NNS	NNS	_	33	pobj	_	_
35	.	_	.	.	_	17	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	suggest	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	9	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	SRG3	_	NN	NN	_	7	nn	_	_
7	protein	_	NN	NN	_	9	nsubjpass	_	_
8	is	_	VBZ	VBZ	_	9	auxpass	_	_
9	involved	_	VBN	VBN	_	3	ccomp	_	_
10	in	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	13	det	_	_
12	glucocorticoid-induced	_	JJ	JJ	_	13	amod	_	_
13	apoptosis	_	NN	NN	_	10	pobj	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	thymoma	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	line	_	NN	NN	_	14	pobj	_	_
19	.	_	.	.	_	3	punct	_	_

1	This	_	DT	DT	_	2	nsubj	_	_
2	implicates	_	VBZ	VBZ	_	0	root	_	_
3	that	_	IN	IN	_	7	mark	_	_
4	the	_	DT	DT	_	5	det	_	_
5	SRG3	_	NN	NN	_	7	nsubj	_	_
6	may	_	MD	MD	_	7	aux	_	_
7	play	_	VB	VB	_	2	ccomp	_	_
8	an	_	DT	DT	_	11	det	_	_
9	important	_	JJ	JJ	_	11	amod	_	_
10	regulatory	_	JJ	JJ	_	9	dep	_	_
11	role	_	NN	NN	_	7	dobj	_	_
12	during	_	IN	IN	_	7	prep	_	_
13	T	_	NN	NN	_	15	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	development	_	NN	NN	_	12	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	thymus	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	2	punct	_	_

1	Cytomegalovirus	_	NN	NN	_	4	nn	_	_
2	immediate	_	JJ	JJ	_	4	amod	_	_
3	early	_	JJ	JJ	_	4	amod	_	_
4	genes	_	NNS	NNS	_	5	nsubj	_	_
5	upregulate	_	VBP	VBP	_	0	root	_	_
6	interleukin-6	_	NN	NN	_	8	nn	_	_
7	gene	_	NN	NN	_	8	nn	_	_
8	expression	_	NN	NN	_	5	dobj	_	_
9	.	_	.	.	_	5	punct	_	_

1	BACKGROUND	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	The	_	DT	DT	_	6	det	_	_
4	immediate	_	JJ	JJ	_	6	amod	_	_
5	early	_	JJ	JJ	_	6	amod	_	_
6	genes	_	NNS	NNS	_	18	nsubjpass	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	IE	_	NN	NN	_	6	appos	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	of	_	IN	IN	_	6	prep	_	_
11	human	_	JJ	JJ	_	12	amod	_	_
12	cytomegalovirus	_	NN	NN	_	10	pobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	CMV	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	can	_	MD	MD	_	18	aux	_	_
17	be	_	VB	VB	_	18	auxpass	_	_
18	expressed	_	VBN	VBN	_	1	dep	_	_
19	in	_	IN	IN	_	18	prep	_	_
20	monocytic	_	JJ	JJ	_	21	amod	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	and	_	CC	CC	_	18	cc	_	_
23	are	_	VBP	VBP	_	24	auxpass	_	_
24	known	_	VBN	VBN	_	18	conj	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	regulate	_	VB	VB	_	24	xcomp	_	_
27	viral	_	JJ	JJ	_	26	dobj	_	_
28	and	_	CC	CC	_	27	cc	_	_
29	cellular	_	JJ	JJ	_	27	conj	_	_
30	genes	_	NNS	NNS	_	27	dep	_	_
31	.	_	.	.	_	18	punct	_	_

1	Interleukin-6	_	NN	NN	_	5	nsubj	_	_
2	-LRB-	_	-LRB-	-LRB-	_	3	punct	_	_
3	IL-6	_	NN	NN	_	1	appos	_	_
4	-RRB-	_	-RRB-	-RRB-	_	3	punct	_	_
5	plays	_	VBZ	VBZ	_	0	root	_	_
6	a	_	DT	DT	_	8	det	_	_
7	central	_	JJ	JJ	_	8	amod	_	_
8	role	_	NN	NN	_	5	dobj	_	_
9	in	_	IN	IN	_	5	prep	_	_
10	numerous	_	JJ	JJ	_	11	amod	_	_
11	inflammatory	_	JJ	JJ	_	9	pobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	immune	_	JJ	JJ	_	11	conj	_	_
14	processes	_	NNS	NNS	_	11	dep	_	_
15	.	_	.	.	_	5	punct	_	_

1	Interleukin-6	_	NN	NN	_	2	nn	_	_
2	levels	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	increased	_	VBN	VBN	_	0	root	_	_
5	in	_	IN	IN	_	4	prep	_	_
6	lung	_	NN	NN	_	8	nn	_	_
7	transplant	_	NN	NN	_	8	nn	_	_
8	patients	_	NNS	NNS	_	5	pobj	_	_
9	clinically	_	RB	RB	_	10	advmod	_	_
10	diagnosed	_	VBN	VBN	_	8	vmod	_	_
11	with	_	IN	IN	_	10	prep	_	_
12	CMV	_	NN	NN	_	13	nn	_	_
13	pneumonitis	_	NN	NN	_	11	pobj	_	_
14	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	regulation	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	IL-6	_	NN	NN	_	3	pobj	_	_
5	is	_	VBZ	VBZ	_	6	cop	_	_
6	dependent	_	JJ	JJ	_	0	root	_	_
7	on	_	IN	IN	_	6	prep	_	_
8	various	_	JJ	JJ	_	9	amod	_	_
9	stimuli	_	NNS	NNS	_	7	pobj	_	_
10	that	_	WDT	WDT	_	11	nsubj	_	_
11	include	_	VBP	VBP	_	9	rcmod	_	_
12	lipopolysaccharide	_	NN	NN	_	11	dobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	LPS	_	NN	NN	_	12	appos	_	_
15	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
16	,	_	,	,	_	12	punct	_	_
17	viruses	_	NNS	NNS	_	12	conj	_	_
18	,	_	,	,	_	12	punct	_	_
19	and	_	CC	CC	_	12	cc	_	_
20	other	_	JJ	JJ	_	21	amod	_	_
21	cytokines	_	NNS	NNS	_	12	conj	_	_
22	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	studies	_	NNS	NNS	_	3	nsubj	_	_
3	examined	_	VBD	VBD	_	0	root	_	_
4	the	_	DT	DT	_	5	det	_	_
5	ability	_	NN	NN	_	3	dobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	CMV	_	NN	NN	_	10	nn	_	_
8	IE	_	NN	NN	_	10	nn	_	_
9	gene	_	NN	NN	_	10	nn	_	_
10	products	_	NNS	NNS	_	6	pobj	_	_
11	to	_	TO	TO	_	12	aux	_	_
12	modulate	_	VB	VB	_	5	vmod	_	_
13	IL-6	_	NN	NN	_	14	nn	_	_
14	production	_	NN	NN	_	12	dobj	_	_
15	.	_	.	.	_	3	punct	_	_

1	METHODS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	THP-1	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	12	nsubjpass	_	_
5	,	_	,	,	_	4	punct	_	_
6	a	_	DT	DT	_	9	det	_	_
7	monocytic	_	JJ	JJ	_	9	amod	_	_
8	cell	_	NN	NN	_	9	nn	_	_
9	line	_	NN	NN	_	4	appos	_	_
10	,	_	,	,	_	4	punct	_	_
11	were	_	VBD	VBD	_	12	auxpass	_	_
12	transfected	_	VBN	VBN	_	1	dep	_	_
13	with	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	17	det	_	_
15	CMV	_	NN	NN	_	17	nn	_	_
16	IE	_	NN	NN	_	17	nn	_	_
17	genes	_	NNS	NNS	_	13	pobj	_	_
18	.	_	.	.	_	1	punct	_	_

1	Interleukin-6	_	NN	NN	_	2	nn	_	_
2	protein	_	NN	NN	_	7	nsubjpass	_	_
3	and	_	CC	CC	_	2	cc	_	_
4	IL-6	_	NN	NN	_	5	nn	_	_
5	mRNA	_	NN	NN	_	2	conj	_	_
6	were	_	VBD	VBD	_	7	auxpass	_	_
7	measured	_	VBN	VBN	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	control	_	JJ	JJ	_	8	pobj	_	_
10	and	_	CC	CC	_	9	cc	_	_
11	CMV	_	NN	NN	_	15	nn	_	_
12	immediate	_	JJ	JJ	_	15	amod	_	_
13	early	_	JJ	JJ	_	15	amod	_	_
14	transfected	_	VBN	VBN	_	15	amod	_	_
15	cells	_	NNS	NNS	_	9	conj	_	_
16	.	_	.	.	_	7	punct	_	_

1	Cotransfection	_	NN	NN	_	19	nsubjpass	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	CMV	_	NN	NN	_	5	nn	_	_
4	IE	_	NN	NN	_	5	nn	_	_
5	genes	_	NNS	NNS	_	2	pobj	_	_
6	and	_	CC	CC	_	5	cc	_	_
7	IL-6	_	NN	NN	_	5	conj	_	_
8	chloramphenicol	_	NN	NN	_	10	nn	_	_
9	acetyl	_	NN	NN	_	10	nn	_	_
10	transferase	_	NN	NN	_	7	dep	_	_
11	-LRB-	_	-LRB-	-LRB-	_	12	punct	_	_
12	CAT	_	NN	NN	_	10	appos	_	_
13	-RRB-	_	-RRB-	-RRB-	_	12	punct	_	_
14	or	_	CC	CC	_	7	cc	_	_
15	IL-6	_	NN	NN	_	16	nn	_	_
16	luciferase	_	NN	NN	_	7	conj	_	_
17	constructs	_	NNS	NNS	_	7	dep	_	_
18	were	_	VBD	VBD	_	19	auxpass	_	_
19	used	_	VBN	VBN	_	0	root	_	_
20	to	_	TO	TO	_	21	aux	_	_
21	study	_	VB	VB	_	19	xcomp	_	_
22	IL-6	_	NN	NN	_	24	nn	_	_
23	promoter	_	NN	NN	_	24	nn	_	_
24	activity	_	NN	NN	_	21	dobj	_	_
25	.	_	.	.	_	19	punct	_	_

1	RESULTS	_	NNS	NNS	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Interleukin-6	_	NN	NN	_	4	nn	_	_
4	protein	_	NN	NN	_	10	nsubjpass	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	mRNA	_	NN	NN	_	7	nn	_	_
7	production	_	NN	NN	_	4	conj	_	_
8	were	_	VBD	VBD	_	10	auxpass	_	_
9	significantly	_	RB	RB	_	10	advmod	_	_
10	increased	_	VBN	VBN	_	1	dep	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	cells	_	NNS	NNS	_	11	pobj	_	_
13	transfected	_	VBN	VBN	_	12	dep	_	_
14	with	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	18	det	_	_
16	CMV	_	NN	NN	_	18	nn	_	_
17	IE	_	NN	NN	_	18	nn	_	_
18	genes	_	NNS	NNS	_	14	pobj	_	_
19	and	_	CC	CC	_	13	cc	_	_
20	stimulated	_	VBN	VBN	_	13	conj	_	_
21	with	_	IN	IN	_	20	prep	_	_
22	LPS	_	NN	NN	_	21	pobj	_	_
23	compared	_	VBN	VBN	_	10	prep	_	_
24	to	_	TO	TO	_	23	pcomp	_	_
25	LPS-stimulated	_	JJ	JJ	_	27	amod	_	_
26	control	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	24	pobj	_	_
28	.	_	.	.	_	1	punct	_	_

1	Cytomegalovirus	_	NN	NN	_	4	nn	_	_
2	IE	_	NN	NN	_	4	nn	_	_
3	gene	_	NN	NN	_	4	nn	_	_
4	products	_	NNS	NNS	_	6	nsubj	_	_
5	significantly	_	RB	RB	_	6	advmod	_	_
6	enhanced	_	VBD	VBD	_	0	root	_	_
7	LPS	_	NN	NN	_	8	nn	_	_
8	stimulation	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	IL-6	_	NN	NN	_	11	nn	_	_
11	promoter	_	NN	NN	_	12	nn	_	_
12	activity	_	NN	NN	_	9	pobj	_	_
13	in	_	IN	IN	_	6	prep	_	_
14	both	_	CC	CC	_	16	preconj	_	_
15	IL-6	_	NN	NN	_	16	nn	_	_
16	CAT	_	NN	NN	_	13	pobj	_	_
17	and	_	CC	CC	_	16	cc	_	_
18	IL-6	_	NN	NN	_	19	nn	_	_
19	luciferase	_	NN	NN	_	16	conj	_	_
20	assays	_	NNS	NNS	_	16	dep	_	_
21	.	_	.	.	_	6	punct	_	_

1	A	_	DT	DT	_	3	det	_	_
2	deletion	_	NN	NN	_	3	nn	_	_
3	construct	_	NN	NN	_	17	nsubj	_	_
4	that	_	WDT	WDT	_	5	nsubj	_	_
5	contains	_	VBZ	VBZ	_	3	rcmod	_	_
6	a	_	DT	DT	_	9	det	_	_
7	NF-kappa	_	NN	NN	_	9	nn	_	_
8	B	_	NN	NN	_	9	nn	_	_
9	site	_	NN	NN	_	5	dobj	_	_
10	but	_	CC	CC	_	5	cc	_	_
11	is	_	VBZ	VBZ	_	12	aux	_	_
12	missing	_	VBG	VBG	_	5	conj	_	_
13	the	_	DT	DT	_	16	det	_	_
14	multiple	_	JJ	JJ	_	16	amod	_	_
15	response	_	NN	NN	_	16	nn	_	_
16	region	_	NN	NN	_	12	dobj	_	_
17	demonstrated	_	VBD	VBD	_	0	root	_	_
18	a	_	DT	DT	_	20	det	_	_
19	continued	_	JJ	JJ	_	20	amod	_	_
20	increase	_	NN	NN	_	17	dobj	_	_
21	in	_	IN	IN	_	20	prep	_	_
22	IL-6	_	NN	NN	_	24	nn	_	_
23	luciferase	_	NN	NN	_	24	nn	_	_
24	activity	_	NN	NN	_	21	pobj	_	_
25	in	_	IN	IN	_	24	prep	_	_
26	LPS-stimulated	_	JJ	JJ	_	29	amod	_	_
27	CMV	_	NN	NN	_	29	nn	_	_
28	transfected	_	JJ	JJ	_	29	amod	_	_
29	cells	_	NNS	NNS	_	25	pobj	_	_
30	.	_	.	.	_	17	punct	_	_

1	CONCLUSION	_	NN	NN	_	0	root	_	_
2	:	_	:	:	_	1	punct	_	_
3	Cytomegalovirus	_	NN	NN	_	7	nn	_	_
4	immediate	_	JJ	JJ	_	7	amod	_	_
5	early	_	JJ	JJ	_	7	amod	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	products	_	NNS	NNS	_	9	nsubj	_	_
8	significantly	_	RB	RB	_	9	advmod	_	_
9	enhanced	_	VBD	VBD	_	1	dep	_	_
10	expression	_	NN	NN	_	9	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	IL-6	_	NN	NN	_	11	pobj	_	_
13	in	_	IN	IN	_	10	prep	_	_
14	LPS-stimulated	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	.	_	.	.	_	1	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	increase	_	NN	NN	_	7	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	IL-6	_	NN	NN	_	6	nn	_	_
5	luciferase	_	NN	NN	_	6	nn	_	_
6	activity	_	NN	NN	_	3	pobj	_	_
7	occurs	_	VBZ	VBZ	_	0	root	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	10	det	_	_
10	absence	_	NN	NN	_	8	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	15	det	_	_
13	multiple	_	JJ	JJ	_	15	amod	_	_
14	response	_	NN	NN	_	15	nn	_	_
15	region	_	NN	NN	_	11	pobj	_	_
16	,	_	,	,	_	15	punct	_	_
17	the	_	DT	DT	_	18	det	_	_
18	area	_	NN	NN	_	15	appos	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	22	det	_	_
21	IL-6	_	NN	NN	_	22	nn	_	_
22	promoter	_	NN	NN	_	19	pobj	_	_
23	responsive	_	JJ	JJ	_	18	amod	_	_
24	to	_	TO	TO	_	23	prep	_	_
25	IL-1	_	NN	NN	_	24	pobj	_	_
26	,	_	,	,	_	25	punct	_	_
27	TNF	_	NN	NN	_	28	nn	_	_
28	alpha	_	NN	NN	_	25	conj	_	_
29	,	_	,	,	_	25	punct	_	_
30	cyclic	_	JJ	JJ	_	31	amod	_	_
31	amp	_	NN	NN	_	25	conj	_	_
32	,	_	,	,	_	25	punct	_	_
33	and	_	CC	CC	_	25	cc	_	_
34	phorbol	_	NN	NN	_	36	nn	_	_
35	12-myristate	_	NN	NN	_	36	nn	_	_
36	13-acetate	_	NN	NN	_	25	conj	_	_
37	.	_	.	.	_	7	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	ability	_	NN	NN	_	13	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	CMV	_	NN	NN	_	7	nn	_	_
5	IE	_	NN	NN	_	7	nn	_	_
6	gene	_	NN	NN	_	7	nn	_	_
7	products	_	NNS	NNS	_	3	pobj	_	_
8	to	_	TO	TO	_	9	aux	_	_
9	enhance	_	VB	VB	_	2	vmod	_	_
10	IL-6	_	NN	NN	_	11	nn	_	_
11	production	_	NN	NN	_	9	dobj	_	_
12	may	_	MD	MD	_	13	aux	_	_
13	play	_	VB	VB	_	0	root	_	_
14	an	_	DT	DT	_	16	det	_	_
15	important	_	JJ	JJ	_	16	amod	_	_
16	role	_	NN	NN	_	13	dobj	_	_
17	in	_	IN	IN	_	13	prep	_	_
18	immune	_	JJ	JJ	_	19	amod	_	_
19	inflammatory	_	JJ	JJ	_	20	amod	_	_
20	states	_	NNS	NNS	_	17	pobj	_	_
21	associated	_	VBN	VBN	_	20	vmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	CMV	_	NN	NN	_	24	nn	_	_
24	infection	_	NN	NN	_	22	pobj	_	_
25	.	_	.	.	_	13	punct	_	_

1	Cellular	_	JJ	JJ	_	3	amod	_	_
2	redox	_	NN	NN	_	3	nn	_	_
3	status	_	NN	NN	_	4	nsubj	_	_
4	influences	_	VBZ	VBZ	_	0	root	_	_
5	both	_	CC	CC	_	6	preconj	_	_
6	cytotoxic	_	JJ	JJ	_	4	dobj	_	_
7	and	_	CC	CC	_	6	cc	_	_
8	NF-kappa	_	NN	NN	_	9	nn	_	_
9	B	_	NN	NN	_	6	conj	_	_
10	activation	_	NN	NN	_	6	dep	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	natural	_	JJ	JJ	_	14	amod	_	_
13	killer	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	23	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	cellular	_	JJ	JJ	_	6	amod	_	_
5	redox	_	NN	NN	_	6	nn	_	_
6	status	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	2	prep	_	_
8	both	_	CC	CC	_	10	preconj	_	_
9	cytotoxic	_	JJ	JJ	_	10	amod	_	_
10	activity	_	NN	NN	_	7	pobj	_	_
11	and	_	CC	CC	_	10	cc	_	_
12	NF-kappa	_	NN	NN	_	13	nn	_	_
13	B	_	NN	NN	_	14	nn	_	_
14	activation	_	NN	NN	_	10	conj	_	_
15	in	_	IN	IN	_	10	prep	_	_
16	natural	_	JJ	JJ	_	21	amod	_	_
17	killer	_	NN	NN	_	21	nn	_	_
18	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
19	NK	_	NN	NN	_	21	nn	_	_
20	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
21	cells	_	NNS	NNS	_	15	pobj	_	_
22	was	_	VBD	VBD	_	23	auxpass	_	_
23	investigated	_	VBN	VBN	_	0	root	_	_
24	.	_	.	.	_	23	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	indicate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	30	mark	_	_
5	stimulation	_	NN	NN	_	30	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	NK	_	NN	NN	_	8	nn	_	_
8	cells	_	NNS	NNS	_	6	pobj	_	_
9	,	_	,	,	_	8	punct	_	_
10	either	_	CC	CC	_	8	dep	_	_
11	freshly	_	RB	RB	_	12	advmod	_	_
12	isolated	_	VBN	VBN	_	10	dep	_	_
13	from	_	IN	IN	_	12	prep	_	_
14	peripheral	_	JJ	JJ	_	16	amod	_	_
15	blood	_	NN	NN	_	16	nn	_	_
16	lymphocytes	_	NNS	NNS	_	13	pobj	_	_
17	-LRB-	_	-LRB-	-LRB-	_	18	punct	_	_
18	PBL	_	NNS	NNS	_	16	appos	_	_
19	-RRB-	_	-RRB-	-RRB-	_	18	punct	_	_
20	or	_	CC	CC	_	10	cc	_	_
21	long-term	_	JJ	JJ	_	24	amod	_	_
22	cultured	_	VBN	VBN	_	24	amod	_	_
23	NK	_	NN	NN	_	24	nn	_	_
24	clones	_	NNS	NNS	_	10	conj	_	_
25	,	_	,	,	_	5	punct	_	_
26	with	_	IN	IN	_	5	prep	_	_
27	specific	_	JJ	JJ	_	29	amod	_	_
28	cell	_	NN	NN	_	29	nn	_	_
29	targets	_	NNS	NNS	_	26	pobj	_	_
30	results	_	VBZ	VBZ	_	3	ccomp	_	_
31	in	_	IN	IN	_	30	prep	_	_
32	an	_	DT	DT	_	35	det	_	_
33	increased	_	VBN	VBN	_	35	amod	_	_
34	binding	_	NN	NN	_	35	nn	_	_
35	activity	_	NN	NN	_	31	pobj	_	_
36	of	_	IN	IN	_	35	prep	_	_
37	NF-kappa	_	NN	NN	_	38	nn	_	_
38	B	_	NN	NN	_	36	pobj	_	_
39	and	_	CC	CC	_	38	cc	_	_
40	AP-1	_	NN	NN	_	38	conj	_	_
41	transcription	_	NN	NN	_	42	nn	_	_
42	factors	_	NNS	NNS	_	38	dep	_	_
43	measured	_	VBN	VBN	_	35	vmod	_	_
44	by	_	IN	IN	_	43	prep	_	_
45	gel	_	NN	NN	_	46	nn	_	_
46	retardation	_	NN	NN	_	44	pobj	_	_
47	.	_	.	.	_	3	punct	_	_

1	Pretreatment	_	NN	NN	_	13	nsubj	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	NK	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	2	pobj	_	_
5	with	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	7	det	_	_
7	antioxidant	_	JJ	JJ	_	5	pobj	_	_
8	pyrrolidine	_	NN	NN	_	9	nn	_	_
9	dithiocarbarmate	_	NN	NN	_	7	dep	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	PDTC	_	NN	NN	_	9	appos	_	_
12	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
13	leads	_	VBZ	VBZ	_	0	root	_	_
14	to	_	TO	TO	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	inhibition	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	NF-kappa	_	NN	NN	_	19	nn	_	_
19	B	_	NN	NN	_	20	nn	_	_
20	activation	_	NN	NN	_	17	pobj	_	_
21	but	_	CC	CC	_	13	cc	_	_
22	the	_	DT	DT	_	24	det	_	_
23	AP-1	_	NN	NN	_	24	nn	_	_
24	binding	_	NN	NN	_	28	nsubjpass	_	_
25	to	_	TO	TO	_	24	prep	_	_
26	DNA	_	NN	NN	_	25	pobj	_	_
27	was	_	VBD	VBD	_	28	auxpass	_	_
28	superinduced	_	VBN	VBN	_	13	conj	_	_
29	.	_	.	.	_	13	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	inhibition	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	NF-kappa	_	NN	NN	_	5	nn	_	_
5	B	_	NN	NN	_	3	pobj	_	_
6	by	_	IN	IN	_	2	prep	_	_
7	PDTC	_	NN	NN	_	6	pobj	_	_
8	paralleled	_	VBD	VBD	_	0	root	_	_
9	with	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	11	det	_	_
11	inhibition	_	NN	NN	_	9	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	spontaneous	_	JJ	JJ	_	14	amod	_	_
14	cytotoxicity	_	NN	NN	_	12	pobj	_	_
15	mediated	_	VBN	VBN	_	14	vmod	_	_
16	by	_	IN	IN	_	15	prep	_	_
17	NK	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	16	pobj	_	_
19	.	_	.	.	_	8	punct	_	_

1	Moreover	_	RB	RB	_	18	advmod	_	_
2	,	_	,	,	_	18	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	inhibitors	_	NNS	NNS	_	18	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	serine	_	NN	NN	_	7	nn	_	_
7	proteases	_	NNS	NNS	_	5	pobj	_	_
8	,	_	,	,	_	4	punct	_	_
9	N-alpha-tosyl-L-lysine	_	NN	NN	_	11	nn	_	_
10	chloromethyl	_	NN	NN	_	11	nn	_	_
11	ketone	_	NN	NN	_	4	appos	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	N-alpha-tosyl-L-phenylalanine	_	NN	NN	_	15	nn	_	_
14	chloromethyl	_	NN	NN	_	15	nn	_	_
15	ketone	_	NN	NN	_	11	conj	_	_
16	,	_	,	,	_	4	punct	_	_
17	also	_	RB	RB	_	18	advmod	_	_
18	blocked	_	VBD	VBD	_	0	root	_	_
19	the	_	DT	DT	_	21	det	_	_
20	cytolytic	_	JJ	JJ	_	21	amod	_	_
21	activity	_	NN	NN	_	18	dobj	_	_
22	of	_	IN	IN	_	21	prep	_	_
23	NK	_	NN	NN	_	24	nn	_	_
24	cells	_	NNS	NNS	_	22	pobj	_	_
25	against	_	IN	IN	_	18	prep	_	_
26	the	_	DT	DT	_	28	det	_	_
27	sensitive	_	JJ	JJ	_	28	amod	_	_
28	target	_	NN	NN	_	25	pobj	_	_
29	K562	_	NN	NN	_	28	dep	_	_
30	.	_	.	.	_	18	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	NK	_	NN	NN	_	5	nn	_	_
5	activity	_	NN	NN	_	8	nsubjpass	_	_
6	was	_	VBD	VBD	_	8	auxpass	_	_
7	not	_	RB	RB	_	8	neg	_	_
8	affected	_	VBN	VBN	_	0	root	_	_
9	by	_	IN	IN	_	8	prep	_	_
10	pretreatment	_	NN	NN	_	9	pobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	14	det	_	_
13	effector	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	11	pobj	_	_
15	with	_	IN	IN	_	10	prep	_	_
16	the	_	DT	DT	_	18	det	_	_
17	proteasome	_	NN	NN	_	18	nn	_	_
18	inhibitor	_	NN	NN	_	15	pobj	_	_
19	N-acetyl-leu-leu-norleucinal	_	NN	NN	_	18	dep	_	_
20	which	_	WDT	WDT	_	22	nsubj	_	_
21	selectively	_	RB	RB	_	22	advmod	_	_
22	inhibits	_	VBZ	VBZ	_	18	rcmod	_	_
23	NF-kappa	_	NN	NN	_	24	nn	_	_
24	B	_	NN	NN	_	25	nn	_	_
25	activation	_	NN	NN	_	22	dobj	_	_
26	.	_	.	.	_	8	punct	_	_

1	Altogether	_	RB	RB	_	5	advmod	_	_
2	,	_	,	,	_	5	punct	_	_
3	these	_	DT	DT	_	4	det	_	_
4	results	_	NNS	NNS	_	5	nsubj	_	_
5	support	_	VBP	VBP	_	0	root	_	_
6	the	_	DT	DT	_	7	det	_	_
7	hypothesis	_	NN	NN	_	5	dobj	_	_
8	that	_	IN	IN	_	14	mark	_	_
9	the	_	DT	DT	_	10	det	_	_
10	activation	_	NN	NN	_	14	nsubj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	NK	_	NN	NN	_	13	nn	_	_
13	cells	_	NNS	NNS	_	11	pobj	_	_
14	involved	_	VBD	VBD	_	7	ccomp	_	_
15	transcriptional	_	JJ	JJ	_	14	dobj	_	_
16	and	_	CC	CC	_	15	cc	_	_
17	post-transcriptional	_	JJ	JJ	_	15	conj	_	_
18	events	_	NNS	NNS	_	15	dep	_	_
19	,	_	,	,	_	14	punct	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	that	_	IN	IN	_	25	mark	_	_
22	reactive	_	JJ	JJ	_	23	amod	_	_
23	intermediates	_	NNS	NNS	_	25	nsubj	_	_
24	may	_	MD	MD	_	25	aux	_	_
25	play	_	VB	VB	_	14	conj	_	_
26	an	_	DT	DT	_	28	det	_	_
27	important	_	JJ	JJ	_	28	amod	_	_
28	role	_	NN	NN	_	25	dobj	_	_
29	in	_	IN	IN	_	25	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	molecular	_	JJ	JJ	_	32	amod	_	_
32	processes	_	NNS	NNS	_	29	pobj	_	_
33	related	_	JJ	JJ	_	32	amod	_	_
34	with	_	IN	IN	_	33	prep	_	_
35	the	_	DT	DT	_	36	det	_	_
36	generation	_	NN	NN	_	34	pobj	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	a	_	DT	DT	_	40	det	_	_
39	cytotoxic	_	JJ	JJ	_	40	amod	_	_
40	response	_	NN	NN	_	37	pobj	_	_
41	by	_	IN	IN	_	36	prep	_	_
42	NK	_	NN	NN	_	43	nn	_	_
43	cells	_	NNS	NNS	_	41	pobj	_	_
44	.	_	.	.	_	5	punct	_	_

1	Abnormal	_	JJ	JJ	_	4	amod	_	_
2	T	_	NN	NN	_	3	nn	_	_
3	lymphocyte	_	NN	NN	_	4	nn	_	_
4	development	_	NN	NN	_	0	root	_	_
5	induced	_	VBN	VBN	_	4	vmod	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	targeted	_	VBN	VBN	_	8	amod	_	_
8	overexpression	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	IkappaB	_	NN	NN	_	11	nn	_	_
11	alpha	_	NN	NN	_	9	pobj	_	_
12	.	_	.	.	_	4	punct	_	_

1	A	_	DT	DT	_	2	det	_	_
2	role	_	NN	NN	_	15	nsubjpass	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	thymic	_	JJ	JJ	_	5	amod	_	_
5	maturation	_	NN	NN	_	3	pobj	_	_
6	for	_	IN	IN	_	2	prep	_	_
7	factors	_	NNS	NNS	_	6	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	NF-kappaB	_	NN	NN	_	11	nn	_	_
11	family	_	NN	NN	_	8	pobj	_	_
12	has	_	VBZ	VBZ	_	15	aux	_	_
13	long	_	RB	RB	_	15	advmod	_	_
14	been	_	VBN	VBN	_	15	auxpass	_	_
15	suspected	_	VBN	VBN	_	0	root	_	_
16	,	_	,	,	_	15	punct	_	_
17	but	_	CC	CC	_	15	cc	_	_
18	not	_	RB	RB	_	19	dep	_	_
19	yet	_	RB	RB	_	20	advmod	_	_
20	proven	_	VBN	VBN	_	15	conj	_	_
21	.	_	.	.	_	15	punct	_	_

1	Transgenic	_	JJ	JJ	_	2	amod	_	_
2	mice	_	NNS	NNS	_	11	nsubjpass	_	_
3	with	_	IN	IN	_	2	prep	_	_
4	a	_	DT	DT	_	6	det	_	_
5	lymphocyte-specific	_	JJ	JJ	_	6	amod	_	_
6	defect	_	NN	NN	_	3	pobj	_	_
7	in	_	IN	IN	_	6	prep	_	_
8	NF-kappaB	_	NN	NN	_	9	nn	_	_
9	activation	_	NN	NN	_	7	pobj	_	_
10	were	_	VBD	VBD	_	11	auxpass	_	_
11	produced	_	VBN	VBN	_	0	root	_	_
12	by	_	IN	IN	_	11	prep	_	_
13	targeted	_	VBN	VBN	_	14	amod	_	_
14	expression	_	NN	NN	_	12	pobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	human	_	JJ	JJ	_	18	amod	_	_
17	IkappaB	_	NN	NN	_	18	nn	_	_
18	alpha	_	NN	NN	_	15	pobj	_	_
19	.	_	.	.	_	11	punct	_	_

1	The	_	DT	DT	_	3	det	_	_
2	thymic	_	JJ	JJ	_	3	amod	_	_
3	cellularity	_	NN	NN	_	9	nsubjpass	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	these	_	DT	DT	_	6	det	_	_
6	mice	_	NNS	NNS	_	4	pobj	_	_
7	was	_	VBD	VBD	_	9	auxpass	_	_
8	significantly	_	RB	RB	_	9	advmod	_	_
9	decreased	_	VBN	VBN	_	0	root	_	_
10	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	proportion	_	NN	NN	_	13	nsubjpass	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	mature	_	JJ	JJ	_	7	amod	_	_
5	,	_	,	,	_	7	punct	_	_
6	TCRhigh	_	JJ	JJ	_	7	amod	_	_
7	thymocytes	_	NNS	NNS	_	3	pobj	_	_
8	of	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	alphabeta	_	NN	NN	_	11	nn	_	_
11	lineage	_	NN	NN	_	8	pobj	_	_
12	was	_	VBD	VBD	_	13	auxpass	_	_
13	reduced	_	VBN	VBN	_	0	root	_	_
14	,	_	,	,	_	13	punct	_	_
15	and	_	CC	CC	_	13	cc	_	_
16	the	_	DT	DT	_	19	det	_	_
17	remaining	_	VBG	VBG	_	19	amod	_	_
18	TCRhigh	_	JJ	JJ	_	19	amod	_	_
19	population	_	NN	NN	_	20	nsubj	_	_
20	contained	_	VBD	VBD	_	13	conj	_	_
21	an	_	DT	DT	_	24	det	_	_
22	unusually	_	RB	RB	_	23	advmod	_	_
23	high	_	JJ	JJ	_	24	amod	_	_
24	proportion	_	NN	NN	_	20	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	double-positive	_	JJ	JJ	_	27	amod	_	_
27	cells	_	NNS	NNS	_	25	pobj	_	_
28	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	defect	_	NN	NN	_	5	nsubj	_	_
3	in	_	IN	IN	_	2	prep	_	_
4	maturation	_	NN	NN	_	3	pobj	_	_
5	resulted	_	VBD	VBD	_	0	root	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	a	_	DT	DT	_	10	det	_	_
8	transgene	_	NN	NN	_	10	nn	_	_
9	dose-dependent	_	JJ	JJ	_	10	amod	_	_
10	reduction	_	NN	NN	_	6	pobj	_	_
11	in	_	IN	IN	_	10	prep	_	_
12	peripheral	_	JJ	JJ	_	14	amod	_	_
13	T	_	NN	NN	_	14	nn	_	_
14	lymphocytes	_	NNS	NNS	_	11	pobj	_	_
15	,	_	,	,	_	5	punct	_	_
16	with	_	IN	IN	_	5	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	CD8	_	NN	NN	_	19	nn	_	_
19	lineage	_	NN	NN	_	23	nsubjpass	_	_
20	being	_	VBG	VBG	_	23	auxpass	_	_
21	more	_	RBR	RBR	_	22	advmod	_	_
22	severely	_	RB	RB	_	23	advmod	_	_
23	affected	_	VBN	VBN	_	16	pcomp	_	_
24	.	_	.	.	_	5	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	data	_	NNS	NNS	_	3	nsubj	_	_
3	provide	_	VBP	VBP	_	0	root	_	_
4	direct	_	JJ	JJ	_	5	amod	_	_
5	evidence	_	NN	NN	_	3	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	involvement	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	NF-kappaB/Rel	_	NN	NN	_	12	nn	_	_
11	family	_	NN	NN	_	12	nn	_	_
12	proteins	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	late	_	JJ	JJ	_	15	amod	_	_
15	stages	_	NNS	NNS	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	T	_	NN	NN	_	18	nn	_	_
18	lymphocyte	_	NN	NN	_	19	nn	_	_
19	development	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	3	punct	_	_
21	coincident	_	JJ	JJ	_	3	advmod	_	_
22	with	_	IN	IN	_	21	prep	_	_
23	positive	_	JJ	JJ	_	22	pobj	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	negative	_	JJ	JJ	_	23	conj	_	_
26	selection	_	NN	NN	_	23	dep	_	_
27	.	_	.	.	_	3	punct	_	_

1	Sequential	_	JJ	JJ	_	2	amod	_	_
2	development	_	NN	NN	_	0	root	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	structural	_	JJ	JJ	_	3	pobj	_	_
5	and	_	CC	CC	_	4	cc	_	_
6	functional	_	JJ	JJ	_	4	conj	_	_
7	alterations	_	NNS	NNS	_	4	dep	_	_
8	in	_	IN	IN	_	4	prep	_	_
9	T	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	8	pobj	_	_
11	from	_	IN	IN	_	10	prep	_	_
12	tumor-bearing	_	NN	NN	_	13	nn	_	_
13	mice	_	NNS	NNS	_	11	pobj	_	_
14	.	_	.	.	_	2	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	TCR	_	NN	NN	_	9	nsubj	_	_
3	alpha	_	NN	NN	_	4	nn	_	_
4	beta	_	NN	NN	_	2	dep	_	_
5	or	_	CC	CC	_	2	cc	_	_
6	-gamma	_	NN	NN	_	7	nn	_	_
7	delta	_	NN	NN	_	2	conj	_	_
8	chains	_	NNS	NNS	_	2	dep	_	_
9	bind	_	VBP	VBP	_	0	root	_	_
10	the	_	DT	DT	_	12	det	_	_
11	peptide	_	NN	NN	_	12	nn	_	_
12	ligand	_	NN	NN	_	9	dobj	_	_
13	,	_	,	,	_	9	punct	_	_
14	whereas	_	IN	IN	_	25	mark	_	_
15	the	_	DT	DT	_	20	dep	_	_
16	associated	_	VBN	VBN	_	20	amod	_	_
17	CD3	_	NN	NN	_	20	nn	_	_
18	delta	_	NN	NN	_	20	nn	_	_
19	epsilon	_	NN	NN	_	20	nn	_	_
20	gamma	_	NN	NN	_	25	nsubj	_	_
21	and	_	CC	CC	_	20	cc	_	_
22	TCR	_	NN	NN	_	24	nn	_	_
23	zeta	_	NN	NN	_	24	nn	_	_
24	subunits	_	NNS	NNS	_	20	conj	_	_
25	couple	_	VBP	VBP	_	9	advcl	_	_
26	the	_	DT	DT	_	27	det	_	_
27	TCR	_	NN	NN	_	25	dobj	_	_
28	to	_	TO	TO	_	25	prep	_	_
29	intracellular	_	JJ	JJ	_	32	amod	_	_
30	signal	_	NN	NN	_	32	nn	_	_
31	transduction	_	NN	NN	_	32	nn	_	_
32	components	_	NNS	NNS	_	28	pobj	_	_
33	.	_	.	.	_	9	punct	_	_

1	Recently	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	several	_	JJ	JJ	_	4	amod	_	_
4	groups	_	NNS	NNS	_	6	nsubj	_	_
5	have	_	VBP	VBP	_	6	aux	_	_
6	described	_	VBN	VBN	_	0	root	_	_
7	marked	_	JJ	JJ	_	8	amod	_	_
8	alterations	_	NNS	NNS	_	6	dobj	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	signal	_	NN	NN	_	12	nn	_	_
11	transduction	_	NN	NN	_	12	nn	_	_
12	elements	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	12	prep	_	_
14	T	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	from	_	IN	IN	_	15	prep	_	_
17	cancer	_	NN	NN	_	18	nn	_	_
18	patients	_	NNS	NNS	_	16	pobj	_	_
19	or	_	CC	CC	_	13	cc	_	_
20	in	_	IN	IN	_	13	conj	_	_
21	mice	_	NNS	NNS	_	20	pobj	_	_
22	bearing	_	VBG	VBG	_	21	vmod	_	_
23	tumor	_	NN	NN	_	22	dobj	_	_
24	for	_	IN	IN	_	22	prep	_	_
25	a	_	DT	DT	_	27	det	_	_
26	few	_	JJ	JJ	_	27	amod	_	_
27	weeks	_	NNS	NNS	_	24	pobj	_	_
28	-LRB-	_	-LRB-	-LRB-	_	29	punct	_	_
29	&gt;	_	JJR	JJR	_	27	dep	_	_
30	26	_	CD	CD	_	31	num	_	_
31	days	_	NNS	NNS	_	29	tmod	_	_
32	-RRB-	_	-RRB-	-RRB-	_	29	punct	_	_
33	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	sequence	_	NN	NN	_	9	nsubj	_	_
3	in	_	IN	IN	_	7	prep	_	_
4	which	_	WDT	WDT	_	3	pobj	_	_
5	these	_	DT	DT	_	6	det	_	_
6	alterations	_	NNS	NNS	_	7	nsubj	_	_
7	develop	_	VBP	VBP	_	2	rcmod	_	_
8	is	_	VBZ	VBZ	_	9	cop	_	_
9	unknown	_	JJ	JJ	_	0	root	_	_
10	.	_	.	.	_	9	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	aim	_	NN	NN	_	6	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	this	_	DT	DT	_	5	det	_	_
5	study	_	NN	NN	_	3	pobj	_	_
6	was	_	VBD	VBD	_	0	root	_	_
7	to	_	TO	TO	_	8	aux	_	_
8	explore	_	VB	VB	_	6	xcomp	_	_
9	the	_	DT	DT	_	10	det	_	_
10	kinetics	_	NNS	NNS	_	8	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	the	_	DT	DT	_	13	det	_	_
13	development	_	NN	NN	_	11	pobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	alterations	_	NNS	NNS	_	14	pobj	_	_
16	in	_	IN	IN	_	15	prep	_	_
17	signal	_	NN	NN	_	19	nn	_	_
18	transduction	_	NN	NN	_	19	nn	_	_
19	molecules	_	NNS	NNS	_	16	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
21	TCR	_	NN	NN	_	23	nn	_	_
22	zeta	_	NN	NN	_	23	nn	_	_
23	chain	_	NN	NN	_	19	dep	_	_
24	,	_	,	,	_	23	punct	_	_
25	NF	_	NN	NN	_	28	nn	_	_
26	kappaB	_	NN	NN	_	28	nn	_	_
27	family	_	NN	NN	_	28	nn	_	_
28	proteins	_	NNS	NNS	_	23	conj	_	_
29	,	_	,	,	_	23	punct	_	_
30	and	_	CC	CC	_	23	cc	_	_
31	tyrosine	_	NN	NN	_	35	nn	_	_
32	kinase	_	NN	NN	_	35	nn	_	_
33	p56	_	NN	NN	_	35	nn	_	_
34	-LRB-	_	-LRB-	-LRB-	_	35	punct	_	_
35	lck	_	NN	NN	_	23	conj	_	_
36	-RRB-	_	-RRB-	-RRB-	_	35	punct	_	_
37	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
38	in	_	IN	IN	_	19	prep	_	_
39	mice	_	NNS	NNS	_	38	pobj	_	_
40	bearing	_	VBG	VBG	_	39	vmod	_	_
41	MC38	_	NN	NN	_	43	nn	_	_
42	colon	_	NN	NN	_	43	nn	_	_
43	adenocarcinoma	_	NN	NN	_	40	dobj	_	_
44	.	_	.	.	_	6	punct	_	_

1	The	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	22	mark	_	_
5	alterations	_	NNS	NNS	_	22	nsubj	_	_
6	in	_	IN	IN	_	5	prep	_	_
7	NF	_	NN	NN	_	10	nn	_	_
8	kappaB	_	NN	NN	_	10	nn	_	_
9	family	_	NN	NN	_	10	nn	_	_
10	proteins	_	NNS	NNS	_	6	pobj	_	_
11	,	_	,	,	_	5	punct	_	_
12	specifically	_	RB	RB	_	14	advmod	_	_
13	the	_	DT	DT	_	14	det	_	_
14	failure	_	NN	NN	_	5	appos	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	p65	_	NN	NN	_	17	nn	_	_
17	translocation	_	NN	NN	_	15	pobj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	nucleus	_	NN	NN	_	18	pobj	_	_
21	,	_	,	,	_	5	punct	_	_
22	occur	_	VBP	VBP	_	3	ccomp	_	_
23	earlier	_	RBR	RBR	_	22	advmod	_	_
24	and	_	CC	CC	_	23	cc	_	_
25	more	_	RBR	RBR	_	26	advmod	_	_
26	frequently	_	RB	RB	_	23	conj	_	_
27	than	_	IN	IN	_	29	mark	_	_
28	the	_	DT	DT	_	29	det	_	_
29	decrease	_	NN	NN	_	23	advcl	_	_
30	in	_	IN	IN	_	29	prep	_	_
31	zeta-chain	_	NN	NN	_	30	pobj	_	_
32	.	_	.	.	_	3	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	defects	_	NNS	NNS	_	4	nsubjpass	_	_
3	are	_	VBP	VBP	_	4	auxpass	_	_
4	paralleled	_	VBN	VBN	_	0	root	_	_
5	by	_	IN	IN	_	4	prep	_	_
6	an	_	DT	DT	_	8	det	_	_
7	impaired	_	JJ	JJ	_	8	amod	_	_
8	ability	_	NN	NN	_	5	pobj	_	_
9	to	_	TO	TO	_	10	aux	_	_
10	produce	_	VB	VB	_	8	vmod	_	_
11	Th1	_	NN	NN	_	12	nn	_	_
12	cytokines	_	NNS	NNS	_	10	dobj	_	_
13	-LRB-	_	-LRB-	-LRB-	_	14	punct	_	_
14	IL-2	_	NN	NN	_	12	dep	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	IFN-gamma	_	NN	NN	_	14	conj	_	_
17	-RRB-	_	-RRB-	-RRB-	_	14	punct	_	_
18	.	_	.	.	_	4	punct	_	_

1	These	_	DT	DT	_	3	det	_	_
2	initial	_	JJ	JJ	_	3	amod	_	_
3	changes	_	NNS	NNS	_	5	nsubjpass	_	_
4	are	_	VBP	VBP	_	5	auxpass	_	_
5	followed	_	VBN	VBN	_	0	root	_	_
6	by	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	9	det	_	_
8	eventual	_	JJ	JJ	_	9	amod	_	_
9	loss	_	NN	NN	_	6	pobj	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	TCR	_	NN	NN	_	13	nn	_	_
12	zeta	_	NN	NN	_	13	nn	_	_
13	chain	_	NN	NN	_	10	pobj	_	_
14	and	_	CC	CC	_	13	cc	_	_
15	p56	_	NN	NN	_	17	nn	_	_
16	-LRB-	_	-LRB-	-LRB-	_	17	punct	_	_
17	lck	_	NN	NN	_	13	conj	_	_
18	-RRB-	_	-RRB-	-RRB-	_	17	punct	_	_
19	and	_	CC	CC	_	9	cc	_	_
20	a	_	DT	DT	_	22	det	_	_
21	marked	_	JJ	JJ	_	22	amod	_	_
22	decrease	_	NN	NN	_	9	conj	_	_
23	in	_	IN	IN	_	22	prep	_	_
24	cytotoxic	_	JJ	JJ	_	25	amod	_	_
25	function	_	NN	NN	_	23	pobj	_	_
26	.	_	.	.	_	5	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	increased	_	VBN	VBN	_	3	amod	_	_
3	rate	_	NN	NN	_	8	nsubj	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	lysosomal	_	JJ	JJ	_	6	amod	_	_
6	degradation	_	NN	NN	_	4	pobj	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	one	_	CD	CD	_	0	root	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	the	_	DT	DT	_	11	det	_	_
11	mechanisms	_	NNS	NNS	_	9	pobj	_	_
12	responsible	_	JJ	JJ	_	11	amod	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	the	_	DT	DT	_	15	det	_	_
15	loss	_	NN	NN	_	13	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	zeta-chain	_	NN	NN	_	16	pobj	_	_
18	.	_	.	.	_	8	punct	_	_

1	Characterization	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	interleukin-10	_	NN	NN	_	4	nn	_	_
4	receptor	_	NN	NN	_	5	nn	_	_
5	expression	_	NN	NN	_	2	pobj	_	_
6	on	_	IN	IN	_	5	prep	_	_
7	B-cell	_	NN	NN	_	11	nn	_	_
8	chronic	_	JJ	JJ	_	11	amod	_	_
9	lymphocytic	_	JJ	JJ	_	11	amod	_	_
10	leukemia	_	NN	NN	_	11	nn	_	_
11	cells	_	NNS	NNS	_	6	pobj	_	_
12	.	_	.	.	_	1	punct	_	_

1	B-cell	_	NN	NN	_	8	nn	_	_
2	chronic	_	JJ	JJ	_	8	amod	_	_
3	lymphocytic	_	JJ	JJ	_	8	amod	_	_
4	leukemia	_	NN	NN	_	8	nn	_	_
5	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
6	B-CLL	_	NN	NN	_	8	nn	_	_
7	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
8	cells	_	NNS	NNS	_	9	nsubj	_	_
9	accumulate	_	VBP	VBP	_	0	root	_	_
10	in	_	FW	FW	_	11	nn	_	_
11	vivo	_	FW	FW	_	9	advmod	_	_
12	in	_	IN	IN	_	9	prep	_	_
13	the	_	DT	DT	_	15	det	_	_
14	G0/G1	_	NN	NN	_	15	nn	_	_
15	phase	_	NN	NN	_	12	pobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	the	_	DT	DT	_	19	det	_	_
18	cell	_	NN	NN	_	19	nn	_	_
19	cycle	_	NN	NN	_	16	pobj	_	_
20	,	_	,	,	_	9	punct	_	_
21	suggesting	_	VBG	VBG	_	9	xcomp	_	_
22	that	_	IN	IN	_	27	mark	_	_
23	their	_	PRP$	PRP$	_	25	poss	_	_
24	malignant	_	JJ	JJ	_	25	amod	_	_
25	expansion	_	NN	NN	_	27	nsubj	_	_
26	is	_	VBZ	VBZ	_	27	cop	_	_
27	due	_	JJ	JJ	_	21	ccomp	_	_
28	,	_	,	,	_	27	punct	_	_
29	at	_	IN	IN	_	31	advmod	_	_
30	least	_	JJS	JJS	_	29	pobj	_	_
31	in	_	IN	IN	_	27	prep	_	_
32	part	_	NN	NN	_	31	pobj	_	_
33	,	_	,	,	_	27	punct	_	_
34	to	_	TO	TO	_	27	prep	_	_
35	a	_	DT	DT	_	36	det	_	_
36	delay	_	NN	NN	_	34	pobj	_	_
37	in	_	IN	IN	_	36	prep	_	_
38	cell	_	NN	NN	_	39	nn	_	_
39	death	_	NN	NN	_	37	pobj	_	_
40	.	_	.	.	_	9	punct	_	_

1	However	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	the	_	DT	DT	_	4	dep	_	_
4	cellular	_	JJ	JJ	_	17	nsubj	_	_
5	or	_	CC	CC	_	4	cc	_	_
6	molecular	_	JJ	JJ	_	7	amod	_	_
7	factors	_	NNS	NNS	_	4	conj	_	_
8	responsible	_	JJ	JJ	_	4	amod	_	_
9	for	_	IN	IN	_	8	prep	_	_
10	a	_	DT	DT	_	11	det	_	_
11	delay	_	NN	NN	_	9	pobj	_	_
12	in	_	IN	IN	_	11	prep	_	_
13	B-CLL	_	NN	NN	_	15	nn	_	_
14	cell	_	NN	NN	_	15	nn	_	_
15	death	_	NN	NN	_	12	pobj	_	_
16	are	_	VBP	VBP	_	17	cop	_	_
17	unknown	_	JJ	JJ	_	0	root	_	_
18	.	_	.	.	_	17	punct	_	_

1	B-CLL	_	NN	NN	_	2	nn	_	_
2	cells	_	NNS	NNS	_	4	nsubj	_	_
3	do	_	VBP	VBP	_	4	aux	_	_
4	express	_	VB	VB	_	0	root	_	_
5	receptors	_	NNS	NNS	_	4	dobj	_	_
6	for	_	IN	IN	_	5	prep	_	_
7	interferon-alpha	_	NN	NN	_	6	pobj	_	_
8	-LRB-	_	-LRB-	-LRB-	_	9	punct	_	_
9	IFN-alpha	_	NN	NN	_	7	appos	_	_
10	-RRB-	_	-RRB-	-RRB-	_	9	punct	_	_
11	and	_	CC	CC	_	7	cc	_	_
12	IFN-gamma	_	NN	NN	_	7	conj	_	_
13	,	_	,	,	_	4	punct	_	_
14	and	_	CC	CC	_	4	cc	_	_
15	activation	_	NN	NN	_	20	nsubjpass	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	both	_	DT	DT	_	16	pobj	_	_
18	has	_	VBZ	VBZ	_	20	aux	_	_
19	been	_	VBN	VBN	_	20	auxpass	_	_
20	shown	_	VBN	VBN	_	4	conj	_	_
21	to	_	TO	TO	_	22	aux	_	_
22	promote	_	VB	VB	_	20	xcomp	_	_
23	B-CLL	_	NN	NN	_	24	nn	_	_
24	survival	_	NN	NN	_	22	dobj	_	_
25	in	_	FW	FW	_	24	amod	_	_
26	vitro	_	FW	FW	_	25	dep	_	_
27	by	_	IN	IN	_	22	prep	_	_
28	preventing	_	VBG	VBG	_	27	pcomp	_	_
29	apoptosis	_	NN	NN	_	28	dobj	_	_
30	.	_	.	.	_	4	punct	_	_

1	The	_	DT	DT	_	6	det	_	_
2	interleukin-10	_	NN	NN	_	6	nn	_	_
3	-LRB-	_	-LRB-	-LRB-	_	6	punct	_	_
4	IL-10	_	NN	NN	_	6	nn	_	_
5	-RRB-	_	-RRB-	-RRB-	_	6	punct	_	_
6	receptor	_	NN	NN	_	9	nsubj	_	_
7	is	_	VBZ	VBZ	_	9	cop	_	_
8	another	_	DT	DT	_	9	det	_	_
9	member	_	NN	NN	_	0	root	_	_
10	of	_	IN	IN	_	9	prep	_	_
11	the	_	DT	DT	_	14	det	_	_
12	IFN	_	NN	NN	_	14	nn	_	_
13	receptor	_	NN	NN	_	14	nn	_	_
14	family	_	NN	NN	_	10	pobj	_	_
15	,	_	,	,	_	9	punct	_	_
16	but	_	CC	CC	_	9	cc	_	_
17	its	_	PRP$	PRP$	_	18	poss	_	_
18	ligand	_	NN	NN	_	24	nsubjpass	_	_
19	,	_	,	,	_	18	punct	_	_
20	IL-10	_	NN	NN	_	18	appos	_	_
21	,	_	,	,	_	18	punct	_	_
22	has	_	VBZ	VBZ	_	24	aux	_	_
23	been	_	VBN	VBN	_	24	auxpass	_	_
24	reported	_	VBN	VBN	_	9	conj	_	_
25	to	_	TO	TO	_	26	aux	_	_
26	induce	_	VB	VB	_	24	xcomp	_	_
27	apoptosis	_	NN	NN	_	26	dobj	_	_
28	in	_	IN	IN	_	26	prep	_	_
29	B-CLL	_	NN	NN	_	30	nn	_	_
30	cells	_	NNS	NNS	_	28	pobj	_	_
31	.	_	.	.	_	9	punct	_	_

1	In	_	IN	IN	_	7	prep	_	_
2	the	_	DT	DT	_	4	det	_	_
3	current	_	JJ	JJ	_	4	amod	_	_
4	study	_	NN	NN	_	1	pobj	_	_
5	,	_	,	,	_	7	punct	_	_
6	we	_	PRP	PRP	_	7	nsubj	_	_
7	undertook	_	VBD	VBD	_	0	root	_	_
8	a	_	DT	DT	_	10	det	_	_
9	biochemical	_	JJ	JJ	_	10	amod	_	_
10	analysis	_	NN	NN	_	7	dobj	_	_
11	of	_	IN	IN	_	10	prep	_	_
12	IL-10	_	NN	NN	_	13	nn	_	_
13	receptor	_	NN	NN	_	14	nn	_	_
14	expression	_	NN	NN	_	11	pobj	_	_
15	on	_	IN	IN	_	14	prep	_	_
16	freshly	_	RB	RB	_	17	advmod	_	_
17	isolated	_	VBN	VBN	_	19	amod	_	_
18	B-CLL	_	NN	NN	_	19	nn	_	_
19	cells	_	NNS	NNS	_	15	pobj	_	_
20	and	_	CC	CC	_	7	cc	_	_
21	characterized	_	VBD	VBD	_	7	conj	_	_
22	the	_	DT	DT	_	24	det	_	_
23	functional	_	JJ	JJ	_	24	amod	_	_
24	responsiveness	_	NN	NN	_	21	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	IL-10	_	NN	NN	_	27	nn	_	_
27	binding	_	NN	NN	_	25	pobj	_	_
28	to	_	TO	TO	_	27	prep	_	_
29	its	_	PRP$	PRP$	_	32	poss	_	_
30	constitutively	_	RB	RB	_	32	advmod	_	_
31	expressed	_	VBN	VBN	_	32	amod	_	_
32	receptor	_	NN	NN	_	28	pobj	_	_
33	.	_	.	.	_	7	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	show	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	6	mark	_	_
4	B-CLL	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	6	nsubj	_	_
6	bind	_	VBP	VBP	_	2	ccomp	_	_
7	IL-10	_	NN	NN	_	6	dobj	_	_
8	with	_	IN	IN	_	6	prep	_	_
9	significant	_	JJ	JJ	_	10	amod	_	_
10	specificity	_	NN	NN	_	8	pobj	_	_
11	and	_	CC	CC	_	6	cc	_	_
12	express	_	VBP	VBP	_	6	conj	_	_
13	between	_	IN	IN	_	12	prep	_	_
14	47	_	CD	CD	_	19	num	_	_
15	and	_	CC	CC	_	14	cc	_	_
16	127	_	CD	CD	_	14	conj	_	_
17	IL-10	_	NN	NN	_	18	nn	_	_
18	receptor	_	NN	NN	_	19	nn	_	_
19	sites	_	NNS	NNS	_	13	pobj	_	_
20	per	_	IN	IN	_	19	prep	_	_
21	cell	_	NN	NN	_	20	pobj	_	_
22	,	_	,	,	_	12	punct	_	_
23	with	_	IN	IN	_	12	prep	_	_
24	a	_	DT	DT	_	26	det	_	_
25	dissociation	_	NN	NN	_	26	nn	_	_
26	constant	_	NN	NN	_	23	pobj	_	_
27	in	_	IN	IN	_	23	prep	_	_
28	the	_	DT	DT	_	29	det	_	_
29	range	_	NN	NN	_	27	pobj	_	_
30	of	_	IN	IN	_	29	prep	_	_
31	168	_	CD	CD	_	33	num	_	_
32	to	_	TO	TO	_	33	dep	_	_
33	426	_	CD	CD	_	36	num	_	_
34	x	_	CC	CC	_	33	cc	_	_
35	10-LRB--12-RRB-	_	CD	CD	_	33	conj	_	_
36	mol/L	_	NN	NN	_	30	pobj	_	_
37	.	_	.	.	_	2	punct	_	_

1	Ligand	_	NN	NN	_	13	nsubj	_	_
2	binding	_	NN	NN	_	1	dep	_	_
3	and	_	CC	CC	_	1	cc	_	_
4	activation	_	NN	NN	_	1	conj	_	_
5	of	_	IN	IN	_	1	prep	_	_
6	the	_	DT	DT	_	8	det	_	_
7	IL-10	_	NN	NN	_	8	nn	_	_
8	receptor	_	NN	NN	_	5	pobj	_	_
9	expressed	_	VBN	VBN	_	8	vmod	_	_
10	on	_	IN	IN	_	9	prep	_	_
11	B-CLL	_	NN	NN	_	12	nn	_	_
12	cells	_	NNS	NNS	_	10	pobj	_	_
13	results	_	VBZ	VBZ	_	0	root	_	_
14	in	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	16	det	_	_
16	phosphorylation	_	NN	NN	_	14	pobj	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	signal	_	NN	NN	_	19	nn	_	_
19	transducer	_	NN	NN	_	17	pobj	_	_
20	and	_	CC	CC	_	19	cc	_	_
21	activator	_	NN	NN	_	23	nn	_	_
22	of	_	IN	IN	_	23	amod	_	_
23	transcription	_	NN	NN	_	19	conj	_	_
24	1	_	CD	CD	_	23	num	_	_
25	-LRB-	_	-LRB-	-LRB-	_	26	punct	_	_
26	STAT1	_	NN	NN	_	19	appos	_	_
27	-RRB-	_	-RRB-	-RRB-	_	26	punct	_	_
28	and	_	CC	CC	_	19	cc	_	_
29	STAT3	_	NN	NN	_	19	conj	_	_
30	proteins	_	NNS	NNS	_	19	dep	_	_
31	.	_	.	.	_	13	punct	_	_

1	This	_	DT	DT	_	2	det	_	_
2	pattern	_	NN	NN	_	8	nsubj	_	_
3	of	_	IN	IN	_	2	prep	_	_
4	STAT	_	NN	NN	_	5	nn	_	_
5	protein	_	NN	NN	_	6	nn	_	_
6	phosphorylation	_	NN	NN	_	3	pobj	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	identical	_	JJ	JJ	_	0	root	_	_
9	to	_	TO	TO	_	8	prep	_	_
10	IL-10	_	NN	NN	_	11	nn	_	_
11	receptor	_	NN	NN	_	12	nn	_	_
12	activation	_	NN	NN	_	9	pobj	_	_
13	on	_	IN	IN	_	12	prep	_	_
14	normal	_	JJ	JJ	_	15	amod	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	and	_	CC	CC	_	8	cc	_	_
17	similar	_	JJ	JJ	_	8	conj	_	_
18	to	_	TO	TO	_	17	prep	_	_
19	IFN-alpha	_	NN	NN	_	18	pobj	_	_
20	-LRB-	_	-LRB-	-LRB-	_	21	punct	_	_
21	STAT1	_	NN	NN	_	19	dep	_	_
22	and	_	CC	CC	_	21	cc	_	_
23	STAT3	_	NN	NN	_	21	conj	_	_
24	-RRB-	_	-RRB-	-RRB-	_	21	punct	_	_
25	and	_	CC	CC	_	19	cc	_	_
26	IFN-gamma	_	NN	NN	_	19	conj	_	_
27	-LRB-	_	-LRB-	-LRB-	_	28	punct	_	_
28	STAT1	_	NN	NN	_	26	appos	_	_
29	-RRB-	_	-RRB-	-RRB-	_	28	punct	_	_
30	receptor	_	NN	NN	_	31	nn	_	_
31	activation	_	NN	NN	_	19	dep	_	_
32	in	_	IN	IN	_	19	prep	_	_
33	CLL	_	NN	NN	_	32	pobj	_	_
34	.	_	.	.	_	8	punct	_	_

1	Further	_	RB	RB	_	20	advmod	_	_
2	,	_	,	,	_	20	punct	_	_
3	in	_	IN	IN	_	20	prep	_	_
4	consecutive	_	JJ	JJ	_	5	amod	_	_
5	samples	_	NNS	NNS	_	3	pobj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	fresh	_	JJ	JJ	_	8	amod	_	_
8	blood	_	NN	NN	_	6	pobj	_	_
9	obtained	_	VBN	VBN	_	8	vmod	_	_
10	from	_	IN	IN	_	9	prep	_	_
11	patients	_	NNS	NNS	_	10	pobj	_	_
12	with	_	IN	IN	_	11	prep	_	_
13	B-CLL	_	NN	NN	_	14	nn	_	_
14	cells	_	NNS	NNS	_	12	pobj	_	_
15	,	_	,	,	_	20	punct	_	_
16	the	_	DT	DT	_	17	det	_	_
17	addition	_	NN	NN	_	20	nsubj	_	_
18	of	_	IN	IN	_	17	prep	_	_
19	IL-10	_	NN	NN	_	18	pobj	_	_
20	inhibited	_	VBD	VBD	_	0	root	_	_
21	B-CLL	_	NN	NN	_	22	nn	_	_
22	proliferation	_	NN	NN	_	20	dobj	_	_
23	,	_	,	,	_	20	punct	_	_
24	enhanced	_	VBD	VBD	_	20	conj	_	_
25	B-CLL	_	NN	NN	_	26	nn	_	_
26	differentiation	_	NN	NN	_	24	dobj	_	_
27	,	_	,	,	_	20	punct	_	_
28	but	_	CC	CC	_	20	cc	_	_
29	did	_	VBD	VBD	_	31	aux	_	_
30	not	_	RB	RB	_	31	neg	_	_
31	induce	_	VB	VB	_	20	conj	_	_
32	apoptosis	_	NN	NN	_	31	dobj	_	_
33	.	_	.	.	_	20	punct	_	_

1	Indeed	_	RB	RB	_	9	advmod	_	_
2	,	_	,	,	_	9	punct	_	_
3	IL-10	_	NN	NN	_	9	nsubj	_	_
4	,	_	,	,	_	3	punct	_	_
5	like	_	IN	IN	_	9	prep	_	_
6	IFN-gamma	_	NN	NN	_	5	pobj	_	_
7	,	_	,	,	_	9	punct	_	_
8	was	_	VBD	VBD	_	9	cop	_	_
9	able	_	JJ	JJ	_	0	root	_	_
10	to	_	TO	TO	_	12	aux	_	_
11	significantly	_	RB	RB	_	12	advmod	_	_
12	reduce	_	VB	VB	_	9	xcomp	_	_
13	the	_	DT	DT	_	14	det	_	_
14	amount	_	NN	NN	_	12	dobj	_	_
15	of	_	IN	IN	_	14	prep	_	_
16	B-CLL	_	NN	NN	_	18	nn	_	_
17	cell	_	NN	NN	_	18	nn	_	_
18	death	_	NN	NN	_	15	pobj	_	_
19	caused	_	VBN	VBN	_	18	vmod	_	_
20	by	_	IN	IN	_	19	prep	_	_
21	hydrocortisone-induced	_	JJ	JJ	_	22	amod	_	_
22	apoptosis	_	NN	NN	_	20	pobj	_	_
23	.	_	.	.	_	9	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	conclude	_	VBP	VBP	_	0	root	_	_
3	that	_	IN	IN	_	15	mark	_	_
4	cytokines	_	NNS	NNS	_	15	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	which	_	WDT	WDT	_	7	nsubj	_	_
7	signal	_	VBP	VBP	_	4	rcmod	_	_
8	through	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	11	det	_	_
10	interferon	_	NN	NN	_	11	nn	_	_
11	family	_	NN	NN	_	8	pobj	_	_
12	of	_	IN	IN	_	11	prep	_	_
13	receptors	_	NNS	NNS	_	12	pobj	_	_
14	,	_	,	,	_	4	punct	_	_
15	have	_	VBP	VBP	_	2	ccomp	_	_
16	comparable	_	JJ	JJ	_	17	amod	_	_
17	functional	_	JJ	JJ	_	18	amod	_	_
18	effects	_	NNS	NNS	_	15	dobj	_	_
19	on	_	IN	IN	_	15	prep	_	_
20	B-CLL	_	NN	NN	_	21	nn	_	_
21	cells	_	NNS	NNS	_	19	pobj	_	_
22	.	_	.	.	_	2	punct	_	_

1	An	_	DT	DT	_	3	det	_	_
2	isotype-specific	_	JJ	JJ	_	3	amod	_	_
3	activator	_	NN	NN	_	0	root	_	_
4	of	_	IN	IN	_	3	prep	_	_
5	major	_	JJ	JJ	_	13	amod	_	_
6	histocompatibility	_	NN	NN	_	13	nn	_	_
7	complex	_	NN	NN	_	13	nn	_	_
8	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
9	MHC	_	NN	NN	_	13	nn	_	_
10	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
11	class	_	NN	NN	_	13	nn	_	_
12	II	_	CD	CD	_	13	num	_	_
13	genes	_	NNS	NNS	_	4	pobj	_	_
14	that	_	WDT	WDT	_	16	nsubj	_	_
15	is	_	VBZ	VBZ	_	16	cop	_	_
16	independent	_	JJ	JJ	_	3	rcmod	_	_
17	of	_	IN	IN	_	16	prep	_	_
18	class	_	NN	NN	_	20	nn	_	_
19	II	_	CD	CD	_	20	num	_	_
20	transactivator	_	NN	NN	_	17	pobj	_	_
21	.	_	.	.	_	3	punct	_	_

1	Patients	_	NNS	NNS	_	13	nsubj	_	_
2	with	_	IN	IN	_	1	prep	_	_
3	one	_	CD	CD	_	4	num	_	_
4	type	_	NN	NN	_	2	pobj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	major	_	JJ	JJ	_	9	amod	_	_
7	histocompatibility	_	NN	NN	_	9	nn	_	_
8	complex	_	NN	NN	_	9	nn	_	_
9	class	_	NN	NN	_	12	nn	_	_
10	II	_	CD	CD	_	9	num	_	_
11	combined	_	JJ	JJ	_	12	amod	_	_
12	immunodeficiency	_	NN	NN	_	5	pobj	_	_
13	have	_	VBP	VBP	_	0	root	_	_
14	mutations	_	NNS	NNS	_	13	dobj	_	_
15	in	_	IN	IN	_	13	prep	_	_
16	a	_	DT	DT	_	17	det	_	_
17	gene	_	NN	NN	_	15	pobj	_	_
18	termed	_	VBN	VBN	_	17	vmod	_	_
19	class	_	NN	NN	_	21	nn	_	_
20	II	_	CD	CD	_	21	num	_	_
21	transactivator	_	NN	NN	_	18	dep	_	_
22	-LRB-	_	-LRB-	-LRB-	_	23	punct	_	_
23	CIITA	_	NN	NN	_	21	appos	_	_
24	-RRB-	_	-RRB-	-RRB-	_	23	punct	_	_
25	,	_	,	,	_	21	punct	_	_
26	which	_	WDT	WDT	_	28	nsubj	_	_
27	coordinately	_	RB	RB	_	28	advmod	_	_
28	controls	_	VBZ	VBZ	_	21	rcmod	_	_
29	the	_	DT	DT	_	30	det	_	_
30	transcription	_	NN	NN	_	28	dobj	_	_
31	of	_	IN	IN	_	30	prep	_	_
32	the	_	DT	DT	_	38	det	_	_
33	three	_	CD	CD	_	38	num	_	_
34	major	_	JJ	JJ	_	38	amod	_	_
35	human	_	JJ	JJ	_	38	amod	_	_
36	class	_	NN	NN	_	38	nn	_	_
37	II	_	CD	CD	_	38	num	_	_
38	genes	_	NNS	NNS	_	31	pobj	_	_
39	,	_	,	,	_	38	punct	_	_
40	HLA-DR	_	NN	NN	_	38	appos	_	_
41	,	_	,	,	_	40	punct	_	_
42	-DQ	_	NN	NN	_	40	conj	_	_
43	,	_	,	,	_	40	punct	_	_
44	and	_	CC	CC	_	40	cc	_	_
45	-DP	_	NN	NN	_	40	conj	_	_
46	.	_	.	.	_	13	punct	_	_

1	However	_	RB	RB	_	13	advmod	_	_
2	,	_	,	,	_	13	punct	_	_
3	the	_	DT	DT	_	8	det	_	_
4	experimentally	_	RB	RB	_	5	advmod	_	_
5	derived	_	VBN	VBN	_	8	amod	_	_
6	B-lymphoblastoid	_	JJ	JJ	_	8	amod	_	_
7	cell	_	NN	NN	_	8	nn	_	_
8	line	_	NN	NN	_	13	nsubj	_	_
9	,	_	,	,	_	8	punct	_	_
10	clone	_	NN	NN	_	8	appos	_	_
11	13	_	CD	CD	_	10	num	_	_
12	,	_	,	,	_	8	punct	_	_
13	expresses	_	VBZ	VBZ	_	0	root	_	_
14	high	_	JJ	JJ	_	15	amod	_	_
15	levels	_	NNS	NNS	_	13	dobj	_	_
16	of	_	IN	IN	_	15	prep	_	_
17	HLADQ	_	NN	NN	_	16	pobj	_	_
18	in	_	IN	IN	_	13	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	absence	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	HLA-DR	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	22	cc	_	_
24	HLA-DP	_	NN	NN	_	22	conj	_	_
25	,	_	,	,	_	13	punct	_	_
26	despite	_	IN	IN	_	13	prep	_	_
27	its	_	PRP$	PRP$	_	28	poss	_	_
28	mapping	_	NN	NN	_	26	pobj	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	complementation	_	NN	NN	_	31	nn	_	_
31	analysis	_	NN	NN	_	29	pobj	_	_
32	to	_	TO	TO	_	28	prep	_	_
33	this	_	DT	DT	_	34	det	_	_
34	group	_	NN	NN	_	32	pobj	_	_
35	.	_	.	.	_	13	punct	_	_

1	It	_	PRP	PRP	_	3	nsubj	_	_
2	was	_	VBD	VBD	_	3	cop	_	_
3	possible	_	JJ	JJ	_	0	root	_	_
4	that	_	IN	IN	_	12	mark	_	_
5	one	_	CD	CD	_	12	nsubj	_	_
6	of	_	IN	IN	_	5	prep	_	_
7	the	_	DT	DT	_	11	det	_	_
8	clone	_	NN	NN	_	11	nn	_	_
9	13	_	CD	CD	_	11	num	_	_
10	CIITA	_	NN	NN	_	11	nn	_	_
11	alleles	_	NNS	NNS	_	6	pobj	_	_
12	bore	_	VBP	VBP	_	3	ccomp	_	_
13	a	_	DT	DT	_	14	det	_	_
14	mutation	_	NN	NN	_	12	dobj	_	_
15	that	_	WDT	WDT	_	16	nsubj	_	_
16	allowed	_	VBD	VBD	_	14	rcmod	_	_
17	HLA-DQ	_	NN	NN	_	16	dobj	_	_
18	,	_	,	,	_	17	punct	_	_
19	but	_	CC	CC	_	17	cc	_	_
20	not	_	RB	RB	_	21	neg	_	_
21	HLA-DR	_	NN	NN	_	17	conj	_	_
22	or	_	CC	CC	_	21	cc	_	_
23	-DP	_	NN	NN	_	21	conj	_	_
24	transcription	_	NN	NN	_	21	dep	_	_
25	.	_	.	.	_	3	punct	_	_

1	Alternatively	_	RB	RB	_	11	advmod	_	_
2	,	_	,	,	_	11	punct	_	_
3	another	_	DT	DT	_	4	det	_	_
4	factor	_	NN	NN	_	11	nsubj	_	_
5	,	_	,	,	_	4	punct	_	_
6	distinct	_	JJ	JJ	_	4	amod	_	_
7	from	_	IN	IN	_	6	prep	_	_
8	CIITA	_	NN	NN	_	7	pobj	_	_
9	,	_	,	,	_	4	punct	_	_
10	might	_	MD	MD	_	11	aux	_	_
11	control	_	VB	VB	_	0	root	_	_
12	HLA-DQ	_	NN	NN	_	13	nn	_	_
13	expression	_	NN	NN	_	11	dobj	_	_
14	.	_	.	.	_	11	punct	_	_

1	We	_	PRP	PRP	_	2	nsubj	_	_
2	report	_	VBP	VBP	_	0	root	_	_
3	here	_	RB	RB	_	2	advmod	_	_
4	that	_	IN	IN	_	22	mark	_	_
5	ectopic	_	JJ	JJ	_	6	amod	_	_
6	expression	_	NN	NN	_	22	nsubj	_	_
7	of	_	IN	IN	_	6	prep	_	_
8	CIITA	_	NN	NN	_	9	nn	_	_
9	cDNAs	_	NNS	NNS	_	7	pobj	_	_
10	derived	_	VBN	VBN	_	9	vmod	_	_
11	by	_	IN	IN	_	10	prep	_	_
12	reverse	_	JJ	JJ	_	16	amod	_	_
13	transcriptase	_	NN	NN	_	16	nn	_	_
14	polymerase	_	NN	NN	_	16	nn	_	_
15	chain	_	NN	NN	_	16	nn	_	_
16	reaction	_	NN	NN	_	11	pobj	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	clone	_	NN	NN	_	17	pobj	_	_
19	13	_	CD	CD	_	18	num	_	_
20	do	_	VBP	VBP	_	22	aux	_	_
21	not	_	RB	RB	_	22	neg	_	_
22	restore	_	VB	VB	_	2	ccomp	_	_
23	expression	_	NN	NN	_	22	dobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	HLA-DQ	_	NN	NN	_	24	pobj	_	_
26	in	_	IN	IN	_	22	prep	_	_
27	another	_	DT	DT	_	30	det	_	_
28	CIITA-deficient	_	JJ	JJ	_	30	amod	_	_
29	cell	_	NN	NN	_	30	nn	_	_
30	line	_	NN	NN	_	26	pobj	_	_
31	,	_	,	,	_	30	punct	_	_
32	RJ2.2.5	_	NN	NN	_	30	appos	_	_
33	.	_	.	.	_	2	punct	_	_

1	In	_	IN	IN	_	8	prep	_	_
2	addition	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	8	punct	_	_
4	no	_	DT	DT	_	6	neg	_	_
5	CIITA	_	NN	NN	_	6	nn	_	_
6	protein	_	NN	NN	_	8	nsubj	_	_
7	is	_	VBZ	VBZ	_	8	cop	_	_
8	detectable	_	JJ	JJ	_	0	root	_	_
9	in	_	IN	IN	_	8	prep	_	_
10	clone	_	NN	NN	_	13	nn	_	_
11	13	_	CD	CD	_	10	num	_	_
12	nuclear	_	JJ	JJ	_	13	amod	_	_
13	extracts	_	NNS	NNS	_	9	pobj	_	_
14	.	_	.	.	_	8	punct	_	_

1	In	_	IN	IN	_	12	prep	_	_
2	contrast	_	NN	NN	_	1	pobj	_	_
3	,	_	,	,	_	12	punct	_	_
4	somatic	_	JJ	JJ	_	6	amod	_	_
5	cell	_	NN	NN	_	6	nn	_	_
6	fusion	_	NN	NN	_	12	nsubj	_	_
7	between	_	IN	IN	_	6	prep	_	_
8	clone	_	NN	NN	_	7	pobj	_	_
9	13	_	CD	CD	_	8	num	_	_
10	and	_	CC	CC	_	8	cc	_	_
11	RJ2.2.5	_	NN	NN	_	8	conj	_	_
12	restored	_	VBD	VBD	_	0	root	_	_
13	expression	_	NN	NN	_	12	dobj	_	_
14	of	_	IN	IN	_	13	prep	_	_
15	the	_	DT	DT	_	17	det	_	_
16	HLA-DQ	_	NN	NN	_	17	nn	_	_
17	haplotype	_	NN	NN	_	14	pobj	_	_
18	encoded	_	VBN	VBN	_	17	vmod	_	_
19	by	_	IN	IN	_	18	prep	_	_
20	the	_	DT	DT	_	23	det	_	_
21	RJ2.2.5	_	NN	NN	_	23	nn	_	_
22	DQB	_	NN	NN	_	23	nn	_	_
23	gene	_	NN	NN	_	19	pobj	_	_
24	.	_	.	.	_	12	punct	_	_

1	Taken	_	VBN	VBN	_	0	root	_	_
2	together	_	RB	RB	_	1	advmod	_	_
3	,	_	,	,	_	1	punct	_	_
4	these	_	DT	DT	_	5	det	_	_
5	data	_	NNS	NNS	_	6	nsubj	_	_
6	demonstrate	_	VBP	VBP	_	1	parataxis	_	_
7	the	_	DT	DT	_	8	det	_	_
8	existence	_	NN	NN	_	6	dobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	an	_	DT	DT	_	14	det	_	_
11	HLA-DQ	_	NN	NN	_	14	nn	_	_
12	isotype-specific	_	JJ	JJ	_	14	amod	_	_
13	trans-acting	_	JJ	JJ	_	14	amod	_	_
14	factor	_	NN	NN	_	9	pobj	_	_
15	,	_	,	,	_	14	punct	_	_
16	which	_	WDT	WDT	_	17	nsubj	_	_
17	functions	_	VBZ	VBZ	_	14	rcmod	_	_
18	independently	_	RB	RB	_	17	advmod	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	CIITA	_	NN	NN	_	19	pobj	_	_
21	.	_	.	.	_	1	punct	_	_

1	Uncoupling	_	NN	NN	_	0	root	_	_
2	of	_	IN	IN	_	1	prep	_	_
3	cell	_	NN	NN	_	5	nn	_	_
4	cycle	_	NN	NN	_	5	nn	_	_
5	arrest	_	NN	NN	_	2	pobj	_	_
6	from	_	IN	IN	_	1	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	expression	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	monocytic	_	JJ	JJ	_	12	amod	_	_
11	differentiation	_	NN	NN	_	12	nn	_	_
12	markers	_	NNS	NNS	_	9	pobj	_	_
13	in	_	IN	IN	_	8	prep	_	_
14	HL60	_	NN	NN	_	16	nn	_	_
15	cell	_	NN	NN	_	16	nn	_	_
16	variants	_	NNS	NNS	_	13	pobj	_	_
17	.	_	.	.	_	1	punct	_	_

1	Differentiation	_	NN	NN	_	3	nsubj	_	_
2	generally	_	RB	RB	_	3	advmod	_	_
3	leads	_	VBZ	VBZ	_	0	root	_	_
4	to	_	TO	TO	_	3	prep	_	_
5	cell	_	NN	NN	_	7	nn	_	_
6	cycle	_	NN	NN	_	7	nn	_	_
7	arrest	_	NN	NN	_	4	pobj	_	_
8	.	_	.	.	_	3	punct	_	_

1	Human	_	JJ	JJ	_	4	amod	_	_
2	leukemia	_	NN	NN	_	4	nn	_	_
3	HL60	_	NN	NN	_	4	nn	_	_
4	cells	_	NNS	NNS	_	5	nsubj	_	_
5	respond	_	VBP	VBP	_	0	root	_	_
6	to	_	TO	TO	_	5	prep	_	_
7	the	_	DT	DT	_	8	det	_	_
8	presence	_	NN	NN	_	6	pobj	_	_
9	of	_	IN	IN	_	8	prep	_	_
10	1,25-dihydroxyvitamin	_	NN	NN	_	11	nn	_	_
11	D3	_	NN	NN	_	9	pobj	_	_
12	-LRB-	_	-LRB-	-LRB-	_	13	punct	_	_
13	1,25D3	_	NN	NN	_	11	appos	_	_
14	-RRB-	_	-RRB-	-RRB-	_	13	punct	_	_
15	by	_	IN	IN	_	5	prep	_	_
16	expressing	_	VBG	VBG	_	15	pcomp	_	_
17	a	_	DT	DT	_	18	det	_	_
18	number	_	NN	NN	_	16	dobj	_	_
19	of	_	IN	IN	_	18	prep	_	_
20	markers	_	NNS	NNS	_	19	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	the	_	DT	DT	_	24	det	_	_
23	monocyte/macrophage	_	NN	NN	_	24	nn	_	_
24	phenotype	_	NN	NN	_	21	pobj	_	_
25	and	_	CC	CC	_	5	cc	_	_
26	become	_	VBP	VBP	_	5	conj	_	_
27	arrested	_	VBN	VBN	_	26	acomp	_	_
28	predominantly	_	RB	RB	_	29	advmod	_	_
29	in	_	IN	IN	_	27	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	G1	_	NN	NN	_	32	nn	_	_
32	phase	_	NN	NN	_	29	pobj	_	_
33	of	_	IN	IN	_	32	prep	_	_
34	the	_	DT	DT	_	36	det	_	_
35	cell	_	NN	NN	_	36	nn	_	_
36	cycle	_	NN	NN	_	33	pobj	_	_
37	.	_	.	.	_	5	punct	_	_

1	We	_	PRP	PRP	_	4	nsubj	_	_
2	have	_	VBP	VBP	_	4	aux	_	_
3	recently	_	RB	RB	_	4	advmod	_	_
4	reported	_	VBN	VBN	_	0	root	_	_
5	a	_	DT	DT	_	8	det	_	_
6	series	_	NN	NN	_	8	nn	_	_
7	-LRB-	_	-LRB-	-LRB-	_	8	punct	_	_
8	A	_	NN	NN	_	4	dobj	_	_
9	-RRB-	_	-RRB-	-RRB-	_	8	punct	_	_
10	of	_	IN	IN	_	8	prep	_	_
11	1,25D3-resistant	_	JJ	JJ	_	12	amod	_	_
12	variants	_	NNS	NNS	_	10	pobj	_	_
13	of	_	IN	IN	_	12	prep	_	_
14	HL60	_	NN	NN	_	15	nn	_	_
15	cells	_	NNS	NNS	_	13	pobj	_	_
16	which	_	WDT	WDT	_	17	nsubj	_	_
17	proliferate	_	VBP	VBP	_	12	rcmod	_	_
18	in	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	presence	_	NN	NN	_	18	pobj	_	_
21	of	_	IN	IN	_	20	prep	_	_
22	1,25D3	_	NN	NN	_	21	pobj	_	_
23	and	_	CC	CC	_	17	cc	_	_
24	do	_	VBP	VBP	_	26	aux	_	_
25	not	_	RB	RB	_	26	neg	_	_
26	express	_	VB	VB	_	17	conj	_	_
27	differentiation	_	NN	NN	_	28	nn	_	_
28	markers	_	NNS	NNS	_	26	dobj	_	_
29	-LRB-	_	-LRB-	-LRB-	_	32	punct	_	_
30	Exp.	_	NNP	NNP	_	32	nn	_	_
31	Cell	_	NNP	NNP	_	32	nn	_	_
32	Res.	_	NNP	NNP	_	4	dep	_	_
33	224	_	CD	CD	_	35	num	_	_
34	,	_	,	,	_	35	punct	_	_
35	312	_	CD	CD	_	32	dep	_	_
36	,	_	,	,	_	32	punct	_	_
37	1996	_	CD	CD	_	32	amod	_	_
38	-RRB-	_	-RRB-	-RRB-	_	32	punct	_	_
39	.	_	.	.	_	4	punct	_	_

1	We	_	PRP	PRP	_	3	nsubj	_	_
2	now	_	RB	RB	_	3	advmod	_	_
3	describe	_	VBP	VBP	_	0	root	_	_
4	another	_	DT	DT	_	7	det	_	_
5	series	_	NN	NN	_	7	nn	_	_
6	-LRB-	_	-LRB-	-LRB-	_	7	punct	_	_
7	B	_	NN	NN	_	3	dobj	_	_
8	-RRB-	_	-RRB-	-RRB-	_	7	punct	_	_
9	of	_	IN	IN	_	7	prep	_	_
10	such	_	JJ	JJ	_	11	amod	_	_
11	variants	_	NNS	NNS	_	9	pobj	_	_
12	,	_	,	,	_	7	punct	_	_
13	which	_	WDT	WDT	_	14	nsubj	_	_
14	differ	_	VBP	VBP	_	7	rcmod	_	_
15	from	_	IN	IN	_	14	prep	_	_
16	A	_	NN	NN	_	18	nn	_	_
17	series	_	NN	NN	_	18	nn	_	_
18	cells	_	NNS	NNS	_	15	pobj	_	_
19	grown	_	VBN	VBN	_	18	vmod	_	_
20	in	_	IN	IN	_	19	prep	_	_
21	similar	_	JJ	JJ	_	22	amod	_	_
22	concentrations	_	NNS	NNS	_	20	pobj	_	_
23	of	_	IN	IN	_	22	prep	_	_
24	1,25D3	_	NN	NN	_	23	pobj	_	_
25	in	_	IN	IN	_	14	prep	_	_
26	that	_	IN	IN	_	28	mark	_	_
27	they	_	PRP	PRP	_	28	nsubj	_	_
28	express	_	VBP	VBP	_	25	pcomp	_	_
29	the	_	DT	DT	_	31	det	_	_
30	CD14	_	NN	NN	_	31	nn	_	_
31	antigen	_	NN	NN	_	28	dobj	_	_
32	and	_	CC	CC	_	31	cc	_	_
33	nonspecific	_	JJ	JJ	_	34	amod	_	_
34	esterase	_	NN	NN	_	31	conj	_	_
35	,	_	,	,	_	28	punct	_	_
36	characteristic	_	JJ	JJ	_	28	advmod	_	_
37	of	_	IN	IN	_	36	prep	_	_
38	the	_	DT	DT	_	39	det	_	_
39	monocyte	_	NN	NN	_	37	pobj	_	_
40	,	_	,	,	_	28	punct	_	_
41	while	_	IN	IN	_	42	mark	_	_
42	continuing	_	VBG	VBG	_	28	advcl	_	_
43	to	_	TO	TO	_	42	xcomp	_	_
44	proliferate	_	NN	NN	_	43	dobj	_	_
45	and	_	CC	CC	_	28	cc	_	_
46	they	_	PRP	PRP	_	47	nsubj	_	_
47	develop	_	VBP	VBP	_	28	conj	_	_
48	hypotetraploid	_	JJ	JJ	_	49	amod	_	_
49	DNA	_	NN	NN	_	53	nn	_	_
50	-LRB-	_	-LRB-	-LRB-	_	51	punct	_	_
51	4C	_	NN	NN	_	49	appos	_	_
52	-RRB-	_	-RRB-	-RRB-	_	51	punct	_	_
53	content	_	NN	NN	_	47	dobj	_	_
54	at	_	IN	IN	_	47	prep	_	_
55	higher	_	JJR	JJR	_	56	amod	_	_
56	concentrations	_	NNS	NNS	_	54	pobj	_	_
57	of	_	IN	IN	_	56	prep	_	_
58	ambient	_	JJ	JJ	_	59	amod	_	_
59	1,25D3	_	NN	NN	_	57	pobj	_	_
60	than	_	IN	IN	_	56	prep	_	_
61	the	_	DT	DT	_	64	det	_	_
62	A	_	NN	NN	_	64	nn	_	_
63	series	_	NN	NN	_	64	nn	_	_
64	cells	_	NNS	NNS	_	60	pobj	_	_
65	.	_	.	.	_	3	punct	_	_

1	Cells	_	NNS	NNS	_	16	nsubj	_	_
2	in	_	IN	IN	_	1	prep	_	_
3	the	_	DT	DT	_	5	det	_	_
4	B	_	NN	NN	_	5	nn	_	_
5	series	_	NN	NN	_	2	pobj	_	_
6	with	_	IN	IN	_	1	prep	_	_
7	4C	_	NN	NN	_	9	nn	_	_
8	DNA	_	NN	NN	_	9	nn	_	_
9	content	_	NN	NN	_	6	pobj	_	_
10	-LRB-	_	-LRB-	-LRB-	_	11	punct	_	_
11	100B	_	NN	NN	_	9	dep	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	200B	_	NN	NN	_	11	conj	_	_
14	-RRB-	_	-RRB-	-RRB-	_	11	punct	_	_
15	also	_	RB	RB	_	16	advmod	_	_
16	differed	_	VBD	VBD	_	0	root	_	_
17	from	_	IN	IN	_	16	prep	_	_
18	the	_	DT	DT	_	22	det	_	_
19	A	_	NN	NN	_	22	nn	_	_
20	series	_	NN	NN	_	22	nn	_	_
21	4C	_	NN	NN	_	22	nn	_	_
22	cells	_	NNS	NNS	_	17	pobj	_	_
23	by	_	IN	IN	_	16	prep	_	_
24	the	_	DT	DT	_	25	det	_	_
25	absence	_	NN	NN	_	23	pobj	_	_
26	of	_	IN	IN	_	25	prep	_	_
27	DNA	_	NN	NN	_	28	nn	_	_
28	binding	_	NN	NN	_	26	pobj	_	_
29	by	_	IN	IN	_	28	prep	_	_
30	the	_	DT	DT	_	32	det	_	_
31	full-length	_	JJ	JJ	_	32	amod	_	_
32	Sp1	_	NN	NN	_	29	pobj	_	_
33	transcription	_	NN	NN	_	34	nn	_	_
34	factor	_	NN	NN	_	32	dep	_	_
35	.	_	.	.	_	16	punct	_	_

1	However	_	RB	RB	_	6	advmod	_	_
2	,	_	,	,	_	6	punct	_	_
3	B	_	NN	NN	_	5	nn	_	_
4	series	_	NN	NN	_	5	nn	_	_
5	cells	_	NNS	NNS	_	6	nsubj	_	_
6	resembled	_	VBD	VBD	_	0	root	_	_
7	the	_	DT	DT	_	10	det	_	_
8	A	_	NN	NN	_	10	nn	_	_
9	series	_	NN	NN	_	10	nn	_	_
10	cells	_	NNS	NNS	_	6	xcomp	_	_
11	in	_	IN	IN	_	6	prep	_	_
12	exhibiting	_	VBG	VBG	_	11	pcomp	_	_
13	faster	_	JJR	JJR	_	15	amod	_	_
14	growth	_	NN	NN	_	15	nn	_	_
15	rates	_	NNS	NNS	_	12	dobj	_	_
16	than	_	IN	IN	_	20	mark	_	_
17	the	_	DT	DT	_	20	det	_	_
18	parental	_	JJ	JJ	_	20	amod	_	_
19	HL60	_	NN	NN	_	20	nn	_	_
20	cells	_	NNS	NNS	_	15	dep	_	_
21	and	_	CC	CC	_	6	cc	_	_
22	showed	_	VBD	VBD	_	6	conj	_	_
23	high	_	JJ	JJ	_	24	amod	_	_
24	levels	_	NNS	NNS	_	22	dobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	vitamin	_	NN	NN	_	28	nn	_	_
27	D	_	NN	NN	_	28	nn	_	_
28	receptor	_	NN	NN	_	25	pobj	_	_
29	and	_	CC	CC	_	28	cc	_	_
30	retinoid	_	NN	NN	_	33	nn	_	_
31	receptor	_	NN	NN	_	33	nn	_	_
32	X	_	NN	NN	_	33	nn	_	_
33	proteins	_	NNS	NNS	_	28	conj	_	_
34	.	_	.	.	_	6	punct	_	_

1	These	_	DT	DT	_	2	det	_	_
2	results	_	NNS	NNS	_	3	nsubj	_	_
3	show	_	VBP	VBP	_	0	root	_	_
4	that	_	IN	IN	_	14	mark	_	_
5	the	_	DT	DT	_	7	det	_	_
6	initial	_	JJ	JJ	_	7	amod	_	_
7	steps	_	NNS	NNS	_	14	nsubj	_	_
8	in	_	IN	IN	_	7	prep	_	_
9	the	_	DT	DT	_	12	det	_	_
10	1,25D3	_	NN	NN	_	12	nn	_	_
11	signaling	_	NN	NN	_	12	nn	_	_
12	pathway	_	NN	NN	_	8	pobj	_	_
13	are	_	VBP	VBP	_	14	cop	_	_
14	intact	_	JJ	JJ	_	3	ccomp	_	_
15	in	_	IN	IN	_	14	prep	_	_
16	B	_	NN	NN	_	19	nn	_	_
17	series	_	NNS	NNS	_	19	nn	_	_
18	resistant	_	JJ	JJ	_	19	amod	_	_
19	cells	_	NNS	NNS	_	15	pobj	_	_
20	and	_	CC	CC	_	14	cc	_	_
21	lead	_	VBP	VBP	_	14	conj	_	_
22	to	_	TO	TO	_	21	prep	_	_
23	the	_	DT	DT	_	24	det	_	_
24	appearance	_	NN	NN	_	22	pobj	_	_
25	of	_	IN	IN	_	24	prep	_	_
26	early	_	JJ	JJ	_	27	amod	_	_
27	markers	_	NNS	NNS	_	25	pobj	_	_
28	of	_	IN	IN	_	27	prep	_	_
29	monocytic	_	JJ	JJ	_	30	amod	_	_
30	differentiation	_	NN	NN	_	28	pobj	_	_
31	.	_	.	.	_	3	punct	_	_

1	However	_	RB	RB	_	17	advmod	_	_
2	,	_	,	,	_	17	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	progression	_	NN	NN	_	17	nsubjpass	_	_
5	to	_	TO	TO	_	4	prep	_	_
6	subsequent	_	JJ	JJ	_	7	amod	_	_
7	events	_	NNS	NNS	_	5	pobj	_	_
8	which	_	WDT	WDT	_	9	nsubj	_	_
9	comprise	_	VBP	VBP	_	7	rcmod	_	_
10	terminal	_	JJ	JJ	_	11	amod	_	_
11	differentiation	_	NN	NN	_	9	dobj	_	_
12	and	_	CC	CC	_	11	cc	_	_
13	cell	_	NN	NN	_	15	nn	_	_
14	cycle	_	NN	NN	_	15	nn	_	_
15	arrest	_	NN	NN	_	11	conj	_	_
16	is	_	VBZ	VBZ	_	17	auxpass	_	_
17	halted	_	VBN	VBN	_	0	root	_	_
18	during	_	IN	IN	_	17	prep	_	_
19	the	_	DT	DT	_	20	det	_	_
20	adaptation	_	NN	NN	_	18	pobj	_	_
21	to	_	TO	TO	_	20	prep	_	_
22	the	_	DT	DT	_	23	det	_	_
23	presence	_	NN	NN	_	21	pobj	_	_
24	of	_	IN	IN	_	23	prep	_	_
25	1,25D3	_	NN	NN	_	24	pobj	_	_
26	in	_	IN	IN	_	23	prep	_	_
27	these	_	DT	DT	_	28	det	_	_
28	cells	_	NNS	NNS	_	26	pobj	_	_
29	.	_	.	.	_	17	punct	_	_

1	Thus	_	RB	RB	_	10	advmod	_	_
2	,	_	,	,	_	10	punct	_	_
3	the	_	DT	DT	_	4	det	_	_
4	availability	_	NN	NN	_	10	nsubj	_	_
5	of	_	IN	IN	_	4	prep	_	_
6	these	_	DT	DT	_	8	det	_	_
7	variant	_	JJ	JJ	_	8	amod	_	_
8	cells	_	NNS	NNS	_	5	pobj	_	_
9	should	_	MD	MD	_	10	aux	_	_
10	provide	_	VB	VB	_	0	root	_	_
11	a	_	DT	DT	_	12	det	_	_
12	system	_	NN	NN	_	10	dobj	_	_
13	for	_	IN	IN	_	12	prep	_	_
14	studying	_	VBG	VBG	_	13	pcomp	_	_
15	the	_	DT	DT	_	16	det	_	_
16	link	_	NN	NN	_	14	dobj	_	_
17	between	_	IN	IN	_	16	prep	_	_
18	differentiation	_	NN	NN	_	17	pobj	_	_
19	and	_	CC	CC	_	18	cc	_	_
20	cell	_	NN	NN	_	22	nn	_	_
21	cycle	_	NN	NN	_	22	nn	_	_
22	arrest	_	NN	NN	_	18	conj	_	_
23	.	_	.	.	_	10	punct	_	_

